Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 3.4.21.120 - oviductin

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Abetalipoproteinemia
Keys to overcoming the challenge of diagnosing autosomal recessive spinocerebellar ataxia.
Abnormalities, Multiple
Fetal echogenic bowel: parameters to be considered in differential diagnosis.
Abortion, Missed
Maternal plasma alpha-feto-protein in missed abortion.
Abortion, Spontaneous
Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
Alpha-fetoprotein (AFP) levels in maternal serum in 115 patients with spontaneous abortion.
Alpha-fetoprotein levels in amniotic fluids from spontaneous abortions.
Low VEGF expression in conceptus material and maternal serum AFP and ?-hCG levels as indicators of defective angiogenesis in first-trimester miscarriages.
Maternal serum alpha-fetoprotein and spontaneous abortion.
Miscarriage determination in first trimester based on alpha-fetoprotein extracted from sanitary pads.
Placental lakes, absent umbilical artery diastolic flow and poor fetal growth in early pregnancy.
Randomised controlled trial of genetic amniocentesis in 4606 low-risk women.
Ratio of immunochemically determined amniotic fluid acetylcholinesterase to butyrylcholinesterase in the differential diagnosis of fetal abnormalities.
Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy.
Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome.
Study of the relationship between elevated maternal serum alpha-fetoprotein and adverse pregnancy outcome.
[Discolored amniotic fluid--results of prenatal diagnosis and clinical significance]
Abortion, Threatened
Alpha-fetoprotein: a marker for threatened abortion.
Human placental lactogen, pregnancy-specific beta-1-glycoprotein and alpha-fetoprotein in serum in threatened abortion.
Maternal serum alpha-fetoprotein levels in anembryonic pregnancy.
Obstetric outcome after threatened miscarriage with and without a hematoma on ultrasound.
[Changes in the blood level of alpha-fetoprotein in threatened abortion]
Abruptio Placentae
Elevated maternal second-trimester serum alpha-fetoprotein as a risk factor for placental abruption.
Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes.
Malignant placental site trophoblastic tumor associated with placental abruption, fetal distress, and elevated CA-125.
Maternal serum alpha-fetoprotein in placental abruption associated with preterm labor.
Placental sonolucency and pregnancy outcome in women with elevated second trimester serum alpha-fetoprotein levels.
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data.
Second-trimester maternal serum alpha-fetoprotein (MSAFP) is elevated in women with adverse pregnancy outcome associated with inherited thrombophilias.
Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome.
The association of abnormal alpha-fetoprotein and adverse pregnancy outcome: does increased fetal surveillance affect pregnancy outcome?
Ultrasonically dense amniotic fluid in early pregnancy in asymptomatic women without vaginal bleeding. A report of two cases.
Abscess
[Hepatic actinomicosis: a case report in a diabetic patient.]
Acidosis, Lactic
[Giant placental angioma with polyhydramnios, high level of alpha-fetoprotein and neonatal congenital lactic acidosis]
[TRMU MUTATIONS - REVERSIBLE INFANTILE LIVER FAILURE OR MULTISYSTEM DISORDER?]
Acquired Immunodeficiency Syndrome
Defective uptake of alpha-fetoprotein (AFP) and transferrin (Tf) by PHA-activated peripheral blood lymphocytes from patients with AIDS and related syndromes.
Expression of alpha-fetoprotein and interleukin 2 receptors and impairment of membrane fluidity in peripheral blood mononuclear cells from AIDS and related syndromes.
[Prenatal diagnosis of Meckel-Gruber's syndrome by ultrasound (author's transl(]
Acromegaly
Hepatocellular carcinoma in a patient with acromegaly and high serum levels of insulin-like growth factor I: report of a case.
Acute-On-Chronic Liver Failure
Alpha-Fetoprotein as a Predictive Marker for Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure.
[Analysis of prognostic factors for patients with acute-on-chronic liver failure.]
[Role of resistin in inflammation of hepatocytes in nonalcoholic steatohepatitis.]
[Value of serum alpha-fetoprotein for the prognostic evaluation of hepatitis B virus-related acute-on-chronic liver failure treated with artificial liver].
acyl-coa dehydrogenase deficiency
Prenatal diagnosis of multiple acyl-CoA dehydrogenase deficiency: association with elevated alpha-fetoprotein and cystic renal changes.
Adenocarcinoma
18F-FDG PET/CT of Primary Mediastinal Hepatoid Adenocarcinoma.
A case of alpha-fetoprotein-producing adenocarcinoma of the endometrium with a hepatoid component as a potential source for alpha-fetoprotein in a postmenopausal woman.
A case of alpha-fetoprotein-producing esophageal adenocarcinoma.
A study on the lectin reactivity of alpha-fetoprotein produced by hepatoid adenocarcinomas and yolk sac tumors.
Advances in biological markers for cancer.
AFP-producing hepatoid adenocarcinoma in association with Barrett's esophagus with multiple liver metastasis responding to paclitaxel/CDDP: a case report.
AFP-producing hepatoid adenocarcinoma of the stomach: a case report.
Alpha fetoprotein producing gastric hepatoid adenocarcinoma.
Alpha-fetoprotein (AFP) elevation gastric adenocarcinoma and importance of AFP change in tumor response evaluation.
Alpha-fetoprotein (AFP)- and des-gamma-carboxy prothrombin (DCP)-producing adenocarcinoma of the stomach with liver metastasis in a patient with chronic hepatitis C.
Alpha-fetoprotein and carbohydrate antigen 19-9 producing advanced adenocarcinoma of renal pelvis and ureter.
Alpha-fetoprotein expressing metastastic adenocarcinoma of the esophago-gastric junction responding favorably to capecitabine and oxaliplatin.
Alpha-fetoprotein producing Barrett's esophageal adenocarcinoma: a case report.
Alpha-fetoprotein producing endometrial adenocarcinoma: report of a case.
Alpha-Fetoprotein Producing Gastric Adenocarcinoma in an Elderly Adult.
Alpha-fetoprotein producing uterine corpus carcinoma: A hepatoid adenocarcinoma of the endometrium.
Alpha-fetoprotein production by a hepatoid adenocarcinoma of the uterus.
Alpha-fetoprotein-producing adenocarcinoma in which the metastatic route was determined from calcified lesions.
Alpha-fetoprotein-producing adenocarcinoma of the sigmoid colon with possible hepatoid differentiation.
Alpha-fetoprotein-producing esophageal adenocarcinoma: a mimicker of hepatocellular carcinoma.
Alpha-fetoprotein-producing gastric carcinoma presenting focal hepatoid differentiation in metastatic lymph nodes.
Alpha-fetoprotein-producing hepatoid gastric adenocarcinoma in a child presenting with spontaneous gastric perforation.
Alpha-Fetoprotein-Producing Lung Hepatoid Adenocarcinoma with Brain Metastasis Treated with S-1.
An AFP-producing gastric carcinoma with features of hepatic differentiation. A case report.
An alpha-fetoprotein-producing hepatoid adenocarcinoma of the endometrium.
An Extremely Rare Presentation of an Alpha-Fetoprotein-Producing Esophageal Adenocarcinoma.
ANGPTL6-mediated angiogenesis promotes alpha fetoprotein-producing gastric cancer progression.
Atypical presentation of hepatocellular carcinoma.
Biochemical characterization of alpha-fetoprotein and other serum proteins produced by a uterine endometrial adenocarcinoma.
Carcinoma of the stomach with hepatocyte differentiation (hepatoid adenocarcinoma).
Carcinosarcoma of the uterine corpus with alpha-fetoprotein-producing hepatoid adenocarcinoma: a report of two cases.
Clear-Cell Adenocarcinoma of the Gallbladder with Alpha-Fetoprotein Production: A Case Report and Review of the Literature.
Clinical implications of alpha-fetoprotein expression in gastric adenocarcinoma.
Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases.
Colon cancer with a high serum alpha-fetoprotein level.
Comparative immunohistochemical study of primary and metastatic carcinomas of the liver.
Des-gamma-carboxy prothrombin (PIVKA-II) and alpha-fetoprotein-producing IIc-type early gastric cancer.
Diagnostic utility of Glut-1 and CA 15-3 in discriminating adenocarcinoma from hepatocellular carcinoma in liver tumors biopsied by fine-needle aspiration.
Diagnostic value of hepatocyte paraffin 1 antibody to discriminate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsies of the liver.
Distinct expression pattern of claudin-6, a primitive phenotypic tight junction molecule, in germ cell tumours and visceral carcinomas.
Education and Imaging. Gastrointestinal: brain metastasis of alpha-fetoprotein producing gastric adenocarcinoma.
Elevated serum alpha-fetoprotein in poorly differentiated adenocarcinoma with neuroendocrine differentiation of the ascending colon: a case report.
Esophageal adenocarcinoma with enteroblastic differentiation arising in ectopic gastric mucosa in the cervical esophagus: a case report and literature review.
Establishment and biological characterization of a novel cell line derived from hepatoid adenocarcinoma originated at the ampulla of Vater.
Expression of liver-enriched nuclear factors and their isoforms in alpha-fetoprotein-producing gastric carcinoma cells.
Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1.
Extensive portal tumor thrombi with portal hypertension in an autopsy case of intrahepatic cholangiocarcinoma.
Extremely high alpha-fetoprotein-producing adrenal hepatoid adenocarcinoma.
Extremely high expression of serum alpha-fetoprotein level of gastric adenocarcinoma: a rare case with an unexpected well-prognosis.
Fetal-type gastrointestinal adenocarcinoma: a morphologically distinct entity with unfavourable prognosis.
Forkhead box protein A2, a pioneer factor for hepatogenesis, is involved in the expression of hepatic phenotype of alpha-fetoprotein-producing adenocarcinoma.
Gastric adenocarcinoma with features of endodermal sinus tumor.
Gastric cancer with adenocarcinoma and yolk sac tumor components: A rare entity.
Gastric cancer with choriocarcinoma and yolk sac tumor components: case report.
Gastric choriocarcinoma admixed with an alpha-fetoprotein-producing adenocarcinoma and separated adenocarcinoma.
Gastric hepatoid adenocarcinoma and familial investigation: does it always produce alpha-fetoprotein?
Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature.
Hepatic carcinosarcoma with heterogeneous carcinomatous and sarcomatous elements: report of a case and review of the literature.
Hepatocellular carcinoma with direct invasion to the stomach.
Hepatoid adenocarcinoma in Barrett's esophagus associated with achalasia: first case report.
Hepatoid adenocarcinoma in the lung.
Hepatoid Adenocarcinoma of the Colon: What Should We Target?
Hepatoid adenocarcinoma of the endometrium associated with alpha-fetoprotein production.
Hepatoid adenocarcinoma of the gallbladder with production of alpha-fetoprotein.
Hepatoid adenocarcinoma of the gallbladder.
Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database.
Hepatoid adenocarcinoma of the peritoneal cavity: Prolonged survival after debulking surgery and 5-fluorouracil, leucovorin and oxaliplatin (FOLFOX) therapy.
Hepatoid adenocarcinoma of the renal pelvis producing alpha-fetoprotein of hepatic type and bile pigment.
Hepatoid adenocarcinoma of the stomach with liver metastasis mimicking hepatocellular carcinoma: a case report.
Hepatoid adenocarcinoma of the stomach. A clinicopathologic and immunohistochemical analysis.
Hepatoid adenocarcinoma of the stomach: an unusual case of elevated alpha-fetoprotein with prior treatment for hepatocellular carcinoma.
Hepatoid adenocarcinoma of the stomach: report of five cases and review of the literature.
Hepatoid adenocarcinoma: a new clinicopathological entity and the hypotheses on carcinogenesis.
HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates.
Heterotransplantation of ovarian serous adenocarcinoma with functioning stroma to nude mice. Disappearance of functioning stroma in transplanted tumor.
High-grade fetal adenocarcinoma of the lung with abnormal expression of alpha-fetoprotein in a female patient: Case report.
Immunohistochemical staining of hepatocellular carcinoma with monoclonal antibody against inhibin.
Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract.
In vitro model of suicide gene therapy for alpha-fetoprotein-producing gastric cancer.
Increased alpha-fetoprotein concentration in association with ileal adenocarcinoma complicating Crohn's disease.
Liver metastasis from hepatoid adenocarcinoma of the esophagus mimicking hepatocellular carcinoma.
Lung carcinoma with metastasis to testicular seminoma.
Malignant mixed Mullerian tumor of the uterine corpus with alpha-fetoprotein-producing hepatoid adenocarcinoma component.
Merged hepatopulmonary features in hepatoid adenocarcinoma of the lung: a systematic review.
Non-?-fetoprotein-producing adrenal hepatoid adenocarcinoma: A case report and literature review.
Oesophageal hepatoid carcinoma with liver metastasis, a diagnostic dilemma.
Ovarian clear cell adenocarcinoma producing alpha-fetoprotein: case report.
Primary adenocarcinoma of the female urethra with three histologic patterns and partial AFP positivity.
Primary gastric choriocarcinoma. Report of an autopsy case with immunohistochemical study.
Primary hepatocellular carcinoma and hepatoid adenocarcinoma of the stomach with liver metastasis: an unusual association.
Primary hepatoid adenocarcinoma of the uterine cervix.
Primary pulmonary hepatoid adenocarcinoma: A case report and review of the literature.
Protein profiling of alpha-fetoprotein producing gastric adenocarcinoma.
Pulmonary adenocarcinomas of the fetal lung type: a clinicopathologic study indicating differences in histology, epidemiology, and natural history of low-grade and high-grade forms.
Pure alpha-fetoprotein-producing neuroendocrine carcinoma of the pancreas: a case report.
Rectal adenocarcinoma with germ-cell differentiation: report of a case.
Review of the adenocarcinoma cell surface receptor for human alpha-fetoprotein; proposed identification of a widespread mucin as the tumor cell receptor.
Scintigraphic detection of breast cancer xenografts with Tc-99m natural and recombinant human alpha-fetoprotein.
Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma.
Synchronous presentation of hepatoid alpha-fetoprotein-producing lung cancer and colorectal adenocarcinoma.
The adenocarcinoma cell surface mucin receptor for alpha-fetoprotein: is the same receptor present on circulating monocytes and macrophages? A commentary.
The chemotherapy of metastatic gastric adenocarcinomas with hypersecretion of alpha-fetoprotein or beta-human chorionic gonadotrophin: report of two cases.
The Clinicopathological Characteristics of Alpha-Fetoprotein-Producing Adenocarcinoma of the Gastrointestinal Tract-A Single-Center Retrospective Study.
The HDAC Inhibitor, SAHA, Combined with Cisplatin Synergistically Induces Apoptosis in Alpha-fetoprotein-producing Hepatoid Adenocarcinoma Cells.
Tumor thrombus in the splenic vein originated from gastric carcinoma that produced alpha-fetoprotein.
Unique characteristics of rectal carcinoma cell lines derived from invasive carcinomas in ulcerative colitis patients.
Uptake of radiolabelled alpha-fetoprotein by experimental mammary adenocarcinoma and adenoma: in vivo and in vitro studies.
["Hepatoid" gastric tumor]
[A case of alpha-fetoprotein-producing female urethral adenocarcinoma].
[A case of hepatoid adenocarcinoma of the urinary bladder]
[A case of liver metastasis of gastric hepatoid adenocarcinoma]
[A case report of uterine carcinosarcoma with alpha-fetoprotein (AFP) production]
[Case of rectal cancer with high level of serum alpha-fetoprotein]
[Detection of serum p53 antibodies in colorectal cancer patients and the clinical significance of postoperative monitoring]
[Hepatoid adenocarcinoma of the lung with negative alpha-fetoprotein: a case report].
[Hepatoid adenocarcinoma of the stomach. Case report and review of the literature]
[Ovarian serous adenocarcinoma with functioning stroma and production of estrogen and alpha-fetoprotein]
[Studies on marker substances in cell lines derived from various human gynecologic tumors (author's transl)]
Adenocarcinoma of Lung
Alpha-fetoprotein-producing primary lung carcinoma: a case report.
Drebrin: A new oncofetal biomarker associated with prognosis of lung adenocarcinoma.
High-grade fetal adenocarcinoma of the lung with abnormal expression of alpha-fetoprotein in a female patient: Case report.
Primary pulmonary hepatoid adenocarcinoma: A case report and review of the literature.
Spontaneous hepatic rupture due to metastatic tumor of lung adenocarcinoma.
Adenocarcinoma, Clear Cell
Ovarian clear cell adenocarcinoma producing alpha-fetoprotein: case report.
Adenocarcinoma, Papillary
Alpha-fetoprotein-producing papillary adenocarcinoma originating from a uterine body. A case report.
Adenoma
A sequential study of methapyrilene hydrochloride-induced liver carcinogenesis in male F344 rats.
Hepatic adenoma and focal nodular hyperplasia.
Intrahepatic bile duct adenoma in a patient with chronic hepatitis B accompanied by elevation of alpha-fetoprotein.
Multicentric hepatocellular carcinoma following phosphate diethylstilbestrol therapy for prostatic cancer.
Uptake of radiolabelled alpha-fetoprotein by experimental mammary adenocarcinoma and adenoma: in vivo and in vitro studies.
Adenoma, Bile Duct
Intrahepatic bile duct adenoma in a patient with chronic hepatitis B accompanied by elevation of alpha-fetoprotein.
Adenoma, Islet Cell
Alpha-fetoprotein associated with islet cell tumors.
Hepatoid carcinoma of the pancreas.
Adenoma, Liver Cell
Focal nodular hyperplasia of the liver: pathological analysis of 11 cases.
Mouse hepatoblastomas: a histologic, ultrastructural, and immunohistochemical study.
Adrenal Insufficiency
Pituitary Dysfunction in Patients with Intracranial Germ Cell Tumors Treated with Radiotherapy.
Adrenocortical Carcinoma
Alpha-fetoprotein (AFP)-producing adrenocortical carcinoma - Long survival with various therapeutic strategies including a lung resection: Report of a case.
Amniotic Band Syndrome
A stillborn fetus with amniotic band syndrome and elevated levels of alpha-fetoprotein plus beta-human chorionic gonadotropin: a case report.
Congenital malformation syndromes and elevation of amniotic fluid alpha-fetoprotein.
Anaplasia
Hepatocellular carcinoma in Taiwan: clinicopathological study of 440 cases from a consecutive 6000 autopsies.
Primary liver cancers in Japan.
[The level of embryonic antigens in the blood serum and cerebrospinal fluid of neuro-oncological patients]
Androgen-Insensitivity Syndrome
Yolk sac tumor in a case of testicular feminization syndrome.
Anemia
Alpha-fetoprotein and Fanconi Anemia: Relevance to DNA Repair and Breast Cancer Susceptibility.
Case report: infantile hemangioendothelioma.
Cuba's Salgen: a provincial informatics network for genetic services to pregnant women and newborns.
Development and Validation of Trigger Algorithms to Identify Delays in Diagnostic Evaluation of Gastroenterological Cancer.
Hepatic resection for hepatocellular carcinoma in end-stage renal disease patients: two decades of experience at Chang Gung Memorial Hospital.
Maternal serum alpha-fetoprotein, fetal middle cerebral artery blood flow velocity and fetal haemoglobin in pregnancies at risk of fetal anaemia.
Patterns of hepatoblastoma and hepatocellular carcinoma in children after universal hepatitis B vaccination in taiwan: a report from a single institution in southern Taiwan.
Prenatal diagnosis and management of fetal anemia secondary to a large chorioangioma.
Prenatal screening.
Primary lymphoma of the spleen with hepatocellular carcinoma.
Primrose syndrome: Characterization of the phenotype in 42 patients.
Proteinase 3 and dihydrolipoamide dehydrogenase (E3) are major autoantigens in hepatitis C virus (HCV) infection.
Solitary AFP- and PIVKA-II-producing hepatoid gastric cancer with giant lymph node metastasis.
Successful resection of a ruptured hepatoblastoma prior to chemotherapy: report of a case.
Successful treatment of advanced pancreatoblastoma by a pylorus-preserving pancreatoduodenectomy after radiation and high-dose chemotherapy.
[Thoracoabdominal primary endodermal sinus tumor: a case report].
Anemia, Aplastic
Serum alpha-fetroprotein concentration in adult patients under corticoid, estroprogestative or androgen therapy.
Anemia, Iron-Deficiency
Development and Validation of Trigger Algorithms to Identify Delays in Diagnostic Evaluation of Gastroenterological Cancer.
Anemia, Neonatal
The Kleihauer-Betke test. Clinical utility, indication, and correlation in patients with placental abruption and cocaine use.
Anemia, Sickle Cell
Cuba's Salgen: a provincial informatics network for genetic services to pregnant women and newborns.
Prenatal screening.
Anencephaly
Alpha-fetoprotein in anencephaly.
Alpha-fetoprotein in antenatal diagnosis of anencephaly and spina bifida.
Alpha-fetoprotein in the antenatal diagnosis of anencephaly and spina bifida.
Alpha-fetoprotein levels in amniotic fluid in normal pregnancy and in pregnancy complicated by anencephaly.
Amniotic fluid alpha-fetoprotein as a marker in prenatal diagnosis of neural tube defects.
Amniotic fluid alpha-fetoprotein in anencephaly.
Amniotic fluid alpha-fetoprotein levels in anencephaly and open spina bifida: validation of median cut-off limits.
Amniotic-fluid acetylcholinesterase as a possible diagnostic test for neural-tube defects in early pregnancy.
Amniotic-fluid alpha-fetoprotein measurement in antenatal diagnosis of anencephaly and open spina bifida in early pregnancy. Second report of the U.K. Collaborative Study on Alpha-fetoprotein in Relation to Neural-tube Defects.
Antecedent circumstances surrounding neural tube defect births in 1990-1991. The Steering Committee of the National Confidential Enquiry into Counselling for Genetic Disorders.
Biamnial elevated alpha-fetoprotein and positive acetylcholinesterase in twins, one with anencephaly.
Combination of elevated maternal serum alpha-fetoprotein (MSAFP) and low estriol is highly predictive of anencephaly.
Comparison of amniotic-fluid and maternal serum alpha-fetoprotein levels in the early antenatal diagnosis of spina bifida and anencephaly.
Concanavalin A binding of alpha-fetoprotein in amniotic fluid as an aid in the diagnosis of neural tube defects.
Effects of folate deficiency on embryonic development.
High levels of maternal serum alpha-fetoprotein and human chorionic gonadotrophins leading to the diagnosis of combined neural tube defect and partial mole.
Impact of maternal serum alpha-fetoprotein screening on antenatal diagnosis.
Letter: amniotic alpha-fetoprotein levels and anencephaly.
Maternal alpha-fetoprotein screening: two years' experience in a low-risk district.
Maternal serum alpha-fetoprotein in fetal neural tube and abdominal wall defects at 10 to 14 weeks of gestation.
Maternal serum alpha-fetoprotein screening for open neural tube defects in twin pregnancies.
Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects.
Open neural tube defects: immunocytochemical demonstration of neuroepithelial cells in amniotic fluid.
Prenatal detection of anencephaly.
Ratio of immunochemically determined amniotic fluid acetylcholinesterase to butyrylcholinesterase in the differential diagnosis of fetal abnormalities.
Reactivity of amniotic fluid alpha-fetoprotein with concanavallin A in diagnosis of neural tube defects.
Relationship between some obstetric landmarks and the concentration of alpha-fetoprotein in maternal blood.
The improvement of the antenatal detection of fetal neural tube defects using discriminant analysis.
The molecular nature of alpha-fetoprotein in anencephaly and spina bifida.
The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-1991.
[Cause for increased alpha-fetoprotein values in amniotic fluid in prenatal diagnosis of genetic defects (author's transl)]
[Contents of alpha-fetoprotein in the blood of pregnant women as a criterion of the presence of congenital heart defects in the fetus]
[First trimester sonographic diagnosis of acrania]
[Prenatal diagnosis of anencephaly and open spina bifida by combined use of amniotic or maternal serum alpha-fetoprotein and maternal urine estrogen/creatinine ratio (author's transl)]
Angelman Syndrome
Alpha-fetoprotein in Angelman syndrome.
Angiomyolipoma
Hepatic Angiomyolipoma: A Clinical Experience in Diagnosis and Treatment.
Anovulation
Alpha-Fetoprotein Controls Female Fertility and Prenatal Development of the Gonadotropin-Releasing Hormone Pathway through an Antiestrogenic Action.
Antiphospholipid Syndrome
Biochemical and Doppler predictors of poor perinatal outcome in a fetus with four umbilical vessels.
Anus, Imperforate
Maternal serum alpha-fetoprotein and anal atresia.
Maternal serum alpha-fetoprotein in fetal anal atresia and other gastro-intestinal obstructions.
Appendicitis
[Unusual clinical presentation of hepatic yolk sac tumour in periappendical region. A case report and review of the literature]
Apraxias
"Pseudodominant inheritance" of ataxia with ocular apraxia type 2 (AOA2).
A novel c.5308_5311delGAGA mutation in Senataxin in a Cypriot family with an autosomal recessive cerebellar ataxia.
Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study.
Ataxia with oculomotor apraxia type 2: novel mutations in six patients with juvenile age of onset and elevated serum alpha-fetoprotein.
Autosomal Recessive Cerebellar Ataxias With Elevated Alpha-Fetoprotein: Uncommon Diseases, Common Biomarker.
Clinical and molecular findings of ataxia with oculomotor apraxia type 2 in 4 families.
Clinical characteristics of ataxia-telangiectasia presenting dystonia as a main manifestation.
Cognitive functions in ataxia with oculomotor apraxia type 2.
Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein.
Disruption of Spermatogenesis and Infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2).
Exome analysis reveals a Japanese family with spinocerebellar ataxia, autosomal recessive 1.
Identification and characterisation of a large Senataxin (SETX) gene duplication in ataxia with ocular apraxia type 2 (AOA2).
Mutations in senataxin responsible for Quebec cluster of ataxia with neuropathy.
Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2.
Sensory neuronopathy in ataxia with oculomotor apraxia type 2.
argininosuccinate lyase deficiency
Chronic liver involvement in urea cycle disorders.
Argininosuccinic Aciduria
Chronic liver involvement in urea cycle disorders.
Arteriovenous Fistula
Combined use of alpha-fetoprotein and ultrasound in the prenatal diagnosis of arteriovenous fistula in the brain.
Arthritis
Suppression of experimental antigen-induced arthritis in transgenic mice producing human alpha-fetoprotein.
Arthritis, Rheumatoid
A randomised, double-blind, placebo-controlled trial of a recombinant version of human alpha-fetoprotein (MM-093) in patients with active rheumatoid arthritis.
Elevated serum alpha-fetoprotein in a pregnant woman with rheumatoid arthritis.
High-level production of alternatively spliced soluble interleukin-6 receptor in serum of patients with adult T-cell leukaemia/HTLV-I-associated myelopathy.
MM-093, a recombinant human alpha-fetoprotein for the potential treatment of rheumatoid arthritis and other autoimmune diseases.
Rheumatic syndromes: clues to occult neoplasia.
Serum alpha-fetroprotein concentration in adult patients under corticoid, estroprogestative or androgen therapy.
arylsulfatase (type i) deficiency
Low maternal serum unconjugated estriol during prenatal screening as an indication of placental steroid sulfatase deficiency and X-linked ichthyosis.
Ataxia
A novel c.5308_5311delGAGA mutation in Senataxin in a Cypriot family with an autosomal recessive cerebellar ataxia.
Alpha-fetoprotein as a biomarker for recessive ataxias.
Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study.
Ataxia with oculomotor apraxia type 2: novel mutations in six patients with juvenile age of onset and elevated serum alpha-fetoprotein.
Ataxia-oculomotor apraxia 2 patients show no increased sensitivity to ionizing radiation.
Ataxia-telangiectasia: linkage analysis in highly inbred Arab and Druze families and differentiation from an ataxia-microcephaly-cataract syndrome.
Autosomal recessive ataxia with peripheral neuropathy and elevated AFP: novel mutations in SETX.
Autosomal Recessive Cerebellar Ataxias With Elevated Alpha-Fetoprotein: Uncommon Diseases, Common Biomarker.
Beyond Typical Ataxia Telangiectasia: How to Identify the Ataxia Telangiectasia-Like Disorders.
Clinical and molecular findings of ataxia with oculomotor apraxia type 2 in 4 families.
Clinical use of tumor markers in childhood malignancies.
Cognitive functions in ataxia with oculomotor apraxia type 2.
Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein.
Consequences of the delayed diagnosis of ataxia-telangiectasia.
Cytogenetic anomalies in a patient with ataxia, immune deficiency, and high alpha-fetoprotein in the absence of telangiectasia.
Disruption of Spermatogenesis and Infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2).
Familial spinocerebellar ataxia with cerebellar atrophy, peripheral neuropathy, and elevated level of serum creatine kinase, gamma-globulin, and alpha-fetoprotein.
Further delineation of the Nijmegen breakage syndrome.
Mutations in senataxin responsible for Quebec cluster of ataxia with neuropathy.
Progressive Ataxia with Elevated Alpha-Fetoprotein: Diagnostic Issues and Review of the Literature.
Radioresistant DNA synthesis and human genetic diseases.
Report of a Family with Fanconi Anemia and Ataxia-Telangiectasia.
Sensory neuronopathy in ataxia with oculomotor apraxia type 2.
Typical Friedreich's ataxia without GAA expansions and GAA expansion without typical Friedreich's ataxia.
Ataxia Telangiectasia
A double missense mutation in the ATM gene of a Dutch family with ataxia telangiectasia.
Alpha-fetoprotein in serum and amniotic fluid in the diagnosis of neonatal hepatitis syndrome, Indian childhood cirrhosis, cystic fibrosis, ataxia telangiectasia and spina bifida.
Ataxia-oculomotor apraxia 2 patients show no increased sensitivity to ionizing radiation.
Ataxia-telangiectasia presenting with a novel immunodeficiency.
Ataxia-telangiectasia: immunocytochemical demonstration of alpha-fetoprotein and hepatitis B surface antigen in the liver.
Ataxia-without-telangiectasia. Progressive multisystem degeneration with IgE deficiency and chromosomal instability.
ATFresno: a phenotype linking ataxia-telangiectasia with the Nijmegen breakage syndrome.
Autosomal Recessive Cerebellar Ataxias With Elevated Alpha-Fetoprotein: Uncommon Diseases, Common Biomarker.
Clinical characteristics of ataxia-telangiectasia presenting dystonia as a main manifestation.
Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein.
Dysgerminoma in a child with ataxia-telangiectasia.
Heterochrony and human malformation.
Mutation analysis of the ATM gene in two Chinese patients with ataxia telangiectasia.
Novel ATM mutations with ataxia-telangiectasia.
Tissue of origin of elevated alpha-fetoprotein in ataxia-telangiectasia.
Autoimmune Diseases
A role of alpha-fetoprotein in autoimmune diseases.
Alpha-fetoprotein inhibits antibody binding to acetylcholine receptor. Significance for myasthenia gravis and other autoimmune diseases.
Engineering of the Saccharomyces cerevisiae yeast strain with multiple chromosome-integrated genes of human alpha-fetoprotein and its high-yield secretory production, purification, structural and functional characterization.
MM-093, a recombinant human alpha-fetoprotein for the potential treatment of rheumatoid arthritis and other autoimmune diseases.
The extrahepatic events of Asian patients with primary biliary cholangitis: A 30-year cohort study.
The use of alpha-fetoprotein for the treatment of autoimmune diseases and cancer.
Barrett Esophagus
AFP-producing hepatoid adenocarcinoma in association with Barrett's esophagus with multiple liver metastasis responding to paclitaxel/CDDP: a case report.
Beckwith-Wiedemann Syndrome
Alpha-fetoprotein in Wiedemann-Beckwith syndrome.
Mesenchymal hamartoma of the liver associated with features of Beckwith-Wiedemann syndrome and high serum alpha-fetoprotein levels.
Serum alpha-fetoprotein levels in Beckwith-Wiedemann syndrome.
Serum alpha-fetoprotein screening for hepatoblastoma in Beckwith-Wiedemann syndrome.
Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolated hemihyperplasia.
The utility of alpha-fetoprotein screening in Beckwith-Wiedemann syndrome.
Biliary Atresia
Chubby face and the biochemical parameters for the early diagnosis of neonatal intrahepatic cholestasis caused by citrin deficiency.
Liver transplantation for biliary atresia associated with malignant hepatic tumors.
Serum alpha-fetoprotein levels in extrahepatic biliary atresia, idiopathic neonatal hepatitis and alpha-1-antitrypsin deficiency (PiZ).
The role of alpha-fetoprotein in the differentiation of neonatal hepatitis and biliary atresia.
Blister
Prenatal diagnosis of pyloric atresia-junctional epidermolysis bullosa syndrome in a fetus not known to be at risk.
Bowen's Disease
Human alpha-fetoprotein in the epidermal cells of Bowen's disease.
Brain Diseases
Clinical features, biochemical parameters, and virological profiles of patients with hepatocellular carcinoma in Hong Kong.
Prognostic features and survival of hepatocellular carcinoma in Italy: impact of stage of disease.
Prognostic features and survival of inoperable hepatocellular carcinoma in Turkish patients with cirrhosis.
Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma.
Sorafenib in a patient with advanced hepatocellular carcinoma and serious impairment of left ventricular function: a case report.
Brain Neoplasms
Brain metastases and elevated alpha-fetoprotein level in a patient with esophageal carcinoma.
Genes Encoding Mammalian Oviductal Proteins Involved in Fertilization are Subjected to Gene Death and Positive Selection.
Heterogeneity of ductular reactions in adult rat and human liver revealed by novel expression of deleted in malignant brain tumor 1.
Radioimmunoassay of alpha-fetoprotein in children with primary intracranial tumors.
Branchio-Oto-Renal Syndrome
The branchio-oto-renal (BOR) syndrome: report of bilateral renal agenesis in three sibs.
Breast Diseases
Effect of long-term freezer storage, thawing, and refreezing on selected constituents of serum.
Breast Neoplasms
A comparative study of four serological tumor markers for the detection of breast cancer.
A peptide derived from alpha-fetoprotein prevents the growth of estrogen-dependent human breast cancers sensitive and resistant to tamoxifen.
A personalized approach to cancer treatment: how biomarkers can help.
Advances in biological markers for cancer.
AFPep, a novel drug for the prevention and treatment of breast cancer, does not disrupt the estrous cycle or fertility in rats.
Alpha-fetoprotein and Fanconi Anemia: Relevance to DNA Repair and Breast Cancer Susceptibility.
Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts.
alpha-fetoprotein levels in maternal serum during pregnancy and maternal breast cancer incidence.
Alpha-fetoprotein receptors in a human breast cancer cell line.
Antiestrogenic and anticancer activities of peptides derived from the active site of alpha-fetoprotein.
Beyond the twinning effect: invited commentary on "Levels of maternal serum alpha-fetoprotein (AFP) in pregnant women and subsequent breast cancer risk".
Biologic markers in cancer diagnosis and treatment.
Detection and measurement of alpha-fetoprotein in human breast cancer cytosol after treatment with 0.4 M potassium chloride.
Development of a synthetic cyclized peptide derived from alpha-fetoprotein that prevents the growth of human breast cancer.
Effect of long-term freezer storage, thawing, and refreezing on selected constituents of serum.
Estrogen action: A historic perspective on the implications of considering alternative approaches.
Estrogen receptor and alpha-fetoprotein in human breast cancer: brief communication.
Ethnic differences in breast cancer risk: a possible role for pregnancy levels of alpha-fetoprotein?
Expression of the alpha-fetoprotein gene in human breast cancer.
Gender of offspring and maternal breast cancer risk.
Human alpha-fetoprotein peptides bind estrogen receptor and estradiol, and suppress breast cancer.
Human chorionic gonadotropin and alpha-fetoprotein concentrations in pregnancy and maternal risk of breast cancer: a nested case-control study.
Hypertension, pregnancy, and risk of breast cancer.
Increased alpha-fetoprotein receptor in the serum of patients with early-stage breast cancer.
Inhibition of estrogen-dependent breast cancer growth by a reaction product of alpha-fetoprotein and estradiol.
Levels and correlates of alpha-fetoprotein in normal pregnancies among Caucasian and Chinese women.
Levels of maternal serum alpha-fetoprotein (AFP) in pregnant women and subsequent breast cancer risk.
Maternal hormones during early pregnancy: a cross-sectional study.
Mean arterial pressure, pregnancy induced hypertension, and preeclampsia. Evaluation as independent risk factors and as surrogates for high maternal serum alpha-protein in estimating breast cancer risk.
Mean arterial pressure, pregnancy-induced hypertension, and preeclampsia: evaluation as independent risk factors and as surrogates for high maternal serum alpha-fetoprotein in estimating breast cancer risk.
Monoclonal antibodies against a component related to soluble estrogen receptor.
Plausible interaction of an alpha-fetoprotein cyclopeptide with the G-protein-coupled receptor model GPR30: docking study by molecular dynamics simulated annealing.
Prevention of N-methyl-N-nitrosourea-induced breast cancer by alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP.
Scintigraphic detection of breast cancer xenografts with Tc-99m natural and recombinant human alpha-fetoprotein.
Screening preeclamptic cord plasma for proteins associated with decreased breast cancer susceptibility.
Serum tumor markers for detection of bone metastasis in breast cancer patients.
Similarity between natural and recombinant human alpha-fetoprotein as inhibitors of estrogen-dependent breast cancer growth.
Specific cytoplasmic alpha-fetoprotein binding protein in MCF-7 human breast cancer cells and primary breast cancer tissue.
Structural Analysis of AFP-like Peptides with Anti-breast Cancer Properties.
Synthetic peptide derived from alpha-fetoprotein inhibits growth of human breast cancer: investigation of the pharmacophore and synthesis optimization.
The recombinant third domain of human alpha-fetoprotein retains the antiestrotrophic activity found in the full-length molecule.
Uptake of radiolabeled alpha-fetoprotein by mouse mammary carcinomas and its usefulness in tumor scintigraphy.
Variations of serum carcinoembryonic antigen, alpha-fetoprotein and immunoglobulin levels in patients with breast cancer.
Vimentin and alpha-fetoprotein expression in breast cancer smears: relationship with various prognostic factors.
XIST and TSIX: Novel Cancer Immune Biomarkers in PD-L1-Overexpressing Breast Cancer Patients.
Breast Neoplasms, Male
Alpha-fetoprotein-producing male breast cancer accompanied with hepatocellular carcinoma: assessment by lectin-affinity profile.
Bronchopneumonia
Mixed malignant germ cell tumour of the liver.
Budd-Chiari Syndrome
Budd-Chiari syndrome as an initial presentation of hepatocellular carcinoma: a case report.
Does hepatic vein outflow obstruction contribute to the pathogenesis of hepatocellular carcinoma?
Hepatocellular carcinoma with inferior vena cava and right atrial tumor thrombus: A case report.
Carcinogenesis
Alpha-fetoprotein (AFP) and alpha 2-macroglobulin (alpha 2-M) as the markers of distinct responses of hepatocytes to carcinogens in the rat: carcinogenesis.
alpha-Fetoprotein and albumin genes of rats: no evidence for amplification-deletion or rearrangement in rat liver carcinogenesis.
alpha-Fetoprotein and albumin mRNA levels in liver regeneration and carcinogenesis.
alpha-Fetoprotein gene sequences mediating Afr2 regulation during liver regeneration.
alpha-Fetoprotein levels and hepatic alterations during chemical carcinogenesis in C57BL/6N mice.
Alpha-fetoprotein molecular heterogeneity. Physiologic correlations with normal growth, carcinogenesis and tumor growth.
Alpha-fetoprotein: A new member of intracellular signal molecules in regulation of the PI3K/AKT signaling in human hepatoma cell lines.
Alteration of DNA methylation in gastrointestinal carcinogenesis.
Antibodies to alpha-fetoprotein disrupt histogenesis in cultured chick retinae.
Cell adhesion proteins and alpha-fetoprotein. Similar structural motifs as prerequisites for common functions.
Cell lineages in liver carcinogenesis: possible clues from studies of the distribution of alpha-fetoprotein RNA sequences in cell populations isolated from normal, regenerating, and preneoplastic rat livers.
Correlation of deoxycytidylate deaminase activity with cell proliferation during hepatocarcinogenesis and tumour growth in transplantable rat hepatomas.
Does alpha-fetoprotein contribute to the mortality and morbidity of human hepatocellular carcinoma? A commentary.
Immunohistochemical study of P53, PCNA and AFP in hepatocellular carcinoma, a comparison between Indonesian and Japanese cases.
Long-term interferon therapy for 1 year or longer reduces the hepatocellular carcinogenesis rate in patients with liver cirrhosis caused by hepatitis C virus: a pilot study.
Maternal risk of breast cancer following multiple births: a nationwide study in Sweden.
Modifications of the expression of liver-specific and non-specific messenger RNAs during azo-dye hepatocarcinogenesis.
On the synthesis of alpha-fetoprotein during liver carcinogenesis by N-2-fluorenylacetamide and its relationships with the intracellular localization of the carcinogen.
Prediction model of hepatocarcinogenesis for patients with hepatitis C virus-related cirrhosis. Validation with internal and external cohorts.
RASSF2A promoter methylation in hepatitis B virus-related hepatocellular carcinogenesis and its correlation with elevated serum alpha-fetoprotein level.
Regulation of alpha-fetoprotein by nuclear factor-kappaB protects hepatocytes from tumor necrosis factor-alpha cytotoxicity during fetal liver development and hepatic oncogenesis.
Relationship between alpha-fetoprotein positive cells and precancerous lesions in rat liver during 3'-methyl-4-dimethylaminoazobenzene carcinogenesis.
RXR-mediated regulation of the alpha-fetoprotein gene through an upstream element.
Sequence content of alpha-fetoprotein, albumin and fibrinogen polypeptide mRNAs in different organs, developing tissues and in liver during carcinogenesis in rats.
Sequence requirements for Afr-2 regulation of alpha-fetoprotein gene expression during liver regeneration.
Sequence requirements for alpha-fetoprotein gene expression during liver regeneration.
Serum alpha-fetoprotein concentrations in urban and rural Southern African blacks with hepatocellular carcinoma.
Sex steroid hormones levels and testicular activity during hepatocarcinogenesis by N-2-fluorenylacetamide.
Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma: a longterm cohort study of 892 patients with viral cirrhosis.
Structural basis for alpha fetoprotein-mediated inhibition of caspase-3 activity in hepatocellular carcinoma cells.
The effects of growth inhibitory peptide on follicular thyroid cancer cell growth, migration, and invasion.
The expression of alpha-fetoprotein and albumin genes in rat liver during chemical carcinogenesis.
The influence of alpha-fetoprotein on Moloney sarcoma virus oncogenesis: evidence for generation of antigen nonspecific suppressor T cells.
Variable gene expression within human tyrosinemia type 1 liver may reflect region-specific dysplasia.
[Characteristics of alpha-fetoprotein synthesis in the early stages of hepatic carcinogenesis in mice with a various sensitivity to ortho-aminoazotoluene]
[Concentration of carcinoembryonic antigen, alpha-fetoprotein and beta-subunit of human chorionic gonadotropin in serum of workers employed directly in the production of coke]
[DAB carcinogenesis in rats and fluctuation of alpha-fetoprotein]
[Possibilities for the spread of alpha-fetoprotein and heterologous antibodies in mother and fetus during transplacental carcinogenesis]
[Several transcription factors participate in the functioning of the alpha-fetoprotein gene promoter]
[Transitory cell antigens of rat liver. 3. The reappearance of alpha-fetoprotein during chemical carcinogenesis (author's transl)]
Carcinoid Tumor
A case of primary lung cancer producing alpha-fetoprotein.
Histochemical studies of dense-core granulated tumors of the lung. Neuron-specific enolase as a marker for granulated cells.
Primary carcinoid tumor of the testis: immunohistochemical, ultrastructural and DNA flow cytometric study of two cases.
Pulmonary atypical carcinoid tumor with marked alphafetoprotein production and features of an adenocarcinoma differentiation.
Statistical evaluation of 2001 carcinoid cases with metastases, collected from literature: a comparative study between ordinary carcinoids and atypical varieties.
Carcinoma
'5-5-500' - yet another extended criteria for HCC or a truly innovative development?
A case of alpha-fetoprotein-producing rectal carcinoma.
A case of gallbladder carcinoma producing both alpha-fetoprotein (AFP) and carcinoembryonic antigen (CEA).
A case of gastric carcinoma whose serum was positive for alpha-fetoprotein, variant alkaline phosphatase and CEA (author's transl)]
A channel-resolved approach coupled with magnet-captured technique for multianalyte chemiluminescent immunoassay.
A disposable multianalyte electrochemical immunosensor array for automated simultaneous determination of tumor markers.
A distinctive antigen present in liver carcinomas induced by 3'-methyl-p-dimethylaminoazobenzene.
A fetuin-like antigen from human nephroblastoma.
A novel diagnostic marker, p28GANK distinguishes hepatocellular carcinoma from potential mimics.
A novel multi-array immunoassay device for tumor markers based on insert-plug model of piezoelectric immunosensor.
A Portable Microfluidic System for Point-of-Care Detection of Multiple Protein Biomarkers.
A primary lung carcinoma producing alpha-fetoprotein, carcinoembryonic antigen, and human chorionic gonadotropin. Immunohistochemical and biochemical studies.
A rational route to hybrid aptamer-molecularly imprinted magnetic nanoprobe for recognition of protein biomarkers in human serum.
A unique pancreatic tumor with exclusive hepatocytic differentiation.
Acinar cell carcinoma of the pancreas with elevated serum alpha-fetoprotein levels: a case report and a review of 28 cases reported in Japan.
Acinar cell carcinoma of the pancreas with elevated serum alpha-fetoprotein.
Acinar-islet cell carcinoma presenting as insulinoma.
Activation of an alpha-fetoprotein (AFP)/receptor autocrine loop in HT-29 human colon carcinoma cells.
Adenocarcinosarcoma at the esophagogastric junction with long esophageal invasion: a case report.
Adenoendocrine cell carcinoma of the gallbladder producing a high level of alpha-fetoprotein.
Advances in biological markers for cancer.
Affinity chromatographic separation of alpha-fetoprotein variants: development of a mini-column procedure, and application to cancer patients.
AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease.
AFP-producing acinar cell carcinoma treated by pancreaticoduodenectomy in a patient with a previous radical subtotal gastrectomy by gastric cancer.
AFP-producing gastric carcinoma: multivariate analysis of prognostic factors in 270 patients.
AFP-producing hepatoid adenocarcinoma of the stomach: a case report.
AFP-producing urothelial carcinoma of the bladder: a case report.
Aggressive gastric carcinoma producing alpha-fetoprotein: a case report and review of the literature.
Aldolase A isoenzyme levels in serum and tissues of patients with liver diseases.
Alpha fetoprotein producing gastric hepatoid adenocarcinoma.
Alpha-fetoprotein (AFP)-producing epithelial ovarian carcinoma (EOC): a retrospective study of 27 cases.
Alpha-fetoprotein (AFP)-producing gastric carcinoma. Is it hepatoid differentiation?
Alpha-fetoprotein and carcinoembryonic antigen in a case of gastric carcinoma metastatic to the liver.
Alpha-fetoprotein and carcinoembryonic antigen in patients with primary liver carcinoma, metastatic liver disease, and alcoholic liver disease.
Alpha-fetoprotein and gastric carcinoma.
Alpha-fetoprotein elevation in NUT midline carcinoma: a case report.
Alpha-fetoprotein in a patient with embryonal cell carcinoma of the testes.
Alpha-fetoprotein in a patient with gastric carcinoma metastatic to the liver.
Alpha-fetoprotein in patients of gastric carcinoma with or without liver metastasis.
Alpha-fetoprotein is an autoantigen in hepatocellular carcinoma and juvenile Batten disease.
Alpha-fetoprotein producing carcinoma of the gallbladder associated with anomalous arrangement of the pancreaticobiliary ductal system--early detection through an attack of acute pancreatitis.
alpha-Fetoprotein producing gastric carcinomas: a comparative study of three different subtypes.
Alpha-fetoprotein producing mucin-producing carcinoma of the pancreas: a case report with immunohistochemical study and lectin-affinity profile.
Alpha-fetoprotein producing ovarian clear cell carcinoma with a neometaplasia to hepatoid carcinoma arising from endometriosis: A case report.
Alpha-fetoprotein producing renal cell carcinoma: a case report.
Alpha-fetoprotein producing undifferentiated carcinoma of the bladder.
Alpha-fetoprotein producing uterine corpus carcinoma: A hepatoid adenocarcinoma of the endometrium.
Alpha-fetoprotein production by non-hepatocellular carcinoma, malignant liver tumor.
Alpha-fetoprotein-positive carcinoma of the pancreas: a case report.
alpha-Fetoprotein-producing (hepatoid) carcinoma of the fallopian tube.
Alpha-fetoprotein-producing acinar cell carcinoma of the pancreas.
alpha-Fetoprotein-producing adenocarcinoma of the pancreas presenting focal hepatoid differentiation.
Alpha-fetoprotein-producing carcinoma of the colon: report of a case and review of the literature.
Alpha-fetoprotein-producing clear cell carcinoma of the gallbladder with neuroendocrine differentiation.
Alpha-Fetoprotein-Producing Early Gastric Cancer with Intramucosal Hepatoid and Fetal Enteric Differentiation.
Alpha-fetoprotein-producing esophageal carcinoma: a case report.
Alpha-fetoprotein-producing gastric carcinoma: biological properties of a cultured cell line.
alpha-Fetoprotein-producing liver carcinomas of primary extrahepatic origin.
Alpha-fetoprotein-producing lung carcinoma: report of three cases.
Alpha-Fetoprotein-Producing Lung Hepatoid Adenocarcinoma with Brain Metastasis Treated with S-1.
Alpha-fetoprotein-producing pancreatic acinar cell carcinoma.
Alpha-fetoprotein-producing pancreatic cancer--a case report and review of 28 cases.
Alpha-fetoprotein-producing pancreatic carcinoma: case report and review of the Japanese literature.
alpha-Fetoprotein-producing rectal carcinoma--a case report.
Alpha-fetoprotein-producing renal cell carcinoma with increased activity of N-acetylglucosaminyl-transferase III.
Alpha-fetoprotein-producing renal cell carcinoma.
Alpha-fetoprotein-producing serous carcinoma of the uterus metastasizing to the ovaries, mimicking primary ovarian yolk sac tumor: a case report and review of the literature.
Alpha-fetoprotein-producing transitional cell carcinoma of the urinary bladder: a case report.
An alpha-fetoprotein-producing carcinoma of the rectum.
An autopsy case of hepatoid carcinoma of the ovary with PIVKA-II production: immunohistochemical study and literature review.
An unusual case, in Italy, of hepatocarcinoma characterized by portal hypertension and absence of cirrhosis.
Analysis of lectin affinity immunoelectrophoretic profiles of serum alpha-fetoprotein from patients with yolk sac tumors and carcinomas of the gastrointestinal tract: correlations with molecular structures.
Angiogenesis of AFP producing gastric carcinoma: correlation with frequent liver metastasis and its inhibition by anti-AFP antibody.
Anti-Cytokeratin CAM 5.2 (Becton Dickinson) is not synonymous with CK8/18 monoclonal antibody. Comment on "Pancreatic-type mixed acinar-endocrine carcinoma with alpha-fetoprotein production arising from the stomach: a report of an extremely rare case. Med Mol Morphol (2009) 42:167-174".
Brain metastases and elevated alpha-fetoprotein level in a patient with esophageal carcinoma.
CA125-producing adenocarcinoma of the seminal vesicle.
Carbohydrate antigens as potential biomarkers for the malignancy in patients with idiopathic deep venous thrombosis: a retrospective cohort study.
Carcinoembryonic antigen, alpha-fetoprotein and carcinoplacental alkaline phosphatase in gastric carcinoma metastatic to the liver.
Carcinoembryonic proteins in gastric carcinoma metastatic to the liver.
Cerebrospinal fluid markers in central nervous system metastases from testicular carcinoma.
Clear cell carcinomas of the gallbladder and extrahepatic bile ducts.
Clear-Cell Adenocarcinoma of the Gallbladder with Alpha-Fetoprotein Production: A Case Report and Review of the Literature.
Clinical characteristics and treatments of patients with alpha-fetoprotein producing gastric carcinoma.
Clinical significance of alpha-fetoprotein mRNA during perioperative period in HCC.
Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM versus alpha-fetoprotein in Egyptian patients with hepatitis C virus-induced hepatocellular carcinoma.
Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein.
Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases.
Co-expression of N-cadherin and alpha-fetoprotein in stomach cancer.
Collecting duct carcinoma of kidney producing alpha-fetoprotein.
Combined Evaluation of Preoperative Serum CEA and CA125 as an Independent Prognostic Biomarker in Patients with Early-Stage Cervical Adenocarcinoma.
Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma.
Comparative immunohistochemical study of primary and metastatic carcinomas of the liver.
CYFRA 21-1. A new marker in lung cancer.
Cytomorphology of combined hepatocellular-cholangiocarcinoma in fine needle aspirates of the liver. A report of two cases.
Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver.
Dendritic cells pulsed with alpha-fetoprotein and mutant P53 fused gene induce bi-targeted cytotoxic T lymphocyte response against hepatic carcinoma.
Detection of serum alpha-fetoprotein in dogs with naturally occurring malignant neoplasia.
Diagnostic and prognostic value of alpha-fetoprotein, des-?-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
Diagnostic value of serum tumor markers in skeletal metastasis of carcinomas.
Different characteristics of hepatoid and non-hepatoid alpha-fetoprotein-producing gastric carcinomas: an experimental study using xenografted tumors.
Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma.
Distinctions between clinicopathological factors and prognosis of alpha-fetoprotein negative and positive hepatocelluar carcinoma patients.
Early Gastric Cancer with Purely Enteroblastic Differentiation and No Conventional Adenocarcinoma Component.
Editoral: Alpha-fetoprotein in primary carcinoma of the liver and other diseases.
Elevated serum alpha-fetoprotein in a patient with undifferentiated carcinoma of the gall bladder.
Elevated serum alpha-fetoprotein levels in primary gallbladder carcinoma without hepatic involvement.
Elevation of CA 19-9 and chromogranin A, in addition to CA 125, are detectable in benign tumors in leiomyomas and endometriosis.
Enhanced liver metastatic potential of alpha-fetoprotein-producing human gastric carcinoma after carbon tetrachloride-induced liver damage in nude mice.
Establishment and characterization of HEPFT, a cell line derived from hepatoid carcinoma of the fallopian tube, with special reference to alpha-fetoprotein, lectin affinity and histogenesis.
Establishment and characterization of HUOT, a human ovarian malignant teratoma cell line producing alpha-fetoprotein.
Establishment of a testicular carcinoma cell line producing alpha-fetoprotein.
Establishment of an alpha-fetoprotein-producing human gastric carcinoma in nude mice.
Estimation of leucine aminopeptidase and 5-nucleotidase increases alpha-fetoprotein sensitivity in human hepatocellular carcinoma cases.
Evaluation of N-acetylneuraminic acid, carcinoembryonic antigen, and alpha-fetoprotein as markers for advanced carcinoma.
Evaluation of serum tumour markers concentrations in patients with homozygous beta-thalassaemia in relation to demographical, clinical and biochemical parameters.
Evaluation of six tumor markers in patients with carcinoma of unknown primary.
Evaluation of the albumin-gamma-glutamyltransferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis.
Evaluation of tumor markers biochip C12 system in the diagnosis of gastric cancer and the strategies for improvement: analysis of 100 cases.
Evaluation of tumor markers in patients with squamous cell carcinoma in the oral cavity.
Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1.
Ferritin, alpha-fetoprotein and carcinoembryonic antigen concentration in the serum of mammary carcinoma patients.
Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation.
Focal nodular hyperplasia of the liver: pathological analysis of 11 cases.
Gallbladder carcinoma producing alpha-fetoprotein.
Gallbladder carcinomas: an immunoprognostic evaluation of P53, Bcl-2, CEA and alpha-fetoprotein.
Gastrointestinal Obstruction due to Solitary Lymph Node Recurrence of Alpha-Fetoprotein-Producing Gastric Carcinoma with Enteroblastic Differentiation.
Gonadal and extragonadal yolk sac carcinomas: a clinicopathologic study of 14 cases.
Hepatocarcinogenesis in the mouse. Combined morphologic-stereologic studies.
Hepatocellular Carcinoma and High Grade Neuroendocrine Carcinoma: A Case Report and Review of the Literature.
Hepatocellular oncofetal protein, glypican 3 is a sensitive marker for alpha-fetoprotein-producing gastric carcinoma.
Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.
Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma.
Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database.
Hepatoid adenocarcinoma: a distinctive histological subtype of alpha-fetoprotein-producing lung carcinoma.
Hepatoid adenocarcinoma: a new clinicopathological entity and the hypotheses on carcinogenesis.
Hepatoid carcinoma of the lung with production of alpha-fetoprotein and abnormal prothrombin: an autopsy case report.
Hepatoid carcinoma of the ovary and management.
Hepatoid carcinoma of the ovary without staining for alpha-fetoprotein.
Hepatoid carcinoma of the ovary: characteristics of its immunoreactivity. A case report.
Hepatoid carcinoma of the pancreas producing protein induced by vitamin K absence or antagonist II (PIVKA-II) and alpha-fetoprotein (AFP).
Hepatoid carcinoma of the stomach: is it still an unusual anatomo-clinical entity? Six cases-report.
Hepatoid carcinoma with serous component of the fallopian tube: a case report with immunohistochemical and ultrastructural studies.
Heterotransplantation of an alpha-fetoprotein-producing human gallbladder carcinoma into nude mice.
Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer.
Histologic and immunohistochemical studies of alpha-fetoprotein (AFP)-producing gastric carcinoma.
HSP72 and gp96 in gastroenterological cancers.
Human alpha-fetoprotein: immunosuppressive activity and microheterogeneity.
Human chorionic gonadotropin in gastric carcinoma. A useful marker for bone metastasis.
Human yolk sac carcinoma antigens--a step beyond alpha-fetoprotein.
Imaging of primary and metastatic liver cancer with 131I monoclonal and polyclonal antibodies against alphafetoprotein.
Immunocytochemical evaluation of liver fine-needle aspirations.
Immunocytochemical evaluation of primary human esophageal carcinomas and their xenografts for keratin, beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Immunocytochemical localization of carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), and human chorionic gonadotropin (HCG) in cervical neoplasia.
Immunofluorescent localization of alpha fetoprotein in yolk sac carcinomas of the rat.
Immunohistochemical differentiation of clear-cell carcinoma of the female genital tract and endodermal sinus tumor with the use of alpha-fetoprotein and Leu-M1.
Immunohistochemical evaluation of canine primary liver carcinomas: distribution of alpha-fetoprotein, carcinoembryonic antigen, keratins and vimentin.
Impact of chronic kidney disease on serum tumor markers concentrations.
In vitro upconverting/downshifting luminescent detection of tumor markers based on Eu3+-activated core-shell-shell lanthanide nanoprobes.
Increasing serum levels of alpha-fetoprotein in a patient with relapsing gallbladder carcinoma.
Influence of testicular carcinoma on ipsilateral spermatogenesis.
Irinotecan plus low-dose cisplatin for alpha-fetoprotein-producing gastric carcinoma with multiple liver metastases: report of two cases.
Large acinar cell carcinoma of the pancreas in a patient with elevated serum AFP level.
Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum.
Late recurrence of testicular cancer.
Lectin affinity electrophoresis of alpha-fetoprotein. Increased specificity and sensitivity as a marker of hepatocellular carcinoma.
Lectin reactivity of alpha-fetoprotein in a case of renal cell carcinoma.
Localization of alpha-fetoprotein synthesis in malignancies other than hepatoma.
Malignant sacrococcygeal germ cell tumors in childhood: The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience.
Merged hepatopulmonary features in hepatoid adenocarcinoma of the lung: a systematic review.
miR-630 Overexpression in Hepatocellular Carcinoma Tissues is Positively Correlated with alpha-Fetoprotein.
Mouse hepatoblastomas: a histologic, ultrastructural, and immunohistochemical study.
Multiplex detection of tumor markers with photonic suspension array.
Nanogram per milliliter-level immunologic detection of alpha-fetoprotein with integrated rotating-resonance microcantilevers for early-stage diagnosis of heptocellular carcinoma.
NTBC treatment in tyrosinaemia type I: long-term outcome in French patients.
Oesophageal hepatoid carcinoma with liver metastasis, a diagnostic dilemma.
Origin of embryo-derived yolk sac carcinomas.
Ovarian and hepatic metastases of gastric carcinoma associated with high serum levels of human chorionic gonadotropin (hCG), alpha-fetoprotein (AFP), and carcinoembryonic antigen (CEA): a case report.
Ovarian hepatoid carcinoma without staining for alpha-fetoprotein in the primary site.
Pancoast syndrome in a patient with malignant lymphoma.
Pancreatic acinar cell carcinoma with excessive alpha-fetoprotein expression.
Pancreatic-type mixed acinar-endocrine carcinoma with alpha-fetoprotein production arising from the stomach: a report of an extremely rare case.
Pathological studies on primary carcinoma of the liver. A study of 89 cases among 3890 necropsies and a study of alpha-fetoprotein in the serum of 17 cases.
Precancerous changes in the stomach.
Primary carcinoma of the liver.
Primary hepatoid carcinoma of ovary in pregnancy.
Primary liver cell carcinoma in the presence or absence of hepatitis B antigen.
Primary lung cancer producing alpha-fetoprotein.
Primary pulmonary hepatoid adenocarcinoma: A case report and review of the literature.
Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Identification of two groups of patients with prospects for prolonged survival.
Prognostic value of alpha-fetoprotein radioimmunoassay in surgically treated patients with embryonal cell carcinoma of the testis.
Prognostic value of immunohistochemically identified CEA, SC, AFP, and S-100 protein-positive cells in gastric carcinoma.
Propensity of ectopic liver to hepatocarcinogenesis: case reports and a review of the literature.
Pure alpha-fetoprotein-producing neuroendocrine carcinoma of the pancreas: a case report.
Quantitative analysis of alpha-fetoprotein mRNA in circulating peripheral blood of patients with hepatocellular and alpha-fetoprotein-producing gastric carcinomas.
Quantitative screening of serum protein biomarkers by reverse phase protein arrays.
Renal cell carcinoma producing alpha-fetoprotein (AFP) with a unique lectins-affinity profile.
Risk-adapted management for patients with clinical stage I non-seminomatous germ cell tumour of the testis.
Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.
Sampling-resolution strategy for one-way multiplexed immunoassay with sequential chemiluminescent detection.
Secretory adenocarcinoma of the endometrium.
Serum alpha-fetoprotein in patients with neoplasms of the gastrointestinal tract.
Serum alpha-fetoprotein levels and microheterogeneity in patients with different liver diseases.
Serum alpha-fetoprotein levels in patients with acute and chronic liver disease. Relation to hepatocellular regeneration and development of primary liver cell carcinoma.
Serum alpha-L-fucosidase activity and early detection of hepatocellular carcinoma: a prospective study of patients with cirrhosis.
Serum biomarkers in metastatic renal cell carcinoma.
Serum levels of CA 125 in patients with gastrointestinal cancers.
Serum N-acetylglucosaminyltransferase III activities in hepatocellular carcinoma.
Simple and robust diagnosis of early, small and AFP-negative primary hepatic carcinomas: an integrative approach of serum fluorescence and conventional blood tests.
Solitary intraperitoneal recurrence of alpha-fetoprotein-producing gastric carcinoma: report of a case.
Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time?
Studies on alpha-fetoprotein produced by renal cell carcinoma.
Testicular cancer with enlarged mediastinal lymph nodes: a diagnostic pitfall.
The clinical significances of carcinoembryonic proteins in patients with ovarian carcinoma.
The efficacy of modified docetaxel-cisplatin-5-fluorouracil regimen as first-line treatment in patients with alpha-fetoprotein producing gastric carcinoma.
The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma.
The Influence of Alpha-fetoprotein on Natural Suppressor Cell Activity and Ehrlich Carcinoma Growth.
The Research of No-Touch Isolation Technique on the Prevention of Postoperative Recurrence and Metastasis of Hepatocellular Carcinoma after Hepatectomy.
The use of radioiodinated alpha-fetoprotein for the scintigraphic detection of mouse mammary carcinomas.
The usefulness of simultaneous determinations of glucosaminylation and fucosylation indices of alpha-fetoprotein in the differential diagnosis of neoplastic diseases of the liver.
The value of ultrasound in the diagnosis and treatment of small hepatocellular carcinoma.
TPA, TATI, CEA, AFP, beta-HCG, PSA, SCC, and CA 19-9 for monitoring transitional cell carcinoma of the bladder.
Transformation of an AFP-positive yolk sac carcinoma into an AFP-negative neoplasm. Evidence for in vivo cloning of the human parietal yolk sac carcinoma.
Triple primary cancers involving kidney, urinary bladder, and liver in a dye worker.
Tumor cell dissemination triggers an intrathecal immune response in neoplastic meningitis.
Tumor markers in biological fluids associated with pregnancy.
Tumor markers in carcinoma and premalignant states of the stomach in humans.
Tumor markers in chronic renal failure and hemodialysis patients.
Tumor markers in testicular cancer.
Tumor of the liver (hepatocellular and high grade neuroendocrine carcinoma): a case report and review of the literature.
Tumor thrombus in the splenic vein originated from gastric carcinoma that produced alpha-fetoprotein.
Tumor-associated antigen levels (carcinoembryonic antigen, human chorionic gonadotropin, and alpha-fetoprotein) antedating the diagnosis of cancer in the Framingham study.
Tumour markers in testicular germ cell tumours. Five-year experience from the DATECA Study 1976-1980.
Undetected hepatocellular carcinoma in patients undergoing liver transplantation: is associated with favorable outcome.
Uninfluenced alpha-fetoprotein and treatment of liver primary carcinoma by lobaplatin in combination with 5-fluorouracil and doxorubicin via chemoembolization and transarterial chemoembolization.
Uptake of radiolabeled alpha-fetoprotein by mouse mammary carcinomas and its usefulness in tumor scintigraphy.
Vimentin-positive and Alpha-fetoprotein-elevated Nuclear Protein of the Testis Midline Carcinoma: A Case Report and Review of the Literature.
Well-differentiated gall bladder hepatoid carcinoma producing alpha-fetoprotein: a case report.
Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets.
[76-year-old patient with adenocarcinoma of the rectum and fibrolamellar hepatocellular 2d carcinoma. Case report with literature review of hepatocellular carcinoma of the fibrolamellar type]
[A case of alpha-fetoprotein, carcinoembryonic antigen and human chorionic gonadotropin producing renal cell carcinoma]
[A case of alpha-fetoprotein-producing gastric carcinoma with histologic features of embryonal carcinoma]
[A case of clear cell carcinoma of the hepatic bile duct with production of alpha-fetoprotein (AFP)]
[A case of hepatoid adenocarcinoma of the urinary bladder]
[A case of IgA-lambda producing gastric plasmacytoma associated with alpha-fetoprotein producing gastric carcinoma]
[A case of liver metastasis of gastric hepatoid adenocarcinoma]
[A case of renal cell carcinoma producing alpha-fetoprotein]
[A case of small cell carcinoma of the urinary bladder]
[A tumor-associated antigen of cervical cancer]
[Adrenal hepatoid carcinoma producing alpha-fetoprotein: a case report]
[Alpha-fetoprotein and its appearance in primary liver carcinoma]
[Alpha-fetoprotein in embryonal cell carcinoma of the testis]
[Alpha-fetoprotein--diagnostic utility in squamous cell carcinoma of the head and neck]
[An alpha-fetoprotein and PIVKA-II producing carcinoma of the colon: report of a case]
[An autopsied case of alpha-fetoprotein (AFP) producing large cell carcinoma of the lung (author's transl)]
[An autopsy case of double cancer (Hepatocellular carcinoma and mixed germ cell tumor of the testis)--significance of alpha-fetoprotein and human chorionic gonadotropin as tumor markers]
[An immunohistological study on an autopsy case of duodenal carcinoma associated with marked increasing of alpha-fetoprotein in the serum (author's transl)]
[Carcinoembryonic antigen, alpha-fetoprotein and hepatoma alkaline phosphatase in gastric carcinoma]
[Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma]
[Current approaches to surgical treatment of liver tumors]
[Cytodiagnosis of primary liver cell carcinoma with reference to alpha-fetoprotein (author's transl)]
[Detection of serum p53 antibodies in colorectal cancer patients and the clinical significance of postoperative monitoring]
[Diagnostic value of serum alpha-fetoprotein, alpha-fetoprotein variant and abnormal prothrombin in primary hepatocellular carcinoma].
[Diagnostic value of the analysis of alpha fetoprotein levels in malignant neoplasms of the digestive system]
[Double primary lung cancers producing alpha-fetoprotein]
[Elevated serum alpha-fetoprotein in a case of rectum carcinoma with liver cirrhosis (author's transl)]
[Highly differentiated primary liver cell carcinoma. 2 case reports]
[Immunological parameters in the differential diagnosis of ascites secondary to peritoneal carcinomatosis, hepatic cirrhosis, and congestive heart failure]
[Increase of serum alpha-fetoprotein in a patient with acinar cell carcinoma of the pancreas]
[Laboratory tests in the diagnosis of stomach cancer]
[On the alpha-fetoprotein in the diagnosis of primary liver carcinoma (author's transl)]
[Pancreatic endocrine tumor with metastases and increase of alpha-fetoprotein. A case report]
[Positive alpha-fetoprotein in a case of metastatic gastric carcinoma, Borrmann type 3]
[Preliminary data on possibilities for the early detection of risk for primary liver carcinoma in chronic HBsAg carriers]
[Serum tumor marker levels during a 12-months growth hormone replacement therapy in patients with adult growth hormone deficiency]
[Significance of arginase-1, glypican-3, hepatocyte paraffin antigen 1 and alpha-fetoprotein in diagnosis and differential diagnosis of liver tumors].
[Significance of serum golgi protein 73 (GP73), alpha-fetoprotein (AFP) and lectin-reactive alpha-fetoprotein (AFP-L3) expresssion in primary hepatic carcinoma].
[Stage IV renal cell carcinoma producing alpha-fetoprotein treated with multimodal treatment. A case report]
[Studies on marker substances in cell lines derived from various human gynecologic tumors (author's transl)]
[The immunohistological study of alpha-fetoprotein on carcinoma of digestive organs (author's transl)]
[The immunologic tumor diagnosis]
[The inhibitory effect of mitomycin C on experimental liver metastasis of alpha-fetoprotein producing human gastric carcinoma induced by intra-splenic transplantation in nude mice]
[The place of tumor markers in breast and gynecologic neoplasms]
[The use of the carbohydrate antigen CA-19-9, the carcinoembryonic antigen and alpha fetoprotein in the diagnosis of pancreatic cancer]
[The use of tumoral markers in clinical practice]
[Three-dimensional conformal radiation therapy for malignant tumors (report of 1,024 cases)]
Carcinoma in Situ
Influence of testicular carcinoma on ipsilateral spermatogenesis.
Carcinoma, Acinar Cell
Acinar cell carcinoma of the pancreas with elevated serum alpha-fetoprotein levels: a case report and a review of 28 cases reported in Japan.
Acinar cell carcinoma of the pancreas with elevated serum alpha-fetoprotein.
AFP-producing acinar cell carcinoma treated by pancreaticoduodenectomy in a patient with a previous radical subtotal gastrectomy by gastric cancer.
Alpha-fetoprotein-positive carcinoma of the pancreas: a case report.
Alpha-fetoprotein-producing pancreatic acinar cell carcinoma.
Alpha-fetoprotein-producing pancreatic cancer--a case report and review of 28 cases.
Large acinar cell carcinoma of the pancreas in a patient with elevated serum AFP level.
Pancreatic acinar cell carcinoma with excessive alpha-fetoprotein expression.
[Increase of serum alpha-fetoprotein in a patient with acinar cell carcinoma of the pancreas]
Carcinoma, Adenosquamous
Unique characteristics of rectal carcinoma cell lines derived from invasive carcinomas in ulcerative colitis patients.
Carcinoma, Embryonal
A human testicular germ cell tumor with borderline histology between seminoma and embryonal carcinoma secreted beta-human chorionic gonadotropin and alpha-fetoprotein only as a xenograft.
A human vitelline component in embryonal carcinoma of the testis.
A suprasellar embryonal carcinoma producing alpha-fetoprotein and human chorionic gonadotropin; treated with combined chemotherapy followed by radiotherapy.
Advances in biological markers for cancer.
Alpha-fetoprotein and human chorionic gonadotropin in embryonal carcinoma of the ovary. An 8-year survival case.
Alpha-fetoprotein-producing non-germ cell tumours of the female genital tract.
Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor.
Detection of alpha-fetoprotein mRNA in seminoma.
Embryonal carcinoma with falsely positive elevation of serum alpha-fetoprotein after curative therapy: a case report.
Enhancement of reporter gene de novo methylation by DNA fragments from the alpha-fetoprotein control region.
Expression of the alpha-fetoprotein gene in pluripotent and committed cells.
Germ cell tumor in an adolescent with extensive testicular microlithiasis: concerns regarding future management.
Immunohistochemistry of alpha-fetoprotein in testicular embryonal carcinoma.
Improved staging for testicular cancer using biologic tumor markers: a prospective study.
Intracranial embryonal carcinoma and precocious puberty.
Intracranial germ-cell tumors. Immunohistochemical study of three autopsy cases.
Intracranial mixed germ cell tumor with syncytiotrophoblastic giant cells and precocious puberty.
Long-term follow-up of germinoma after stereotactic biopsy and brain radiotherapy: a cell kinetics study.
MicroRNAs in testicular cancer: implications for pathogenesis, diagnosis, prognosis and therapy.
Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?
Ovarian endometrioid adenocarcinoma with ectopic production of alpha-fetoprotein.
Primary chemotherapy followed by a selective retroperitoneal lymphadenectomy in the management of clinical stage II testicular carcinoma: a preliminary report.
Suspected extragonadal germ-cell cancer syndrome presenting with an orbital mass and elevation of serum CEA, CA 19-9 and CA50 levels.
Synthesis of alpha-fetoprotein and some other serum proteins in testicular tumors.
Testicular germ-cell neoplasms: recent advances in diagnosis and therapy.
The capacity for differentiation and production of human chorionic gonadotropin and alpha-fetoprotein in human embryonal carcinoma cell lines.
The ontogeny of expression of murine metallothionein: comparison with the alpha-fetoprotein gene.
The role of tumor markers in gynecologic oncology.
Tissue-specific activation of a cloned alpha-fetoprotein gene during differentiation of a transfected embryonal carcinoma cell line.
Treatment of nongerminomatous germ-cell tumors of the pineal region.
Tumour markers in gynaecologic oncology.
VAB-4 combination chemotherapy in the treatment of metastatic testis tumors.
[A case of alpha-fetoprotein producing embryonal carcinoma of the stomach]
[A case of alpha-fetoprotein producing primary intracranial embryonal carcinoma treated with combination chemotherapy with cis-platinum, vinblastine and bleomycin (author's transl)]
[Embryonal carcinoma and vitelline tumor of the mediastinum. Diagnostic and prognostic value of alpha-fetoprotein levels. A propos of 5 cases]
[Significance of tumor markers in the treatment of patients with ovarian malignancies]
[Tumor markers in gynecologic malignancies]
Carcinoma, Endometrioid
Ovarian endometrioid adenocarcinoma with ectopic production of alpha-fetoprotein.
Ovarian yolk sac tumor associated with endometrioid carcinoma and mucinous cystadenoma of the ovary.
Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of alpha-fetoprotein, sex steroid receptors, and p53.
Papers to appear in forthcoming issues
Pseudoglandular hepatoid differentiation in endometrioid carcinoma of the ovary simulates oxyphilic cell change.
Uterine Carcinosarcoma with Alpha-Fetoprotein-Producing Hepatoid Component: A Case Report and Literature Review.
Carcinoma, Hepatocellular
240 hepatocellular carcinomas: ultrasound features, tumor size, cytologic and histologic patterns, serum alpha-fetoprotein and HBs Ag.
68Ga-PSMA PET/CT Versus 18F-FDG PET/CT for Imaging of Hepatocellular Carcinoma
8-Quinolineboronic acid as a potential phosphorescent molecular switch for the determination of alpha-fetoprotein variant for the prediction of primary hepatocellular carcinoma.
9-cis-retinoic acid is more effective than all-trans-retinoic acid in upregulating expression of the alpha-fetoprotein gene.
A case of alpha-fetoprotein-producing adenocarcinoma of the endometrium with a hepatoid component as a potential source for alpha-fetoprotein in a postmenopausal woman.
A case of alpha-fetoprotein-producing esophageal adenocarcinoma.
A case of hepatocellular carcinoma that resisted identification.
A case of hepatocellular carcinoma with the sign of Leser-Trelat: a possible role of a cutaneous marker for internal malignancy.
A case report of retroperitoneal extrahepatic hepatocellular carcinoma presented with elevated level of Alpha fetoprotein.
A case report of targeted therapy with apatinib in a patient with advanced gastric cancer and high serum level of alpha-fetoprotein.
A Case-Control Study of Correlation between Preoperative Serum AFP and Recurrence of Hepatocellular Carcinoma after Curative Hepatectomy.
A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients.
A comparison between alpha-fetoprotein and p53 antibodies in the diagnosis of hepatocellular carcinoma.
A comparison between des-gamma-carboxy prothrombin and alpha-fetoprotein as markers of hepatocellular carcinoma in southern African blacks.
A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis.
A contribution to early diagnosis of primary hepatic cell carcinoma occurring in patients with liver cirrhosis.
A fetuin-like antigen from human nephroblastoma.
A fluorometric aptamer nanoprobe for alpha-fetoprotein by exploiting the FRET between 5-carboxyfluorescein and palladium nanoparticles.
A high expression of GDP-fucose transporter in hepatocellular carcinoma is a key factor for increases in fucosylation.
A lectin-based monoclonal enzyme immunoassay to distinguish fucosylated and non-fucosylated alpha-fetoprotein molecular variants.
A malignant, stem cell-like somatic hybrid between a mouse teratocarcinoma and a rat ascitic hepatoma is differentiation competent.
A Markov model for analysing cancer markers and disease states in survival studies.
A Meta-Analysis on the Rate of Hepatocellular Carcinoma Recurrence after Liver Transplant and Associations to Etiology, Alpha-Fetoprotein, Income and Ethnicity.
A Model Predicting Survival of Patients with Recurrent or Progressive Hepatocellular Carcinoma: The MORE Score.
A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice.
A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis.
A new hepato-pancreato-renal disorder resembling tyrosinemia involving neuropathy and abnormal metabolism of polyunsaturated acids.
A new method to assay des-gamma-carboxyprothrombin. Results obtained in 75 cases of hepatocellular carcinoma.
A new restriction fragment length polymorphism of the human alpha-fetoprotein gene in Japanese individuals: detection of loss of heterozygosity in human hepatocellular carcinoma.
A novel approach for inducing enhanced and selective transgene expression in hepatocellular-carcinoma cells.
A novel biomarker TERTmRNA is applicable for early detection of hepatoma.
A novel core fucose-specific lectin from the mushroom Pholiota squarrosa.
A novel diagnostic marker, p28GANK distinguishes hepatocellular carcinoma from potential mimics.
A novel immunotherapy to hepatocellular carcinoma: CD40-activated B lymphocytes transfected with AFPmRNA.
A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides.
A position-dependent silencer plays a major role in repressing alpha-fetoprotein expression in human hepatoma.
A possible mechanism of inverse developmental regulation of alpha-fetoprotein and albumin genes. Studies with epidermal growth factor and phorbol ester.
A preliminary study of plasma cyclase-associated protein 2 as a novel biomarker for early stage and alpha-fetoprotein negative hepatocellular carcinoma patients.
A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter.
A prospective multicenter study of hepatocellular carcinoma in italian hemophiliacs with chronic hepatitis C. The Study Group of the Association of Italian Hemophilia Centers.
A prospective study of blood alpha-fetoprotein messenger RNA as a predictor of hepatocellular carcinoma in patients with cirrhosis.
A rare case of a spontaneously ruptured secondary hepatic malignant lymphoma.
A Rare Presentation of Hepatocellular Carcinoma in a Young Adult: A Case Report.
A retrospective study on the patterns of sequential fluctuation of serum alpha-fetoprotein level during progression from liver cirrhosis to hepatocellular carcinoma.
A sequential study of methapyrilene hydrochloride-induced liver carcinogenesis in male F344 rats.
A simultaneous monitoring of Lens culinaris agglutinin A-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin as an early diagnosis of hepatocellular carcinoma in the follow-up of cirrhotic patients.
A specific alpha-fetoprotein gene binding protein in alpha-fetoprotein producing rat hepatomas.
A study of alpha-fetoprotein in primary liver cancer in Tanzania.
A suggested guiding panel of seromarkers for efficient discrimination between primary and secondary human hepatocarcinoma.
A-G Score Associated With Outcomes in Solitary Hepatocellular Carcinoma Patients After Hepatectomy.
Aberrant expression of a fetal glycoprotein 68 in hepatocellular carcinoma: a comparative study on the expression of alpha-fetoprotein and carcinoembryonic antigen.
Aberrant expression of alpha-fetoprotein in intrahepatic cholangiocarcinoma: an exceptional occurrence.
Aberrant expressions of annexin A10 short isoform, osteopontin and alpha-fetoprotein at chromosome 4q cooperatively contribute to progression and poor prognosis of hepatocellular carcinoma.
Abnormal plasma prothrombin (PIVKA-II) levels in hepatocellular carcinoma.
Absolute Quantification of N-Glycosylation of Alpha-Fetoprotein Using Parallel Reaction Monitoring with Stable Isotope-Labeled N-Glycopeptide as an Internal Standard.
Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review.
Acetylation of alpha-fetoprotein promotes hepatocellular carcinoma progression.
Activation of alpha-fetoprotein synthesis in rat hepatoma cells with reduced sensitivity to dexamethasone.
Acute exacerbation of hepatitis in liver cirrhosis with very high levels of alpha-fetoprotein but no occurrence of hepatocellular carcinoma.
Acute hepatic injury after discontinuation of chemotherapy in a patient with non-Hodgkin's lymphoma and chronic hepatitis B virus infection.
Adult hepatic cavernous haemangioma with highly elevated alpha-fetoprotein.
Advances in biological markers for cancer.
Affinity chromatographic separation of alpha-fetoprotein variants: development of a mini-column procedure, and application to cancer patients.
AFP computational secreted network construction and analysis between human hepatocellular carcinoma (HCC) and no-tumor hepatitis/cirrhotic liver tissues.
AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC.
AFP-L3 in chronic liver diseases with persistent elevation of alpha-fetoprotein.
AFP-L3: a new generation of tumor marker for hepatocellular carcinoma.
AFP-producing Xp11 translocation renal cell carcinoma: Case report and review of the literature.
AFP-synthesis induction in mouse hepatomas.
Ag/SiO2 core-shell nanoparticle-based surface-enhanced Raman probes for immunoassay of cancer marker using silica-coated magnetic nanoparticles as separation tools.
Age-distribution of alpha-fetoprotein in hepatocellular carcinoma.
Albumin and alpha-fetoprotein gene expression and DNA methylation in rat hepatoma cell lines.
Albumin and alpha-fetoprotein gene transcription in rat hepatoma cell lines is correlated with specific DNA hypomethylation and altered chromatin structure in the 5' region.
Aldolase A isoenzyme levels in serum and tissues of patients with liver diseases.
Allelic loss on chromosomes 4q and 16q in hepatocellular carcinoma: association with elevated alpha-fetoprotein production.
Allomyrina dichotoma lectin-nonreactive alpha-fetoprotein in hepatocellular carcinoma and other tumors: comparison with Ricinus communis agglutinin-I.
Alpha Fetoprotein-Secreting Gastric Cancer in the Setting of Chronic Hepatitis B: The Role of Endoscopy.
Alpha-1-thymosin and transcatheter arterial chemoembolization in hepatocellular carcinoma patients: a preliminary experience.
Alpha-fetoprotein (AFP) expression in clones of McA-RH 7777 rat hepatoma: correlation with the occurrence of homogeneously staining regions on chromosome 14.
Alpha-fetoprotein (AFP)- and des-gamma-carboxy prothrombin (DCP)-producing adenocarcinoma of the stomach with liver metastasis in a patient with chronic hepatitis C.
Alpha-fetoprotein (AFP)-derived peptides as epitopes for hepatoma immunotherapy: a commentary.
alpha-Fetoprotein (alphaFP) as a marker for hepatoma and yolk sac tumors.
Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus.
Alpha-fetoprotein accelerates the progression of hepatocellular carcinoma by promoting Bcl-2 gene expression through an RA-RAR signalling pathway.
Alpha-fetoprotein activates AKT/mTOR signaling to promote CXCR4 expression and migration of hepatoma cells.
Alpha-fetoprotein acts as a novel signal molecule and mediates transcription of Fn14 in human hepatocellular carcinoma.
Alpha-fetoprotein and 18F-FDG standard uptake value predict tumor recurrence after liver transplantation for hepatocellular carcinoma with portal vein tumor thrombosis: Preliminary experience.
Alpha-fetoprotein and albumin produced by subclonal cell population of the ascites hepatoma AH-66 in vitro.
Alpha-Fetoprotein and albumin synthesis during the cell cycle.
Alpha-fetoprotein and des-gamma-carboxy-prothrombin at twenty-four weeks after interferon-based therapy predict hepatocellular carcinoma development.
Alpha-Fetoprotein and hepatitis B antigen in hepatoma and hepatitis.
Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity.
Alpha-fetoprotein and hepatocellular carcinoma.
Alpha-fetoprotein and human telomerase reverse transcriptase mRNA levels in peripheral blood of patients with hepatocellular carcinoma.
alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
Alpha-fetoprotein and its concanavalin A affinity in acute exacerbation of chronic hepatitis B.
Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: a brilliant star raises again.
Alpha-fetoprotein and p53 autoantibodies in patients with chronic hepatitis C.
Alpha-fetoprotein and serum golgi phosphoprotein 2 are equally discriminative in detecting early hepatocellular carcinomas.
Alpha-fetoprotein and the acute phase response. A study using acute pelvic inflammatory disease as a model system.
Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma.
Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma.
Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Alpha-fetoprotein as an aid for diagnosis of primary hepatoma.
Alpha-fetoprotein assessment for hepatocellular carcinoma after transarterial chemoembolization.
Alpha-fetoprotein before and after pegylated interferon therapy for predicting hepatocellular carcinoma development.
Alpha-fetoprotein changes in the course of chronic hepatitis: relation to bridging hepatic necrosis and hepatocellular carcinoma.
Alpha-fetoprotein concentrations measured by radioimmunoassay in diagnosing and excluding hepatocellular carcinoma.
Alpha-Fetoprotein Decrease from > 1,000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes.
Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts.
alpha-Fetoprotein detected in rat transplantable hepatomas by radioimmunoassay.
Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection.
Alpha-fetoprotein enhances the proliferation of human hepatoma cells in vitro.
Alpha-fetoprotein expression in hepatocellular carcinoma: a clinical study.
Alpha-fetoprotein expression is a potential prognostic marker in hepatocellular carcinoma.
Alpha-fetoprotein for hepatocellular carcinoma diagnosis: the demise of a brilliant star.
alpha-Fetoprotein gene expression. Control of alpha-fetoprotein mRNA levels in cultured rat hepatoma cells.
alpha-Fetoprotein gene methylation and hepatocarcinogenesis in rats fed a choline-devoid diet.
Alpha-fetoprotein glycosylation is abnormal in some hepatocellular carcinoma, including white patients with a normal alpha-fetoprotein concentration.
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.
Alpha-fetoprotein impairs APC function and induces their apoptosis.
Alpha-fetoprotein in bovine hepatocellular carcinoma.
Alpha-fetoprotein in early hepatocellular carcinoma.
Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the dead.
Alpha-fetoprotein in hepatocellular carcinoma with an abnormal electrophoretic alpha-1-fraction.
Alpha-fetoprotein in hepatocellular carcinoma: a serological and histochemical study in Malaysian patients.
alpha-Fetoprotein in liver disease.
Alpha-fetoprotein in monkeys with hepatoma.
alpha-fetoprotein in noneoplastic hepatic disorders.
Alpha-fetoprotein in patients with hepatocellular carcinoma after transcatheter arterial embolization.
Alpha-fetoprotein in plasma and serum of healthy adults: preanalytical, analytical and biological sources of variation and construction of age-dependent reference intervals.
Alpha-fetoprotein in serum and tumor tissues in dogs with hepatocellular carcinoma.
Alpha-fetoprotein in the diagnosis of hepatoma.
Alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma.
Alpha-fetoprotein in the woodchuck model of hepadnavirus infection and disease: immunochemical analysis of woodchuck alpha-fetoprotein and measurement in serum by quantitative monoclonal radioimmunoassay.
Alpha-fetoprotein in the woodchuck model of hepadnavirus infection and disease: normal physiological patterns and responses to woodchuck hepatitis virus infection and hepatocellular carcinoma.
Alpha-fetoprotein in tumor-bearing mice assayed by particle agglutination inhibition.
Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling.
Alpha-fetoprotein is a biomarker of unfolded protein response and altered proteostasis in hepatocellular carcinoma cells exposed to sorafenib.
Alpha-fetoprotein is an autoantigen in hepatocellular carcinoma and juvenile Batten disease.
Alpha-fetoprotein is correlated with intrahepatic recurrence of hepatocellular carcinoma after a hepatectomy.
Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study.
Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria.
Alpha-fetoprotein Level Predicts Recurrence After Transplantation in Hepatocellular Carcinoma.
Alpha-fetoprotein level to total tumor volume as a predictor of hepatocellular carcinoma recurrence after resection. A retrospective cohort study.
Alpha-Fetoprotein levels in normal males from seven ethnic groups with different hepatocellular carcinoma risks.
Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
alpha-Fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma.
Alpha-fetoprotein mRNA detection in peripheral blood for prediction of hepatocellular carcinoma recurrence after liver transplantation.
alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study.
Alpha-fetoprotein mRNA: variation of half-life in rat hepatoma cell lines and destabilization by sodium butyrate.
Alpha-fetoprotein normalization as a prognostic surrogate in small hepatocellular carcinoma after stereotactic body radiotherapy: a propensity score matching analysis.
Alpha-fetoprotein on human peripheral blood lymphocytes does not block complement-dependent lymphocytotoxicity.
Alpha-fetoprotein producing clones derived from ascites hepatoma AH70B culture.
Alpha-fetoprotein production by a malignant mixed Müllerian tumor of the ovary.
Alpha-fetoprotein production by hepatocellular carcinoma is prognostic of poor patient survival.
Alpha-Fetoprotein Promoter-Driven Cre/LoxP-Switched RNA Interference for Hepatocellular Carcinoma Tissue-Specific Target Therapy.
Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.
Alpha-fetoprotein reaction to Pisum sativum agglutinin in differentiation of benign liver diseases from hepatocellular carcinoma.
Alpha-Fetoprotein Regulates the Expression of Immune-Related Proteins through the NF-?B (P65) Pathway in Hepatocellular Carcinoma Cells.
Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma.
Alpha-Fetoprotein Response After Locoregional Therapy for Hepatocellular Carcinoma: Oncologic Marker of Radiologic Response, Progression, and Survival.
Alpha-fetoprotein response at different time-points is associated with efficacy of nivolumab monotherapy for unresectable hepatocellular carcinoma.
Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: A subgroup analysis.
Alpha-fetoprotein response following transarterial chemoembolization indicates improved survival for intermediate-stage hepatocellular carcinoma.
Alpha-fetoprotein response in advanced hepatocellular carcinoma receiving cytostatic agent.
alpha-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma.
alpha-Fetoprotein screening in patients with idiopathic hemochromatosis and liver cirrhosis.
alpha-Fetoprotein shields hepatocellular carcinoma cells from apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand.
Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the american association for the study of liver diseases.
Alpha-fetoprotein Slope >7.5 ng/ml/month Predicts Micro-vascular Invasion and Tumor Recurrence after Liver Transplantation for Hepatocellular Carcinoma.
Alpha-fetoprotein specific CD4 and CD8 T cell responses in patients with hepatocellular carcinoma.
Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
Alpha-fetoprotein stimulated the expression of some oncogenes in human hepatocellular carcinoma Bel 7402 cells.
Alpha-Fetoprotein synthesis in cultured cells: studies on Yoshida sarcoma and ascites hepatoma in vitro.
Alpha-fetoprotein synthesis in human hepatocellular carcinoma: correlation with hepatitis B surface antigen expression.
Alpha-fetoprotein testing is still necessary for the detection of small hepatocellular carcinomas.
Alpha-fetoprotein to transaminase ratio is related to higher diagnostic efficacy for hepatocellular carcinoma.
Alpha-fetoprotein triggers hepatoma cells escaping from immune surveillance through altering the expression of Fas/FasL and tumor necrosis factor related apoptosis-inducing ligand and its receptor of lymphocytes and liver cancer cells.
alpha-Fetoprotein, Des-gamma Carboxyprothrombin, and Lectin-Bound alpha-Fetoprotein in Early Hepatocellular Carcinoma.
Alpha-Fetoprotein, Des-Gamma-Carboxy Prothrombin, and Modified RECIST Response as Predictors of Survival after Transarterial Radioembolization for Hepatocellular Carcinoma.
Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology.
Alpha-fetoprotein, stem cells and cancer: how study of the production of alpha-fetoprotein during chemical hepatocarcinogenesis led to reaffirmation of the stem cell theory of cancer.
Alpha-fetoprotein, tissue polypeptide antigen and ferritin in diagnosing primary hepatocellular carcinoma in patients with liver cirrhosis.
Alpha-fetoprotein-L3 and Golgi protein 73 may serve as candidate biomarkers for diagnosing alpha-fetoprotein-negative hepatocellular carcinoma.
Alpha-fetoprotein-producing capacity, chromosomal and morphological properties in human hepatoma cells treated with various chemotherapeutic agents.
Alpha-fetoprotein-producing carcinoma of the renal pelvis exhibiting hepatoid and urothelial differentiation.
Alpha-fetoprotein-producing Colon Carcinoma with Rapidly Increasing Liver Metastases That Resulted in Death: A Case Report.
Alpha-fetoprotein-producing gastric carcinoma with enteroblastic differentiation.
Alpha-fetoprotein-producing male breast cancer accompanied with hepatocellular carcinoma: assessment by lectin-affinity profile.
Alpha-fetoprotein-producing non-germ cell tumours of the female genital tract.
Alpha-fetoprotein-producing pancreatic acinar cell carcinoma.
Alpha-fetoprotein-producing rectal cancer successfully responded to preoperative chemoradiotherapy: case report.
Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma.
alpha-Fetoprotein-specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccination.
Alpha-fetoprotein-thymidine kinase-luciferase knockin mice: A novel model for dual modality longitudinal imaging of tumorigenesis in liver.
Alpha-fetoprotein/endoplasmic reticulum stress signaling mitigates injury in hepatoma cells.
Alpha-fetoprotein: a controversial prognostic biomarker for small hepatocellular carcinoma.
Alpha-fetoprotein: A new member of intracellular signal molecules in regulation of the PI3K/AKT signaling in human hepatoma cell lines.
Alpha-fetoprotein: diagnostic and prognostic use in patients with hepatomas.
Alpha-fetoprotein: from a diagnostic biomarker to a key role in female fertility.
Alpha-fetoprotein: its immunofluorescent localization in human fetal liver and hepatoma.
alpha-Fetoprotein: studies of tumor-associated antigen cytotoxicity in mouse hepatoma BW7756.
Alpha-Fetoprotein: The Predictor of Microvascular Invasion in Solitary Small Hepatocellular Carcinoma and Criterion for Anatomic or Non-Anatomic Hepatic Resection.
Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in southern African blacks.
Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand.
Altered dynamics of alpha-fetoprotein production following pyridoxine and adenosine 5'-triphosphate administration to cirrhotic patients with or without primary hepatomas and to liver-injured and hepatoma-bearing rats.
Altered glycosylation of alpha-fetoprotein in hepadnavirus-induced hepatocellular carcinoma of the woodchuck.
An acute form of tyrosinemia type I with multiple intrahepatic mass lesions.
An advanced strategy of enhanced specific gene expression for hepatocellular carcinoma.
An analysis of the UNOS liver transplant registry: High serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma.
An attenuated Salmonella oral DNA vaccine prevents the growth of hepatocellular carcinoma and colon cancer that express alpha-fetoprotein.
An elevated neutrophil-to-lymphocyte ratio predicts a poor postoperative survival in primary hepatocellular carcinoma patients with a normal preoperative serum level of alpha-fetoprotein.
An evaluation of cellular lineages in the pathogenesis of experimental hepatocellular carcinoma.
An fluorescent aptasensor for sensitive detection of tumor marker based on the FRET of a sandwich structured QDs-AFP-AuNPs.
An immuno-electron microscopic study on intra and extracellular localization of alpha-fetoprotein in human hepatocellular carcinoma.
An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19.
An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results.
Analysis and optimization of nonequilibrium capillary electrophoresis of alpha-fetoprotein isoforms.
Analysis of alpha-fetoprotein gene expression in hepatocellular carcinoma and liver cirrhosis by in situ hybridization.
Analysis of alpha-fetoprotein mRNA level on the tumor cell hematogenous spread of patients with hepatocellular carcinoma undergoing orthotopic liver transplantation.
Analysis of CD4+ T-Cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patients.
Analysis of polarized secretion of fucosylated alpha-fetoprotein in HepG2 cells.
Analysis of Serum Paraoxonase 1 Using Mass Spectrometry and Lectin Immunoassay in Patients With Alpha-Fetoprotein Negative Hepatocellular Carcinoma.
Analytical and Clinical Performance Evaluation of the Abbott Architect PIVKA Assay.
Angiogenesis and clinicopathologic characteristics in different hepatocellular carcinoma subtypes defined by EpCAM and alpha-fetoprotein expression status.
Angiographically undetected small hepatocellular carcinoma: clinicopathological characteristics, follow-up and treatment.
ANGPTL6-mediated angiogenesis promotes alpha fetoprotein-producing gastric cancer progression.
Anti-p53 autoantibodies in hepatitis C virus-infected patients.
Antiangiogenic activity of vitexicarpine in experimentally induced hepatocellular carcinoma: Impact on vascular endothelial growth factor pathway.
Antisense oligodeoxynucleotide against c-myc mRNA induces differentiation of human hepatocellular carcinoma cells.
Antitumor effect of adriamycin entrapped in liposomes conjugated with anti-human alpha-fetoprotein monoclonal antibody.
Antitumoral effects of recombinant adenovirus YKL-1001, conditionally replicating in alpha-fetoprotein-producing human liver cancer cells.
Apolipoproteinemia A and alpha-fetoprotein in the diagnosis of hepatocellular carcinoma and cirrhosis: several interpretations.
Apoptosis induction by acyclic retinoid: a molecular basis of 'clonal deletion' therapy for hepatocellular carcinoma.
Appearance of alpha-fetoprotein in rat serum during induction of primary hepatoma with regard to development of histological changes in liver tissue.
Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma.
Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma.
Application of des-gamma-carboxy prothrombin as a complementary tumor marker with alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Are both PIVKA-II and alpha-fetoprotein necessary in follow-up management after hepatic resection for hepatocellular carcinoma?
Are hepatocellular carcinoma surveillance programs effective at improving the therapeutic options.
Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
Ascitic fluid analysis in malignancy-related ascites.
Ascorbic acid induces redifferentiation and growth inhibition in human hepatoma cells by increasing endogenous hydrogen peroxide.
ASO Author Reflections: Fibrolamellar Hepatocellular Carcinoma and Alpha-Fetoprotein.
Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal.
Assessment of Alpha-Fetoprotein in the Diagnosis of Hepatocellular Carcinoma in Middle Eastern Patients.
Assessment of Liver Stiffness Regression and Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients after Treatment with Direct-Acting Antiviral Drugs.
Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Assessment of treatment outcomes based on tumor marker trends in patients with recurrent hepatocellular carcinoma undergoing trans-catheter arterial chemo-embolization.
Associated measurement of fucosylated levels of AFP, DCP, and GPC3 for early diagnosis in hepatocellular carcinoma.
Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood.
Association of Common Variants in HNF1A Gene with Serum AFP Level in Healthy Chinese Individuals and HCC Patients.
Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml).
Author Correction: Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling.
Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma.
Autoantibody signature in hepatocellular carcinoma using seromics.
Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1.
bcl 10 gene mutation in hepatocellular carcinoma.
Beta2-microglobulin levels of serum and ascites in malignant diseases.
Bile acid synthesis by long-term cultured cell line established from human hepatoblastoma.
Biliary alkaline phosphatase measured by mini-column chromatography on DEAE-cellulose: application to detection of hepatobiliary diseases.
Biochemical formulations of embryonic gene control.
Biology and significance of alpha-fetoprotein in hepatocellular carcinoma.
Biosynthesis of alpha-fetoprotein in cultured hepatoma cells.
Bleeding index after the first course of endoscopic treatment for esophageal varices in liver cirrhotic patients with and without hepatocellular carcinoma.
Blood transcobalamin levels in malignant hepatoma.
Bone scintigraphy of skeletal metastasis in hepatoma patients treated by TAE.
Boronate affinity chromatography of gamma-glutamyltransferase in patients with hepatocellular carcinoma.
Budd-Chiari syndrome and hepatocellular carcinoma: a case report and review of the literature.
Budd-Chiari syndrome as an initial presentation of hepatocellular carcinoma: a case report.
c-Ha-ras down regulates the alpha-fetoprotein gene but not the albumin gene in human hepatoma cells.
C-Reactive Protein and Platelet-Lymphocyte Ratio as Potential Tumor Markers in Low-Alpha-Fetoprotein Hepatocellular Carcinoma.
Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation?
Cancer in Bangladesh: a model for some problems and proposed solutions in the Third World.
Capillary electrochromatography immunoassay for alpha-fetoprotein based on poly(guanidinium ionic liquid) monolithic material.
Capillary electrophoresis-electrospray ionization mass spectrometry for rapid and sensitive N-glycan analysis of glycoproteins as 9-fluorenylmethyl derivatives.
Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans.
Carbohydrate-based measurements on alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma.
Carcinoembryonic character of gamma-glutamyltranspeptidase in primary hepatocellular carcinoma.
Carcinogenicity of aflatoxin B1 in rhesus monkeys: two additional cases of primary liver cancer.
Case of clear-cell hepatocellular carcinoma that developed in the normal liver of a middle-aged woman.
Cell-mediated immune responses to alpha-fetoprotein and other antigens in hepatocellular carcinoma.
Cellular fibronectin concentration in the plasma of patients with malignant and benign diseases: a comparison with CA 19-9 and CEA.
Change of alpha-fetoprotein content during cell cycle of human hepatoma cells in vitro: flow cytometric analysis.
Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter.
Changes in highly sensitive alpha-fetoprotein for the prediction of the outcome in patients with hepatocellular carcinoma after hepatectomy.
Changes in serum alpha-fetoprotein and chorionic gonadotropin in response to cancer therapy.
Changes of alpha-fetoprotein levels could predict recurrent hepatocellular carcinoma survival after trans-arterial chemoembolization.
Changes of serum alpha-fetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma: prognostic significance.
Characteristics of hepatocellular carcinoma in hemodialysis patients in hepatitis B endemic area.
Characteristics of liver diseases in the elderly: a review.
Characterization and nucleotide sequences of the variable regions of a monoclonal antibody against alpha-fetoprotein.
Characterization of alpha-fetoprotein secreted from cultured reuber H-35 hepatoma cells.
Characterization of HBeAg-negative chronic hepatitis B in western Brazilian Amazonia.
Chemerin reverses the malignant phenotype and induces differentiation of human hepatoma SMMC7721 cells.
Chemoprevention and screening in primary sclerosing cholangitis.
Cholangiography of icteric type hepatoma.
Cholestasis is the main determinant of abnormal CA 19-9 levels in patients with liver cirrhosis.
Chromosome analysis of hepatocellular carcinoma 7777 and correlation with alpha-fetoprotein production.
Chronological change in alpha-fetoprotein levels in hepatocellular carcinoma after eradication of hepatitis C virus.
Circulating exosomal miR-92b: Its role for cancer immunoediting and clinical value for prediction of posttransplant hepatocellular carcinoma recurrence.
Circulating intercellular adhesion molecule-1 in patients with hepatocellular carcinoma.
Circulating messenger RNA of alpha-fetoprotein: a possible risk factor of recurrence after resection of hepatocellular carcinoma.
Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: a quantitative evaluation.
Cirrhotic patients with or without hepatocellular carcinoma harbour AFP-specific T-lymphocytes that can be activated in vitro by human alpha-fetoprotein.
Clinical Advantage of Highly Sensitive On-Chip Immunoassay for Fucosylated Fraction of Alpha-Fetoprotein in Patients with Hepatocellular Carcinoma.
Clinical and Experimental Evaluation of Diagnostic Significance of Alpha-Fetoprotein and Osteopontin at the Early Stage of Hepatocellular Cancer.
Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein level in an Asia-Pacific island cohort.
Clinical Application of Determining Serum AFP-IgM Complexes for Diagnosis of Small Hepatocellular Carcinoma.
Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases.
Clinical benefits of hepatocellular carcinoma surveillance: a single-center, hospital-based study.
Clinical characteristics among patients with hepatocellular carcinoma according to the serum levels of alpha-fetoprotein and des-y-carboxy prothrombin.
Clinical characteristics analysis of 1180 patients with hepatocellular carcinoma secondary to hepatitis B, hepatitis C and alcoholic liver disease.
Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes.
Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels.
Clinical characteristics of hepatocellular carcinoma patients with normal serum alpha-fetoprotein level: A study of 112 consecutive cases.
Clinical classification of hepatoma in Japan according to serial changes in serum alpha-fetoprotein levels.
Clinical correlation of miR-375 and alpha-fetoprotein in hepatocellular carcinoma: Comparison in mice and humans.
Clinical evaluation of a monoclonal antibody to serum KM01 for the diagnosis of hepatocellular carcinoma.
Clinical evaluation of lens culinaris agglutinin-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin in histologically proven hepatocellular carcinoma in the United States.
Clinical evaluation of lentil lectin-reactive alpha-fetoprotein-L3 in histology-proven hepatocellular carcinoma.
Clinical evaluation of pancreatitis-associated protein as a serum marker of hepatocellular carcinoma: comparison with alpha-fetoprotein.
Clinical evaluation of serum alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) levels in patients with hepatocellular carcinoma following interventional radiology.
Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma.
Clinical evaluation of serum alpha-fetoprotein-IgM immune complexes on the diagnosis of primary hepatocellular carcinoma.
Clinical evaluation of urinary transforming growth factor-beta1 and serum alpha-fetoprotein as tumour markers of hepatocellular carcinoma.
Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients.
Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II.
Clinical implications of alpha-fetoprotein in liver cirrhosis: five-year follow-up study.
Clinical observations during a relatively early stage of hepatocellular carcinoma, with special reference to serum alpha-fetoprotein levels.
Clinical outcomes of patients with a high alpha-fetoprotein level but without evident recurrence on CT or MRI in surveillance after curative-intent treatment for hepatocellular carcinoma.
Clinical relevance of alpha-fetoprotein in determining resection margin for hepatocellular carcinoma.
Clinical role of combining alpha-fetoprotein and lens culinaris agglutinin-reactive fraction of alpha-fetoprotein for hepatocellular carcinoma: Evidence from literature and an original study.
Clinical significance of abnormal prothrombin (DCP) in relation to postoperative survival and prognosis in patients with hepatocellular carcinoma.
Clinical Significance of Alpha-Fetoprotein in Alpha-Fetoprotein Negative Hepatocellular Carcinoma Underwent Curative Resection.
Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma.
Clinical Significance of Alpha-Fetoprotein mRNA in Peripheral Blood in Liver Resection for Hepatocellular Carcinoma.
Clinical significance of alpha-fetoprotein: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinoma.
Clinical significance of elevated alpha-fetoprotein (AFP) in chronic hepatitis C without hepatocellular carcinoma.
Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma.
Clinical significance of lens culinaris agglutinin-reactive fraction of serum alpha-fetoprotein in patients with hepatocellular carcinoma.
Clinical significance of mrp gene in primary hepatocellular carcinoma.
Clinical Significance of Preoperative Hepatocellular Carcinoma With High Lens culinaris Agglutinin-reactive Fraction of Alpha-Fetoprotein, But Low Alpha-Fetoprotein.
Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
Clinical significance of tumor markers in detection of recurrent hepatocellular carcinoma after radiofrequency ablation.
Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM versus alpha-fetoprotein in Egyptian patients with hepatitis C virus-induced hepatocellular carcinoma.
Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis.
Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein <20?ng/mL.
Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis.
Clinical utility of lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a Thai referral population.
Clinical utility of prothrombin induced by vitamin K absence in the detection of hepatocellular carcinoma in Indian population.
Clinical utility of simultaneous measurement of alpha-fetoprotein and des-?-carboxy prothrombin for diagnosis of patients with hepatocellular carcinoma in China: A multi-center case-controlled study of 1,153 subjects.
Clinical utility of simultaneous measurement of serum high-sensitivity des-gamma-carboxy prothrombin and Lens culinaris agglutinin A-reactive alpha-fetoprotein in patients with small hepatocellular carcinoma.
Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients.
Clinical value of LHPP-associated microRNAs combined with protein induced by vitamin K deficiency or antagonist-II in the diagnosis of alpha-fetoprotein-negative hepatocellular carcinoma.
Clinical value of urinary and serum pseudouridine in diagnosis and monitoring of primary liver cancer.
Clinico-cytopathological spectrum of hepatocellular carcinoma, its correlation with serum alpha-fetoprotein level, and hepatitis B and C viral markers.
Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
Clinicopathologic features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein-L3 and seronegative for des-gamma-carboxy prothrombin in comparison with those seropositive for des-gamma-carboxy prothrombin alone.
Clinicopathologic features of patients with primary malignant hepatic tumors seropositive for alpha-fetoprotein-L3 alone in comparison with other patients seropositive for alpha-fetoprotein-L3.
Clinicopathologic significance of protein induced vitamin K absence or antagonist II and alpha-fetoprotein in hepatocellular carcinoma.
Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma.
Coagulation assays as diagnostic markers of hepatocellular carcinoma.
Coexistence of expressed and non-expressed alpha-fetoprotein genes in somatic cell hybrids.
Collecting duct carcinoma of kidney producing alpha-fetoprotein.
Combination of alpha-1-acid glycoprotein and alpha-fetoprotein as an improved diagnostic tool for hepatocellular carcinoma.
Combination of alpha-fetoprotein mRNA-based detection of hematogenously disseminating hepatocellular carcinoma cells and analysis of cancer cell membrane fluidity is more accurate in screening patients at risk of postoperative recurrence.
Combination of dual serum fluorescence, AFP and hepatic function tests is valuable to identify HCC in AFP-elevated liver diseases.
Combination of exosomes and circulating microRNAs may serve as a promising tumor marker complementary to alpha-fetoprotein for early-stage hepatocellular carcinoma diagnosis in rats.
Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma.
Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation.
Combined analysis of serum alpha-fetoprotein and MAGE-A3-specific cytotoxic T lymphocytes in peripheral blood for diagnosis of hepatocellular carcinoma.
Combined assessment of TGF-beta-1 and alpha-fetoprotein values improves specificity in the diagnosis of hepatocellular carcinoma and other chronic liver diseases in Malaysia.
Combined Detection of mRNA Expression of Alpha-Fetoprotein in Peripheral Blood and Telomerase Activity of Monocytes in Hepatocellular Carcinoma Patients.
Combined effect of alpha-fetoprotein antisense oligodeoxy-nucleotides and 5-fluorouracil on human hepatoma cell growth.
Combined hepatocellular-cholangiocarcinoma with stem cell features, cholangiolocellular subtype after inferior vena cava stent placement for a patient with Budd-Chiari syndrome.
Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study.
Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study.
Combined measurement of preoperative ?-fetoprotein and des-?-carboxyprothrombin predicts recurrence after curative resection in patients with hepatitis-B related hepatocellular carcinoma.
Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation study.
Comment on Alpha-Fetoprotein Decrease from > 1.000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes.
Comparative analysis of core-fucose-binding lectins from Lens culinaris and Pisum sativum using frontal affinity chromatography.
Comparative Efficacy of Cabozantinib and Ramucirumab After Sorafenib for Patients with Hepatocellular Carcinoma and Alpha-fetoprotein???400 ng/mL: A Matching-Adjusted Indirect Comparison.
Comparing the diagnostic value of serum oligosaccharide chain (G-test) and alpha-fetoprotein for hepatitis B virus-related liver cancer.
Comparison between human-telomerase reverse transcriptase mRNA and alpha-fetoprotein mRNA as a predictive value for recurrence of hepatocellular carcinoma in living donor liver transplantation.
Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases.
Comparison of AFP-L3 and p53 Antigen Concentration with Alpha-Fetoprotein as Serum Markers for Hepatocellular Carcinoma.
Comparison of alpha-fetoprotein with some other tumour markers in Malaysians with hepatocellular carcinoma.
Comparison of clinicopathological features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein alone and those seropositive for des-gamma-carboxy prothrombin alone.
Comparison of serum tumor markers for intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
Comparison of the acute phase response of cultured Morris hepatoma 7777 cells and of rat hepatocytes.
Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
Comparison of ultrasound guided versus CT guided radiofrequency ablation on liver function, serum PIVKA-II, AFP levels and recurrence in patients with primary hepatocellular carcinoma.
Complete and Sustained Off-Therapy Response to Sorafenib in Advanced Hepatocellular Carcinoma.
Computational intelligence identifies alkaline phosphatase (ALP), alpha-fetoprotein (AFP), and hemoglobin levels as most predictive survival factors for hepatocellular carcinoma.
Concanavalin A affinity molecular variants of alpha-fetoprotein in neonatal rat serum and in the serum of rats bearing hepatomas.
Concanavalin A affinity of alpha-fetoprotein. Its use in differentiating tumors.
Concanavalin-A-affinity molecular heterogeneity of human hepatoma AFP and cord-serum AFP.
Concurrent evaluation of p53, beta-catenin, and alpha-fetoprotein expression in human hepatocellular carcinoma.
Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma.
Conditions required for activation of the mouse albumin or alpha-fetoprotein gene in hybrids between mouse lymphoblastoma and rat hepatoma cells.
Connection of ductlike structures induced by a chemical hepatocarcinogen to portal bile ducts in the rat liver detected by injection of bile ducts with a pigmented barium gelatin medium.
Connexin-43 can delay early recurrence and metastasis in patients with hepatitis B-related hepatocellular carcinoma and low serum alpha-fetoprotein after radical hepatectomy.
Considerations regarding current diagnosis and prognosis of hepatocellular carcinoma.
Continued value of the serum alpha-fetoprotein test in surveilling at-risk populations for hepatocellular carcinoma.
Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma.
Control of albumin and alpha-fetoprotein expression in rat liver and in some transplantable hepatocellular carcinomas.
Control of serum protein production in hepatocyte hybridomas: immortalization and expression of normal hepatocyte genes.
Coordinate secretion of mouse alphafetoprotein, mouse albumin and rat albumin by mouse hepatoma-rat hepatoma hybrid cells.
Correction to: Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and Validation.
Correlating serum alpha-fetoprotein in hepatocellular carcinoma with response to Yttrium-90 transarterial radioembolization with glass microspheres (TheraSphere™).
Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy.
Correlation and prognostic significance of beta-galactoside alpha-2,6-sialyltransferase and serum monosialylated alpha-fetoprotein in hepatocellular carcinoma.
Correlation between HBV protein preS2 and tumor markers of hepatocellular carcinoma.
Correlation between hepatitis B virus surface antigen level and alpha-fetoprotein in patients free of hepatocellular carcinoma or severe hepatitis.
Correlation between preoperative serum alpha-fetoprotein levels and survival with respect to the surgical treatment of hepatocellular carcinoma at a tertiary care hospital in Veracruz, Mexico.
Correlation between Retinoic Acid Sensitivity and IGFBP-3, AFP Protein Expression in Hepatoma Cell Lines.
Correlation between serum level of, and tissue positivity for, alpha-fetoprotein in hepatocellular carcinoma.
Corrigendum: Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis.
Cost-effectiveness analysis of hepatocellular carcinoma screening by combinations of ultrasound and alpha-fetoprotein among Alaska Native people, 1983-2012.
CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma.
Cre/loxP system controlled by specific promoter for radiation-mediated gene therapy of hepatoma.
Cryptic epitopes on alpha-fetoprotein induce spontaneous immune responses in hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis patients.
Culturing of human hepatocellular carcinoma. A simple and reproducible method.
Current role of local ablative treatments for hepatocellular carcinoma.
Cytokine evaluation in liver cirrhosis and hepatocellular carcinoma.
Cytophotometric measurements of nuclear DNA content in hepatocellular carcinomas.
Cytoplasmic alpha-fetoprotein functions as a co-repressor in RA-RAR signaling to promote the growth of human hepatoma Bel 7402 cells.
Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver.
Cytotoxic effects of daunomycin-fatty acid complexes on rat hepatoma cells.
Cytotoxicity induced by monoclonal antibody to alpha-fetoprotein coadministered with spleen cells of nude mice.
Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: A multicenter retrospective study.
Datura stramonium agglutinin-reactive alpha-fetoprotein isoforms in hepatocellular carcinoma and other tumors.
Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis C virus infection receiving interferon therapy: a single center study.
Decrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals.
Defective function of lymphokine-activated killer cells and natural killer cells in patients with hepatocellular carcinoma.
Delayed morbidity and mortality of albumin/SV40 T-antigen transgenic mice after insertion of an alpha-fetoprotein/herpes virus thymidine kinase transgene and treatment with ganciclovir.
Deletion of serum lectin-reactive alpha-fetoprotein by acyclic retinoid: a potent biomarker in the chemoprevention of second primary hepatoma.
Delineation of antigenic pathways of ethionine-induced liver cancer in the rat.
Demonstration of a novel cellular retinol-binding protein, F-type, in hepatocellular carcinoma.
Dendritic cell-based vaccines positively impact natural killer and regulatory T cells in hepatocellular carcinoma patients.
Dendritic cells pulsed with alpha-fetoprotein and mutant P53 fused gene induce bi-targeted cytotoxic T lymphocyte response against hepatic carcinoma.
Depressed immune function in patients with cirrhosis before emergence of hepatocellular carcinoma.
Des-?-carboxy prothrombin ratio measured by P-11 and P-16 antibodies is a novel biomarker for hepatocellular carcinoma.
Des-gamma carboxy prothrombin (PIVKA-II) and alpha-fetoprotein producing gastric cancer with multiple liver metastases.
Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma.
Des-gamma-carboxy prothrombin and alpha-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinoma.
Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Design and validation of risk prediction model for hepatocellular carcinoma development after sustained virological response in patients with chronic hepatitis C.
Detection of AFP mRNA-expressing cells in the peripheral blood for prediction of HCC recurrence after living donor liver transplantation.
Detection of alpha-fetoprotein and hepatitis-B surface antigen in blood spotted on filter paper: use as a screen for hepatocellular carcinoma in Alaska Natives.
Detection of Alpha-Fetoprotein in Hepatocellular Carcinoma Patient Plasma with Graphene Field-Effect Transistor.
Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma.
Detection of hepatocellular carcinoma with a new alpha-fetoprotein antibody imaging kit.
Detection of hepatocellular carcinoma-specific alpha-fetoprotein by isoelectric focusing.
Detection of membrane-bound alpha-fetoprotein in human hepatoma cell lines by monoclonal antibody 19F12.
Detection of messenger RNAs of alpha-fetoprotein and albumin in a human hepatoma cell line by in situ hybridization.
Detection of tumor cells in peritoneal lavages from patients with gastrointestinal cancer by multiplex reverse transcriptase PCR.
Detection, Isolation, and Characterization of alpha-fetoprotein-specific T Cell Populations and Clones Using MHC Class I Multimer Magnetic Sorting.
Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: Implications for its clinical use.
Determination of alpha-fetoprotein in human serum by a quartz crystal microbalance-based immunosensor.
Determination of optimum cutoff levels of plasma des-gamma-carboxy prothrombin and serum alpha-fetoprotein for the diagnosis of hepatocellular carcinoma using receiver operating characteristic curves.
Development and application of a fluorescence protein microarray for detecting serum alpha-fetoprotein in patients with hepatocellular carcinoma.
Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
Development And Validation Of A Simple Model For Detection Of Early Hepatocellular Carcinoma In A Liver Cirrhosis Cohort.
Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
Development of a Listeria monocytogenes-based vaccine against hepatocellular carcinoma.
Development of a multiple-marker RT-PCR assay for detection of micrometastases of hepatocellular carcinoma.
Development of a novel assay to quantify serum human telomerase reverse transcriptase messenger RNA and its significance as a tumor marker for hepatocellular carcinoma.
Development of a novel panel based on micro-RNAs (21, 29a, 200 and 335) and alpha-fetoprotein as diagnostic biomarkers for hepatocellular carcinoma associated with hepatitis C infection.
Development of des-gamma-carboxy prothrombin (DCP) measuring reagent using the LiBASys clinical analyzer.
Development of hepatocellular carcinoma after successful management of esophageal variceal bleeding.
Development of high-performance magnetic chemiluminescence enzyme immunoassay for alpha-fetoprotein (AFP) in human serum.
Development of on-chip fully automated immunoassay system "?TASWako i30" to measure the changes in glycosylation profiles of alpha-fetoprotein in patients with hepatocellular carcinoma.
Dexamethasone inhibition of rat hepatoma growth and alpha-fetoprotein synthesis.
Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications.
Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography. A study in 51 patients.
Diagnosis of hepatocellular carcinoma by concanavalin A affinity electrophoresis of serum alpha-fetoprotein.
Diagnosis of hepatocellular carcinoma in patients with liver cirrhosis using liver function assays.
Diagnostic accuracy of osteopontin plus alpha-fetoprotein in the hepatocellular carcinoma: A meta-analysis.
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection.
Diagnostic and mechanistic implications of serum free light chains, albumin and alpha-fetoprotein in hepatocellular carcinoma.
Diagnostic and prognostic potential of serum miR-132/212 cluster in patients with hepatocellular carcinoma.
Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?
Diagnostic and Prognostic Role of Serum Interleukin-6 in Malignant Transformation of Liver Cirrhosis.
Diagnostic and prognostic value of alpha-fetoprotein, des-?-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
Diagnostic clues for recurrent hepatocellular carcinoma: comparison of tumour markers and imaging studies.
Diagnostic performance of alpha-fetoprotein, lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: a systematic review and meta-analysis protocol.
Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma.
Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patients.
Diagnostic role and correlation with staging systems of PIVKA-II compared with AFP.
Diagnostic Role of Blood Tumor Markers in Predicting Hepatocellular Carcinoma in Liver Cirrhosis Patients Undergoing Liver Transplantation.
Diagnostic significance of estimation of serum apolipoprotein A along with alpha-fetoprotein in alcoholic cirrhosis and hepatocellular carcinoma patients.
Diagnostic utility of alpha-fetoprotein and des-gamma-carboxyprothrombin in nigerians with hepatocellular carcinoma.
Diagnostic utility of Glut-1 and CA 15-3 in discriminating adenocarcinoma from hepatocellular carcinoma in liver tumors biopsied by fine-needle aspiration.
Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma.
Diagnostic value of alpha-fetoprotein, Lens culinaris agglutinin-reactive alpha-fetoprotein, and des-gamma-carboxyprothrombin in hepatitis B virus-related hepatocellular carcinoma.
Diagnostic value of alpha-fetoprotein-L3 and Golgi protein 73 in hepatocellular carcinomas with low AFP levels.
Diagnostic value of alpha-L-fucosidase for hepatocellular carcinoma: a meta-analysis.
Diagnostic value of gamma-glutamyltransferase/aspartate aminotransferase ratio, protein induced by vitamin K absence or antagonist II, and alpha-fetoprotein in hepatitis B virus-related hepatocellular carcinoma.
Diagnostic value of hepatocyte paraffin 1 antibody to discriminate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsies of the liver.
Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma.
Diagnostic value of protein induced by vitamin K absence (PIVKAII) and hepatoma-specific band of serum gamma-glutamyl transferase (GGTII) as hepatocellular carcinoma markers complementary to alpha-fetoprotein.
Diagnostic Value of Serum Biomarkers for Patients Undergoing Curative Resection with Non-B, Non-C Hepatocellular Carcinoma.
Diagnostic value of serum gamma-glutamyl transferase isoenzyme for hepatocellular carcinoma: a 10-year study.
Diagnostic value of serum tumor markers in asymptomatic individuals.
Diagnostic value of the ?-glutamyltransferase and alanine transaminase ratio, alpha-fetoprotein, and protein induced by vitamin K absence or antagonist II in hepatitis B virus-related hepatocellular carcinoma.
Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis.
Diagnostic value of gamma-glutamyl transpeptidase to alkaline phosphatase ratio combined with gamma-glutamyl transpeptidase to aspartate aminotransferase ratio and alanine aminotransferase to aspartate aminotransferase ratio in alpha-fetoprotein-negative hepatocellular carcinoma.
Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma.
Did AFP-L3 save ultrasonography in community screening?
Differences in survival based on the type of follow-up for the detection of hepatocellular carcinoma: an analysis of 547 patients.
Differential alpha-fetoprotein lectin binding in hepatocellular carcinoma. Diagnostic utility at low serum levels.
Differential alternative splicing between hepatocellular carcinoma with normal and elevated serum alpha-fetoprotein.
Differential effects of dimethyl sulfoxide and sodium butyrate on alpha-fetoprotein, albumin, and transferrin production by rat hepatomas in culture.
Differential Expression of Glypican-3 and Insulin–Like Growth Factor-II mRNAs and Alpha-Fetoprotein and Ki-67 Markers in HCV Related Hepatocellular Carcinomas In Egyptian Patients
Differential lectin reactivities of alpha-fetoprotein in hepatocellular carcinoma: diagnostic value when serum alpha-fetoprotein levels are slightly raised.
Differential reactivity of alpha-fetoprotein with lectins and evaluation of its usefulness in the diagnosis of hepatocellular carcinoma.
Differential regulation of albumin gene expression by heparin-binding epidermal growth factor-like growth factor in alpha-fetoprotein-producing and -nonproducing human hepatoma cells.
Differential vascular endothelial growth factor A protein expression between small hepatocellular carcinoma and cirrhosis correlates with serum vascular endothelial growth factor A and alpha-fetoprotein.
Diffuse intrahepatic recurrence after resection of hepatocellular carcinoma.
Direct Monitoring of Fucosylated Glycopeptides of Alpha-Fetoprotein in Human Serum for Early Hepatocellular Carcinoma by Liquid Chromatography-Tandem Mass Spectrometry with Immunoprecipitation.
Discovery and validation of urinary metabotypes for the diagnosis of hepatocellular carcinoma in West Africans.
Disposition of epirubicin in an oily contrast medium after intravenous and intrahepato-arterial administration in liver cancer: a preliminary report.
Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice.
Distinctions between clinicopathological factors and prognosis of alpha-fetoprotein negative and positive hepatocelluar carcinoma patients.
Distribution of alpha-fetoprotein and immunoreactive carcinoembryonic antigen in human hepatocellular carcinoma and hepatoblastoma.
Distribution of alpha-fetoprotein-producing cells and proliferating cells in human hepatoma cells transplanted into athymic mice.
Diverse efficacy of vaccination therapy using the alpha-fetoprotein gene against mouse hepatocellular carcinoma.
DNA vaccination with AFP-encoding plasmid DNA prevents growth of subcutaneous AFP-expressing tumors and does not interfere with liver regeneration in mice.
Do overexpressed oncoproteins cause malignant growth of cancer cells?--Studied by antisense oligonucleotides.
Does surgical resection of hepatocellular carcinoma accelerate cancer dissemination?
Does the Preoperative Alpha-fetoprotein Predict the recurrence and mortality after Hepatectomy for Hepatocellular Carcinoma without macrovascular invasion in patients with normal liver function?
Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection?
Dose-dependent regulation of superoxide anion on the proliferation, differentiation, apoptosis and necrosis of human hepatoma cells: the role of intracellular Ca 2+.
Double- and Triple-Positive Tumor Markers Predict Early Recurrence and Poor Survival in Patients with Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh Class A.
Down-regulation of ATBF1 is a major inactivating mechanism in hepatocellular carcinoma.
Downregulation of alpha-fetoprotein siRNA inhibits proliferation of SMMC-7721 cells.
DR-70 immunoassay for the surveillance of hepatocellular carcinoma.
Dracocephalum: novel anticancer plant acting on liver cancer cell mitochondria.
Dramatic reduction of the alpha-fetoprotein level after lamivudine treatment of patients with chronic hepatitis B virus infection and cirrhosis.
Dual-Effect of Magnetic Resonance Imaging Reporter Gene in Diagnosis and Treatment of Hepatocellular Carcinoma.
Duplex pulsed Doppler sonography of hepatocellular carcinoma treated with transcatheter arterial embolization.
Dynamic Changes in Serum Markers and Their Utility in the Early Diagnosis of All Stages of Hepatitis B-Associated Hepatocellular Carcinoma.
Dynamics of alpha-fetoprotein production compared to alpha 2-macroglobulin during induction of primary hepatoma with 4-dimethylaminoazobenzene in rats.
Dynamics of serum alpha-fetoprotein during spontaneous hepatocellular carcinoma development in mice.
Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma.
Early detection of hepatocellular carcinoma associated with cirrhosis by combined assay of des-gamma-carboxy prothrombin and alpha-fetoprotein: a prospective study.
Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study.
Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy.
Early Detection of Hepatocellular Carcinoma Recurrence Using the Highly Sensitive Fucosylated Fraction of Alpha-Fetoprotein.
Early detection of primary hepatocellular carcinoma by screening for alpha-fetoprotein in high-risk families. A case-report.
Early detection of primary hepatocellular carcinoma. Screening for primary hepatocellular carcinoma among persons infected with hepatitis B virus.
Early development of de novo hepatocellular carcinoma after direct-acting agent therapy: Comparison with pegylated interferon-based therapy in chronic hepatitis C patients.
Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study.
Early diagnosis of hepatocellular carcinoma with lectin electrophoresis of serum alpha-fetoprotein.
Early on-treatment predictions of clinical outcomes using AFP and DCP responses in patients with advanced hepatocellular carcinoma.
Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.
Early recurrence after surgery of hepatocellular carcinoma.
Effect of alpha-fetoprotein and albumin on the uptake of polyunsaturated fatty acids by rat hepatoma cells and fetal rat hepatocytes.
Effect of alpha-fetoprotein and other serum factors derived from hepatoma-bearing rats on the mixed lymphocyte response.
Effect of alpha-interferon on anti-alpha-fetoprotein-monoclonal-antibody targeting of hepatoma.
Effect of anti-alpha-fetoprotein serum on growth and plating efficiency of alpha-fetoprotein-producing hepatoma cells in vitro.
Effect of antiviral treatment on alfa-fetoprotein levels in HBV-related cirrhotic patients: early detection of hepatocellular carcinoma.
Effect of BCG on hepatocarcinogenesis of the rat induced by 3'-methyl-4-(dimethylamino)azobenzene.
Effect of cross-reactivity of alpha-fetoprotein monoclonal antibody on quantitation of serum AFP and radioimmunodetection of hepatocellular carcinoma.
Effect of cyclic AMP and related substances on the production of alpha-fetoprotein by ascites hepatoma AH-66 cells in culture.
Effect of cytokines on glycosylation of acute phase proteins in human hepatoma cell lines.
Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study.
Effect of insulin on the growth of a human hepatoma cell line PLC/PRF/5: a possible role of insulin receptor.
Effect of phorbol esters and hormones on rat hepatoma cells producing alpha-fetoprotein.
Effect of pre- and post-treatment ?-fetoprotein levels and tumor size on survival of patients with hepatocellular carcinoma treated by resection, transarterial chemoembolization or radiofrequency ablation: a retrospective study.
Effect of selenium-enriched malt on hepatocarcinogenesis, paraneoplastic syndrome and the hormones regulating blood glucose in rats treated by diethylnitrosamine.
Effect of silymarin on N-nitrosodiethylamine induced hepatocarcinogenesis in rats.
Effect of simvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, on alpha-fetoprotein gene expression through interaction with the ras-mediated pathway.
Effect of sodium butyrate on alpha-fetoprotein gene expression in rat hepatoma cells in vitro.
Effect of specific immunotherapy with preimmunization against alpha-fetoprotein on a mouse transplantable hepatoma.
Effect of surgical and chemotherapeutic treatment on alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Effects of AFP-activated PI3K/Akt signaling pathway on cell proliferation of liver cancer.
Effects of alpha-difluoromethyl ornithine on alpha-fetoprotein and albumin secretion in human hepatoma cell line, PLC/PRF/5.
Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma.
Effects of arsenic trioxide on the expression of ezrin in hepatocellular carcinoma.
Effects of chemotherapeutic agents on alpha-fetoprotein secretion and growth of human hepatoma cell lines in vitro.
Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines.
Effects of dexamethasone and insulin on the acute phase response of Morris hepatoma cells and of rat hepatocytes in culture.
Effects of dibutyryl adenosine 3'-5' cyclic monophosphate on the ultrastructure of rat ascites hepatoma cells and on the intracellular localization of alpha-fetoprotein.
Effects of hexamethylene bisacetamide on alpha-fetoprotein, albumin, and transferrin production by two rat hepatoma cell lines.
Effects of IFN-alpha on alpha-fetoprotein expressions in hepatocellular carcinoma cells.
Effects of serum and serum-derived factors on the growth and production of alpha-fetoprotein and albumin by human hepatoma cell lines.
Effects of sodium n-butyrate on alpha-fetoprotein and albumin secretion in the human hepatoma cell line PLC/PRF/5.
Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients: 24-month Results From the Pooled Analysis of 2 Randomized Controlled Trials.
Efficacy and Safety of Ramucirumab in Asian and Non-Asian Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Individual Data Analysis of Two Randomized Studies.
Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma.
Efficacy of ultrasonography and alpha-fetoprotein on early detection of hepatocellular carcinoma.
Efficiency of composite laboratory tests in the diagnosis of liver malignancies.
Efficiency of whole-body 18F-FDG PET CT in detecting the cause of rising serum AFP level in post-therapeutic follow-up for HCC patients.
Elevated alpha-fetoprotein levels in hepatocellular carcinoma.
Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
Elevated paraneoplastic hypercholesterolemia in a case of hepatoid adenocarcinoma of the stomach with liver metastasis.
Elevated serum alpha-fetoprotein in poorly differentiated adenocarcinoma with neuroendocrine differentiation of the ascending colon: a case report.
Elevated serum alpha-fetoprotein level of nude mice bearing hepatoma cells by treatment with monoclonal antibodies to alpha-fetoprotein.
Elevated serum alpha-fetoprotein levels are associated with poor prognosis of hepatocellular carcinoma after surgical resection: A systematic review and meta-analysis.
Elevated serum alpha-fetoprotein levels in primary gallbladder carcinoma without hepatic involvement.
Elevated urinary transforming growth factor-beta1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma.
Elevation of alpha-fetoprotein level without evidence of recurrence after hepatectomy for hepatocellular carcinoma.
Elevation of circulating immune complexes and its relationship to alpha-fetoprotein levels in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.
Elevation of cytokeratin 19 fragment in serum in patients with hepatoma: its clinical significance.
Elevation of transforming growth factor alpha and its relationship to the epidermal growth factor and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Embryo extracts opotherapy reduces alpha-fetoprotein levels in hepatocellular carcinoma patients.
Endoscopic injection sclerotherapy for esophageal varices associated with concomitant portal venous thrombus of hepatocellular carcinoma.
Engineered cytotoxic T lymphocytes with AFP-specific TCR gene for adoptive immunotherapy in hepatocellular carcinoma.
Enhanced Detection of Early Hepatocellular Carcinoma by Serum SELDI-TOF Proteomic Signature Combined with Alpha-Fetoprotein Marker.
Enhanced detection of hepatocellular carcinoma.
Enzymatic basis of sugar structures of alpha-fetoprotein in hepatoma and hepatoblastoma cell lines: correlation with activities of alpha 1-6 fucosyltransferase and N-acetylglucosaminyltransferases III and V.
EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.
Ephrin-A1 expression contributes to the malignant characteristics of {alpha}-fetoprotein producing hepatocellular carcinoma.
Epidermal growth factor stimulates proliferation of rat hepatoma cells producing alpha-fetoprotein.
Epitope-optimized alpha-fetoprotein genetic vaccines prevent carcinogen-induced murine autochthonous hepatocellular carcinoma.
Erratum to: Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis.
Erythropoietin production in hepatocellular carcinoma cells associated with polycythemia: immunohistochemical evidence.
Establishment and characterization of human hepatocellular carcinoma cell line FHCC-98.
Establishment and characterization of primary canine hepatocellular carcinoma cell lines producing alpha-fetoprotein.
Establishment of an AFP-producing serum-independent culture cell line of human liver cancer and changes in protein synthesis associated with the absence of serum (second part).
Estimation of leucine aminopeptidase and 5-nucleotidase increases alpha-fetoprotein sensitivity in human hepatocellular carcinoma cases.
Evaluating histologic differentiation of hepatitis B virus-related hepatocellular carcinoma using intravoxel incoherent motion and AFP levels alone and in combination.
Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein.
Evaluation of a monoclonal immunoenzymometric assay for alpha-fetoprotein.
Evaluation of alpha-fetoprotein as a screening marker for hepatocellular carcinoma in hepatitis prevalent areas.
Evaluation of alpha-fetoprotein assay in ascitic fluid for the diagnosis of hepatocellular carcinoma.
Evaluation of alpha-fetoprotein in detecting hepatocellular carcinoma recurrence after radiofrequency ablation.
Evaluation of alpha-fetoprotein staging system for hepatocellular carcinoma in noncirrhotic patients.
Evaluation of CA 125 as a serum marker of hepatocellular carcinoma.
Evaluation of click chemistry microarrays for immunosensing of alpha-fetoprotein (AFP).
Evaluation of curability and prediction of prognosis after surgical treatment for hepatocellular carcinoma by lens culinaris agglutinin-reactive alpha-fetoprotein.
Evaluation of cytokeratin-1 in the diagnosis of hepatocellular carcinoma.
Evaluation of Diagnostic Efficiency of Alpha-Fetoprotein in Patients with Liver Cirrhosis and Hepatocellular Carcinoma: Single-Center Experience.
Evaluation of hepatoma chemotherapy by alpha-fetoprotein determination.
Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis.
Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
Evaluation of midkine as a diagnostic serum biomarker in hepatocellular carcinoma.
Evaluation of serum AFP and DCP levels in the diagnosis of early-stage HBV-related HCC under different backgrounds.
Evaluation of Serum GDF15, AFP, and PIVKA-II as Diagnostic Markers for HBV-Associated Hepatocellular Carcinoma.
Evaluation of serum PIVKA-II and MIF as diagnostic markers for HCV/HBV induced hepatocellular carcinoma.
Evaluation of seven different staging systems for alpha-fetoprotein expression in hepatocellular carcinoma after hepatectomy.
Evaluation of the albumin-gamma-glutamyltransferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis.
Evaluation of the Alpha-Fetoprotein Model for Predicting Recurrence and Survival in Patients With Hepatitis B Virus (HBV)-Related Cirrhosis Who Received Liver Transplantation for Hepatocellular Carcinoma.
Evaluation of the diagnostic accuracy of des-gamma-carboxy prothrombin and alpha-fetoprotein alone or in combination for hepatocellular carcinoma: A systematic review and meta-analysis.
Evaluation of the diagnostic value of alpha-l-fucosidase, alpha-fetoprotein and thymidine kinase 1 with ROC and logistic regression for hepatocellular carcinoma.
Evaluation of tumor markers for the detection of hepatocellular carcinoma in Yangon General Hospital, Myanmar.
Evaluation of Tumor Response Using Alpha-fetoprotein and Des-gamma-carboxy Prothrombin in Hepatocellular Carcinoma Patients Who Underwent Transarterial Chemoembolization.
Evaluation of tumour necrosis factor-alpha, soluble P-selectin, gamma-glutamyl transferase, glutathione S-transferase-pi and alpha-fetoprotein in patients with hepatocellular carcinoma before and during chemotherapy.
Excessive alpha-fetoprotein concentrations in hepatocellular carcinoma.
Expansion of anti-AFP Th1 and Tc1 responses in hepatocellular carcinoma occur in different stages of disease.
Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma.
Expression and hypomethylation of alpha-fetoprotein gene in unicentric and multicentric human hepatocellular carcinomas.
Expression and methylation of the mouse alpha-fetoprotein gene in embryonic, adult, and neoplastic tissues.
Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma.
Expression of ?-catenin protein in hepatocellular carcinoma and its relationship with alpha-fetoprotein.
Expression of AFPmRNA in blood of patients with recurrent hepatocellular carcinoma.
Expression of alpha fetoprotein messenger RNA in BEL-7404 human hepatoma cells and effect of L-4 oxalysine on the expression.
Expression of alpha-fetoprotein and albumin genes in a rat hepatoma cell line SY/1/80: evidence for the need of species specific serum factors.
Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy.
Expression of alpha-fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reaction.
Expression of alpha1-6 fucosyltransferase in rat tissues and human cancer cell lines.
Expression of an oncodevelopmental gene product (alpha-fetoprotein) during fetal development and adult oncogenesis.
Expression of hepatitis B virus nuclear core antigen in young cirrhotic patients is associated with an unfavourable long-term outcome.
Expression of miR-20a: A serum biomarker in the diagnostic approach for hepatocellular carcinoma.
Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1.
Expression pattern analysis of hepatocellular carcinoma tumor markers in viral hepatitis B and C patients undergoing liver transplantation and resection.
External validation of an individual prognostic calculator after trans-arterial chemo-embolization for hepatocellular carcinoma.
External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV.
External validation of the French alpha-fetoprotein model for hepatocellular carcinoma liver transplantation in a recent unicentric cohort - a retrospective study.
Extinction of alpha-fetoprotein gene expression in somatic cell hybrids involves cis-acting DNA elements.
Extremely elevated alpha-fetoprotein due to acute exacerbation of chronic hepatitis B without malignancy: a case report.
Extremely high alpha-fetoprotein-producing adrenal hepatoid adenocarcinoma.
Extremely High Preoperative Alpha-Fetoprotein Level Is Associated with Vascular Invasion, Non-R0 Resection, and Poor Prognosis in Hepatocellular Carcinoma Patients.
Ezrin expression is associated with hepatocellular carcinoma possibly derived from progenitor cells and early recurrence after surgical resection.
Fabrication of Carboxylated Silicon Nitride Sensor Chips for Detection of Antigen-Antibody Reaction Using Microfluidic Reflectometric Interference Spectroscopy.
Facile Synthesis of Water-Soluble Zn-Doped AgIn5S8/ZnS Core/Shell Fluorescent Nanocrystals and Their Biological Application.
False-negative rate of abdominal sonography for detecting hepatocellular carcinoma in patients with hepatitis B and elevated serum alpha-fetoprotein levels.
Family members p53 and p73 act together in chromatin modification and direct repression of alpha-fetoprotein transcription.
Favorable alpha-fetoprotein decrease as a prognostic surrogate in patients with hepatocellular carcinoma after radiofrequency ablation.
Favorable Outcomes of Chinese HCV-Related Cirrhotic Patients with Sustained Virological Response after Pegylated Interferon Plus Ribavirin Treatment.
Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma.
Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention.
Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation.
Fibrolamellar carcinoma of the liver in the Orient.
Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation.
Fibrolamellar Carcinoma: A Multimodal Approach.
Fibrolamellar variant of hepatocellular carcinoma presenting during pregnancy: management dilemmas.
Fifty years of discovery of alpha-fetoprotein as the first tumor marker.
Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human alpha-fetoprotein.
Fluorescence analysis with quantum dot probes for hepatoma under one- and two-photon excitation.
Fluorescence Immunoassay System via Enzyme-Enabled in Situ Synthesis of Fluorescent Silicon Nanoparticles.
Focal nodular hyperplasia of the liver: pathological analysis of 11 cases.
Frequency and significance of serum alpha-fetoprotein elevation in severe hepatitis B surface antigen-negative chronic active hepatitis.
Frequency of deaths in hepatitis C virus infected hepatocellular carcinoma patients and its relationship with raised serum alpha-fetoprotein levels.
Frequency of raised alpha-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C.
Fucosylated alpha-fetoprotein as marker of early hepatocellular carcinoma.
Fucosylated Fraction of Alpha-Fetoprotein as a Predictor of Prognosis in Patients with Hepatocellular Carcinoma After Curative Treatment.
Fucosylated Fraction of Alpha-fetoprotein as a Serological Marker of Early Hepatocellular Carcinoma.
Fucosylated fraction of alpha-fetoprotein, L3, as a useful prognostic factor in patients with hepatocellular carcinoma with special reference to low concentrations of serum alpha-fetoprotein.
Fucosylation index of alpha-fetoprotein, a possible aid in the early recognition of hepatocellular carcinoma in patients with cirrhosis.
Fucosylation is a promising target for cancer diagnosis and therapy.
Fucosylation of alpha-fetoprotein in hepatocellular carcinomas.
Fucosylation of N-glycans regulates the secretion of hepatic glycoproteins into bile ducts.
Fucosylation of serum alpha-fetoprotein in patients with primary hepatocellular carcinoma.
Functional mapping of tissue-specific elements of the human alpha-fetoprotein gene enhancer.
Further resolution of alpha-fetoprotein glycoforms by two-dimensional isoelectric focusing and lectin affinity electrophoresis.
GADD45-alpha expression in cirrhosis and hepatocellular carcinoma: relationship with DNA repair and proliferation.
Gallic acid against hepatocellular carcinoma: An integrated scheme of the potential mechanisms of action from in vivo study.
Gallium scanning in the diagnosis of hepatocellular carcinoma: a clinicopathological study of 45 patients.
Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature.
Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma.
Gene expression in clonally derived cell lines produced by in vitro transformation of rat fetal hepatocytes: isolation of cell lines which retain liver-specific markers.
Gene expression of alpha1-6 fucosyltransferase in human hepatoma tissues: a possible implication for increased fucosylation of alpha-fetoprotein.
Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
Gene therapy for hepatocellular carcinoma based on tumour-selective suicide gene expression using the alpha-fetoprotein (AFP) enhancer and a housekeeping gene promoter.
Gene therapy for hepatocellular carcinoma using two recombinant adenovirus vectors with alpha-fetoprotein promoter and Cre/lox P system.
Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
Gene therapy vectors harboring AFP regulatory sequences. Preparation of an adenoviral vector.
Gene transfer of kringle 1-5 suppresses tumor development and improves prognosis of mice with hepatocellular carcinoma.
Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein.
Genetic correction of serum AFP level improves risk prediction of primary hepatocellular carcinoma in the Dongfeng-Tongji cohort study.
Genomic and proteomic biomarkers for diagnosis and prognosis of hepatocellular carcinoma.
Germ cell tumors express a specific alpha-fetoprotein variant detectable by isoelectric focusing.
Ghrelin in chronic liver disease.
Glucocorticoid receptors in hepatocellular carcinoma and adjacent liver tissue.
Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour.
Glycomic analyses of glycoproteins in bile and serum during rat hepatocarcinogenesis.
Glycomic analysis of alpha-fetoprotein L3 in hepatoma cell lines and hepatocellular carcinoma patients.
Glycylproline dipeptidyl aminopeptidase isoenzyme in diagnosis of primary hepatocellular carcinoma.
Glypican-3 and hepatocyte paraffin-1 combined with alpha-fetoprotein as a novel risk scoring model for predicting early recurrence of hepatocellular carcinoma after curative resection.
Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis.
Gold nanoparticles and polyethylene glycols functionalized conducting polyaniline nanowires for ultrasensitive and low fouling immunosensing of alpha-fetoprotein.
Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta- analysis.
Golgi Protein 73 versus Alpha-Fetoprotein as a New Biomarker in Early Diagnosis of Hepatocellular Carcinoma.
GPX2 overexpression indicates poor prognosis in patients with hepatocellular carcinoma.
Growth and hepatospecific gene expression of human hepatoma cells in a defined medium.
Growth velocity of the portal vein tumor thrombus accelerated by its progression, alpha-fetoprotein level, and liver fibrosis stage in patients with hepatocellular carcinoma.
Half-life of serum alpha-fetoprotein: an early prognostic index of recurrence and survival after hepatic resection for hepatocellular carcinoma.
HBP1-mediated transcriptional repression of AFP inhibits hepatoma progression.
Heat shock protein 70 chaperoned alpha-fetoprotein in human hepatocellular carcinoma cell line BEL-7402.
Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver.
Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment.
Hepatic inflammatory pseudotumor associated with primary biliary cholangitis and elevated alpha-fetoprotein lectin 3 fraction mimicking hepatocellular carcinoma.
Hepatic Resection for "BCLC Stage A" Hepatocellular Carcinoma. The Prognostic Role of Alpha-Fetoprotein.
Hepatitis B surface antigen and alpha-fetoprotein in patients with hepatocellular carcinoma.
Hepatitis B surface antigenemia in patients with hepatocellular carcinoma in relation to clinical course and alpha-fetoprotein.
Hepatitis B Virus Reactivation during Treatment with Multi-Tyrosine Kinase Inhibitor for Hepatocellular Carcinoma.
Hepatitis B virus X protein upregulates alpha-fetoprotein to promote hepatocellular carcinoma by targeting miR-1236 and miR-329.
Hepatitis B virus, alpha-fetoprotein synthesis, and hepatocellular carcinoma in Zaire.
Hepatitis B- and hepatitis C-associated hepatocellular carcinoma: evaluation of alpha-fetoprotein as a diagnostic marker.
Hepatoblastoma: a rare pediatric neoplasm.
Hepatocarcinogenesis in the mouse. Combined morphologic-stereologic studies.
Hepatocellular carcinoma and a variant alkaline phosphatase.
Hepatocellular carcinoma as a rare cause of an excessive increase in alpha-fetoprotein during pregnancy.
Hepatocellular carcinoma complicated with coexisting hepatolithiasis: pitfalls in diagnosis and management.
Hepatocellular carcinoma in a pregnant woman detected by routine screening of maternal alpha-fetoprotein.
Hepatocellular carcinoma in Alagille's syndrome: a family study.
Hepatocellular carcinoma in children and young patients with chronic HBV infection and the usefulness of alpha-fetoprotein assessment.
Hepatocellular carcinoma in HBsAg-negative chronic active hepatitis.
Hepatocellular carcinoma in Italian patients with cirrhosis.
Hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis in Denmark: A nationwide cohort study.
Hepatocellular carcinoma in primary biliary cirrhosis: detection by alpha-fetoprotein estimation.
Hepatocellular carcinoma presenting as intracranial metastasis.
Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
Hepatocellular Carcinoma Surveillance: Does Alpha-Fetoprotein Have a Role?
Hepatocellular carcinoma with and without cirrhosis. A comparison in southern African blacks.
Hepatocellular carcinoma with inferior vena cava and right atrial tumor thrombus: A case report.
Hepatocellular carcinoma with Pancoast's syndrome as an initial symptom: a case report.
Hepatocellular carcinoma with right atrial extension in a young patient with congenitally unguarded tricuspid orifice.
Hepatocellular carcinoma: patients with increasing alpha-fetoprotein but no mass on ultrasound.
Hepatocellular carcinoma: relation to alcohol, HB-antigen and alpha-fetoprotein.
Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.
Hepatocyte growth factor down-regulates the alpha-fetoprotein gene expression in PLC/PRF/5 human hepatoma cells.
Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma.
Hepatoid adenocarcinoma of the gallbladder: a mimicker of hepatocellular carcinoma.
Hepatoid Adenocarcinoma of the Rectum With Liver Metastasis in a Patient With Ulcerative Colitis.
Hepatoid adenocarcinoma of the stomach: an unusual case of elevated alpha-fetoprotein with prior treatment for hepatocellular carcinoma.
Hepatoid adenocarcinoma of the stomach: dual-time-point (18)F-FDG PET/CT findings.
Hepatoid adenocarcinoma of the urinary bladder.
Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases.
Hepatoid adenocarcinoma: a new clinicopathological entity and the hypotheses on carcinogenesis.
Hepatoid carcinoma of the ovary and management.
Hepatoid carcinoma of the ovary without staining for alpha-fetoprotein.
Hepatoid carcinoma of the ovary: characteristics of its immunoreactivity. A case report.
Hepatoid pancoast tumor. A case report and review of the literature.
Hepatoma cell-specific expression of a retrovirally transferred gene is achieved by alpha-fetoprotein but not insulinlike growth factor II regulatory sequences.
Hepatoma cell-specific ganciclovir-mediated toxicity of a lentivirally transduced HSV-TkEGFP fusion protein gene placed under the control of rat alpha-fetoprotein gene regulatory sequences.
Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis.
Hepatomas seen on follow-up angiograms in patients with liver cirrhosis.
HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates.
Hereditary Persistence of Alpha-Fetoprotein in Chronic Liver Disease-Confusing Genes!
Hereditary persistence of alpha-fetoprotein. Case report and review of the literature.
Heterochronous development of intrahepatic cholangiocellular carcinoma following hepatocellular carcinoma in a hepatitis B virus carrier.
Heterogeneous hepatic venous pressures in patients with liver cancer.
High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
High alpha-fetoprotein level in HCV-related nodular liver cell dysplasia.
High expression of alpha-1-6 fucosyltransferase during rat hepatocarcinogenesis.
High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection.
High pre-treatment static and dynamic alpha-fetoprotein values predict reduced overall survival in hepatocellular carcinoma.
High pretreatment static and dynamic alpha-fetoprotein values predict reduced overall survival in hepatocellular carcinoma.
High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity.
High serum level of alpha-fetoprotein in focal nodular hyperplasia of the liver.
High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma.
High-sensitivity Lens culinaris agglutinin-reactive alpha-fetoprotein assay predicts early detection of hepatocellular carcinoma.
High-yield and high-degree purification of human alpha-fetoprotein produced by adaptation of the human hepatoma cell line Hep G2 in a serum-free medium.
Higher Ratio of Serum Alpha-Fetoprotein Could Predict Outcomes in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma and Normal Alanine Aminotransferase.
Highly enhanced fucosylation of serum glycoproteins in patients with hepatocellular carcinoma.
Highly sensitive alpha-fetoprotein, Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxyprothrombin for hepatocellular carcinoma detection.
Highly-sensitive identification of alpha-fetoprotein mRNA in circulating peripheral blood of hepatocellular carcinoma patients.
Histopathologic differentiation of the main nodule determines outcome after hepatic resection for synchronous multicentric hepatocellular carcinomas.
Histopathology and immunohistochemistry of large hepatocellular carcinoma with undetectable or low serum levels of alpha-fetoprotein.
HLA antigen in Chinese patients with hepatocellular carcinomas.
Hormonal control of alpha-fetoprotein secretion in human hepatoma cell lines proliferating in chemically defined medium.
Hormonal regulation during secretion of alpha-fetoprotein in hepatoma cells grown in synthetic medium.
Hormonal therapy for hepatocellular carcinoma.
HSP72 and gp96 in gastroenterological cancers.
HSP90? combined with AFP and TK1 improved the diagnostic value for hepatocellular carcinoma.
Human alpha-fetoprotein: immunosuppressive activity and microheterogeneity.
Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients.
Icaritin inhibits the expression of alpha-fetoprotein in hepatitis B virus-infected hepatoma cell lines through post-transcriptional regulation.
Icteric type hepatocellular carcinoma: revisited 20 years later.
Identification of alpha-fetoprotein-derived peptides recognized by cytotoxic T lymphocytes in HLA-A24+ patients with hepatocellular carcinoma.
Identification of alpha-fetoprotein-P4 sugar chain as alpha 2-->6 monosialylated biantennary complex-type oligosaccharides with an exposed galactose on the mannose alpha 1-->6 arm by two-dimensional extended agarose gel-lectin affinity electrophoresis.
Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCs.
Identification of Key Hydroxymethylated Genes and Transcription Factors Associated with Alpha-Fetoprotein-Negative Hepatocellular Carcinoma.
Identification of osteopontin as a novel marker for early hepatocellular carcinoma.
Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma.
Identifying Genes for Establishing a Multigenic Test for Hepatocellular Carcinoma Surveillance in Hepatitis C Virus-Positive Cirrhotic Patients.
Imaging Findings Within the First 12 Months of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy.
Imaging, Pathology, and Immune Correlates in the Woodchuck Hepatic Tumor Model.
Immunobiologic studies in hepatoma-bearing mice passively immunized to alpha-fetoprotein.
Immunocytochemical localization of oncodevelopmental proteins in human germ cell and hepatic tumors.
Immunoelectron microscopic observation of alpha-fetoprotein synthesis in human non-malignant liver tissues using immunoperoxidase methods.
Immunoelectronmicroscopic study of alpha-fetoprotein synthesis in hepatoma cells.
Immunohistochemical and affinity electrophoretic studies of alpha-fetoprotein of a patient with hepatocellular carcinoma in the intrathoracic space.
Immunohistochemical Coexpression of Epithelial Cell Adhesion Molecule and Alpha-Fetoprotein in Hepatocellular Carcinoma.
Immunohistochemical demonstration of alpha-fetoprotein in small hepatocellular carcinoma.
Immunohistochemical detection of alpha-fetoprotein, carcinoembryonic antigen, and ferritin in formalin-paraffin sections from hepatocellular carcinoma.
Immunohistochemical differentiation of yolk sac-type alpha-fetoprotein from hepatic-type alpha-fetoprotein.
Immunohistochemical expression of pi class glutathione S-transferase and alpha-fetoprotein in hepatocellular carcinoma and chronic liver disease.
Immunohistochemical staining of hepatocellular carcinoma with monoclonal antibody against inhibin.
Immunohistochemical study of fibronectin, lysozyme, and alpha-fetoprotein (AFP) in human hepatocellular carcinoma.
Immunohistologic study on the expressions of alpha-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma.
Immunolocalization of alpha-fetoprotein and albumin in Morris 7777 hepatoma cells grown in vivo.
Immunoprecipitation assay of alpha-fetoprotein synthesis by cultured mouse hepatoma cells treated with estrogens and glucocorticoids.
Immunoradioautographic study of alpha-fetoprotein in hepatoma cells.
Immunoregulation of dendritic and T cells by alpha-fetoprotein in patients with hepatocellular carcinoma.
Immunosuppressive activity of isolated rat and human fetoproteins.
Immunotherapy directed against alpha-fetoprotein results in autoimmune liver disease during liver regeneration in mice.
Immunotherapy of hepatocellular carcinoma with a vaccine based on xenogeneic homologous alpha fetoprotein in mice.
Immunotherapy of murine hepatocellular carcinoma by alpha-fetoprotein DNA vaccination combined with adenovirus-mediated chemokine and cytokine expression.
Immunotoxins composed of monoclonal antibody to alpha-fetoprotein and gelonin as a potent hepatoma-targeted drug delivery system.
Impact of alpha-fetoprotein on hepatocellular carcinoma development during entecavir treatment of chronic hepatitis B virus infection.
Impact of hepatitis C virus infection on schistosomal liver disease.
Impact of hepatologists to extend survival of hepatocellular carcinoma patients with cirrhosis: a comparison with non-hepatologists.
Implementing evidenced-based practice guidelines for the management of chronic hepatitis B virus infection.
Implication of an extremely high preoperative alpha-fetoprotein value (>4,000 ng/mL) for the long-term outcomes of hepatectomy for resectable hepatocellular carcinoma.
Improved Detection of Hepatocellular Carcinoma by Using a Longitudinal Alpha-Fetoprotein Screening Algorithm.
Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV cirrhosis with Normal Alanine Transaminase.
Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
Improvement of liver cancer detection with simultaneous assessment of circulating levels of free alpha-fetoprotein (AFP) and AFP-IgM complexes.
In vitro alpha-fetoprotein synthesis by monkey hepatocellular carcinoma.
In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector.
In vitro cloning of a rat ascites hepatoma cell line, AH66, with special reference to alpha-fetoprotein synthesis.
In vitro radionuclide therapy and in vivo scintigraphic imaging of alpha-fetoprotein-producing hepatocellular carcinoma by targeted sodium iodide symporter gene expression.
In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene.
In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2.
In whom, how and how often is surveillance for hepatocellular carcinoma cost-effective?
Incidence and risk factors of hepatocellular carcinoma after orthotopic liver transplantation.
Incorporating alpha-fetoprotein within dimensional criteria for hepatocellular carcinoma transplantation.
Incorporating Tumor Biology to Predict Hepatocellular Carcinoma Recurrence in Patients Undergoing Living Donor Liver Transplantation Using Expanded Selection Criteria.
Increase in serum alpha-fetoprotein without recurrent disease after hepatectomy for hepatocellular carcinoma.
Increase of fucosylated serum cholinesterase in relation to high risk groups for hepatocellular carcinomas.
Increased alpha-fetoprotein serum level is predictive for survival and recurrence of hepatocellular carcinoma in non-cirrhotic livers.
Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector.
Increased Expression of a Disintegrin and Metalloprotease-9 in Hepatocellular Carcinoma: Implications for Tumor Progression and Prognosis.
Increased GABAergic activity inhibits alpha-fetoprotein mRNA expression and the proliferative activity of the HepG2 human hepatocellular carcinoma cell line.
Increased histone acetylation and deacetylation in rat ascites hepatoma cells.
Increased plasma cathepsin D concentration in hepatic carcinoma and cirrhosis but not in breast cancer.
Increased serum levels of monosialo-alpha-fetoprotein in hepatocellular carcinoma and other malignancies.
Increased steady-state levels of alpha-fetoprotein mRNA in hepatocellular carcinoma: an analysis by in situ hybridization.
Increasing serum levels of alpha-fetoprotein in a patient with relapsing gallbladder carcinoma.
Indications and outcome of liver transplantation in tyrosinaemia type 1.
Inducible protein in rat hepatomas with expression alternative to alpha-fetoprotein.
Induction of alpha-fetoprotein-specific CD4- and CD8-mediated T-cell response using RNA-transfected dendritic cells.
Induction of apoptosis in human hepatoma cells by alpha-fetoprotein.
Induction of hepatomas secreting large amounts of alpha-fetoprotein.
Infantile hepatic hemangioendothelioma with elevated serum alpha-fetoprotein.
Influence of Alanine Transaminase Levels on Alpha-Fetoprotein for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Infection.
Influence of alpha-fetoprotein on the in vitro and in vivo immune response to acetylcholine receptor.
Influence of exogenous RAR alpha gene on MDR1 expression and P-glycoprotein function in human and rodent cell lines.
Influence of transfection with connexin 26 gene on malignant potential of human hepatoma cells.
Influence of vascular endothelial growth factor and alpha-fetoprotein on hepatocellular carcinoma.
Inhibition of lymphocyte proliferation by sera from patients with hepatocellular carcinoma: lack of correlation with serum alpha-fetoprotein levels.
Inhibition of alpha-fetoprotein production in a hepatoma cell line by antisense oligonucleotide analogues.
Inhibition of rat hepatocellular carcinoma tumor growth after multiple infusions of recombinant Ad.AFPtk followed by ganciclovir treatment.
Inhibition of synthesis of alpha-fetoprotein by glucocorticoids in cultured hepatoma cells.
Inhibitory effect of prostaglandin delta 12-PGJ2 on cell proliferation and alpha-fetoprotein expression in HuH-7 human hepatoma cells.
Inhibitory effects of polyprenoic acid (E5166) on production and secretion of alpha-fetoprotein and on cell kinetics in human hepatoma cells.
Integrated analysis of the rhesus monkey liver transcriptome during development and human primary HCC AFP-related gene expression.
Interaction between heat shock protein 72 and alpha-fetoprotein in human hepatocellular carcinomas.
Interaction of a hepatoma-specific nuclear factor with transcription-regulatory sequences of the human alpha-fetoprotein and albumin genes.
Interaction of lectins with their ligand carbohydrate of alpha-fetoprotein: analysis by mixed-lectin affinity electrophoresis.
Interrelations between elevated alpha-fetoprotein levels and tumor morphology of patients with hepatocellular carcinoma.
Intracellular alpha-fetoprotein interferes with all-trans retinoic acid induced ATG7 expression and autophagy in hepatocellular carcinoma cells.
Intracellular alpha-fetoprotein level in cultured ascites hepatoma cells of the rat determined as alpha-fetoprotein-negative.
Intracellular synthesis of alpha-fetoprotein and fibrinogen without secretion by Zajdela rat ascites hepatoma cells.
Investigation of Alpha-Fetoprotein Antibody Modified Fluorescent Magnetic Probe on HepG? Cell and Cancer Model Mouse.
Investigation of Potential Molecular Biomarkers for Diagnosis and Prognosis of AFP-Negative HCC.
Involvement of an AFP1-binding site in cell-specific transcription of the pre-S1 region of the human hepatitis B virus surface antigen gene.
Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma.
Is anti-HBc IgM a useful clinical test in patients with HBsAg-positive chronic hepatitis or primary hepatocellular carcinoma?
Is inconsistency of alpha-fetoprotein level a good prognosticator for hepatocellular carcinoma recurrence?
Is it Time to Abandon the Milan Criteria?: Results of a Bicoastal US Collaboration to Redefine Hepatocellular Carcinoma Liver Transplantation Selection Policies.
IS RESECTION OF HEPATOCELLULAR CARCINOMA IN THE ERA OF LIVER TRANSPLANTATION WORTHWILE? A single center experience.
Is Serum Alpha-Fetoprotein Useful for Predicting Recurrence and Mortality Specific to Hepatocellular Carcinoma After Hepatectomy? A Test Based on Propensity Scores and Competing Risks Analysis.
Is there a role for immunotherapy in hepatocellular carcinoma?
Isolation and characterization of alpha-fetoprotein from the mouse hepatoma BW7756.
Isolation of alpha-fetoprotein messenger ribonucleic acid from AH-66 ascites hepatoma cells.
Knockdown of alpha-fetoprotein expression inhibits HepG2 cell growth and induces apoptosis.
Lack of correlation among gamma-glutamyltranspeptidase activity, production of alpha-fetoprotein, and transplantability in rat liver epithelial-like cell cultures.
Lack of correlation between alpha-fetoprotein and tumor size in hepatocellular carcinoma.
Lack of expression of glutathione-S-transferase P, gamma-glutamyl transpeptidase, and alpha-fetoprotein messenger RNAs in liver tumors induced by peroxisome proliferators.
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis.
Large acinar cell carcinoma of the pancreas in a patient with elevated serum AFP level.
Lectin affinity electrophoresis of alpha-fetoprotein. Increased specificity and sensitivity as a marker of hepatocellular carcinoma.
Lectin-reactive alpha-fetoprotein (AFP-L3%) curability and prediction of clinical course after treatment of non-seminomatous germ cell tumors.
Lectin-reactive alpha-fetoprotein in patients with tyrosinemia type I and hepatocellular carcinoma.
Lectin-reactive patterns of markedly elevated serum alpha-fetoprotein in patients with chronic active hepatitis.
Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions.
Lens culinaris agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis: a histopathological study of surgically resected hepatocellular carcinoma.
Lens culinaris agglutinin-reactive alpha-fetoprotein as a prognostic marker in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization.
Lens Culinaris Agglutinin-Reactive Fraction of Alpha-Fetoprotein as a Marker of Prognosis and a Monitor of Recurrence of Hepatocellular Carcinoma After Curative Liver Resection.
Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein improves diagnostic accuracy for hepatocellular carcinoma.
Letter: Alpha-fetoprotein in urine of hepatoma patients.
Level of Alpha-Fetoprotein Predicts Mortality among Patients with Hepatitis C-Related Hepatocellular Carcinoma.
Linoleate and linolenate desaturation by rat hepatoma cells.
Lipiodolization for unresectable hepatocellular carcinoma: an analysis of 205 patients using univariate and multivariate analysis.
Lipopolysaccharide Enhances Beta2-Glycoprotein I Activation of Nuclear Factor ?B in Liver Cancer Cells.
Liver metastasis from hepatoid adenocarcinoma of the esophagus mimicking hepatocellular carcinoma.
Liver Stiffness and Serum Alpha-Fetoprotein in Discriminating Small Hepatocellular Carcinoma from Cirrhotic Nodule.
Liver transplant for large hepatocellular carcinoma in Malatya: The role of gamma glutamyl transferase and alpha-fetoprotein, a retrospective cohort study.
Liver transplantation (lt) for hepatocellular carcinoma (hcc): relationship between alpha-fetoprotein (afp) and outcome.
Liver Transplantation for Extended Criteria Hepatocellular Carcinoma Using Stable Response to Locoregional Therapy and Alpha-Fetoprotein as Selection Criteria.
Liver transplantation for hepatocellular carcinoma and cirrhosis in candidates with undetectable or very low alpha-fetoprotein levels: is an expansion of the listing criteria justified?
Liver transplantation for hepatocellular carcinoma in Ireland: Pre-operative alpha-fetoprotein predicts tumour recurrence in a 14-year single-centre national experience.
Liver transplantation for hepatocellular carcinoma: alpha-fetoprotein should be included in selection criteria.
Liver transplantation for hepatocellular carcinoma: analysis of factors predicting outcome in 1074 patients in OPTN Region 5.
Liver Transplantation for Hepatocellular carcinoma: Evaluation of the AFP model in a multicenter cohort from Latin America.
Liver transplantation for hepatocellular carcinoma: one center's experience, 1987-1994.
Living related donor liver transplantation for preoperative alpha-fetoprotein mRNA-positive patients of hepatocellular carcinoma: description of five cases.
Local regional therapy before liver transplantation for hepatocellular carcinoma.
Localization of alpha-fetoprotein by immunofluorescent method during induction of rat liver tumors by 3'-methyl-4-dimethylaminoazobenzene.
Localization of alpha-fetoprotein synthesis in malignancies other than hepatoma.
Localization of radioiodinated antibody to alpha-fetoprotein in hepatoma transplanted in rats and a case report of alpha-fetoprotein antibody treatment of a hepatoma patient.
Long-term follow-up study of asymptomatic HBsAg-positive voluntary blood donors in Austria: a clinical and histologic evaluation of 242 cases.
Long-term impact of hepatitis B, C virus infection on renal transplantation.
Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.
Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis.
Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early Stage Hepatocellular Carcinoma.
Loss of alpha-fetoprotein in rat hepatoma culture cells.
Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus-related hepatocellular carcinoma metastasis through the upregulation of ADAM9.
Low alpha-fetoprotein hepatocellular carcinoma.
Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis.
Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2b.
Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma.
Macroregenerative nodules in cirrhosis are not associated with elevated serum or stainable tissue alpha-fetoprotein.
Magnitude of change in alpha-fetoprotein in response to transarterial chemoembolization predicts survival in patients undergoing liver transplantation for hepatocellular carcinoma.
Major chromatin changes accompany extinction of alpha-fetoprotein gene in hepatoma x fibroblast hybrids.
Malignancy-related ascites and ascitic fluid "humoral tests of malignancy".
Management of patients with cirrhosis in southern california: results of a practitioner survey.
Marked episodic elevations of alpha-fetoprotein without hepatocellular carcinoma in a patient with hepatitis B.
Marked hypophosphatemia with decreased serum 1,25-dihydroxyvitamin D in a patient with hepatocellular carcinoma complicating liver cirrhosis.
Markedly elevated alpha-fetoprotein levels without hepatocellular carcinoma.
Mass screening of primary hepatocellular carcinoma by alpha-fetoprotein in a rural area of Taiwan--a dried blood spot method.
MDM2 promoter SNP309 is associated with the risk of hepatocellular carcinoma in patients with chronic hepatitis C.
Measurement of Cyclin D2 (CCND2) Gene Promoter Methylation in Plasma and Peripheral Blood Mononuclear Cells and Alpha-Fetoprotein Levels in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Measurement of glycosylated alpha-fetoprotein improves diagnostic power over the native form in hepatocellular carcinoma.
Measuring fucosylated alpha-fetoprotein in hepatocellular carcinoma: A comparison of ?TAS and parallel reaction monitoring.
Mechanism of the dexamethasone effect on alpha-fetoprotein gene expression in McA-RH8994 rat hepatoma cells.
Mechanisms and Functions of MiR-200 Family in Hepatocellular Carcinoma.
Mechanisms of alpha-fetoprotein synthesis in hepatoma cells. Combined electron microscopic immunocytochemistry and autoradiography.
Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
Metastasis of hepatocellular carcinoma to the proximal jejunum manifested by occult gastrointestinal bleeding.
Metastatic neuroendocrine carcinoma presenting as multifocal liver lesions with elevated alpha-fetoprotein.
Metastatic Recurrent Hepatocellular Carcinoma Post Liver Transplant With Marked Pretransplant Elevation of Alpha Fetoprotein and No Evidence of Primary Neoplasm.
Methylation of the alpha-fetoprotein gene in isogenic rat hepatoma and liver cell lines.
Methylation of the alpha-fetoprotein gene in productive and nonproductive rat hepatocellular carcinomas.
Microchip-based ELISA strategy for the detection of low-level disease biomarker in serum.
Microsatellite alterations in human hepatocellular carcinoma infected with hepatitis B virus: associated with the elevation of serum alpha-fetoprotein.
Microwave ablation with cooled-tip electrode for liver cancer: An analysis of 160 cases.
miR-1236 down-regulates alpha-fetoprotein, thus causing PTEN accumulation, which inhibits the PI3K/Akt pathway and malignant phenotype in hepatoma cells.
miR-630 Overexpression in Hepatocellular Carcinoma Tissues is Positively Correlated with alpha-Fetoprotein.
miR-675 Mediates Downregulation of Twist1 and Rb in AFP-Secreting Hepatocellular Carcinoma.
Modulation of miR-29 expression by alpha-fetoprotein is linked to the hepatocellular carcinoma epigenome.
Modulation of tumor incidence by oncofetal products in a syngeneic hepatoma cell-spleen cell model.
Molecular background of alpha-fetoprotein in liver cancer cells as revealed by global RNA expression analysis.
Molecular diagnosis of primary liver cancer by microsatellite DNA analysis in the serum.
Molecular heterogeneity of alpha-fetoprotein secreted by primary and transplantable hepatocellular carcinomas.
Molecular mechanism of extinction of liver-specific functions in mouse hepatoma x rat fibroblast hybrids: extinction of the albumin gene.
Molecular mechanisms of extinction of liver-specific functions in mouse hepatoma rat fibroblast hybrids: extinction of alpha-fetoprotein gene.
Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials.
Monitoring hepatocellular carcinoma by using a monoclonal immunoenzymometric assay for alpha-fetoprotein.
Monitoring of lectin-reactive alpha-fetoproteins in patients with hepatocellular carcinoma treated using transcatheter arterial embolization.
Morphological and biological changes of a hepatocellular carcinoma cell line cultured in a three-dimensional matrix of collagen.
Mouse alpha-fetoprotein-specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in mice.
MR imaging in diffuse-type hepatocellular carcinoma with synchronous portal vein thrombi.
Multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of Lens culinaris agglutinin-reactive alpha-fetoprotein.
Multicentric hepatocellular carcinoma following phosphate diethylstilbestrol therapy for prostatic cancer.
Multifunctional nanocatalyst-based ultrasensitive detection of human tissue transglutaminase 2.
Multiple antigens as marker substances in germinal tumors of the testis.
Multiple echogenic liver masses from multifocal nodular steatosis in a 55-year-old male with chronic hepatitis C.
Multiple non-tumorous arterioportal shunts due to chronic liver disease mimicking hepatocellular carcinoma: outcomes and the associated elevation of alpha-fetoprotein.
Multiplication of alpha-fetoprotein and protein induced by vitamin K absence-II is a powerful predictor of prognosis and recurrence in hepatocellular carcinoma patients after a hepatectomy.
N-glycan fingerprint predicts alpha-fetoprotein negative hepatocellular carcinoma: A large-scale multicenter study.
Nanohoneycomb Surface-Enhanced Raman Spectroscopy-Active Chip for the Determination of Biomarkers of Hepatocellular Carcinoma.
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers.
Necrosis of hepatocellular carcinoma caused by spontaneously arising arterial thrombus.
New application of human tumor clonogenic assay to in vitro evaluation of tumor-targeting efficiency of immunoconjugates.
New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma.
New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy.
NIH conference. Hepatocellular carcinoma.
Nodular transformation of the liver, alpha-fetoprotein, and hepatocellular carcinoma.
Nomograms to predict the long-time prognosis in patients with alpha-fetoprotein negative hepatocellular carcinoma following radical resection.
Non-invasive diagnostic criteria for hepatocellular carcinoma: the value of contrast washout at imaging and the death of alpha-fetoprotein.
Non-operative arterial embolisation in primary liver tumours.
Non-specific tumoral markers in hepatocellular carcinoma.
Non-specificity of messenger RNA of alpha-fetoprotein in peripheral blood in detecting early spread of hepatocellular carcinoma in black Africans.
Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.
Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal?
Novel and sensitive enzyme immunoassay (immune-complex-transfer enzyme immunoassay) for alpha-fetoprotein from hepatocellular carcinoma.
Nuclear oncogenes and alpha-fetoprotein gene expression in hepatoma cell lines.
Number of hepatocellular carcinoma nodules in patients listed for liver transplantation within alpha-fetoprotein score: a new prognostic risk factor.
Occult hepatocellular carcinoma with high fucosylated alpha-fetoprotein.
Occurrence of oval-type cells in hepatitis B virus-associated human hepatocarcinogenesis.
Oesophageal hepatoid carcinoma with liver metastasis, a diagnostic dilemma.
On the Electrochemical Detection of Alpha-Fetoprotein Using Aptamers: DNA Isothermal Amplification Strategies to Improve the Performance of Weak Aptamers.
On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir.
Optimizing Surveillance Performance of Alpha-Fetoprotein by Selection of Proper Target Population in Chronic Hepatitis B.
Optimizing the Diagnostic Role of Alpha-Fetoprotein and Abdominal Ultrasound by Adding Overexpressed Blood mRNA Matrix Metalloproteinase-12 for Diagnosis of HCV-Related Hepatocellular Carcinoma.
Organization of the albumin and alpha-fetoprotein genes in fetal and adult rat tissues, and rat hepatomas.
Osteopontin versus alpha-fetoprotein as a diagnostic marker for hepatocellular carcinoma: a meta-analysis.
Outcome of Hepatitis B Virus Infection After Living-Donor Liver Transplant: A Single-center Experience Over 20 Years.
Overcoming effect of antibody against rat alpha-fetoprotein (AFP) on the growth of daunorubicin-resistant mutant rat ascites hepatoma cell line AH66.
Overlap syndrome between autoimmune hepatitis and primary biliary cirrhosis complicated by hepatocellular carcinoma.
P53 is a risk factor of de-novo hepatitis C-related hepatocellular carcinoma treated with direct-acting antivirals: a case-control study.
p53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding.
p55PIK regulates alpha-fetoprotein expression through the NF-?B signaling pathway.
Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells.
Pattern analysis of serum alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma in liver cirrhosis.
Percutaneous ethanol injection of hepatic tumors: single-session therapy with general anesthesia.
Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients.
Performance evaluation of serum PIVKA-II measurement using HISCL-5000 and a method comparison of HISCL-5000, LUMIPULSE G1200, and ARCHITECT i2000.
Performance of Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) for Hepatocellular Carcinoma Screening in Chinese Population.
Peri-Transplant Change in AFP Level: a Useful Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation.
Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literature.
Personalized treatment of patients with very early hepatocellular carcinoma.
Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition.
Phase I study of recombinant leukocyte A interferon (IFN-alpha 2A, Roferon-A) with doxorubicin in advanced malignant disease.
Phenotypic variability of cultured rat hepatoma cell population in respect to alpha-fetoprotein synthesis.
Plasma abnormal prothrombin levels in patients with small hepatocellular carcinoma.
Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patients.
Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma.
Plasma fucosyltransferase activity in patients with hepatocellular carcinoma, with special reference to correlation with fucosylated species of alpha-fetoprotein.
Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients.
Plasma nitrite/nitrate concentrations as a tumor marker for hepatocellular carcinoma.
PLC/PRF/5 (Alexander) hepatoma cell line: further characterization and studies of infectivity.
Positive status of alpha-fetoprotein and des-gamma-carboxy prothrombin: important prognostic factor for recurrent hepatocellular carcinoma.
Post-treatment alpha-fetoprotein response predicts prognosis of patients with hepatocellular carcinoma: A meta-analysis.
Postoperative changes in protein-induced vitamin K absence or antagonist II levels after hepatectomy in patients with hepatocellular carcinoma: relationship to prognosis.
Postoperative detection of alpha-fetoprotein mRNA in blood as a predictor for metastatic recurrence of hepatocellular carcinoma.
Postoperative serum alpha-fetoprotein level is a useful predictor of recurrence after hepatectomy for hepatocellular carcinoma.
Posttranscriptional regulation of albumin and alpha-fetoprotein messenger RNA by transforming growth factor-beta 1 requires de novo RNA and protein synthesis.
Potent viral suppression and improvements in alpha-fetoprotein and measures of fibrosis in Japanese patients receiving a daclatasvir/asunaprevir/beclabuvir fixed-dose combination for the treatment of HCV genotype-1 infection.
Potential of alpha-fetoprotein as a prognostic marker after curative radiofrequency ablation of hepatocellular carcinoma.
Potential of ramucirumab in treating hepatocellular carcinoma patients with elevated baseline alpha-fetoprotein.
Pre and postoperative changes of alpha-fetoprotein and human chorionic gonadotropin in hepatoma of children.
Pre-transplant alpha-fetoprotein is associated with post-transplant hepatocellular carcinoma recurrence mortality.
Pre-treatment alphafeto protein in hepatocellular carcinoma with non-viral aetiology - a prospective study.
Prediction of invasive activities in hepatocellular carcinomas with special reference to alpha-fetoprotein and des-gamma-carboxyprothrombin.
Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers.
Prediction of recurrence of hepatocellular carcinoma after curative hepatectomy using preoperative Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein.
Prediction of vascular invasion in hepatocellular carcinoma by next-generation des-r-carboxy prothrombin.
Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma.
Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients.
Predictive Role of AURKA rs 1047972 Gene Polymorphism and the Risk of Development of Hepatocellular Carcinoma.
Predictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis B virus infection - Results from a clinic-based longitudinal cohort.
Predictive Value of Alpha-fetoprotein in the Survival of Living Donor Liver Transplantation Recipients for Hepatocellular Carcinoma.
Predictive value of protein induced by absence of vitamin K absence or antagonist II, alpha-fetoprotein and gamma-glutamyltransferase/aspartate aminotransferase ratio for the diagnosis of hepatocellular carcinoma in transplantation candidates.
Predictive value of tumor markers in patients with recurrent hepatocellular carcinoma in different vascular invasion pattern.
Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
Predictors of postoperative diffuse intrahepatic recurrence of hepatocellular carcinoma.
Preliminary observation on human saliva alpha-fetoprotein in patients with hepatocellular carcinoma.
Preoperative alpha-fetoprotein (AFP) in hepatocellular carcinoma (HCC): is this 50-year biomarker still up-to-date?
Preoperative Alpha-Fetoprotein Has No Prognostic Role in Small Hepatocellular Carcinoma in Non-Cirrhotic Patients After Surgical Resection.
Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation.
Preoperative Carbohydrate Antigen 19-9: Its Neglected Role in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients.
Preoperative investigation and indication for operation in hepatocellular carcinoma.
Preoperative predictors of early recurrence after resection for hepatocellular carcinoma.
Preparation of [131I]lipiodol as a hepatoma therapeutic agent.
Presence of alpha-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma.
Preserved liver function, portal thrombosis and absence of oesophageal varices are risk factors for metastasis of hepatocellular carcinoma.
Preventive strategies in chronic liver disease: part II. Cirrhosis.
Primary cultures of aspiration residual specimens predict outcomes of hepatocellular carcinoma patients receiving curative treatment.
Primary hepatocellular carcinoma and hepatitis B infection during childhood.
Primary hepatocellular carcinoma with hepatitis B virus infection in a 16-year-old noncirrhotic patient.
Primary hepatoid adenocarcinoma of the uterine cervix.
Primary hepatoma presenting with central abdominal pain and diagnosed from a raised serum alpha-fetoprotein level.
Primary liver cell carcinoma. New insight for a more correct approach to its classification.
Primary vs metastatic hepatic carcinoma. An immunohistochemical study of 34 cases.
Proceedings: Serum alpha-fetoprotein and Ga67 citrate uptake in hepatoma.
Production of alpha-fetoprotein and normal serum proteins by xenotransplanted human hepatomas in relation to their growth and morphology.
Production of alpha-fetoprotein by cultured rat ascites hepatoma cells determined in vivo as alpha-fetoprotein-negative.
Prognosis evaluation in alpha-fetoprotein negative hepatocellular carcinoma after hepatectomy: comparison of five staging systems.
Prognosis of unresectable hepatocellular carcinoma: an evaluation based on multivariate analysis of 90 cases.
Prognostic factors in patients with HBV-related hepatocellular carcinoma following hepatic resection.
Prognostic Impact of Alpha Fetoprotein at Diagnosis on Overall Survival of Single Small Hepatocellular Carcinomas.
Prognostic importance of fucosylated alpha-fetoprotein in hepatocellular carcinoma patients with low alpha-fetoprotein.
Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation.
Prognostic role of alpha-fetoprotein response after hepatocellular carcinoma resection.
Prognostic role of serial alpha-fetoprotein levels in hepatocellular carcinoma treated with locoregional therapy.
Prognostic significance of a combination of pre- and post-treatment tumor markers for hepatocellular carcinoma curatively treated with hepatectomy.
Prognostic Significance of Alpha-fetoprotein Status in the Outcome of Hepatocellular Carcinoma after Treatment of Transarterial Chemoembolization.
Prognostic significance of Lens culinaris agglutinin A-reactive alpha-fetoprotein in small hepatocellular carcinomas.
Prognostic Significance of Preoperative Serum Alpha- fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors: a Single-center Experience from China.
Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma.
Prognostic significance of urinary neopterin levels in patients with hepatocellular carcinoma.
Prognostic value of ?-fetoprotein and des-?-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization.
Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma.
Prognostic Value of Pre-transplantation Serum Alpha-Fetoprotein Levels in Hepatocellular Carcinoma Recurrence.
Prognostic value of preoperative alpha-fetoprotein (AFP) level in patients receiving curative hepatectomy- an analysis of 1,182 patients in Hong Kong.
Prognostic Value of Serum AFP, AFP-L3, and GP73 in Monitoring Short-term Treatment Response and Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation.
Prognostic Values of Alpha-Fetoprotein and Des-Gamma-Carboxyprothrombin in Hepatocellular Carcinoma in China: An Analysis of 4792 Patients.
Prognostic Values of alpha-fetoprotein and Protein Induced by Vitamin K Absence or Antagonist-II in Hepatitis B Virus-related Hepatocellular Carcinoma: A Prospective Study.
Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and Validation.
Programmable Synthetic Protein Circuits for the Identification and Suppression of Hepatocellular Carcinoma.
Propensity Score Matching Analysis of Changes in Alpha-Fetoprotein Levels after Combined Radiotherapy and Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma.
Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery.
Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.
Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis.
Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis.
Prospective study on the diagnosis of hepatocellular carcinoma by using alpha-fetoprotein reactive to lentil lectin.
Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma. Comparison with alpha-fetoprotein.
Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysis.
Prussian blue nanoparticle-labeled aptasensing platform on graphene oxide for voltammetric detection of ?-fetoprotein in hepatocellular carcinoma with target recycling.
Publisher Correction: Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling.
Purification and characterization of a bioactive alpha-fetoprotein produced by HEK-293 cells.
Pylephlebitis and liver abscess mimicking hepatocellular carcinoma.
Quantification and utility of monosialylated alpha-fetoprotein in the diagnosis of hepatocellular carcinoma with nondiagnostic serum total alpha-fetoprotein.
Quantitation of alpha-fetoprotein and albumin messenger RNA in human hepatocellular carcinoma.
Quantitation of alpha-fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: a prospective pilot study.
Quantitative analysis of alpha-fetoprotein mRNA in circulating peripheral blood of patients with hepatocellular and alpha-fetoprotein-producing gastric carcinomas.
Quantitative screening of serum protein biomarkers by reverse phase protein arrays.
Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis.
Racial disparities in alpha-fetoprotein testing and alpha-fetoprotein status associated with the diagnosis and outcome of hepatocellular carcinoma patients.
Radioiodine gene therapy of hepatocellular carcinoma targeted human alpha fetoprotein.
Radiolabelled monoclonal antibodies against alpha-fetoprotein for in vivo localization of human hepatocellular carcinoma by immunotomoscintigraphy.
Ramucirumab after prior sorafenib in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Japanese subgroup analysis of the REACH-2 trial.
Ramucirumab as a second-line treatment for hepatocellular carcinoma: reaching out further to patients with elevated alpha-fetoprotein.
Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP) following first-line sorafenib: Pooled efficacy and safety across two global randomized Phase 3 studies (REACH-2 and REACH).
Ramucirumab in advanced hepatocellular carcinoma and elevated alpha-fetoprotein following sorafenib: outcomes by prior transarterial chemoembolisation from two randomised, double-blind, placebo-controlled phase 3 studies (REACH-2 and REACH).
Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib in REACH and REACH-2.
Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials.
Rapid and selective shutoff of plasma protein production in herpes simplex virus type 2-infected hepatoma cells.
Rat alpha-macrofetoprotein (acute-phase alpha 2-macroglobulin) during hepatocarcinogenesis.
Reappraisal of the diagnostic value of alpha-fetoprotein for surveillance of HBV-related hepatocellular carcinoma in the era of antiviral therapy.
Reciprocal regulation of alpha-fetoprotein and albumin gene expression by butyrate in human hepatoma cells.
Recombinant heat shock protein 70 functional peptide and alpha-fetoprotein epitope peptide vaccine elicits specific anti-tumor immunity.
Recombinant leukocyte A interferon with doxorubicin. A phase I study in advanced solid neoplasms and implications for hepatocellular carcinoma.
Redifferentiation of human hepatoma cell induced by 6-(p-chlorophenyl)-3-[1-(p-chlorophenyl)-5-methyl-1 H-1,2,3-triazol-4-yl]-s-triazolo[3,4-b]-1,3,4-thiadiazole (TDZ).
Reference change value for alpha-fetoprotein and its application in early detection of hepatocellular carcinoma in patients with hepatic disease.
Regenerative nodule mimicking hepatocellular carcinoma in a cirrhotic child due to hepatitis B: an imaging dilemma.
Regression of hepatocellular carcinoma during vitamin K administration.
Regulation effect of zinc fingers and homeoboxes 2 on alpha-fetoprotein in human hepatocellular carcinoma.
Regulation of albumin and alpha-fetoprotein gene expression by colloid osmotic pressure in human hepatoma cells.
Regulation of alpha-fetoprotein and transferrin synthesis and secretion in mouse hepatoma cells.
Regulation of rat alpha-fetoprotein production by methionine during ethionine-hepatocarcinogenesis.
Regulation of the alpha-fetoprotein gene by the isoforms of ATBF1 transcription factor in human hepatoma.
Regulation of the rat alpha-fetoprotein gene expression in liver. Both the promoter region and an enhancer element are liver-specific and negatively modulated by dexamethasone.
Regulatory regions of growth-related genes can activate an exogenous gene of the alpha-fetoprotein promoter to a comparable degree in human hepatocellular carcinoma cells.
Relationship between alpha-fetoprotein serum levels, tumour volume and growth rate of hepatocellular carcinoma in a western population.
Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses.
Relationship between expression of alpha-fetoprotein messenger RNA and some clinical parameters of human hepatocellular carcinoma.
Relationship between Lens culinaris agglutinin reactive alpha-fetoprotein and biological features of hepatocellular carcinoma.
Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma.
Relationship between pathologic prognostic factors and abnormal levels of des-gamma-carboxy prothrombin and alpha-fetoprotein in hepatocellular carcinoma.
Relationship of p16 methylation status and serum alpha-fetoprotein concentration in hepatocellular carcinoma patients.
Relationship of serum alpha-fetoprotein to circulating immune complexes and complements in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.
Report of a pilot study of intra-arterial injection of I-131 lipiodol for the treatment of hepatoma.
Report of hereditary persistence of alpha-fetoprotein in a Spanish family: molecular basis and clinical concerns.
Repression of alpha-fetoprotein gene expression under hypoxic conditions in human hepatoma cells: characterization of a negative hypoxia response element that mediates opposite effects of hypoxia inducible factor-1 and c-Myc.
Resected case of hepatocellular carcinoma associated with lupoid hepatitis.
Resection versus Ablation for Alpha-fetoprotein Positive Hepatocellular Carcinoma within the Milan Criteria: A Propensity Score Analysis.
Response of alpha-fetoprotein to chemotherapy in patients with hepatomas.
Response of serum alpha-fetoprotein to entecavir therapy predicts risk for hepatocellular carcinoma in patients with chronic hepatitis B.
Response to Ablation and resection for hepatocellular carcinoma within the Milan criteria and high alpha-fetoprotein levels.
Results of a surgical resection of pulmonary metastasis from hepatocellular carcinoma: prognostic impact of the preoperative serum alpha-fetoprotein level.
Retinoic acid mediates down-regulation of the alpha-fetoprotein gene through decreased expression of hepatocyte nuclear factors.
Retraction: Silencing Alpha-Fetoprotein Inhibits VEGF and MMP-2/9 Production in Human Hepatocellular Carcinoma Cell.
Retrovirus-mediated gene therapy for hepatocellular carcinoma with reversely oriented therapeutic gene expression regulated by alpha-fetoprotein enhancer/promoter.
Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
Retrovirus-mediated gene therapy for human hepatocellular carcinoma transplanted in athymic mice.
Reversing hepatocellular carcinoma progression by using networked biological therapies.
Review of the clinicopathologic features of fibrolamellar carcinoma.
Risk factors for hepatocellular carcinoma among patients with chronic liver disease.
Risk factors for recurrence of large HCC in patients treated by combined TAE and PEI.
Risk factors of hepatocellular carcinoma recurrence after liver transplantation: accuracy of the alpha-fetoprotein model in a single-center experience.
Risk Score Model for Microvascular Invasion in Hepatocellular Carcinoma: The Role of Tumor Burden and Alpha-Fetoprotein.
Role of AFP mRNA expression in peripheral blood as a predictor for postsurgical recurrence of hepatocellular carcinoma: a systematic review and meta-analysis.
Role of alpha-fetoprotein in hepatocellular carcinoma: prognostication, treatment monitoring or both?
Role of alpha-fetoprotein in selection of patients with hepatocellular carcinoma waiting for liver transplantation: must we reconsider it?
Role of alpha-fetoprotein in the diagnosis and management of hepatocellular carcinoma.
Role of interleukin-8 and oxidative stress in patients with hepatocellular carcinoma.
Role of superoxide dismutase in hepatitis B virus-related hepatocellular carcinoma.
Role of the alpha-fetoprotein response in immune checkpoint inhibitor-based treatment of patients with hepatocellular carcinoma.
Role of the model for end-stage liver disease and serum alpha-fetoprotein as prognostic predictors for hepatocellular carcinoma.
Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver.
RPL39L is an example of a recently evolved ribosomal protein paralog that shows highly specific tissue expression patterns and is upregulated in ESCs and HCC tumors.
RXR-mediated regulation of the alpha-fetoprotein gene through an upstream element.
Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical study.
Salvage therapy for hepatocellular carcinoma with thalidomide.
Sarcomatoid hepatocellular-carcinoma showing rhabdomyoblastic differentiation in the adult cirrhotic liver.
Sarcopenia and Alpha-fetoprotein Level in Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation: In Response.
Screening for cancer: is it cost effective?
Screening for hepatocellular carcinoma.
Screening methods for early detection of hepatocellular carcinoma.
Secondary prevention of hepatocellular carcinoma.
Selection of patients with hepatocellular carcinoma before liver transplantation: need to combine alpha-fetoprotein with morphology?
Selection tool alpha-fetoprotein for patients waiting for liver transplantation: How to easily manage a fractal algorithm.
Selective effects of Lipiodolized antitumor agents.
Selective inhibition of hepatoma cells using diphtheria toxin A under the control of the promoter/enhancer region of the human alpha-fetoprotein gene.
Selective prognostic impact of serum alpha-fetoprotein level in patients with hepatocellular carcinoma: analysis of 543 patients in a single center.
Semi-quantitative Measurement of a Specific Glycoform Using a DNA-tagged Antibody and Lectin Affinity Chromatography for Glyco-biomarker Development.
Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival.
Sensitive assay for detection of hepatocellular carcinoma associated gene transcription (alpha-fetoprotein mRNA) in blood.
Sensitive measurement of serum abnormal prothrombin (PIVKA-II) as a marker of hepatocellular carcinoma.
Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size.
Sequence analysis of the proximal promoter region of the human alpha-fetoprotein gene in hepatocellular carcinoma.
Sequence content of alpha-fetoprotein, albumin and fibrinogen polypeptide mRNAs in different organs, developing tissues and in liver during carcinogenesis in rats.
Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
Sequential study of serum glycoprotein fucosylation in acute hepatitis.
Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients.
Serological markers of hepatitis B virus and alpha-fetoprotein levels preceding primary hepatocellular carcinoma in Alaskan Eskimos.
Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular Carcinoma.
Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein.
Serum alpha 1-antitrypsin in patients with hepatocellular carcinoma.
Serum alpha fetoprotein heterogeneity as a means of differentiating between primary hepatocellular carcinoma and hepatic secondaries.
Serum alpha-fetoprotein (AFP) in benign and malignant gastrointestinal diseases: evaluation of an immunoenzymatic assay.
Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab.
Serum alpha-fetoprotein and hepatitis B antigen in subjects with hepatoma in south India.
Serum alpha-fetoprotein and hepatocellular carcinoma size.
Serum alpha-fetoprotein and lens culinaris agglutinin-reactive fraction of alpha-fetoprotein in patients with hepatocellular carcinoma.
Serum alpha-fetoprotein and variant alkaline phosphatase in human hepatocellular carcinoma.
Serum alpha-fetoprotein as a biochemical marker for hepatocellular carcinoma.
Serum alpha-fetoprotein concentrations in urban and rural Southern African blacks with hepatocellular carcinoma.
Serum alpha-fetoprotein estimations and doubling time in hepatocellular carcinoma: influence of therapy and possible value in early detection.
Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.
Serum Alpha-Fetoprotein Has High Specificity for the Early Detection of Hepatocellular Carcinoma After Hepatitis C Virus Eradication in Patients.
Serum alpha-fetoprotein in 184 Ugandan patients with hepatocellular carcinoma. Clinical, laboratory, and histopathologic correlations.
Serum alpha-fetoprotein in a mouse strain (C3H-Avy fB) with spontaneous hepatocellular carcinomas.
Serum alpha-fetoprotein in chronic liver disease.
Serum alpha-fetoprotein in experimental hepatocellular carcinomas in rats.
Serum alpha-fetoprotein in patients with neoplasms of the gastrointestinal tract.
Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma.
Serum alpha-fetoprotein in the relatively early stages of hepatocellular carcinoma and its relationship to gross anatomical types.
Serum alpha-fetoprotein level independently predicts post-transplantation survival in patients with hepatocellular carcinoma.
Serum alpha-fetoprotein level per total tumor volume as a predictor of recurrence of hepatocellular carcinoma after resection.
Serum alpha-fetoprotein level per tumor volume reflects prognosis in patients with hepatocellular carcinoma after curative hepatectomy.
Serum alpha-fetoprotein levels after hepatic artery ligation and postoperative chemotherapy: correlation with clinical status in patients with hepatocellular carcinoma.
Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular Carcinoma.
Serum alpha-fetoprotein levels and microheterogeneity in patients with different liver diseases.
Serum Alpha-Fetoprotein Levels During and After Interferon Therapy and the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C.
Serum alpha-fetoprotein levels in healthy Japanese adults.
Serum alpha-fetoprotein levels in neonatal cholestasis.
Serum alpha-fetoprotein levels in patients with acute and chronic liver disease. Relation to hepatocellular regeneration and development of primary liver cell carcinoma.
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.
Serum alpha-fetoprotein may have a significant role in the surveillance of hepatocellular carcinoma in hepatitis B endemic areas.
Serum alpha-fetoprotein measurement in predicting clinical outcome related to autologous cytokine-induced killer cells in patients with hepatocellular carcinoma undergone minimally invasive therapy.
Serum alpha-fetoprotein response as a surrogate for clinical outcome in patients receiving systemic therapy for advanced hepatocellular carcinoma.
Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy.
Serum alpha-fetoprotein subfractions in patients with primary hepatoma or hepatic metastasis of gastric cancer.
Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma.
Serum alpha-L-fucosidase. A more sensitive marker for hepatocellular carcinoma?
Serum anti-P53 antibodies and alpha-fetoprotein in patients with non-B non-C hepatocellular carcinoma.
Serum CA 125 as a marker of hepatocellular carcinoma.
Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis.
Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits.
Serum cytoskeleton-associated protein 4 as a biomarker for the diagnosis of hepatocellular carcinoma.
Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma.
Serum ferritin level after resection of hepatocellular carcinoma. Correlation with alpha-fetoprotein level.
Serum Golgi Phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.
Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma.
Serum insulin-like growth factor-II and alpha-fetoprotein as tumor markers of hepatocellular carcinoma.
Serum insulin-like growth factor-II as a serologic marker of small hepatocellular carcinoma.
Serum levels of gamma-glutamyl transpeptidase in relation to HCC human biology and prognosis.
Serum metabolites may be useful markers to assess vascular invasion and identify normal alpha-fetoprotein in hepatocellular carcinoma undergoing liver resection: a pilot study.
Serum miR-18a: A Potential Marker for Hepatitis B Virus-Related Hepatocellular Carcinoma Screening.
Serum peptide pattern differentially diagnoses Hepatitis B Virus-related hepatocellular carcinoma from liver cirrhosis.
Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis.
Serum pseudouridine as a biochemical marker in patients with hepatocellular carcinoma.
Serum tumor markers in patients with hepatocellular carcinoma: diagnosis of alpha-fetoprotein -low or -negative patients.
Serum tumor markers.
Sgo1 is a potential therapeutic target for hepatocellular carcinoma.
Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
Significance of alpha-fetoprotein levels for detection of early recurrence of hepatocellular carcinoma after hepatic resection.
Significance of alpha-fetoprotein mRNA level in hepatocellular carcinoma patients treated with radiofrequency ablation.
Signification of Serum Alpha-Fetoprotein Levels in Cases of Compensated Cirrhosis and Hepatitis C Virus without Hepatocellular Carcinoma.
Silencing alpha-fetoprotein expression induces growth arrest and apoptosis in human hepatocellular cancer cell.
Silencing alpha-fetoprotein inhibits VEGF and MMP-2/9 production in human hepatocellular carcinoma cell.
Simultaneous determination of alpha-fetoprotein immune complexes and alpha-fetoprotein concentration in hepatocellular carcinoma using dual-label time-resolved immunofluorometric assays.
Simultaneous determination of percentage of Lens culinaris agglutinin-reactive alpha-fetoprotein and alpha-fetoprotein concentration using the LiBASys clinical auto-analyzer.
Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
Simultaneous multicentric occurrence of early hepatocellular carcinoma in a patient with persistent alpha-fetoprotein elevation.
Simultaneous voltammetric immunodetection of alpha-fetoprotein and glypican-3 using a glassy carbon electrode modified with magnetite-conjugated dendrimers.
Single nucleotide polymorphism in the promoter region of human alpha-fetoprotein (AFP) gene and its significance in hepatocellular carcinoma (HCC).
Small and asymptomatic hepatocellular carcinoma detected by alpha-fetoprotein screening in black hepatitis B carriers. A report of 2 cases.
Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells.
Sofosbuvir plus ribavirin is tolerable and effective even in elderly patients 75-years-old and over.
Soluble CD25 as a predictor of hepatocellular carcinoma compared with alpha-fetoprotein.
Sorafenib and hepatocellular carcinoma: is alpha-fetoprotein a biomarker predictive of tumor biology and primary resistance?
Specific activation of sodium iodide symporter gene in hepatoma using alpha-fetoprotein promoter combined with hepatitis B virus enhancer (EIIAPA).
Specific diagnosis of hepatocellular carcinoma by delayed hepatobiliary imaging.
Specific enzyme immunoassay for alpha-fetoprotein from hepatocellular carcinoma.
Specific measurement of hypocarboxylated prothrombin in plasma or serum and application to the diagnosis of hepatocellular carcinoma.
Specific molecular markers in hepatocellular carcinoma.
Specific uptake of alpha-fetoprotein and albumin by rat Morris 7777 hepatoma cells.
Specificities of serum alpha-fetoprotein in HBsAg+ and HBsAg- patients in the diagnosis of hepatocellular carcinoma.
Sphingosine kinase regulates hepatoma cell differentiation: roles of hepatocyte nuclear factor and retinoid receptor.
Spiral computed tomography versus ultrasound in the follow-up of cirrhotic patients previously treated for hepatocellular carcinoma: a prospective study.
Spontaneous complete regression of hepatocellular carcinoma with portal vein tumor thrombus.
Spontaneous drastic reduction of alpha-fetoprotein in hepatocellular carcinoma.
Spontaneous regression of a hepatoma with ring calcification.
Spontaneous regression of hepatocellular carcinoma.
Spontaneous rupture of metastatic alpha-fetoprotein-producing gastric cancer of the liver.
Stable transfection of retinoblastoma gene promotes contact inhibition of cell growth and hepatocyte nuclear factor-1-mediated transcription in human hepatoma cells.
Streamline phenomena in liver metastasis of gastrointestinal tumor - an experimental-study using rats.
Structures of disease-specific serum alpha-fetoprotein isoforms.
Studies on human alpha-fetoprotein. Isolation and characterization of monomeric and polymeric forms and amino-terminal sequence analysis.
Studies on liver cancer. II. Production of alpha-fetoprotein by experimental hepatoma and its characterization.
Studies on the correlation among the fucosylation index, concentration of alpha-fetoprotein and des-gamma-carboxy prothrombin as prognostic indicators in hepatocellular carcinoma.
Subclinical hepatocellular carcinoma in Hong Kong Chinese.
Sublingual vein parameters, AFP, AFP-L3, and GP73 in patients with hepatocellular carcinoma.
Substitution of amino acid 70 in the hepatitis C virus core region of genotype 1b is an important predictor of elevated alpha-fetoprotein in patients without hepatocellular carcinoma.
Subtle hepatocellular carcinoma: a persisting role for alpha-fetoprotein monitoring in high-risk patients with cirrhosis.
Successful treatment of hepatocellular carcinoma with percutaneous ethanol injection therapy and local hyperthermia.
Sugar chains of human cord serum alpha-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas.
Suppression of albumin and alpha-fetoprotein gene expression by butyrolactone I, a selective inhibitor of the cdk family, in HuH-7 human hepatoma cells.
Suppression of the tumorigenicity of human hepatoma hep3B cells by long-term retinoic acid treatment.
Surgically treated cases of mixed hepatocellular carcinoma and cholangiocarcinoma.
Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?
Surveillance for Early-Stage Hepatocellular Carcinoma by Ultrasound Plus Alpha-Fetoprotein Measurement: More Details, More Significance.
Surveillance for gastrointestinal malignancies.
Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America.
Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
Survival outcomes of liver transplantation for hepatocellular carcinoma in patients with normal, high and very high preoperative alpha-fetoprotein levels.
Synchronous Hepatocellular Carcinoma and Cholangiocellular Carcinoma on 18F-FDG PET/CT
Synergistic Impact of Alpha-Fetoprotein and Tumor Burden on Long-Term Outcomes Following Curative-Intent Resection of Hepatocellular Carcinoma.
Synthesis and secretion of alpha-fetoprotein and acute-phase alpha 2-macroglobulin by Zajdela rat ascites hepatoma.
Synthesis of alpha-fetoprotein by membrane-bound polysomes of rat ascites hepatoma cells.
Synthesis of alpha-fetoprotein by rat ascites hepatoma cells.
Systematic review: the prognostic role of alpha-fetoprotein following liver transplant for hepatocellular carcinoma.
Tailored algorithms for hepatocellular carcinoma surveillance: Is one-size-fits-all strategy outdated?
Tandem arrangement of the albumin and alpha-fetoprotein genes in the human genome.
Target cell populations in virus-associated hepatocarcinogenesis.
Targeting alpha-fetoprotein represses the proliferation of hepatoma cells via regulation of the cell cycle.
TCP10L negatively regulates alpha-fetoprotein expression in hepatocellular carcinoma.
Telomerase inhibition decreases alpha-fetoprotein expression and secretion by hepatocellular carcinoma cell lines: in vitro and in vivo study.
Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis.
The alpha-fetoprotein serum is still reliable as a biomarker for the surveillance of hepatocellular carcinoma in Indonesia.
The alpha1-6-fucosyltransferase gene and its biological significance.
The antagonistic effect of dexamethasone and insulin on alpha-fetoprotein secretion by cultured H4-II-E-C3 cells derived from the Reuber H-35 hepatoma.
The biocompatibility of quantum dot probes used for the targeted imaging of hepatocellular carcinoma metastasis.
The c-jun proto-oncogene down-regulates the rat alpha-fetoprotein promoter in HepG2 hepatoma cells without binding to DNA.
The Clinical Significance of Alpha-Fetoprotein mRNAs in Patients with Hepatocellular Carcinoma.
The control of serum protein synthesis in hepatoma-fibroblast hybrids.
The des-gamma-carboxyprothrombin for the diagnosis of hepatocellular carcinoma.
The development of laboratory tests for cancer in Japan with special reference to carcinoembryonic proteins.
The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepatocellular Carcinoma Patients.
The diagnostic value of the combination of Golgi protein 73, glypican-3 and alpha-fetoprotein in hepatocellular carcinoma: a diagnostic meta-analysis.
The E2F Transcription Factor 1 Transactives Stathmin 1 in Hepatocellular Carcinoma.
The effect of anti-alpha-fetoprotein-adriamycin conjugate on a human hepatoma.
The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.
The effects of dexamethasone on alpha-fetoprotein and albumin synthesis in cultured hepatoma 7777 cells.
The effects of retinoic acid on the expression of alpha-fetoprotein and albumin genes in rat hepatoma cell lines.
The EIIAPA Chimeric Promoter for Tumor Specific Gene Therapy of Hepatoma.
The enzymatic basis for the conversion of nonfucosylated to fucosylated alpha-fetoprotein by acyclic retinoid treatment in human hepatoma cells: activation of alpha1-6 fucosyltransferase.
The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
The fatty acid levels of rat alpha-fetoprotein derived from fetuses, pregnancy and hepatoma sera.
The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma.
The fucosylation index of alpha-fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinoma.
The fucosylation index of serum alpha-fetoprotein as useful prognostic factor in patients with hepatocellular carcinoma in special reference to chronological changes.
The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma.
The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma.
The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status.
The immunosuppression role of alpha-fetoprotein in human hepatocellular carcinoma.
The impact of immigration on the increasing incidence of hepatocellular carcinoma in the United States.
The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma.
The influence of antisera specific for alpha-fetoprotein and mouse serum albumin on the viability and protein synthesis of cultured mouse hepatoma cells.
The inhibitory effects of horse anti-rat AFP antiserum on the uptake of 2-deoxy-D-glucose by AFP-producing rat hepatoma cells.
The low positive rate of serum alpha-fetoprotein levels in hepatitis C virus antibody-positive patients with hepatocellular carcinoma.
The mechanism of the bidirectional regulation of the rat alpha-fetoprotein gene by glucocorticoid hormone.
The mouse alpha-fetoprotein promoter is repressed in HepG2 hepatoma cells by hepatocyte nuclear factor-3 (FOXA).
The natural course of hepatitis B surface antigen-positive chronic active hepatitis in Taiwan.
The postresection alpha-fetoprotein in cirrhotic patients with hepatocellular carcinoma. An independent predictor of outcome.
The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.
The Predictive Power of Serum ?-Fetoprotein and Des-?-Carboxy Prothrombin for Survival Varies by Tumor Size in Hepatocellular Carcinoma.
The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma.
The prognostic utility of baseline alpha-fetoprotein for hepatocellular carcinoma patients.
The Prognostic Value of Alpha-Fetoprotein Response for Advanced-Stage Hepatocellular Carcinoma Treated with Sorafenib Combined with Transarterial Chemoembolization.
The promoting molecular mechanism of alpha-fetoprotein on the growth of human hepatoma Bel7402 cell line.
The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation.
The role of alpha-fetoprotein in hepatocellular carcinoma drug resistance.
The role of circulating microRNAs for the diagnosis of hepatitis B virus-associated hepatocellular carcinoma with low alpha-fetoprotein level: a systematic review and meta-analysis.
The role of ERCC1 and AFP gene polymorphism in hepatocellular carcinoma.
The role of methylation in regulating the expression of the alpha-fetoprotein gene in developing rat liver and hepatoma cell lines.
The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma.
The significance of alpha-fetoprotein and other tumour markers in differential immunocytochemistry of primary liver tumours.
The significance of early alpha-fetoprotein level changes in predicting clinical and survival benefits in advanced hepatocellular carcinoma patients receiving sorafenib.
The Significance of Gamma-Glutamyl Transpeptidase to Lymphocyte Count Ratio in the Early Postoperative Recurrence Monitoring and Prognosis Prediction of AFP-Negative Hepatocellular Carcinoma.
The targeted expression of the human interleukin-2/interferon alpha2b fused gene in alpha-fetoprotein-expressing hepatocellular carcinoma cells.
The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.
The tumor marker score is an independent predictor of survival in patients with recurrent hepatocellular carcinoma.
The use of a monoclonal antibody against alpha-fetoprotein for the radioimmunodetection of hepatocellular carcinoma.
The use of tissue polypeptide specific antigen as a marker in liver diseases.
The usefulness of simultaneous determinations of glucosaminylation and fucosylation indices of alpha-fetoprotein in the differential diagnosis of neoplastic diseases of the liver.
The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.
The value of serum alpha-fetoprotein in predicting tumor recurrence after liver transplantation for hepatocellular carcinoma.
The value of serum tissue polypeptide specific antigen in the diagnosis of hepatocellular carcinoma.
The value of the Barcelona Clinic Liver Cancer and alpha-fetoprotein in the prognosis of hepatocellular carcinoma.
The value of tumour marker kinetics in the management of patients with primary hepatocellular carcinoma.
Theoretical mechanisms for synthesis of carcinogen-induced embryonic proteins: X. Correlation of the induceability of hepatomas and alpha-fetoprotein gene activity.
Therapeutic effect of coenzyme Q10 against experimentally-induced hepatocellular carcinoma in rats.
Therapeutic effect of treatment with polyclonal or monoclonal antibodies to alpha-fetoprotein that have been conjugated to daunomycin via a dextran bridge: studies with an alpha-fetoprotein-producing rat hepatoma tumor model.
Thorotrast-induced hepatic angiosarcoma, and combined hepatocellular and cholangiocarcinoma in a single patient.
Thyroid hormone effect on alpha-fetoprotein and albumin coordinate expression by a human hepatoma cell line.
Thyroxine-binding globulin as a marker of liver tumors.
Thyroxine-binding globulin in elderly patients with hepatocellular carcinoma.
Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors for salvage liver transplantation.
Tissue antigen distribution in hepatocellular carcinoma.
Tissue-specific expression of herpes simplex virus thymidine kinase gene delivered by adeno-associated virus inhibits the growth of human hepatocellular carcinoma in athymic mice.
Tissular immunoenzymatic detection of hepatic alphafetoprotein in human hepatomas.
Toll-like receptor 7 mRNA is reduced in hepatitis C-based liver cirrhosis and hepatocellular carcinoma, out-performs alpha-fetoprotein levels, and with age and serum aspartate aminotransferase is a new diagnostic index.
Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation.
Transactivation of human alpha-fetoprotein gene by X-gene product of hepatitis B virus in human hepatoma cells.
Transcription factor AP-2 functions as a repressor that contributes to the liver-specific expression of serum amyloid A1 gene.
Transcriptional regulation of alpha-fetoprotein expression by dexamethasone in human hepatoma cells.
Transforming growth factor beta 1 differentially regulates alpha-fetoprotein and albumin in HuH-7 human hepatoma cells.
Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma.
Transforming growth factor-beta1 as a useful serologic marker of small hepatocellular carcinoma.
Triple primary cancers involving kidney, urinary bladder, and liver in a dye worker.
Tumor Characteristics and Long-Term Outcome of Incidental Hepatocellular Carcinoma After Orthotopic Liver Transplant.
Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma.
Tumor vascularity and lens culinaris agglutinin reactive alpha-fetoprotein are predictors of long-term prognosis in patients with hepatocellular carcinoma after percutaneous ethanol injection therapy.
Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma.
Tumour-specific induction of immune complexes: DCP-IgM in hepatocellular carcinoma.
Type 1 tyrosinemia in Finland: a nationwide study.
Tyrosinemia: a report of three cases from India.
Ultrasonographic and radionuclide detection of hepatocellular carcinoma in cirrhotics with low alpha-fetoprotein levels.
Ultrasonography and alpha-fetoprotein in diagnosis of hepatocellular carcinoma in cirrhosis.
Ultrastructural observation of alpha-fetoprotein producing cells in human hepatocellular carcinoma using immunoperoxidase methods--comparison with fetal liver.
Undetected hepatocellular carcinoma: clinical features and outcome after liver transplantation.
Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-gamma-carboxy prothrombin and low serum alpha-fetoprotein.
Unique structure of glycopeptide from alpha-fetoprotein produced in human hepatoma cell line, as determined by 1H-nuclear magnetic resonance spectroscopy.
Unsuspected primary malignancy in the setting of elevated serum alpha-fetoprotein.
Unusual presentation of hepatocellular carcinoma: a case report.
Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinoma.
Up-regulation of multidrug resistance transporter expression by berberine in human and murine hepatoma cells.
Urinary excretion of pseudouridine in patients with hepatocellular carcinoma.
Urinary pseudouridine as a biochemical marker in the diagnosis and monitoring of primary hepatocellular carcinoma.
Urinary transforming growth factor-beta 1 in relation to serum alpha-fetoprotein in hepatocellular carcinoma.
Use of Cytokeratin-19 Concentration to Assess Early Recurrence and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma following Radical Resection in Patients with a Low Serum Alpha-Fetoprotein Concentration.
Usefulness of a new inflammation-based scoring system for prognostication of patients with hepatocellular carcinoma after hepatectomy.
Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma.
Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Usefulness of Alpha-fetoprotein Response in Patients Treated with Sorafenib for Advanced Hepatocellular Carcinoma.
Usefulness of Circulating Methylated p16 as a Noninvasive Molecular Biomarker for Hepatitis C-Related Hepatocellular Carcinoma with Normal Serum Alpha-Fetoprotein Levels.
Usefulness of Lens culinaris agglutinin A-reactive fraction of alpha-fetoprotein (AFP-L3) as a marker of distant metastasis from hepatocellular carcinoma.
Usefulness of measurement of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma.
Usefulness of preoperative C-reactive protein and alpha-fetoprotein levels for prognostication of patients with hepatocellular carcinoma after living donor liver transplantation.
Usefulness of serum des-gamma-carboxy prothrombin in detection of hepatocellular carcinoma.
Usefulness of simultaneous determination of alpha-fetoprotein and des-gamma-carboxy prothrombin in hepatocellular carcinoma.
Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma.
Using receiver operating characteristic curves to evaluate the diagnostic value of the combination of multislice spiral CT and alpha-fetoprotein levels for small hepatocellular carcinoma in cirrhotic patients.
Utility of FDG-PET for investigating unexplained serum AFP elevation in patients with suspected hepatocellular carcinoma recurrence.
Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma.
Utility of lentil lectin affinity of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Utility of serum des-gamma-carboxyprothrombin in the diagnosis of hepatocellular carcinoma among Nigerians, a case-control study.
Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor.
Utilization of variant-type of human alpha-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma.
Utilizing alpha-fetoprotein expression to enhance oncolytic viral therapy in hepatocellular carcinoma.
Validation and update of a multivariable prediction model for the identification and management of patients at risk for hepatocellular carcinoma.
Validation of a novel model for the early detection of hepatocellular carcinoma.
Validation of an alpha-fetoprotein model to predict recurrence after liver resection for hepatocellular carcinoma.
Validation of the alpha-fetoprotein model for hepatocellular carcinoma recurrence after transplantation in an Asian population.
Validation of the Updated Hepatocellular Carcinoma Early Detection Screening Algorithm in a Community-based Cohort of Patients With Cirrhosis of Multiple Etiologies.
Value of highly sensitive fucosylated fraction of alpha-fetoprotein for prediction of hepatocellular carcinoma recurrence after curative treatment.
Value of serum alpha-fetoprotein and ferritin in the diagnosis of hepatocellular carcinoma.
Values of circulating GPC-3 mRNA and alpha-fetoprotein in detecting patients with hepatocellular carcinoma.
Variety and Dynamics of Proteoforms in the Human Proteome: Aspects of Markers for Hepatocellular Carcinoma.
Very high alpha-fetoprotein in a young man due to concomitant presentation of hepatocellular carcinoma and Sertoli cell testis tumor.
Well-differentiated gall bladder hepatoid carcinoma producing alpha-fetoprotein: a case report.
What is the best surveillance for hepatocellular carcinoma in chronic carriers of hepatitis B?
Zhx2 and Zbtb20: novel regulators of postnatal alpha-fetoprotein repression and their potential role in gene reactivation during liver cancer.
ZHX2 and ZHX3 repress cancer markers in normal hepatocytes.
ZHX2 is a repressor of alpha-fetoprotein expression in human hepatoma cell lines.
[131I-labelled tumor-specific antibodies: a trials to concentrate radioisotoopes specifically in the tumor. II. The binding of 131I-labelled anti-human alpha-fetoprotein antibody to the cultured human hepatoma cells]
[18F-Fluorodeoxyglucose uptake in hepatocellular carcinoma on positron emission tomography correlates with alpha-fetoprotein]
[76-year-old patient with adenocarcinoma of the rectum and fibrolamellar hepatocellular 2d carcinoma. Case report with literature review of hepatocellular carcinoma of the fibrolamellar type]
[A case of hepatocellular carcinoma with bone metastasis which responded to oral administration of UFT]
[A clinicopathological study of primary liver cancer associated with alcoholic liver injury]
[A mini-review of targeting gene-virotherapy of cancer]
[A new method of preparation of doxorubicin-in-oil suspension using ultrasonificator attached with Cuphorn]
[Alpha 1-proteinase inhibitor deficiency and isolated liver cirrhosis without pulmonary emphysema in a 53-year-old female patient]
[Alpha-fetoprotein and its fucosylation index in the early diagnosis of hepatocellular carcinoma]
[Alpha-fetoprotein in non-hepatocellular malignant tumors]
[Alpha-fetoprotein producing hepatocellular carcinoma, AT-III producing hepatocellular carcinoma]
[Alpha-fetoprotein synthesis in clonogenic cells of rat hepatoma McA-RH 7777]
[Alpha-fetoprotein: diagnostic value in hepatic disorders]
[Analysis of clinicopathological features and prognosis between alpha-fetoprotein negative and positive hepatocellular carcinoma patients after R0 radical hepatectomy].
[Antigen showing alternative to alpha-fetoprotein expression in rat hepatomas]
[Application of alpha-fetoprotein and osteopontin combination for early diagnosis of hepatocellular carcinoma associated with hepatitis C.]
[Application of alpha-fetoprotein determination by radioimmunoassay to the diagnosis of primary hepatoma]
[Application of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma]
[Biological markers of cancer. Critical study]
[Biomarkers for neoplasmas in digestive organs]
[Carcinoembryonic antigen, alpha-fetoprotein and hepatoma alkaline phosphatase in gastric carcinoma]
[Changes in the rhythms of the alpha-fetoprotein content of the blood serum of mice with hepatoma 22A and of tumor cell proliferation depending on the time of cyclophosphane administration]
[Characteristics of contrast-enhanced ultrasound in alpha-fetoprotein-negative recurrent small hepatocellular carcinoma].
[Clinical and etiologic features of hepatocarcinoma in Sicily]
[Clinical application studies on AFP-L3 detected by micro-spin column method].
[Clinical evaluation of alpha-fetoprotein as tumor marker for hepatocellular carcinoma (author's transl)]
[Clinical Significance of Serum GPDA-F Determined by Immunoelectrophoresis in Diagnosis of Hepatocellular Carcinoma.]
[Clinical usefulness of lectin-reactive fraction of alpha-fetoprotein in hepatocellular carcinoma]
[Comparative evaluation of ultrasonography, computerized tomography, angiography and lipiodol CT in defining extent of hepatocarcinoma. A multicenter study]
[Comparison of scintigraphy, CT and serum alpha-fetoprotein in patients with hepatocellular carcinoma]
[Construction of eukaryotic expression vector of mouse alpha-fetoprotein cDNA and its expression in dendritic cells and in vitro antitumor effect on hepatoma]
[Correlation between serum alpha-fetoprotein variant levels in patients with hepatocellular carcinoma and the presence of alpha-fetoprotein mRNA in the circulating blood]
[Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma]
[Correlation of somatostatin receptor expression in human hepatocellular carcinoma tissue to serum alpha-fetoprotein concentration]
[Could patients who underwent hepatic resection due to hepatocellular carcinoma with high alpha-fetoprotein be monitored for recurrence by alpha-fetoprotein level?]
[Cytodiagnosis of primary liver cell carcinoma with reference to alpha-fetoprotein (author's transl)]
[Dendritic cell vaccine modified by murine mAFP gene enhances immunoprotective effect on liver carcinogenesis and tumor development in mice]
[Detection and comparison of transcriptional activities of tumor-specific survivin and alpha-fetoprotein promoters in human hepatocellular carcinoma cells]
[Detection of GGT-II by dot-ELISA with monoclonal antibody in the diagnosis of hepatocellular carcinoma]
[Diagnosis of hepatoma by alpha-fetoprotein]
[Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
[Distribution of alpha-fetoprotein and albumin in paraffin sections of cells of Zaidel's ascitic hepatoma]
[Distribution of alpha-fetoprotein and albumin-positive cells in hepatocellular carcinoma as well as their surrounding liver tissue]
[DNA vaccine encoding alpha-fetoprotein with fused ornithine decarboxylase degradation signal significantly suppresses hepatocellular carcinoma growth in mice].
[Early detection of hepatocellular carcinoma with lectin reactive alpha-fetoprotein]
[Early determination of the effect of preoperative TAE by observation of serum AFP changes in patients with hepatocellular carcinoma]
[Effect of alpha-fetoprotein on the growth of human hepatoma cells in vitro]
[Effect of antibody to rat alpha-fetoprotein (AFP) on protein and DNA synthesis of rat ascites hepatoma AH66 cells]
[Effect of cyclophosphamide on alpha-fetoprotein content in the blood serum of mice with hepatoma 22a depending upon the period of tumor development]
[Effects of alpha-fetoprotein on the expression of TRAIL death receptor-2 and its role on resisting the cytotoxicity of TRAIL in hepatoma cells].
[Effects of oxidative stress on the proliferation, differentiation and apoptosis in the human hepatoma cells]
[Effects of oxygen free radicals on cell growth and productions of alpha-fetoprotein (AFP) and albumin (ALB) by human hepatoma cell line (HH2-6)]
[Epidemiology of hepatocellular carcinoma in the department of Calvados]
[Evaluation of diagnostic performance of alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP) for HCV related hepatocellular carcinoma developed after long-term follow up].
[Evaluation of transcatheter arterial embolization in terms of serum alpha-fetoprotein doubling time in hepatocellular carcinoma]
[Experimental studies in vitro on the alpha-fetoprotein-specific promoter mediated target gene therapy of hepatocellular carcinoma]
[Experimental studies on targeting chemotherapy using adriamycin entrapped in liposomes conjugated with anti-human alpha-fetoprotein monoclonal antibody]
[Expression of alpha-fetoprotein and hepatocyte nuclear factors in rat hepatoma clones: effect of retinoic acid]
[Expression of glypican-3, hepatocyte antigen, alpha-fetoprotein, CD34 and CD10 in hepatocellular carcinoma: a clinicopathologic analysis of 375 cases].
[Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis]
[Hepatitis B antigen and alpha-fetoprotein in hepatoma in Taiwan]
[Hepatocellular carcinoma as a rare cause of excessive rise in alpha-fetoprotein in pregnancy]
[Immunization with dendritic cells infected with human AFP adenovirus vector effectively elicits immunity against mouse hepatocellular carcinomas]
[Independence of alpha-fetoprotein expression from production of adult rat serum proteins in hepatoma McA-RH7777]
[Induction of alpha-fetoprotein synthesis in highly differentiated spontaneous hepatomas in mice]
[Inhibition of alpha-fetoprotein synthesis in hepatocytes of adult mice by dextran sulfate in vivo and in vitro]
[Inhibitory effects of human AFP-derived peptide-pulsed dendritic cells on mouse hepatocellular carcinoma]
[Isolated tumor cells in primary malignant liver tumors]
[Killing effect of PNP/MeP-dR suicide gene system driven by an AFP promoter AF0.3 on AFP-positive hepatoma cells]
[Lectin-reactive alpha-fetoprotein in tyrosinaemia type I]
[Long-term course in asymptomatic carriers of HBsAg in an area of low prevalence of hepatocarcinoma]
[Massive venous thrombosis with cardiac invasion as primary manifestation of hepatocarcinoma]
[Measurement of alpha-fetoprotein with L3 fraction in the early diagnosis of patients with hepatocellular carcinoma]
[Measurement of radioimmunoassay of alpha-fetoprotein in dried blood samples on paper for mass screening of hepatocellular carcinoma]
[Metastatic pancreatic endocrine tumor with elevation of alpha-fetoprotein]
[Microspectrophotometric analysis of nuclear DNA contents related to the presence of alpha-fetoprotein in human hepatocellular carcinoma]
[Molecular markers for the monitoring of malignant transformation of hepatocytes and early diagnosis of liver cancer].
[Mutation of p53 gene and expression of alphafetoprotein during hepatocarcinogenesis]
[Non surgical treatment of hepatocellular carcinoma]
[Nuclear-medical methods in hepatology]
[Optimal Cut-off Value of PIVKA-II for Diagnosis of Hepatocellular Carcinoma: Using ROC Curve.]
[Pathology of hepatocellular carcinoma]
[Ploidy level and alpha-fetoprotein production in spontaneous murine hematomas in relation to the degree of histological differentiation]
[Portal thrombosis and liver cirrhosis. Value of ultrasound-guided puncture-biopsy of the thrombus]
[Production of an Anti-PIVKA-II Recombinant Single-Chain-Antibody in Escherichia Coli].
[Prognostic marker of serum alpha-fetoprotein levels in hepatocellular carcinoma: retrospective analysis of 230 patients]
[Prognostic value of pre- and postoperative alpha-fetoprotein in the follow-up of patients with surgically-treated hepatocellular carcinoma]
[Prospective study on the diagnosis of hepatocellular carcinoma by using alpha-fetoprotein reactive to lentil lectin]
[Quantitation of alpha-fetoprotein messenger RNA in peripheral blood of nude mice and its relationship with tumor recurrence and metastasis after curative resection of hepatocellular carcinoma]
[Recent advances in laboratory tests for liver diseases]
[Reconstruction of transcriptional regulatory elements of human alpha-fetoprotein gene]
[Research progress of alpha-fetoprotein vaccine in hepatocellular carcinoma].
[Research progress of serum biomarkers for early screening of hepatocellular carcinoma].
[Results of a 4-year of alpha-fetoprotein in Vietnam (1969--1973)]
[Retroviral-mediated transcriptional regulatory elements of alpha-fetoprotein gene directed specific expression of interleukin-2 in murine hepatoma]
[Screening of hepatocellular carcinoma: role of the alpha-fetoprotein (AFP) and ultrasonography]
[Serological examinations in children with hepatoma and teratoma of alpha-fetoprotein and alpha-2-H-globulin and the diagnostic and prognostic value (author's transl)]
[Serum alpha-fetoprotein and hepatitis B surface antigen in patients with hepatocellular carcinoma (author's transl)]
[Serum concentrations of prolactin, growth hormone, and alpha-fetoprotein under long-term administration of an oral contraceptive containing cyproterone acetate (author's transl)]
[Significance of arginase-1, glypican-3, hepatocyte paraffin antigen 1 and alpha-fetoprotein in diagnosis and differential diagnosis of liver tumors].
[Small hepatocellular carcinoma. New concepts on intrahepatic recurrence after hepatectomy in orthotopic liver transplantation]
[Small unilocular hepatocellular carcinoma (0 < 5 cm) in patients with liver cirrhosis. Early diagnosis, surgical indications, resection and prognosis]
[Spontaneous regression of hepatocellular carcinoma in a cirrhotic patient]
[Stable isotope labeling and parallel reaction monitoring-based proteomic quantification for biomarker screening and validation of hepatocellular carcinoma].
[Structure and expression of alpha-fetoprotein gene--current progress in research]
[Studies on AFP-producing capacity and some other properties of human hepatoma cells treated with various anticancer drugs]
[Study on the evaluation of recurrence of HCC and the effect after transcatheter hepatic arterial embolization--fluctuations in AFP values]
[Suppression of alpha-fetoprotein gene expression in somatic hybrids of AFP-positive and AFP-negative clones of rat hepatoma]
[Surveillance for hepatocellular carcinoma: does it work?]
[Surveillance of cirrhosis for hepatocellular carcinoma--clinical validation of new serological biomarkers for improved diagnosis]
[Synergic Effect of Adenoviral Vector-encoding Human Alpha-fetoprotein and Interferon-gamma on Immunity against Hepatocellular Carcinoma in Mice.]
[Synthesis of alpha-fetoprotein, albumin and transferrin by long-term cultured cells of murine hepatoma]
[The anti-apoptotic effect of cytoplasmic alpha-fetoprotein in hepatoma cells induced by all-trans retinoic acid involves activation of the PI3K/AKT signaling pathway].
[The clinical significance of PIVKA-II determination in patients with hepatocellular carcinoma: a comparative study with alpha-fetoprotein]
[The clinical significance of PIVKA-II in hepatocellular carcinoma: a comparative study with alpha-fetoprotein: preliminary report]
[The Clinical Significance of Serum Alpha-fetoprotein in Diagnosing Hepatocellular Carcinoma in a Health Screening Population].
[The degree of methylation of alpha-fetoprotein in rat hepatoma cell lines and their clones producing and not producing this protein]
[The efficacy and prognosis of transcatheter chemoembolization for hepatocellular carcinoma in the elderly]
[The prognostic value of focusylated alpha-fetoprotein measurement in liver cancer patients after surgery]
[The role of interleukin-1 beta in the regulation of liver-specific gene expression in human hepatoblastoma cells]
[The studies on clinical value of AFP-L3 detected by microspincolum method for judgment of treatment response in patients with HCC undergoing TACE].
[The studies on early warning of Lens culinaris-reactive alpha-Fetoprotein (AFP-L3) detecting in primary hepatocellular carcinoma]
[Treatment of liver cancer and concomitant esophageal varices]
[Triplet anti-tumor therapy based on thymosin ?-1 attenuates incidence of hepatoma and serum alpha-fetoprotein level in rat hepatoma model].
[Tumor markers for hepatocellular carcinoma]
[Tumor markers for hepatocellular carcinoma].
[Tumor markers of hepatocellular carcinoma]
[Tumor markers--personal experience. The use of tumor markers for cancer of digestive organs]
[Tumor markers: neoplasmas in digestive organs]
[Use of a lipid lymphographic agent, lipiodol, as a carrier of high molecular weight antitumor agent, smancs, for hepatocellular carcinoma]
[Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without hcc development]
[Value of (18)F-FDG PET/CT and CECT in detecting postoperative recurrence and extrahepatic metastasis of hepatocellular carcinoma in patients with elevated serum alpha-fetoprotein].
[Value of ultrasonography in the early diagnosis of hepatocellular carcinoma]
[Variable clinical symptoms of hepatocellular carcinoma]
Carcinoma, Islet Cell
[Pancreatic endocrine tumor with metastases and increase of alpha-fetoprotein. A case report]
Carcinoma, Large Cell
Primary lung cancer producing alpha-fetoprotein.
[An autopsied case of alpha-fetoprotein (AFP) producing large cell carcinoma of the lung (author's transl)]
[Double primary lung cancers producing alpha-fetoprotein]
Carcinoma, Medullary
Human mammary tumor cell proliferation: primary role of platelet-derived growth factor and possible synergism with human alpha-fetoprotein.
Carcinoma, Neuroendocrine
Alpha-fetoprotein Secreting Neuroendocrine Carcinoma of the Liver: a Case Report and Literature Review.
Hepatocellular Carcinoma and High Grade Neuroendocrine Carcinoma: A Case Report and Review of the Literature.
Large cell neuroendocrine carcinoma of the mediastinum with alpha-fetoprotein production.
Metastatic neuroendocrine carcinoma presenting as multifocal liver lesions with elevated alpha-fetoprotein.
Metastatic neuroendocrine pancreatic tumor - Case report.
Tumor of the liver (hepatocellular and high grade neuroendocrine carcinoma): a case report and review of the literature.
Carcinoma, Non-Small-Cell Lung
A case report of a three-year survivor with advanced non-small cell lung cancer producing alpha-fetoprotein.
Carcinoma, Ovarian Epithelial
Alpha-fetoprotein (AFP)-producing epithelial ovarian carcinoma (EOC): a retrospective study of 27 cases.
Alpha-fetoprotein in advanced epithelial ovarian cancer.
CA125-producing adenocarcinoma of the seminal vesicle.
Evaluation of the sensitivity and specificity of serum level of prostasin, CA125, LDH, AFP, and hCG+? in epithelial ovarian cancer patients.
Immunohistochemical localization of tumor markers in epithelial ovarian cancer.
Carcinoma, Renal Cell
Advances in biological markers for cancer.
Alpha-fetoprotein producing renal cell carcinoma: a case report.
Alpha-fetoprotein-producing renal cell carcinoma with increased activity of N-acetylglucosaminyl-transferase III.
Alpha-fetoprotein-producing renal cell carcinoma.
Collecting duct carcinoma of kidney producing alpha-fetoprotein.
Lectin reactivity of alpha-fetoprotein in a case of renal cell carcinoma.
Renal cell carcinoma producing alpha-fetoprotein (AFP) with a unique lectins-affinity profile.
Serum biomarkers in metastatic renal cell carcinoma.
Studies on alpha-fetoprotein produced by renal cell carcinoma.
Triple primary cancers involving kidney, urinary bladder, and liver in a dye worker.
[A case of alpha-fetoprotein, carcinoembryonic antigen and human chorionic gonadotropin producing renal cell carcinoma]
[A case of renal carcinoma with bone metastasis, producing alpha-fetoprotein]
[A case of renal cell carcinoma producing alpha-fetoprotein]
[Stage IV renal cell carcinoma producing alpha-fetoprotein treated with multimodal treatment. A case report]
Carcinoma, Small Cell
Hepatocellular Carcinoma and High Grade Neuroendocrine Carcinoma: A Case Report and Review of the Literature.
Tumor of the liver (hepatocellular and high grade neuroendocrine carcinoma): a case report and review of the literature.
[A case of small cell carcinoma of the urinary bladder]
Carcinoma, Squamous Cell
Adenocarcinosarcoma at the esophagogastric junction with long esophageal invasion: a case report.
AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease.
Carbohydrate antigens as potential biomarkers for the malignancy in patients with idiopathic deep venous thrombosis: a retrospective cohort study.
Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM versus alpha-fetoprotein in Egyptian patients with hepatitis C virus-induced hepatocellular carcinoma.
Combined Evaluation of Preoperative Serum CEA and CA125 as an Independent Prognostic Biomarker in Patients with Early-Stage Cervical Adenocarcinoma.
Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma.
CYFRA 21-1. A new marker in lung cancer.
Diagnostic and prognostic value of alpha-fetoprotein, des-?-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
Diagnostic value of serum tumor markers in skeletal metastasis of carcinomas.
Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma.
Elevation of CA 19-9 and chromogranin A, in addition to CA 125, are detectable in benign tumors in leiomyomas and endometriosis.
Evaluation of tumor markers in patients with squamous cell carcinoma in the oral cavity.
Impact of chronic kidney disease on serum tumor markers concentrations.
Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time?
TPA, TATI, CEA, AFP, beta-HCG, PSA, SCC, and CA 19-9 for monitoring transitional cell carcinoma of the bladder.
Tumor markers in biological fluids associated with pregnancy.
Tumor markers in chronic renal failure and hemodialysis patients.
[Double primary lung cancers producing alpha-fetoprotein]
[Studies on marker substances in cell lines derived from various human gynecologic tumors (author's transl)]
[The place of tumor markers in breast and gynecologic neoplasms]
Carcinoma, Transitional Cell
Alpha-fetoprotein-producing transitional cell carcinoma of the urinary bladder: a case report.
TPA, TATI, CEA, AFP, beta-HCG, PSA, SCC, and CA 19-9 for monitoring transitional cell carcinoma of the bladder.
Triple primary cancers involving kidney, urinary bladder, and liver in a dye worker.
Carcinosarcoma
Carcinosarcoma of the gallbladder producing alpha-fetoprotein and manifesting as leukocytosis with elevated serum granulocyte colony-stimulating factor: Report of a case.
Carcinosarcoma of the stomach with alpha-fetoprotein-producing hepatoid adenocarcinoma: an unexpected combination of two rare subtypes of gastric cancer in one tumor.
Carcinosarcoma of the Uterine Corpus on 18F-FDG PET/CT in a Postmenopausal Woman With Elevated AFP.
Carcinosarcoma of the uterine corpus with alpha-fetoprotein-producing hepatoid adenocarcinoma: a report of two cases.
[A case report of uterine carcinosarcoma with alpha-fetoprotein (AFP) production]
Cardiomegaly
Prenatal diagnosis of partial monosomy 13q associated with occipital encephalocoele in a fetus.
Central Nervous System Diseases
Alpha-fetoprotein and the prenatal diagnosis of central nervous system disorders. A review.
Cerebellar Ataxia
A double missense mutation in the ATM gene of a Dutch family with ataxia telangiectasia.
A novel nonsense mutation in a Japanese family with ataxia with oculomotor apraxia type 2 (AOA2).
Ataxia telangiectasia with hepatocellular carcinoma in a 15-year-old girl and studies of her kindred.
Autosomal Recessive Cerebellar Ataxias With Elevated Alpha-Fetoprotein: Uncommon Diseases, Common Biomarker.
Autosomal-Recessive Cerebellar Ataxias and Movement Disorders With Elevated Alpha-Fetoprotein.
Beyond Typical Ataxia Telangiectasia: How to Identify the Ataxia Telangiectasia-Like Disorders.
Clinical and molecular findings of ataxia with oculomotor apraxia type 2 in 4 families.
Disruption of Spermatogenesis and Infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2).
Exome analysis reveals a Japanese family with spinocerebellar ataxia, autosomal recessive 1.
Identification and characterisation of a large Senataxin (SETX) gene duplication in ataxia with ocular apraxia type 2 (AOA2).
Mutation analysis of the ATM gene in two Chinese patients with ataxia telangiectasia.
Novel ATM mutations with ataxia-telangiectasia.
Reply to: "Autosomal-Recessive Cerebellar Ataxias With Elevated Alpha-Fetoprotein: Uncommon Diseases, Common Biomarker".
SETX mutations are a frequent genetic cause of juvenile and adult onset cerebellar ataxia with neuropathy and elevated serum alpha-fetoprotein.
The Clinical Spectrum of Ataxia with Oculomotor Apraxia Type 2.
Chemical and Drug Induced Liver Injury
Alpha-fetoprotein and tissue polypeptide antigen in non neoplastic hepatic disorders.
Chickenpox
Regulated expression of artificial chimeric genes contained in retroviral vectors: implications for virus-directed enzyme prodrug therapy (VDEPT) and other gene therapy applications.
Cholangiocarcinoma
A case of an alpha-fetoprotein-producing intrahepatic cholangiocarcinoma suggests probable cancer stem cell origin.
Aberrant expression of alpha-fetoprotein in intrahepatic cholangiocarcinoma: an exceptional occurrence.
Alpha-fetoprotein producing cells act as cancer progenitor cells in human cholangiocarcinoma.
An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19.
Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.
Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma.
Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study.
Comparative immunohistochemical study of primary and metastatic carcinomas of the liver.
Comparison of serum tumor markers for intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver.
Difference in biological characteristics and sensitivity to chemotherapy and radiotherapy between intrahepatic and extrahepatic cholangiocarcinoma cells in vitro.
HBV-associated intrahepatic cholangiocarcinoma with high serum alpha-fetoprotein: a case report with review of literature.
Hepatocellular carcinoma complicated with coexisting hepatolithiasis: pitfalls in diagnosis and management.
Human chorionic gonadotropin and alpha-fetoprotein in cholangiocarcinoma in relation to the expression of ras p21: an immunohistochemical study.
Icteric type hepatocellular carcinoma: revisited 20 years later.
Immunocytochemical evaluation of liver fine-needle aspirations.
Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma: a prospective study.
Liver transplantation for hepatocellular carcinoma: is zero recurrence theoretically possible?
Primary liver cell carcinoma. New insight for a more correct approach to its classification.
Cholangitis
Hepatic inflammatory pseudotumor associated with primary biliary cholangitis and elevated alpha-fetoprotein lectin 3 fraction mimicking hepatocellular carcinoma.
Cholestasis
Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis.
Progressive familial intrahepatic cholestasis - farnesoid X receptor deficiency due to NR1H4 mutation: A case report.
Serum alpha-fetoprotein levels in neonatal cholestasis.
[The noninvasive evaluation of degree of expression of fibrosis of liver and significance of polymorphism of gene of hyaluronic acid under chronic hepatitis C].
Cholestasis, Intrahepatic
Citrin deficiency in a Romanian child living in Spain highlights the worldwide distribution of this defect and illustrates the value of nutritional therapy.
Intrahepatic cholestasis of pregnancy has no effect on maternal serum second trimester alpha-fetoprotein and hCG.
Maternal midtrimester free beta-HCG and AFP serum levels in spontaneous singleton pregnancies complicated by gestational diabetes mellitus, pregnancy-induced hypertension or obstetric cholestasis.
Molecular and clinical characterization of citrin deficiency in a cohort of Chinese patients in Hong Kong.
Chordoma
Immunohistochemical and ultrastructural study of skull base chordomas.
Chorea
Radioresistant DNA synthesis and human genetic diseases.
Choriocarcinoma
Advances in biological markers for cancer.
alpha-Fetoprotein, carcinoembryonic antigen, human chorionic gonadotropin and its beta subunit in metastatic choriocarcinoma: short-term follow-up and determinations of resistance during chemotherapy.
Gastric cancer with choriocarcinoma and yolk sac tumor components: case report.
Gastric choriocarcinoma admixed with an alpha-fetoprotein-producing adenocarcinoma and separated adenocarcinoma.
Germ cell tumor in an adolescent with extensive testicular microlithiasis: concerns regarding future management.
Hepatoid adenocarcinoma in Barrett's esophagus associated with achalasia: first case report.
Intracranial germ-cell tumors. Immunohistochemical study of three autopsy cases.
Markedly elevated maternal serum alpha-fetoprotein associated with a normal fetus and choriocarcinoma of the placenta.
Maternal serum alpha-fetoprotein screening and choriocarcinoma.
MicroRNAs in testicular cancer: implications for pathogenesis, diagnosis, prognosis and therapy.
Ovarian mixed germ cell tumor composed of dysgerminoma, endodermal sinus tumor, choriocarcinoma and mature teratoma in a 44-year-old woman: case report and literature review.
Primary gastric choriocarcinoma. Report of an autopsy case with immunohistochemical study.
Radioimmunoassay of alpha-fetoprotein: a contribution to the diagnosis of choriocarcinoma and hydatidiform mole.
Salvage chemotherapy with high-dose carboplatin plus etoposide and autologous peripheral blood stem cell transplant in male pure choriocarcinoma: a retrospective analysis of 13 cases.
Serum alpha-fetoprotein in hydatidiform mole, choriocarcinoma, and twin pregnancy.
Testicular germ-cell neoplasms: recent advances in diagnosis and therapy.
Treatment of nongerminomatous germ-cell tumors of the pineal region.
Value of tumor markers in the treatment of endodermal sinus tumors and choriocarcinomas in the pineal region.
[Studies on marker substances in cell lines derived from various human gynecologic tumors (author's transl)]
Choriocarcinoma, Non-gestational
Imaging in gynecological disease (22): clinical?and?ultrasound characteristics of ovarian embryonal carcinomas, non-gestational choriocarcinomas and malignant mixed germ cell tumors.
Chromosome Disorders
Alpha-fetoprotein in fetal serum, amniotic fluid, and maternal serum.
Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?
First-trimester maternal serum alpha-fetoprotein as a marker for fetal chromosomal disorders. Dutch Working Party on Prenatal Diagnosis.
First-trimester maternal serum alpha-fetoprotein screening for chromosome defects.
[Comparative study of the occurrence of beta-2-glycoprotein I antibodies (anti-beta-2-GPI) and anticardiolipin antibodies (ACA) in the blood of pregnant women]
Cleft Lip
Prenatal diagnosis of omphalocele associated with umbilical cord cyst.
Coinfection
Complementary adenoviral vectors for oncolysis.
Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study.
Colonic Neoplasms
An attenuated Salmonella oral DNA vaccine prevents the growth of hepatocellular carcinoma and colon cancer that express alpha-fetoprotein.
Biologic markers in cancer diagnosis and treatment.
Carcinoembryonic antigen and alpha-fetoprotein in the diagnosis of gastric and colonic cancer: a comparative clinical evaluation.
Colon cancer in pregnancy with elevated maternal serum alpha-fetoprotein level at presentation.
Colon cancer with a high serum alpha-fetoprotein level.
Detection of tumor cells in peritoneal lavages from patients with gastrointestinal cancer by multiplex reverse transcriptase PCR.
The fucose-specific lectin ANL from Aspergillus niger possesses anti-cancer activity by inducing the intrinsic apoptosis pathway in hepatocellular and colon cancer cells.
[Liver metastasis of colon cancer with a high serum alpha-fetoprotein level: report of a case]
[The evaluation of the efficiency in the detection of embryonal cancer and tumor-related antigens as tumor markers in gastrointestinal cancer]
[Tumor markers--a diagnostic and prognostic test]
Colorectal Neoplasms
Alpha-fetoprotein-producing colon cancer with atypical bulky lymph node metastasis.
Carcinoembryonic antigen (CEA), alpha-fetoprotein, CA 19.9 and CA 125 in advanced colorectal cancer (ACC).
Diagnostic value of serum tumor markers in asymptomatic individuals.
Models of logistic regression analysis, support vector machine, and back-propagation neural network based on serum tumor markers in colorectal cancer diagnosis.
Serum alpha-fetoprotein in patients with neoplasms of the gastrointestinal tract.
The serum levels of human alpha-fetoprotein, AFP, choriogonadotropin, hCG, placental lactogen, hPL, and pregnancy-specific beta 1-glycoprotein, SP1, are of no clinical significance in colorectal carcinoma.
[Hepatic metastases from alpha-fetoprotein producing colorectal cancer that responded remarkably to transcatheter arterial chemo-embolization]
Coma
A single institution's experience (1982-1999) with plasma-exchange therapy in patients with fulminant hepatic failure.
Communicable Diseases
The use of alpha-fetoprotein for the treatment of autoimmune diseases and cancer.
Congenital Abnormalities
A reappraisal of amniotic fluid alpha-fetoprotein measurement at the time of genetic amniocentesis and midtrimester ultrasonography.
Acute reactive hepatitis in pregnancy induced by alpha-methyldopa.
Alpha-fetoprotein concanavalin A-binding variants in the diagnosis of neural tube defects and other communicating fetal abnormalities.
Alpha-fetoprotein content of amniotic fluid in normal and abnormal pregnancies.
Alpha-fetoprotein, vaginal bleeding and pregnancy risk.
Amniocentesis and chorionic villus sampling.
Amniotic fluid alpha-fetoprotein concentrations in twin gestations: dependence on placental membrane anatomy.
An apparent dimerization motif in the third domain of alpha-fetoprotein: molecular mimicry of the steroid/thyroid nuclear receptor superfamily.
Antepartum evaluation of the high-risk fetus: problems and prospects.
Anxiety concerning fetal malformations in pregnant women exposed or not exposed to an antenatal serum alpha-fetoprotein screening program.
Are obese women at higher risk for producing malformed offspring?
Assessment of equine alpha-fetoprotein levels in mares and newborn foals in the periparturient period.
Attitudes to prenatal screening, diagnosis and research among pregnant women who accept or decline an alpha-fetoprotein test.
Biological roles of alpha-fetoprotein during pregnancy and perinatal development.
Can low birth weight after elevated maternal serum alpha-fetoprotein be explained by maternal weight?
CGH in the detection of confined placental mosaicism (CPM) in placentas of abnormal pregnancies.
Choroid plexus cysts: Is biochemical testing a valuable adjunct to targeted ultrasonography?
Comparison of amniotic fluid alpha-fetoprotein reactivity to Lens culinaris agglutinin and concanavalin A in crossed-affinity immunoelectrophoresis: ancillary tests in the prenatal diagnosis of severe fetal malformations.
Concanavalin A binding of alpha-fetoprotein in amniotic fluid as an aid in the diagnosis of neural tube defects.
Concanavalin A--non-reactive alpha-fetoprotein and communicating fetal malformation.
Editorial: Alpha-fetoprotein and prenatal diagnosis of congenital abnormalities.
Elevated maternal serum alpha-fetoprotein: association with placental sonolucencies, fetomaternal hemorrhage, vaginal bleeding, and pregnancy outcome in the absence of fetal anomalies.
Elevated second trimester maternal serum beta-HCG concentrations and subsequent adverse pregnancy outcome.
Fetal anomaly scan potentially will replace routine AFAFP assays for the detection of neural tube defects.
Fetal malformation and serum alpha-fetoprotein concentration of diabetic mothers.
Human alpha-fetoprotein contains potential heterodimerization motifs capable of interaction with nuclear receptors and transcription/growth factors.
Identification of second trimester screen positive pregnancies at increased risk for congenital heart defects.
Letter: Raised alpha-fetoprotein levels and congenital defect.
Management of epilepsy in women of childbearing age: practical recommendations.
Maternal serum alpha-fetoprotein is a marker for fetal anomalies in pediatric surgery.
Maternal serum alpha-fetoprotein screening: further consideration of low-volume testing.
Maternal-serum-alphafetoprotein screening for fetal malformations in 28 062 pregnancies. A four-year experience from a low-risk area.
Open fetal malformations in incorrectly dated pregnancies with initially low maternal serum alpha-fetoprotein.
Outcomes in patients with unusually high maternal serum alpha-fetoprotein levels.
Physiology of alpha-fetoprotein as a biomarker for perinatal distress: relevance to adverse pregnancy outcome.
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data.
Prenatal diagnosis and pediatric neurosurgery.
Prenatal screening for open neural tube defects.
Prospective study of an inverse relationship between maternal glycosylated hemoglobin and serum alpha-fetoprotein concentrations in pregnant women with diabetes.
Raised alpha-fetoprotein levels associated with minor congenital defect.
Raised maternal serum alpha-fetoprotein levels not associated with fetal malformations. A case report.
Reactivity of amniotic fluid alpha-fetoprotein with concanavalin A in relation to gestational age: clinical implications.
Reactivity of amniotic fluid alpha-fetoprotein with concanavalin A-sepharose in pre-natal diagnosis of fetal malformations.
Relationship between some obstetric landmarks and the concentration of alpha-fetoprotein in maternal blood.
Results of 12 years' combined maternal serum alpha-fetoprotein screening and ultrasound fetal monitoring for prenatal detection of fetal malformations in Havana City, Cuba.
Risk of anomalies as a function of level of elevated maternal serum alpha-fetoprotein.
Routine prenatal screening policy of fetal malformations by both maternal serum alpha-fetoprotein and ultrasound in eastern Hungary.
Screening for fetal malformations using ultrasound and measurements of alpha-fetoprotein in maternal serum.
The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications.
The role of ultrasonography and amniocentesis in the evaluation of pregnancies at risk for neural tube defects.
Treatment of polyhydramnios with prostaglandin synthetase inhibitor (indomethacin).
Unusual prenatal sonographic findings without an elevated maternal serum alpha-fetoprotein level in a fetus with epidermolysis bullosa.
Zinc and alpha-fetoprotein in amniotic fluid from early pregnancies with fetal malformations.
[Attitude of pregnant women to prenatal screening]
[Correlation between elevated maternal serum alpha-fetoprotein, certain pregnancy complications and fetal death]
[Hydramnios and fetal malformations. Use of estimating the level of alpha-fetoprotein and of bilirubin in the amniotic fluid during the last trimester of pregnancy (author's transl)]
Congenital Hypothyroidism
Alpha-fetoprotein in congenital hypothyroidism.
Maternal serum alpha-fetoprotein in congenital hypothyroidism.
Serum alpha-fetoprotein--a biochemical indicator of prenatal hypothyroidism.
Cough
[Mediastinal dissection of hepatocellular carcinoma with bilateral hilar and mediastinal lymph node metastasis]
Craniopharyngioma
Alpha-fetoprotein secretion in a craniopharyngioma. Are craniopharyngiomas part of the germ cell tumor family?
Crohn Disease
Increased alpha-fetoprotein concentration in association with ileal adenocarcinoma complicating Crohn's disease.
Cryptorchidism
Maternal serum alpha-fetoprotein level during pregnancy and isolated cryptorchidism in male offspring.
The role of tumor size, ultrasonographic findings, and serum tumor markers in predicting the likelihood of malignant testicular histology.
Yolk sac tumor in a patient with transverse testicular ectopia: a case report.
Cystadenocarcinoma
Advances in biological markers for cancer.
An alpha-fetoprotein producing pancreatic cystadenocarcinoma.
Cystadenocarcinoma, Mucinous
An alpha-fetoprotein producing pancreatic cystadenocarcinoma.
Ovarian mucinous cystadenocarcinoma producing alpha-fetoprotein.
Ovarian mucinous cystadenocarcinoma producing alpha-fetoprotein. A case report.
Cystadenocarcinoma, Papillary
Serous papillary cystadenocarcinoma associated with alpha-fetoprotein production.
Cystadenocarcinoma, Serous
Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer.
Cystic Adenomatoid Malformation of Lung, Congenital
Type III congenital cystic adenomatoid malformation associated with elevated maternal serum alpha-fetoprotein.
Cystic Fibrosis
alpha-Fetoprotein and cystic fibrosis.
Alpha-fetoprotein in serum and amniotic fluid in the diagnosis of neonatal hepatitis syndrome, Indian childhood cirrhosis, cystic fibrosis, ataxia telangiectasia and spina bifida.
Carcinoembryonic antigen, alpha 1-antitrypsin, and alpha-fetoprotein in the pancreas of patients with cystic fibrosis.
Fatty acids, alpha-fetoprotein, and cystic fibrosis.
Letter: Serum alpha-fetoprotein in cystic fibrosis.
Prolactin, growth hormone and alpha-fetoprotein in children with cystic fibrosis.
Serum alpha - fetoprotein levels in patients with cystic fibrosis and their parents and siblings.
The direct early diagnosis of cystic fibrosis by the detection of the delta F508 CFTR gene mutation in a prematurely delivered boy.
Timing and sequence of differentiation of embryonic rat hepatocytes along the biliary epithelial lineage.
[Alpha-fetoprotein and cystic fibrosis (author's transl)]
[The diagnostic potentialities of determining alpha-fetoprotein in the blood of patients with mucoviscidosis]
Cysts
Alcoholic hepatitis accelerates early hepatobiliary cancer by increasing stemness and miR-122-mediated HIF-1? activation.
CA 125, CA 15.3, CA 27.29, CEA, beta-hCG and alpha-fetoprotein levels in cyst fluid of breast macrocysts.
Choroid plexus cysts: Is biochemical testing a valuable adjunct to targeted ultrasonography?
Clinico-biological behavior of germ-cell tumors.
Cyst fluid tumor-associated trypsin inhibitor may be helpful in the differentiation of cystic pancreatic lesions.
Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma.
Ependymal cyst producing alpha-fetoprotein. Case report.
Hepatic mesenchymal hamartoma associated with mesenchymal stem villous hyperplasia of the placenta.
Maternal serum alpha-fetoprotein levels in ectopic pregnancy. A prospective study.
Prenatal diagnosis of omphalocele associated with umbilical cord cyst.
Serum and Cyst Fluid Tumor Marker Levels in the Differential Diagnosis of Benign Ovarian Cysts
Undifferentiated embryonal sarcoma of the liver with an unusual presentation: case report and review of the literature.
[Retroperitoneal cyst: a case report]
Cytomegalovirus Infections
Elevated second trimester maternal serum alpha-fetoprotein and cytomegalovirus infection.
Increased serum alpha-fetoprotein levels in cytomegalovirus infections.
De Lange Syndrome
Prenatal findings in Brachmann-de Lange syndrome.
Decompression Sickness
Primary mediastinal malignant germ cell tumour. Single institution experience in Chinese patients and correlation with specific alpha-fetoprotein bends.
Denys-Drash Syndrome
Elevated maternal serum and amniotic fluid alpha-fetoprotein levels in the Denys-Drash syndrome.
Dermatomyositis
Rheumatic syndromes: clues to occult neoplasia.
Successful cure of dermatomyositis after treatment of nonseminomatous testicular cancer.
Diabetes Insipidus, Neurogenic
Management of children and young people with idiopathic pituitary stalk thickening, central diabetes insipidus, or both: a national clinical practice consensus guideline.
Pituitary Dysfunction in Patients with Intracranial Germ Cell Tumors Treated with Radiotherapy.
Diabetes Mellitus
Ability of the post-operative ALBI grade to predict the outcomes of hepatocellular carcinoma after curative surgery.
Assessment of Liver Stiffness Regression and Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients after Treatment with Direct-Acting Antiviral Drugs.
Comparison of twelve liver functional reserve models for outcome prediction in patients with hepatocellular carcinoma undergoing surgical resection.
Early detection of hepatocellular carcinoma in patients with diabetes mellitus.
Gamma-glutamyl transpeptidase-to-platelet ratio is an independent predictor of hepatitis B virus-related liver cancer.
Maternal serum alpha-fetoprotein and diabetes mellitus.
Metastatic neuroendocrine pancreatic tumor - Case report.
Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis.
Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis.
Predictive Role of AURKA rs 1047972 Gene Polymorphism and the Risk of Development of Hepatocellular Carcinoma.
Prenatal diagnosis in diabetic gravidas: utility of ultrasound and maternal serum alpha-fetoprotein screening.
Regression of hepatocellular carcinoma during vitamin K administration.
Relationship of hepatitis B virus infection to the recurrence of hepatocellular carcinoma after direct acting antivirals.
Risk factors of the recurrence of hepatocellular carcinoma originating from residual cancer cells after hepatectomy.
Up-regulation of dbpA mRNA in hepatocellular carcinoma associated with metabolic syndrome.
[Factors linked to 5-year survival after hepatectomy for hepatocellular carcinoma: univariate and multivariate analyses of 312 patients]
[Maternal serum AFP screening in type I diabetic patients]
Diabetes Mellitus, Type 1
A prenatal diagnostic center's first-year experience with the California alpha-Fetoprotein Screening Program.
Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?
Cord serum alpha-fetoprotein and maternal insulin-dependent diabetes mellitus.
Decreased alpha-fetoprotein in amniotic fluid and maternal serum in diabetic pregnancy.
Effect of adjustment of maternal serum alpha-fetoprotein levels in insulin-dependent diabetes mellitus.
Maternal serum alpha-fetoprotein and diabetes mellitus.
Diabetes, Gestational
Alpha-fetoprotein in diabetic pregnancy. A reassessment.
Correlation and diagnostic value of maternal serum alpha-fetoprotein level, predelivery age and body mass with gestational diabetes mellitus.
Maternal midtrimester free beta-HCG and AFP serum levels in spontaneous singleton pregnancies complicated by gestational diabetes mellitus, pregnancy-induced hypertension or obstetric cholestasis.
Maternal serum alpha-fetoprotein levels in pregnant women with gestational diabetes.
Serum markers in quadruple screening associated with adverse pregnancy outcomes: A case-control study in China.
The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Digestive System Diseases
Alpha-fetoprotein in infantile obstructive jaundice in comparison with the normal ranges.
Digestive System Neoplasms
"Humors from tumors": carcinoembryonic antigen, alpha-fetoprotein, and digestive system cancer.
Diphtheria
Cell-specific expression of the diphtheria toxin A-chain coding sequence under the control of the upstream region of the human alpha-fetoprotein gene.
Selective inhibition of hepatoma cells using diphtheria toxin A under the control of the promoter/enhancer region of the human alpha-fetoprotein gene.
Disorder of Sex Development, 46,XY
Elevated maternal serum and amniotic fluid alpha-fetoprotein levels in the Denys-Drash syndrome.
Diverticulum
Selective bipotential differentiation of mouse embryonic hepatoblasts in vitro.
Down Syndrome
2nd-trimester maternal serum human chorionic gonadotropin and alpha-fetoprotein levels in male and female fetuses with Down syndrome.
46,XY,i(21q) identified by maternal serum screening.
A comparison of total and free beta-HCG assays in Down syndrome screening.
A novel method for the detection of Down syndrome with the use of four serum markers.
A prenatal trisomy 21 screening program using alpha-fetoprotein, human chorionic gonadotropin, and free estriol assays on maternal dried blood.
A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol.
A six year study of the antenatal detection of fetal abnormality in six Scottish health boards.
A sonographic screening method for Down syndrome.
ADAM12 is an effective marker in the second trimester of pregnancy for prenatal screening of Down syndrome.
Advent of maternal serum markers for Down syndrome screening.
Adverse perinatal outcome in patients screen-positive for neural tube defects and fetal Down syndrome.
Adverse pregnancy outcome after a false-positive screen for Down syndrome using multiple markers.
AFP and age screening for Down syndrome.
Age-independent indices in second-trimester serum screening for Down's syndrome are useless.
All MoMs are not equal: some statistical properties associated with reporting results in the form of multiples of the median.
Alpha-fetoprotein and ultrasound scanning in the prenatal diagnosis of Turner's syndrome.
Alpha-fetoprotein in fetal serum, amniotic fluid, and maternal serum.
Alpha-fetoprotein microheterogeneity: a potential biochemical marker for Down's syndrome.
alpha-Fetoprotein screening.
Alpha-fetoprotein, free beta-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome.
Alpha-fetoprotein: an enhanced-sensitivity assay for neural tube defect and Down syndrome evaluation.
Alpha-fetoprotein: from a diagnostic biomarker to a key role in female fertility.
Alteration in age-specific risks for chromosomal trisomy by maternal serum alpha-fetoprotein and human chorionic gonadotropin screening.
Amniotic fluid acetylcholinesterase activity and alpha-fetoprotein in chromosomal anomalies and neural tube defects.
Amniotic fluid alpha-fetoprotein levels and prenatal diagnosis of autosomal trisomies.
Amniotic fluid alpha-fetoprotein levels and trisomy 21.
Amniotic fluid alpha-fetoprotein levels during midtrimester of trisomy pregnancies.
Amniotic fluid alpha-fetoprotein levels in Down syndrome.
Amniotic fluid alpha-fetoprotein subfractions in fetal Trisomy 21 affected pregnancies.
An alpha-fetoprotein radioimmunoassay for use in maternal serum screening for Down's syndrome: limitations and improvements.
An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcome.
Analysis of maternal serum alpha-fetoprotein and free beta human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screening.
Assessment of atypicality: an adjunct to prenatal screening for Down's syndrome that facilitates detection of other abnormalities.
Between-pregnancy biological variability of maternal serum alpha-fetoprotein and free beta hCG: implications for Down syndrome screening in subsequent pregnancies.
Biochemical screening for Down syndrome in pregnancies following renal transplantation.
CA-125 as a maternal serum marker for Down's syndrome in the first and second trimesters.
Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estriol, and hCG: impact on Down syndrome screening.
Clinical application of inhibin a measurement: prenatal serum screening for Down syndrome.
Collaborative study of Down syndrome screening using maternal serum alpha-fetoprotein and maternal age.
Combined ultrasound biometry, serum markers and age for Down syndrome risk estimation.
Combining fetal nuchal fold thickness with second-trimester biochemistry to screen for trisomy 21.
Combining maternal age and serum alpha-fetoprotein to predict the risk of Down syndrome.
Combining maternal age and serum alpha-fetoprotein to predict the risk of Down's syndrome.
Combining maternal serum alpha-fetoprotein measurements and age to screen for Down syndrome in pregnant women under age 35. New England Regional Genetics Group Prenatal Collaborative Study of Down Syndrome Screening.
Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
Concanavalin A variants of alpha-fetoprotein in first trimester fetuses with trisomy 21 and with normal karyotypes.
Congenital pulmonary airway malformation (congenital cystic adenomatoid malformation) with multiple extrapulmonary anomalies: autopsy report of a fetus at 19 weeks of gestation.
Cord serum alpha-fetoprotein and Down's syndrome.
Correlation of second-trimester sonographic and biochemical markers.
Counseling for low maternal serum alpha-fetoprotein should emphasize all chromosome anomalies, not just Down syndrome.
Current difficulties in use of maternal serum alpha-fetoprotein levels in counseling mid-trimester older pregnant women regarding risk of a Down syndrome fetus.
Current techniques of prenatal screening for Down syndrome.
Cutis marmorata telangiectatica congenita associated with an elevated maternal serum human chorionic gonadotrophin level and transitory isolated fetal ascites.
Decreased levels of amniotic fluid alpha-fetoprotein associated with Down syndrome.
Dependence of maternal serum [AFP]/[hCG] median ratios on age of gestation: comparison of trisomy 21 to euploid pregnancies.
Diagnostic and therapeutic technology assessment. Maternal serum alpha-fetoprotein testing and Down's syndrome.
Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
Doubts using family history, age, alpha-fetoprotein and total human chorionic gonadotrophin in screening for Down's syndrome.
Down syndrome and low maternal serum alpha fetoprotein.
Down syndrome maternal serum marker screening after 18 weeks of gestation: a countrywide study.
Down syndrome screening in an Asian population using alpha-fetoprotein and free beta-hCG: a report of the Taiwan Down Syndrome Screening Group.
Down syndrome screening in women under 35 with maternal serum hCG.
Down syndrome: prenatal risk assessment and diagnosis.
Down's syndrome screening in multiple pregnancies using alpha-fetoprotein and free beta hCG.
Down's syndrome: current screening techniques.
Economic evaluation of prenatal screening for Down syndrome in the U.S.A.
Effect of allowing for ethnic group in prenatal screening for Down's syndrome.
Effect of gravidity on maternal serum markers for Down's syndrome.
Effect of incorrect gestational dating on Down's syndrome and neural tube risk assessment.
Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
Efficacy of maternal serum screening in the prenatal detection of fetal chromosome abnormalities in Japanese women.
Efficacy of screening for fetal Down syndrome in the United States from 1974 to 1997.
Elevated human chorionic gonadotropin levels in pregnancies with sex chromosome abnormalities.
Elevated maternal midtrimester serum free beta-human chorionic gonadotropin levels in vegetarian pregnancies that cause increased false-positive Down syndrome screening results.
Elevated second-trimester free beta-hCG as an isolated finding and pregnancy outcomes.
Elevated second-trimester maternal serum hCG in patients undergoing haemodialysis.
Enhanced twin pregnancy detection within an open neural tube defect and Down syndrome screening protocol using free-beta hCG and AFP.
Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level.
Evaluating health and maturation of the unborn: the role of the clinical laboratory.
Evaluation of effect of analytical imprecision in maternal serum screening for Down's syndrome.
Evaluation of maternal serum alpha-fetoprotein and ultrasound examination to screen fetal chromosomal abnormalities.
Evaluation of multiple-marker screening for Down syndrome in a statewide population.
Evaluation of the impact of vasa previa on feto-placental hormonal synthesis and fetal growth.
Expanding multiple marker screening for Down's syndrome to include Edward's syndrome.
Extreme second-trimester serum analyte values in down syndrome pregnancies with hydrops fetalis.
Fetal gender impact on multiple-marker screening results.
Fetal hepatic alpha-fetoprotein mRNA expression in fetuses with trisomy 21 and 18 at 12-15 weeks gestation.
Fetal pyelectasis and Down syndrome: is genetic amniocentesis warranted?
First trimester maternal serum alpha-fetoprotein in fetal trisomies.
First trimester maternal serum alpha-fetoprotein screening for Down syndrome and other aneuploidies.
First-trimester alpha-fetoprotein screening for Down syndrome.
First-trimester biochemical markers for Down syndrome.
First-trimester Down syndrome screening: free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A.
First-trimester maternal serum alpha-fetoprotein screening for chromosome defects.
First-trimester maternal serum unconjugated oestriol and alpha-fetoprotein in fetal Down's syndrome.
First-trimester screening for trisomy 21 using alpha-fetoprotein.
Four-marker serum screening for Down's syndrome.
Free beta human choriogonadotropin in Down's syndrome screening: a multicentre study of its role compared with other biochemical markers.
Genetic conditions among patients receiving genetic services in middle Tennessee.
Gestational age at maternal serum alpha-fetoprotein screening and the detection of Down syndrome.
Human chorionic gonadotrophin and trisomy 18.
Humeral shortening in second-trimester fetuses with Down syndrome.
Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: A new basis for gestational Down syndrome screening.
Identification of second trimester screen positive pregnancies at increased risk for congenital heart defects.
Identifying Ultrasound Markers for Down Syndrome.
Impact on spina bifida screening of shifting prenatal Down syndrome maternal serum screening from the second trimester to the first.
Implications of 'low' maternal serum alpha-fetoprotein levels: are maternal age risk criteria obsolete?
Improved parameters for risk estimation in Down's syndrome screening.
Improved performance in a prenatal screening programme for Down's syndrome incorporating serum-free hCG subunit analyses.
Incorporation of inhibin-A in second-trimester screening for Down syndrome.
Increased maternal serum alpha-fetoprotein and human chorionic gonadotropin in compromised pregnancies other than for neural tube defects or Down syndrome.
Increased nuchal translucency as a marker for fetal chromosomal defects.
Incremental cost-effectiveness of incorporating oestriol evaluation in Down syndrome screening programmes.
Insulin-like growth factor binding protein-3 in the detection of fetal Down syndrome pregnancies.
Is maternal serum total hCG a marker of trisomy 21 in the first trimester of pregnancy?
Is routine AFP screening in pregnancy reassuring?
Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study.
Lens culinaris agglutinin-reactive alpha-fetoprotein, an alternative variant to alpha-fetoprotein in prenatal screening for Down's syndrome.
Local norms of maternal serum alpha-fetoprotein values in early second trimester: a prelude to a Down's syndrome screening programme incorporating maternal serum alpha-fetoprotein values.
Long-bone growth in fetuses with Down syndrome.
Low estriol levels in the maternal triple-marker screen as a predictor of isolated adrenocorticotropic hormone deficiency caused by a new mutation in the TPIT gene.
Low maternal serum alpha-fetoprotein and Down syndrome.
Low maternal serum alpha-fetoprotein at 10 weeks gestation and fetal Down's syndrome.
Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome.
Maternal alpha-fetoprotein screening for Down's syndrome.
Maternal serum alpha-fetoprotein and dimeric inhibin A detect aneuploidies other than Down syndrome.
Maternal serum alpha-fetoprotein and fetal trisomy-21 in women 35 years and older: implications for alpha-fetoprotein screening programs.
Maternal serum alpha-fetoprotein and human chorionic gonadotrophin in pregnancies conceived after intracytoplasmic sperm injection and conventional in-vitro fertilization.
Maternal serum alpha-fetoprotein as screening test for Down syndrome.
Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome.
Maternal serum alpha-fetoprotein prenatal screening for Down syndrome.
Maternal serum alpha-fetoprotein screening and Down's syndrome.
Maternal serum alpha-fetoprotein screening for chromosomal abnormalities: a prospective study in women aged 35 and older.
Maternal serum alpha-fetoprotein screening for Down syndrome and repeat testing.
Maternal serum alpha-fetoprotein screening for Down syndrome: economic considerations.
Maternal serum alpha-fetoprotein screening for fetal Down syndrome in the United States: results of a survey.
Maternal serum alpha-fetoprotein screening programs and quality control for laboratories performing maternal serum and amniotic fluid alpha-fetoprotein assays: policy statement. American Society of Human Genetics.
Maternal serum alpha-fetoprotein screening: benefits, risks, and costs.
Maternal serum alpha-fetoprotein, age, and Down syndrome risk.
Maternal serum and amniotic fluid alpha-fetoprotein testing: our approach to screening, diagnosis and counseling.
Maternal serum Down syndrome screening: free beta-protein is a more effective marker than human chorionic gonadotropin.
Maternal serum free beta hCG screening: results of studies including 480 cases of Down syndrome.
Maternal serum markers. Estimation of the risk of Down's syndrome: a prospective study.
Maternal serum screening for chromosome defects: human chorionic gonadotropin versus its free-beta subunit.
Maternal serum screening for down syndrome by using alpha-fetoprotein and human chorionic gonadotropin in an asian population. a prospective study.
Maternal serum screening for Down syndrome in a teaching hospital in Hong Kong.
Maternal serum screening for down syndrome in pregnancies conceived by intra-uterine insemination.
Maternal serum screening for Down syndrome in the United States: a 1995 survey.
Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight.
Maternal serum screening for fetal Down syndrome in the United States: a 1992 survey.
Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study.
Maternal serum screening for fetal Down's syndrome, a retrospective study.
Maternal serum screening in Ontario using the triple marker test.
Maternal serum screening.
Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome.
Maternal smoking: age distribution, levels of alpha-fetoprotein and human chorionic gonadotrophin, and effect on detection of Down syndrome pregnancies in second-trimester screening.
Measuring quantitative serum human chorionic gonadotropin. Variations in levels between kits.
Medians for second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol; differences between races or ethnic groups.
Multiple-marker screening in pregnancies with hydropic and nonhydropic Turner syndrome.
Neural tube defects/alpha-fetoprotein/Down's syndrome screening.
New Down syndrome screening algorithm: ultrasonographic biometry and multiple serum markers combined with maternal age.
Normal nuchal thickness in the midtrimester indicates reduced risk of Down syndrome in pregnancies with abnormal triple-screen results.
Nuchal thickening in Jacobsen syndrome.
Nuchal translucence incorporated into a one-stage multifactorial screening model for Down syndrome prediction at second-trimester pregnancy.
Nuchal translucency and first trimester biochemical markers for down syndrome screening: a cost-effectiveness analysis.
Outcome validation of the Beckman Coulter access analyzer in a second-trimester Down syndrome serum screening application.
Perinatal findings and molecular cytogenetic analyses of de novo interstitial deletion of 9q (9q22.3-->q31.3) associated with Gorlin syndrome.
Poor pregnancy outcome associated with elevated maternal serum alpha-fetoprotein in combination with increased risk for Down syndrome.
Positive serum screening for fetal Down syndrome does not predict adverse pregnancy outcome in absence of fetal aneuploidy.
Practical strategies in contingent sequential screening for Down syndrome.
Precise gaussian distribution functions of maternal serum alpha-fetoprotein and free beta-subunit of human chorionic gonadotropin for trisomy 21 screening: improved accuracy for patient counseling.
Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free beta-hCG levels.
Predictive value of the triple screening test for the phenotype of Down syndrome.
Prenatal diagnosis by chorionic villus sampling.
Prenatal diagnosis of a deletion of 18q in a fetus associated with multiple-marker screen positive results.
Prenatal diagnosis of de novo t(2;18;14)(q33.1;q12.2;q31.2), dup(5)(q34q34), del(7)(p21.1p21.1), and del(10)(q25.3q25.3) and a review of the prenatally ascertained de novo apparently balanced complex and multiple chromosomal rearrangements.
Prenatal diagnosis of de novo terminal deletion of chromosome 7q.
Prenatal diagnosis of Smith-Lemli-Opitz syndrome in a pregnancy with low maternal serum oestriol and a sex-reversed fetus.
Prenatal diagnosis of structural abnormalities.
Prenatal maternal dried blood screening with alpha-fetoprotein and free beta-human chorionic gonadotropin for open neural tube defect and Down syndrome.
Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha-fetoprotein, and age.
Prenatal screening for Down syndrome and neural tube defects in twin pregnancies.
Prenatal screening for Down syndrome with maternal serum human chorionic gonadotropin levels.
Prenatal screening for Down's syndrome using inhibin-A as a serum marker.
Prenatal screening for Down's syndrome with use of maternal serum markers.
Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
Prenatal screening: when and for whom?
Prenatal trisomy 21 screening using the Lens culinaris agglutinin-reactive alpha-fetoprotein ratio.
Prospective evaluation of prenatal maternal serum screening for trisomy 18.
Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin.
Racial differences in maternal serum human chorionic gonadotropin and unconjugated oestriol levels.
Reduced fetal hepatic alpha-fetoprotein levels in Down's syndrome.
Refinements in managing maternal weight adjustment for interpreting prenatal screening results.
Repeat maternal serum alpha-fetoprotein testing in antenatal screening programmes for Down's syndrome.
Replacing Alpha-Fetoprotein With Alpha-Fetoprotein-L3 Increases the Sensitivity of Prenatal Screening for Trisomy 21.
Risk factors for placenta accreta.
Risk prediction for Down's syndrome in young pregnant women using maternal serum biomarkers: determination of cut-off risk from receiver operating characteristic curve analysis.
Role of prenatal ultrasonography in women with positive screen for Down syndrome on the basis of maternal serum markers.
Screening for Down syndrome at 14 weeks of pregnancy.
Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.
Screening for Down's syndrome and neural tube defect in Croatia. A regional prospective study.
Screening for Down's syndrome in older women based on maternal serum alpha-fetoprotein levels and age: preliminary results.
Screening for Down's syndrome using an iso-risk curve based on maternal age and serum alpha-fetoprotein level.
Screening for Down's syndrome: changes in marker levels and detection rates between first and second trimesters.
Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels.
Screening for fetal Down's syndrome with maternal serum markers--an experience in Italy.
Screening for trisomies 21 and 18 with maternal serum placental isoferritin p43 component.
Screening of maternal serum for fetal Down's syndrome in the first trimester.
Screening.
Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review.
Second trimester screening for Down's syndrome: 7 years experience.
Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong.
Second-trimester maternal serum free-beta-human chorionic gonadotropin and alpha-fetoprotein levels in normal twin and singleton pregnancies: a report of local Chinese population.
Second-trimester maternal serum inhibin-A screening for fetal Down syndrome in Asian women.
Second-trimester maternal serum markers in twin pregnancy with complete mole: report of 2 cases.
Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol.
Second-trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: experience of a regional programme.
Second-trimester placental biopsy for rapid fetal karyotyping.
Second-trimester unconjugated oestriol levels in maternal serum from chromosomally abnormal pregnancies using an optimized assay.
Selection and validation of alpha-fetoprotein assay kits for the screening of Down syndrome.
Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age.
Serum free beta-HCG and alpha-fetoprotein levels in IVF, ICSI and frozen embryo transfer pregnancies in maternal mid-trimester serum screening for Down's syndrome.
Serum insulin-like growth factor binding protein-1 at 16 weeks and subsequent preeclampsia.
Serum markers for Down's syndrome in relation to number of previous births and maternal age.
Serum parameters and nuchal translucency in first trimester screening for fetal chromosomal abnormalities.
Sonographic scoring index for prenatal detection of chromosomal abnormalities.
SURUSS in perspective.
Taking account of vaginal bleeding in screening for Down's syndrome.
The association between an abnormal nuchal skin fold, trisomy 21, and ultrasound abnormalities identified during the second trimester of pregnancy.
The effect of estimating gestational age by ultrasound cephalometry on the sensitivity of alpha-fetoprotein screening for Down's syndrome.
The effect of fetal gender on the false-positive rate of Down syndrome by maternal serum screening.
The effect of fetal gender on the prediction of Down syndrome by means of maternal serum alpha-fetoprotein and ultrasonographic parameters.
The effect of gestational age on maternal serum alpha-fetoprotein levels in pregnancies with Down syndrome.
The effect of gestational age on the detection rate of Down's syndrome by maternal serum alpha-fetoprotein screening.
The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome.
The effects of analytical factors on second trimester risk estimations.
The influence of fetal sex in screening for Down syndrome in the second trimester using AFP and free beta-hCG.
The Influence of Maternal Weight Correction Formulas in Asian Down Syndrome Screening Using alpha-Fetoprotein and Free beta-Human Chorionic Gonadotropin
The role of maternal serum alpha-fetoprotein, human chorionic gonadotrophin and oestriol in the antenatal screening of Down's syndrome.
The second-trimester fetus with Down syndrome: detection using sonographic features.
The triple-marker test in predicting fetal aneuploidy: a compromise between sensitivity and specificity.
The utility of fetal biometry as an adjunct to the multiple-marker screening test for Down syndrome.
The value of screening for Down's syndrome in a socioeconomically deprived area with a high ethnic population.
The variation of risk estimates through pregnancy in second trimester maternal serum screening for Down syndrome.
Total alpha-fetoprotein and Lens culinaris agglutinin-reactive alpha-fetoprotein in fetal chromosomal abnormalities.
Total hCG versus free beta-hCG combined with alpha-fetoprotein for Down syndrome screening in Taiwan.
Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study.
Triploid partial molar pregnancy detected through maternal serum alpha-fetoprotein and HCG screening.
Triploidy identified through second-trimester serum screening.
Trisomy 16 mosaicism in amniotic fluid cell cultures.
Ultrasonographic dating of pregnancy causes significant errors in Down syndrome risk assessment that may be minimized by use of biparietal diameter-based means.
Uptake of prenatal screening for chromosomal anomalies: impact of test results in a previous pregnancy.
Use of maternal serum alpha-fetoprotein measurements to screen for Down's syndrome.
Value of maternal serum unconjugated oestriol measurement in prenatal screening for Down's syndrome.
Variability in predicted rates of Down syndrome associated with elevated maternal serum alpha-fetoprotein levels in older women.
Very low alpha-fetoprotein in Down syndrome maternal serum screening.
Weights of fetuses with autosomal trisomies at termination of pregnancy: an investigation of the etiologic factors of low serum alpha-fetoprotein values.
[A study on the screening of prenatal trisomy 21 using the fucosylated alpha-fetoprotein ratio measured by a liquid-phase binding assay]
[Alpha-fetoprotein and trisomy 21]
[Concanavalin A reactivity of alpha-fetoprotein in the amniotic fluid in autosomal trisomies of the fetus]
[Decreased alpha fetoprotein in maternal serum in relation to increased alpha fetoprotein in amniotic fluid in a case of fetal trisomy 21 associated with esophageal atresia]
[Evaluation of trisomy 21 risk by serial determination of chorionic gonadotrophin hormone and alpha-fetoprotein: results of a national pilot study]
[Low maternal serum alpha-fetoprotein concentration and Down syndrome]
[Maternal serum AFP determination in the 2d trimester: a suitable screening method for detection of fetuses with Down's syndrome in young females?]
[Maternal serum alpha-fetoprotein as a screening test for fetal Down syndrome]
[Maternal serum screening: possibilities of using in the complex diagnosis of fetal malformation]
[Serum Ca-125 levels in aneuploidy screening in first pregnancy trimester. Authors' experience]
[The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers]
[Trisomy-21 screening using AFPplus in the eastern part of Switzerland]
Duodenal Obstruction
First-trimester diagnosis of duodenal stenosis associated with oesophageal atresia.
Dysarthria
Mutations in senataxin responsible for Quebec cluster of ataxia with neuropathy.
Dysentery, Amebic
Letter: Alpha-fetoprotein in amoebic colitis and liver abscess.
Dysgerminoma
A case of mixed-type dysgerminoma with a high serum concentration of both human chorionic gonadotropin and alpha-fetoprotein in a child.
Dysgerminoma in a child with ataxia-telangiectasia.
Dysgerminoma of the ovary with precocious puberty: a case report.
Dysgerminoma with a slightly elevated alpha-fetoprotein level diagnosed as a mixed germ cell tumor after recurrence.
Human chorionic gonadotropin and alpha-fetoprotein in sera and tumor cells of a patient with pure dysgerminoma of the ovary. A case report with radio-immunoassay and immunoperoxidase.
Large mononuclear cells in seminoma--an immunohistochemical analysis of 21 cases.
Malignant ovarian germ cell tumors in pediatric patients: The AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) study.
Ovarian mixed germ cell tumor composed of dysgerminoma, endodermal sinus tumor, choriocarcinoma and mature teratoma in a 44-year-old woman: case report and literature review.
Ovarian tumors in the pediatric age group: 37 cases treated over an 8-year period.
Serum lactic dehydrogenase as a tumor marker in dysgerminoma.
[Tumor markers in gynecologic malignancies]
Dyslipidemias
A Case Report: Can Citrin Deficiency Lead to Hepatocellular Carcinoma in Children?
Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals.
Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort study.
Dystonia
Clinical characteristics of ataxia-telangiectasia presenting dystonia as a main manifestation.
Echinococcosis
Serum tumor marker CA19-9 in the follow-up of patients with cystic echinococcosis.
[Cystic echinococcosis and hepatocellular carcinoma--a coincidence? A case report].
Echogenic Bowel
Factors associated with fetal demise in fetal echogenic bowel.
Ectodermal Dysplasia
Aplasia Cutis Congenita in a Setting of Fetus Papyraceus Associated with Small Fetal Abdominal Circumference and High Alpha-Fetoprotein and Amniotic Acetylcholinesterase.
Aplasia cutis congenita, elevated alpha-fetoprotein, and a distinct amniotic fluid acetylcholinesterase electrophoretic band.
Aplasia cutis congenita: a rare cause of elevated alpha-fetoprotein levels.
Epidermolysis bullosa in association with aplasia cutis congenita and pyloric atresia.
Increased amniotic acetylcholinesterase activity with a fetus papyraceus and aplasia cutis congenita.
Report of a case with aplasia cutis congenita, elevated amniotic fluid alpha-fetoprotein, and positive acetylcholinesterase band.
The association of congenital skin disorders with acetylcholinesterase in amniotic fluid.
Ectromelia
[Sirenomelia in a dead fetus in utero, discovered by a rise in maternal serum alpha-fetoprotein]
Embolism
Analysis of circulating tumor cells in patients with hepatocellular carcinoma recurrence following liver transplantation.
Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma.
[A case report of distal gastrectomy with thrombectomy after NAC for Gastric cancer].
[Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma]
Encephalocele
A reappraisal of amniotic fluid alpha-fetoprotein measurement at the time of genetic amniocentesis and midtrimester ultrasonography.
Prenatal diagnosis and perinatal management of frontoethmoidal meningoencephalocele.
Ratio of immunochemically determined amniotic fluid acetylcholinesterase to butyrylcholinesterase in the differential diagnosis of fetal abnormalities.
Encephalomyelitis, Autoimmune, Experimental
Alpha-fetoprotein suppresses experimental allergic encephalomyelitis.
Treatment of experimental allergic encephalomyelitis in rabbits with alpha-fetoprotein.
End Stage Liver Disease
[The therapeutic value of alpha-fetoprotein and cholinesterase in patients with hepatitis B virus related acute onset chronic liver failure].
Endodermal Sinus Tumor
A case of yolk sac tumor of the vagina in an infant.
A human vitelline component in embryonal carcinoma of the testis.
A radioresistant variant cell line, NMT-1R, isolated from a radiosensitive rat yolk sac tumour cell line, NMT-1: differences of early radiation-induced morphological changes, especially apoptosis.
A study on alpha-fetoprotein and endodermal sinus tumor.
A study on the lectin reactivity of alpha-fetoprotein produced by hepatoid adenocarcinomas and yolk sac tumors.
Adult hepatic cavernous haemangioma with highly elevated alpha-fetoprotein.
Advanced extragonadal yolk sac tumor serially followed up with (18) F-fluorodexyglucose-positoron emission tomography and computerized tomography and serum alpha-fetoprotein.
Advances in biological markers for cancer.
AFP in yolk sac tumor and solid teratoma of the ovary: significance of postoperative serum AFP.
AFP-producing Xp11 translocation renal cell carcinoma: Case report and review of the literature.
Aggressive chemotherapy in endodermal sinus tumor.
Alpha-fetoprotein (AFP) levels in normal children.
alpha-Fetoprotein (alphaFP) as a marker for hepatoma and yolk sac tumors.
Alpha-fetoprotein and endodermal sinus tumor of the ovary.
Alpha-fetoprotein and germ cell tumors: a possible role of yolk sac tumor in production of alpha-fetoprotein.
alpha-Fetoprotein and other serum proteins synthesized by endodermal sinus tumor transplanted into nude mice.
Alpha-fetoprotein in the management of germ cell tumors of the ovary.
Alpha-Fetoprotein in yolk sac tumor.
Alpha-fetoprotein production by a malignant mixed Müllerian tumor of the ovary.
Alpha-fetoprotein subfractions in germ cell tumors identified by Con A or LCH crossed-line affinity immunoelectrophoresis.
Alpha-fetoprotein synthesis in tissue culture of human testicular tumors and an examination of experimental yolk sac tumors in the rat.
Alpha-fetoprotein, prealbumin, albumin, alpha-1-antitrypsin and transferrin as diagnostic and therapeutic markers for endodermal sinus tumors.
Alpha-fetoprotein-producing carcinoma of the renal pelvis exhibiting hepatoid and urothelial differentiation.
Alpha-fetoprotein-producing Colon Carcinoma with Rapidly Increasing Liver Metastases That Resulted in Death: A Case Report.
Alpha-fetoprotein-producing gastric carcinoma with enteroblastic differentiation.
Alpha-fetoprotein-producing non-germ cell tumours of the female genital tract.
Alpha-fetoprotein-producing ovarian clear cell adenocarcinoma with fetal gut differentiation: a rare case report and literature review.
Alpha-fetoprotein-producing rectal cancer successfully responded to preoperative chemoradiotherapy: case report.
Alpha-fetoprotein-producing renal cell carcinoma.
Alpha-fetoprotein-producing serous carcinoma of the uterus metastasizing to the ovaries, mimicking primary ovarian yolk sac tumor: a case report and review of the literature.
Analysis of lectin affinity immunoelectrophoretic profiles of serum alpha-fetoprotein from patients with yolk sac tumors and carcinomas of the gastrointestinal tract: correlations with molecular structures.
Biphagic pulmonary blastoma with a lesion of yolk sac tumor.
Cervical sarcoma botryoides and ovarian Sertoli-Leydig cell tumor.
Clear cell (mesonephroid) tumors of the ovary with characteristics resembling endodermal sinus tumor.
Clinical and Computed Tomography Features of Female Pelvic Malignant Germ Cell Tumors in Children and Adolescents: A Series of 30 Cases.
Clinical characteristics and treatments of patients with alpha-fetoprotein producing gastric carcinoma.
Clinical significance of serum alpha-fetoprotein subfractionation in pediatric diseases.
Clinical stage I nonseminomatous germ cell tumors of the testis in childhood and adolescence: an analysis of 31 cases.
Clinical use of tumor markers in childhood malignancies.
Combination chemotherapy in the management of ovarian germ cell malignancies.
Detection of a metastatic lesion and tiny yolk sac tumors in two teenage patients by FDG-PET: report of two cases.
Detection of alpha-fetoprotein mRNA in seminoma.
Developmental alterations of alpha-fetoprotein sugar chain in amniotic fluids analyzed by lectin affinity electrophoresis.
Diagnostic Utility of SALL4 in Extragonadal Yolk Sac Tumors: An Immunohistochemical Study of 59 Cases With Comparison to Placental-like Alkaline Phosphatase, Alpha-fetoprotein, and Glypican-3.
Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system: a study of 77 cases.
Dysgerminoma with a slightly elevated alpha-fetoprotein level diagnosed as a mixed germ cell tumor after recurrence.
Elevated serum alpha-fetoprotein in poorly differentiated adenocarcinoma with neuroendocrine differentiation of the ascending colon: a case report.
Endodermal sinus tumor of the ovary during pregnancy: a case report.
Endodermal sinus tumor of vagina in infants.
Endodermal sinus tumour of the ovary: serum alpha-fetoprotein levels before and after treatment and during pregnancy. Case report.
Eosinophilic globules in Kaposi's sarcoma. A histochemical, immunohistochemical, and ultrastructural study.
Epidemiological and clinical behavior of prepubertal testicular tumors in Korea.
Establishment and characterization of a human ovarian endodermal sinus tumor cell line--producing specific type of alpha-fetoprotein subfraction.
Establishment and characterization of a rat yolk sac tumor cell line, NMT-1, producing alpha-fetoprotein, with potential for lymphatic metastasis.
Fine needle aspiration cytology of primary mediastinal germ cell tumors.
Gastric adenocarcinoma with features of endodermal sinus tumor.
Gastric cancer with choriocarcinoma and yolk sac tumor components: case report.
Germ cell neoplasms of head and neck soft tissues: a pathologic spectrum of teratomatous and endodermal sinus tumors.
Germ cell tumor in an adolescent with extensive testicular microlithiasis: concerns regarding future management.
Glypican 3 has a higher sensitivity than alpha-fetoprotein for testicular and ovarian yolk sac tumour: immunohistochemical investigation with analysis of histological growth patterns.
Half-life of alpha-fetoprotein in patients with a teratoma, endodermal sinus tumor, or hepatoblastoma.
Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma.
Hepatocytic differentiation in retiform Sertoli-Leydig cell tumors: distinguishing a heterologous element from Leydig cells.
High-level expression of divergent endodermal lineage markers in gonadal and extra-gonadal yolk sac tumors.
Human endodermal sinus tumour in nude mice and its markers for diagnosis and management.
Immature teratoma producing alpha-fetoprotein without components of yolk sac tumor in the pineal region.
Immunofluorescent demonstration of alpha- fetoprotein and other plasma proteins in yolk sac tumor.
Immunofluorescent localization of alpha-fetoprotein synthesis in endodermal sinus tumor (yolk sac tumor).
Immunohistochemical differentiation of clear-cell carcinoma of the female genital tract and endodermal sinus tumor with the use of alpha-fetoprotein and Leu-M1.
Immunohistochemical differentiation of yolk sac-type alpha-fetoprotein from hepatic-type alpha-fetoprotein.
Immunohistochemical localisation of alpha-fetoprotein (AFP) in germ cell tumours: evidence for AFP production by tissues different from endodermal sinus tumour.
Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
Increased serum levels of monosialo-alpha-fetoprotein in hepatocellular carcinoma and other malignancies.
Intracardiac yolk sac tumor and dysrhythmia as an etiology of pediatric syncope.
Intracranial germ-cell tumors. Immunohistochemical study of three autopsy cases.
Intratubular germ cell neoplasia of the testis and its associated cancers: the use of novel biomarkers.
Juvenile Granulosa Cell Tumor of the Testicle - Report of a Neonatal Case with Positive Alpha-fetoprotein Immunohistochemical Staining.
Juvenile granulosa cell tumor of the testis:: contemporary clinical management and pathological diagnosis.
Malignant müllerian mixed tumor of the uterus with a prominent alpha-fetoprotein-producing component of yolk sac tumor.
Malignant ovarian germ cell tumours: experience in the National University Hospital of Singapore.
Malignant sacrococcygeal germ cell tumors in childhood: The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience.
Management of advanced endodermal sinus tumor of the ovary with preservation of reproductive function.
Mature and immature extracranial teratomas in children: the UK Children's Cancer Study Group Experience.
Metastatic endodermal sinus tumor: CT appearances.
Microcystic Leydig cell tumors mimicking yolk sac tumor: a report of four cases.
MicroRNAs in testicular cancer: implications for pathogenesis, diagnosis, prognosis and therapy.
Novel human alpha-fetoprotein mRNA isoform lacking exon 1 identified in ovarian yolk sac tumor.
Ovarian endometrioid adenocarcinoma with ectopic production of alpha-fetoprotein.
Ovarian mixed germ cell tumor composed of dysgerminoma, endodermal sinus tumor, choriocarcinoma and mature teratoma in a 44-year-old woman: case report and literature review.
Ovarian mucinous cystadenocarcinoma with yolk sac tumor in a 71-year-old woman.
Ovarian tumors in the pediatric age group: 37 cases treated over an 8-year period.
Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of alpha-fetoprotein, sex steroid receptors, and p53.
Percentage of Teratoma in Orchiectomy and Risk of Retroperitoneal Teratoma at the Time of Postchemotherapy Retroperitoneal Lymph Node Dissection in Germ Cell Tumors.
Perforating abomasal ulcer caused by yolk sac tumor in a Holstein calf.
Peritoneal implantation of endodermal sinus tumor of the pineal region via a ventriculoperitoneal shunt. Cytodiagnosis with immunocytochemical demonstration of alpha-fetoprotein.
Periventricular metastases of a primary intracranial alpha-fetoprotein-producing germ cell tumor.
Postchemotherapy retroperitoneal residual mass in infantile yolk sac tumor.
Pregnancy following treatment of endodermal sinus tumor of the ovary with combination chemotherapy, including cis-platinum.
Primary intracranial yolk sac tumor: immunofluorescent demonstration of alpha-fetoprotein synthesis.
Primary mediastinal and retroperitoneal malignant germ cell tumors in children and adolescents: Results of the TGM95 trial, a study of the French Society of Pediatric Oncology (Société Française des Cancers de l'Enfant).
Primary yolk sac tumor originating from the endometrium: A case report and literature review.
Primary yolk sac tumors of the mesentery. A report of two cases.
Production of 13 plasma proteins by human testicular yolk sac tumor transplanted into nude mice.
Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors.
Pulmonary blastoma with germ cell (yolk sac) differentiation: report of two cases.
Pure Primary Extragonadal Retroperitoneal Yolk Sac Tumour in a Young Child: A Case Report.
Raised maternal serum alpha-fetoprotein levels during pregnancy following treatment of an endodermal sinus tumour. Case report.
Recent developments in the pathology of germ cell tumors.
Residual retroperitoneal mass following chemotherapy for infantile yolk sac tumor.
Sacrococcygeal teratomas: a review of 68 cases.
Second-look laparotomy in endodermal sinus tumor: a report of two patients with normal levels of alpha-fetoprotein and residual tumor at reexploration.
Secretion of human chorionic gonadotropin and alpha-fetoprotein by an ovarian germ cell tumor of apparent yolk sac origin.
Selective in vitro and in vivo growth inhibition against human yolk sac tumor cell lines by purified antibody against human alpha-fetoprotein conjugated with mitomycin C via human serum albumin.
Serial serum determination on alpha-fetoprotein as a marker of the effect of postoperative chemotherapy in ovarian endodermal sinus tumor.
Serum alpha-fetoprotein and its lectin reactivity in liver diseases: a review.
Serum alpha-fetoprotein as a marker for the effect of post-operative radiation therapy and/or chemotherapy in eight cases of ovarian endodermal sinus tumour.
Serum alpha-fetoprotein subfractions identified by Ricinus communis agglutinin I in hepatic malignancies, yolk sac tumor, benign hepatic diseases, and fetal stage.
Sugar chain of alpha-fetoprotein produced in human yolk sac tumor.
Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group.
Synthesis of alpha-fetoprotein by human yolk sac tumor transplanted into nude mice.
Testicular sex cord-stromal tumors in children: clinicopathologic study of sixteen children with review of the literature.
The differential diagnosis of yolk sac tumor and seminoma. Usefulness of cytokeratin, alpha-fetoprotein, and alpha-1-antitrypsin immunoperoxidase reactions.
The histogenetic-embryologic basis for reappearance of alpha-fetoprotein in endodermal sinus tumors (yolk sac tumors) and teratomas.
The role of subfractionation of alpha-fetoprotein in the treatment of pediatric surgical patients.
The role of tumor markers in gynecologic oncology.
Treatment of nongerminomatous germ-cell tumors of the pineal region.
Tumour markers in gynaecologic oncology.
Ultrasound and magnetic resonance images of endodermal sinus tumor.
Ultrastructure and immunohistochemical staining of a transplanted endodermal sinus tumor.
Value of tumor markers in the treatment of endodermal sinus tumors and choriocarcinomas in the pineal region.
Yolk sac tumor (endodermal sinus tumor) and alpha-fetoprotein. A report of three cases.
Yolk sac tumor and alpha-fetoprotein: clinicopathological study of four cases.
Yolk sac tumor of the anterior mediastinum. Case report with light- and electron-microscopic examination and immunohistochemical study of alpha-fetoprotein.
Yolk sac tumor of the anterior mediastinum: the role of palliative surgery.
Yolk sac tumor of the liver combined with hepatocellular carcinoma.
Yolk sac tumor of the stomach with an adenocarcinomatous component: a case report with immunohistochemical analysis.
Yolk sac tumor of the testicle: is retroperitoneal lymph node dissection necessary?
Yolk sac tumors and alpha-fetoprotein in first year of life.
[A case of immature mediastinal teratoma]
[A case report for primary yolk sac tumor of endometrium].
[Alpha-fetoprotein in non-hepatocellular malignant tumors]
[An experimental study on alpha-fetoprotein producing yolk sac tumor (author's transl)]
[Anti-tumor activity of an anti-human alpha-fetoprotein antibody-human serum albumin-mitomycin C conjugate against human yolk sac tumor maintained in vitro and in nude mice in vivo]
[Case of yolk sac tumor of the anterior mediastinum with superior vena cava syndrome]
[Combined treatment with resection, intraoperative hypotonic and post-operative systemic chemotherapy using cis-platinum for a mediastinal yolk sac tumor: a case report]
[Effect of anti-human alpha-fetoprotein serum on human endodermal sinus tumor transplanted in nude mice (author's transl)]
[Molecular heterogeneity of alpha-fetoprotein in ovarian or extragonadal yolk sac tumor]
[Proceedings: Yolk sac tumor and alpha-fetoprotein]
[Yolk sac tumor by fetectomy in the rat: histopathological characteristics and histogenesis (author's transl)]
Endometrial Hyperplasia
Papers to appear in forthcoming issues
Endometrial Neoplasms
Alpha-fetoprotein producing uterine corpus carcinoma: A hepatoid adenocarcinoma of the endometrium.
Predictive power of sexual hormones and tumor markers in endometrial cancer.
Endometriosis
Alpha-fetoprotein producing ovarian clear cell carcinoma with a neometaplasia to hepatoid carcinoma arising from endometriosis: A case report.
Concentrations of alpha-fetoprotein, insulin-like growth factor binding protein-3, c-erbB-2, and epidermal growth factor in serum of patients with endometriosis.
Elevation of CA 19-9 and chromogranin A, in addition to CA 125, are detectable in benign tumors in leiomyomas and endometriosis.
Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of alpha-fetoprotein, sex steroid receptors, and p53.
Tumor markers in endometriosis.
Eosinophilia
Undifferentiated embryonal sarcoma of the liver with an unusual presentation: case report and review of the literature.
Ependymoma
Case report: a preterm infant with an extradural myxopapillary ependymoma component of a teratoma and high levels of alpha-fetoprotein.
Epidermal Cyst
[Clinical and ultrasonographic features of testis tumor in children of different ages].
Epidermolysis Bullosa
Epidermolysis bullosa in association with aplasia cutis congenita and pyloric atresia.
Genetic counseling of high-risk isolated populations: A worldwide challenge.
Unusual prenatal sonographic findings without an elevated maternal serum alpha-fetoprotein level in a fetus with epidermolysis bullosa.
Epidermolysis Bullosa Dystrophica
Association of generalized dystrophic epidermolysis bullosa with positive acetylcholinesterase and markedly elevated maternal serum and amniotic fluid alpha-fetoprotein.
Markedly elevated alpha-fetoprotein and positive acetylcholinesterase in amniotic fluid from a pregnancy affected with dystrophic epidermolysis bullosa.
The association of congenital skin disorders with acetylcholinesterase in amniotic fluid.
Epidermolysis Bullosa, Junctional
Alpha-fetoprotein and acetylcholinesterase are not predictive of fetal junctional epidermolysis bullosa, Herlitz variant.
Alpha-fetoprotein and acetylcholinesterase are not predictors of fetal junctional epidermolysis bullosa, Herlitz variant.
Prenatal detection of epidermolysis bullosa letalis with pyloric atresia in a fetus by abnormal ultrasound and elevated alpha-fetoprotein.
Role of elevated alpha-fetoprotein in prenatal diagnosis of junctional epidermolysis bullosa and pyloric atresia.
Epididymitis
Hereditary persistence of alpha-fetoprotein mimicking testicular cancer in a patient with acute epididymitis.
Epilepsy
Alpha-fetoprotein concentrations in sera from epileptic patients with immunodeficiency.
First and Second Trimester Biochemical Markers in Maternal Epilepsy: A Case-Control Study.
[Observations on the development of pregnancy in women with epilepsy based on analysis of protein placental hormones and alpha fetoprotein]
Erythema Infectiosum
Maternal serum alpha-fetoprotein and human chorionic gonadotropin in pregnant women with acute parvovirus B19 infection with and without fetal complications.
Maternal serum alpha-fetoprotein--a marker of fetal aplastic crisis during intrauterine human parvovirus infection.
Maternal serum biochemical markers in pregnancies with fetal parvovirus B19 infection.
Esophageal and Gastric Varices
Bleeding index after the first course of endoscopic treatment for esophageal varices in liver cirrhotic patients with and without hepatocellular carcinoma.
Endoscopic injection sclerotherapy for esophageal varices associated with concomitant portal venous thrombus of hepatocellular carcinoma.
Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis.
Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center.
Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan.
Survival and prognostic factors in patients with hepatocellular carcinoma treated by percutaneous ethanol injection: a 10-year experience.
Esophageal Atresia
[Decreased alpha fetoprotein in maternal serum in relation to increased alpha fetoprotein in amniotic fluid in a case of fetal trisomy 21 associated with esophageal atresia]
Esophageal Neoplasms
An enzyme immunoassay for galactosyltransferase isoenzyme II, and its clinical application to cancer diagnosis.
Brain metastases and elevated alpha-fetoprotein level in a patient with esophageal carcinoma.
Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Immunocytochemical evaluation of primary human esophageal carcinomas and their xenografts for keratin, beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Fanconi Anemia
Alpha-fetoprotein and Fanconi Anemia: Relevance to DNA Repair and Breast Cancer Susceptibility.
Constitutive elevation of serum alpha-fetoprotein in Fanconi anemia.
Intermethod discordance for alpha-fetoprotein measurements in Fanconi anemia.
Maternal serum alpha-fetoprotein levels are normal in Fanconi anemia: Can it be a lack of postnatal inhibition of AFP gene resulting in the elevation?
Serum alpha-fetoprotein level in Fanconi's anemia: evaluation of 33 Turkish patients.
Fanconi Syndrome
A new hepato-pancreato-renal disorder resembling tyrosinemia involving neuropathy and abnormal metabolism of polyunsaturated acids.
Fatty Liver
Abnormal fucosylation of alpha-fetoprotein in patients with non-alcoholic steatohepatitis.
Association between alpha-fetoprotein and metabolic syndrome in a Chinese asymptomatic population: a cross-sectional study.
Association between serum alpha-fetoprotein levels and fatty liver disease: a cross-sectional study.
Association between steatohepatitis biomarkers and hepatocellular carcinoma after hepatitis C elimination.
Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?
Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection.
Serum alpha-fetoprotein levels in liver steatosis.
Steatotic hepatocellular carcinoma: a variant associated with metabolic factors and late tumour relapse.
Felty Syndrome
Rheumatic syndromes: clues to occult neoplasia.
Fetal Alcohol Spectrum Disorders
Alpha-fetoprotein, human placental lactogen, and pregnancy-specific beta 1-glycoprotein in pregnant women who drink: relation to fetal alcohol syndrome.
Fetal Death
Alpha-fetoprotein: a biomarker for pregnancy outcome.
Biochemical and Doppler predictors of poor perinatal outcome in a fetus with four umbilical vessels.
Clinical evaluation of a single antibody RIA assay for alpha-fetoprotein.
Cost-benefit analysis of targeted ultrasonography for prenatal detection of spina bifida in patients with an elevated concentration of second-trimester maternal serum alpha-fetoprotein.
Does unexplained second-trimester (15 to 20 weeks' gestation) maternal serum alpha-fetoprotein elevation presage adverse perinatal outcome? Pitfalls and preliminary studies with late second- and third-trimester maternal serum alpha-fetoprotein.
Elevated alpha-fetoprotein and human chorionic gonadotropin as a marker for placental trisomy 16 in the second trimester?
Elevated maternal alpha-fetoprotein levels with subsequent fetal exsanguination.
Elevated maternal serum alpha-fetoprotein, very low unconjugated oestriol, and very low human chorionic gonadotropin associated with recent fetal death.
Elevated maternal serum midtrimester alpha-fetoprotein levels are associated with fetoplacental ischemia.
Elevated second-trimester human chorionic gonadotropin levels in association with poor pregnancy outcome.
Factors associated with fetal demise in fetal echogenic bowel.
Fetal proteinuria in diagnosis of congenital nephrosis detected by raised alpha-fetoprotein in maternal serum.
Letter: Alpha-fetoprotein in amniotic fluid in early normal pregnancy and intrauterine fetal death.
Maternal serum biochemical markers in pregnancies with fetal parvovirus B19 infection.
Mechanisms of fetal demise in pregnant mice immunized to murine alpha-fetoprotein.
Persistently elevated AFP and AChE in amniotic fluid from a normal fetus following demise of its twin.
Placental sonolucency and pregnancy outcome in women with elevated second trimester serum alpha-fetoprotein levels.
Prediction of pregnancy outcome with single versus serial maternal serum alpha-fetoprotein tests.
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data.
Reactivity of amniotic fluid alpha-fetoprotein with concanavallin A in diagnosis of neural tube defects.
Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy.
Second-trimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death.
Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome.
Significance of meconium in midtrimester diagnostic amniocentesis.
The association of abnormal alpha-fetoprotein and adverse pregnancy outcome: does increased fetal surveillance affect pregnancy outcome?
The effect of fetomaternal bleeding on the risk of adverse pregnancy outcome in patients with elevated second-trimester maternal serum alpha-fetoprotein levels.
The Kleihauer-Betke test. Clinical utility, indication, and correlation in patients with placental abruption and cocaine use.
Unexplained elevation in maternal serum alpha-fetoprotein and subsequent fetal loss.
Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: a harbinger of fetal death.
Very low versus undetectable maternal serum alpha-fetoprotein values and fetal death.
[Correlation between elevated maternal serum alpha-fetoprotein, certain pregnancy complications and fetal death]
Fetal Diseases
Heterochrony and human malformation.
Fetal Growth Retardation
A discrepancy between gestational age estimated by last menstrual period and biparietal diameter may indicate an increased risk of fetal death and adverse pregnancy outcome.
A rat model of placental inflammation explains the unexplained elevated maternal serum alpha-fetoprotein associated with adverse pregnancy outcomes.
Amniotic fluid alpha-fetoprotein levels and the prenatal diagnosis of neural tube defects: a collaborative study of 2180 pregnancies in the Netherlands.
Antepartum evaluation of the high-risk fetus: problems and prospects.
Association of low maternal serum alpha-fetoprotein levels and intrauterine growth retardation.
CGH in the detection of confined placental mosaicism (CPM) in placentas of abnormal pregnancies.
Circulating intercellular adhesion molecule-1 in amniotic fluid, maternal serum alpha-fetoprotein levels, and intrauterine growth retardation.
Diffuse mesangial sclerosis in a fetus.
Elevated levels of midtrimester maternal serum alpha-fetoprotein are associated with preterm delivery but not with fetal growth retardation.
Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes.
Elevated maternal serum midtrimester alpha-fetoprotein levels are associated with fetoplacental ischemia.
Elevated second-trimester human chorionic gonadotropin levels in association with poor pregnancy outcome.
Factors associated with fetal demise in fetal echogenic bowel.
Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
Maternal serum transformed alpha-fetoprotein levels in women with intrauterine growth retardation.
Midtrimester amniocentesis: is it safe? A single centre controlled prospective study of 517 consecutive amniocenteses.
Midtrimester diagnosis and anomalies in the dup(22q) syndrome: correlation of aneuploidy with low maternal serum alpha-fetoprotein and oligohydramnios.
Midtrimester Rh sensitization associated with circulating anticardiolipin antibodies and elevated maternal serum alpha-fetoprotein. A case report.
Outcome in infants born to mothers with unexplained elevations of maternal serum alpha-fetoprotein.
Placental lesions: is growth a predictor of bad outcome?
Placental pathology at term associated with elevated midtrimester maternal serum alpha-fetoprotein concentration.
Postnatal placental confirmation of trisomy 2 and trisomy 16 detected at chorionic villus sampling: a possible association with intrauterine growth retardation and elevated maternal serum alpha-fetoprotein.
Prenatal diagnosis of an infant with mosaic trisomy 16 of paternal origin.
Prenatal diagnosis of congenital anomalies in an intrauterine growth retarded fetus.
Prenatal diagnosis of omphalocele associated with umbilical cord cyst.
Prenatal diagnosis of partial monosomy 13q associated with occipital encephalocoele in a fetus.
Protective effect of metformin on a rat model of lipopolysaccharide-induced preeclampsia.
Second trimester serum alpha-fetoprotein level is a significant positive predictor for intrauterine growth restriction in pregnant women with hyperemesis gravidarum.
Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy.
Second-trimester maternal serum alpha-fetoprotein (MSAFP) is elevated in women with adverse pregnancy outcome associated with inherited thrombophilias.
Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome.
Significance of opaque discolored amniotic fluid at second-trimester amniocentesis.
Study of the relationship between elevated maternal serum alpha-fetoprotein and adverse pregnancy outcome.
The association of abnormal alpha-fetoprotein and adverse pregnancy outcome: does increased fetal surveillance affect pregnancy outcome?
The association of early-onset fetal growth restriction, elevated maternal serum alpha-fetoprotein, and the development of severe pre-eclampsia.
The effect of fetomaternal bleeding on the risk of adverse pregnancy outcome in patients with elevated second-trimester maternal serum alpha-fetoprotein levels.
The use of biochemical markers in prenatal diagnosis of intrauterine growth retardation: insulin-like growth factor I, Leptin, and alpha-fetoprotein.
Uterine torsion and subsequent rupture in a gravid bicornuate uterus associated with an elevated alpha-fetoprotein.
[Radioimmunological assay of alpha-fetoprotein in maternal serum and intrauterine fetal growth retardation]
Fetal Hypoxia
Cord blood alpha-fetoprotein concentrations in term newborns of smoking mothers.
Fetomaternal Transfusion
Detecting fetomaternal hemorrhage after first-trimester abortion with the Kleihauer-Betke test and rise in maternal serum alpha-fetoprotein.
Elevated maternal serum alpha-fetoprotein: association with placental sonolucencies, fetomaternal hemorrhage, vaginal bleeding, and pregnancy outcome in the absence of fetal anomalies.
Fetomaternal transfusion after amniocentesis and cordocentesis.
Fetomaternal transfusion and pregnancy outcome after cordocentesis.
Fetomaternal transfusion depends on amount of chorionic villi aspirated but not on method of chorionic villus sampling.
Measurement of alpha-fetoprotein and fetal erythrocyte levels for detecting fetomaternal hemorrhage.
Nonimmune hydrops fetalis caused by a massive fetomaternal hemorrhage associated with elevated maternal serum alpha-fetoprotein levels. A case report.
Umbilical vein administration of oxytocin for the management of retained placenta: is it effective?
Fibrocystic Breast Disease
CA 125, CA 15.3, CA 27.29, CEA, beta-hCG and alpha-fetoprotein levels in cyst fluid of breast macrocysts.
Focal Nodular Hyperplasia
Clinical value of spectral CT imaging combined with AFP in identifying liver cancer and hepatic focal nodular hyperplasia.
Focal nodular hyperplasia masquerading as malignancy in an infant with elevated alpha-fetoprotein: A case report with literature review.
Focal nodular hyperplasia of the liver and elevated alpha fetoprotein level in an infant with isolated hemihyperplasia.
High serum level of alpha-fetoprotein in focal nodular hyperplasia of the liver.
Telangiectatic focal nodular hyperplasia of the liver in an infant with spontaneous regression: a case report.
Gallbladder Neoplasms
Alpha-fetoprotein, carcinoembryonic antigen, and carbohydrate antigen 19-9-producing gallbladder cancer.
[A case of gall bladder cancer with high level alpha-fetoprotein]
Ganglioglioma
Pineal ganglioglioma in a patient with familial basal ganglia calcification and elevated serum alpha-fetoprotein: case report.
Gastric Dilatation
Prenatal detection of epidermolysis bullosa letalis with pyloric atresia in a fetus by abnormal ultrasound and elevated alpha-fetoprotein.
Prenatal findings in epidermolysis bullosa with pyloric atresia in a family not known to be at risk.
Gastritis, Atrophic
Tumor markers in carcinoma and premalignant states of the stomach in humans.
Gastrointestinal Diseases
Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases.
Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases.
Letter: Radioimmunoassay of alpha-fetoprotein in gastrointestinal diseases.
Serum alpha-fetoprotein (AFP) in benign and malignant gastrointestinal diseases: evaluation of an immunoenzymatic assay.
Serum alpha-fetoprotein in patients with neoplasms of the gastrointestinal tract.
Gastrointestinal Neoplasms
Clinicopathological features and prognosis of AFP-producing colorectal cancer: a single-center analysis of 20 cases.
Detection of tumor cells in peritoneal lavages from patients with gastrointestinal cancer by multiplex reverse transcriptase PCR.
Immunologic tests for the detection of gastrointestinal cancers: status report on carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP).
Serum alpha-fetoprotein in patients with neoplasms of the gastrointestinal tract.
The HDAC Inhibitor, SAHA, Combined with Cisplatin Synergistically Induces Apoptosis in Alpha-fetoprotein-producing Hepatoid Adenocarcinoma Cells.
Gastroschisis
Altered lipid metabolism in gastroschisis: a novel hypothesis.
Amniotic fluid alpha-fetoprotein and acetylcholinesterase measurements in pregnancies associated with gastroschisis.
Fetal protein loss in gastroschisis as an explanation of associated morbidity.
Gastroschisis and alpha-fetoprotein.
Impact of demographic factors on prenatal diagnosis and elective pregnancy termination because of abdominal wall defects, Hawaii, 1986-1997.
Prenatal diagnosis and management of anterior abdominal wall defects in the west of Scotland.
Prenatal diagnosis of two cases of gastroschisis following alpha-fetoprotein (AFP) screening.
Ratio of amniotic fluid acetylcholinesterase to pseudocholinesterase as an antenatal diagnostic test for exomphalos and gastroschisis.
Second-trimester maternal serum alpha-fetoprotein levels in pregnancies associated with gastroschisis and omphalocele.
Second-trimester maternal serum alpha-fetoprotein, unconjugated estriol, and hCG levels in pregnancies with ventral wall defects.
The omega-6 fatty acid linoleic acid is associated with risk of gastroschisis: A novel dietary risk factor.
Vanishing gastroschisis and short-bowel syndrome.
[Contents of alpha-fetoprotein in the blood of pregnant women as a criterion of the presence of congenital heart defects in the fetus]
[Gastroschisis and omphalocele in the same family (author's transl)]
Genetic Diseases, Inborn
A novel embryological theory of autism causation involving endogenous biochemicals capable of initiating cellular gene transcription: A possible link between twelve autism risk factors and the autism 'epidemic'
Alpha-fetoprotein values in maternal serum and amniotic fluid for prenatal screening of genetic disorders.
Results of 12 years' combined maternal serum alpha-fetoprotein screening and ultrasound fetal monitoring for prenatal detection of fetal malformations in Havana City, Cuba.
Unusual prenatal sonographic findings without an elevated maternal serum alpha-fetoprotein level in a fetus with epidermolysis bullosa.
Genital Diseases, Female
Multiple biochemical markers in patients with gynecologic malignancies.
Genital Neoplasms, Female
[Carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in malignant female genital neoplasms]
Germinoma
Endoscopic Transsphenoidal Approach in Treatment of Germinomas of the Chiasmosellar Region.
Factors affecting functional prognosis in survivors of primary central nervous system germinal tumors.
Germ cell tumor presenting as sellar mass with suprasellar extension and long history of hypopituitarism.
Germinoma with malignant transformation to nongerminomatous germ cell tumor.
Improved outcome of central nervous system germ cell tumors: implications for the role of risk-adapted intensive chemotherapy.
Intracranial multiple midline germinomas: is histological verification crucial for therapy?
Malignant ganglioneuroma arising from mediastinal mixed germ cell tumor.
Occult Langerhans Cell Histiocytosis Presenting with Papillary Thyroid Carcinoma, a Thickened Pituitary Stalk and Diabetes Insipidus.
Primary chemotherapy for intracranial germ cell tumors: results of the third international CNS germ cell tumor study.
Stereotactic radiosurgery followed by whole ventricular irradiation for primary intracranial germinoma of the pineal region.
Suprasellar germinoma and late perioptic seeding.
Synchronous mixed germ cell tumor of the pineal gland and suprasellar region with a predominant angiomatous component: a diagnostic challenge.
Tissue AP-2gamma and Oct-3/4, and serum CA 125 as diagnostic and prognostic markers of malignant ovarian germ cell tumors.
Vimentin-positive and Alpha-fetoprotein-elevated Nuclear Protein of the Testis Midline Carcinoma: A Case Report and Review of the Literature.
[Highly sensitive test for alpha-fetoprotein in the differential diagnosis of germinomas of the testis and in evaluating the effectiveness of their treatment]
Giant Cell Arteritis
Rheumatic syndromes: clues to occult neoplasia.
Glycogen Storage Disease
Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature.
Glycogen Storage Disease Type I
Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature.
Gonadal Dysgenesis
Ataxia-without-telangiectasia. Progressive multisystem degeneration with IgE deficiency and chromosomal instability.
Gout
An abnormal elevation of serum CA72-4 rather than other tumor markers can be caused by use of colchicine.
Graft vs Host Disease
Allogeneic graft-versus-hepatoblastoma effect.
Granuloma
Focal non granulomatous orchitis in a patient with Crohn's disease.
Granulosa Cell Tumor
Juvenile Granulosa Cell Tumor of the Testicle - Report of a Neonatal Case with Positive Alpha-fetoprotein Immunohistochemical Staining.
Juvenile granulosa cell tumour with hepatocyte-like cells and raised serum alpha-fetoprotein.
Gynecomastia
[Testicular tumors: association between preoperative clinical, radiological and immuno-serological factors, and histology and stage]
Hamartoma
Fetal and neonatal hepatic tumors.
Mesenchymal hamartoma of the liver associated with features of Beckwith-Wiedemann syndrome and high serum alpha-fetoprotein levels.
Stromal-predominant mesenchymal hamartoma of the liver with elevated serum alpha-fetoprotein level.
Heart Defects, Congenital
[Contents of alpha-fetoprotein in the blood of pregnant women as a criterion of the presence of congenital heart defects in the fetus]
Heart Diseases
Diverse maternal and fetal pathology associated with absent diastolic flow in the umbilical artery of high-risk fetuses.
Heart Failure
The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology.
HELLP Syndrome
Midtrimester triple test levels in women with severe preeclampsia and HELLP syndrome.
Hemangioendothelioma
Elevated alpha-fetoprotein in a neonate with a benign hemangioendothelioma of the liver.
Infantile hemangioendothelioma with a highly elevated serum alpha-fetoprotein level.
Infantile hepatic hemangioendothelioma with elevated serum alpha-fetoprotein.
Solitary hepatic hemangioendothelioma with extensive cystic necrosis and markedly elevated alpha-fetoprotein.
[Infantile hemangioendothelioma with increased serum alpha-fetoprotein]
Hemangioma
A giant cord hemangioma with extramedullary hematopoiesis and elevated maternal serum human chorionic gonadotropin: a case report and review of the literature.
Chorioangioma and its severe infantile sequelae: case report.
Chorioangioma: a new inclusion in the prospective and retrospective evaluation of elevated maternal serum alpha-fetoprotein.
Elevated Serum Levels of Alpha-Fetoprotein in Patients with Infantile Hemangioma Are Not Derived from within the Tumor.
Fetal and neonatal hepatic tumors.
Giant congenital right atrial epithelioid-capillary hemangioma with prolonged QT interval: Case report and practical surgical treatment strategy for primary cardiac tumors in children based on 25-year review of 299 cases.
Maternal serum alpha-fetoprotein levels in chorioangiomas.
Not all chorioangiomas are associated with elevated maternal serum alpha-fetoprotein.
Placental chorioangioma: a rare cause of elevated amniotic fluid alpha-fetoprotein.
Prenatal diagnosis and management of fetal anemia secondary to a large chorioangioma.
Rare causes of elevated maternal serum alpha-fetoprotein. A report of three cases.
Umbilical cord hemangioma associated with extremely high alpha-fetoprotein levels.
[Giant placental angioma with polyhydramnios, high level of alpha-fetoprotein and neonatal congenital lactic acidosis]
[Placental hemangiomas]
Hemangiosarcoma
Effect of lifetime exposure to aflatoxin b1 in rats.
Hematologic Diseases
Letter: Alpha-fetoprotein radioimmunoassay in blood diseases.
Hemochromatosis
alpha-Fetoprotein screening in patients with idiopathic hemochromatosis and liver cirrhosis.
Detection of treatable neonatal liver disease by expanded newborn screening.
Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival.
High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis.
Neonatal hemochromatosis in monochorionic twins.
Post mortem identification of deoxyguanosine kinase (DGUOK) gene mutations combined with impaired glucose homeostasis and iron overload features in four infants with severe progressive liver failure.
Hemoperitoneum
A case of hepatoblastoma misdiagnosed as combined hepatocellular carcinoma and cholangiocarcinoma in an adult.
A rare case of a spontaneously ruptured secondary hepatic malignant lymphoma.
Hepatocellular carcinoma associated with erythrocytosis and hypoglycemia in a yearling filly.
Midtrimester hemoperitoneum caused by placenta percreta in association with elevated maternal serum alpha-fetoprotein level.
Hemoptysis
[Usefulness of carcinoembryonic antigen and other markers in patients with hemoptysis]
Hemothorax
[A child with successfully treated posterior mediastinal endodermal sinus tumor]
Hepatic Encephalopathy
A new multiparameter integrated MELD model for prognosis of HBV-related acute-on-chronic liver failure.
Cytochrome c is a possible new marker for fulminant hepatitis in humans.
Prognostic factors for chronic severe hepatitis and construction of a prognostic model.
Resolution of ascites and hepatic encephalopathy and absence of variceal bleeding in decompensated hepatitis C virus cirrhosis patients.
Serum alpha-fetoprotein in viral hepatitis and its complications.
Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons.
[Analysis of prognostic factors and construction of a logistic regression model for patients with drug-induced liver failure].
[Analysis of prognostic factors for patients with acute-on-chronic liver failure.]
[Multivariate analysis of hepatic encephalopathy occurrence in patients with liver failure].
[Role of resistin in inflammation of hepatocytes in nonalcoholic steatohepatitis.]
Hepatitis
A case of alpha-fetoprotein-producing esophageal adenocarcinoma.
A prospective randomized trial of colchicine in prevention of liver cirrhosis in chronic hepatitis B patients.
Acute exacerbation of hepatitis in liver cirrhosis with very high levels of alpha-fetoprotein but no occurrence of hepatocellular carcinoma.
Adult capillary hemangioma of the liver: Case report and literature review.
Alcoholic liver disease. Absence of alpha-fetoprotein elevations in the recovery phase.
Alpha-fetoprotein and acute viral hepatitis type B.
Alpha-fetoprotein and hepatitis B antigen in acute hepatitis and primary cancer of the liver.
Alpha-Fetoprotein and hepatitis B antigen in hepatoma and hepatitis.
Alpha-fetoprotein and tissue polypeptide antigen in non neoplastic hepatic disorders.
Alpha-Fetoprotein as a Predictive Marker for Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure.
Alpha-fetoprotein in acute viral hepatitis.
Alpha-fetoprotein in adult normals, bilharzial hepatic fibrosis and viral hepatitis in Egypt.
Alpha-fetoprotein in hepatitis superimposed on cirrhosis: a case of concomitant hepatitis B surface antigen and antibody associated with a major but transient increase in the alpha-fetoprotein level.
alpha-Fetoprotein in liver disease.
Alpha-fetoprotein in serum and amniotic fluid in the diagnosis of neonatal hepatitis syndrome, Indian childhood cirrhosis, cystic fibrosis, ataxia telangiectasia and spina bifida.
Alpha-fetoprotein in the woodchuck model of hepadnavirus infection and disease: immunochemical analysis of woodchuck alpha-fetoprotein and measurement in serum by quantitative monoclonal radioimmunoassay.
Alpha-fetoprotein in the woodchuck model of hepadnavirus infection and disease: normal physiological patterns and responses to woodchuck hepatitis virus infection and hepatocellular carcinoma.
Alpha-fetoprotein screening in patients with hepatitis C-induced cirrhosis who achieved a sustained virologic response in the direct-acting antiviral agents era.
Amplification of c-myc in hepatocellular carcinoma: correlation with clinicopathologic features, proliferative activity and p53 overexpression.
Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal.
Assessment of hepatic fibrosis by fibroscan in egyptian chronic hemodialysis patients with chronic Hepatitis C (genotype 4): A single-center study.
Autotaxin Expression in Hepatocellular Carcinoma.
Blood serum alpha fetoprotein enhancer binding protein, a tumor suppressor, decreases in chronic HBV hepatitis patients as hepatocellular cancer appears.
Case of clear-cell hepatocellular carcinoma that developed in the normal liver of a middle-aged woman.
Characterization of HBeAg-negative chronic hepatitis B in western Brazilian Amazonia.
Cholangiography of icteric type hepatoma.
Chronic viral hepatitis in renal transplant recipients with allografts functioning for more than 20 years.
Chubby face and the biochemical parameters for the early diagnosis of neonatal intrahepatic cholestasis caused by citrin deficiency.
Circulating and hepatic Fas expression in HCV-induced chronic liver disease and hepatocellular carcinoma.
Clinical impact of screening first-degree relatives of patients with hepatocellular carcinoma.
Clinical predictors of liver fibrosis in patients with chronic hepatitis B virus infection from children to adults.
Clinical significance of alpha-fetoprotein in hepatitis and liver cirrhosis.
Clinicopathologic analysis of risk factors for distant metastasis of hepatocellular carcinoma.
Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases.
Comparing the diagnostic value of serum oligosaccharide chain (G-test) and alpha-fetoprotein for hepatitis B virus-related liver cancer.
Connexin-43 can delay early recurrence and metastasis in patients with hepatitis B-related hepatocellular carcinoma and low serum alpha-fetoprotein after radical hepatectomy.
Contrast-enhanced ct and angiographic findings in hepatic perivascular epithelioid cell tumor.
Correlation between hepatitis B virus surface antigen level and alpha-fetoprotein in patients free of hepatocellular carcinoma or severe hepatitis.
Correlation between low platelet count and multicentricity of hepatocellular carcinoma in patients with chronic hepatitis C.
Cyclin dependent kinase inhibitor p27(kip1) expression and subcellular localization in relation to cell proliferation in hepatocellualr carcinoma.
Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Detection of alpha-fetoprotein in mice infected with mouse hepatitis virus.
Determinants of Serum Alpha-Fetoprotein Levels in Hepatitis C-Infected Patients.
Diagnosis efficacy of CEUS for hepatic inflammatory lesions.
Diagnostic value of serum gamma-glutamyl transferase isoenzyme for hepatocellular carcinoma: a 10-year study.
Distinctive clinicopathological features and KRAS and IDH1/2 mutation status of cholangiolocellular carcinoma.
Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study.
Efficacy and safety of thalidomide in patients with hepatocellular carcinoma.
Evaluation of alpha-fetoprotein as a screening marker for hepatocellular carcinoma in hepatitis prevalent areas.
Evaluation of curability and prediction of prognosis after surgical treatment for hepatocellular carcinoma by lens culinaris agglutinin-reactive alpha-fetoprotein.
False Positive Diagnosis of Hepatocellular Carcinoma in Liver Resection Patients.
Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation.
Follistatin Like 5 (FSTL5) inhibits epithelial to mesenchymal transition in hepatocellular carcinoma.
Frequency and significance of serum alpha-fetoprotein elevation in severe hepatitis B surface antigen-negative chronic active hepatitis.
Hepatic Angiomyolipoma: A Clinical Experience in Diagnosis and Treatment.
Hepatitis B surface antigen, hepatitis B surface antibody and alpha-fetoprotein in urban endemic hepatitis at Aurangabad.
Hepatitis B virus markers, alpha-fetoprotein and survival in fulminant viral hepatitis.
Hepatitis B- and hepatitis C-associated hepatocellular carcinoma: evaluation of alpha-fetoprotein as a diagnostic marker.
Hepatocellular carcinoma in HBsAg-negative chronic active hepatitis.
Hepatocellular carcinoma in noncirrhotic patients. A laparoscopic study of 92 cases in Taiwan.
Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis.
High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
High alpha-fetoprotein level in HCV-related nodular liver cell dysplasia.
Immunohistochemical detection of aberrant p53 expression in hepatocellular carcinoma: correlation with cell proliferative activity indices, including mitotic index and MIB-1 immunostaining.
Impact of hepatologists to extend survival of hepatocellular carcinoma patients with cirrhosis: a comparison with non-hepatologists.
Impact of interferon-alpha therapy on the serum level of alpha-fetoprotein in patients with chronic viral hepatitis.
Increased serum levels of monosialo-alpha-fetoprotein in hepatocellular carcinoma and other malignancies.
Indocyanine green clearance test in non-cirrhotic hepatitis patients: a comparison and analysis between conventional blood sampling method and Finger Piece Monitoring method.
Initial Alpha-Fetoprotein Response Predicts Prognosis in Hepatitis B-related Solitary HCC Patients After Radiofrequency Ablation.
Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma.
Is anti-HBc IgM a useful clinical test in patients with HBsAg-positive chronic hepatitis or primary hepatocellular carcinoma?
Lectin-reactive patterns of markedly elevated serum alpha-fetoprotein in patients with chronic active hepatitis.
Letter: Alpha-fetoprotein in hepatitis.
Level of Alpha-Fetoprotein Predicts Mortality among Patients with Hepatitis C-Related Hepatocellular Carcinoma.
Liver with hypoechoic nodular pattern as a risk factor for hepatocellular carcinoma.
Living-Donor Liver Transplant for Fibrolamellar Hepatocellular Carcinoma With Hilar Lymph Node Metastasis: A Case Report.
Niemann-Pick disease type C presenting as neonatal hepatitis: report of one case.
Nomogram based on inflammatory indices for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
Occurrence of alpha-fetoprotein in acute viral hepatitis.
On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir.
Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis.
Outcome of patients with fibrolamellar hepatocellular carcinoma.
Paraneoplastic syndromes in patients with hepatocellular carcinoma in Taiwan.
Pedunculated Hepatocellular Carcinoma Mimicking Right Adrenal Tumor on FDG PET/CT.
Preoperative predictors of survival after resection of small hepatocellular carcinomas.
Preserved liver function, portal thrombosis and absence of oesophageal varices are risk factors for metastasis of hepatocellular carcinoma.
Primary hepatic neuroendocrine tumors: A case report.
Primary liver cancers in Japan.
Prognostic factors for pulmonary metastasectomy in the treatment of hepatocellular carcinoma.
Prognostic Implications of Arginase and Cytokeratin 19 Expression in Hepatocellular Carcinoma After Curative Hepatectomy: Correlation With Recurrence-Free Survival.
Prognostic implications of serum alpha-fetoprotein levels in neonatal hepatitis.
Prognostic role of PD-L1 for HCC patients after potentially curative resection: a meta-analysis.
Prognostic value of programmed cell death ligand 1 (PD-L1) for hepatocellular carcinoma: a meta-analysis.
Pulmonary metastases from primary hepatocellular carcinoma in a 26-year-old patient: a case report.
Radiological and clinical features of sarcomatoid hepatocellular carcinoma in 11 cases.
Reappearance of alpha-fetoprotein in spontaneous hepatitis in the rat.
Reciprocal changes in serum albumin and alpha-fetoprotein levels in the recovery course of acute viral hepatitis stimulated by glucagon and insulin therapy: analysis of a double blind controlled trial.
Regional prevalence of hepatitis B, delta, and human immunodeficiency virus infection in southern Africa: a large population survey.
Relation of alpha-fetoprotein in acute hepatitis to severity and prognosis.
Relationship of serum alpha-fetoprotein to the severity and duration of illness in patients with viral hepatitis.
Resistin and Insulin Resistance: A Link Between Inflammation and Hepatocarcinogenesis.
Schistosoma mansoni infection and the occurrence, characteristics, and survival of patients with hepatocellular carcinoma: an observational study over a decade.
Sequential study of serum glycoprotein fucosylation in acute hepatitis.
Serum alpha-fetoprotein (AFP) in benign and malignant gastrointestinal diseases: evaluation of an immunoenzymatic assay.
Serum alpha-fetoprotein in viral hepatitis and its complications.
Serum alpha-fetoprotein levels in acute viral hepatitis.
Serum alpha-fetoprotein levels in extrahepatic biliary atresia, idiopathic neonatal hepatitis and alpha-1-antitrypsin deficiency (PiZ).
Serum alpha-fetoprotein levels in patients with acute and chronic liver disease. Relation to hepatocellular regeneration and development of primary liver cell carcinoma.
Serum alpha-fetoprotein levels in patients with chronic hepatitis C. Relationships with serum alanine aminotransferase values, histologic activity index, and hepatocyte MIB-1 scores.
Serum alpha-fetoprotein. A prognostic indicator of liver-cell necrosis and regeneration following experimental injury by galactosamine in rats.
Serum alpha-L-fucosidase. A more sensitive marker for hepatocellular carcinoma?
Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma: a longterm cohort study of 892 patients with viral cirrhosis.
Specificities of serum alpha-fetoprotein in HBsAg+ and HBsAg- patients in the diagnosis of hepatocellular carcinoma.
Superoxide dismutase in hepatocellular carcinoma affects patient prognosis.
Surgery for large primary liver cancer more than 10 cm in diameter.
The role of alpha-fetoprotein in the differentiation of neonatal hepatitis and biliary atresia.
The use of tissue polypeptide specific antigen as a marker in liver diseases.
Three cases of small hepatocellular carcinoma presenting as obstructive jaundice.
Toll-like receptor 7 mRNA is reduced in hepatitis C-based liver cirrhosis and hepatocellular carcinoma, out-performs alpha-fetoprotein levels, and with age and serum aspartate aminotransferase is a new diagnostic index.
Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China.
Usefulness of Circulating Methylated p16 as a Noninvasive Molecular Biomarker for Hepatitis C-Related Hepatocellular Carcinoma with Normal Serum Alpha-Fetoprotein Levels.
Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis.
[A case ectopic hepatocellular carcinoma with peritoneal dissemination].
[A case of virus B hepatitis with massive hepatic cell necrosis (funnel liver) and transient high serum alpha-fetoprotein concentration (author's transl)]
[A high risk group of hepatocellular carcinoma in man, with special reference to its clinical significance for the screening of early liver cancer. Gifu Study Group for Early Liver Cancer]
[Alpha-fetoprotein in 2 cases of viral hepatitis]
[Alpha-fetoprotein in acute viral hepatitis type A]
[Alpha-fetoprotein in infants with a hepatitis syndrome]
[Analysis of prognostic factors for patients with acute-on-chronic liver failure.]
[Case-controlled study of entecavir treatment for chronic severe hepatitis B]
[Changes in plasma values of alpha-fetoprotein in subjects with prior acute hepatitis]
[Clinical and etiologic features of hepatocarcinoma in Sicily]
[Comparative study of alpha-fetoprotein and Australian antigen in viral and serum hepatitis in young children]
[Embryonic serum protein, alpha-fetoprotein, and viral hepatitis in children]
[Fatal acute hepatic failure with hepatocarcinoma presentation in a patient with renal transplant with asymptomatic chronic B and C hepatitis]
[Fibrolamellar hepatocarcinoma. Case report]
[Long-term course in asymptomatic carriers of HBsAg in an area of low prevalence of hepatocarcinoma]
[Occurrence of alpha-fetoprotein in various forms of hepatitis, cirrhosis and primary hepatic cancer]
[Occurrence of increased alpha-fetoprotein in non-neoplastic hepatopathies of alcoholic or non-alcoholic origin]
[On the alpha-fetoprotein in the diagnosis of primary liver carcinoma (author's transl)]
[Prophylaxis and treatment of chronic viral hepatitis as the prevention of hepatocellular carcinoma]
[Role of resistin in inflammation of hepatocytes in nonalcoholic steatohepatitis.]
[Serum alpha-fetoprotein (AFP) levels in liver cirrhosis and viral hepatitis cases]
[Surgical therapy of hepatic fibrolamellar carcinoma]
[The incidence and clinical significance of paraneoplastic syndromes in patients with hepatocellular carcinoma]
Hepatitis A
Assessment of Adherence to Baseline Quality Measures for Cirrhosis and the Impact of Performance Feedback in a Regional VA Medical Center.
Clinical significance of elevated serum alpha-fetoprotein (AFP) level in acute viral hepatitis A (AHA).
[Alpha-fetoprotein in infectious hepatitis in children]
Hepatitis B
A comprehensive programme to reduce the incidence of hepatitis B virus infection and its sequelae in Alaskan natives.
A nomogram incorporating six easily obtained parameters to discriminate intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
A Systematic Review: Treatment and Prognosis of Patients with Fibrolamellar Hepatocellular Carcinoma.
Abnormality of Wnt3a expression as novel specific biomarker for diagnosis and differentiation of hepatocellular carcinoma.
Adriamycin treatment for hepatocellular carcinoma. Experience with 109 patients.
Age-related, different clinicopathologic features of hepatocellular carcinoma patients.
Allelic loss of chromosome 4q21 approximately 23 associates with hepatitis B virus-related hepatocarcinogenesis and elevated alpha-fetoprotein.
Alpha-fetoprotein and hepatitis B antigen in acute hepatitis and primary cancer of the liver.
Alpha-Fetoprotein and hepatitis B antigen in hepatocarcinogenesis.
Alpha-Fetoprotein and hepatitis B antigen in hepatoma and hepatitis.
Alpha-fetoprotein and hepatitis B virus infection in chronic liver disease.
Alpha-fetoprotein and its concanavalin A affinity in acute exacerbation of chronic hepatitis B.
Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B.
Alpha-fetoprotein changes in the course of chronic hepatitis: relation to bridging hepatic necrosis and hepatocellular carcinoma.
Alpha-fetoprotein in hepatitis superimposed on cirrhosis: a case of concomitant hepatitis B surface antigen and antibody associated with a major but transient increase in the alpha-fetoprotein level.
alpha-Fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma.
Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
Alpha-fetoprotein synthesis in human hepatocellular carcinoma: correlation with hepatitis B surface antigen expression.
An aged male patient with autoimmune hepatitis complicated by hepatocellular carcinoma.
An analysis of DNA ploidy pattern of hepatocellular carcinoma.
An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results.
Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival.
Analysis of Clinicopathological Characteristics and Prognosis of Young Patients with Hepatocellular Carcinoma after Hepatectomy.
Androgen and estrogen receptors in hepatocellular carcinoma and the surrounding liver in women.
Angiographically undetected small hepatocellular carcinoma: clinicopathological characteristics, follow-up and treatment.
Antigenic markers of hepatocellular carcinoma.
Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal.
Assessment of Adherence to Baseline Quality Measures for Cirrhosis and the Impact of Performance Feedback in a Regional VA Medical Center.
Assessment of hepatic fibrosis by fibroscan in egyptian chronic hemodialysis patients with chronic Hepatitis C (genotype 4): A single-center study.
Ataxia-telangiectasia: immunocytochemical demonstration of alpha-fetoprotein and hepatitis B surface antigen in the liver.
Autopsy case of colocalized tumors of hepatocellular carcinoma and malignant lymphoma.
Bivariate flow cytometric analysis of p53 and DNA content in hepatocellular carcinoma.
Case report: fibrolamellar hepatocellular carcinoma in a Japanese woman: a case report and review of Japanese cases.
Case report: multiple cancers: hepatocellular carcinoma and adenocarcinomas of the common bile duct and the gall-bladder in a woman with primary biliary cirrhosis.
Cesium Lead Bromide (CsPbBr3) Perovskite Quantum Dot-Based Photosensor for Chemiluminescence Immunoassays.
Changes of serum hepatitis B virus DNA in two types of clinical events preceding spontaneous hepatitis B e antigen seroconversion in chronic type B hepatitis.
Characteristics of fibrolamellar hepatocellular carcinoma. A study of nine cases and a review of the literature.
Characteristics of hepatocellular carcinoma in hemodialysis patients in hepatitis B endemic area.
Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases.
Clinical biocharacterization of immunophenotype in hepatocellular carcinoma patients.
Clinical features and prognosis of hepatocellular carcinoma in young patients from a hepatitis B-endemic area.
Clinical features of treatment-naive patients with hepatitis B virus infection: A community-based survey from high- and intermediate-hepatitis B endemicity regions in Southeast China.
Clinical features, biochemical parameters, and virological profiles of patients with hepatocellular carcinoma in Hong Kong.
Clinical implications of alpha-fetoprotein in liver cirrhosis: five-year follow-up study.
Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.
Clinico-cytopathological spectrum of hepatocellular carcinoma, its correlation with serum alpha-fetoprotein level, and hepatitis B and C viral markers.
Clinicopathological and Prognostic Role of Programmed Cell Death-1 in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Clinicopathological comparison of resectable hepatocellular carcinoma between the young and the elderly patients.
Clinicopathological significance and prognostic role of p-STAT3 in patients with hepatocellular carcinoma.
Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation.
Combined hepato-cholangiocarcinoma arising in a gallbladder intracystic papillary neoplasm. A new view on so-called "hepatoid adenocarcinoma of the gallbladder".
Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features.
Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study.
Combined pre-S deletion and core promoter mutations related to hepatocellular carcinoma: A nested case-control study in China.
Comparing the diagnostic value of serum oligosaccharide chain (G-test) and alpha-fetoprotein for hepatitis B virus-related liver cancer.
Comparison between diploid and aneuploid hepatocellular carcinomas: a flow cytometric study.
Comparison of the on-treatment risks for hepatocellular carcinoma between entecavir and tenofovir: A propensity score matching analysis.
Continuing five or more locoregional therapies before living donor salvage liver transplantation for hepatocellular carcinoma is related to poor recurrence-free survival.
Contrast-Enhanced Ultrasound Findings and Differential Diagnosis of Hepatic Epithelioid Angiomyolipoma Compared With Hepatocellular Carcinoma.
Correlation between hepatitis B virus surface antigen level and alpha-fetoprotein in patients free of hepatocellular carcinoma or severe hepatitis.
Cre/loxP system controlled by specific promoter for radiation-mediated gene therapy of hepatoma.
Detection of hepatocellular carcinoma during a clinical follow-up of chronic liver disease: observations in 31 patients.
Development of a Listeria monocytogenes-based vaccine against hepatocellular carcinoma.
Development of hepatocellular carcinoma after successful management of esophageal variceal bleeding.
Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patients.
Diagnostic value of alpha-fetoprotein, Lens culinaris agglutinin-reactive alpha-fetoprotein, and des-gamma-carboxyprothrombin in hepatitis B virus-related hepatocellular carcinoma.
Diagnostic value of gamma-glutamyltransferase/aspartate aminotransferase ratio, protein induced by vitamin K absence or antagonist II, and alpha-fetoprotein in hepatitis B virus-related hepatocellular carcinoma.
Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma.
Diagnostic value of the ?-glutamyltransferase and alanine transaminase ratio, alpha-fetoprotein, and protein induced by vitamin K absence or antagonist II in hepatitis B virus-related hepatocellular carcinoma.
Do HIV care providers appropriately manage hepatitis B in coinfected patients treated with antiretroviral therapy?
Does Hepatocellular Carcinoma Surveillance Increase Survival in At-Risk Populations? Patient Selection, Biomarkers, and Barriers.
Donor interleukin 6 gene polymorphisms predict the recurrence of hepatocellular carcinoma after liver transplantation.
Doxorubicin conjugates of monoclonal antibodies to hepatoma-associated antigens.
Dramatic reduction of the alpha-fetoprotein level after lamivudine treatment of patients with chronic hepatitis B virus infection and cirrhosis.
Droplet digital PCR detects high rate of TP53 R249S mutants in cell-free DNA of middle African patients with hepatocellular carcinoma.
Dynamic Changes in Serum Markers and Their Utility in the Early Diagnosis of All Stages of Hepatitis B-Associated Hepatocellular Carcinoma.
Early detection of primary hepatocellular carcinoma. Screening for primary hepatocellular carcinoma among persons infected with hepatitis B virus.
Elevation of circulating immune complexes and its relationship to alpha-fetoprotein levels in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.
Enlarged focal nodular hyperplasia of the liver under the influence of oral contraceptives.
Epidemiological studies of alpha-fetoprotein and hepatitis B antigen in Tomié Town, Nagasaki, Japan.
Establishment of a human cell line (HCC-T) from a patient with hepatoma bearing no evidence of hepatitis B or A virus infection.
Establishment, validation and evaluation of predictive model for early relapse after R0 resection in hepatocellular carcinoma patients with microvascular invasion.
Estrogen receptors in hepatocellular carcinoma.
Etiological and clinicopathologic characteristics of intrahepatic cholangiocarcinoma in young patients.
Evaluating histologic differentiation of hepatitis B virus-related hepatocellular carcinoma using intravoxel incoherent motion and AFP levels alone and in combination.
Evaluation of serum AFP and DCP levels in the diagnosis of early-stage HBV-related HCC under different backgrounds.
Evaluation of Serum GDF15, AFP, and PIVKA-II as Diagnostic Markers for HBV-Associated Hepatocellular Carcinoma.
Evaluation of the Alpha-Fetoprotein Model for Predicting Recurrence and Survival in Patients With Hepatitis B Virus (HBV)-Related Cirrhosis Who Received Liver Transplantation for Hepatocellular Carcinoma.
Expression of cancer-testis antigens in hepatocellular carcinoma.
Expression of FOXO6 is Associated With Oxidative Stress Level and Predicts the Prognosis in Hepatocellular Cancer: A Comparative Study.
Expression of insulin-like growth factor II, alpha-fetoprotein and hepatitis B virus transcripts in human primary liver cancer.
Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis.
Extrahepatic primary malignant neoplasms associated with hepatocellular carcinoma: high occurrence of B cell tumors.
Extremely elevated alpha-fetoprotein due to acute exacerbation of chronic hepatitis B without malignancy: a case report.
Factors associated with compliance with recommendations for liver cancer screening in Korea: a nationwide survey in Korea.
False-negative rate of abdominal sonography for detecting hepatocellular carcinoma in patients with hepatitis B and elevated serum alpha-fetoprotein levels.
Fibrolamellar hepatocellular carcinoma in a Japanese man: report of a case.
Fibrolamellar hepatocellular carcinoma: a case report with distinct radiological features.
Fibrolamellar hepatocellular carcinoma: a case report.
Fine needle aspiration biopsy of hepatocellular carcinoma. Diagnostic dilemma at the ends of the spectrum.
Fixed polarizer ellipsometry for simple and sensitive detection of thin films generated by specific molecular interactions: applications in immunoassays and DNA sequence detection.
Focal nodular hyperplasia of the liver without central scar.
Follow-up examination schedule of postoperative HCC patients based on tumor volume doubling time.
Forecasting the development of primary hepatocellular carcinoma by the use of risk factors: studies in West Africa.
Frequency and significance of serum alpha-fetoprotein elevation in severe hepatitis B surface antigen-negative chronic active hepatitis.
Frequency of raised alpha-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C.
Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma.
HBS Ag seroclearance and seroconversion time in Patients with chronic hepatitis B Infection.
Hepatic resection for minute hepatocellular carcinoma.
Hepatitis B and alcohol affect survival of hepatocellular carcinoma patients.
Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course, and management.
Hepatitis B surface antigen and alpha-fetoprotein in patients with hepatocellular carcinoma.
Hepatitis B surface antigen and alpha-fetoprotein secreting human primary liver cell cancer in athymic mice.
Hepatitis B surface antigen, hepatitis B surface antibody and alpha-fetoprotein in urban endemic hepatitis at Aurangabad.
Hepatitis B surface antigenemia at birth: a long-term follow-up study.
Hepatitis B surface antigenemia in patients with hepatocellular carcinoma in relation to clinical course and alpha-fetoprotein.
Hepatitis B viral transactivator HBx alleviates p53-mediated repression of alpha-fetoprotein gene expression.
Hepatitis B virus markers, alpha-fetoprotein and survival in fulminant viral hepatitis.
Hepatitis B virus serological markers in Africans with liver cirrhosis and hepatocellular carcinoma.
Hepatitis B virus X protein induces expression of alpha-fetoprotein and activates PI3K/mTOR signaling pathway in liver cells.
Hepatitis B virus X protein upregulates alpha-fetoprotein to promote hepatocellular carcinoma by targeting miR-1236 and miR-329.
Hepatitis B virus, alpha-fetoprotein synthesis, and hepatocellular carcinoma in Zaire.
Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Hepatocellular carcinoma associated with anabolic steroid therapy: report of a case and review of the Japanese literature.
Hepatocellular carcinoma coexisted with second malignancy--a study of 13 cases from a consecutive 440 autopsy cases of HCC.
Hepatocellular carcinoma complicated with coexisting hepatolithiasis: pitfalls in diagnosis and management.
Hepatocellular carcinoma during pregnancy and its comparison with other pregnancy-associated malignancies.
Hepatocellular carcinoma in a pregnant woman detected by routine screening of maternal alpha-fetoprotein.
Hepatocellular carcinoma in children.
Hepatocellular carcinoma in Israel: relationship to hepatitis B virus infection.
Hepatocellular carcinoma in Taiwan: clinicopathological study of 440 cases from a consecutive 6000 autopsies.
Hepatocellular carcinoma presenting as bone metastasis.
Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study.
Hepatocellular carcinoma with and without cirrhosis. A comparison in southern African blacks.
Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters.
Hepatocellular carcinoma. A comparison of Oriental and Caucasian patients.
Hepatocellular carcinoma. A retrospective analysis of treatments to manage disease confined to the liver.
Hepatocellular dysplasia: immunohistochemical and morphometrical evaluation.
Hepatoid adenocarcinoma of the stomach with liver metastasis mimicking hepatocellular carcinoma: a case report.
High burden of hepatocellular carcinoma and viral hepatitis in Southern and Central Vietnam: Experience of a large tertiary referral center, 2010 to 2016.
High-powered microwave ablation of larger hepatocellular carcinoma: evaluation of recurrence rate and factors related to recurrence.
Higher Ratio of Serum Alpha-Fetoprotein Could Predict Outcomes in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma and Normal Alanine Aminotransferase.
HLA antigen in Chinese patients with hepatocellular carcinomas.
Icaritin inhibits the expression of alpha-fetoprotein in hepatitis B virus-infected hepatoma cell lines through post-transcriptional regulation.
Immune therapy for hepatocellular carcinoma.
Immunocytochemical evaluation of liver fine-needle aspirations.
Immunohistochemical characterization of 130 cases of primary hepatic carcinomas.
Impact of hepatologists to extend survival of hepatocellular carcinoma patients with cirrhosis: a comparison with non-hepatologists.
Impact of radiofrequency ablation on the management of patients with hepatocellular carcinoma in a specialized centre.
Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma.
Influence of Alanine Transaminase Levels on Alpha-Fetoprotein for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Infection.
Inhibition of human hepatocellular carcinoma and hepatoblastoma cell lines by deferoxamine.
Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma.
Intrahepatic mass-forming cholangiocarcinoma growing in a giant hepatic hemangioma: A case report.
Is anti-HBc IgM a useful clinical test in patients with HBsAg-positive chronic hepatitis or primary hepatocellular carcinoma?
Is the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection?
Is there a sex difference in postoperative prognosis of hepatocellular carcinoma?
Lactate Dehydrogenase Is an Important Prognostic Indicator for Hepatocellular Carcinoma after Partial Hepatectomy.
Laparoscopic Right Hemihepatectomy for Hepatocellular Carcinoma.
Late development of hepatocellular carcinoma after viral clearance in patients with chronic hepatitis C: A need for continual surveillance.
LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma.
Liver adenoma and focal nodular hyperplasia associated with oral contraceptives.
Liver cell dysplasia in cirrhosis. A serologic and immunohistochemical study.
Liver lesions detected in a hepatitis B core total antibody-positive patient masquerading as hepatocellular carcinoma: a rare case of peliosis hepatis and a review of the literature.
Liver resection for hepatocellular carcinoma in octogenarians.
Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinoma.
Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy.
Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus-related hepatocellular carcinoma metastasis through the upregulation of ADAM9.
LSA--a new liver-specific antigen in the rat. II: Immunological and biological properties.
Lymphoma-like presentation of hepatocellular carcinoma.
Management of hepatocellular carcinoma.
Marked episodic elevations of alpha-fetoprotein without hepatocellular carcinoma in a patient with hepatitis B.
Measurement of Cyclin D2 (CCND2) Gene Promoter Methylation in Plasma and Peripheral Blood Mononuclear Cells and Alpha-Fetoprotein Levels in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Metabolomic Profiles for HBV Related Hepatocellular Carcinoma Including Alpha-Fetoproteins Positive and Negative Subtypes.
Metastasis of hepatocellular carcinoma to Virchow's node: have the tumor cells gone astray?
Metastatic Spinal Cord Compression Secondary to Liver Cancer.
MicroRNA-421 mediates immunosensitivity in late-stage human liver cancer.
Microsatellite alterations in human hepatocellular carcinoma infected with hepatitis B virus: associated with the elevation of serum alpha-fetoprotein.
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers.
Natural history of chronic hepatitis B virus infection in children of different ethnic origins: a cohort study with up to 12 years' follow-up in northern Greece.
Natural history of compensated cirrhosis in the Child-Pugh class a compared between 490 patients with hepatitis C and 167 with B virus infections.
Neither diabetes mellitus nor overweight is a risk factor for hepatocellular carcinoma in a dual HBV and HCV endemic area: community cross-sectional and case-control studies.
Occurrence of oval-type cells in hepatitis B virus-associated human hepatocarcinogenesis.
Orthotopic implantation of human hepatocellular carcinoma in mice: analysis of tumor progression and establishment of the BCLC-9 cell line.
Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma.
Overexpression of p53 in hepatocellular carcinomas: a clinicopathological and prognostic correlation.
Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients.
Pale bodies in hepatocellular carcinoma.
PARP-1 serves as a novel molecular marker for hepatocellular carcinoma in a Southern Chinese Zhuang population.
Pathologic features and patient survival in hepatocellular carcinoma in relation to age.
Patterns of antigen expression in hepatoblastoma and hepatocellular carcinoma in childhood.
Phenotypic characterization of hepatic proliferation. Antigenic expression by proliferating epithelial cells in fetal liver, massive hepatic necrosis, and nodular transformation of the liver.
PLC/PRF/5 (Alexander) hepatoma cell line: further characterization and studies of infectivity.
PLZF and PLZF-MAPK10 can predict the prognosis of postoperative patients with hepatocellular carcinoma.
Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation.
Predictive Role of AURKA rs 1047972 Gene Polymorphism and the Risk of Development of Hepatocellular Carcinoma.
Predictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis B virus infection - Results from a clinic-based longitudinal cohort.
Prenatal screening.
Preoperative prediction of poorly differentiated components in small-sized hepatocellular carcinoma for safe local ablation therapy.
Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT.
Primary carcinoma of the liver.
Prognostic and clinicopathologic significance of SIRT1 expression in hepatocellular carcinoma.
Prognostic and clinicopathological significance of PD-1 expression in hepatocellular carcinoma: a meta-analysis.
Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Identification of two groups of patients with prospects for prolonged survival.
Prognostic features and survival of hepatocellular carcinoma in Italy: impact of stage of disease.
Prognostic features and survival of inoperable hepatocellular carcinoma in Turkish patients with cirrhosis.
Prognostic Values of alpha-fetoprotein and Protein Induced by Vitamin K Absence or Antagonist-II in Hepatitis B Virus-related Hepatocellular Carcinoma: A Prospective Study.
Radical resection of hepatic polycystic echinococcosis complicated with hepatocellular carcinoma: A case report.
Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome.
Raman based hepatocellular carcinoma biomarker detection.
Rapid determination of serological cytokine biomarkers for hepatitis B virus-related hepatocellular carcinoma using antibody microarrays.
RASSF2A promoter methylation in hepatitis B virus-related hepatocellular carcinogenesis and its correlation with elevated serum alpha-fetoprotein level.
Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Recombinant DNA and the liver: studies with albumin, alpha-fetoprotein, hepatitis B virus, and other DNA probes.
Regenerative nodule mimicking hepatocellular carcinoma in a cirrhotic child due to hepatitis B: an imaging dilemma.
Regional prevalence of hepatitis B, delta, and human immunodeficiency virus infection in southern Africa: a large population survey.
Relationship between polymorphism of angiotensin-converting enzyme gene insertion/deletion and risk of hepatocellular carcinoma in a Chinese Dai population.
Relationship of hepatitis B surface antigen to serum alpha-fetoprotein in nonmalignant diseases of the liver.
Relationship of serum alpha-fetoprotein to circulating immune complexes and complements in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.
Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection.
Risk factors for recurrence of large HCC in patients treated by combined TAE and PEI.
Role of monocyte-to-lymphocyte ratio in predicting sorafenib response in patients with advanced hepatocellular carcinoma.
Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population.
Screening for hepatocellular carcinoma.
Serological markers of hepatitis B virus and alpha-fetoprotein levels preceding primary hepatocellular carcinoma in Alaskan Eskimos.
Serum alpha-fetoprotein and hepatitis B antigen in subjects with hepatoma in south India.
Serum alpha-fetoprotein level is higher in hepatitis C than hepatitis B infected chronic liver disease patients.
Serum alpha-fetoprotein levels and microheterogeneity in patients with different liver diseases.
Serum alpha-fetoprotein may have a significant role in the surveillance of hepatocellular carcinoma in hepatitis B endemic areas.
Serum peptide pattern differentially diagnoses Hepatitis B Virus-related hepatocellular carcinoma from liver cirrhosis.
Small and asymptomatic hepatocellular carcinoma detected by alpha-fetoprotein screening in black hepatitis B carriers. A report of 2 cases.
Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma.
Specific activation of sodium iodide symporter gene in hepatoma using alpha-fetoprotein promoter combined with hepatitis B virus enhancer (EIIAPA).
Spontaneous hepatic rupture due to metastatic tumor of lung adenocarcinoma.
Spontaneous regression of hepatocellular carcinoma.
Stratified alpha-fetoprotein pattern accurately predicts mortality in patients with acute-on-chronic hepatitis B liver failure.
Subclinical hepatocellular carcinoma: an analysis of 391 patients.
Suppression of the tumorigenicity of human hepatoma hep3B cells by long-term retinoic acid treatment.
Surgical and nonsurgical management of primary and metastatic liver tumors.
Surgical resection for small hepatocellular carcinoma.
Surgical treatment of 109 patients with symptomatic and asymptomatic hepatocellular carcinoma.
Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
Target cell populations in virus-associated hepatocarcinogenesis.
The acute phase protein alpha-1-antitrypsin inhibits transferrin uptake in PLC/PRF/5 cells and increases release of hepatitis B virus surface antigen and alpha-fetoprotein.
The development of cirrhosis in patients with chronic type B hepatitis: a prospective study.
The efficacy of the immunoperoxidase technique for the detection of several antigens after destaining of stored stained sections.
The EIIAPA Chimeric Promoter for Tumor Specific Gene Therapy of Hepatoma.
The Intention-to-Treat Effect of Bridging Treatments in the Setting of Milan Criteria-In Patients Waiting for Liver Transplantation.
The presence of hepatitis B surface antigen and deoxyribonucleic acid in amniotic fluid and cord blood.
The prognosis in cases of hepatocellular carcinoma after hepatectomy: young patients versus older patients.
The Prognostic Role of Mitotic Index in Hepatocellular Carcinoma Patients after Curative Hepatectomy.
The role of circulating microRNAs for the diagnosis of hepatitis B virus-associated hepatocellular carcinoma with low alpha-fetoprotein level: a systematic review and meta-analysis.
The X-gene of human hepatitis B virus transactivates the c-jun and alpha-fetoprotein genes.
Tissue antigen distribution in hepatocellular carcinoma.
TOP2A Amplification and Overexpression in Hepatocellular Carcinoma Tissues.
Transactivation of human alpha-fetoprotein gene by X-gene product of hepatitis B virus in human hepatoma cells.
Tumorigenicity and transcriptional modulation of c-myc and N-ras oncogenes in a human hepatoma cell line.
Tumorigenicity in nude mice of a human hepatoma cell line containing hepatitis B virus DNA.
Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan.
Up-regulation of BRCA1-associated RING Domain 1 Promotes Hepatocellular Carcinoma Progression by Targeting Akt Signaling.
Upregulation of colonic and hepatic tumor overexpressed gene is significantly associated with the unfavorable prognosis marker of human hepatocellular carcinoma.
Use of Cytokeratin-19 Concentration to Assess Early Recurrence and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma following Radical Resection in Patients with a Low Serum Alpha-Fetoprotein Concentration.
Value of hepatic blood flow study in the diagnosis of hepatoma.
[A randomized controlled trial on 240-week monotherapy with entecavir or adefovir in patients with chronic hepatitis B and cirrhosis].
[Analysis on influencing factors that leading to nonspecific responses to indeterminate results of HIV antibodies].
[Community-based hepatocellular carcinoma screening in seven townships in Taiwan]
[Expression and clinical significance of hepatocellular cancer antigen genes in human hepatocellular carcinoma]
[Expression of ATAD2 in different liver lesions and its clinical significance].
[Expression of MAGE-B genes in hepatocellular carcinoma]
[Hepatitis B antigen and alpha-fetoprotein in hepatoma in Taiwan]
[Hepatocellular carcinoma]
[Importance of carcinoembryonic antigen, alpha-fetoprotein and cholylglycine in differential diagnosis of viral hepatitis B and mechanical jaundice]
[Pathology of hepatocellular carcinoma]
[Serum alpha-fetoprotein and hepatitis B surface antigen in patients with hepatocellular carcinoma (author's transl)]
[The therapeutic value of alpha-fetoprotein and cholinesterase in patients with hepatitis B virus related acute onset chronic liver failure].
[Value of serum alpha-fetoprotein for the prognostic evaluation of hepatitis B virus-related acute-on-chronic liver failure treated with artificial liver].
[Variable clinical symptoms of hepatocellular carcinoma]
Hepatitis B, Chronic
Alpha-fetoprotein and its concanavalin A affinity in acute exacerbation of chronic hepatitis B.
Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B.
Alpha-fetoprotein level as a biomarker of liver fibrosis status: a cross-sectional study of 619 consecutive patients with chronic hepatitis B.
alpha-Fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma.
Alpha-fetoprotein-producing pancreatic acinar cell carcinoma.
Clinical Value Evaluation of microRNA-324-3p and Other Available Biomarkers in Patients With HBV Infection-Related Hepatocellular Carcinoma.
Clinico-Radio-Pathological and Molecular Features of Hepatocellular Carcinomas with Keratin 19 Expression.
Correlation between clinical indication for treatment and liver histology in HBeAg-negative chronic hepatitis B: a novel role of alpha-fetoprotein.
Decreasing serum alpha-fetoprotein levels in predicting poor prognosis of acute hepatic failure in patients with chronic hepatitis B.
Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma.
Dramatic reduction of the alpha-fetoprotein level after lamivudine treatment of patients with chronic hepatitis B virus infection and cirrhosis.
Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.
Effect of antiviral treatment on alfa-fetoprotein levels in HBV-related cirrhotic patients: early detection of hepatocellular carcinoma.
Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study.
Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B.
Evaluation of serum matrix metalloproteinase (MMP)-9 to MMP-2 ratio as a biomarker in hepatocellular carcinoma.
Extremely elevated alpha-fetoprotein due to acute exacerbation of chronic hepatitis B without malignancy: a case report.
Hepatocellular carcinoma with right atrial extension in a young patient with congenitally unguarded tricuspid orifice.
Impact of alpha-fetoprotein on hepatocellular carcinoma development during entecavir treatment of chronic hepatitis B virus infection.
Intrahepatic bile duct adenoma in a patient with chronic hepatitis B accompanied by elevation of alpha-fetoprotein.
Monitoring of serum alpha-fetoprotein levels in children with chronic hepatitis B virus infection.
On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir.
Optimizing Surveillance Performance of Alpha-Fetoprotein by Selection of Proper Target Population in Chronic Hepatitis B.
Oral antiviral therapy improves the diagnostic accuracy of alpha-fetoprotein levels in patients with chronic hepatitis B.
Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis.
Persistently elevated alpha-fetoprotein associated with chronic hepatitis B during chemotherapy for malignant ovarian germ cell tumors: a case series and a review of the literature.
Primary cultures of aspiration residual specimens predict outcomes of hepatocellular carcinoma patients receiving curative treatment.
Response of serum alpha-fetoprotein to entecavir therapy predicts risk for hepatocellular carcinoma in patients with chronic hepatitis B.
Screening for hepatocellular carcinoma.
Serum miR-375 Levels Are Closely Related to Disease Progression from HBV Infection to HBV-Related Hepatocellular Carcinoma.
Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis.
What is the best surveillance for hepatocellular carcinoma in chronic carriers of hepatitis B?
Hepatitis C
A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis.
Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus.
Alpha-fetoprotein and highly active antiretroviral therapy in patients coinfected with HIV-1 and hepatitis C virus.
Alpha-fetoprotein and p53 autoantibodies in patients with chronic hepatitis C.
An aged male patient with autoimmune hepatitis complicated by hepatocellular carcinoma.
Anti-p53 autoantibodies in hepatitis C virus-infected patients.
Assessment of hepatic fibrosis by fibroscan in egyptian chronic hemodialysis patients with chronic Hepatitis C (genotype 4): A single-center study.
Case report: multiple cancers: hepatocellular carcinoma and adenocarcinomas of the common bile duct and the gall-bladder in a woman with primary biliary cirrhosis.
Characteristics of hepatocellular carcinoma in hemodialysis patients in hepatitis B endemic area.
Chronological change in alpha-fetoprotein levels in hepatocellular carcinoma after eradication of hepatitis C virus.
Clinical and contrast-enhanced image features in the prediction model for the detection of small hepatocellular carcinomas.
Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II.
Clinical implication of hypovascular hepatocellular carcinoma studied in 4,474 patients with solitary tumour equal or less than 3 cm.
Clinical significance of elevated alpha-fetoprotein (AFP) in chronic hepatitis C without hepatocellular carcinoma.
Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM versus alpha-fetoprotein in Egyptian patients with hepatitis C virus-induced hepatocellular carcinoma.
Clinicopathologic features and factors related to survival of patients with small hepatocellular carcinoma after hepatic resection.
Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Clinicopathological features and surgical outcome of patients with fibrolamellar hepatocellular carcinoma (experience with 22 patients over a 15-year period).
Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features.
Combined treatment of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates hepatic dysplastic nodule in a patient with liver cirrhosis.
Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis C virus infection receiving interferon therapy: a single center study.
Decrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals.
Developing a prediction rule to assess hepatic malignancy in patients with cirrhosis.
Development of a novel panel based on micro-RNAs (21, 29a, 200 and 335) and alpha-fetoprotein as diagnostic biomarkers for hepatocellular carcinoma associated with hepatitis C infection.
Development of hepatocellular carcinoma after successful management of esophageal variceal bleeding.
Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.
Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study.
Efficacy of on-demand intrahepatic arterial therapy in combination with sorafenib for advanced hepatocellular carcinoma.
Endoscopic prediction of hepatocellular carcinoma by evaluation of bleeding esophageal varices.
Enlarged focal nodular hyperplasia of the liver under the influence of oral contraceptives.
Evaluation of circulating Transforming growth factor-beta1, Glypican-3 and Golgi protein-73 mRNAs expression as predictive markers for hepatocellular carcinoma in Egyptian patients.
Evaluation of serum PIVKA-II and MIF as diagnostic markers for HCV/HBV induced hepatocellular carcinoma.
Expression of cancer-testis antigens in hepatocellular carcinoma.
Expression signature of lysosomal-associated transmembrane protein 4B in hepatitis C virus-induced hepatocellular carcinoma.
Fibrolamellar hepatocellular carcinoma in a Japanese man: report of a case.
Focal nodular hyperplasia of the liver without central scar.
Frequency of deaths in hepatitis C virus infected hepatocellular carcinoma patients and its relationship with raised serum alpha-fetoprotein levels.
Frequency of raised alpha-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C.
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study.
Hepatocellular carcinoma associated with anabolic steroid therapy: report of a case and review of the Japanese literature.
Hepatocellular carcinoma with a central scar and a scalloped tumor margin resembling focal nodular hyperplasia in macroscopic appearance.
Hepatocellular carcinoma with a tumour thrombus extending to the tricuspid valve: report of a successful en bloc resection.
High burden of hepatocellular carcinoma and viral hepatitis in Southern and Central Vietnam: Experience of a large tertiary referral center, 2010 to 2016.
Improving the Detection of Hepatocellular Carcinoma Using Serum AFP Expression in Combination with GPC3 and Micro-RNA MiR-122 Expression.
Inhibition of hepatocellular carcinoma by PegIFN?-2a in patients with chronic hepatitis C: a nationwide multicenter cooperative study.
Is the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection?
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis.
Liver adenoma and focal nodular hyperplasia associated with oral contraceptives.
Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinoma.
Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy.
Measurement of tumor markers in chronic hemodialysis patients.
Metastatic neuroendocrine pancreatic tumor - Case report.
Natural History of Incidental Enhancing Nodules on Cone-Beam Computed Tomography during Transarterial Therapy of Hepatocellular Carcinoma.
Patient and tumour biology predict survival beyond the Milan criteria in liver transplantation for hepatocellular carcinoma.
Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patients.
Polymer adhesive surface as flexible generic platform for multiplexed assays biochip production.
Predictive Role of AURKA rs 1047972 Gene Polymorphism and the Risk of Development of Hepatocellular Carcinoma.
Preoperative prediction of poorly differentiated components in small-sized hepatocellular carcinoma for safe local ablation therapy.
Prognostic factors in patients with HBV-related hepatocellular carcinoma following hepatic resection.
Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization.
Prognostic significance of E-cadherin expression in hepatocellular carcinoma: correlations with clinical features.
Prognostic Values of Alpha-Fetoprotein and Des-Gamma-Carboxyprothrombin in Hepatocellular Carcinoma in China: An Analysis of 4792 Patients.
Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis.
Raman based hepatocellular carcinoma biomarker detection.
Resolution of ascites and hepatic encephalopathy and absence of variceal bleeding in decompensated hepatitis C virus cirrhosis patients.
Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection.
Risk factors for recurrence of large HCC in patients treated by combined TAE and PEI.
Role of interleukin-8 and oxidative stress in patients with hepatocellular carcinoma.
Serum Alpha-Fetoprotein Has High Specificity for the Early Detection of Hepatocellular Carcinoma After Hepatitis C Virus Eradication in Patients.
Serum alpha-fetoprotein level is higher in hepatitis C than hepatitis B infected chronic liver disease patients.
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.
Serum alpha-fetoprotein predicts virologic response to hepatitis C treatment in HIV coinfected patients.
Signification of Serum Alpha-Fetoprotein Levels in Cases of Compensated Cirrhosis and Hepatitis C Virus without Hepatocellular Carcinoma.
Substitution of amino acid 70 in the hepatitis C virus core region of genotype 1b is an important predictor of elevated alpha-fetoprotein in patients without hepatocellular carcinoma.
Surgical and nonsurgical management of primary and metastatic liver tumors.
Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis.
The efficacy of immune checkpoint inhibitors in advanced hepatocellular carcinoma: a meta-analysis based on 40 cohorts incorporating 3697 individuals.
The Intention-to-Treat Effect of Bridging Treatments in the Setting of Milan Criteria-In Patients Waiting for Liver Transplantation.
The low positive rate of serum alpha-fetoprotein levels in hepatitis C virus antibody-positive patients with hepatocellular carcinoma.
The Prognostic Correlation of Heart Rate Variability at Diagnosis with Survival of Patients with Hepatocellular Carcinoma.
Toll-like receptor 7 mRNA is reduced in hepatitis C-based liver cirrhosis and hepatocellular carcinoma, out-performs alpha-fetoprotein levels, and with age and serum aspartate aminotransferase is a new diagnostic index.
Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan.
Usefulness of tumor pressure as a prognostic factor in cases of hepatocellular carcinoma where the diameter of the tumor is 3 cm or less.
Volumetric parameters on FDG PET can predict early intrahepatic recurrence-free survival in patients with hepatocellular carcinoma after curative surgical resection.
[Application of alpha-fetoprotein and osteopontin combination for early diagnosis of hepatocellular carcinoma associated with hepatitis C.]
[Clinical and etiologic features of hepatocarcinoma in Sicily]
[Community-based hepatocellular carcinoma screening in seven townships in Taiwan]
[Expression and clinical significance of hepatocellular cancer antigen genes in human hepatocellular carcinoma]
[Expression of MAGE-B genes in hepatocellular carcinoma]
[Serum alpha-fetoprotein levels in pregnant women with indeterminate result of anti hepatitis C virus antibodies analysis].
[Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without hcc development]
Hepatitis C, Chronic
A 70-year-old woman with 10 years of markedly elevated alpha-fetoprotein measurements.
A case of an alpha-fetoprotein-producing intrahepatic cholangiocarcinoma suggests probable cancer stem cell origin.
Alpha-fetoprotein (AFP)- and des-gamma-carboxy prothrombin (DCP)-producing adenocarcinoma of the stomach with liver metastasis in a patient with chronic hepatitis C.
Alpha-fetoprotein and p53 autoantibodies in patients with chronic hepatitis C.
Alpha-fetoprotein in chronic hepatitis C.
Chronic hepatitis C and markedly elevated serum alpha-fetoprotein: complete response to treatment with alpha-interferon.
Clinical course of chronic hepatitis C in patients with very high serum alpha-fetoprotein levels and normal hepatic imaging.
Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II.
Clinical Implications of Alpha-fetoprotein in Chronic Hepatitis C.
Clinical significance of elevated alpha-fetoprotein (AFP) in chronic hepatitis C without hepatocellular carcinoma.
Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma.
Clinical significance of elevated alpha-fetoprotein in Alaskan Native patients with chronic hepatitis C.
Clinical, virologic, and pathologic significance of elevated serum alpha-fetoprotein levels in patients with chronic hepatitis C.
Direct-acting antiviral-based triple therapy on alpha-fetoprotein level in chronic hepatitis C patients.
Efficacy of low dose long-term interferon monotherapy in aged patients with chronic hepatitis C genotype 1 and its relation to alpha-fetoprotein: A pilot study.
Evaluation of Serum Alpha-Fetoprotein Level in Chronic Hepatitis C Patients.
Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment.
Hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis in Denmark: A nationwide cohort study.
Hepatocyte proliferation in chronic hepatitis C: correlation with degree of liver disease and serum alpha-fetoprotein.
Improved Serum Alpha-Fetoprotein Levels after Iron Reduction Therapy in HCV Patients.
Marked reduction of the alpha-fetoprotein levels among individuals with chronic hepatitis C, following PEG-interferon and ribavirin treatment.
Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
Primary cultures of aspiration residual specimens predict outcomes of hepatocellular carcinoma patients receiving curative treatment.
Rapidly growing hepatocellular carcinoma recurrence during direct-acting antiviral treatment for chronic hepatitis C.
Serum Adiponectin, Vitamin D, and Alpha-Fetoprotein in Children with Chronic Hepatitis C: Can They Predict Treatment Response?
Serum alpha-fetoprotein levels and liver histology in patients with chronic hepatitis C.
Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients with Chronic Hepatitis C: real-world results from 1716 patients in Egypt.
Serum Alpha-Fetoprotein Levels During and After Interferon Therapy and the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C.
Serum alpha-fetoprotein levels in patients with chronic hepatitis C. Relationships with serum alanine aminotransferase values, histologic activity index, and hepatocyte MIB-1 scores.
Serum alpha-fetoprotein levels predict early virologic response in HIV-positive subjects treated for chronic hepatitis C.
Serum alpha-fetoprotein predicts treatment outcome in chronic hepatitis C patients regardless of HCV genotype.
Spontaneous regression of a large hepatocellular carcinoma with portal vein tumor thrombi: report of a case.
Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinoma.
[Application of alpha-fetoprotein and osteopontin combination for early diagnosis of hepatocellular carcinoma associated with hepatitis C.]
[The laboratory evaluation of dynamics of progression of liver fibrosis under chronic hepatitis].
Hepatitis D
Antigenic markers of hepatocellular carcinoma.
Isolation of Human Fetal Liver Progenitors and Their Enhanced Proliferation by Three-Dimensional Coculture with Endothelial Cells.
Isolation of human fetal liver progenitors and their enhanced proliferation by three-dimensional coculture with endothelial cells.
Regional prevalence of hepatitis B, delta, and human immunodeficiency virus infection in southern Africa: a large population survey.
Hepatitis, Alcoholic
Human hepatocyte growth factor in alcoholic liver disease: a comparison with change in alpha-fetoprotein. Department of Veterans Affairs Cooperative Study Group 275.
Presence of serum alpha-1-fetoprotein in alcoholic hepatitis.
Hepatitis, Autoimmune
Autoimmune hepatitis with raised alpha-fetoprotein level as the presenting symptoms of systemic lupus erythematosus: a case report.
Increase of fucosylated alpha-fetoprotein fraction at the onset of autoimmune hepatitis and acute liver failure.
Two patients with extremely elevated tumor markers: where is the malignancy?
Hepatitis, Chronic
Alpha-fetoprotein and its concanavalin A affinity in acute exacerbation of chronic hepatitis B.
Alpha-fetoprotein and tissue polypeptide antigen in non neoplastic hepatic disorders.
Alpha-fetoprotein changes in the course of chronic hepatitis: relation to bridging hepatic necrosis and hepatocellular carcinoma.
Alpha-fetoprotein in hepatic pathology and hepatocarcinoma.
alpha-Fetoprotein in liver disease.
Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand.
Anti-p53 autoantibodies in hepatitis C virus-infected patients.
Chromogranin A (CgA) serum level as a marker of progression in hepatocellular carcinoma (HCC) of elderly patients.
Cryptic epitopes on alpha-fetoprotein induce spontaneous immune responses in hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis patients.
Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma.
Dramatic reduction of the alpha-fetoprotein level after lamivudine treatment of patients with chronic hepatitis B virus infection and cirrhosis.
Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study.
Evaluation of tumor markers for the detection of hepatocellular carcinoma in Yangon General Hospital, Myanmar.
Fibrolamellar carcinoma of the liver in the Orient.
Fibrolamellar variant of hepatocellular carcinoma presenting during pregnancy: management dilemmas.
Frequency and significance of serum alpha-fetoprotein elevation in severe hepatitis B surface antigen-negative chronic active hepatitis.
Hepatocellular carcinoma in HBsAg-negative chronic active hepatitis.
Hepatocellular carcinoma with a sarcomatous appearance: report of a case.
High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity.
Immunoelectron microscopic observation of alpha-fetoprotein synthesis in human non-malignant liver tissues using immunoperoxidase methods.
Improvement of liver cancer detection with simultaneous assessment of circulating levels of free alpha-fetoprotein (AFP) and AFP-IgM complexes.
Increase of fucosylated serum cholinesterase in relation to high risk groups for hepatocellular carcinomas.
Is anti-HBc IgM a useful clinical test in patients with HBsAg-positive chronic hepatitis or primary hepatocellular carcinoma?
Lectin-reactive patterns of markedly elevated serum alpha-fetoprotein in patients with chronic active hepatitis.
Liver cancer and its prevention.
Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity.
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers.
Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis.
Persistence of circulating complexes between HBsAg and immunoglobulin M in sera of hepatitis B surface antigen positive patients suffering from liver cirrhosis or primary liver cancer.
Post-radiation survival time in hepatocellular carcinoma based on predictors for CT-determined, transarterial embolization and various other parameters.
Predicting clinical outcomes in patients with HBsAg-positive chronic hepatitis.
Report of hereditary persistence of alpha-fetoprotein in a Spanish family: molecular basis and clinical concerns.
Risk factors for hepatocellular carcinoma among patients with chronic liver disease.
Screening for hepatocellular carcinoma.
Secreted ERBB3 isoforms are serum markers for early hepatoma in patients with chronic hepatitis and cirrhosis.
Sensitive detection of human telomerase reverse transcriptase mRNA in the serum of patients with hepatocellular carcinoma.
Sensitive measurement of serum abnormal prothrombin (PIVKA-II) as a marker of hepatocellular carcinoma.
Serum alpha-fetoprotein (AFP) in benign and malignant gastrointestinal diseases: evaluation of an immunoenzymatic assay.
Serum Alpha-Fetoprotein Has High Specificity for the Early Detection of Hepatocellular Carcinoma After Hepatitis C Virus Eradication in Patients.
Serum alpha-fetoprotein in viral hepatitis and its complications.
Serum alpha-fetoprotein subfractions identified by Ricinus communis agglutinin I in hepatic malignancies, yolk sac tumor, benign hepatic diseases, and fetal stage.
Serum alpha-L-fucosidase. A more sensitive marker for hepatocellular carcinoma?
Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma.
Serum N-acetylglucosaminyltransferase III activities in hepatocellular carcinoma.
Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
Specificities of serum alpha-fetoprotein in HBsAg+ and HBsAg- patients in the diagnosis of hepatocellular carcinoma.
Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer.
Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma.
The use of tissue polypeptide specific antigen as a marker in liver diseases.
Unsuspected primary malignancy in the setting of elevated serum alpha-fetoprotein.
Usefulness of the novel oncofetal antigen glypican-3 for diagnosis of hepatocellular carcinoma and melanoma.
[A case of hepatocellular carcinoma with survival of more than 7 years after extended right lobectomy]
[Hepatitis viruses and development of hepatocellular carcinoma]
[Long-term course in asymptomatic carriers of HBsAg in an area of low prevalence of hepatocarcinoma]
[M2-type pyruvate kinase in the diagnosis of hepatocarcinoma--a pilot study]
[Occurrence of increased alpha-fetoprotein in non-neoplastic hepatopathies of alcoholic or non-alcoholic origin]
[The clinical significance of PIVKA-II determination in patients with hepatocellular carcinoma: a comparative study with alpha-fetoprotein]
[The diagnostic potentialities of determining alpha-fetoprotein in the blood of patients with mucoviscidosis]
Hepatoblastoma
A case of well-differentiated, fetal-type hepatoblastoma with very low serum alpha-fetoprotein.
A Novel Method for Observing Tumor Margin in Hepatoblastoma Based on Microstructure 3D Reconstruction.
A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a Children's Oncology Group study.
Alpha-fetoprotein (AFP) levels in normal children.
An immunohistochemical study of hepatoblastoma producing human chorionic gonadotropin.
Ante situm liver resection with inferior vena cava replacement under hypothermic cardiopolmunary bypass for hepatoblastoma: Report of a case and review of the literature.
Antitumor effect of hepatocyte growth factor on hepatoblastoma.
Appropriate Management of Attenuated Familial Adenomatous Polyposis: Report of a Case and Review of the Literature.
Can we predict the prognosis of resectable hepatoblastoma from serum alpha-fetoprotein response during preoperative chemotherapy?
Chromosome aberrations in an alpha-fetoprotein-producing hepatoblastoma.
Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma.
Cost-effectiveness Analysis of Screening Extremely Low Birth Weight Children for Hepatoblastoma Using Serum Alpha-fetoprotein.
Defining an optimal time window to screen for hepatoblastoma in children with Beckwith-Wiedemann syndrome.
Defining hepatoblastoma responsiveness to induction therapy as measured by tumor volume and serum alpha-fetoprotein kinetics.
Diagnostic value of lectin reactive alpha-fetoprotein for neoinfantile hepatic tumors and malignant germ cell tumors: preliminary study.
Diffuse infantile hepatic hemangiomas in a patient with Beckwith-Wiedemann syndrome: A new association?
Distribution of alpha-fetoprotein and immunoreactive carcinoembryonic antigen in human hepatocellular carcinoma and hepatoblastoma.
Effect of postoperative chemotherapy on the serum alpha-fetoprotein level in hepatoblastoma.
Effects of chemotherapeutic agents on alpha-fetoprotein secretion and growth of human hepatoma cell lines in vitro.
Elevated maternal serum ?-fetoprotein level in a fetus with Beckwith-Wiedemann syndrome in the second trimester of pregnancy.
Enzymatic basis of sugar structures of alpha-fetoprotein in hepatoma and hepatoblastoma cell lines: correlation with activities of alpha 1-6 fucosyltransferase and N-acetylglucosaminyltransferases III and V.
Establishment of a cell line and its clonal sublines from a patient with hepatoblastoma.
Establishment of a human hepatoblastoma model in athymic nude mice. Producibility of fatty acid-binding protein, alpha-fetoprotein, and alpha 1-acid glycoprotein.
Establishment of an experimental model of human hepatoblastoma.
Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas.
Extremely elevated alpha-fetoprotein due to acute exacerbation of chronic hepatitis B without malignancy: a case report.
Fetal and neonatal hepatic tumors.
Half-life of alpha-fetoprotein in patients with a teratoma, endodermal sinus tumor, or hepatoblastoma.
Hepatoblastoma associated with Beckwith-Wiedemann syndrome and hemihypertrophy.
Hepatoblastoma presenting as precocious puberty: a case report.
Hepatoblastoma producing both alpha-fetoprotein and human chorionic gonadotropin. Clinicopathologic analysis of four cases and a review of the literature.
Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: The SIOPEL group experience.
Hepatoblastoma with erythrocytosis in a young female horse.
Hepatoblastoma with Precocious Puberty.
Hepatoblastoma: an immunohistochemical and ultrastructural study.
Hormonal control of alpha-fetoprotein secretion in human hepatoma cell lines proliferating in chemically defined medium.
Immunocytochemical identification of human chorionic gonadotropin- and alpha-fetoprotein-producing cells of hepatoblastoma associated with precocious puberty.
Immunofluorescent demonstration of alpha- fetoprotein and other plasma proteins in yolk sac tumor.
Immunoscintigraphy of xenotransplanted hepatoblastoma with iodine 131-labeled anti-alpha-fetoprotein monoclonal antibody.
Infantile hemangioendothelioma with a highly elevated serum alpha-fetoprotein level.
Infantile hepatic hemangioendothelioma with elevated serum alpha-fetoprotein.
Intrahepatic hematoma: hepatic lesion in a newborn with high alpha-fetoprotein level.
Irinotecan as maintenance therapy in high-risk hepatoblastoma.
Liver Transplant for Posthepatectomy Liver Failure in Hepatoblastoma.
Longitudinal Monitoring of Alpha-Fetoprotein by Dried Blood Spot for Hepatoblastoma Screening in Beckwith?Wiedemann Syndrome.
Malignant hepatic tumor occurring 10 yrs after a histocompatible sibling donor bone marrow transplantation for severe aplastic anemia.
Mesenchymal hamartoma of the liver associated with features of Beckwith-Wiedemann syndrome and high serum alpha-fetoprotein levels.
Mouse hepatoblastomas: a histologic, ultrastructural, and immunohistochemical study.
Neonatal hepatoblastoma in a newborn with severe phenotype of Beckwith-Wiedemann syndrome.
Neuroendocrine differentiation in hepatoblastoma. An immunohistochemical investigation.
Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group.
Prognostic factors and staging systems in childhood hepatoblastoma.
Prognostic implications of serum alpha-fetoprotein response during treatment of hepatoblastoma.
Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma.
Purification and characterization of Alpha-Fetoprotein from the human hepatoblastoma HepG2 cell line in serum-free medium.
Rapid decrease of serum alpha-fetoprotein and tumor volume predicts outcome in children with hepatoblastoma treated with neoadjuvant chemotherapy.
Recurrent hepatoblastoma with localization by PET-CT.
Semiquantification of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction.
Serum Alpha-Fetoprotein Concentrations in Extremely-Low-Birth-Weight Infants.
Serum alpha-fetoprotein levels in neonatal cholestasis.
Serum alpha-fetoprotein screening for hepatoblastoma in Beckwith-Wiedemann syndrome.
Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolated hemihyperplasia.
Serum vascular endothelial growth factor as a significant marker of treatment response in pediatric malignancies.
Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss.
Strategy for hepatoblastoma management: Transplant versus nontransplant surgery.
Subcutaneous and intrahepatic growth of human hepatoblastoma in immunodeficient mice.
The ratio of fucosylation of alpha-fetoprotein in hepatoblastoma.
The significance of alpha-fetoprotein and other tumour markers in differential immunocytochemistry of primary liver tumours.
The utility of alpha-fetoprotein screening in Beckwith-Wiedemann syndrome.
Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group.
Tl-201 positive, Ga-67 negative hepatoblastoma: a case report of a 12-year-old boy.
Treatment of alpha-fetoprotein secreting hepatoblastoma by response of serum alpha-fetoprotein levels: a new concept.
Variable antigen expression in hepatoblastomas.
[Hepatoblastoma cells producing alpha-fetoprotein: morphometric, immunohistochemical and electron microscopic studies]
[Mouse hepatoblastoma: comparative aspects]
[Pediatric liver tumor: What to do?].
[The modulation of the phenotype of the human hepatoblastoma cell line HepG2 under the action of dimethyl sulfoxide]
Hepatomegaly
Diffuse infantile hepatic hemangiomas in a patient with Beckwith-Wiedemann syndrome: A new association?
Disposition of epirubicin in an oily contrast medium after intravenous and intrahepato-arterial administration in liver cancer: a preliminary report.
Hepatoblastoma in an adult with metastasis to the ovaries.
Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402).
Primary hepatocellular carcinoma in intertropical Africa: relationship between age and hepatitis B virus etiology.
Pulmonary metastases from primary hepatocellular carcinoma in a 26-year-old patient: a case report.
Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma.
Spinal cord compression: an unusual presentation of hepatocellular carcinoma.
Hepatorenal Syndrome
Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons.
[Analysis of prognostic factors and construction of a logistic regression model for patients with drug-induced liver failure].
Hernia, Umbilical
Amniotic fluid alpha-fetoprotein elevation with fetal omphalocele and a possible mechanism for its occurrence.
Concanavalin A binding of alpha-fetoprotein in amniotic fluid as an aid in the diagnosis of neural tube defects.
Familial Beckwith-Wiedemann syndrome: Prenatal manifestation and a possible expansion of the phenotype.
High levels of maternal serum alpha-fetoprotein and human chorionic gonadotrophins leading to the diagnosis of combined neural tube defect and partial mole.
Impact of demographic factors on prenatal diagnosis and elective pregnancy termination because of abdominal wall defects, Hawaii, 1986-1997.
Letter: Amniotic alpha-fetoprotein and omphalocele.
Letter: Maternal alpha-fetoprotein and fetal exomphalos.
Maternal serum alpha-fetoprotein in fetal neural tube and abdominal wall defects at 10 to 14 weeks of gestation.
Mechanisms by which amniotic-fluid alpha-fetoprotein may be increased in fetal abnormalities.
Prenatal diagnosis and management of anterior abdominal wall defects in the west of Scotland.
Raised maternal serum and amniotic fluid alpha-fetoprotein (AFP) associated with exomphalos in the fetus.
Ratio of amniotic fluid acetylcholinesterase to pseudocholinesterase as an antenatal diagnostic test for exomphalos and gastroschisis.
Screening for fetal malformations using ultrasound and measurements of alpha-fetoprotein in maternal serum.
Second-trimester maternal serum alpha-fetoprotein levels in pregnancies associated with gastroschisis and omphalocele.
Second-trimester maternal serum alpha-fetoprotein, unconjugated estriol, and hCG levels in pregnancies with ventral wall defects.
The ultrasonographic spectrum of fetal omphalocele.
Trisomy 18 and maternal serum and amniotic fluid alpha-fetoprotein.
[Cause for increased alpha-fetoprotein values in amniotic fluid in prenatal diagnosis of genetic defects (author's transl)]
Hernias, Diaphragmatic, Congenital
Low material serum alpha-fetoprotein levels and congenital diaphragmatic defects.
Prenatal diagnosis of mosaic trisomy 16 associated with congenital diaphragmatic hernia and elevated maternal serum alpha-fetoprotein and human chorionic gonadotrophin.
Herpes Simplex
Comparison of chemiluminescence and absorptiometry in enzyme immunoassays for protein quantification.
Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
Gene therapy for hepatocellular carcinoma based on tumour-selective suicide gene expression using the alpha-fetoprotein (AFP) enhancer and a housekeeping gene promoter.
Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene.
Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
Inhibition of rat hepatocellular carcinoma tumor growth after multiple infusions of recombinant Ad.AFPtk followed by ganciclovir treatment.
Rapid and selective shutoff of plasma protein production in herpes simplex virus type 2-infected hepatoma cells.
Retrovirus-mediated gene therapy for hepatocellular carcinoma with reversely oriented therapeutic gene expression regulated by alpha-fetoprotein enhancer/promoter.
Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
Retrovirus-mediated gene therapy for human hepatocellular carcinoma transplanted in athymic mice.
Tissue-specific expression of herpes simplex virus thymidine kinase gene delivered by adeno-associated virus inhibits the growth of human hepatocellular carcinoma in athymic mice.
Utilization of variant-type of human alpha-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma.
[Gene therapy of primary cancers of the liver: hopes and realities]
Herpes Zoster
Allelic polymorphism and chromosomal localization of the human oviductin gene (MUC9).
Biochemical characterization of hamster oviductin as a sulphated zona pellucida-binding glycoprotein.
Detection of nascent and/or mature forms of oviductin in the female reproductive tract and post-ovulatory oocytes by use of a polyclonal antibody against recombinant hamster oviductin.
Effects of recombinant OVGP1 protein on in vitro bovine embryo development.
Immunolocalization of oviductin in endocytic compartments in the blastomeres of developing embryos in the golden hamster.
Purification, sequence characterization and effect of goat oviduct-specific glycoprotein on in vitro embryo development.
Recombinant feline oviductin--a powerful tool for functional IVF studies in the domestic cat.
Regulated expression of artificial chimeric genes contained in retroviral vectors: implications for virus-directed enzyme prodrug therapy (VDEPT) and other gene therapy applications.
Size variations in the mucin-type domain of hamster oviductin: identification of the polypeptide precursors and characterization of their biosynthetic maturation.
Histiocytic Sarcoma
Robb-Smith type malignant histiocytosis associated with a mediastinal germ cell tumor.
HIV Infections
Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study.
Hoarseness
Characteristics of thymoma successfully resected by videothoracoscopic surgery.
Hodgkin Disease
Elevated alpha-fetoprotein secondary to Hodgkin's lymphoma.
Localization of alpha-fetoprotein synthesis in malignancies other than hepatoma.
Testicular cancer and Hodgkin disease in the same patient.
Hyaline Membrane Disease
Abnormal serum protein levels in infants with hyaline membrane disease--evidence of an underlying immunological disorder.
Hydatidiform Mole
Absence of alpha-fetoprotein in the fluid of a hydatidiform mole.
Maternal serum alpha-fetoprotein in the diagnosis of hydatidiform mole. A report of two cases with elevated levels of maternal serum AFP.
Radioimmunoassay of alpha-fetoprotein: a contribution to the diagnosis of choriocarcinoma and hydatidiform mole.
Serum alpha-fetoprotein in hydatidiform mole, choriocarcinoma, and twin pregnancy.
Triploid fetus: an important consideration in the evaluation of very high maternal serum alpha-fetoprotein.
Triploid partial molar pregnancy detected through maternal serum alpha-fetoprotein and HCG screening.
Very low versus undetectable maternal serum alpha-fetoprotein values and fetal death.
[The significance of alpha-fetoprotein-negativity in the interstitial area of total hydatidiform mole tissue]
Hydrocephalus
Amniotic fluid alpha-fetoprotein and congenital hydrocephalus.
CGH in the detection of confined placental mosaicism (CPM) in placentas of abnormal pregnancies.
CRB2 mutations produce a phenotype resembling congenital nephrosis, Finnish type, with cerebral ventriculomegaly and raised alpha-fetoprotein.
Diffuse mesangial sclerosis in a fetus.
Expansion of phenotype and genotypic data in CRB2-related syndrome.
Genetic and preimplantation diagnosis of cystic kidney disease with ventriculomegaly.
Increased amniotic fluid alpha-fetoprotein, familial hydrocephalus, and renal dysmorphology.
Maternal serum alpha-fetoprotein levels in fetal hydrocephalus: a retrospective population based study.
[Electrophoresis of cholinesterases of the amniotic fluid in the prenatal diagnosis of closure defects of the neural tube]
Hydrops Fetalis
Congenital malformation syndromes and elevation of amniotic fluid alpha-fetoprotein.
Elevated maternal serum alpha-fetoprotein and hydrops fetalis in association with fetal parvovirus B-19 infection.
Erythema infectiosum and pregnancy-related complications.
Maternal serum alpha-fetoprotein--a marker of fetal aplastic crisis during intrauterine human parvovirus infection.
Maternal serum biochemical markers in pregnancies with fetal parvovirus B19 infection.
Nonimmune hydrops fetalis caused by a massive fetomaternal hemorrhage associated with elevated maternal serum alpha-fetoprotein levels. A case report.
Hyperemesis Gravidarum
Second trimester serum alpha-fetoprotein level is a significant positive predictor for intrauterine growth restriction in pregnant women with hyperemesis gravidarum.
The impact of severe hyperemesis gravidarum on the triple test screening results.
Hyperferritinemia
Immunohistochemical ferritin in testicular seminoma.
Hyperprolactinemia
Pituitary Dysfunction in Patients with Intracranial Germ Cell Tumors Treated with Radiotherapy.
Hypersensitivity
Albumin and alpha-fetoprotein gene transcription in rat hepatoma cell lines is correlated with specific DNA hypomethylation and altered chromatin structure in the 5' region.
Linkage studies exclude the AT-V gene(s) from the translocation breakpoints in an AT-V patient.
Novel ATM mutations with ataxia-telangiectasia.
[Ataxia telangiectasia and characterization of its immunological disorders]
Hypertension
Design and validation of risk prediction model for hepatocellular carcinoma development after sustained virological response in patients with chronic hepatitis C.
Diverse maternal and fetal pathology associated with absent diastolic flow in the umbilical artery of high-risk fetuses.
Early prediction of uteroplacental complications of pregnancy using Doppler ultrasound, placental function tests and combination testing.
Hypertension, pregnancy, and risk of breast cancer.
Maternal midtrimester free beta-HCG and AFP serum levels in spontaneous singleton pregnancies complicated by gestational diabetes mellitus, pregnancy-induced hypertension or obstetric cholestasis.
Mean arterial pressure, pregnancy induced hypertension, and preeclampsia. Evaluation as independent risk factors and as surrogates for high maternal serum alpha-protein in estimating breast cancer risk.
Mean arterial pressure, pregnancy-induced hypertension, and preeclampsia: evaluation as independent risk factors and as surrogates for high maternal serum alpha-fetoprotein in estimating breast cancer risk.
Midtrimester amniotic fluid tumor necrosis factor-alpha does not predict small-for-gestational-age infants.
Obstetric outcomes in women with elevated maternal serum human chorionic gonadotropin.
Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort study.
Protective effect of metformin on a rat model of lipopolysaccharide-induced preeclampsia.
Second-trimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death.
Serum markers in quadruple screening associated with adverse pregnancy outcomes: A case-control study in China.
Steatotic hepatocellular carcinoma: a variant associated with metabolic factors and late tumour relapse.
The extrahepatic events of Asian patients with primary biliary cholangitis: A 30-year cohort study.
The use of clinical, biochemical, and ultrasound parameters for the diagnosis of intrauterine growth retardation.
Ultrasonographic investigation of placental morphologic characteristics and size during the second trimester of pregnancy.
[An unusual renal tumor, associating nephroblastoma, nephroblastomatosis, teratoma, and cystic dysplasia with arterial hypertension and secretion of alpha-fetoprotein]
Hypertension, Portal
Development and validation of an individualized prediction calculator of postoperative mortality within 6 months after surgical resection for hepatocellular carcinoma: an international multicenter study.
Excellent safety and effectiveness of high-dose myrcludex-B monotherapy administered for 48?weeks in HDV-related compensated cirrhosis: A case report of 3 patients.
HIGHER VALUES IN LIVER ELASTOGRAPHY AND MELD SCORE ARE MORTALITY PREDICTORS ON LIVER TRANSPLANT WAITING LIST.
Liver resection associated with better outcomes for single large hepatocellular carcinoma located in the same section.
Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: long-term survival in the experience of a single radiologic referral center.
Personalized treatment of patients with very early hepatocellular carcinoma.
Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.
Resection versus Ablation for Alpha-fetoprotein Positive Hepatocellular Carcinoma within the Milan Criteria: A Propensity Score Analysis.
Surveillance Program for Diagnosis of HCC in Liver Cirrhosis: Role of Ultrasound Echo Patterns.
Hypertension, Pregnancy-Induced
Maternal midtrimester free beta-HCG and AFP serum levels in spontaneous singleton pregnancies complicated by gestational diabetes mellitus, pregnancy-induced hypertension or obstetric cholestasis.
Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia.
Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
Mean arterial pressure, pregnancy-induced hypertension, and preeclampsia: evaluation as independent risk factors and as surrogates for high maternal serum alpha-fetoprotein in estimating breast cancer risk.
Midtrimester amniotic fluid tumor necrosis factor-alpha does not predict small-for-gestational-age infants.
Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome.
The association of abnormal alpha-fetoprotein and adverse pregnancy outcome: does increased fetal surveillance affect pregnancy outcome?
Hyperthyroidism
An IgM lambda antibody to Escherichia coli produces false-positive results in multiple immunometric assays.
Chromosomal instability in a woman with infertility and two unaffected brothers: a new familial chromosomal breakage syndrome?
Partial hydatidiform molar pregnancy presenting with severe preeclampsia prior to twenty weeks gestation: a case report and review of the literature.
Hypervitaminosis A
Amniotic and maternal serum alpha-fetoprotein levels of rats with induced neural tube defects.
Hypoalbuminemia
Clinical presentation of chronic hepatitis C in patients with end-stage renal disease and on hemodialysis versus those with normal renal function.
Hypoglycemia
A new hepato-pancreato-renal disorder resembling tyrosinemia involving neuropathy and abnormal metabolism of polyunsaturated acids.
Hepatocellular carcinoma associated with erythrocytosis and hypoglycemia in a yearling filly.
Radioimmunoassay of serum IGF-I and IGF-II in patients with chronic liver diseases and hepatocellular carcinoma with or without hypoglycemia.
[DGUOK-related mitochondrial DNA depletion syndrome: a case report and literature review].
[Studies on the clinical manifestation and SLC25A13 gene mutation of Chinese patients with neonatal intrahepatic cholestasis caused by citrin deficiency.]
[TRMU MUTATIONS - REVERSIBLE INFANTILE LIVER FAILURE OR MULTISYSTEM DISORDER?]
Hypogonadism
Hypergonadotrophic hypogonadism in a patient with transaldolase deficiency: novel mutation in the pentose phosphate pathway.
Pituitary Dysfunction in Patients with Intracranial Germ Cell Tumors Treated with Radiotherapy.
[Usefulness of tumor markers in the treatment of germ cell tumors]
Hyponatremia
[Analysis of prognostic factors for patients with acute-on-chronic liver failure.]
[Role of resistin in inflammation of hepatocytes in nonalcoholic steatohepatitis.]
Hypophosphatasia
Prenatal diagnosis of hypophosphatasia; genetic, biochemical, and clinical studies.
Hypophosphatemia
Marked hypophosphatemia with decreased serum 1,25-dihydroxyvitamin D in a patient with hepatocellular carcinoma complicating liver cirrhosis.
Hypoproteinemia
A new hepato-pancreato-renal disorder resembling tyrosinemia involving neuropathy and abnormal metabolism of polyunsaturated acids.
[Studies on the clinical manifestation and SLC25A13 gene mutation of Chinese patients with neonatal intrahepatic cholestasis caused by citrin deficiency.]
Hypospadias
A risk prediction model for fetal hypospadias by testing maternal serum AFP and free beta-HCG.
Hypothyroidism
Alpha-fetoprotein and hypothyroidism in infants.
Pituitary Dysfunction in Patients with Intracranial Germ Cell Tumors Treated with Radiotherapy.
Serum concentrations of alpha-fetoprotein in children with primary hypothyroidism.
IgA Deficiency
Ataxia telangiectasia with hepatocellular carcinoma in a 15-year-old girl and studies of her kindred.
Ataxia telangiectasia: a review.
Utility of DNA, RNA, Protein, and Functional Approaches to Solve Cryptic Immunodeficiencies.
Immune System Diseases
Suppression of experimental antigen-induced arthritis in transgenic mice producing human alpha-fetoprotein.
Infections
A new risk score based on twelve hepatocellular carcinoma-specific gene expression can predict the patients' prognosis.
A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma.
Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus.
Alpha-fetoprotein in the woodchuck model of hepadnavirus infection and disease: immunochemical analysis of woodchuck alpha-fetoprotein and measurement in serum by quantitative monoclonal radioimmunoassay.
Alpha-fetoprotein in the woodchuck model of hepadnavirus infection and disease: normal physiological patterns and responses to woodchuck hepatitis virus infection and hepatocellular carcinoma.
Alpha-fetoprotein synthesis in human hepatocellular carcinoma: correlation with hepatitis B surface antigen expression.
Analysis of Clinicopathological Characteristics and Prognosis of Young Patients with Hepatocellular Carcinoma after Hepatectomy.
Asociación Mexicana de Hepatología A.C. Clinical guideline on hepatitis B.
Association between Helicobacter pylori infection and tumor markers: an observational retrospective study.
Association of TIP30 expression and prognosis of hepatocellular carcinoma in patients with HBV infection.
Ataxia-ocular motor apraxia: a syndrome mimicking ataxia-telangiectasia.
Characteristics and prognosis of patients with large well-differentiated hepatocellular carcinoma who have undergone resection.
Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II.
Clinical significance of elevated alpha-fetoprotein (AFP) in chronic hepatitis C without hepatocellular carcinoma.
Clinical significance of elevated alpha-fetoprotein in Alaskan Native patients with chronic hepatitis C.
Clinicopathologic features and factors related to survival of patients with small hepatocellular carcinoma after hepatic resection.
Clinicopathological comparison of resectable hepatocellular carcinoma between the young and the elderly patients.
Clinicopathological significance of loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in China.
Decrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals.
Development of a novel panel based on micro-RNAs (21, 29a, 200 and 335) and alpha-fetoprotein as diagnostic biomarkers for hepatocellular carcinoma associated with hepatitis C infection.
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection.
Effect of encephalomyocarditis (EMC) virus on murine foetal and placental growth monitored by quantification of maternal plasma levels of pregnancy-associated murine protein-2 and alpha-fetoprotein.
Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study.
Effect of mannosylated derivatives on HIV-1 infection of macrophages and lymphocytes.
Efficiency of ginger (Zingbar officinale) against Schistosoma mansoni infection during host-parasite association.
Elevated maternal serum alpha-fetoprotein and hydrops fetalis in association with fetal parvovirus B-19 infection.
Elevated second trimester maternal serum alpha-fetoprotein and cytomegalovirus infection.
Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients.
Evaluation of Helicobacter pylori Infection in Patients with Chronic Hepatic Disease.
Evidence that alpha-fetoprotein suppresses the immunological function in transgenic mice.
Expression of cancer-testis antigens in hepatocellular carcinoma.
First and Second Trimester Markers of Fetal Aneuploidy in Pregnant Women with HIV Infection.
Forecasting the development of primary hepatocellular carcinoma by the use of risk factors: studies in West Africa.
Gene therapy for hepatocellular carcinoma using two recombinant adenovirus vectors with alpha-fetoprotein promoter and Cre/lox P system.
Hepatitis B in children: complexities in management.
Hepatitis B virus and hepatitis C virus play different prognostic roles in intrahepatic cholangiocarcinoma: A meta-analysis.
Hepatitis B virus X protein upregulates alpha-fetoprotein to promote hepatocellular carcinoma by targeting miR-1236 and miR-329.
Hepatocellular carcinoma complicated with coexisting hepatolithiasis: pitfalls in diagnosis and management.
Hepatocellular carcinoma in children and young patients with chronic HBV infection and the usefulness of alpha-fetoprotein assessment.
Hepatocyte proliferation in chronic hepatitis C: correlation with degree of liver disease and serum alpha-fetoprotein.
High burden of hepatocellular carcinoma and viral hepatitis in Southern and Central Vietnam: Experience of a large tertiary referral center, 2010 to 2016.
HIGHER VALUES IN LIVER ELASTOGRAPHY AND MELD SCORE ARE MORTALITY PREDICTORS ON LIVER TRANSPLANT WAITING LIST.
Human alpha-fetoprotein binds to primary macrophages.
Increased serum alpha-fetoprotein levels in cytomegalovirus infections.
Influence of Alanine Transaminase Levels on Alpha-Fetoprotein for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Infection.
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?
Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy.
Maternal serum alpha-fetoprotein and human chorionic gonadotropin in pregnant women with acute parvovirus B19 infection with and without fetal complications.
Maternal serum alpha-fetoprotein--a marker of fetal aplastic crisis during intrauterine human parvovirus infection.
Maternal serum biochemical markers in pregnancies with fetal parvovirus B19 infection.
Natural history of chronic hepatitis B virus infection in children of different ethnic origins: a cohort study with up to 12 years' follow-up in northern Greece.
p53 protein expression in patients with hepatocellular carcinoma from the high incidence area of Guangxi, Southern China.
Patient and tumour biology predict survival beyond the Milan criteria in liver transplantation for hepatocellular carcinoma.
Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 is a diagnostic and prognostic biomarker for hepatocellular carcinoma.
Postoperative Adjuvant Transarterial Chemoembolization Improves Short-Term Prognosis of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Propensity-Score Matching Study.
Potent viral suppression and improvements in alpha-fetoprotein and measures of fibrosis in Japanese patients receiving a daclatasvir/asunaprevir/beclabuvir fixed-dose combination for the treatment of HCV genotype-1 infection.
Prognostic and clinicopathologic significance of SIRT1 expression in hepatocellular carcinoma.
Prognostic factors for chronic severe hepatitis and construction of a prognostic model.
Prognostic index of liver cirrhosis with ascites with and without hepatocellular carcinoma.
Rapid and selective shutoff of plasma protein production in herpes simplex virus type 2-infected hepatoma cells.
Regression of hepatocellular carcinoma during vitamin K administration.
Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma.
Relationship between polymorphism of angiotensin-converting enzyme gene insertion/deletion and risk of hepatocellular carcinoma in a Chinese Dai population.
Risk factors for naturally-occurring early-onset hepatocellular carcinoma in patients with HBV-associated liver cirrhosis in China.
Role of monocyte-to-lymphocyte ratio in predicting sorafenib response in patients with advanced hepatocellular carcinoma.
Screening for hepatocellular carcinoma.
Serological markers of hepatitis B virus and alpha-fetoprotein levels preceding primary hepatocellular carcinoma in Alaskan Eskimos.
Serum alpha-fetoprotein level is higher in hepatitis C than hepatitis B infected chronic liver disease patients.
Serum immunoreactivity of SMP30 and its tissues expression in hepatocellular carcinoma.
Serum peptide pattern differentially diagnoses Hepatitis B Virus-related hepatocellular carcinoma from liver cirrhosis.
Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
STROBE-clinical characteristics and prognosis factors of gastric cancer in young patients aged ?30 years.
The Clinicopathologic and Prognostic Significance of Gross Classification on Solitary Hepatocellular Carcinoma After Hepatectomy.
The hepatocyte-specific phenotype of murine liver cells correlates with high expression of connexin32 and connexin26 but very low expression of connexin43.
What is the best surveillance for hepatocellular carcinoma in chronic carriers of hepatitis B?
[A preliminary study on the antenatal diagnosis and prevention of the fetus toxoplasmosis infection]
[Multivariate analysis of hepatic encephalopathy occurrence in patients with liver failure].
Infertility
Case-control study of severe pre-eclampsia of early onset.
Inflammatory Bowel Diseases
Hepatoid Adenocarcinoma of the Rectum With Liver Metastasis in a Patient With Ulcerative Colitis.
Post-treatment persistent alpha-fetoprotein elevation in a patient with testicular cancer.
Influenza, Human
Assessment of Adherence to Baseline Quality Measures for Cirrhosis and the Impact of Performance Feedback in a Regional VA Medical Center.
Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
Insulin Resistance
Associations between Vitamin D and ?-Cell Function and Colorectal Cancer-Associated Tumor Markers in Chinese Type 2 Diabetic Patients with Albuminuria.
Insulinoma
Malignant insulinoma with hepatoid differentiation: a unique case with alpha-fetoprotein production.
Intestinal Neoplasms
Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer.
Iron Overload
Reversing hepatocellular carcinoma progression by using networked biological therapies.
Ischemic Stroke
[The alpha-fetoprotein in prognosis of survival of and functional rehabilitation of patients with ischemic stroke].
[The fetal proteins in prognosis of development of pneumonia in patients with ischemic stroke].
Jaundice, Neonatal
'Idiopathic' jaundice in Sardinian full-term newborn infants: a multivariate study.
Cord plasma alpha-fetoprotein values and neonatal jaundice.
[Cord blood alpha-fetoprotein, gamma-glutamyl transpeptidase and neonatal jaundice]
Kasabach-Merritt Syndrome
Prenatal aspects of giant fetal cranial haemangio-endothelioma.
Kidney Diseases
Genetic and preimplantation diagnosis of cystic kidney disease with ventriculomegaly.
Kidney Diseases, Cystic
Genetic and preimplantation diagnosis of cystic kidney disease with ventriculomegaly.
Prenatal diagnosis of multiple acyl-CoA dehydrogenase deficiency: association with elevated alpha-fetoprotein and cystic renal changes.
Kidney Failure, Chronic
A case report of retroperitoneal extrahepatic hepatocellular carcinoma presented with elevated level of Alpha fetoprotein.
Clinical presentation of chronic hepatitis C in patients with end-stage renal disease and on hemodialysis versus those with normal renal function.
Pretreatment Inflammation-Based Markers Predict Survival Outcomes in Patients with Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation.
Klinefelter Syndrome
Treatment of mediastinal immature teratoma in a child with precocious puberty and Klinefelter's syndrome.
Klippel-Trenaunay-Weber Syndrome
Prenatal sonographic findings of Klippel-Trénaunay-Weber syndrome.
Leiomyoma
Elevation of CA 19-9 and chromogranin A, in addition to CA 125, are detectable in benign tumors in leiomyomas and endometriosis.
Leukemia
Characterization of an immortalized oviduct cell line from the cynomolgus monkey (Macaca fascicularis).
Embryoid-body cells derived from a mouse embryonic stem cell line show differentiation into functional hepatocytes.
Radioimmunoassay of alpha-fetoprotein in the serum of patients with leukemia and malignant melanoma.
Specific uptake of alpha-fetoprotein by malignant human lymphoid cells.
[Preparation of paraffin sections for the immunofluorescent analysis of antigens of differing chemical nature]
[The distribution of iodine-125 labeled alpha-fetoprotein in the animal organism and its accumulation in the tumor].
Leukemia, T-Cell
[Analysis on influencing factors that leading to nonspecific responses to indeterminate results of HIV antibodies].
Leukocytosis
Carcinosarcoma of the gallbladder producing alpha-fetoprotein and manifesting as leukocytosis with elevated serum granulocyte colony-stimulating factor: Report of a case.
Leydig Cell Tumor
Advances in biological markers for cancer.
Liposarcoma
alpha-fetoprotein expression in a dedifferentiated liposarcoma.
Retroperitoneal liposarcoma associated with small plaque parapsoriasis.
Liver Abscess
Letter: Alpha-fetoprotein in amoebic colitis and liver abscess.
Liver Abscess, Amebic
Alpha-fetoprotein in amebic liver abscess.
Letter: Alpha-fetoprotein and amoebic liver abscess.
The pathogenesis of raised serum alpha-fetoprotein levels in amoebic and pyogenic hepatic abscesses.
[Serum levels of alpha-fetoprotein in amebic liver abscess during the tissue regeneration phase]
Liver Abscess, Pyogenic
The pathogenesis of raised serum alpha-fetoprotein levels in amoebic and pyogenic hepatic abscesses.
Liver Cirrhosis
A contribution to early diagnosis of primary hepatic cell carcinoma occurring in patients with liver cirrhosis.
A retrospective study on the patterns of sequential fluctuation of serum alpha-fetoprotein level during progression from liver cirrhosis to hepatocellular carcinoma.
Ability of the post-operative ALBI grade to predict the outcomes of hepatocellular carcinoma after curative surgery.
Abnormality of Wnt3a expression as novel specific biomarker for diagnosis and differentiation of hepatocellular carcinoma.
Acute exacerbation of hepatitis in liver cirrhosis with very high levels of alpha-fetoprotein but no occurrence of hepatocellular carcinoma.
Age-related, different clinicopathologic features of hepatocellular carcinoma patients.
Alpha-fetoprotein and p53 autoantibodies in patients with chronic hepatitis C.
Alpha-fetoprotein level as a biomarker of liver fibrosis status: a cross-sectional study of 619 consecutive patients with chronic hepatitis B.
alpha-Fetoprotein screening in patients with idiopathic hemochromatosis and liver cirrhosis.
Alpha-fetoprotein serum concentration in different stages of liver cirrhosis.
Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology.
Alpha-fetoprotein, tissue polypeptide antigen and ferritin in diagnosing primary hepatocellular carcinoma in patients with liver cirrhosis.
Alpha-fetoprotein-producing early gastric cancer accompanying liver cirrhosis: a case report.
An analysis of DNA ploidy pattern of hepatocellular carcinoma.
Analysis of alpha-fetoprotein gene expression in hepatocellular carcinoma and liver cirrhosis by in situ hybridization.
Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection.
Autotaxin Expression in Hepatocellular Carcinoma.
Characterization of HBeAg-negative chronic hepatitis B in western Brazilian Amazonia.
Cholangiography of icteric type hepatoma.
Clinical and contrast-enhanced image features in the prediction model for the detection of small hepatocellular carcinomas.
Clinical evaluation of a monoclonal antibody to serum KM01 for the diagnosis of hepatocellular carcinoma.
Clinical implications of alpha-fetoprotein in liver cirrhosis: five-year follow-up study.
Clinical predictors of liver fibrosis in patients with chronic hepatitis B virus infection from children to adults.
Clinical significance of alpha-fetoprotein in hepatitis and liver cirrhosis.
Clinical significance of serum alpha-fetoprotein in patients with liver cirrhosis.
Clinical significance of serum ferritin determination for hepatocellular carcinoma.
Clinicopathological significance and prognostic role of p-STAT3 in patients with hepatocellular carcinoma.
Combined treatment of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates hepatic dysplastic nodule in a patient with liver cirrhosis.
Comparison of the on-treatment risks for hepatocellular carcinoma between entecavir and tenofovir: A propensity score matching analysis.
Cross-Linked Multimeric Pro-Peptides of Type III Collagen (PC3X) in Hepatocellular Carcinoma - A Biomarker That Provides Additional Prognostic Value in AFP Positive Patients.
Cryptic epitopes on alpha-fetoprotein induce spontaneous immune responses in hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis patients.
Cytokine evaluation in liver cirrhosis and hepatocellular carcinoma.
Design and validation of risk prediction model for hepatocellular carcinoma development after sustained virological response in patients with chronic hepatitis C.
Determination of plasma urokinase-type plasminogen activator antigen in patients with primary liver cancer: characterization as tumor-associated antigen and comparison with alpha-fetoprotein.
Development And Validation Of A Simple Model For Detection Of Early Hepatocellular Carcinoma In A Liver Cirrhosis Cohort.
Development of colorectal cancer predicts increased risk of subsequent hepatocellular carcinoma in patients with alcoholic liver disease: case-control and cohort study.
Diagnosis of hepatocellular carcinoma by fine needle biopsy of portal vein thrombosis.
Diagnosis of hepatocellular carcinoma in patients with liver cirrhosis using liver function assays.
Diagnostic Performance of microRNA-122 and microRNA-224 in Hepatitis C Virus-Induced Hepatocellular Carcinoma (HCC).
Diagnostic Role of Blood Tumor Markers in Predicting Hepatocellular Carcinoma in Liver Cirrhosis Patients Undergoing Liver Transplantation.
Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon-free versus interferon-based therapy and the risk of developing hepatocellular carcinoma after eradication of hepatitis C virus in Japan.
Do CA 19-9 and TPA play a minor role as compared to AFP in diagnosing primary hepatocellular carcinoma?
Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy: Prioritize who needs urgent direct-acting antiviral agents.
Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy.
Early diagnosis of hepatocellular carcinoma.
Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection.
Efficacy of ultrasound-, computed tomography-, and magnetic resonance imaging-guided radiofrequency ablation for hepatocellular carcinoma.
Efficiency of ginger (Zingbar officinale) against Schistosoma mansoni infection during host-parasite association.
Enhanced Detection of Early Hepatocellular Carcinoma by Serum SELDI-TOF Proteomic Signature Combined with Alpha-Fetoprotein Marker.
Evaluation of Diagnostic Efficiency of Alpha-Fetoprotein in Patients with Liver Cirrhosis and Hepatocellular Carcinoma: Single-Center Experience.
Evaluation of transforming growth factor alpha and vascular endothelial growth factor in diagnosis of hepatocellular carcinoma.
Experience with major hepatic resections for hepatocellular carcinoma.
Expression and prognostic value of VEGFR-2, PDGFR-?, and c-Met in advanced hepatocellular carcinoma.
Factors associated with survival exceeding 5 years after transcatheter arterial embolization for hepatocellular carcinoma.
Factors associated with the progression of fibrosis on liver biopsy in Alaska Native and American Indian persons with chronic hepatitis C.
Growth velocity of the portal vein tumor thrombus accelerated by its progression, alpha-fetoprotein level, and liver fibrosis stage in patients with hepatocellular carcinoma.
HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway.
Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment.
Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis.
Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals.
Hepatocellular carcinoma complicated with coexisting hepatolithiasis: pitfalls in diagnosis and management.
Hepatocellular carcinoma with a central scar and a scalloped tumor margin resembling focal nodular hyperplasia in macroscopic appearance.
Hepatocellular carcinoma with Pancoast's syndrome as an initial symptom: a case report.
Hepatomas seen on follow-up angiograms in patients with liver cirrhosis.
High alpha-fetoprotein level in HCV-related nodular liver cell dysplasia.
Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma.
Immunoelectron microscopic observation of alpha-fetoprotein synthesis in human non-malignant liver tissues using immunoperoxidase methods.
Impact Factors for Microinvasion in Patients with Hepatocellular Carcinoma: Possible Application to the Definition of Clinical Tumor Volume.
Improving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trial.
Increase of fucosylated serum cholinesterase in relation to high risk groups for hepatocellular carcinomas.
Inflammatory pseudotumor of the liver masquerading as hepatocellular carcinoma after a hepatitis B virus infection: Report of a case.
Is the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection?
Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions.
Liver cancer and its prevention.
Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study.
Long-term outcome after surgery for asymptomatic small hepatocellular carcinoma.
Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study.
Marked hypophosphatemia with decreased serum 1,25-dihydroxyvitamin D in a patient with hepatocellular carcinoma complicating liver cirrhosis.
Normalization using a tagged-internal standard assay for analysis of antibody arrays and the evaluation of serological biomarkers for liver disease.
On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir.
Pattern analysis of serum alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma in liver cirrhosis.
Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study.
Plasma abnormal prothrombin (PIVKA-II): a new and reliable marker for the detection of hepatocellular carcinoma.
Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort study.
Prognostic and clinicopathological value of Nanog in hepatocellular carcinoma: A meta-analysis.
Registries in Japan: current status of hepatocellular carcinoma in Japan. Liver Cancer Study Group of Japan.
Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma.
Relationship of serum alpha-fetoprotein to circulating immune complexes and complements in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.
Results of three-dimensional conformal radiotherapy and thalidomide for advanced hepatocellular carcinoma.
Review of 336 patients with hepatocellular carcinoma at Songklanagarind Hospital.
Risk factors for hepatocellular carcinoma among patients with chronic liver disease.
RNA sequencing of plasma exosomes revealed novel functional long noncoding RNAs in hepatocellular carcinoma.
Sensitive detection of human telomerase reverse transcriptase mRNA in the serum of patients with hepatocellular carcinoma.
Sensitive measurement of serum abnormal prothrombin (PIVKA-II) as a marker of hepatocellular carcinoma.
Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein.
Serum alpha-fetoprotein subfractions identified by Ricinus communis agglutinin I in hepatic malignancies, yolk sac tumor, benign hepatic diseases, and fetal stage.
Serum alpha-L-fucosidase. A more sensitive marker for hepatocellular carcinoma?
Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis.
Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma.
Serum markers of hepatocellular carcinoma.
Serum N-acetylglucosaminyltransferase III activities in hepatocellular carcinoma.
Serum neopterin levels in patients with hepatocellular carcinoma.
Serum peptide pattern differentially diagnoses Hepatitis B Virus-related hepatocellular carcinoma from liver cirrhosis.
Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
Specific enzyme immunoassay for alpha-fetoprotein from hepatocellular carcinoma.
Spontaneous regression of hepatocellular carcinoma.
Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan.
Subclinical hepatocellular carcinoma: an analysis of 391 patients.
Surgical outcomes of pulmonary metastasectomy in hepatocellular carcinoma patients according to approach method: thoracoscopic versus open approach.
Survival factors after resection of small hepatocellular carcinoma.
Targeted sonography for small hepatocellular carcinoma discovered by CT or MRI: factors affecting sonographic detection.
The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection.
The Clinical Values of Serum Markers in the Early Prediction of Hepatocellular Carcinoma.
The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma.
The Prognostic Role of Mitotic Index in Hepatocellular Carcinoma Patients after Curative Hepatectomy.
The Role of Dermcidin in the Diagnosis and Staging of Hepatocellular Carcinoma.
The Singapore Liver Cancer Recurrence (SLICER) Score for relapse prediction in patients with surgically resected hepatocellular carcinoma.
Three cases of small hepatocellular carcinoma presenting as obstructive jaundice.
Toll-like receptor 7 mRNA is reduced in hepatitis C-based liver cirrhosis and hepatocellular carcinoma, out-performs alpha-fetoprotein levels, and with age and serum aspartate aminotransferase is a new diagnostic index.
Transferrin receptor 1 overexpression is associated with tumour de-differentiation and acts as a potential prognostic indicator of hepatocellular carcinoma.
Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma.
Urinary excretion of free and acetylated polyamines in hepatocellular carcinoma.
Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Usefulness of the novel oncofetal antigen glypican-3 for diagnosis of hepatocellular carcinoma and melanoma.
[An Abnormal Alpha-Fetoprotein Fractionation Provides Additional Information: A Case of Retroperitoneal Germ Cell Tumor Accompanied by Liver Cirrhosis Type C].
[Analysis of prognostic factors for patients with acute-on-chronic liver failure.]
[Analysis of urine metabolic profile in patients with hepatocellular carcinoma].
[Application of alpha-fetoprotein and osteopontin combination for early diagnosis of hepatocellular carcinoma associated with hepatitis C.]
[Capsule formation in hepatocellular carcinomas arising from liver cirrhosis]
[Clinical significance of alpha-fetoprotein and carcinoembryonic antigen in the serum of patients with liver cirrhosis]
[Community-based hepatocellular carcinoma screening in seven townships in Taiwan]
[Development and predictive factors of hepatocellular carcinoma in patients with chronic liver disease over a long follow-up period]
[Diagnostic significance of the study of alpha-fetoprotein in liver cirrhosis and primary cancer of the liver]
[Elevated serum alpha-fetoprotein in a case of rectum carcinoma with liver cirrhosis (author's transl)]
[Expression and significance of EGF mRNA and EGFR mRNA in hepatocellular carcinoma]
[Expression of ATAD2 in different liver lesions and its clinical significance].
[Hepatocellular carcinoma: risk groups--screening]
[Hepatocellular carcinoma]
[Heterogeneity of alpha-fetoprotein with concanavalin A-binding properties in the serum and ascites of liver neoplasms and liver cirrhosis]
[Immunochemical determination of alpha-fetoprotein in the dynamics of development of liver cirrhosis and hepatocellular cancer]
[Liver transplantation for hepatocellular carcinoma: prognostic analysis of 89 cases]
[Multivariate analysis of hepatic encephalopathy occurrence in patients with liver failure].
[Observation on short-term therapeutic effect of zhenggan recipe in treating liver cirrhosis with alpha-feto-protein]
[On the alpha-fetoprotein in the diagnosis of primary liver carcinoma (author's transl)]
[Prognostic factors influencing postoperative survival in patients with
[Role of resistin in inflammation of hepatocytes in nonalcoholic steatohepatitis.]
[Screening for the early diagnosis of hepatocellular carcinoma: cost-effectiveness analysis]
[Serum alpha-fetoprotein (AFP) levels in liver cirrhosis and viral hepatitis cases]
[Serum alpha-fetoprotein in liver cirrhosis]
[Small unilocular hepatocellular carcinoma (0 < 5 cm) in patients with liver cirrhosis. Early diagnosis, surgical indications, resection and prognosis]
[Surgical therapy of hepatocellular carcinoma]
[The clinical significance of PIVKA-II determination in patients with hepatocellular carcinoma: a comparative study with alpha-fetoprotein]
[The diagnostic approach to hepatocellular carcinoma.]
[Transcatether chemoembolization in the treatment of hepatocellular carcinoma]
[Tumor markers--personal experience. The use of tumor markers for cancer of digestive organs]
[Two patients with liver cirrhosis who presented with alpha-fetoprotein values diagnostic of hepatocarcinoma but without evidence of neoplasms]
Liver Cirrhosis, Alcoholic
alpha-Fetoprotein in liver disease.
Diagnostic significance of estimation of serum apolipoprotein A along with alpha-fetoprotein in alcoholic cirrhosis and hepatocellular carcinoma patients.
Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening.
Pleomorphic hepatocellular carcinoma following consumption of hypericum perforatum in alcoholic cirrhosis.
[Spontaneous regression of hepatocellular carcinoma in a cirrhotic patient]
Liver Cirrhosis, Biliary
Alpha-fetoprotein and tissue polypeptide antigen in non neoplastic hepatic disorders.
Hepatic inflammatory pseudotumor associated with primary biliary cholangitis and elevated alpha-fetoprotein lectin 3 fraction mimicking hepatocellular carcinoma.
Hepatocellular carcinoma in primary biliary cirrhosis: detection by alpha-fetoprotein estimation.
[Elevated alpha-fetoprotein in primary biliary cirrhosis]
Liver Diseases
A Case Report: Can Citrin Deficiency Lead to Hepatocellular Carcinoma in Children?
A Model Predicting Survival of Patients with Recurrent or Progressive Hepatocellular Carcinoma: The MORE Score.
A pilot study of vasculogenic mimicry immunohistochemical expression in hepatocellular carcinoma.
Abnormal fucosylation of alpha-fetoprotein in patients with non-alcoholic steatohepatitis.
Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review.
Acute exacerbation of hepatitis in liver cirrhosis with very high levels of alpha-fetoprotein but no occurrence of hepatocellular carcinoma.
Affinity chromatographic separation of alpha-fetoprotein variants: development of a mini-column procedure, and application to cancer patients.
AFP-L3 in chronic liver diseases with persistent elevation of alpha-fetoprotein.
AGMA Score: A Novel Prognostic Score for Patients Undergoing Liver Transplant for Hepatocellular Carcinoma.
Alcoholic liver disease. Absence of alpha-fetoprotein elevations in the recovery phase.
Alpha-fetoprotein (AFP) in benign liver disease. Evidence that normal liver regeneration does not induce AFP synthesis.
Alpha-fetoprotein alterations in alcoholics with liver disease. V.A. Cooperative Study Groups.
Alpha-fetoprotein and carcinoembryonic antigen in patients with primary liver carcinoma, metastatic liver disease, and alcoholic liver disease.
Alpha-fetoprotein and hepatitis B virus infection in chronic liver disease.
Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B.
Alpha-fetoprotein antibody-lectin enzyme immunoassay to characterize sugar chains for the study of liver diseases.
Alpha-fetoprotein elevation in NUT midline carcinoma: a case report.
alpha-Fetoprotein in liver disease.
Alpha-fetoprotein in liver diseases in Taiwan.
Alpha-fetoprotein in patients with primary liver cancer and other liver diseases.
alpha-Fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma.
Alpha-fetoprotein reaction to Pisum sativum agglutinin in differentiation of benign liver diseases from hepatocellular carcinoma.
Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the american association for the study of liver diseases.
Alpha-fetoprotein, carcinoembryonic antigen and various biochemical tests in patients with tumorous and inflammatory liver diseases.
Alpha-fetoprotein-concanavalin A binding as a marker to discriminate between germ cell tumours and liver diseases.
Alpha-fetoprotein: immunochemical purification and chemical properties. Expression in normal state and in malignant and non-malignant liver disease.
An isolate alpha-fetoprotein producing gastric cancer liver metastasis emerged in a patient previously affected by radiation induced liver disease.
Angiographically undetected small hepatocellular carcinoma: clinicopathological characteristics, follow-up and treatment.
Application of des-gamma-carboxy prothrombin as a complementary tumor marker with alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Assessment of alpha-fetoprotein in chronic HBsAg carriers and in HBsAg negative cirrhosis of the liver.
Association between alpha-fetoprotein and metabolic syndrome in a Chinese asymptomatic population: a cross-sectional study.
Association between serum alpha-fetoprotein levels and fatty liver disease: a cross-sectional study.
Association between steatohepatitis biomarkers and hepatocellular carcinoma after hepatitis C elimination.
Automatic Time-Resolved Fluorescence Immunoassay of Serum Alpha Fetoprotein-L3 Variant via LCA Magnetic Cationic Polymeric Liposomes Improves the Diagnostic Accuracy of Liver Cancer.
Biological response under treatment and prognostic value of protein induced by vitamin K absence or antagonist-II in a French cohort of patients with hepatocellular carcinoma.
Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation?
Carbohydrate 19-9 antigen as a marker of non-malignant hepatocytic ductular transformation in patients with acute liver failure. A comparison with alpha-fetoprotein and carcinoembryonic antigen.
Carbohydrate-based measurements on alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma.
Characterization of hepatocellular carcinoma in Mexico.
Charting the Path Forward for Risk Prediction in Liver Transplant for Hepatocellular Carcinoma: International Validation of HALTHCC Among 4,089 Patients.
Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
Clinical aspects and outcomes of volunteer blood donors testing positive for hepatitis-C virus infection in Taiwan: a prospective study.
Clinical evaluation of lentil lectin-reactive alpha-fetoprotein-L3 in histology-proven hepatocellular carcinoma.
Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
Clinical significance of elevated alpha-fetoprotein in adults and children.
Clinical significance of serum alpha-fetoprotein subfractionation in pediatric diseases.
Clinicopathologic analysis of risk factors for distant metastasis of hepatocellular carcinoma.
Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma.
Combating hepatocellular carcinoma with an integrated approach.
Combination of dual serum fluorescence, AFP and hepatic function tests is valuable to identify HCC in AFP-elevated liver diseases.
Combined assessment of TGF-beta-1 and alpha-fetoprotein values improves specificity in the diagnosis of hepatocellular carcinoma and other chronic liver diseases in Malaysia.
Comparison between diploid and aneuploid hepatocellular carcinomas: a flow cytometric study.
Cranial metastasis of hepatocellular carcinoma in a female--case report.
Detection of hepatocellular carcinoma during a clinical follow-up of chronic liver disease: observations in 31 patients.
Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography. A study in 51 patients.
Differential alpha-fetoprotein lectin binding in hepatocellular carcinoma. Diagnostic utility at low serum levels.
Differential diagnosis of liver diseases using serum biomarkers.
Differential lectin reactivities of alpha-fetoprotein in hepatocellular carcinoma: diagnostic value when serum alpha-fetoprotein levels are slightly raised.
Differential reactivity of alpha-fetoprotein with lectins and its usefulness in the diagnosis of various liver diseases.
Diffuse cirrhosis-like hepatocellular carcinoma: a clinically and radiographically undetected variant mimicking cirrhosis.
Direct-Acting Antiviral Drugs and Occurrence of Hepatocellular Carcinoma: Unjust or Oppressed.
Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study.
Effects of maintenance immunosuppression with sirolimus after liver transplant for hepatocellular carcinoma.
Efficiency of composite laboratory tests in the diagnosis of liver malignancies.
Elevated plasma osteopontin levels in patients with hepatocellular carcinoma.
Evaluation of tumor markers for the detection of hepatocellular carcinoma in Yangon General Hospital, Myanmar.
Evaluation of tumour necrosis factor-alpha, soluble P-selectin, gamma-glutamyl transferase, glutathione S-transferase-pi and alpha-fetoprotein in patients with hepatocellular carcinoma before and during chemotherapy.
Evidence for liver disease preceding amino acid abnormalities in hereditary tyrosinemia.
Factors Associated With Detection and Survival of T1 Hepatocellular Carcinoma in the United States: National Cancer Database Analysis.
False elevations of alpha-fetoprotein associated with liver dysfunction in germ cell tumors.
Follow-up examination schedule of postoperative HCC patients based on tumor volume doubling time.
Forecasting the development of primary hepatocellular carcinoma by the use of risk factors: studies in West Africa.
Guide for diagnosis and treatment of hepatocellular carcinoma.
HCC Detection on Surveillance US: Comparing Focused Liver Protocol Using US LI-RADS Technical Guidelines to a General Complete Abdominal US Protocol.
Hepatoblastoma with congenital absence of the portal vein - a case report.
Hepatocellular Carcinoma and Liver Transplantation: A Single-Center Experience.
Hepatocellular Carcinoma-Circulating Tumor Cells Expressing PD-L1 Are Prognostic and Potentially Associated With Response to Checkpoint Inhibitors.
Hepatocellular carcinoma: the high-risk patient.
Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases.
Hepatocyte proliferation in chronic hepatitis C: correlation with degree of liver disease and serum alpha-fetoprotein.
Hepatoid adenocarcinoma of the gallbladder: a mimicker of hepatocellular carcinoma.
Hepatoid adenocarcinoma of the stomach with liver metastasis mimicking hepatocellular carcinoma: a case report.
High mobility group box 3 as an emerging biomarker in diagnosis and prognosis of hepatocellular carcinoma.
Highly enhanced fucosylation of alpha-fetoprotein in patients with germ cell tumor.
Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients.
Immunohistochemical detection of aberrant p53 expression in hepatocellular carcinoma: correlation with cell proliferative activity indices, including mitotic index and MIB-1 immunostaining.
Immunohistochemical expression of pi class glutathione S-transferase and alpha-fetoprotein in hepatocellular carcinoma and chronic liver disease.
Immunotherapy directed against alpha-fetoprotein results in autoimmune liver disease during liver regeneration in mice.
Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers.
Impact of preoperative fine-needle aspiration cytologic examination on clinical outcome in patients with hepatocellular carcinoma in a tertiary referral center.
Importance of Multislice Computed Tomography in Determining the Severity of Chronic Liver Disease State.
Improved survival following transarterial radioembolization of infiltrative-appearance hepatocellular carcinoma.
Inadequate Hepatocellular Carcinoma Screening in Patients With Nonalcoholic Steatohepatitis Cirrhosis.
Incidental hepatocellular carcinoma after liver transplantation: population characteristics and outcomes.
Is transarterial chemoembolization beneficial for patients with diffuse infiltrative hepatocellular carcinoma?
Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions.
Lens culinaris agglutinin-A-reactive alpha-fetoprotein as a marker for liver atrophy in fulminant hepatic failure.
Lentil-lectin-reactive alpha-fetoprotein in the differential diagnosis of benign and malignant liver disease.
Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
Liver transplantation for hepatocellular cancer: should the current indication criteria be changed?
Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan.
Long-term follow-up study of asymptomatic HBsAg-positive voluntary blood donors in Austria: a clinical and histologic evaluation of 242 cases.
Long-term surgical outcomes in patients with hepatocellular carcinoma undergoing laparoscopic vs. open liver resection: A retrospective and propensity score-matched study.
Marked increase in serum alpha-fetoprotein level in cirrhosis: a case report.
Meta-analysis of circulating microRNAs for the diagnosis of hepatocellular carcinoma.
Metastatic Recurrent Hepatocellular Carcinoma Post Liver Transplant With Marked Pretransplant Elevation of Alpha Fetoprotein and No Evidence of Primary Neoplasm.
Mixed malignant germ cell tumour of the liver.
Monoclonal antibodies recognizing a recombinant portion of human alpha-fetoprotein with antigenic selectivity versus albumin.
MR imaging in diffuse-type hepatocellular carcinoma with synchronous portal vein thrombi.
Multiple non-tumorous arterioportal shunts due to chronic liver disease mimicking hepatocellular carcinoma: outcomes and the associated elevation of alpha-fetoprotein.
Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis.
Natural History of Untreated Hepatocellular Carcinoma in a US Cohort and the Role of Cancer Surveillance.
No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5?cm.
Nodules less than 20 mm and vascular invasion are predictors of survival in small hepatocellular carcinoma.
Non-tumoral elevation of alpha-fetoprotein (AFP): a 10 year follow-up in two subjects.
Normal and increased alpha-fetoprotein in neoplastic and non-neoplastic liver disease.
Novel changes in glycosylation of serum Apo-J in patients with hepatocellular carcinoma.
NRAGE is a potential diagnostic biomarker of hepatocellular carcinoma.
Overexpression of p53 in hepatocellular carcinomas: a clinicopathological and prognostic correlation.
Overlap syndrome between autoimmune hepatitis and primary biliary cirrhosis complicated by hepatocellular carcinoma.
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice.
Pediatric hepatocellular carcinoma.
Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literature.
Personalized treatment of patients with very early hepatocellular carcinoma.
Plasma fucosyltransferase activity in patients with hepatocellular carcinoma, with special reference to correlation with fucosylated species of alpha-fetoprotein.
Plasma proteins glycosylation and its alteration in disease.
Plasminogen activator inhibitor-2 and alpha-fetoprotein in various liver disease states.
Polymer adhesive surface as flexible generic platform for multiplexed assays biochip production.
Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation.
Predictive factors for recurrence after percutaneous ethanol injection for solitary hepatocellular carcinoma.
Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients.
Preliminary study of alpha-fetoprotein in nonmalignant liver diseases. A clinico-biochemical evaluation.
Preserved liver function, portal thrombosis and absence of oesophageal varices are risk factors for metastasis of hepatocellular carcinoma.
Primary liver cancers in Japan.
Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma.
Prolonged survival after repeat resection of pulmonary metastasis from hepatocellular carcinoma.
Radioimmunoassay of alpha-fetoprotein in human serum: clinical value in patients with liver diseases.
Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey.
Relationship of hepatitis B surface antigen to serum alpha-fetoprotein in nonmalignant diseases of the liver.
Resolution of ascites and hepatic encephalopathy and absence of variceal bleeding in decompensated hepatitis C virus cirrhosis patients.
Risk Factors for Hepatocellular Carcinoma Recurrence and Survival after Liver Transplantation in Patients with HCV-Related Cirrhosis.
Role of the model for end-stage liver disease and serum alpha-fetoprotein as prognostic predictors for hepatocellular carcinoma.
Sensitive detection of human telomerase reverse transcriptase mRNA in the serum of patients with hepatocellular carcinoma.
Serum alpha-fetoprotein (AFP) in benign and malignant gastrointestinal diseases: evaluation of an immunoenzymatic assay.
Serum alpha-fetoprotein and its lectin reactivity in liver diseases: a review.
Serum alpha-fetoprotein and lens culinaris agglutinin-reactive fraction of alpha-fetoprotein in patients with hepatocellular carcinoma.
Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.
Serum alpha-fetoprotein in chronic liver disease.
Serum alpha-fetoprotein in nonneoplastic liver diseases.
Serum alpha-fetoprotein in patients with nonalcoholic fatty liver disease.
Serum alpha-fetoprotein level is higher in hepatitis C than hepatitis B infected chronic liver disease patients.
Serum alpha-fetoprotein level per total tumor volume as a predictor of recurrence of hepatocellular carcinoma after resection.
Serum alpha-fetoprotein levels and microheterogeneity in patients with different liver diseases.
Serum alpha-fetoprotein levels in patients with acute and chronic liver disease. Relation to hepatocellular regeneration and development of primary liver cell carcinoma.
Serum alpha-fetoprotein: diagnostic significance in liver disease.
Serum alpha-L-fucosidase. A more sensitive marker for hepatocellular carcinoma?
Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
Severe Vitamin D Deficiency Increases Mortality Among Patients With Liver Cirrhosis Regardless of the Presence of HCC.
Significance of alpha-fetoprotein in liver disease.
Somatostatin Receptor in Human Hepatocellular Carcinomas: Biological, Patient and Tumor Characteristics.
Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation.
Specific measurement of hypocarboxylated prothrombin in plasma or serum and application to the diagnosis of hepatocellular carcinoma.
Specificities of serum alpha-fetoprotein in HBsAg+ and HBsAg- patients in the diagnosis of hepatocellular carcinoma.
Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients.
Stratified alpha-fetoprotein pattern accurately predicts mortality in patients with acute-on-chronic hepatitis B liver failure.
Subclinical primary liver carcinoma.
Successful surgical management of pulmonary and adrenal metastases from hepatocellular carcinoma.
Sugar chains of human cord serum alpha-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas.
Surgical Resection vs. Ablative Therapies Through a Laparoscopic Approach for Hepatocellular Carcinoma: a Comparative Study.
Surgical treatment of hepatocellular cancer in the era of hepatic transplantation.
Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America.
Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study.
The des-gamma-carboxyprothrombin for the diagnosis of hepatocellular carcinoma.
The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients.
The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma.
The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology.
The Intention-to-Treat Effect of Bridging Treatments in the Setting of Milan Criteria-In Patients Waiting for Liver Transplantation.
The MAAPE score in intermediate and advanced hepatocellular carcinoma treated with Yttrium-90 resin microsphere radioembolization.
The natural course of hepatitis B surface antigen-positive chronic active hepatitis in Taiwan.
The role of subfractionation of alpha-fetoprotein in the treatment of pediatric surgical patients.
The usefulness of simultaneous determinations of glucosaminylation and fucosylation indices of alpha-fetoprotein in the differential diagnosis of neoplastic diseases of the liver.
Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma.
Tumor thrombus in the splenic vein originated from gastric carcinoma that produced alpha-fetoprotein.
Ultrasound determination of liver size and assessment of patients with malignant liver disease.
Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
VAB-6 chemotherapy causes spurious elevation of alpha-fetoprotein associated with liver dysfunctions.
Vascular endothelial growth factor receptor-1 levels in hepatocellular carcinoma and correlations with clinicopathological features.
[A long term follow-up study in patients with chronic liver diseases with special reference to serum alpha-fetoprotein]
[Alpha-fetoprotein in the serum of patients with chronic liver diseases]
[Alpha-fetoprotein in the serum of patients with liver diseases]
[Analysis of prognostic factors and construction of a logistic regression model for patients with drug-induced liver failure].
[Clinical application studies on AFP-L3 detected by micro-spin column method].
[Clinical studies on alpha-fetoprotein (AFP). Alpha-fetoprotein levels in pregnant women, newborn infants and patients with various liver diseases]
[Clinical study of subclinical hepatic cancer--analysis of 187 patients]
[Clinicophathological studies of alpha-fetoprotein. (1). Clinical and experimental studies of various non-malignant liver diseases]
[Diagnosis of hepatocellular carcinoma]
[Diagnosis, treatment and prognosis of single-nodular minute hepatocellular carcinoma]
[Epidemiology of hepatocellular carcinoma in the department of Calvados]
[Evaluation of diagnostic performance of alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP) for HCV related hepatocellular carcinoma developed after long-term follow up].
[Evaluation of hepatic resection for hepatocellular carcinoma on cirrhotic livers]
[Heterogeneous reactivity of alpha-fetoprotein from primary liver neoplasms and benign liver diseases with lectins]
[Importance of serum alpha-fetoprotein follow-up analysis in chronic liver diseases]
[Lectin-reactive alpha-fetoprotein in tyrosinaemia type I]
[Long-term course in asymptomatic carriers of HBsAg in an area of low prevalence of hepatocarcinoma]
[Non surgical treatment of hepatocellular carcinoma]
[Occurrence of increased alpha-fetoprotein in non-neoplastic hepatopathies of alcoholic or non-alcoholic origin]
[On the alpha-fetoprotein in the diagnosis of primary liver carcinoma (author's transl)]
[Significance of serum alpha-fetoprotein determination. Experiences with our own radioimmunoassay]
[Studies on the clinical manifestation and SLC25A13 gene mutation of Chinese patients with neonatal intrahepatic cholestasis caused by citrin deficiency.]
[Studies on the immunosuppressive effect of alpha-fetoprotein (AFP) appeared in the serum of patients with liver disease (author's transl)]
[Study on alpha-fetoprotein in serum of liver diseases (author's transl)]
[Surgical treatment of hepatocellular carcinoma: resection or transplantation? Results of a multivariate analysis]
[The efficacy and prognosis of transcatheter chemoembolization for hepatocellular carcinoma in the elderly]
[Value of ultrasonography in the early diagnosis of hepatocellular carcinoma]
Liver Diseases, Alcoholic
Alcoholic liver disease. Absence of alpha-fetoprotein elevations in the recovery phase.
Alpha-fetoprotein alterations in alcoholics with liver disease. V.A. Cooperative Study Groups.
Alpha-fetoprotein and carcinoembryonic antigen in patients with primary liver carcinoma, metastatic liver disease, and alcoholic liver disease.
Human hepatocyte growth factor in alcoholic liver disease: a comparison with change in alpha-fetoprotein. Department of Veterans Affairs Cooperative Study Group 275.
Markedly increased alpha-fetoprotein concentration in serum in alcoholic liver disease: malignant tumor or nonneoplastic changes?
Rib metastasis revealing hepatocellular carcinoma.
[Serum alpha-fetoprotein in alcoholic liver disease (author's transl)]
Liver Failure
Apparent Acetaminophen Toxicity in a Patient with Transaldolase Deficiency.
Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation?
Cavernous sinus syndrome and hepatoma metastasis.
Indications and outcome of liver transplantation in tyrosinaemia type 1.
Stratified alpha-fetoprotein pattern accurately predicts mortality in patients with acute-on-chronic hepatitis B liver failure.
[TRMU MUTATIONS - REVERSIBLE INFANTILE LIVER FAILURE OR MULTISYSTEM DISORDER?]
Liver Failure, Acute
Alpha-fetoprotein and prognosis in acute liver failure.
Alpha-fetoprotein as a prognostic marker in acute liver failure: a pilot study.
Carbohydrate 19-9 antigen as a marker of non-malignant hepatocytic ductular transformation in patients with acute liver failure. A comparison with alpha-fetoprotein and carcinoembryonic antigen.
Decreasing serum alpha-fetoprotein levels in predicting poor prognosis of acute hepatic failure in patients with chronic hepatitis B.
Differential alpha-fetoprotein lectin binding in hepatocellular carcinoma. Diagnostic utility at low serum levels.
Green neutrophilic inclusions in liver disease.
Increase of fucosylated alpha-fetoprotein fraction at the onset of autoimmune hepatitis and acute liver failure.
Lens culinaris agglutinin-A-reactive alpha-fetoprotein as a marker for liver atrophy in fulminant hepatic failure.
Prognostic value of serum alpha-fetoprotein in fulminant hepatic failure including patients treated by charcoal haemoperfusion.
Serum alpha-fetoprotein increases prior to fibrosis resolution in a patient with acute liver failure.
The arterial ketone body ratio and serum alpha-fetoprotein level in patients with acute hepatic failure.
Liver Neoplasms
"Six-and-twelve" score for outcome prediction of hepatocellular carcinoma following transarterial chemoembolization. In-depth analysis from a multicenter French cohort.
A high accuracy cantilever array sensor for early liver cancer diagnosis.
A novel microfluidic co-culture system for investigation of bacterial cancer targeting.
A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
A sensitive, universal and homogeneous method for determination of biomarkers in biofluids by resonance light scattering correlation spectroscopy (RLSCS).
A simple electrochemical immunosensor based on worm-like platinum for highly sensitive determination of alpha-fetoprotein.
A study of alpha-fetoprotein in primary liver cancer in Tanzania.
A-kinase interacting protein 1 (AKIP1) associates with advanced overall disease condition, tumor properties, and unfavorable prognosis in hepatocellular carcinoma patients.
AAV3-mediated transfer and expression of the pyruvate dehydrogenase E1 alpha subunit gene causes metabolic remodeling and apoptosis of human liver cancer cells.
Affinity chromatography used in distinguishing alpha-fetoprotein in serum from patients with tumors of hepatic parenchyma and of germ cells.
Alpha-fetoprotein and Australia antigen in primary liver cancer.
Alpha-fetoprotein and hepatitis B antigen in acute hepatitis and primary cancer of the liver.
Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity.
Alpha-fetoprotein and modified response evaluation criteria in Solid Tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation.
Alpha-fetoprotein and other tumour-associated antigens for immunotherapy of hepatocellular cancer.
Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B.
Alpha-fetoprotein in patients with primary liver cancer and other liver diseases.
Alpha-fetoprotein in primary liver cancer and other diseases.
Alpha-fetoprotein in the treatment of primary liver cancer.
alpha-Fetoprotein levels in cirrhosis and cancer of the liver.
Alpha-fetoprotein triggers hepatoma cells escaping from immune surveillance through altering the expression of Fas/FasL and tumor necrosis factor related apoptosis-inducing ligand and its receptor of lymphocytes and liver cancer cells.
Alpha-fetoprotein-producing renal cell carcinoma.
An inflammation-based prognostic index predicts survival advantage after transarterial chemoembolization in hepatocellular carcinoma.
An integrated microfluidic system for rapid screening of alpha-fetoprotein-specific aptamers.
An isoenzyme of 5'-nucleotide phosphodiesterase and alpha-fetoprotein in human hepatic cancer patient sera.
Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma.
Apoptosis induction by acyclic retinoid: a molecular basis of 'clonal deletion' therapy for hepatocellular carcinoma.
Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood.
Automatic Time-Resolved Fluorescence Immunoassay of Serum Alpha Fetoprotein-L3 Variant via LCA Magnetic Cationic Polymeric Liposomes Improves the Diagnostic Accuracy of Liver Cancer.
Biologic markers in cancer diagnosis and treatment.
Cascade enzyme-linked immunosorbent assay (CELISA).
Changes of phosphatidylcholine-specific phospholipase C in hepatocarcinogenesis and in the proliferation and differentiation of rat liver cancer cells.
Cholestasis is the main determinant of abnormal CA 19-9 levels in patients with liver cirrhosis.
Circular RNA 0016788 displays as a biomarker for tumor progression and poor prognosis in surgical hepatocellular carcinoma patients.
Circulating exosomal miR-92b: Its role for cancer immunoediting and clinical value for prediction of posttransplant hepatocellular carcinoma recurrence.
Circulating microRNA-301 as a promising diagnostic biomarker of hepatitis C virus-related hepatocellular carcinoma.
Clinical and Experimental Evaluation of Diagnostic Significance of Alpha-Fetoprotein and Osteopontin at the Early Stage of Hepatocellular Cancer.
Clinical features and prognosis of hepatocellular carcinoma in young patients from a hepatitis B-endemic area.
Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: Analysis adjusted with inverse probability weighting.
Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors.
Clinical value of spectral CT imaging combined with AFP in identifying liver cancer and hepatic focal nodular hyperplasia.
Clinicopathologic features of hepatic neoplasms in explanted livers: a single institution experience.
Clinicopathological and Prognostic Role of Programmed Cell Death-1 in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study.
Comparing the diagnostic value of serum oligosaccharide chain (G-test) and alpha-fetoprotein for hepatitis B virus-related liver cancer.
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome.
Complete and Sustained Off-Therapy Response to Sorafenib in Advanced Hepatocellular Carcinoma.
Comprehensive study of tumour single nucleotide polymorphism array data reveals significant driver aberrations and disrupted signalling pathways in human hepatocellular cancer.
Computed Tomography-Guided High-Dose-Rate Brachytherapy in Hepatocellular Carcinoma: Safety, Efficacy, and Effect on Survival.
Conductometric immunoassay of alpha-fetoprotein in sera of liver cancer patients using bienzyme-functionalized nanometer-sized silica beads.
Current status of surgical therapy for primary liver cancer in Japan.
Decreased expression of hsa_circ_0003570 in hepatocellular carcinoma and its clinical significance.
Delta-slope of alpha-fetoprotein improves the ability to select liver transplant patients with hepatocellular cancer.
Dependence of the specificity of the serologic test for primary liver cancer in different areas of the world on sensitivity of the method used for detecting alpha-fetoprotein.
Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma.
Determination of plasma urokinase-type plasminogen activator antigen in patients with primary liver cancer: characterization as tumor-associated antigen and comparison with alpha-fetoprotein.
Diagnosis of primary liver cancer using lectin affinity chromatography of serum alkaline phosphatase.
Discriminant analysis in the clinical and biochemical diagnosis of primary liver cancer.
Does alpha-fetoprotein contribute to the mortality and morbidity of human hepatocellular carcinoma? A commentary.
Early Detection of Cancer: Immunoassays for Plasma Tumor Markers.
Effects of transcatheter arterial chemoembolization with oral chemotherapy on hepatic neoplasms.
Efficacy of drug-eluting bead transarterial chemoembolization (DEB-TACE) combined with radiofrequency ablation versus DEB-TACE alone in Chinese hepatocellular carcinoma patients.
Electrochemical immunosensors with AuPt-vertical graphene/glassy carbon electrode for alpha-fetoprotein detection based on label-free and sandwich-type strategies.
Electrokinetic analyte transport assay for alpha-fetoprotein immunoassay integrates mixing, reaction and separation on-chip.
Evaluation of combined assays of serum ferritin, alpha-1-antitrypsin and alpha-fetoprotein in liver cancer.
Evaluation of survival of patients with hepatocellular carcinoma: A comparative analysis of prognostic systems.
Evaluation of the therapeutic effect of TAE on primary liver cancer.
Expected outcomes and patients' selection before chemoembolization-"Six-and-Twelve or Pre-TACE-Predict" scores may help clinicians: Real-life French cohorts results.
Expression of insulin-like growth factor II, alpha-fetoprotein and hepatitis B virus transcripts in human primary liver cancer.
External validation of a simplified BCLC staging system for early hepatocellular carcinoma.
External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV.
Facile and cost-effective liver cancer diagnosis by water-gated organic field-effect transistors.
Factors associated with compliance with recommendations for liver cancer screening in Korea: a nationwide survey in Korea.
Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection.
Fibrolamellar variant of hepatocellular carcinoma presenting during pregnancy: management dilemmas.
Fluorescence and Scattering Light Cross Correlation Spectroscopy and Its Applications in Homogeneous Immunoassay.
Gallium-67-citrate scanning in primary cancer of the liver: diagnostic value in the presence of cirrhosis and relation to alpha-fetoprotein.
Growth inhibition of human liver cancer cells by alpha-fetoprotein antisense strategy.
Hepatitis B and alcohol affect survival of hepatocellular carcinoma patients.
Hepatitis BS antigen, malaria titers, and primary liver cancer in South Vietnam.
Hepatoid gastric carcinoma. A case report.
High-Intensity Focused Ultrasound Ablation for Unresectable Primary and Metastatic Liver Cancer: Real-World Research in a Chinese Tertiary Center With 275 Cases.
How to assess the efficacy or failure of targeted therapy: Deciding when to stop sorafenib in hepatocellular carcinoma.
Identification of two clinical hepatocellular carcinoma patient phenotypes from results of standard screening parameters.
Immunohistochemical analysis of hepatocellular and adenocarcinoma in the liver: MOC31 compares favorably with other putative markers.
Immunotherapy using Freund's adjuvant and recombinant interleukin-2 combined with transarterial chemoembolization for hepatocellular carcinoma.
Impact of branched-chain amino acid supplementation on the survival in patients with advanced hepatocellular carcinoma treated with sorafenib; a multicenter retrospective cohort study.
Impact of interventions and tumor stage on health-related quality of life in patients with hepatocellular carcinoma.
Impact of locoregional therapy and alpha-fetoprotein on outcomes in transplantation for liver cancer: a UNOS Region 6 pooled analysis--conclusion about locoregional therapy.
Impact of locoregional therapy and alpha-fetoprotein on outcomes in transplantation for liver cancer: a UNOS Region 6 pooled analysis.
Improvement of liver cancer detection with simultaneous assessment of circulating levels of free alpha-fetoprotein (AFP) and AFP-IgM complexes.
Interrelations between elevated alpha-fetoprotein levels and tumor morphology of patients with hepatocellular carcinoma.
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?
Lessons learned from cancer vaccine trials and target antigen choice.
Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma: a prospective study.
Long non-coding RNAs (CASC2 and TUG1) in hepatocellular carcinoma: Clinical significance.
Metastatic Spinal Cord Compression Secondary to Liver Cancer.
Molecular background of alpha-fetoprotein in liver cancer cells as revealed by global RNA expression analysis.
Monoclonal antibodies recognizing a recombinant portion of human alpha-fetoprotein with antigenic selectivity versus albumin.
Novel Albumin-Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization.
Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis.
Persistence of circulating complexes between HBsAg and immunoglobulin M in sera of hepatitis B surface antigen positive patients suffering from liver cirrhosis or primary liver cancer.
Photoelectrochemical immunosensor for sensitive detection of alpha-fetoprotein based on a graphene honeycomb film.
Polarized SERS Controlled by Anisotropic Growth on Ordered Curvature Substrate.
Polymer adhesive surface as flexible generic platform for multiplexed assays biochip production.
Potential chemoprevention of diethylnitrosamine-initiated and 2-acetylaminofluorene-promoted hepatocarcinogenesis by zerumbone from the rhizomes of the subtropical ginger (Zingiber zerumbet).
Predictive Role of AURKA rs 1047972 Gene Polymorphism and the Risk of Development of Hepatocellular Carcinoma.
Preoperative Aspartate Aminotransferase to White Blood Cell Count Ratio Predicting Postoperative Outcomes of Hepatocellular Carcinoma.
Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma.
Preserved liver function, portal thrombosis and absence of oesophageal varices are risk factors for metastasis of hepatocellular carcinoma.
Preventive care in chronic liver disease.
Prognostic Factors of Survival of Advanced Liver Cancer Patients Treated With Palliative Radiotherapy: A Retrospective Study.
Prognostic role of plasma level of angiopoietin-1, angiopoietin-2, and vascular endothelial growth factor in hepatocellular carcinoma.
Prognostic value of serum biological markers in patients with hepatocellular carcinoma.
Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
Quantitative serum proteomics from surface plasmon resonance imaging.
Radio frequency ablation for hepatocellular carcinoma in cirrhotic patients: prognostic factors for survival.
Random Survival Forests to Predict Disease Control for Hepatocellular Carcinoma Treated With Transarterial Chemoembolization Combined With Sorafenib.
Rapid fabrication of electrode for the detection of alpha fetoprotein based on MnO2 functionalized mesoporous carbon hollow sphere.
Recombinant aequorin with a reactive cysteine residue for conjugation with maleimide-activated antibody.
Resin versus Glass Microspheres for Yttrium-90 Transarterial Radioembolization: Comparing Survival in Unresectable Hepatocellular Carcinoma using Pretreatment Partition Model Dosimetry.
Risk factors for hepatocellular carcinoma among patients with chronic liver disease.
Risk factors for intraocular metastasis of primary liver cancer in diabetic patients: Alpha-fetoprotein and cancer antigen 125.
Role of Matrix Metallopeptidase 12 in the Development of Hepatocellular Carcinoma.
Screening and Identifying a Novel ssDNA Aptamer against Alpha-fetoprotein Using CE-SELEX.
Screening differential circular RNA expression profiles reveals hsa_circ_0004018 is associated with hepatocellular carcinoma.
Search for Effective Serum Tumor Markers for Early Diagnosis of Hepatocellular Carcinoma Associated with Hepatitis C.
Selection and characterization of a novel affibody peptide and its application in a two-site ELISA for the detection of cancer biomarker alpha-fetoprotein.
Selective Toxicity of Apigenin on Cancerous Hepatocytes by Directly Targeting their Mitochondria.
Serum alpha-fetoprotein and resection of primary hepatic cancer.
Serum alpha-fetoprotein in a mouse strain (C3H-Avy fB) with spontaneous hepatocellular carcinomas.
Serum alpha-fetoprotein subfractions identified by Ricinus communis agglutinin I in hepatic malignancies, yolk sac tumor, benign hepatic diseases, and fetal stage.
Serum alpha-fetoprotein subfractions in hepatic malignancies identified by different reactivities with concanavalin A, lentil lectin or phytohemagglutinin-E.
Serum Biomarkers AFP, CEA and CA19-9 Combined Detection for Early Diagnosis of Hepatocellular Carcinoma.
Serum copper, ceruloplasmin, protein thiols and thiobarbituric acid reactive substance status in liver cancer associated with elevated levels of alpha-fetoprotein.
Serum Liver-Type Fatty Acid-Binding Protein Is a Possible Prognostic Factor in Human Chronic Liver Diseases From Chronic Hepatitis to Liver Cirrhosis and Hepatocellular Carcinoma.
Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
Silencing alpha-fetoprotein expression induces growth arrest and apoptosis in human hepatocellular cancer cell.
Silencing alpha-fetoprotein inhibits VEGF and MMP-2/9 production in human hepatocellular carcinoma cell.
Single particle technique for one-step homogeneous detection of cancer marker using gold nanoparticle probes.
Studies on liver cancer. II. Production of alpha-fetoprotein by experimental hepatoma and its characterization.
Subclinical primary liver carcinoma.
Subtle hepatocellular carcinoma: a persisting role for alpha-fetoprotein monitoring in high-risk patients with cirrhosis.
Surgical and nonsurgical management of primary and metastatic liver tumors.
Survival and prognostic factors in patients with hepatocellular carcinoma treated by percutaneous ethanol injection: a 10-year experience.
T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancer.
Targeted retardation of hepatocarcinoma cells by specific replacement of alpha-fetoprotein RNA.
Targeting alpha-fetoprotein (AFP)-MHC complex with CAR T cell therapy for liver cancer.
The Effect of Alpha-Fetoprotein on the Activation and Phagocytosis of Granulocytes and Monocytes.
The efficacy of immune checkpoint inhibitors in advanced hepatocellular carcinoma: a meta-analysis based on 40 cohorts incorporating 3697 individuals.
The Evolution of the Use of Serum Alpha-fetoprotein in Clinical Liver Cancer Surveillance.
The growing impact of alpha-fetoprotein in the field of liver transplantation for hepatocellular cancer: time for a revolution.
The Prognostic Role of Mitotic Index in Hepatocellular Carcinoma Patients after Curative Hepatectomy.
The value of the Barcelona Clinic Liver Cancer and alpha-fetoprotein in the prognosis of hepatocellular carcinoma.
The Warsaw Proposal for the Use of Extended Selection Criteria in Liver Transplantation for Hepatocellular Cancer.
Tin Oxide Nanosheet Assembly for Hydrophobic/Hydrophilic Coating and Cancer Sensing.
Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma.
Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study.
Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled study.
Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump.
TSC2 Mutations Were Associated with the Early Recurrence of Patients with HCC Underwent Hepatectomy.
Tumour stiffness associated with tumour response to conventional transarterial chemoembolisation for hepatocellular carcinoma: preliminary findings.
Tyrosinemia type I treated by NTBC: how does AFP predict liver cancer?
Unsuspected primary malignancy in the setting of elevated serum alpha-fetoprotein.
Up-regulation of BRCA1-associated RING Domain 1 Promotes Hepatocellular Carcinoma Progression by Targeting Akt Signaling.
Use of a Novel Thyroid-Stimulating Hormone Model for Predicting the Progression of Hepatocellular Carcinoma.
Usefulness of examination of some tumor markers in diagnostics of liver cancer.
Utility of ascitic fluid analysis in patients with malignancy-related ascites.
Value of alpha-fetoprotein and clinical characteristics in patients with liver neoplasm.
Yttrium-90 microspheres for the treatment of hepatocellular carcinoma.
Zhx2 and Zbtb20: novel regulators of postnatal alpha-fetoprotein repression and their potential role in gene reactivation during liver cancer.
[A preliminary study of serum marker alpha-enolase in the diagnosis of hepatocellular carcinoma].
[Alpha-fetoprotein (AFP) variant in the diagnosis of small liver cancer]
[Alpha-fetoprotein and liver cancer]
[Alpha-fetoprotein in the diagnosis of primary liver neoplasms]
[Alpha-fetoprotein variants and their significance in the differential diagnosis of primary liver cancer]
[Analysis of liver cancer screening results and influencing factors of urban residents in Zhejiang Province from 2013 to 2018].
[Analysis of urine metabolic profile in patients with hepatocellular carcinoma].
[Carcinoembryonic type specific markers and liver cancer immunotherapy].
[Clinical significance of low-level alpha-fetoprotein in the diagnosis and treatment of primary liver cancer]
[Clinical significance of serum "hepatoma-specific" gamma-glutamyl transferase and alkaline phosphatase]
[Clinical value of serum tissue polypeptide specific antigen detection for primary hepatic cancer]
[Comparative study of 3 serum markers of primary liver cancer: ferritin, alpha-fetoprotein and alpha-fucosidase]
[Construction of a hepatoma-targeting vector of adeno-associated virus containing human alpha-fetoprotein promoter and wild p53 gene in gene therapy of liver cancer]
[Diagnostic and prognostic importance of the alpha-fetoprotein test in liver cancer and cirrhosis]
[Diagnostic significance of the study of alpha-fetoprotein in liver cirrhosis and primary cancer of the liver]
[Evaluation of detecting 9 tumor markers in serum for diagnosis of primary liver cancer]
[Evaluation of the use of highly sensitive methods of determining alpha-fetoprotein for the diagnosis of hepatocellular cancer and teratoblastoma]
[Heterogeneity of alpha-fetoprotein with concanavalin A-binding properties in the serum and ascites of liver neoplasms and liver cirrhosis]
[Heterogeneous reactivity of alpha-fetoprotein from primary liver neoplasms and benign liver diseases with lectins]
[Immunochemical determination of alpha-fetoprotein in the dynamics of development of liver cirrhosis and hepatocellular cancer]
[Levels of serum alpha-fetoprotein before and after transcatheter embolization of hepatocellular tumors with Lipiodol]
[Occurrence of alpha-fetoprotein in various forms of hepatitis, cirrhosis and primary hepatic cancer]
[On the alpha-fetoprotein in the diagnosis of primary liver carcinoma (author's transl)]
[Possibility of detection of alpha-fetoprotein in the erythrocytes of patients with primary liver cancer]
[Preliminary study of the origin of alpha-fetoprotein (AFP) in the host hepatocytes of human liver cancer: immunohistochemical analysis of 48 cases]
[Radiofrequency thermal ablation combined with arterial embolization for primary liver cancer]
[Radioimmunoassay of alpha-fetoprotein in primary and secondary cancer of the liver.]
[Relation of the specificity of the serologic test for primary liver cancer in different areas of the world to the sensitivity of the method for detecting alpha-fetoprotein]
[Relations between the morphological characteristics and alpha-fetoprotein in primary cancer of the liver (apropos of 92 cases]
[Research progress in prognostic factors of hepatitis B virus-associated end-stage liver disease].
[Research progress of serum biomarkers for early screening of hepatocellular carcinoma].
[Secondary liver cancer of gastric origin with positive alpha-fetoprotein]
[Serum alpha-fetoprotein (AFP) after primary liver cancer resection in adult value of its determination in the detection of recurrence]
[Significance of determination of alpha-fetoprotein in surgery of hepatic cancer]
[Study of Australia antigen in primary liver cancers. Correlation with alpha-fetoprotein]
[The prognostic value of alpha-fetoprotein (AFP) in hepatocellular cancer in chronic carriers of HBsAg and positive HBeAg]
[The prognostic value of focusylated alpha-fetoprotein measurement in liver cancer patients after surgery]
[The value of methods of increased sensitivity for detecting alpha-fetoprotein in the diagnosis of primary liver cancer]
[Triplet anti-tumor therapy based on thymosin ?-1 attenuates incidence of hepatoma and serum alpha-fetoprotein level in rat hepatoma model].
Liver Neoplasms, Experimental
alpha-Fetoprotein gene expression. Control of alpha-fetoprotein mRNA levels in cultured rat hepatoma cells.
Changes in expression of albumin and alpha-fetoprotein genes during rat liver development and neoplasia.
Effect of glucocorticoids on the production of lactate dehydrogenase, malate dehydrogenase and alpha-fetoprotein by Morris hepatoma 7777 in vitro.
Isolation of rat alpha-fetoprotein from Morris hepatoma 7777.
No evidence for post-transcriptional control of albumin and alpha-fetoprotein gene expression in developing rat liver neoplasia.
Studies on liver cancer. II. Production of alpha-fetoprotein by experimental hepatoma and its characterization.
Lordosis
Female mice deficient in alpha-fetoprotein show female-typical neural responses to conspecific-derived pheromones.
Lung Neoplasms
A case of primary lung cancer producing alpha-fetoprotein.
A case report of a three-year survivor with advanced non-small cell lung cancer producing alpha-fetoprotein.
A resected case of metachronous liver metastasis from lung cancer producing alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist II (PIVKA-II).
Alpha-fetoprotein and human chorionic gonadotropin-producing lung cancer.
Alpha-fetoprotein as tumor marker in lung cancer diagnosis.
Alpha-fetoprotein-producing adenocarcinoma of the lung.
Alpha-fetoprotein-producing primary lung carcinoma: a case report.
An immunohistochemical study of keratin, carcinoembryonic antigen, human chorionic gonadotropin and alpha-fetoprotein in lung cancer.
Biomarkers in the lung cancer diagnosis: a clinical perspective.
Carcinoembryonic antigen, alpha 1-fetoprotein, ferritin, and alpha 2-pregnancy associated glycoprotein in the serum of lung cancer patients and its demonstration in lung tumor tissues.
Fetal onset of aberrant gene expression relevant to pulmonary carcinogenesis in lung adenocarcinoma development induced by in utero arsenic exposure.
High-grade fetal adenocarcinoma of the lung with abnormal expression of alpha-fetoprotein in a female patient: Case report.
Markers and characteristics of human SCLC cell lines. Neuroendocrine markers, classical tumor markers, and chromosomal characteristics of permanent human small cell lung cancer cell lines.
Organ-specific profiles of genetic changes in cancers caused by activation-induced cytidine deaminase expression.
Primary lung cancer producing alpha-fetoprotein.
Primary lung cancer producing alpha-fetoprotein: a case report.
Soluble interleukin-2 receptors and other markers in primary lung cancer.
Successful resection of alpha-fetoprotein-producing lung cancer.
[A case of alpha-fetoprotein producing lung cancer without metastasis to the liver]
[A case of alpha-fetoprotein producing lung cancer]
[A case of lung cancer producing alpha-fetoprotein]
[Alpha fetoprotein levels in the serum and bronchoalveolar lavage fluid in patients with lung cancer and other diseases of the respiratory system]
[Blood tumor markers in patients with lung cancer]
[Double primary lung cancers producing alpha-fetoprotein]
[Radioimmunological analysis of the carcinoembryonic antigen and alpha-fetoprotein levels in the blood of lung cancer patients]
Lupus Erythematosus, Systemic
Autoimmune hepatitis with raised alpha-fetoprotein level as the presenting symptoms of systemic lupus erythematosus: a case report.
Elevation of maternal alpha-fetoprotein in systemic lupus erythematosus: a controlled study.
Rheumatic syndromes: clues to occult neoplasia.
Lymphadenopathy
A case of primary biliary cirrhosis that complicated with combined hepatocellular and cholangiocellular carcinoma.
Endolymphatic immunotherapy in inoperable hepatocellular carcinoma.
Gastric hepatoid adenocarcinoma: a computed tomography report of six cases.
Hepatoid adenocarcinoma of the colon in a patient with inflammatory bowel disease.
Hepatoid adenocarcinoma of the gallbladder with production of alpha-fetoprotein.
Hepatoid adenocarcinoma: computed tomographic imaging findings with histopathologic correlation in 6 cases.
Metastatic hepatocellular carcinoma: When surgery and successive palliative treatments lead to remission.
Primary focal T-cell lymphoma of the liver: a case report and review of the literature.
Primary lymphoma of the liver: a case report and review.
Primary mediastinal seminoma.
Sarcoidosis and testicular tumors.
Testicular cancer and Hodgkin disease in the same patient.
[A case of alpha-fetoprotein producing embryonal carcinoma of the stomach]
Lymphangioma, Cystic
Alpha-fetoprotein and ultrasound scanning in the prenatal diagnosis of Turner's syndrome.
Amniotic fluid alpha-fetoprotein levels in the differential diagnosis of cystic hygroma.
Amniotic fluid levels of alpha-fetoprotein and other proteins in a case of Turner's syndrome of the fetus.
Biochemical analyses of mesenchymal fluid in early pregnancy.
Congenital malformation syndromes and elevation of amniotic fluid alpha-fetoprotein.
Elevated alpha-fetoprotein levels in the 45,x (Turner syndrome) fetus with cystic hygroma. Case reports.
Etiology, prognosis and management of nuchal cystic hygroma: 25 new cases and literature review.
First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
Prenatal diagnosis of Turner syndrome using cells cultured from cystic hygromas in two pregnancies with normal maternal serum alpha-fetoprotein.
[Differential diagnostic procedure in sonographically detected fetal cystic hygroma]
[Extremely high alpha-fetoprotein levels in a puncture specimen with few cells following amniocentesis and interpretation by sonography]
Lymphatic Metastasis
A radioresistant variant cell line, NMT-1R, isolated from a radiosensitive rat yolk sac tumour cell line, NMT-1: differences of early radiation-induced morphological changes, especially apoptosis.
Aldo-keto Reductase Family 1 Member B 10 Mediates Liver Cancer Cell Proliferation through Sphingosine-1-Phosphate.
Anti-programmed cell death ligand 1-based immunotherapy in recurrent hepatocellular carcinoma with inferior vena cava tumor thrombus and metastasis: Three case reports.
C14orf166 Is a Biomarker for Predicting Hepatocellular Carcinoma Recurrence.
Clinico-Radio-Pathological and Molecular Features of Hepatocellular Carcinomas with Keratin 19 Expression.
Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma.
Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Clinicopathological implications of immunohistochemically demonstrated mucin core protein expression in hepatocellular carcinoma.
Clinicopathological variables associated with lymph node metastasis in submucosal invasive gastric cancer.
Decision Making in a Data-Poor Environment: Management of Brain Metastases From Testicular and Extragonadal Germ Cell Tumors.
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia-Pacific trial.
Establishment and characterization of a rat yolk sac tumor cell line, NMT-1, producing alpha-fetoprotein, with potential for lymphatic metastasis.
Expression and Significance of LncRNA-MINCR and CDK2 mRNA in Primary Hepatocellular Carcinoma.
Follistatin Like 5 (FSTL5) inhibits epithelial to mesenchymal transition in hepatocellular carcinoma.
Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis.
Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Hypothesis: when is a seminoma not a seminoma?
Impact of age on the prognosis after liver transplantation for patients with hepatocellular carcinoma: a single-center experience.
Krukenberg tumor with yolk sac tumor differentiation.
LncRNA CASC9 promotes proliferation, migration and inhibits apoptosis of hepatocellular carcinoma cells by down-regulating miR-424-5p.
Lymphocyte to monocyte ratio-based nomogram for predicting outcomes of hepatocellular carcinoma treated with sorafenib.
Overexpression of lncRNA MT1JP Mediates Apoptosis and Migration of Hepatocellular Carcinoma Cells by Regulating miR-24-3p.
Prognostic factors and rational approach in the treatment of submucosal cancer of the stomach.
Prognostic factors for patients with hepatocellular carcinoma with macroscopic portal vein or inferior vena cava tumor thrombi receiving external-beam radiation therapy.
Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience.
Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients.
Serum-soluble interleukin-2 receptor concentrations in patients with gastric cancer.
Significant response to ramucirumab monotherapy in chemotherapy-resistant recurrent alpha-fetoprotein-producing gastric cancer: A case report.
[A giant testicular tumor detected with dyspnea due to lung metastases: a case report]
[Correlation analysis of Ki67, Ck19 with clinicopathological features and apparent diffusion coefficient value of hepatocellular carcinoma].
Lymphoma
Alpha-fetoprotein in canine multicentric lymphoma.
Clinical applications of the enzyme labeled antibody method. Immunoperoxidase methods in diagnostic histopathology.
Detection of serum alpha-fetoprotein in dogs with naturally occurring malignant neoplasia.
Imaging diagnosis of testicular lymphoma.
Primary hepatic B-cell lymphoma in a child.
Primary lymphoma of the liver. Ten cases and a review of the literature.
Primary non-Hodgkin lymphoma of liver.
Tumor cell dissemination triggers an intrathecal immune response in neoplastic meningitis.
Lymphopenia
Ataxia telangiectasia: a review.
Lysosomal Storage Diseases
Prenatal diagnosis of Pena-Shokeir syndrome type 1.
Malnutrition
Elevated serum alpha-fetoprotein and impaired immune response in malnutrition.
Massive Hepatic Necrosis
Alcoholic liver disease. Absence of alpha-fetoprotein elevations in the recovery phase.
Hepatitis B virus markers, alpha-fetoprotein and survival in fulminant viral hepatitis.
Phenotypic characterization of hepatic proliferation. Antigenic expression by proliferating epithelial cells in fetal liver, massive hepatic necrosis, and nodular transformation of the liver.
Serum alpha-fetoprotein (AFP) in benign and malignant gastrointestinal diseases: evaluation of an immunoenzymatic assay.
Serum alpha-fetoprotein in fulminant hepatitis and hepatic regeneration following partial hepatectomy.
Serum alpha-fetoprotein in patients with massive hepatic necrosis.
Meconium Ileus
The direct early diagnosis of cystic fibrosis by the detection of the delta F508 CFTR gene mutation in a prematurely delivered boy.
Medulloblastoma
Radioimmunoassay of alpha-fetoprotein in children with primary intracranial tumors.
The value of surveillance testing in childhood brain tumors.
Melanoma
A mapping study of 13 genes on human chromosome bands 4q11-->q25.
Development of a Listeria monocytogenes-based vaccine against hepatocellular carcinoma.
Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
Radioimmunoassay of alpha-fetoprotein in the serum of patients with leukemia and malignant melanoma.
Tumor cell dissemination triggers an intrathecal immune response in neoplastic meningitis.
Meningitis
Tumor cell dissemination triggers an intrathecal immune response in neoplastic meningitis.
Meningomyelocele
A meningomyelocele with normal intracranial signs on ultrasound and false-negative amniotic fluid alpha-fetoprotein and acetylcholinesterase.
Effacement of the fetal cisterna magna in association with myelomeningocele.
Myelocele and alpha-fetoprotein in amniotic fluid.
Metabolic Diseases
Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation.
Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals.
Metabolic Syndrome
Association between alpha-fetoprotein and metabolic syndrome in a Chinese asymptomatic population: a cross-sectional study.
Metabolism, Inborn Errors
Detection of treatable neonatal liver disease by expanded newborn screening.
[Progress in prenatal diagnosis]
Microcephaly
A reappraisal of amniotic fluid alpha-fetoprotein measurement at the time of genetic amniocentesis and midtrimester ultrasonography.
Further delineation of the Nijmegen breakage syndrome.
Linkage studies exclude the AT-V gene(s) from the translocation breakpoints in an AT-V patient.
Movement Disorders
Autosomal-Recessive Cerebellar Ataxias and Movement Disorders With Elevated Alpha-Fetoprotein.
Radioresistant DNA synthesis and human genetic diseases.
Mucopolysaccharidosis I
A clinical service for prenatal diagnosis.
Multiple Acyl Coenzyme A Dehydrogenase Deficiency
Prenatal diagnosis of multiple acyl-CoA dehydrogenase deficiency: association with elevated alpha-fetoprotein and cystic renal changes.
Multiple Sclerosis
MM-093, a recombinant human alpha-fetoprotein for the potential treatment of rheumatoid arthritis and other autoimmune diseases.
The clinical course of multiple sclerosis during pregnancy and the puerperium.
Musculoskeletal Pain
Bone scintigraphy of skeletal metastasis in hepatoma patients treated by TAE.
Myasthenia Gravis
alpha-Fetoprotein and neonatal transient myasthenia gravis.
Alpha-fetoprotein inhibits antibody binding to acetylcholine receptor. Significance for myasthenia gravis and other autoimmune diseases.
Immunosuppression of experimental autoimmune myasthenia gravis by alpha-fetoprotein rich formation.
Influence of alpha-fetoprotein on the in vitro and in vivo immune response to acetylcholine receptor.
Inhibitory effect of alpha-fetoprotein on the binding of myasthenia gravis antibody to acetylcholine receptor.
MM-093, a recombinant human alpha-fetoprotein for the potential treatment of rheumatoid arthritis and other autoimmune diseases.
[Myasthenia gravis and pregnancy. Review of the literature and considerations on the immunoprotective effect of alpha-fetoprotein through the observation of a clinical case]
Myasthenia Gravis, Autoimmune, Experimental
Experimental myasthenia gravis induced in mice by passive transfer of human myasthenic immunoglobulin. Evidence for an ameliorating effect by alpha-fetoprotein.
Mycosis Fungoides
Advances in biological markers for cancer.
Myelodysplastic Syndromes
Clinical study on the serum carcinoembryonic antigen, CA 19-9, CA 50 and alpha-fetoprotein levels in patients with myelodysplastic syndromes.
Myocardial Infarction
An IgM lambda antibody to Escherichia coli produces false-positive results in multiple immunometric assays.
Myocarditis
Restoration of FAS-Mediated Apoptosis of Lymphocytes in Patients with Myocarditis by Specific Peptide Sequence of Human Alpha-Fetoprotein (AFP(13-19)).
Myoclonus
Myoclonus.
Nasopharyngeal Carcinoma
Significance of tumour markers in nasopharyngeal carcinoma.
Neoplasm Metastasis
A CASE OF GROWING TERATOMA SYNDROME.
A case of hepatocellular carcinoma with pulmonary metastases treated successfully with a combination of repeated hepatic arterial infusion epirubicin and Cisplatin chemotherapy and systemic low-dose infusion of 5-Fluorouracil.
A Case of Mixed Germ Cell Tumor in the Intramedullary Spinal-cord.
A model to estimate survival in ambulatory patients with hepatocellular carcinoma.
A new risk-stratification system for hepatoblastoma in children under six years old and the significance for prognosis evaluation-a 14-year retrospective study from a single center.
A resected case of metachronous liver metastasis from lung cancer producing alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist II (PIVKA-II).
A unique case of an alpha-fetoprotein-producing lung cancer with testicular metastasis.
Abnormality of Wnt3a expression as novel specific biomarker for diagnosis and differentiation of hepatocellular carcinoma.
Acinar-islet cell carcinoma presenting as insulinoma.
Activation of c-Src gene product in hepatocellular carcinoma is highly correlated with the indices of early stage phenotype.
Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania.
Advanced hepatocellular carcinoma responds to MK615, a compound extract from the Japanese apricot "Prunus mume".
Advances in the management of metastatic non-seminomatous germ cell tumours during the cisplatin era: a single-institution experience.
AFP-producing adenocarcinoma of the esophagogastric junction: report of a case with atypical immunohistochemical findings responding to palliative chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT regime).
AFP-producing hepatoid adenocarcinoma in association with Barrett's esophagus with multiple liver metastasis responding to paclitaxel/CDDP: a case report.
Aggressive excision of pulmonary metastases is warranted in the management of childhood hepatic tumors.
Aldo-keto Reductase Family 1 Member B 10 Mediates Liver Cancer Cell Proliferation through Sphingosine-1-Phosphate.
Alpha-fetoprotein (AFP)- and des-gamma-carboxy prothrombin (DCP)-producing adenocarcinoma of the stomach with liver metastasis in a patient with chronic hepatitis C.
Alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
Alpha-fetoprotein in patients of gastric carcinoma with or without liver metastasis.
Alpha-fetoprotein in the serum of patients with neoplasms of the gastrointestinal tract.
Alpha-fetoprotein receptor as an early indicator of HBx-driven hepatocarcinogenesis and its applications in tracing cancer cell metastasis.
Alpha-Fetoprotein Regulates the Expression of Immune-Related Proteins through the NF-?B (P65) Pathway in Hepatocellular Carcinoma Cells.
Alpha-fetoprotein- and des-gamma-carboxy prothrombin-producing advanced gastric cancer.
Alpha-fetoprotein-producing acinar cell carcinoma of the pancreas.
Alpha-fetoprotein-producing gastric cancer.
Alpha-fetoprotein-producing renal cell carcinoma.
An isolate alpha-fetoprotein producing gastric cancer liver metastasis emerged in a patient previously affected by radiation induced liver disease.
An Oxygen-Concentration-Controllable Multiorgan Microfluidic Platform for Studying Hypoxia-Induced Lung Cancer-Liver Metastasis and Screening Drugs.
Analysis of prognostic factors in patients receiving transarterial radioembolization for unresectable hepatocellular carcinoma.
Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma.
Analysis of survival rates and prognosis of hepatoblastoma in children: a retrospective study from a single center in China.
Angiogenesis of AFP producing gastric carcinoma: correlation with frequent liver metastasis and its inhibition by anti-AFP antibody.
Anti-programmed cell death ligand 1-based immunotherapy in recurrent hepatocellular carcinoma with inferior vena cava tumor thrombus and metastasis: Three case reports.
ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma.
Association of reduced cell adhesion regulator messenger RNA expression with tumor progression in human hepatocellular carcinoma.
Biological aggressiveness of alpha-fetoprotein (AFP)-positive gastric cancer.
Brain metastases and elevated alpha-fetoprotein level in a patient with esophageal carcinoma.
c-Myc-mediated SNRPB upregulation functions as an oncogene in hepatocellular carcinoma.
C14orf166 Is a Biomarker for Predicting Hepatocellular Carcinoma Recurrence.
Carcino-fetal proteins and gastric cancer: the site of alpha-fetoprotein synthesis in gastric cancer.
Carcinoembryonic proteins in gastric carcinoma metastatic to the liver.
Characteristics of hepatocellular carcinoma associated with extrahepatic primary malignancies in southern Japan.
Circular RNA circARPP21 Acts as a Sponge of miR-543 to Suppress Hepatocellular Carcinoma by Regulating LIFR.
Cisplatin, etoposide, bleomycin first-line therapy and early resection of residual tumor in far-advanced germinal testis cancer.
Clinical Characteristics of Long-Term Survivors After Sorafenib Treatment for Unresectable Hepatocellular Carcinoma: A Korean National Multicenter Retrospective Cohort Study.
Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy.
Clinical features, biochemical parameters, and virological profiles of patients with hepatocellular carcinoma in Hong Kong.
Clinical manifestations in patients with alpha-fetoprotein-producing gastric cancer.
Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India.
Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma.
Clinical significance of combination study of apoptotic factors and proliferating cell nuclear antigen in estimating the prognosis of hepatocellular carcinoma.
Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association.
Clinico-Radio-Pathological and Molecular Features of Hepatocellular Carcinomas with Keratin 19 Expression.
Clinicopathologic features of gastric cancers producing alpha-fetoprotein.
Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma.
Clinicopathological and Prognostic Role of Programmed Cell Death-1 in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Clinicopathological features of early gastric cancer: results of 100 cases from a rural general hospital.
Clinicopathological features of malignancy in hepatocellular carcinoma.
Clinicopathological implications of immunohistochemically demonstrated mucin core protein expression in hepatocellular carcinoma.
Clinicopathological significance of loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in China.
Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma.
Clinicopathological variables associated with lymph node metastasis in submucosal invasive gastric cancer.
Combined transarterial chemoembolization and radiotherapy as a first-line treatment for hepatocellular carcinoma with macroscopic vascular invasion: Necessity to subclassify Barcelona Clinic Liver Cancer stage C.
Complete response after short-term sorafenib treatment in a patient with lymph node metastasis of hepatocellular carcinoma.
Complete response of hepatocellular carcinoma with systemic combination chemotherapy: not to get out the chemotherapy?
Connexin-43 can delay early recurrence and metastasis in patients with hepatitis B-related hepatocellular carcinoma and low serum alpha-fetoprotein after radical hepatectomy.
CT volume measurement for prognostic evaluation of unresectable hepatocellular carcinoma after TACE.
Current management of hepatocellular carcinoma.
Decision Making in a Data-Poor Environment: Management of Brain Metastases From Testicular and Extragonadal Germ Cell Tumors.
Des-gamma carboxy prothrombin (PIVKA-II) and alpha-fetoprotein producing gastric cancer with multiple liver metastases.
Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma.
Detection of tumor cells in peritoneal lavages from patients with gastrointestinal cancer by multiplex reverse transcriptase PCR.
Development and Identification of a Nomogram Prognostic Model for Patients with Primary Clear Cell Carcinoma of the Liver.
Diagnostic utility of immunohistochemistry in hepatocellular carcinoma, its variants and their mimics.
Diagnostic value of serum tumor markers in skeletal metastasis of carcinomas.
Difficulties of a surveillance study omitting retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germ cell tumors of the testis.
Discrete nature of EpCAM(+) and CD90(+) cancer stem cells in human hepatocellular carcinoma.
Does alpha-fetoprotein contribute to the mortality and morbidity of human hepatocellular carcinoma? A commentary.
Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma.
Early treatment response to transcatheter arterial chemoembolization is associated with time to the development of extrahepatic metastasis and overall survival in intermediate-stage hepatocellular carcinoma.
Education and Imaging. Gastrointestinal: brain metastasis of alpha-fetoprotein producing gastric adenocarcinoma.
Effectiveness of Lipiodol in transcatheter arterial embolization of hepatocellular carcinoma.
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia-Pacific trial.
Efficacy of a Hepatectomy and a Tumor Thrombectomy for Hepatocellular Carcinoma with Tumor Thrombus Extending to the Main Portal Vein.
Efficiency of composite laboratory tests in the diagnosis of liver malignancies.
Elevation of MAP17 enhances the malignant behavior of cells via the Akt/mTOR pathway in hepatocellular carcinoma.
Embryonal carcinoma of the testis associated with prostate cancer in a 72-year-old man.
Engineered measles virus Edmonston strain used as a novel oncolytic viral system against human hepatoblastoma.
Evaluation of PRL-3 expression, and its correlation with angiogenesis and invasion in hepatocellular carcinoma.
Evaluation of six tumor markers in patients with carcinoma of unknown primary.
Evaluation of VEGF and VEGF-C expression in gastric cancer cells producing alpha-fetoprotein.
Expression and Clinical Significance of CMTM6 in Hepatocellular Carcinoma.
Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma.
Expression and Significance of LncRNA-MINCR and CDK2 mRNA in Primary Hepatocellular Carcinoma.
Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
Fifty years of discovery of alpha-fetoprotein as the first tumor marker.
Follistatin Like 5 (FSTL5) inhibits epithelial to mesenchymal transition in hepatocellular carcinoma.
GABPA predicts prognosis and inhibits metastasis of hepatocellular carcinoma.
Gastric hepatoid adenocarcinoma: a computed tomography report of six cases.
Gender difference in clinicopathologic features and survival of patients with hepatocellular carcinoma.
Gene transfer of kringle 1-5 suppresses tumor development and improves prognosis of mice with hepatocellular carcinoma.
Genetic alterations of the ATBF1 gene in gastric cancer.
Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Hepatocellular carcinoma in the elderly: clinical characteristics, treatment, survival analysis in Korean patients older than 70 years.
Hepatocellular carcinoma presenting as bone metastasis.
Hepatocellular carcinoma with Pancoast's syndrome as an initial symptom: a case report.
Hepatoid adenocarcinoma of the stomach with liver metastasis mimicking hepatocellular carcinoma: a case report.
Hepatoid adenocarcinoma of the stomach: dual-time-point (18)F-FDG PET/CT findings.
Hepatoid adenocarcinoma: computed tomographic imaging findings with histopathologic correlation in 6 cases.
Hepatoid carcinoma of the stomach: is it still an unusual anatomo-clinical entity? Six cases-report.
High alpha-fetoprotein level in HCV-related nodular liver cell dysplasia.
High frequency of c-Met expression in gastric cancers producing alpha- fetoprotein.
High-dose chemotherapy in children with metastatic hepatoblastoma.
How to assess the efficacy or failure of targeted therapy: Deciding when to stop sorafenib in hepatocellular carcinoma.
Human chorionic gonadotropin in gastric carcinoma. A useful marker for bone metastasis.
Hypothesis: when is a seminoma not a seminoma?
Identification of N-glycosylation sites on secreted proteins of human hepatocellular carcinoma cells with a complementary proteomics approach.
Immunocytochemical presentation of alpha-fetoprotein-producing gastric cancer in ascitic fluid: a case study.
Immunohistochemical expression profiles of solute carrier transporters in alpha-fetoprotein-producing gastric cancer.
Impact of age on the prognosis after liver transplantation for patients with hepatocellular carcinoma: a single-center experience.
Importance of achieving complete necrosis during the first treatment for hepatocellular carcinoma to prevent bone metastasis: a prospective study.
Incidence, risk factors, and prognosis in patients with primary hepatocellular carcinoma and lung metastasis: a population-based study.
Increased alpha-fetoprotein concentration in association with ileal adenocarcinoma complicating Crohn's disease.
Indicators of Lung Shunt Fraction Determined by Technetium-99 m Macroaggregated Albumin in Patients with Hepatocellular Carcinoma.
International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.
Intrahepatic metastasis is more risky than multiple occurrence in hepatocellular carcinoma patients after curative liver resection.
Irinotecan plus low-dose cisplatin for alpha-fetoprotein-producing gastric carcinoma with multiple liver metastases: report of two cases.
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?
Jie-du granule preparation for the treatment of advanced hepatocellular carcinoma: a retrospective cohort study of 177 patients.
KAI1 gene expression in hepatocellular carcinoma and its relationship with intrahepatic metastases.
Krukenberg tumor with yolk sac tumor differentiation.
Late recurrence of testicular cancer.
Lipiodolization for unresectable hepatocellular carcinoma: an analysis of 205 patients using univariate and multivariate analysis.
Liver resection for hepatocellular carcinoma in patients with cirrhosis.
Living Donor Liver Re-Transplantation for Recurrent Hepatoblastoma in the Liver Graft following Complete Eradication of Peritoneal Metastases under Indocyanine Green Fluorescence Imaging.
LncRNA CASC9 promotes proliferation, migration and inhibits apoptosis of hepatocellular carcinoma cells by down-regulating miR-424-5p.
Local tumor control of thoracoabdominal wall seeding tumor from hepatocellular carcinoma with ultrasound-guided interventional treatment: A summarized study.
Localisation of malignant germ-cell tumours by external scanning after injection of radiolabelled anti-alpha-fetoprotein.
Long-term Outcome of Chemotherapy for Advanced Testicular and Extragonadal Germ Cell Tumors: A Single-center 27-year Experience.
Long-term survival achieved by repeated resections of metachronous pulmonary and adrenal metastases of alpha-fetoprotein-producing gastric cancer: report of a case.
Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus-related hepatocellular carcinoma metastasis through the upregulation of ADAM9.
Lymphocyte to monocyte ratio-based nomogram for predicting outcomes of hepatocellular carcinoma treated with sorafenib.
Malignant cervical teratoma: report of a case in a newborn.
Mechanism of Cancer Growth Suppression of Alpha-Fetoprotein Derived Growth Inhibitory Peptides (GIP): Comparison of GIP-34 versus GIP-8 (AFPep). Updates and Prospects.
Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
Metastatic neuroendocrine carcinoma presenting as multifocal liver lesions with elevated alpha-fetoprotein.
Metastatic Spinal Cord Compression Secondary to Liver Cancer.
Multidisciplinary treatment of advanced testicular tumor with bulky liver metastasis.
Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer Multiinstitutional Phase III Study.
Multivariate analysis of serum tumor markers for diagnosis of skeletal metastases.
Negative impact of low body mass index on liver cirrhosis patients with hepatocellular carcinoma.
NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma.
Non-palpable testicular embryonal carcinoma diagnosed by ultrasound: a case report.
Nonpalpable testicular pure seminoma with elevated serum alpha-fetoprotein presenting with retroperitoneal metastasis: a case report.
Oncogenic Roles of RAD51AP1 in Tumor Tissues Related to Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma.
Orchiectomy alone in clinical stage I nonseminomatous testis cancer: a critical appraisal.
Outcome of Hepatitis B Virus Infection After Living-Donor Liver Transplant: A Single-center Experience Over 20 Years.
Ovarian and hepatic metastases of gastric carcinoma associated with high serum levels of human chorionic gonadotropin (hCG), alpha-fetoprotein (AFP), and carcinoembryonic antigen (CEA): a case report.
Ovarian yolk sac tumor arising from an endometrioid carcinoma.
Overexpression of lncRNA MT1JP Mediates Apoptosis and Migration of Hepatocellular Carcinoma Cells by Regulating miR-24-3p.
Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
Pancreatoblastoma.
PARP-1 serves as a novel molecular marker for hepatocellular carcinoma in a Southern Chinese Zhuang population.
Partial response of metastatic hepatocellular carcinoma after treatment with thymostimulin.
Patterns of hepatoblastoma and hepatocellular carcinoma in children after universal hepatitis B vaccination in taiwan: a report from a single institution in southern Taiwan.
Pediatric Liver Transplant For Hepatoblastoma: A Single-Center Experience.
Pediatric liver transplantation for hepatoblastoma: a single center experience.
Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 is a diagnostic and prognostic biomarker for hepatocellular carcinoma.
Population-based assessment of the national comprehensive cancer network recommendations for baseline imaging of hepatocellular carcinoma.
Postoperative detection of alpha-fetoprotein mRNA in blood as a predictor for metastatic recurrence of hepatocellular carcinoma.
Predictive factors in patients with hepatocellular carcinoma receiving sorafenib therapy using time-dependent receiver operating characteristic analysis.
Predictors of postoperative diffuse intrahepatic recurrence of hepatocellular carcinoma.
Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.
Pretreatment prognostic factors for children with hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1.
Primary liver cancers in Japan.
Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems.
Prognostic and clinicopathological significance of PD-1 expression in hepatocellular carcinoma: a meta-analysis.
Prognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinoma.
Prognostic factors and rational approach in the treatment of submucosal cancer of the stomach.
Prognostic factors and staging systems in childhood hepatoblastoma.
Prognostic factors for patients with hepatocellular carcinoma with macroscopic portal vein or inferior vena cava tumor thrombi receiving external-beam radiation therapy.
Prognostic factors for pulmonary metastasectomy in the treatment of hepatocellular carcinoma.
Prognostic factors in children with extracranial germ cell tumors treated with cisplatin-based chemotherapy.
Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Identification of two groups of patients with prospects for prolonged survival.
Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience.
Prognostic Factors of Survival of Advanced Liver Cancer Patients Treated With Palliative Radiotherapy: A Retrospective Study.
Prognostic Importance of 18F-FDG Uptake Pattern of Hepatocellular Cancer Patients Who Received SIRT.
Prognostic model for hepatocellular carcinoma with time-dependent factors.
Prognostic nomogram for hepatocellular carcinoma with fibrosis of varying degrees: a retrospective cohort study.
Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma.
Prognostic significance of pretreatment albumin/globulin ratio in patients with hepatocellular carcinoma.
Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma.
Prognostic value of tumor size, metastases, extension into bone, and increased tumor marker in children with malignant sacrococcygeal germ cell tumors: a prospective evaluation of 71 patients treated in the German cooperative protocols Maligne Keimzelltumoren (MAKEI) 83/86 and MAKEI 89.
Proposal and validation of a new model to estimate survival for hepatocellular carcinoma patients.
Pulmonary atypical carcinoid tumor with marked alphafetoprotein production and features of an adenocarcinoma differentiation.
Radiofrequency ablation for the treatment of bone metastases from hepatocellular carcinoma.
Radiological and clinical features of sarcomatoid hepatocellular carcinoma in 11 cases.
Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey.
Relationship between pathologic prognostic factors and abnormal levels of des-gamma-carboxy prothrombin and alpha-fetoprotein in hepatocellular carcinoma.
Resection of liver metastases from an alpha-fetoprotein-producing gastric cancer.
Resection of liver metastasis from alpha-fetoprotein-producing early gastric cancer: report of a case.
Resection of peritoneal metastases from hepatocellular carcinoma.
Results of a surgical resection of pulmonary metastasis from hepatocellular carcinoma: prognostic impact of the preoperative serum alpha-fetoprotein level.
Review of 336 patients with hepatocellular carcinoma at Songklanagarind Hospital.
Rib metastasis revealing hepatocellular carcinoma.
Risk and prognostic nomograms for hepatocellular carcinoma with newly-diagnosed pulmonary metastasis using SEER data.
Risk factors for intraocular metastasis of primary liver cancer in diabetic patients: Alpha-fetoprotein and cancer antigen 125.
Risk factors of the recurrence of hepatocellular carcinoma originating from residual cancer cells after hepatectomy.
RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma.
Role of C11-FDG dual-tracer PET-CT scan in metastatic screening of hepatocellular carcinoma-a cost-effectiveness analysis.
Salvage chemotherapy with high-dose carboplatin plus etoposide and autologous peripheral blood stem cell transplant in male pure choriocarcinoma: a retrospective analysis of 13 cases.
Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood.
Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients.
Serum alpha-fetoprotein subfractions identified by Ricinus communis agglutinin I in hepatic malignancies, yolk sac tumor, benign hepatic diseases, and fetal stage.
Serum alpha-fetoprotein subfractions in hepatic malignancies identified by different reactivities with concanavalin A, lentil lectin or phytohemagglutinin-E.
Serum alpha-fetoprotein subfractions in patients with primary hepatoma or hepatic metastasis of gastric cancer.
Serum biomarkers in metastatic renal cell carcinoma.
Serum immunoreactivity of SMP30 and its tissues expression in hepatocellular carcinoma.
Serum tumor markers for detection of bone metastasis in breast cancer patients.
Serum-soluble interleukin-2 receptor concentrations in patients with gastric cancer.
Significant response to ramucirumab monotherapy in chemotherapy-resistant recurrent alpha-fetoprotein-producing gastric cancer: A case report.
Specific prognostic factors in hepatitis B virus-related and non-hepatitis B virus-related intrahepatic cholangiocarcinoma after macroscopic curative resection.
Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer.
Stage migration and the increasing proportion of complete responders in patients with advanced germ cell tumors.
Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma.
Statistical evaluation of 2001 carcinoid cases with metastases, collected from literature: a comparative study between ordinary carcinoids and atypical varieties.
Sub-Classification of Advance-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with Sorafenib.
Successful cure of dermatomyositis after treatment of nonseminomatous testicular cancer.
Successful paclitaxel-based chemotherapy for an alpha-fetoprotein-producing gastric cancer patient with multiple liver metastases.
Successful resection of metachronous liver metastasis from alpha-fetoprotein-producing gastric cancer: report of a case.
Successful treatment of good-risk disseminated testicular cancer with cisplatin, bleomycin, and reduced-dose vinblastine.
Successfully treated metachronous liver metastasis of alpha-fetoprotein-producing early gastric cancer: case report.
Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers.
Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
Survival of patients with nonseminomatous germ cell cancer: a review of the IGCC classification by Cox regression and recursive partitioning.
Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
Tg737 acts as a key driver of invasion and migration in liver cancer stem cells and correlates with poor prognosis in patients with hepatocellular carcinoma.
The efficacy of immune checkpoint inhibitors in advanced hepatocellular carcinoma: a meta-analysis based on 40 cohorts incorporating 3697 individuals.
The impact of interferon gamma receptor expression on the mechanism of escape from host immune surveillance in hepatocellular carcinoma.
The monitoring role of plasma CEA alone and in association with other tumor markers in colorectal and mammary carcinoma.
The prognosis of hepatocellular carcinoma after curative hepatectomy in young patients.
The Prognostic Role of Mitotic Index in Hepatocellular Carcinoma Patients after Curative Hepatectomy.
The Research of No-Touch Isolation Technique on the Prevention of Postoperative Recurrence and Metastasis of Hepatocellular Carcinoma after Hepatectomy.
The use of a monoclonal antibody against alpha-fetoprotein for the radioimmunodetection of hepatocellular carcinoma.
Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma.
Thyroxine-binding globulin as a marker of liver tumors.
Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China.
Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.
Transarterial Chemoembolization for the Treatment of Advanced-Stage Hepatocellular Carcinoma.
Transarterial chemoembolization in unresectable hepatocellular carcinoma--assessing the factors affecting the survival: An audit from a tertiary care center in northern India.
Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors.
Transesophageal echocardiography in the detection of inferior vena cava and cardiac metastasis in hepatocellular carcinoma.
Use of Cytokeratin-19 Concentration to Assess Early Recurrence and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma following Radical Resection in Patients with a Low Serum Alpha-Fetoprotein Concentration.
Usefulness of Lens culinaris agglutinin A-reactive fraction of alpha-fetoprotein (AFP-L3) as a marker of distant metastasis from hepatocellular carcinoma.
Uterine Carcinosarcoma with Alpha-Fetoprotein-Producing Hepatoid Component: A Case Report and Literature Review.
Well-differentiated gall bladder hepatoid carcinoma producing alpha-fetoprotein: a case report.
What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?
[A case of alpha-fetoprotein producing lung cancer without metastasis to the liver]
[A case of bilateral germ cell tumor of the testis]
[A case of hepatocellular carcinoma with bone metastasis which responded to oral administration of UFT]
[A case of postoperative liver metastasis of alpha-fetoprotein producing gastric cancer successfully treated with intrahepatic chemotherapy (adriamycin, cisplatin, irinotecan hydrochloride)]
[A case of renal carcinoma with bone metastasis, producing alpha-fetoprotein]
[A case of stage IIIB2 infantile yolk sac tumor of testis achieved complete remission by "COMPE" chemotherapy]
[A complete response to one-shot hepatic arterial infusion of epirubicin in a patient with highly advanced hepatocellular carcinoma]
[A giant testicular tumor detected with dyspnea due to lung metastases: a case report]
[Alpha-fetoprotein secreting adrenal metastasis after hepatectomy for non-secreting hepatocarcinoma. Description of a case]
[Alpha-fetoprotein. 3. Evaluation of alpha-fetoprotein in gastric cancer and its liver metastasis]
[Bone metastases in a cirrhotic patient with normal alpha-fetoprotein levels and imaging tests: detection of hepatocarcinoma 6 months later]
[Complete disappearance with oral UFT administration of recurrent hepatocellular carcinoma of the remnant liver and multiple lung metastasis after hepatic resection]
[Correlation analysis of Ki67, Ck19 with clinicopathological features and apparent diffusion coefficient value of hepatocellular carcinoma].
[Diagnosis of hepatocellular carcinoma with bone metastasis using fine needle aspiration biopsy: report of 2 cases]
[Expression and significance of c-jun-activation-domain binding protein (JAB1) in hepatocellular carcinoma]
[Expression and significance of EGF mRNA and EGFR mRNA in hepatocellular carcinoma]
[Expression and significance of epidermal growth factor receptor variant type III in hepatocellular carcinoma]
[Expression of the Fra-1 gene in the peripheral blood of children with Wilms tumor].
[Factors linked to 5-year survival after hepatectomy for hepatocellular carcinoma: univariate and multivariate analyses of 312 patients]
[Gastric cancer with liver metastasis producing alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist II (PIVKA-II); a case report]
[Hepatic metastases from alpha-fetoprotein producing colorectal cancer that responded remarkably to transcatheter arterial chemo-embolization]
[Increase of alpha-fetoprotein in pancreatic endocrine tumors with hepatic metastases. Apropos of 2 cases]
[Laboratory tests in the diagnosis of stomach cancer]
[Liver metastasis of colon cancer with a high serum alpha-fetoprotein level: report of a case]
[Lung Metastasis from Alpha-Fetoprotein Resulting in Esophagogastric Junction Cancer-A Case Report].
[Outcome of pulmonary resection for metastases from hepatocellular carcinoma].
[Pancreatic endocrine tumor with metastases and increase of alpha-fetoprotein. A case report]
[Prognostic factors in patients with non-active treatment of hepatocellular carcinoma.]
[Pure yolk sac tumor of the testis with brain metastasis: report of an adult case]
[Quantitation of alpha-fetoprotein messenger RNA in peripheral blood of nude mice and its relationship with tumor recurrence and metastasis after curative resection of hepatocellular carcinoma]
[Stage IV renal cell carcinoma producing alpha-fetoprotein treated with multimodal treatment. A case report]
[Successful Treatment for Advanced Hepatocellular Carcinoma by Hepatic Arterial Infusion of CDDP Powder as Second-Line Chemotherapy.]
[The analysis of prognostic factors of primary hepatocellular carcinoma with Cox model]
[The diagnostic and prognostic value of tumor markers in nonseminomatous stage-III to -IV testicular tumors]
[The inhibitory effect of mitomycin C on experimental liver metastasis of alpha-fetoprotein producing human gastric carcinoma induced by intra-splenic transplantation in nude mice]
[The use of the carbohydrate antigen CA-19-9, the carcinoembryonic antigen and alpha fetoprotein in the diagnosis of pancreatic cancer]
[Therapy-Related Acute Myeloid Leukemia Following Etoposide Based Chemotherapy in Germ Cell Tumor].
[Treatment and outcome of 14 children with hepatoblastoma]
[Tumor thrombus arising from the superior vena cava and extending into the right atrium in a patient with advanced testicular germ cell tumor]
[Two cases of alpha-fetoprotein producing gastric cancer, showing marked response to continuous hepatic arterial infusion (HAI) chemotherapy with adriamycin]
[Value of (18)F-FDG PET/CT and CECT in detecting postoperative recurrence and extrahepatic metastasis of hepatocellular carcinoma in patients with elevated serum alpha-fetoprotein].
Neoplasm Micrometastasis
Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma.
Detection and clinical significance of bone marrow micrometastases in patients undergoing liver transplantation for hepatocellular carcinoma.
Development of a multiple-marker RT-PCR assay for detection of micrometastases of hepatocellular carcinoma.
Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery.
Quantitative analysis of alpha-fetoprotein mRNA in circulating peripheral blood of patients with hepatocellular and alpha-fetoprotein-producing gastric carcinomas.
[Isolated tumor cells in primary malignant liver tumors]
Neoplasm, Residual
Complete remission of hepatocellular carcinoma with portal vein tumor thrombus and lymph node metastases by arterial infusion of 5-fluorouracil and interferon-alpha combination therapy following hepatic resection.
Evaluation of curability and prediction of prognosis after surgical treatment for hepatocellular carcinoma by lens culinaris agglutinin-reactive alpha-fetoprotein.
Favorable alpha-fetoprotein decrease as a prognostic surrogate in patients with hepatocellular carcinoma after radiofrequency ablation.
Mildly Elevated Serum Alpha-Fetoprotein (AFP) Among Patients With Testicular Cancer May Not Be Associated With Residual Cancer Or Need For Treatment.
Residual pulmonary nodules after combination chemotherapy of testicular cancer.
Second-look laparotomy in endodermal sinus tumor: a report of two patients with normal levels of alpha-fetoprotein and residual tumor at reexploration.
Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
[Surgery of mediastinal tumors.]
[Treatment and outcome of 14 children with hepatoblastoma]
[Value of (18)F-FDG PET/CT and CECT in detecting postoperative recurrence and extrahepatic metastasis of hepatocellular carcinoma in patients with elevated serum alpha-fetoprotein].
Neoplasms
"Humors from tumors": carcinoembryonic antigen, alpha-fetoprotein, and digestive system cancer.
"Six-and-twelve" score for outcome prediction of hepatocellular carcinoma following transarterial chemoembolization. In-depth analysis from a multicenter French cohort.
'5-5-500' - yet another extended criteria for HCC or a truly innovative development?
131I lipiodol therapy for unresectable hepatocellular carcinoma.
131I-rose bengal therapy in hepatoblastoma patients.
131Iodine-DEM TACE vs. conventional TACE in cirrhotic patients with hepatocellular carcinoma: a single center experiment.
240 hepatocellular carcinomas: ultrasound features, tumor size, cytologic and histologic patterns, serum alpha-fetoprotein and HBs Ag.
3D printed smart silk wearable sensors.
A 35 Year Old Bangladeshi Lady with Hereditary Mucinous Ovarian Cancer, Complicated with Omental Metastasis.
A 40-bp insertion/deletion polymorphism in the constitutive promoter of MDM2 confers risk for hepatocellular carcinoma in a Chinese population.
A 7-year history of an intratesticular mass: patient description and review of the literature about dermoid cysts of the testis.
A cancer-related protein 14-3-3? is a potential tumor-associated antigen in immunodiagnosis of hepatocellular carcinoma.
A case of alpha-fetoprotein-producing esophageal adenocarcinoma.
A case of an alpha-fetoprotein-producing intrahepatic cholangiocarcinoma suggests probable cancer stem cell origin.
A case of ectopic hepatocellular carcinoma in the jejunum.
A case of endodermal sinus tumor associated with the first pregnancy and successful management of the second pregnancy: a case report and review of the literature.
A CASE OF GROWING TERATOMA SYNDROME.
A case of hepatocellular carcinoma that resisted identification.
A case of metastasis from gastric cancer to the thyroid gland.
A case of mixed mesodermal tumor of the uterus with alpha-fetoprotein production.
A case of primary biliary cirrhosis that complicated with combined hepatocellular and cholangiocellular carcinoma.
A case of primary ovarian pregnancy.
A case of resected hepatocellular carcinoma after drug-eluting bead transarterial chemoembolization.
A case of spontaneous regression of hepatocellular carcinoma with bone metastasis.
A case of the cirrhotic patient performed living donor liver transplantation after carbon-ion radiotherapy for hepatocellular carcinoma.
A case of yolk sac tumor of the vagina in an infant.
A case report of a three-year survivor with advanced non-small cell lung cancer producing alpha-fetoprotein.
A case report of retroperitoneal extrahepatic hepatocellular carcinoma presented with elevated level of Alpha fetoprotein.
A case with sarcomatoid hepatocellular carcinoma.
A Clinical Scoring System for Predicting Microvascular Invasion in Patients with Hepatocellular Carcinoma Within the Milan Criteria.
A clinical scoring system for predicting tumor recurrence after percutaneous radiofrequency ablation for 3 cm or less hepatocellular carcinoma.
A Clinicopathological Study of Paediatric Liver Tumours in a Tertiary Care Hospital.
A comparative study of four serological tumor markers for the detection of breast cancer.
A Comparison between Three-Dimensional Visualization Guided Hepatectomy and Ultrasonography Guided Radiofrequency Ablation in the Treatment of Small Hepatocellular Carcinoma within the Milan Criteria.
A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire.
A comparison of patients with hepatitis B- or hepatitis C-based advanced-stage hepatocellular carcinoma.
A comparison of the risk factors of intrahepatic recurrence, early recurrencen, and multiple recurrences after resection for single nodular hepatocellular carcinoma.
A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function.
A direct intersection between p53 and transforming growth factor beta pathways targets chromatin modification and transcription repression of the alpha-fetoprotein gene.
A double missense mutation in the ATM gene of a Dutch family with ataxia telangiectasia.
A fluorescent molecularly-imprinted polymer gate with temperature and pH as inputs for detection of alpha-fetoprotein.
A hepatic sclerosed hemangioma with significant morphological change over a period of 10 years: a case report.
A Hepatocellular Carcinoma Aggressiveness Index and Its Relationship to Liver Enzyme Levels.
A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
A high expression of GDP-fucose transporter in hepatocellular carcinoma is a key factor for increases in fucosylation.
A human testicular germ cell tumor with borderline histology between seminoma and embryonal carcinoma secreted beta-human chorionic gonadotropin and alpha-fetoprotein only as a xenograft.
A human vitelline component in embryonal carcinoma of the testis.
A long-term study of the effects of antiviral therapy on survival of patients with HBV-associated hepatocellular carcinoma (HCC) following local tumor ablation.
A long-term survival case of gastric cancer treated by continuous low-dosage 5-fluorouracil and cisplatin: a case report.
A long-term survival case underwent repeated hepatic arterial infusion chemotherapy with portal branch ligation and wrapping of the liver using sheets for hepatocellular carcinoma.
A mediastinal germ cell tumor of yolk sac type--case report.
A Model for Adaptive Decision Making of "Ablate-and-Wait" Versus Transplantation in Patients With Hepatocellular Carcinoma.
A Model Predicting Survival of Patients with Recurrent or Progressive Hepatocellular Carcinoma: The MORE Score.
A model to estimate survival in ambulatory patients with hepatocellular carcinoma.
A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis.
A new cancer marker: a possible cancer screening method based on the suppression of phosphofructokinase by sera from cancer patients.
A new prognostic staging system for hepatocellular carcinoma: value of the biomarker combined Japan integrated staging score.
A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators.
A new system for targeted delivery of doxorubicin into tumor cells.
A Nomogram Estimation for the Risk of Microvascular Invasion in Hepatocellular Carcinoma Patients Meeting the Milan Criteria.
A nomogram for predicting the benefit of adjuvant cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma.
A Nomogram Predicting Extrahepatic Metastases for Patients with Adjuvant Transarterial Chemoembolization after Hepatectomy.
A nomogram predicting pulmonary metastasis of hepatocellular carcinoma following partial hepatectomy.
A novel core fucose-specific lectin from the mushroom Pholiota squarrosa.
A novel embryological theory of autism causation involving endogenous biochemicals capable of initiating cellular gene transcription: A possible link between twelve autism risk factors and the autism 'epidemic'
A novel immunotherapy to hepatocellular carcinoma: CD40-activated B lymphocytes transfected with AFPmRNA.
A novel microchip electrophoresis-based chemiluminescence immunoassay for the detection of alpha-fetoprotein in human serum.
A novel microfluidic biosensor based on an electrical detection system for alpha-fetoprotein.
A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations.
A novel multi-array immunoassay device for tumor markers based on insert-plug model of piezoelectric immunosensor.
A novel piezoelectric quartz crystal immnuosensor based on hyperbranched polymer films for the detection of alpha-Fetoprotein.
A Novel Pre-treatment Model Predicting Risk of Developing Refractoriness to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma.
A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma.
A novel waitlist dropout score for hepatocellular carcinoma - identifying a threshold that predicts worse post-transplant survival.
A paper-based microfluidic electrochemical immunodevice integrated with amplification-by-polymerization for the ultrasensitive multiplexed detection of cancer biomarkers.
A patient with huge hepatocellular carcinoma who had a complete clinical response to p53 gene combined with chemotherapy and transcatheter arterial chemoembolization.
A peptide derived from alpha-fetoprotein inhibits the proliferation induced by estradiol in mammary tumor cells in culture.
A peptide derived from alpha-fetoprotein prevents the growth of estrogen-dependent human breast cancers sensitive and resistant to tamoxifen.
A personalized approach to cancer treatment: how biomarkers can help.
A phase II study of mitoxantrone combined with beta-interferon in unresectable hepatocellular carcinoma.
A piezoelectric immunosensor for the detection of alpha-fetoprotein using an interface of gold/hydroxyapatite hybrid nanomaterial.
A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours.
A practical nomogram from the SEER database to predict the prognosis of hepatocellular carcinoma in patients with lymph node metastasis.
A pre-operative clinical model to predict microvascular invasion and long-term outcome after resection of hepatocellular cancer: The Australian experience.
A prognostic fingerprint in liver transplantation for hepatocellular carcinoma based on plasma metabolomics profiling.
A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.
A proposed unified mechanism for the reduction of human breast cancer risk by the hormones of pregnancy.
A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up.
A radiomics nomogram for preoperative prediction of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma.
A radioresistant variant cell line, NMT-1R, isolated from a radiosensitive rat yolk sac tumour cell line, NMT-1: differences of early radiation-induced morphological changes, especially apoptosis.
A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma.
A randomized trial of cytoreductive surgery followed by chemotherapy versus chemotherapy alone in bulky stage testicular cancer with poor prognostic features.
A rare case of alpha-fetoprotein-producing early gastric cancer.
A Rare Case of Lymph Node Metastasis from Early Gastric Cancer.
A rare germ-cell tumor site: vaginal endodermal sinus tumor.
A rare neoplasm of the testis: capillary hemangioma.
A resected case of a small hepatocellular carcinoma developing within the bile duct.
A sensitive fluorescent sensor for quantification of alpha-fetoprotein based on immunosorbent assay and click chemistry.
A simple electrochemical immunosensor based on worm-like platinum for highly sensitive determination of alpha-fetoprotein.
A single-center retrospective analysis of liver transplantation on 255 patients with hepatocellular carcinoma.
A study of serological markers and lipid profile in non-alcoholic liver cirrhosis patients.
A study on alpha-fetoprotein and endodermal sinus tumor.
A study on the lectin reactivity of alpha-fetoprotein produced by hepatoid adenocarcinomas and yolk sac tumors.
A study on the microheterogeneity of alpha-fetoproteins produced by yolk sac and germ cell tumors.
A study, by electron microscopy, of the specific uptake of alpha-fetoprotein by mouse embryonic fibroblasts in relation to in vitro aging, and by human mammary epithelial tumour cells in comparison with normal donors' cells.
A synthetic peptide derived from alpha-fetoprotein inhibits the estradiol-induced proliferation of mammary tumor cells in culture through the modulation of p21.
A teratoid Wilms' tumor with raised serum alpha-fetoprotein level.
A two-dimensional electrophoresis preliminary approach to human hepatocarcinoma differentiation induced by PPAR-agonists.
A unilateral teratoid Wilms' tumor with raised serum alpha-fetoprotein level.
A unique case of an alpha-fetoprotein-producing lung cancer with testicular metastasis.
A Viral Exposure Signature Defines Early Onset of Hepatocellular Carcinoma.
A yolk sac tumor of the pancreas and derived xenograft model effectively responded to VIP chemotherapy.
A-kinase interacting protein 1 (AKIP1) associates with advanced overall disease condition, tumor properties, and unfavorable prognosis in hepatocellular carcinoma patients.
Abdominal wall metastases after surgical resection of an immature teratoma of the ovary.
Aberrant expressions of annexin A10 short isoform, osteopontin and alpha-fetoprotein at chromosome 4q cooperatively contribute to progression and poor prognosis of hepatocellular carcinoma.
Ablation therapy in containing extension of hepatocellular carcinoma: a simulative analysis of dropout from the waiting list for liver transplantation.
Abnormal prothrombin: evaluation as a tumour marker and localization in tissues of patients with hepatocellular carcinoma.
Abnormality of Wnt3a expression as novel specific biomarker for diagnosis and differentiation of hepatocellular carcinoma.
ABO-incompatible Living Donor Liver Transplantation with Rituximab and Total Plasma Exchange Does Not Increase Hepatocellular Carcinoma Recurrence.
Accelerated tumor growth and changes in images concomitant with vascularization in a patient with hepatocellular carcinoma.
Acinar-islet cell carcinoma presenting as insulinoma.
Actual half-life of alpha-fetoprotein as a prognostic tool in pediatric malignant tumors.
Acute changes of alpha-fetoprotein and human chorionic gonadotropin during induction chemotherapy of germ cell tumors.
Acute hepatic injury after discontinuation of chemotherapy in a patient with non-Hodgkin's lymphoma and chronic hepatitis B virus infection.
Acyclic retinoid in the chemoprevention of hepatocellular carcinoma (review).
Add-on sorafenib is beneficial for hepatocellular carcinoma patients with transarterial chemoembolization refractoriness: a real-world experience.
Adenocarcinoma of the uterine cervix with choriocarcinomatous and hepatoid differentiation: report of a case.
Adenocarcinosarcoma at the esophagogastric junction with long esophageal invasion: a case report.
Adenoendocrine cell carcinoma of the gallbladder producing a high level of alpha-fetoprotein.
Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: propensity score analysis.
Administration of interferon for two or more years decreases early stage hepatocellular carcinoma recurrence rate after radical ablation: A retrospective study of hepatitis C virus-related liver cancer.
Adoptive Cell Therapy in Hepatocellular Carcinoma: Biological Rationale and First Results in Early Phase Clinical Trials.
Adriamycin and cisplatin for hepatoblastoma.
Adriamycin coated silica microspheres as labels for cancer biomarker alpha-fetoprotein detection.
Adriamycin treatment for hepatocellular carcinoma. Experience with 109 patients.
Adriamycin-lipiodol suspension for i.a. chemotherapy of hepatocellular carcinoma.
Adult hepatic cavernous haemangioma with highly elevated alpha-fetoprotein.
Advanced extragonadal yolk sac tumor serially followed up with (18) F-fluorodexyglucose-positoron emission tomography and computerized tomography and serum alpha-fetoprotein.
Advanced hepatocellular carcinoma treated effectively with irinotecan via hepatic arterial infusion followed by proton beam therapy.
Advancements of liver transplantation for hepatocellular carcinoma in Korea.
Advances in biological markers for cancer.
Advances in hepatic resection and results for hepatocellular carcinoma.
Affinity chromatographic separation of alpha-fetoprotein variants: development of a mini-column procedure, and application to cancer patients.
Affinity chromatography used in distinguishing alpha-fetoprotein in serum from patients with tumors of hepatic parenchyma and of germ cells.
AFP in yolk sac tumor and solid teratoma of the ovary: significance of postoperative serum AFP.
AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC.
AFP-producing Xp11 translocation renal cell carcinoma: Case report and review of the literature.
Ag/SiO2 core-shell nanoparticle-based surface-enhanced Raman probes for immunoassay of cancer marker using silica-coated magnetic nanoparticles as separation tools.
Age-dependent growth inhibition of estrogen-sensitive rat mammary tumors. Probable role of alpha-fetoprotein.
Aggressive chemotherapy in endodermal sinus tumor.
Aggressive gastric carcinoma producing alpha-fetoprotein: a case report and review of the literature.
AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study.
AGMA Score: A Novel Prognostic Score for Patients Undergoing Liver Transplant for Hepatocellular Carcinoma.
Alcoholic hepatitis accelerates early hepatobiliary cancer by increasing stemness and miR-122-mediated HIF-1? activation.
Alfa-fetoprotein secreting ovarian sex cord-stromal tumor.
Allogeneic graft-versus-hepatoblastoma effect.
Allomyrina dichotoma lectin-nonreactive alpha-fetoprotein in hepatocellular carcinoma and other tumors: comparison with Ricinus communis agglutinin-I.
Allotransplantation of whole spleen in patients with hepatic malignant tumors or hemophilia A. Operative technique and preliminary results.
Alpha Fetoprotein-Secreting Gastric Cancer in the Setting of Chronic Hepatitis B: The Role of Endoscopy.
Alpha-fetoprotein (AFP) and human chorionic gonadotropin (HCG) in testicular germ cell tumours. A comparison of histologic and serologic occurrence of tumour markers.
Alpha-fetoprotein (AFP) and human chorionic gonadotropin (HCG) in testicular germ cell tumours. A prospective immunohistochemical study.
Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimic.
Alpha-fetoprotein (AFP) elevation gastric adenocarcinoma and importance of AFP change in tumor response evaluation.
Alpha-fetoprotein (AFP) expression in clones of McA-RH 7777 rat hepatoma: correlation with the occurrence of homogeneously staining regions on chromosome 14.
Alpha-fetoprotein (AFP) in germ cell tumors of the testis.
Alpha-fetoprotein (AFP) levels in normal children.
alpha-Fetoprotein (AFP), human chorionic gonadotropin (HCG), and carcinoembryonic antigen (CEA) demonstrated in the immature glands of mediastinal teratocarcinoma: a case report.
Alpha-fetoprotein (AFP)- and des-gamma-carboxy prothrombin (DCP)-producing adenocarcinoma of the stomach with liver metastasis in a patient with chronic hepatitis C.
Alpha-fetoprotein (AFP)-producing ovarian tumor in an elderly woman.
alpha-Fetoprotein (alphaFP) as a marker for hepatoma and yolk sac tumors.
Alpha-fetoprotein and (18)F-FDG positron emission tomography predict tumor recurrence better than Milan criteria in living donor liver transplantation.
Alpha-fetoprotein and 18F-FDG standard uptake value predict tumor recurrence after liver transplantation for hepatocellular carcinoma with portal vein tumor thrombosis: Preliminary experience.
Alpha-fetoprotein and albumin synthesis by heterotransplanted rat liver tumor cells.
Alpha-fetoprotein and beta-human chorionic gonadotropin: their clinical significance as tumour markers.
Alpha-fetoprotein and endodermal sinus tumor of the ovary.
Alpha-fetoprotein and germ cell tumors: a possible role of yolk sac tumor in production of alpha-fetoprotein.
Alpha-fetoprotein and hepatitis B antigen in acute hepatitis and primary cancer of the liver.
Alpha-fetoprotein and human chorionic gonadotrophin-beta as prognostic markers in neuroendocrine tumour patients.
Alpha-fetoprotein and human chorionic gonadotropin in a patient with a primary intracranial germ cell tumor.
Alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
Alpha-fetoprotein and mediastinal germ cell tumors.
Alpha-fetoprotein and modified response evaluation criteria in Solid Tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation.
Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: a brilliant star raises again.
alpha-Fetoprotein and other serum proteins synthesized by endodermal sinus tumor transplanted into nude mice.
Alpha-fetoprotein and p53 autoantibodies in patients with chronic hepatitis C.
Alpha-fetoprotein and the acute phase response. A study using acute pelvic inflammatory disease as a model system.
Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma.
Alpha-fetoprotein antagonizes X-linked inhibitor of apoptosis protein anticaspase activity and disrupts XIAP-caspase interaction.
alpha-Fetoprotein as a biochemical marker in patients with gynecologic malignancy.
Alpha-fetoprotein as a marker of embryo-specific differentiations in normal and tumor tissues.
Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Alpha-fetoprotein as tumor marker in lung cancer diagnosis.
Alpha-fetoprotein associated with islet cell tumors.
Alpha-Fetoprotein Binding Mucin and Scavenger Receptors: An Available Bio-Target for Treating Cancer.
alpha-fetoprotein causes apoptosis in tumor cells via a pathway independent of CD95, TNFR1 and TNFR2 through activation of caspase-3-like proteases.
Alpha-fetoprotein concentrations measured by radioimmunoassay in diagnosing and excluding hepatocellular carcinoma.
Alpha-fetoprotein contributes to THP-1 cell invasion and chemotaxis via protein kinase and Gi-protein-dependent pathways.
Alpha-fetoprotein elevation in NUT midline carcinoma: a case report.
Alpha-fetoprotein enhances the proliferation of human hepatoma cells in vitro.
Alpha-fetoprotein for Gastric Cancer Staging: An Essential or Redundant Tumor Marker?
Alpha-fetoprotein growth inhibitory peptides: potential leads for cancer therapeutics.
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.
alpha-Fetoprotein in cancer and fetal development.
Alpha-fetoprotein in cancer.
Alpha-fetoprotein in germ cell tumors. An immunohistochemical study.
Alpha-fetoprotein in intracranial malignant teratoma.
Alpha-fetoprotein in malignant germ cell tumors of the ovary.
Alpha-fetoprotein in ontogenesis and its association with malignant tumors.
Alpha-fetoprotein in pericardial, peritoneal, and pleural fluids: A body fluid matrix evaluation.
Alpha-fetoprotein in plasma and serum of healthy adults: preanalytical, analytical and biological sources of variation and construction of age-dependent reference intervals.
Alpha-fetoprotein in serum and tumor tissues in dogs with hepatocellular carcinoma.
alpha-Fetoprotein in the laboratory testing for cancer.
Alpha-fetoprotein in the management of germ cell tumors of the ovary.
Alpha-fetoprotein in the serum of patients with neoplasms of the gastrointestinal tract.
Alpha-fetoprotein in tumours derived from cystic and simple embryoid bodies.
Alpha-Fetoprotein in yolk sac tumor.
Alpha-fetoprotein level to total tumor volume as a predictor of hepatocellular carcinoma recurrence after resection. A retrospective cohort study.
Alpha-fetoprotein levels correlate with the pathologic grade and surgical outcomes of pediatric retroperitoneal teratomas.
alpha-Fetoprotein levels in cirrhosis and cancer of the liver.
alpha-fetoprotein levels in maternal serum during pregnancy and maternal breast cancer incidence.
Alpha-fetoprotein molecular heterogeneity. Physiologic correlations with normal growth, carcinogenesis and tumor growth.
alpha-Fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma.
Alpha-fetoprotein positively regulates cytochrome c-mediated caspase activation and apoptosome complex formation.
Alpha-fetoprotein producing cells act as cancer progenitor cells in human cholangiocarcinoma.
Alpha-fetoprotein producing pulmonary blastoma in a patient with systemic sclerosis: pathogenetic analysis.
alpha-Fetoprotein producing renal pelvic and ureter tumor.
Alpha-fetoprotein producing rhabdomyosarcoma of the adult liver.
Alpha-fetoprotein producing tumor cells in children with Wilms' tumor.
Alpha-fetoprotein producing undifferentiated carcinoma of the bladder.
Alpha-fetoprotein producing urachal tumor.
Alpha-fetoprotein production by a malignant mixed Müllerian tumor of the ovary.
Alpha-fetoprotein production by a malignant mixed müllerian tumour of the uterus.
Alpha-fetoprotein production by non-hepatocellular carcinoma, malignant liver tumor.
Alpha-fetoprotein production by pancreatic tumors exhibiting acinar cell differentiation: study of five cases, one arising in a mediastinal teratoma.
Alpha-fetoprotein production by rhabdomyosarcoma of the urinary bladder.
Alpha-fetoprotein receptor as an early indicator of HBx-driven hepatocarcinogenesis and its applications in tracing cancer cell metastasis.
Alpha-Fetoprotein Response After Locoregional Therapy for Hepatocellular Carcinoma: Oncologic Marker of Radiologic Response, Progression, and Survival.
Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: A subgroup analysis.
alpha-Fetoprotein screening in patients with idiopathic hemochromatosis and liver cirrhosis.
Alpha-fetoprotein secretion in a craniopharyngioma. Are craniopharyngiomas part of the germ cell tumor family?
alpha-Fetoprotein shields hepatocellular carcinoma cells from apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand.
Alpha-fetoprotein Slope >7.5 ng/ml/month Predicts Micro-vascular Invasion and Tumor Recurrence after Liver Transplantation for Hepatocellular Carcinoma.
Alpha-fetoprotein specific CD4 and CD8 T cell responses in patients with hepatocellular carcinoma.
Alpha-fetoprotein subfractions in germ cell tumors identified by Con A or LCH crossed-line affinity immunoelectrophoresis.
Alpha-fetoprotein surge following high-dose chemotherapy in germ cell tumours.
Alpha-fetoprotein synthesis in tissue culture of human testicular tumors and an examination of experimental yolk sac tumors in the rat.
Alpha-fetoprotein triggers hepatoma cells escaping from immune surveillance through altering the expression of Fas/FasL and tumor necrosis factor related apoptosis-inducing ligand and its receptor of lymphocytes and liver cancer cells.
Alpha-fetoprotein, alpha-1-antitrypsin, and transferrin in gonadal yolk-sac tumours.
Alpha-Fetoprotein, Des-Gamma-Carboxy Prothrombin, and Modified RECIST Response as Predictors of Survival after Transarterial Radioembolization for Hepatocellular Carcinoma.
Alpha-fetoprotein, prealbumin, albumin, alpha-1-antitrypsin and transferrin as diagnostic and therapeutic markers for endodermal sinus tumors.
Alpha-fetoprotein, stem cells and cancer: how study of the production of alpha-fetoprotein during chemical hepatocarcinogenesis led to reaffirmation of the stem cell theory of cancer.
Alpha-fetoprotein-concanavalin A binding as a marker to discriminate between germ cell tumours and liver diseases.
Alpha-fetoprotein-lectin binding as a marker of tumour activity or liver damage.
Alpha-fetoprotein-positive adenocarcinoma of the pancreas.
Alpha-fetoprotein-producing acinar cell carcinoma of the pancreas.
Alpha-fetoprotein-producing adenocarcinoma of the lung.
Alpha-fetoprotein-producing adenocarcinoma of the ureter.
Alpha-fetoprotein-producing cancer of the ampulla of Vater.
Alpha-fetoprotein-producing carcinoma of the renal pelvis exhibiting hepatoid and urothelial differentiation.
Alpha-fetoprotein-producing Colon Carcinoma with Rapidly Increasing Liver Metastases That Resulted in Death: A Case Report.
Alpha-fetoprotein-producing early gastric cancer of the remnant stomach: report of a case.
Alpha-Fetoprotein-Producing Early Gastric Cancer with Intramucosal Hepatoid and Fetal Enteric Differentiation.
Alpha-fetoprotein-producing early rectal carcinoma: a rare case report and review.
Alpha-Fetoprotein-producing esophageal adenocarcinoma: report of a case.
Alpha-Fetoprotein-Producing Extrahepatic Tumor: Clinical and Histopathological Significance of a Case.
Alpha-Fetoprotein-Producing Gastric Cancer with Nonbiliary Pancreatitis.
Alpha-fetoprotein-producing gastric carcinoma with enteroblastic differentiation.
Alpha-Fetoprotein-Producing Lung Hepatoid Adenocarcinoma with Brain Metastasis Treated with S-1.
Alpha-fetoprotein-producing non-germ cell tumours of the female genital tract.
Alpha-fetoprotein-producing ovarian clear cell adenocarcinoma with fetal gut differentiation: a rare case report and literature review.
Alpha-fetoprotein-producing pancreatic acinar cell carcinoma.
Alpha-fetoprotein-producing pancreatic cancer cells possess cancer stem cell characteristics.
Alpha-fetoprotein-producing pancreatoblastoma. A case report.
Alpha-fetoprotein-producing rectal cancer successfully responded to preoperative chemoradiotherapy: case report.
Alpha-fetoprotein-producing renal cell carcinoma with increased activity of N-acetylglucosaminyl-transferase III.
Alpha-fetoprotein-producing renal cell carcinoma.
Alpha-fetoprotein-producing serous carcinoma of the uterus metastasizing to the ovaries, mimicking primary ovarian yolk sac tumor: a case report and review of the literature.
Alpha-fetoprotein: from a diagnostic biomarker to a key role in female fertility.
Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in southern African blacks.
Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand.
Alpha1-antitrypsin and alpha-fetoprotein. Protein markers in endodermal sinus (yolk sac) tumors.
Alphafetoprotein-producing gastric adenocarcinoma.
Alteration of DNA methylation in gastrointestinal carcinogenesis.
An abnormal elevation of serum CA72-4 rather than other tumor markers can be caused by use of colchicine.
An advanced strategy of enhanced specific gene expression for hepatocellular carcinoma.
An alpha-fetoprotein producing pancreatic cystadenocarcinoma.
An alpha-fetoprotein-producing hepatoid adenocarcinoma of the endometrium.
An analysis of clinicopathological features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP-producing gastric cancer.
An anti-alpha-fetoprotein antibody-daunorubicin conjugate with a novel poly-L-glutamic acid derivative as intermediate drug carrier.
An apparent dimerization motif in the third domain of alpha-fetoprotein: molecular mimicry of the steroid/thyroid nuclear receptor superfamily.
An attenuated Salmonella oral DNA vaccine prevents the growth of hepatocellular carcinoma and colon cancer that express alpha-fetoprotein.
An atypical presentation of an ovarian lymphoma: a case report.
An elevated maternal serum alpha-fetoprotein leading to the diagnosis of an immature teratoma.
An icteric type hepatocellular carcinoma with no detectable tumor in the liver: report of a case.
An IgM lambda antibody to Escherichia coli produces false-positive results in multiple immunometric assays.
An immunohistochemical study of hepatoblastoma producing human chorionic gonadotropin.
An immunohistochemical study of sarcomatoid liver carcinomas.
An inflammation-based prognostic index predicts survival advantage after transarterial chemoembolization in hepatocellular carcinoma.
An ischemic skin lesion after chemoembolization of the right internal mammary artery in a patient with hepatocellular carcinoma.
An isolate alpha-fetoprotein producing gastric cancer liver metastasis emerged in a patient previously affected by radiation induced liver disease.
An Oxygen-Concentration-Controllable Multiorgan Microfluidic Platform for Studying Hypoxia-Induced Lung Cancer-Liver Metastasis and Screening Drugs.
An Unusual Case of Primary Retroperitoneal Germ Cell Tumour in a Young Man.
An unusual case, in Italy, of hepatocarcinoma characterized by portal hypertension and absence of cirrhosis.
Analyses of clinical efficacy of ultrasound-guided radiofrequency ablation in liver cancer adjacent to the gallbladder and its prognosis.
Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival.
Analysis of a non-ras 21-kDa protein in patients with metastatic testicular germ-cell tumors.
Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization.
Analysis of alpha-fetoprotein mRNA level on the tumor cell hematogenous spread of patients with hepatocellular carcinoma undergoing orthotopic liver transplantation.
Analysis of CD4+ T-Cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patients.
Analysis of circulating tumor cells in patients with hepatocellular carcinoma recurrence following liver transplantation.
Analysis of Clinicopathological Characteristics and Prognosis of Young Patients with Hepatocellular Carcinoma after Hepatectomy.
Analysis of cost-effectiveness of different strategies for hepatocellular carcinoma screening in hepatitis B virus carriers.
Analysis of lectin affinity immunoelectrophoretic profiles of serum alpha-fetoprotein from patients with yolk sac tumors and carcinomas of the gastrointestinal tract: correlations with molecular structures.
Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib.
Analysis of prognostic factors of more/equal to10 years of survival for liver cancer patients after liver transplantation.
Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma.
Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression.
Analysis of survival predictors in a prospective cohort of patients undergoing transarterial chemoembolization for hepatocellular carcinoma in a single Canadian centre.
Analytical performance and clinical concordance of the cancer biomarkers CA 15-3, CA 19-9, CA 125 II, Carcinoembryonic Antigen, and Alpha-Fetoprotein on the Dimension Vista® System.
Anaplasia rediviva.
Anaplastic variant of spermatocytic seminoma.
Anatomic resection and wide resection margin play an important role in hepatectomy for hepatocellular carcinoma with peritumoural micrometastasis.
Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription.
Angiographically undetected small hepatocellular carcinoma: clinicopathological characteristics, follow-up and treatment.
Angiotensin Receptor 1 Blockers Prolong Time to Recurrence after Radiofrequency Ablation in Hepatocellular Carcinoma patients: A Retrospective Study.
Annona senegalensis extract demonstrates anticancer properties in N-diethylnitrosamine-induced hepatocellular carcinoma in male Wistar rats.
Anti-inflammatory and antioxidant role of resveratrol on nicotine-induced lung changes in male rats.
Anti-prostate cancer and anti-breast cancer activities of two peptides derived from alpha-fetoprotein.
Antibodies to a surface membrane marker from human mammary carcinoma cell line.
Antigenic markers in extragonadal germ cell tumors.
Antisense oligonucleotides targeting midkine inhibit tumor growth in an in situ human hepatocellular carcinoma model.
Antitumor activity of conjugates of the oncofetal protein alpha-fetoprotein and phthalocyanines in vitro.
Antitumor immunity induced by DNA vaccine encoding alpha-fetoprotein/heat shock protein 70.
Antiviral prophylaxis and recurrence of hepatocellular carcinoma following liver transplantation in patients with hepatitis B.
Apoptosis, redifferentiation and arresting proliferation simultaneously triggered by oxidative stress in human hepatoma cells.
Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method - Analysis of 2010 Taiwanese patients.
Application of a microfluidic paper-based bioimmunosensor with laser-induced fluorescence detection in the determination of alpha-fetoprotein from serum of hepatopaths.
Application of des-gamma-carboxy prothrombin as a complementary tumor marker with alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Application of Six Sigma for evaluating the analytical quality of tumor marker assays.
Are both PIVKA-II and alpha-fetoprotein necessary in follow-up management after hepatic resection for hepatocellular carcinoma?
ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma.
Arsenic-induced aberrant gene expression in fetal mouse primary liver-cell cultures.
Arterial-injection chemotherapy for hepatocellular carcinoma using monodispersed poppy-seed oil microdroplets containing fine aqueous vesicles of epirubicin. Initial medical application of a membrane-emulsification technique.
Asociación Mexicana de Hepatología A.C. Clinical guideline on hepatitis B.
Aspiration cytology of mediastinal seminoma: report of a case with emphasis on the diagnostic role of aspiration cytology, cell block and immunocytochemistry.
Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection.
ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
Assessment of pattern and treatment of intrahepatic recurrence after resection of hepatocellular carcinoma.
Assessment of response to sorafenib in advanced hepatocellular carcinoma using perfusion computed tomography: Results of a pilot study.
Assessment of the role of interleukin-6 in diagnosis of hepatocellular carcinoma.
Association between esophagogastric varices in hepatocellular carcinoma and poor prognosis after transarterial chemoembolization: A propensity score matching analysis.
Association between Helicobacter pylori infection and tumor markers: an observational retrospective study.
Association between insulin-like growth factor-2 and metastases after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma: a prospective study.
ASSOCIATION BETWEEN MURINE DOUBLE MINUTE 2 - T309G polymorphism and recurrence of hepatocellular carcinoma after surgical treatment.
Association between platelet count and hepatocellular carcinoma overall survival: a large retrospective cohort study.
Association of 5-methylcytosine and 5-hydroxymethylcytosine with mitochondrial DNA content and clinical and biochemical parameters in hepatocellular carcinoma.
Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype.
Association of Common Variants in HNF1A Gene with Serum AFP Level in Healthy Chinese Individuals and HCC Patients.
Association of Histone Methyltransferase G9a and Overall Survival After Liver Resection of Patients With Hepatocellular Carcinoma With a Median Observation of 40 Months.
Association of reduced cell adhesion regulator messenger RNA expression with tumor progression in human hepatocellular carcinoma.
Association of TIP30 expression and prognosis of hepatocellular carcinoma in patients with HBV infection.
Astragalus saponins induce apoptosis via an ERK-independent NF-kappaB signaling pathway in the human hepatocellular HepG2 cell line.
Asymptomatic hepatocellular carcinoma in Child's A cirrhosis. A comparison of natural history and surgical treatment.
Atypical presentation of hepatocellular carcinoma.
Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1.
Autotaxin Expression in Hepatocellular Carcinoma.
bcl 10 gene mutation in hepatocellular carcinoma.
Benefit of downsizing hepatocellular carcinoma in a liver transplant population.
Benign and malignant struma ovarii.
Benzylidene-indolinones are effective as multi-targeted kinase inhibitor therapeutics against hepatocellular carcinoma.
Beta2-microglobulin levels of serum and ascites in malignant diseases.
Bilateral testicular tumors in an infant.
Bile acid secretion during rat liver carcinogenesis.
Binding characterization of the targeting drug AIMPILA to AFP receptors in human tumor xenografts.
Binding of bilirubin by bovine and human alpha-fetoprotein.
Bioactive phytochemicals from Salvia officinalis attenuate cadmium-induced oxidative damage and genotoxicity in rats.
Biochemical Evidence for the Antitumor Potential of Garcinia mangostana Linn. On Diethylnitrosamine-Induced Hepatic Carcinoma.
Biodegradable mitomycin C microspheres given intra-arterially for inoperable hepatic cancer. With particular reference to a comparison with continuous infusion of mitomycin C and 5-fluorouracil.
Biologic markers in cancer diagnosis and treatment.
Biological markers of hepatocellular carcinoma for use as selection criteria in liver transplantation.
Biological microchip for a simultaneous quantitative immunoassay of tumor markers in human serum.
Biological role of alpha-fetoprotein in cancer: prospects for anticancer therapy.
Biological roles of alpha-fetoprotein during pregnancy and perinatal development.
Biomarkers in the lung cancer diagnosis: a clinical perspective.
Biomarkers of Pineal Region Tumors: A Review.
Biphagic pulmonary blastoma with a lesion of yolk sac tumor.
Biphasic pulmonary blastoma with germ cell differentiation in a 36-year-old man.
Bivariate flow cytometric analysis of p53 and DNA content in hepatocellular carcinoma.
Bleomycin, vinblastine, and cis-platinum in the treatment of advanced endodermal sinus tumor.
Blood serum alpha fetoprotein enhancer binding protein, a tumor suppressor, decreases in chronic HBV hepatitis patients as hepatocellular cancer appears.
Blood-group antigen expression during pancreatic cancer induction in hamsters.
Brain metastases and elevated alpha-fetoprotein level in a patient with esophageal carcinoma.
Brain Metastases as Presenting Feature in 'Burned Out' Testicular Germ Cell Tumor.
c-Myc-mediated SNRPB upregulation functions as an oncogene in hepatocellular carcinoma.
C-reactive protein and hepatocellular carcinoma: analysis of its relationships to tumor factors.
C-Reactive Protein and Platelet-Lymphocyte Ratio as Potential Tumor Markers in Low-Alpha-Fetoprotein Hepatocellular Carcinoma.
C14orf166 Is a Biomarker for Predicting Hepatocellular Carcinoma Recurrence.
Ca125 and neuron-specific enolase (NSE) as tumour markers for intra-abdominal desmoplastic small round-cell tumours.
CA125-producing adenocarcinoma of the seminal vesicle.
Calcifying nested stromal-epithelial tumor of the liver: Case report of a rare primary liver tumor.
Camel Milk: Potential Utility as an Adjunctive Therapy to Peg-IFN/RBV in HCV-4 Infected Patients in Egypt.
Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation?
Cancer in Bangladesh: a model for some problems and proposed solutions in the Third World.
Capillary electrochromatography immunoassay for alpha-fetoprotein based on poly(guanidinium ionic liquid) monolithic material.
Capillary electrophoresis-electrospray ionization mass spectrometry for rapid and sensitive N-glycan analysis of glycoproteins as 9-fluorenylmethyl derivatives.
Capillary electrophoretic immunoassay for alpha-fetoprotein with chemiluminescence detection.
Capillary hemangioma of the testis. A case report of a rare benign tumor.
Carbohydrate antigens as potential biomarkers for the malignancy in patients with idiopathic deep venous thrombosis: a retrospective cohort study.
Carbohydrate structure of the concanavalin A molecular variants of alpha-fetoprotein.
Carbon Nanotubes Multifunctionalized by Rolling Circle Amplification and Their Application for Highly Sensitive Detection of Cancer Markers.
Carcinoembryonic proteins in gastric carcinoma metastatic to the liver.
Carcinogenicity of aflatoxin B1 in rhesus monkeys: two additional cases of primary liver cancer.
Cardiac metastasis from yolk sac tumor: case report and review.
Case of atypical fibroxanthoma in the palpebral conjunctiva.
Case of clear-cell hepatocellular carcinoma that developed in the normal liver of a middle-aged woman.
Case report: ectopic hepatocellular carcinoma arising from the left diaphragm.
Case Report: Paratesticular Rhabdomyosarcoma.
Case-control Indian buffet process identifies biomarkers of response to Codrituzumab.
Casein and other tumor markers in relation to cancer of the breast.
CD200R, a co-inhibitory receptor on immune cells, predicts the prognosis of human hepatocellular carcinoma.
CDCA2 protects against oxidative stress by promoting BRCA1-NRF2 signaling in hepatocellular carcinoma.
CdZnTeS quantum dots based electrochemiluminescent image immunoanalysis.
Cell-free circulating DNA: diagnostic value in patients with testicular germ cell cancer.
Cellular aspects of alpha-fetoprotein reexpression in tumors.
Cellular localization of alpha-fetoprotein and human chorionic gonadotropin in germ cell tumors of the testis using and indirect immunoperoxidase technique.
Central diabetes insipidus developing in a 6-year-old patient 4 years after the remission of unifocal bone Langerhans cell histiocytosis.
Central nervous system germ cell tumors: controversies in diagnosis and treatment.
Cerebrospinal fluid alpha-fetoprotein in germ cell neoplasms.
Cervical sarcoma botryoides and ovarian Sertoli-Leydig cell tumor.
Cesium Lead Bromide (CsPbBr3) Perovskite Quantum Dot-Based Photosensor for Chemiluminescence Immunoassays.
Challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer.
Changes in expression of albumin and alpha-fetoprotein genes during rat liver development and neoplasia.
Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter.
Changes in highly sensitive alpha-fetoprotein for the prediction of the outcome in patients with hepatocellular carcinoma after hepatectomy.
Changes in methylation pattern of albumin and alpha-fetoprotein genes in developing rat liver and neoplasia.
Changes in serum alpha-fetoprotein and chorionic gonadotropin in response to cancer therapy.
Changes in Tumor Markers and Their Implications in Selecting Liver Transplantation for Patients With Hepatocellular Carcinoma.
Changes of serum alpha-fetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma: prognostic significance.
Characterisation of the cell line HC-AFW1 derived from a pediatric hepatocellular carcinoma.
Characteristics and prognosis of patients with large well-differentiated hepatocellular carcinoma who have undergone resection.
Characterization and nucleotide sequences of the variable regions of a monoclonal antibody against alpha-fetoprotein.
Characterization of alpha-fetoprotein effects on dendritic cell and its function as effector immune response activator.
Characterization of hepatocellular carcinoma in Mexico.
Characterization of murine hepatoma BW7756. III. Hematological profile of a tumor-associated anemia.
Characterization of new human pancreatic cancer cell lines which propagate in a protein-free chemically defined medium.
Characterization of urinary biomarkers of hepatocellular carcinoma using magnetic resonance spectroscopy in a Nigerian population.
Charting the Path Forward for Risk Prediction in Liver Transplant for Hepatocellular Carcinoma: International Validation of HALTHCC Among 4,089 Patients.
Chemoprevention of hepatocellular carcinoma: concept, progress and perspectives.
Chemotherapy for alpha-fetoprotein producing gastric cancers expressing human epidermal growth factor receptor 2.
Chemotherapy of extragonadal germ cell tumors.
Chemotherapy of human yolk sac tumor heterotransplanted in nude mice.
Chemotherapy of metastatic testicular germ cell tumors: relationship of histologic response to size reduction and changes in tumor markers.
Chemotherapy with cisplatin for AFP-secreting germ-cell tumors of the central nervous system.
Chest wall hernia induced by high intensity focused ultrasound treatment of unresectable massive hepatocellular carcinoma: A case report.
CircSMYD4 regulates proliferation, migration and apoptosis of hepatocellular carcinoma cells by sponging miR-584-5p.
Circular RNA 0016788 displays as a biomarker for tumor progression and poor prognosis in surgical hepatocellular carcinoma patients.
Circular RNA circARPP21 Acts as a Sponge of miR-543 to Suppress Hepatocellular Carcinoma by Regulating LIFR.
Circular RNA CircEPB41L2 Functions as Tumor Suppressor in Hepatocellular Carcinoma Through Sponging miR-590-5p.
Circulating intercellular adhesion molecule-1 in chronic liver disease and hepatocellular carcinoma.
Circulating intercellular adhesion molecule-1 in patients with hepatocellular carcinoma.
Circulating messenger RNA of alpha-fetoprotein: a possible risk factor of recurrence after resection of hepatocellular carcinoma.
Circulating microRNA-301 as a promising diagnostic biomarker of hepatitis C virus-related hepatocellular carcinoma.
Circulating Tumor Cells for Predicting the Prognostic of Patients with Hepatocellular Carcinoma: A Meta Analysis.
Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma.
Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach--results of the first prospective study of the International Society of Pediatric Oncology.
Cisplatin, etoposide, bleomycin first-line therapy and early resection of residual tumor in far-advanced germinal testis cancer.
Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications.
Clear cell (mesonephroid) tumors of the ovary with characteristics resembling endodermal sinus tumor.
Clear cell hepatocellular carcinoma with abundant myxoid stroma.
Clinical and biological significance of Cdk10 in hepatocellular carcinoma.
Clinical and Computed Tomography Features of Female Pelvic Malignant Germ Cell Tumors in Children and Adolescents: A Series of 30 Cases.
Clinical and contrast-enhanced image features in the prediction model for the detection of small hepatocellular carcinomas.
Clinical applications of serum carcinoembryonic antigen and alpha-fetoprotein levels in children with solid tumours.
Clinical applications of the enzyme labeled antibody method. Immunoperoxidase methods in diagnostic histopathology.
Clinical behavior and a contemporary management algorithm for prepubertal testis tumors: a summary of the Prepubertal Testis Tumor Registry.
Clinical characteristics and outcome of primary hepatic neuroendocrine tumors after comprehensive therapy.
Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes.
Clinical characteristics and treatment analysis of pancreatic acinar cell carcinoma: A single institutional comparison to pancreatic ductal adenocarcinoma.
Clinical characteristics and treatments of patients with alpha-fetoprotein producing gastric carcinoma.
Clinical Efficacy and Prognosis Factors for Advanced Hepatoblastoma in Children: A 6-year Retrospective Study.
Clinical efficacy of endovascular radiofrequency ablation in the treatment of portal vein tumor thrombus of primary hepatocellular carcinoma.
Clinical evaluation of a monoclonal antibody to serum KM01 for the diagnosis of hepatocellular carcinoma.
Clinical evaluation of erythrocytosis in patients with hepatocellular carcinoma.
Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer.
Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma.
Clinical evaluation of serum tissue inhibitor of metalloproteinases-1 levels in patients with liver diseases.
Clinical evaluation of urinary transforming growth factor-beta1 and serum alpha-fetoprotein as tumour markers of hepatocellular carcinoma.
Clinical experience with conservative surgery for vaginal endodermal sinus tumor.
Clinical features and prognosis of hepatocellular carcinoma in young patients from a hepatitis B-endemic area.
Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy.
Clinical features of small hepatocellular carcinomas as assessed by histologic grades.
Clinical features of solitary necrotic nodule of the liver.
Clinical features of three girls with mosaic genome-wide paternal uniparental isodisomy.
Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma.
Clinical impact of the treatment modality on small, solitary, recurrent intrahepatic hepatocellular carcinomas after primary liver resection.
Clinical implication of hypovascular hepatocellular carcinoma studied in 4,474 patients with solitary tumour equal or less than 3 cm.
Clinical Indication for Computed Tomography During Hepatic Arteriography (CTHA) in Addition to Dynamic CT Studies to Identify Hypervascularity of Hepatocellular Carcinoma.
Clinical observations during a relatively early stage of hepatocellular carcinoma, with special reference to serum alpha-fetoprotein levels.
Clinical Performance of CEA, CA19-9, CA15-3, CA125 and AFP in Gastrointestinal Cancer Using LOCI™-based Assays.
Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
Clinical relevance of HER-2/neu overexpression in patients with testicular nonseminomatous germ cell tumor.
Clinical significance and function of RDH16 as a tumor-suppressing gene in hepatocellular carcinoma.
Clinical significance of alpha-fetoprotein: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinoma.
Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma.
Clinical significance of circulating tumor cells via combined whole exome sequencing in early stage cancer screening: A case report.
Clinical significance of combination study of apoptotic factors and proliferating cell nuclear antigen in estimating the prognosis of hepatocellular carcinoma.
Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma.
Clinical significance of serum alpha-fetoprotein subfractionation in pediatric diseases.
Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association.
Clinical significance of tumor markers in detection of recurrent hepatocellular carcinoma after radiofrequency ablation.
Clinical stage I nonseminomatous germ cell tumors of the testis in childhood and adolescence: an analysis of 31 cases.
Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein.
Clinical study of intracranial nongerminomatous germ cell tumors producing alpha-fetoprotein.
Clinical study on treatment of primary hepatocellular carcinoma by Shenqi mixture combined with microwave coagulation.
Clinical use of tumor markers in childhood malignancies.
Clinical use of tumor markers in oncology.
Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors.
Clinical utility of circulating miR-371a-3p for the management of patients with intracranial malignant germ cell tumors.
Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma.
Clinico-biological behavior of germ-cell tumors.
Clinico-pathological criteria with prognostic relevance in hepatoblastoma.
Clinicopathologic analysis of risk factors for distant metastasis of hepatocellular carcinoma.
Clinicopathologic analysis of stage II-III hepatocellular carcinoma showing early massive recurrence after liver resection.
Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
Clinicopathologic risk factors for recurrence after a curative hepatic resection for hepatocellular carcinoma.
Clinicopathologic study on combined hepatocellular carcinoma and cholangiocarcinoma: with emphasis on the intermediate cell morphology.
Clinicopathological and Prognostic Role of Programmed Cell Death-1 in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Clinicopathological comparison of resectable hepatocellular carcinoma between the young and the elderly patients.
Clinicopathological features of alpha-fetoprotein producing early gastric cancer with enteroblastic differentiation.
Clinicopathological features of early gastric cancer: results of 100 cases from a rural general hospital.
Clinicopathological features of malignancy in hepatocellular carcinoma.
Clinicopathological features, post-surgical survival and prognostic indicators of elderly patients with hepatocellular carcinoma.
Clinicopathological implications of immunohistochemically demonstrated mucin core protein expression in hepatocellular carcinoma.
Clinicopathological significance and prognostic role of p-STAT3 in patients with hepatocellular carcinoma.
Clinicopathological significance of loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in China.
Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma.
Clinicopathological studies of minute hepatocellular carcinoma. Analysis of 20 cases, including 4 with hepatic resection.
Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution.
Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor.
Coagulation disorders and tumor markers in the diagnosis of pancreatic cancer.
Combination chemotherapy in the management of ovarian germ cell malignancies.
Combination chemotherapy of hepatocellular carcinoma with doxorubicin and streptozotocin.
Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: long-term follow-up.
Combination of acoustic radiation force impulse imaging, serological indexes and contrast-enhanced ultrasound for diagnosis of liver lesions.
Combination of alpha-fetoprotein mRNA-based detection of hematogenously disseminating hepatocellular carcinoma cells and analysis of cancer cell membrane fluidity is more accurate in screening patients at risk of postoperative recurrence.
Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation.
Combination of CA125 and RECAF biomarkers for early detection of ovarian cancer.
Combination of exosomes and circulating microRNAs may serve as a promising tumor marker complementary to alpha-fetoprotein for early-stage hepatocellular carcinoma diagnosis in rats.
Combination of hepatocyte specific delivery and transformation dependent expression of shRNA inducing transcriptional gene silencing of c-Myc promoter in hepatocellular carcinoma cells.
Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
Combination of PAPPA, fhCG?, AFP, PlGF, sTNFR1, and Maternal Characteristics in Prediction of Early-onset Preeclampsia.
Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma.
Combination treatment for advanced hepatocellular carcinoma with portal vein tumour thrombus: A case report.
Combined Chemoembolization and Radiotherapy Versus Chemoembolization Alone for Hepatocellular Carcinoma Invading the Hepatic Vein or Inferior Vena Cava.
Combined Detection of Exosome Concentration and Tumor Markers in Gastric Cancer.
Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma.
Combined hepatocellular carcinoma and cholangiocarcinoma growing into the common bile duct.
Combined hepatocellular-cholangiocarcinoma after tetralogy of Fallot repair: a case report and review of literature.
Combined hepatocellular-cholangiocarcinoma with stem cell features, cholangiolocellular subtype after inferior vena cava stent placement for a patient with Budd-Chiari syndrome.
Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study.
Combined hepatocellular-cholangiocarcinoma: a clinicopathological study.
Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma.
Combined measurement of preoperative ?-fetoprotein and des-?-carboxyprothrombin predicts recurrence after curative resection in patients with hepatitis-B related hepatocellular carcinoma.
Combined prognostic nutritional index and albumin-bilirubin grade to predict the postoperative prognosis of HBV-associated hepatocellular carcinoma patients.
Combined transarterial chemoembolization and radiotherapy as a first-line treatment for hepatocellular carcinoma with macroscopic vascular invasion: Necessity to subclassify Barcelona Clinic Liver Cancer stage C.
Combined treatment of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates hepatic dysplastic nodule in a patient with liver cirrhosis.
Combined Ultrasound and CT-Guided Iodine-125 Seeds Implantation for Treatment of Residual Hepatocellular Carcinoma Located at Complex Sites After Transcatheter Arterial Chemoembolization.
Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
Combining Preoperative and Postoperative Inflammatory Indicators Can Better Predict the Recurrence of Hepatocellular Carcinoma After Partial Hepatectomy.
Common and Rare Sequence Variants Influencing Tumor Biomarkers in Blood.
Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma.
Comparative analysis of certain metals and tumor markers in bronchopulmonary cancer and colorectal cancers. Metals and tumor markers in the neoplastic process.
Comparative immunohistochemical characterization of canine seminomas and Sertoli cell tumors.
Comparative morphology of endodermal sinus tumor (Teilum) to human yolk sac and a proposal of endodermal cell tumor.
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome.
Comparison between human-telomerase reverse transcriptase mRNA and alpha-fetoprotein mRNA as a predictive value for recurrence of hepatocellular carcinoma in living donor liver transplantation.
Comparison between radioimmunotherapy and external beam radiation therapy for patients with hepatocellular carcinoma.
Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases.
Comparison of AFP-L3 and p53 Antigen Concentration with Alpha-Fetoprotein as Serum Markers for Hepatocellular Carcinoma.
Comparison of alpha-fetoprotein with some other tumour markers in Malaysians with hepatocellular carcinoma.
Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases.
Comparison of carbohydrate structures of serum alpha-fetoprotein by sequential glycosidase digestion and lectin affinity electrophoresis.
Comparison of clinical and pathological staging and long-term results of liver transplantation for hepatocellular carcinoma in a single transplant center.
Comparison of liver resection for hepatocellular carcinoma in hepatitis B and hepatitis C-related cirrhotic patients.
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population.
Comparison of serum tumor markers for intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
Comparison of the effects of postoperative prophylactic transcatheter arterial chemoembolization (TACE) and transhepatic arterial infusion (TAI) after hepatectomy for primary liver cancer.
Comparison of the outcomes of hepatocellular carcinoma after hepatectomy between two regional medical centers in China and Japan.
Comparison of twelve liver functional reserve models for outcome prediction in patients with hepatocellular carcinoma undergoing surgical resection.
Comparison of unenhanced magnetic resonance imaging and ultrasound in detecting very small hepatocellular carcinoma.
Competing risks analysis of predictors of delisting owing to tumor progression in liver transplant candidates with hepatocellular carcinoma.
Complementary action of CXCL1 and CXCL8 in pathogenesis of gastric carcinoma.
Complete and Sustained Off-Therapy Response to Sorafenib in Advanced Hepatocellular Carcinoma.
Complete disappearance of unresectable hepatoblastoma by continuous infusion therapy through hepatic artery.
Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
Complete necrotization of hepatocellular carcinoma by chemotherapy and subsequent intravascular coagulation: a case report.
Complete remission of hepatocellular carcinoma with portal vein tumor thrombus and lymph node metastases by arterial infusion of 5-fluorouracil and interferon-alpha combination therapy following hepatic resection.
Complete remission of unresectable hepatocellular carcinoma on healthy liver by the combination of aggressive surgery and high-dose-intensity chemotherapy by CPT-11.
Complete response with sorafenib and transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma.
Composite criteria using clinical and FDG PET/CT factors for predicting recurrence of hepatocellular carcinoma after living donor liver transplantation.
Comprehensive study of tumour single nucleotide polymorphism array data reveals significant driver aberrations and disrupted signalling pathways in human hepatocellular cancer.
Computed tomography imaging and clinical features of congenital hepatoblastoma: A retrospective analysis.
Computed Tomography-Guided High-Dose-Rate Brachytherapy in Hepatocellular Carcinoma: Safety, Efficacy, and Effect on Survival.
Concanavalin A affinity of alpha-fetoprotein. Its use in differentiating tumors.
Concentrations of alpha-fetoprotein, insulin-like growth factor binding protein-3, c-erbB-2, and epidermal growth factor in serum of patients with endometriosis.
Congenital ependymoblastoma presenting as a sacrococcygeal mass in a newborn: an immunohistochemical, light and electron microscopic study.
Congenital immature teratoma of the tongue: an autopsy case.
Congenital teratoma: a clinicopathologic study of 22 fetal and neonatal tumors.
Conservative parenchymal surgery in testicular tumors.
Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients.
Contrast-enhanced ct and angiographic findings in hepatic perivascular epithelioid cell tumor.
Contrast-enhanced dynamic magnetic resonance imaging findings of hepatocellular carcinoma and their correlation with histopathologic findings.
Contrast-enhanced intraoperative ultrasonography for vascular imaging of hepatocellular carcinoma: Clinical and biological significance.
Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma.
Control of growth of estrogen-sensitive cells: role for alpha-fetoprotein.
Controlling data quality and reproducibility of a high-sensitivity immunoassay using isotachophoresis in a microchip.
Conversion Hepatectomy for Huge Hepatocellular Carcinoma With Arterioportal Shunt After Chemoembolization and Lenvatinib Therapy.
Correlation between serum level of, and tissue positivity for, alpha-fetoprotein in hepatocellular carcinoma.
Correlation of PDK1 expression with clinicopathologic features and prognosis of hepatocellular carcinoma.
Correlation of tumour markers in ascitic fluid and serum: are measurements of ascitic tumour markers a futile attempt?
Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis.
Cross-Match as an Immuno-Oncological Risk Factor for Hepatocellular Carcinoma Recurrence and Inferior Survival After Living Donor Liver Transplantation: A Call for Further Investigation.
CT arterial portography and CT hepatic arteriography in detection of micro liver cancer.
CT volume measurement for prognostic evaluation of unresectable hepatocellular carcinoma after TACE.
Current and Emerging Tools for Hepatocellular Carcinoma Surveillance.
Current management of hepatocellular carcinoma.
Current role of ultrasound for the management of hepatocellular carcinoma.
Cushing's syndrome due to ovarian serous adenocarcinoma secreting multiple endocrine substances: a case report and immunohistochemical analysis.
Cyclooxygenase-2 expression is associated with initiation of hepatocellular carcinoma, while prostaglandin receptor-1 expression predicts survival.
Cytokine evaluation in liver cirrhosis and hepatocellular carcinoma.
Cytopathologic and clinicopathologic features of ovarian hepatoid carcinoma. A case report.
Cytopathologic findings and differential diagnostic considerations of primary clear cell carcinoma of the lung.
Cytoplasmic expression of CD133 is an important risk factor for overall survival in hepatocellular carcinoma.
Cytotoxic effects of daunomycin-fatty acid complexes on rat hepatoma cells.
Datura stramonium agglutinin-reactive alpha-fetoprotein isoforms in hepatocellular carcinoma and other tumors.
Daunorubicin conjugated with alpha-fetoprotein selectively eliminates myeloid-derived suppressor cells (MDSCs) and inhibits experimental tumor growth.
Decreased expression of hsa_circ_0003570 in hepatocellular carcinoma and its clinical significance.
Defining hepatoblastoma responsiveness to induction therapy as measured by tumor volume and serum alpha-fetoprotein kinetics.
Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients.
Dendritic cells pulsed with alpha-fetoprotein and mutant P53 fused gene induce bi-targeted cytotoxic T lymphocyte response against hepatic carcinoma.
Des-?-carboxy prothrombin ratio measured by P-11 and P-16 antibodies is a novel biomarker for hepatocellular carcinoma.
Des-gamma-carboxy prothrombin (PIVKA-II) and alpha-fetoprotein-producing IIc-type early gastric cancer.
Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients.
Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Detection of a metastatic lesion and tiny yolk sac tumors in two teenage patients by FDG-PET: report of two cases.
Detection of AFP and HCG in metastatic testicular cancer after treatment with chemotherapy or radiation therapy.
Detection of AFP mRNA-expressing cells in the peripheral blood for prediction of HCC recurrence after living donor liver transplantation.
Detection of alpha-fetoprotein mRNA in seminoma.
Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma.
Detection of craniospinal dissemination of intracranial germ cell tumours based on serum and cerebrospinal fluid levels of tumour markers.
Detection of germ-cell tumor cells in the peripheral blood by nested reverse transcription-polymerase chain reaction for alpha-fetoprotein-messenger RNA and beta human chorionic gonadotropin-messenger RNA.
Detection of hepatocellular carcinoma during a clinical follow-up of chronic liver disease: observations in 31 patients.
Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma.
Detection of point mutations of BCL10 gene in hepatocellular carcinoma tissues: report of 46 cases.
Detection of serum alpha-fetoprotein in dogs with hepatic tumors.
Detection of serum alpha-fetoprotein in dogs with naturally occurring malignant neoplasia.
Detection of tumor cells in peritoneal lavages from patients with gastrointestinal cancer by multiplex reverse transcriptase PCR.
Determinants of survival after sorafenib failure in patients with BCLC-C hepatocellular carcinoma in real-world practice.
Determination of alpha-fetoprotein by radioimmunoassay. Ten year experience in applying a locally produced kit.
Developing a prediction rule to assess hepatic malignancy in patients with cirrhosis.
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma.
Development and validation of a nomogram combining hematological and imaging features for preoperative prediction of microvascular invasion in hepatocellular carcinoma patients.
Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation.
Development and validation of an individualized prediction calculator of postoperative mortality within 6 months after surgical resection for hepatocellular carcinoma: an international multicenter study.
Development and Validation of Pre- and Post-Operative Models to Predict Recurrence After Resection of Solitary Hepatocellular Carcinoma: A Multi-Institutional Study.
Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
Development of a multiple-marker RT-PCR assay for detection of micrometastases of hepatocellular carcinoma.
Development of a novel assay to quantify serum human telomerase reverse transcriptase messenger RNA and its significance as a tumor marker for hepatocellular carcinoma.
Development of a novel panel based on micro-RNAs (21, 29a, 200 and 335) and alpha-fetoprotein as diagnostic biomarkers for hepatocellular carcinoma associated with hepatitis C infection.
Development of a predictive nomogram for early recurrence of hepatocellular carcinoma in patients undergoing liver transplantation.
Development of a prognostic scoring model for predicting the survival of elderly patients with hepatocellular carcinoma.
Development of a survival evaluation model for liver transplant recipients with hepatocellular carcinoma secondary to hepatitis B.
Development of Asialoglycoprotein Receptor-Targeted Nanoparticles for Selective Delivery of Gemcitabine to Hepatocellular Carcinoma.
Development of des-gamma-carboxy prothrombin (DCP) measuring reagent using the LiBASys clinical analyzer.
Development of high-performance magnetic chemiluminescence enzyme immunoassay for alpha-fetoprotein (AFP) in human serum.
Development of liver tumors in transforming growth factor alpha transgenic mice.
Development of testicular alpha-fetoprotein-secreting germ cell tumor 3 years after treatment of intracranial lesion identified as non-secreting germ cell tumor on the basis of clinical data--case report.
Developmental alterations of alpha-fetoprotein sugar chain in amniotic fluids analyzed by lectin affinity electrophoresis.
Diagnosis of hepatocellular carcinoma by concanavalin A affinity electrophoresis of serum alpha-fetoprotein.
Diagnosis of hepatocellular carcinoma by quantitative detection of hepatoma-specific bands of serum gamma-glutamyltransferase.
Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases.
Diagnosis, staging and treatment of hepatocellular carcinoma.
Diagnostic accuracy of preoperative alpha-fetoprotein as an ovarian tumor marker in children and adolescents: not as good as we thought?
Diagnostic accuracy of serum alpha-fetoprotein levels in diagnosing recurrent sacrococcygeal teratoma: A systematic review.
Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
Diagnostic difficulties before definitive treatment of an extragonadal retroperitoneal germ cell tumor.
Diagnostic Performance of microRNA-122 and microRNA-224 in Hepatitis C Virus-Induced Hepatocellular Carcinoma (HCC).
Diagnostic relevance of a novel multiplex immunoassay panel in breast cancer.
Diagnostic utility and correlation of tumor markers in the serum and cerebrospinal fluid of children with intracranial germ cell tumors.
Diagnostic utility of immunohistochemistry in hepatocellular carcinoma, its variants and their mimics.
Diagnostic Utility of SALL4 in Extragonadal Yolk Sac Tumors: An Immunohistochemical Study of 59 Cases With Comparison to Placental-like Alkaline Phosphatase, Alpha-fetoprotein, and Glypican-3.
Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system: a study of 77 cases.
Diagnostic value of CA-153 and CYFRA 21-1 in predicting intraocular metastasis in patients with metastatic lung cancer.
Diagnostic value of lectin reactive alpha-fetoprotein for neoinfantile hepatic tumors and malignant germ cell tumors: preliminary study.
Diagnostic value of serum gamma-glutamyl transferase isoenzyme for hepatocellular carcinoma: a 10-year study.
Diagnostic value of serum tumor markers in asymptomatic individuals.
Diagnostic value of serum tumor markers in skeletal metastasis of carcinomas.
Diagnostic value of tumour marker regression models in stage 1 marker-positive testicular cancer.
Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia.
Difference in biological characteristics and sensitivity to chemotherapy and radiotherapy between intrahepatic and extrahepatic cholangiocarcinoma cells in vitro.
Different transformation of mature teratoma in a patient with mixed germ cell tumor of the testis.
Differential gene alteration among hepatoma cell lines demonstrated by cDNA microarray-based comparative genomic hybridization.
Differential immunoprofiles of hepatocellular carcinoma, renal cell carcinoma, and adrenocortical carcinoma: a systemic immunohistochemical survey using tissue array technique.
Differentiated rhabdomyomatous tumors after chemotherapy for metastatic testicular germ-cell tumors: a clinicopathological study of seven cases mandating separation from rhabdomyosarcoma.
Direct-Acting Antiviral Therapy not Associated with Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study.
Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma.
Direct-acting Antivirals Do Not Increase the Risk of Hepatocellular Carcinoma Recurrence after Local-Regional Therapy or Liver Transplant Waitlist Dropout.
Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice.
Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis.
Distinct expression pattern of claudin-6, a primitive phenotypic tight junction molecule, in germ cell tumours and visceral carcinomas.
Distinguishing Tumor from Bland Portal Vein Thrombus in Liver Transplant Candidates with Hepatocellular Carcinoma: The "A-VENA" Criteria.
Distribution of five antigens in hepatocellular carcinoma.
Distribution of tumor-associated antigens in the various histologic components of germ cell tumors of the testis.
DLX4 as a prognostic marker for hepatocellular carcinoma.
DNA vaccination with AFP-encoding plasmid DNA prevents growth of subcutaneous AFP-expressing tumors and does not interfere with liver regeneration in mice.
Do We Need to Be Limited by Matching Milan Criteria for Survival in Living Donor Liver Transplantation?
Doctor's dilemma: incorporating tumor markers into clinical decision-making.
Does additional doxorubicin chemotherapy improve outcome in patients with hepatocellular carcinoma treated by liver transplantation?
Does Donation After Cardiac Death Utilization Adversely Effect Hepatocellular Cancer Survival?
Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer?--Results of a study in 50 patients.
Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors?
Does surgical resection of hepatocellular carcinoma accelerate cancer dissemination?
Does surveillance for hepatocellular carcinoma in HCV cirrhotic patients improve treatment outcome mainly due to better clinical status at diagnosis?
Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection?
Donation After Circulatory Death Is Associated With Similar Posttransplant Survival in All but the Highest-Risk Hepatocellular Carcinoma Patients.
Dose-dependent regulation of superoxide anion on the proliferation, differentiation, apoptosis and necrosis of human hepatoma cells: the role of intracellular Ca 2+.
Double- and Triple-Positive Tumor Markers Predict Early Recurrence and Poor Survival in Patients with Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh Class A.
Downregulation of alpha-fetoprotein expression by LHX4: a critical role in hepatocarcinogenesis.
Downregulation of phorbol 12-myristate 13-acetate-induced tumor necrosis factor-alpha and interleukin-1 beta production and gene expression in human monocytic cells by human alpha-fetoprotein.
Downstaging therapy followed by liver transplantation for hepatocellular carcinoma beyond Milan criteria.
Doxorubicin, L-arginine, or their combination as a prophylactic agent against hepatic carcinoma in mice.
Drebrin: A new oncofetal biomarker associated with prognosis of lung adenocarcinoma.
Drug-resistance patterns assessed from tumor marker analysis.
Dysgerminoma with a slightly elevated alpha-fetoprotein level diagnosed as a mixed germ cell tumor after recurrence.
Early cancer-related death after resection of hepatocellular carcinoma.
Early Detection of Cancer: Immunoassays for Plasma Tumor Markers.
Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.
Early Detection of Hepatocellular Carcinoma Recurrence Using the Highly Sensitive Fucosylated Fraction of Alpha-Fetoprotein.
Early increase of serum alpha-fetoprotein in spontaneous hepatocarcinogenesis in mice.
Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors.
Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.
Early Recurrence after Curative Resection in Oligonodular Hepatocellular Carcinoma.
Early Versus Late Hepatocellular Carcinoma Recurrence After Transplantation: Predictive Factors, Patterns, and Long-term Outcome.
EAU-ESPU pediatric urology guidelines on testicular tumors in prepubertal boys.
Ectopic hepatocellular carcinoma mimicking a retroperitoneal tumor: A case report.
Effect of a conjugate of daunomycin and antibodies to rat alpha-fetoprotein on the growth of alpha-fetoprotein-producing tumor cells.
Effect of a conjugate of daunomycin and purified polyclonal or monoclonal antibodies to rat alpha-fetoprotein on the growth of alpha-fetoprotein-producing tumor cells.
Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report.
Effect of hemodialysis on the concentration of the seven tumor markers carcinoembryonic antigen, alpha-fetoprotein, squamous cell carcinoma-related antigen, neuron-specific enolase, CA 125, CA 19-9 and CA 15-3 in uremic patients.
Effect of horse antibody to rat alpha-fetoprotein upon the growth of AH-66 in Donryu rats.
Effect of human lymphoblastoid interferon on human yolk sac tumors in nude mice.
Effect of mid-late mouse fetus' microenvironment on the growth of tumor cells after intrauterine transplantation.
Effect of pre- and post-treatment ?-fetoprotein levels and tumor size on survival of patients with hepatocellular carcinoma treated by resection, transarterial chemoembolization or radiofrequency ablation: a retrospective study.
Effect of selenium-enriched malt on hepatocarcinogenesis, paraneoplastic syndrome and the hormones regulating blood glucose in rats treated by diethylnitrosamine.
Effective relief of obstructive jaundice in a patient with nonresectable icteric-type hepatocellular carcinoma by external beam radiation therapy: case report.
Effectiveness and feasibility of external beam radiotherapy for hepatocellular carcinoma with inferior vena cava and/or right atrium involvement: a multicenter trial in Korea (KROG 17-10).
Effectiveness of Lipiodol in transcatheter arterial embolization of hepatocellular carcinoma.
Effects of ascorbic acid and DL-alpha-tocopherol on human hepatoma cell proliferation and redifferentiation.
Effects of ascorbic acid and sodium selenite on growth and redifferentiation in human hepatoma cells and its mechanisms.
Effects of ascorbic acid on human hepatoma cell proliferation and redifferentiation.
Effects of curcumin in pediatric epithelial liver tumors: inhibition of tumor growth and alpha-fetoprotein in vitro and in vivo involving the NFkappaB- and the beta-catenin pathways.
Effects of exercise type on estrogen, tumor markers, immune function, antioxidant function, and physical fitness in postmenopausal obese women.
Effects of maintenance immunosuppression with sirolimus after liver transplant for hepatocellular carcinoma.
Effects of paclitaxel and doxorubicin in histocultures of hepatocelular carcinomas.
Effects of ricin A chain conjugates of monoclonal antibodies to human alpha-fetoprotein and placental alkaline phosphatase on antigen-producing tumor cells in culture.
Effects of the irreversible ornithine decarboxylase inhibitor, alpha-difluoromethylornithine, aflatoxin B1, and choline deficiency on hepatocarcinogenesis.
Efficacy and Safety of Drug Eluting Bead TACE with Microspheres <150 ?m for the Treatment of Hepatocellular Carcinoma.
Efficacy and safety of lenvatinib for patients with advanced hepatocellular carcinoma: A retrospective, real-world study conducted in China.
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia-Pacific trial.
Efficacy and safety of thalidomide in patients with hepatocellular carcinoma.
Efficacy of argon-helium cryosurgical ablation on primary hepatocellular carcinoma: a pilot clinical study.
Efficacy of Chemoembolization for Recurrent HCC after Curative Ablation Therapy.
Efficacy of drug-eluting bead transarterial chemoembolization (DEB-TACE) combined with radiofrequency ablation versus DEB-TACE alone in Chinese hepatocellular carcinoma patients.
Efficacy of neoadjuvant therapy and surgical rescue for locally advanced hepatoblastomas: 10 year single-center experience and literature review.
Efficacy of neuroendoscopic procedures in minimally invasive preferential management of pineal region tumors: a prospective study.
Efficacy of ultrasound-, computed tomography-, and magnetic resonance imaging-guided radiofrequency ablation for hepatocellular carcinoma.
Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection.
Efficiency of composite laboratory tests in the diagnosis of liver malignancies.
Elevated alpha-fetoprotein and a pancreatic tumour.
Elevated alpha-fetoprotein secondary to Hodgkin's lymphoma.
Elevated concentrations of serum alpha-fetoprotein in rats with chemically induced liver tumors.
Elevated lactate dehydrogenase isoenzyme 1 as a tumour marker in patients with germ cell testicular tumours.
Elevated levels of circulating cell-free DNA in the blood of patients with hepatitis C virus-associated hepatocellular carcinoma.
Elevated maternal serum ?-fetoprotein level in a fetus with Beckwith-Wiedemann syndrome in the second trimester of pregnancy.
Elevated paraneoplastic hypercholesterolemia in a case of hepatoid adenocarcinoma of the stomach with liver metastasis.
Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma.
Elevated Preoperative Serum Gamma-glutamyltranspeptidase Predicts Poor Prognosis for Hepatocellular Carcinoma after Liver Transplantation.
Elevated serum alpha-fetoprotein associated with Sertoli-Leydig cell tumors of the ovary.
Elevated serum alpha-fetoprotein in a patient with undifferentiated carcinoma of the gall bladder.
Elevated serum alpha-fetoprotein in poorly differentiated adenocarcinoma with neuroendocrine differentiation of the ascending colon: a case report.
Elevated serum alpha-fetoprotein in Wilms tumor may follow the same pattern of other fetal neoplasms after treatment: evidence from three cases.
Elevated serum CA 19-9 levels in hepatobiliary cystadenoma with mesenchymal stroma. Two case reports with immunohistochemical confirmation.
Elevated Serum Levels of Alpha-Fetoprotein in Patients with Infantile Hemangioma Are Not Derived from within the Tumor.
Elevated serum levels of IGF-binding protein 2 in patients with non-seminomatous germ cell cancer: correlation with tumor markers alpha-fetoprotein and human chorionic gonadotropin.
Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma.
Elevation of CA 19-9 and chromogranin A, in addition to CA 125, are detectable in benign tumors in leiomyomas and endometriosis.
Elevation of transforming growth factor alpha and its relationship to the epidermal growth factor and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Elevation of tumour markers TGF-?, M
Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program.
Embryonal carcinoma in the abdominal cavity of a male calf.
Embryonal carcinoma of the ovary: a clinicopathologic entity distinct from endodermal sinus tumor resembling embryonal carcinoma of the adult testis.
Endodermal sinus (yolk sac) tumor of oral cavity originating from gingiva.
Endodermal sinus (yolk sac) tumor of the parotid gland: a case report.
Endodermal sinus (yolk sac) tumors of the anterior mediastinum.
Endodermal sinus (yolk sac) tumour of the liver. A case report and review of the literature.
Endodermal sinus tumor (yolk sac tumor), seminoma and hemangiopericytoma. Rare primary mediastinal tumors. A report on the course of the disease in nine patients.
Endodermal sinus tumor arising in the endometrium.
Endodermal sinus tumor in pregnancy: report of a case and review of the literature.
Endodermal sinus tumor of the infant vagina treated exclusively with chemotherapy.
Endodermal sinus tumor of the infant vagina.
Endodermal sinus tumor of the ovary during pregnancy: a case report.
Endodermal sinus tumor of the ovary. Clinicopathologic study of 6 cases.
Endodermal sinus tumor of the ovary: a clinical and pathologic analysis of 71 cases.
Endodermal sinus tumor of the paranasal sinuses.
Endodermal sinus tumor of the parotid gland in a child.
Endodermal sinus tumor of the pineal region. Metastases through a ventriculoperitoneal shunt.
Endodermal sinus tumor of the pineal region: case report.
Endodermal sinus tumor of the stomach.
Endodermal sinus tumor of vagina in infants.
Endodermal sinus tumour of the ovary: serum alpha-fetoprotein levels before and after treatment and during pregnancy. Case report.
Endoscopic Transsphenoidal Approach in Treatment of Germinomas of the Chiasmosellar Region.
Engineering of the Saccharomyces cerevisiae yeast strain with multiple chromosome-integrated genes of human alpha-fetoprotein and its high-yield secretory production, purification, structural and functional characterization.
Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma.
Enhanced detection of hepatocellular carcinoma.
Enhancement of tumor-specific T cell responses by transcatheter arterial embolization with dendritic cell infusion for hepatocellular carcinoma.
Eosinophilic globules in Kaposi's sarcoma. A histochemical, immunohistochemical, and ultrastructural study.
EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.
EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features.
Ephrin-A1 expression contributes to the malignant characteristics of {alpha}-fetoprotein producing hepatocellular carcinoma.
Epidemiologic study of 230 cases of testicular/paratesticular tumors or masses: 15-year experience of a single center.
Epidemiological and clinical behavior of prepubertal testicular tumors in Korea.
Epidemiology and clinical features of patients with hepatocellular carcinoma at a tertiary hospital in Jeddah.
Epididymal melanotic neuroectodermal tumor of infancy.
Epithelioid angiosarcoma: A neoplasm with potential diagnostic challenges.
Equine primary liver tumors: a case series and review of the literature.
Errors in measurement and reporting of serum markers in patients with germ cell tumors.
Erythrocytosis caused by an erythropoietin-producing hepatocellular carcinoma.
Erythropoietin production in hepatocellular carcinoma cells associated with polycythemia: immunohistochemical evidence.
Establishment and biological characterization of a novel cell line derived from hepatoid adenocarcinoma originated at the ampulla of Vater.
Establishment and characterization of a cancer cell line derived from an aggressive childhood liver tumor.
Establishment and characterization of a cell line from a chemically-induced mouse hepatoblastoma.
Establishment and characterization of a human ovarian endodermal sinus tumor cell line--producing specific type of alpha-fetoprotein subfraction.
Establishment and characterization of a rat yolk sac tumor cell line, NMT-1, producing alpha-fetoprotein, with potential for lymphatic metastasis.
Establishment and characterization of human hepatocellular carcinoma cell line FHCC-98.
Establishment of a cell line and its clonal sublines from a patient with hepatoblastoma.
Establishment of a human hepatoblastoma model in athymic nude mice. Producibility of fatty acid-binding protein, alpha-fetoprotein, and alpha 1-acid glycoprotein.
Establishment, validation and evaluation of predictive model for early relapse after R0 resection in hepatocellular carcinoma patients with microvascular invasion.
Estrogen receptor and alpha-fetoprotein in human breast cancer: brief communication.
Estrogen receptors in hepatocellular carcinoma.
Ethnic differences in the behavior of hepatocellular carcinoma.
Evaluation of a CLEIA automated assay system for the detection of a panel of tumor markers.
Evaluation of AFP glycosylation heterogeneity in cancer patients with AFP-producing tumors.
Evaluation of alpha-fetoprotein assay in ascitic fluid for the diagnosis of hepatocellular carcinoma.
Evaluation of Circulating miRNA Biomarkers of Testicular Germ Cell Tumors during Therapy and Follow-up-A Copenhagen Experience.
Evaluation of epidermal growth factor receptor, carcinoembryonic antigen and Lewis carbohydrate antigens in human colorectal and liver neoplasias.
Evaluation of HCPTd1,d14-double passaged intervening chemotherapy protocol for hepatocellular carcinoma.
Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
Evaluation of model for end stage liver disease (MELD)-based systems as prognostic index for hepatocellular carcinoma.
Evaluation of Recurrence Predictors and Survival Probability After Liver Transplantation for Hepatocellular Carcinoma: Analysis From a Single Center.
Evaluation of serum levels of p53 in hepatocellular carcinoma in Egypt.
Evaluation of survival of patients with hepatocellular carcinoma: A comparative analysis of prognostic systems.
Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy.
Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model.
Evaluation of the prognostic value of paraoxonase 1 in the recurrence and metastasis of hepatocellular carcinoma and establishment of a liver-specific predictive model of survival.
Evaluation of the sensitivity and specificity of serum level of prostasin, CA125, LDH, AFP, and hCG+? in epithelial ovarian cancer patients.
Evaluation of the therapeutic effect of TAE on primary liver cancer.
Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma.
Evaluation of the UniCel™ DxI 800 immunoassay analyzer in measuring five tumor markers.
Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma.
Evaluation of tumor markers biochip C12 system in the diagnosis of gastric cancer and the strategies for improvement: analysis of 100 cases.
Evaluation of tumor markers in patients with squamous cell carcinoma in the oral cavity.
Evaluation of Tumor Response Using Alpha-fetoprotein and Des-gamma-carboxy Prothrombin in Hepatocellular Carcinoma Patients Who Underwent Transarterial Chemoembolization.
Evaluation of tumour necrosis factor-alpha, soluble P-selectin, gamma-glutamyl transferase, glutathione S-transferase-pi and alpha-fetoprotein in patients with hepatocellular carcinoma before and during chemotherapy.
Evidence for association with hepatocellular carcinoma at the PAPSS1 locus on chromosome 4q25 in a family-based study.
Evolution of prognostic factors in hepatocellular carcinoma in Japan.
Excellent Response to Anti-PD-1 Therapy in a Patient with Hepatocellular Carcinoma Intolerant to Sorafenib.
Excellent response to Anti-PD-1 therapy in a patient with hepatocellular carcinoma: case report and review of literature.
Exogenous estrogen therapy, testicular cancer, and the male to female transgender population: a case report.
Expanded criteria for liver transplantation in patients with hepatocellular carcinoma.
Expanded living-donor liver transplantation criteria for patients with hepatocellular carcinoma based on the Japanese nationwide survey: the 5-5-500 rule - a retrospective study.
Expanded Milan criteria on pathological examination after liver transplantation: analysis of preoperative data.
Experience with 8 cases of prenatally diagnosed sacrococcygeal teratomas.
Experience with serum alpha-fetoprotein and human chorionic gonadotropin in non-seminomatous testicular tumors.
Experience with the management of primary endodermal sinus tumor of the mediastinum.
Experimental yolk-sac tumors produced by fetectomy without virus infection in rats.
Expression and characterization of a recombinant Fab fragment derived from an anti-human alpha-fetoprotein monoclonal antibody.
Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma.
Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma.
Expression and prognostic value of VEGFR-2, PDGFR-?, and c-Met in advanced hepatocellular carcinoma.
Expression and Significance of LncRNA-MINCR and CDK2 mRNA in Primary Hepatocellular Carcinoma.
Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy.
Expression of alpha-fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reaction.
Expression of alpha-fetoprotein by ovarian Sertoli-Leydig cell tumors. Case report and review of the literature.
Expression of Aurora B and alternative variant forms in hepatocellular carcinoma and adjacent tissue.
Expression of cancer-testis antigens in hepatocellular carcinoma.
Expression of cancer/testis (CT) antigens in Chinese hepatocellular carcinoma and its correlation with clinical parameters.
Expression of CD147 as a significantly unfavorable prognostic factor in hepatocellular carcinoma.
Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
Expression of FOXO6 is Associated With Oxidative Stress Level and Predicts the Prognosis in Hepatocellular Cancer: A Comparative Study.
Expression of heparanase in hepatocellular carcinoma has prognostic significance: a tissue microarray study.
Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
Expression of human regenerating gene mRNA and its product in normal and neoplastic human pancreas.
Expression of insulin-like growth factor II, alpha-fetoprotein and hepatitis B virus transcripts in human primary liver cancer.
Expression of matrix metalloproteinase-9 in predicting prognosis of hepatocellular carcinoma after liver transplantation.
Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates with Early Recurrence and Aggressive Features of HBV-Associated HCC.
Expression of P-glycoprotein in rat hepatocarcinogenesis by diethylnitrosamine and the modulation by anticancer drugs.
Expression of prothymosin alpha predicts early recurrence and poor prognosis of hepatocellular carcinoma.
Expression of Src and FAK in Hepatocellular Carcinoma and the Effect of Src Inhibitors on Hepatocellular Carcinoma In Vitro.
Expression of the alpha-fetoprotein gene in human breast cancer.
Expression of transforming growth factor-beta 1 mRNA in human hepatocellular carcinoma.
Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas.
Extensive portal tumor thrombi with portal hypertension in an autopsy case of intrahepatic cholangiocarcinoma.
External validation of an individual prognostic calculator after trans-arterial chemo-embolization for hepatocellular carcinoma.
Extragonadal germ cell tumor in the retrovesical region associated with Klinefelter's syndrome: a case report and review of the literature.
Extragonadal germ cell tumor of the prostate associated with Klinefelter's syndrome.
Extragonadal germ cell tumors. Clinicopathologic findings and treatment experience in 12 patients.
Extraneural metastasis of choriocarcinomatous element in pineal germ-cell tumor. Case report.
Extremely elevated alpha-fetoprotein due to acute exacerbation of chronic hepatitis B without malignancy: a case report.
Extremely high alpha-fetoprotein-producing adrenal hepatoid adenocarcinoma.
Extremely high expression of serum alpha-fetoprotein level of gastric adenocarcinoma: a rare case with an unexpected well-prognosis.
Fabrication of a simple and sensitive QDs-based electrochemiluminescence immunosensor using a nanostructured composite material for the detection of tumor markers alpha-fetoprotein.
Fabrication of Gold Nanoparticle-Embedded Metal-Organic Framework for Highly Sensitive Surface-Enhanced Raman Scattering Detection.
Fabrication of stable antibody-modified field effect transistors using electrical activation of Schiff base cross-linkages for tumor marker detection.
Factors affecting functional prognosis in survivors of primary central nervous system germinal tumors.
Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection.
Factors Associated With Ovarian Preservation in Children and Adolescents With Primary Tumors of Ovary.
Factors associated with survival exceeding 5 years after transcatheter arterial embolization for hepatocellular carcinoma.
Factors predictive for long-term survival of male patients with hepatocellular carcinoma after curative resection.
Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma.
Fairly rare small-diameter hepatocellular carcinoma with right adrenal gland metastasis having an inferior vena cava tumor thrombus: a case report.
False elevation of human chorionic gonadotropin in a patient with testicular cancer.
False elevations of alpha-fetoprotein associated with liver dysfunction in germ cell tumors.
False Positive Diagnosis of Hepatocellular Carcinoma in Liver Resection Patients.
Family members p53 and p73 act together in chromatin modification and direct repression of alpha-fetoprotein transcription.
Fast protein detection using absorption properties of gold nanoparticles.
Favorable outcome in children with Beckwith-Wiedemann syndrome and intraabdominal malignant tumors.
Feasibility and diagnostic impact of fluorescence-based diagnostic laparoscopy in hepatocellular carcinoma: a case report.
Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma.
Feasibility of SBRT for hepatocellular carcinoma in Brazil - a prospective pilot study.
Feeding artery ablation before radiofrequency ablation for hepatocellular carcinoma may reduce critical recurrence.
Fetal hemoglobin and alpha-fetoprotein in various malignancies.
Fetal-type gastrointestinal adenocarcinoma: a morphologically distinct entity with unfavourable prognosis.
Fibrolamellar carcinoma of the liver in a middle-aged Korean man.
Fibrolamellar Carcinoma: A Multimodal Approach.
Fibrolamellar hepatocellular carcinoma with a recurrence of classic hepatocellular carcinoma: a case report and review of Oriental cases.
Fifty years of discovery of alpha-fetoprotein as the first tumor marker.
Fine needle aspiration cytology of hepatoblastoma. A report of two cases.
Fine needle aspiration cytology of primary mediastinal germ cell tumors.
Fine needle aspiration diagnosis of necrotizing eosinophilic abscess clinically mimicking hepatic neoplasia: a case report.
Fine-needle aspiration biopsy of hepatic angiosarcoma: report of a case with immunocytochemical findings.
Fine-needle aspiration cytology of pulmonary adenocarcinoma of fetal type: report of a case with immunohistochemical and ultrastructural studies.
First report of the unique expression of RECAF (receptor for alfa feto-protein) in adult B-NHL/CLL patients.
Flow cytometric analysis of DNA ploidy in hepatocellular carcinoma.
Flow cytometric DNA analysis of hepatocellular carcinoma: preliminary report.
Focal nodular hyperplasia masquerading as malignancy in an infant with elevated alpha-fetoprotein: A case report with literature review.
Follistatin Like 5 (FSTL5) inhibits epithelial to mesenchymal transition in hepatocellular carcinoma.
Follow-up examination schedule of postoperative HCC patients based on tumor volume doubling time.
Frequency of alpha-fetoprotein production by Sertoli-Leydig cell tumors of the ovary: an immunohistochemical study of eight cases.
Frequency of intratubular germ cell neoplasia with invasive testicular germ cell tumors. Histologic and immunocytochemical features.
Fucosylation of N-glycans regulates the secretion of hepatic glycoproteins into bile ducts.
Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and (18)F-FDG PET/CT in patients on waiting-list for liver transplantation.
GABPA predicts prognosis and inhibits metastasis of hepatocellular carcinoma.
GADD45-alpha expression in cirrhosis and hepatocellular carcinoma: relationship with DNA repair and proliferation.
Gallbladder carcinomas: an immunoprognostic evaluation of P53, Bcl-2, CEA and alpha-fetoprotein.
Gallium-67-citrate scanning in primary cancer of the liver: diagnostic value in the presence of cirrhosis and relation to alpha-fetoprotein.
Gastric adenocarcinoma with features of endodermal sinus tumor.
Gastric cancer with adenocarcinoma and yolk sac tumor components: A rare entity.
Gastric cancer with choriocarcinoma and yolk sac tumor components: case report.
Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature.
Gastric hepatoid adenocarcinoma: a computed tomography report of six cases.
Gene expression analysis for evaluation of potential biomarkers in hepatocellular carcinoma.
Gene therapy for hepatocellular carcinoma using two recombinant adenovirus vectors with alpha-fetoprotein promoter and Cre/lox P system.
Gene transfer of kringle 1-5 suppresses tumor development and improves prognosis of mice with hepatocellular carcinoma.
Generalized intraperitoneal seeding of hepatocellular carcinoma after microwave coagulation therapy: a case report.
Genetic alterations of the ATBF1 gene in gastric cancer.
Genetic correction improves prediction efficiency of serum tumor biomarkers on digestive cancer risk in the elderly Chinese cohort study.
Genetic correction of serum AFP level improves risk prediction of primary hepatocellular carcinoma in the Dongfeng-Tongji cohort study.
Genetically fused protein A-luciferase for immunological blotting analyses.
Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups.
Germ cell function and hormonal status in patients with testicular cancer.
Germ cell neoplasms of head and neck soft tissues: a pathologic spectrum of teratomatous and endodermal sinus tumors.
Germ cell tumor in an adolescent with extensive testicular microlithiasis: concerns regarding future management.
Germ cell tumor in the basal ganglia: immunohistochemical demonstration of alpha-fetoprotein, human chorionic gonadotropin, and carcinoembryonic antigen.
Germ cell tumors express a specific alpha-fetoprotein variant detectable by isoelectric focusing.
Germ cell tumors in infancy and childhood: a 45-year experience.
Germ cell tumors of the mediastinum and testis: a comparative immunohistochemical study of 120 cases.
Germ cell tumours of testis: prognostic factors and results.
Germinoma with malignant transformation to nongerminomatous germ cell tumor.
Glasgow Prognostic Score and Prognosis After Hepatectomy for Hepatocellular Carcinoma.
Glutamine synthetase immunostaining correlates with pathologic features of hepatocellular carcinoma and better survival after radiofrequency thermal ablation.
Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour.
Glycomic analyses of glycoproteins in bile and serum during rat hepatocarcinogenesis.
Glycomic analysis of alpha-fetoprotein L3 in hepatoma cell lines and hepatocellular carcinoma patients.
Glypican 3 has a higher sensitivity than alpha-fetoprotein for testicular and ovarian yolk sac tumour: immunohistochemical investigation with analysis of histological growth patterns.
Glypican-3 and hepatocyte paraffin-1 combined with alpha-fetoprotein as a novel risk scoring model for predicting early recurrence of hepatocellular carcinoma after curative resection.
Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker.
Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma.
Gonadal and extragonadal yolk sac carcinomas: a clinicopathologic study of 14 cases.
Gonadotropin releasing hormone-independent precocious puberty in a 5 year-old girl with suprasellar germ cell tumor secreting beta-hCG and alpha-fetoprotein.
GPX2 overexpression indicates poor prognosis in patients with hepatocellular carcinoma.
Granulosa-theca-cell tumour in a 17-month-old girl.
Growth in culture and tumorigenicity after transfection with the ras oncogene of liver epithelial cells from carcinogen-treated rats.
Growth inhibition of estrogen-sensitive rat mammary tumors. Effect of an alpha-fetoprotein-secreting hepatoma.
Growth inhibition of estrogen-sensitive tumor cells in newborn rats. Probable role of alpha-fetoprotein.
Growth kinetics of hepatocellular carcinoma.
Growth of hepatocellular carcinoma in the regenerating liver.
Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications.
Growth suppression of the hepatocellular carcinoma cell line Hepa1-6 by an activatable interferon regulatory factor-1 in mice.
Growth velocity of the portal vein tumor thrombus accelerated by its progression, alpha-fetoprotein level, and liver fibrosis stage in patients with hepatocellular carcinoma.
Growth-regulative activity of human alpha-fetoprotein for different types of tumor and normal cells.
Guide for diagnosis and treatment of hepatocellular carcinoma.
H1(0) histones of normal and cancer human cells. Amino acid composition of H1 purified by polyacrylamide gel electrophoresis.
Half-life of alpha-fetoprotein in neonatal sacrococcygeal teratoma.
Half-life of alpha-fetoprotein in patients with a teratoma, endodermal sinus tumor, or hepatoblastoma.
Hangzhou criteria as downstaging criteria in hepatocellular carcinoma before liver transplantation: A multicenter study from China.
Hepatectomy Combined with Diaphragmatic Resection for Hepatocellular Carcinoma with Diaphragmatic Involvement: A Propensity Score-Matched Analysis.
Hepatectomy for Hepatocellular Carcinoma with Bile Duct Tumor Thrombus, Including Cases with Obstructive Jaundice.
Hepatic Angiomyolipoma: A Clinical Experience in Diagnosis and Treatment.
Hepatic arterial embolization with microencapsulated mitomycin C for unresectable hepatocellular carcinoma in cirrhosis.
Hepatic Epithelioid Hemangioendothelioma as a Rare Indication for Liver Transplantation.
Hepatic Epithelioid Hemangioendothelioma Presenting Synchronously with Hepatocellular Carcinoma.
Hepatic incidentaloma. Retrospective analysis of 35 cases.
Hepatic intra-arterial infusion of yttrium-90 microspheres in the treatment of recurrent hepatocellular carcinoma after liver transplantation: A case report.
Hepatic mensenchymal hamartoma of an infant.
Hepatic mesenchymal hamartoma combined with infantile hepatic hemangioendothelioma in an infant.
Hepatic perfusion index: a new and useful factor in predicting survival among patients with hepatocellular carcinoma.
Hepatic resection for hepatocellular carcinoma in end-stage renal disease patients: two decades of experience at Chang Gung Memorial Hospital.
Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis.
Hepatic Resection Is Associated With Improved Long-Term Survival Compared to Radio-Frequency Ablation in Patients With Multifocal Hepatocellular Carcinoma.
Hepatic resection is not enough for hepatocellular carcinoma. A follow-up study of 92 patients.
Hepatic resection of metastatic tumor from serous cystadenocarcinoma of the ovary.
Hepatitis B and alcohol affect survival of hepatocellular carcinoma patients.
Hepatitis B surface antigen and alpha-fetoprotein secreting human primary liver cell cancer in athymic mice.
Hepatitis B viral transactivator HBx alleviates p53-mediated repression of alpha-fetoprotein gene expression.
Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis.
Hepatitis B- and C-related hepatocellular carcinomas yield different clinical features and prognosis.
Hepatoblastoma as a cause of intrauterine fetal death. Case report.
Hepatoblastoma associated with Beckwith-Wiedemann syndrome and hemihypertrophy.
Hepatoblastoma in the neonatal period: An unusual presentation.
Hepatoblastoma presenting as isosexual precocity. The clinical importance of histologic and serologic parameters.
Hepatoblastoma presenting as precocious puberty: a case report.
Hepatoblastoma with erythrocytosis in a young female horse.
Hepatoblastoma with Precocious Puberty.
Hepatoblastoma with pure fetal epithelial differentiation in a 10-year-old boy: A rare case report and review of the literature.
Hepatoblastoma: a rare pediatric neoplasm.
Hepatoblastoma: the Indiana experience with preoperative chemotherapy for inoperable tumors; clinicopathological considerations.
Hepatocarcinoma in a child with the Alagille syndrome.
Hepatocellular cancer in the non-cirrhotic liver.
Hepatocellular Carcinoma and High Grade Neuroendocrine Carcinoma: A Case Report and Review of the Literature.
Hepatocellular carcinoma and octreotide: treatment results in prospectively assigned patients with advanced tumor and cirrhosis stage.
Hepatocellular carcinoma associated with erythrocytosis and hypoglycemia in a yearling filly.
Hepatocellular carcinoma complicating biliary cirrhosis caused by biliary atresia: report of a case.
Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents.
Hepatocellular carcinoma in a low-incidence region. Surgical perspectives.
Hepatocellular carcinoma in a patient with acromegaly and high serum levels of insulin-like growth factor I: report of a case.
Hepatocellular carcinoma in corticosteroid-treated severe autoimmune chronic active hepatitis.
Hepatocellular carcinoma in HBsAg-negative chronic active hepatitis.
Hepatocellular carcinoma in Israel: relationship to hepatitis B virus infection.
Hepatocellular carcinoma in Italian patients with cirrhosis.
Hepatocellular carcinoma in Lebanon: Etiology and prognostic factors associated with short-term survival.
Hepatocellular carcinoma in patients with autoimmune liver diseases: two case reports and literature review.
Hepatocellular carcinoma in primary biliary cirrhosis: detection by alpha-fetoprotein estimation.
Hepatocellular carcinoma in renal transplant patients.
Hepatocellular carcinoma in Taiwan: clinicopathological study of 440 cases from a consecutive 6000 autopsies.
Hepatocellular carcinoma in thalassemia major.
Hepatocellular carcinoma in the noncirrhotic liver: Clinical features and outcomes in Veracruz, Mexico.
Hepatocellular carcinoma in Txnip-deficient mice.
Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate.
Hepatocellular carcinoma macroscopic gross appearance on imaging: predictor of outcome after transarterial chemoembolization in a real-life multicenter French cohort.
Hepatocellular carcinoma metastatic to the testis.
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis.
Hepatocellular carcinoma recurrence after liver transplantation: Risk factors, screening and clinical presentation.
Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis.
Hepatocellular Carcinoma that Relapsed 54 Months after Living Donor Liver Transplantation.
Hepatocellular carcinoma with an unusual neuroendocrine component.
Hepatocellular carcinoma with inferior vena cava and right atrial tumor thrombus: A case report.
Hepatocellular carcinoma with mesothelioma-like dissemination.
Hepatocellular carcinoma with metastasis to the spleen in a Holstein cow.
Hepatocellular carcinoma with peritoneal dissemination which was regressed during vitamin K2 and vitamin E administration.
Hepatocellular Carcinoma-Circulating Tumor Cells Expressing PD-L1 Are Prognostic and Potentially Associated With Response to Checkpoint Inhibitors.
Hepatocellular carcinoma.
Hepatocellular carcinoma. Prognostic factors and survival analysis in 135 Italian patients.
Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?
Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction.
Hepatocellular carcinoma: when is liver transplantation oncologically futile?
Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.
Hepatocyte nuclear factor 1? is a novel prognostic marker independent of the milan criteria in transplantable hepatocellular carcinoma: A retrospective analysis based on tissue microarrays.
Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma.
Hepatocytic differentiation in retiform Sertoli-Leydig cell tumors: distinguishing a heterologous element from Leydig cells.
Hepatoid adenocarcinoma in Barrett's esophagus associated with achalasia: first case report.
Hepatoid adenocarcinoma in the lung.
Hepatoid Adenocarcinoma of the Colon: What Should We Target?
Hepatoid adenocarcinoma of the gallbladder with production of alpha-fetoprotein.
Hepatoid adenocarcinoma of the gallbladder: a mimicker of hepatocellular carcinoma.
Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database.
Hepatoid adenocarcinoma of the lung: report of a case of an unusual alpha-fetoprotein-producing lung tumor.
Hepatoid adenocarcinoma of the lung: Review of a rare form of lung cancer.
Hepatoid Adenocarcinoma of the Rectum With Liver Metastasis in a Patient With Ulcerative Colitis.
Hepatoid adenocarcinoma of the stomach - a different histology for not so different gastric adenocarcinoma: a case report.
Hepatoid adenocarcinoma of the stomach with liver metastasis mimicking hepatocellular carcinoma: a case report.
Hepatoid adenocarcinoma of the stomach: Thirteen case reports and review of literature.
Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases.
Hepatoid adenocarcinoma: computed tomographic imaging findings with histopathologic correlation in 6 cases.
Hepatoid carcinoma of the gallbladder.
Hepatoid carcinoma of the lung with production of alpha-fetoprotein and abnormal prothrombin: an autopsy case report.
Hepatoid carcinoma of the ovary - A case report and literature review.
Hepatoid carcinoma of the ovary without staining for alpha-fetoprotein.
Hepatoid carcinoma of the ovary: a case report.
Hepatoid carcinoma of the ovary: characteristics of its immunoreactivity. A case report.
Hepatoid carcinoma of the pancreas penetrating into the gastric cavity: a case report and literature review.
Hepatoid carcinoma of the pancreas with lymphoid stroma: first description of the clinical, morphological, immunohistochemical, and molecular characteristics of an unusual pancreatic carcinoma.
Hepatoid carcinoma of the pancreas.
Hepatoid carcinoma of the stomach.
Hepatoid carcinoma of the stomach: is it still an unusual anatomo-clinical entity? Six cases-report.
Hepatoid carcinoma of the uterus that collided with carcinosarcoma.
Hepatoid gastric adenocarcinoma. A histological and immunohistochemical study of a case.
Hepatoid gastric carcinoma. A case report.
Hepatoid pancoast tumor. A case report and review of the literature.
Hepatoid variant of yolk sac tumor of the testis.
Hepatoid yolk sac tumor of the ovary (endodermal sinus tumor with hepatoid differentiation): a light microscopic, ultrastructural and immunohistochemical study of seven cases.
Hepatoid yolk sac tumors of the mediastinum: a clinicopathologic and immunohistochemical study of four cases.
Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis.
Hereditary persistence of alpha-fetoprotein (HPAF P): review of the literature.
Hereditary persistence of alpha-fetoprotein in a child with testicular germ cell tumor.
Hereditary Persistence of Alpha-Fetoprotein in Chronic Liver Disease-Confusing Genes!
Hereditary persistence of alpha-fetoprotein.
Hereditary persistence of alpha-fetoprotein. Case report and review of the literature.
High alpha-fetoprotein level in HCV-related nodular liver cell dysplasia.
High burden of hepatocellular carcinoma and viral hepatitis in Southern and Central Vietnam: Experience of a large tertiary referral center, 2010 to 2016.
High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma.
High expression of GFAT1 predicts unfavorable prognosis in patients with hepatocellular carcinoma.
High GSTP1 inhibits cell proliferation by reducing Akt phosphorylation and is associated with a better prognosis in hepatocellular carcinoma.
High Hepatitis B Viral Load Predicts Recurrence of Small Hepatocellular Carcinoma after Curative Resection.
High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma.
High level of expression of alpha-fetoprotein receptor in gastric cancers.
High plasma concentrations of endothelin-like immunoreactivities in patients with hepatocellular carcinoma.
High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: a matched-pair analysis.
High-efficient expression, refolding and purification of functional recombinant C-terminal fragment of human alpha-fetoprotein.
High-level expression of divergent endodermal lineage markers in gonadal and extra-gonadal yolk sac tumors.
Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer.
Highly enhanced fucosylation of alpha-fetoprotein in patients with germ cell tumor.
Highly sensitive, label-free and real-time detection of alpha-fetoprotein using a silicon nanowire biosensor.
Histochemical studies of dense-core granulated tumors of the lung. Neuron-specific enolase as a marker for granulated cells.
Histologic Grade and Mitotic Index as Predictors of Microvascular Invasion in Hepatocellular Carcinoma.
Histologic markers in primary and metastatic tumors of the liver.
Histological and immunohistochemical study of hepatoblastoma: correlation with tumour behaviour and survival.
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.
HMGCS2 in metabolic pathways was associated with overall survival in hepatocellular carcinoma: A LASSO-derived study.
Hodgkin's disease--a histochemical study with special emphasis on the character of Hodgkin's cell and Reed-Sternberg cell.
Hormonal therapy for hepatocellular carcinoma.
How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system.
Huge pancreatic acinar cell carcinoma with high levels of AFP and fucosylated AFP (AFP-L3).
Human alpha-fetoprotein contains potential heterodimerization motifs capable of interaction with nuclear receptors and transcription/growth factors.
Human alpha-fetoprotein: immunosuppressive activity and microheterogeneity.
Human CD4+ T Cells Recognize an Epitope within {alpha}-Fetoprotein Sequence and Develop into TGF-{beta}-Producing CD4+ T Cells.
Human chorionic gonadotrophin and alpha-fetoprotein in testicular germ cell tumours: a retrospective immunohistochemical study.
Human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP) in sera and tumor cells of patients with testicular seminoma: a prospective study.
Human chorionic gonadotropin and alpha-fetoprotein in cholangiocarcinoma in relation to the expression of ras p21: an immunohistochemical study.
Human chorionic gonadotropin and alpha-fetoprotein in sera and tumor cells of a patient with pure dysgerminoma of the ovary. A case report with radio-immunoassay and immunoperoxidase.
Human chorionic gonadotropin and alpha-fetoprotein in testicular germ cell tumors. An immunohistochemical study in comparison with tissue concentrations.
Human endodermal sinus tumour in nude mice and its markers for diagnosis and management.
Human fetal and tumor alpha-fetoproteins differ in conformationally dependent epitope variants expression.
Human hepatocellular carcinoma tumor xenografts. Their androgen-receptor status and growth responses to castration.
Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients.
Human mammary tumor cell proliferation: primary role of platelet-derived growth factor and possible synergism with human alpha-fetoprotein.
Human seminal plasma analysis of five tumor markers: CA 125, alpha-fetoprotein, CA 50, CA 19.9, and CA 195.
HVJ-liposome-mediated transfection of HSVtk gene driven by AFP promoter inhibits hepatic tumor growth of hepatocellular carcinoma in SCID mice.
Hyaline globules and papillary fragments in cytologic smears from two intra-abdominal tumors (ovarian and hepatic) in female patients: A diagnostic pitfall with histologic correlation.
Identification of alpha-fetoprotein as an autoantigen in juvenile Batten disease.
Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCs.
Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: implications for the current organ allocation policy.
Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells.
Identification of two clinical hepatocellular carcinoma patient phenotypes from results of standard screening parameters.
Identifying candidates with favorable prognosis following liver transplantation for hepatocellular carcinoma: Data mining analysis.
Idiopathic hypothalamic diabetes insipidus, pituitary stalk thickening, and the occult intracranial germinoma in children and adolescents.
Imaging in gynecological disease (22): clinical?and?ultrasound characteristics of ovarian embryonal carcinomas, non-gestational choriocarcinomas and malignant mixed germ cell tumors.
Imaging, Pathology, and Immune Correlates in the Woodchuck Hepatic Tumor Model.
Immature endodermal teratoma of the ovary: embryologic correlations and immunohistochemistry.
Immature presacral teratoma in an adult female.
Immature teratoma of the ovary.
Immature teratoma producing alpha-fetoprotein without components of yolk sac tumor in the pineal region.
Immature teratomas in children: pathologic considerations: a report from the combined Pediatric Oncology Group/Children's Cancer Group.
Immature teratomas: identification of patients at risk for malignant recurrence.
Immune monitoring of surgical colorectal malignancies through carcinoembryonic antigen and alpha-fetoprotein serum levels, flow-cytometric blood lymphocyte phenotyping and tumor DNA analysis.
Immunobiology and gene-based immunotherapy of hepatocellular carcinoma.
Immunochemical determination of human chorionic gonadotropin and alpha-fetoprotein in sera and tumors of patients with testicular cancer.
Immunocytochemical discordance in localization of pregnancy specific beta-1 glycoprotein, alpha-fetoprotein and human chorionic gonadotropin in testicular cancers.
Immunocytochemical evaluation of primary human esophageal carcinomas and their xenografts for keratin, beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Immunocytochemical evidence of heterogeneous origin of alpha-fetoprotein in immature teratoma of the ovary.
Immunocytochemical localization of carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), and human chorionic gonadotropin (HCG) in cervical neoplasia.
Immunocytochemical localization of oncodevelopmental proteins in human germ cell and hepatic tumors.
Immunodevice for simultaneous detection of two relevant tumor markers based on separation of different microparticles by dielectrophoresis.
Immunofluorescent demonstration of alpha- fetoprotein and other plasma proteins in yolk sac tumor.
Immunofluorescent localization of alpha-fetoprotein synthesis in endodermal sinus tumor (yolk sac tumor).
Immunohistochemical and affinity electrophoretic studies of alpha-fetoprotein of a patient with hepatocellular carcinoma in the intrathoracic space.
Immunohistochemical and ultrastructural study on erythropoiesis in hepatoblastoma.
Immunohistochemical demonstration of alpha-fetoprotein in testicular germ cell tumors.
Immunohistochemical detection of aberrant p53 expression in hepatocellular carcinoma: correlation with cell proliferative activity indices, including mitotic index and MIB-1 immunostaining.
Immunohistochemical differentiation of clear-cell carcinoma of the female genital tract and endodermal sinus tumor with the use of alpha-fetoprotein and Leu-M1.
Immunohistochemical differentiation of yolk sac-type alpha-fetoprotein from hepatic-type alpha-fetoprotein.
Immunohistochemical examination of mucinous cystadenoma of the testis.
Immunohistochemical expression of pi class glutathione S-transferase and alpha-fetoprotein in hepatocellular carcinoma and chronic liver disease.
Immunohistochemical expression profiles of solute carrier transporters in alpha-fetoprotein-producing gastric cancer.
Immunohistochemical localisation of alpha-fetoprotein (AFP) in germ cell tumours: evidence for AFP production by tissues different from endodermal sinus tumour.
Immunohistochemical localization of metallothionein in human thyroid tumors.
Immunohistochemical markers for hepatocellular carcinoma prognosis after liver resection and liver transplantation.
Immunohistochemical study of P53, PCNA and AFP in hepatocellular carcinoma, a comparison between Indonesian and Japanese cases.
Immunohistochemical type distinction of alpha-fetoprotein in various alpha-fetoprotein-secreting tumors.
Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
Immunohistochemistry of ovarian granulosa cell tumours. The value of tissue specific proteins and tumour markers.
Immunologic testing of patients with genitourinary malignancies.
Immunological crossreaction between alpha-fetoprotein and albumin.
Immunoradioautography test for alpha-fetoprotein in the differential diagnosis of germinogenic tumours of the testis and in the evaluation of effectiveness of their treatment.
Impact Factors for Microinvasion in Patients with Hepatocellular Carcinoma: Possible Application to the Definition of Clinical Tumor Volume.
Impact of age on the prognosis after liver transplantation for patients with hepatocellular carcinoma: a single-center experience.
Impact of chronic kidney disease on serum tumor markers concentrations.
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance.
Impact of gender as a prognostic factor in HBV-related Hepatocellular Carcinoma: the survival strength of female patients in BCLC stage 0-B.
Impact of hepatologists to extend survival of hepatocellular carcinoma patients with cirrhosis: a comparison with non-hepatologists.
Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients.
Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma.
Impact of radiofrequency ablation on the management of patients with hepatocellular carcinoma in a specialized centre.
Impairment of Spermatogenesis in Rats by Mercuric Chloride: Involvement of Low 17beta-Estradiol Level in Induction of Acute Oxidative Stress.
Importance of achieving complete necrosis during the first treatment for hepatocellular carcinoma to prevent bone metastasis: a prospective study.
Important role of hepatitis C virus infection as a cause of chronic liver disease in Somalia.
Improved results of transplantation for hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation.
Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass.
In silico and in vivo characterization of cabralealactone, solasodin and salvadorin in a rat model: potential anti-inflammatory agents.
Inappropriate practice in tumor marker requests at a university hospital in Western Saudi Arabia: A 3-year retrospective study.
Incidence and epidemiological factors of hepatocellular carcinoma in Valencia during the year 2000.
Incidence, risk factors, and prognosis in patients with primary hepatocellular carcinoma and lung metastasis: a population-based study.
Incorporating Tumor Biology to Predict Hepatocellular Carcinoma Recurrence in Patients Undergoing Living Donor Liver Transplantation Using Expanded Selection Criteria.
Increase of serum beta2-microglobulin in patients affected by HCV correlated hepatocellular carcinoma.
Increased alpha-fetoprotein concentration in association with ileal adenocarcinoma complicating Crohn's disease.
Increased alpha-fetoprotein levels in mixed mesodermal tumor of the ovary.
Increased alpha-fetoprotein receptor in the serum of patients with early-stage breast cancer.
Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector.
Increased Liquefactive Necrosis Formation After Transarterial Chemoembolization Combined with Molecular Targeted Agents Plus Immune Checkpoint Inhibitors for Hepatocellular Carcinoma.
Increased serum levels of macrophage inflammatory protein-3alpha in hepatocellular carcinoma: relationship with clinical factors and prognostic importance during therapy.
Increased serum levels of monosialo-alpha-fetoprotein in hepatocellular carcinoma and other malignancies.
Increased Serum Levels of Trypsin Inhibitor Kazal1 in Patients with HBV-Related Hepatocellular Carcinoma Predict a Poor Prognosis.
Increased steady-state levels of alpha-fetoprotein mRNA in hepatocellular carcinoma: an analysis by in situ hybridization.
Increasing serum levels of alpha-fetoprotein in a patient with relapsing gallbladder carcinoma.
Indicators of Lung Shunt Fraction Determined by Technetium-99 m Macroaggregated Albumin in Patients with Hepatocellular Carcinoma.
Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
Induction of hepatomas secreting large amounts of alpha-fetoprotein.
Induction of immune tolerance toward tumor-associated-antigens enables growth of human hepatoma in mice.
Infantile epididymitis with calcification.
Infantile hemangioendothelioma of the liver: ultrastructural study of a type II case.
Infantile hepatic hemangioendothelioma with elevated serum alpha-fetoprotein.
Infantile vaginal tumour with alpha-fetoprotein synghesis.
Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.
Inflammatory cytokines and antioxidants in midtrimester amniotic fluid: correlation with pregnancy outcome.
Inflammatory markers C-reactive protein and PLR in relation to HCC characteristics.
Inflammatory pseudotumor of the liver masquerading as hepatocellular carcinoma after a hepatitis B virus infection: Report of a case.
Inflammatory pseudotumor of the liver.
Influence of cardiopulmonary resuscitation on levels of tumour markers.
Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.
Influence of prognostic factors on the outcome of liver transplantation for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis.
Influence of testicular carcinoma on ipsilateral spermatogenesis.
Influence of transfection with connexin 26 gene on malignant potential of human hepatoma cells.
Inhibition of hepatocellular carcinoma growth by antisense oligonucleotides to type I insulin-like growth factor receptor in vitro and in an orthotopic model.
Inhibition of normal allogenic lymphocyte mitogenesis by a soluble inhibitor extracted from human colonic carcinoma.
Inhibition of rat hepatocellular carcinoma tumor growth after multiple infusions of recombinant Ad.AFPtk followed by ganciclovir treatment.
Inhibitory Effect of Nelumbo nucifera Leaf Extract on 2-Acetylaminofluorene-induced Hepatocarcinogenesis Through Enhancing Antioxidative Potential and Alleviating Inflammation in Rats.
Inhibitory effect of the angiogenesis inhibitor TNP-470 on tumor growth and metastasis in nude mice bearing human hepatocellular carcinoma.
Inoperable hepatocellular carcinoma: transarterial 188Re HDD-labeled iodized oil for treatment--prospective multicenter clinical trial.
Integrated microfluidic device for serum biomarker quantitation using either standard addition or a calibration curve.
Integrative transcriptome analysis of liver cancer profiles identifies upstream regulators and clinical significance of ACSM3 gene expression.
Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma.
Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker.
Intention to treat outcome of T1 hepatocellular carcinoma with the "wait and not ablate" approach until meeting T2 criteria for liver transplant listing.
Interlaboratory surveys of the determination of tumour markers scatter and repeatability of the results.
Interleukin-8 level as a prognostic marker in patients with hepatitis B virus-associated hepatocellular carcinoma treated with transarterial chemoembolization.
Internal radiation therapy for hepatocellular carcinoma. Results of a French multicenter phase II trial of transarterial injection of iodine 131-labeled Lipiodol.
Interrelations between elevated alpha-fetoprotein levels and tumor morphology of patients with hepatocellular carcinoma.
Interstitial deletion of the long arm of chromosome 4 [del(4)(q21.22q23)] and a liver tumor.
Intra arterial treatment of hepatocellular carcinoma: Comparison of MELD score variations between radio-embolization and chemo-embolization.
Intraabdominal testis with yolk sac tumor in a 2-year-old child.
Intraarterial chemotherapy with lipid contrast medium for hepatic malignancies in infants.
Intraarterial injection of anti-tumor drugs dispersed in lipid contrast medium: a choice for initially unresectable hepatoblastoma in infants.
Intracardiac yolk sac tumor and dysrhythmia as an etiology of pediatric syncope.
Intracranial germ cell tumor indicating a high level of alpha-fetoprotein (AFP).
Intracranial germ cell tumors.
Intracranial germ cell tumours. A review with special reference to endocrine manifestations.
Intracranial germ-cell tumors. Immunohistochemical study of three autopsy cases.
Intracranial multiple midline germinomas: is histological verification crucial for therapy?
Intrahepatic arterial injections of cisplatin-phosphatidylcholine-Lipiodol suspension in two unresectable hepatoblastoma cases.
Intrahepatic chemoembolization in unresectable pediatric liver malignancies.
Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma.
Intrahepatic cholangiocarcinomas associated with nonbiliary cirrhosis. A clinicopathologic study.
Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: Analysis of the pattern and risk factors.
Intrapericardial yolk sac tumor in an infant girl.
Intrathymic selection: new insight into tumor immunology.
Intratubular germ cell neoplasia of the testis and its associated cancers: the use of novel biomarkers.
Intratumoral plasmacytoid dendritic cells as a poor prognostic factor for hepatocellular carcinoma following curative resection.
Introduction of the ras oncogene transforms a simian virus 40-immortalized hepatocyte cell line without loss of expression of albumin and other liver-specific genes.
Invasion of the cardiovascular system in childhood malignant hepatic tumors.
Investigation of Alpha-Fetoprotein Antibody Modified Fluorescent Magnetic Probe on HepG? Cell and Cancer Model Mouse.
Investigation of histological vascular invasion from preoperative evaluation in patients with hepatocellular carcinoma who underwent living donor liver transplantation.
IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line.
Irreversible Electroporation for Unresectable Hepatocellular Carcinoma: Initial Experience.
Is alpha-fetoprotein decline a prognostic factor of childhood non-seminomatous germ cell tumours? Results of the French TGM95 study.
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?
Is hepatectomy beneficial in the treatment of multinodular hepatocellular carcinoma?
Is it Time to Abandon the Milan Criteria?: Results of a Bicoastal US Collaboration to Redefine Hepatocellular Carcinoma Liver Transplantation Selection Policies.
Is laparatomy the first step in treatment of childhood liver tumors?--The experience from the German Cooperative Pediatric Liver Tumor Study HB-89.
Is SP-1 a marker for testicular cancer?
Is the Cancer of the Liver Italian Program system an adequate weighting for survival of hepatocellular carcinoma? Evaluation of intrascore prognostic value among 36 subgroups.
Is there a role for immunotherapy in hepatocellular carcinoma?
Ischemia-reperfusion injury and the risk of hepatocellular carcinoma recurrence after deceased donor liver transplantation.
Isolation of three stem cell lines from human sacrococcygeal teratomas.
Juvenile Granulosa Cell Tumor of the Testicle - Report of a Neonatal Case with Positive Alpha-fetoprotein Immunohistochemical Staining.
Juvenile granulosa cell tumor of the testis:: contemporary clinical management and pathological diagnosis.
Juvenile granulosa cell tumour with hepatocyte-like cells and raised serum alpha-fetoprotein.
KAI1 gene expression in hepatocellular carcinoma and its relationship with intrahepatic metastases.
Ki-67 antigen expression in hepatocellular carcinoma using monoclonal antibody MIB1. A comparison with proliferating cell nuclear antigen.
Kinetics of serum tumor marker concentrations and usefulness in clinical monitoring.
Krukenberg tumor with concomitant ipsilateral hydronephrosis and spermatic cord metastasis in a man: A case report.
Label-free immunosensing for alpha-fetoprotein in human plasma using surface plasmon resonance.
Label-free immunosensor based on Pd nanoplates for amperometric immunoassay of alpha-fetoprotein.
Lack of correlation between alpha-fetoprotein and tumor size in hepatocellular carcinoma.
Lack of expression of glutathione-S-transferase P, gamma-glutamyl transpeptidase, and alpha-fetoprotein messenger RNAs in liver tumors induced by peroxisome proliferators.
Lactate Dehydrogenase Is an Important Prognostic Indicator for Hepatocellular Carcinoma after Partial Hepatectomy.
Lamivudine therapy for hepatitis B virus reactivation in a patient receiving intra-arterial chemotherapy for advanced hepatocellular carcinoma.
Laparoscopic ethanol injection therapy for hepatocellular carcinoma.
Large acinar cell carcinoma of the pancreas in a patient with elevated serum AFP level.
Large cell calcifying Sertoli cell tumor: a clinicopathologic study of 1 malignant and 3 benign tumors using histomorphology, immunohistochemistry, ultrastructure, comparative genomic hybridization, and polymerase chain reaction analysis of the PRKAR1A gene.
Large cell neuroendocrine carcinoma of the mediastinum with alpha-fetoprotein production.
Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum.
Late presentation of an alpha-fetoprotein secreting isolated large upper abdominal retroperitoneal Sertoli-Leydig cell tumor recurrence.
Late recurrence of testicular cancer.
Late relapse of testicular cancer presenting as differentiated teratoma - report of a case and discussion of the clinical implications.
Lectin affinity electrophoresis of alpha-fetoprotein in cancer diagnosis.
Lectin-based glycoproteomics to explore and analyze hepatocellular carcinoma-related glycoprotein markers.
Lectin-reactive alpha-fetoprotein (AFP-L3%) curability and prediction of clinical course after treatment of non-seminomatous germ cell tumors.
Lectin-reactive alpha-fetoprotein in patients with tyrosinemia type I and hepatocellular carcinoma.
Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions.
Lens Culinaris Agglutinin-reactive Fraction of Alpha-fetoprotein as a Tumor Marker in a Patient With Nonseminomatous Germ Cell Tumor With Normal Alpha-fetoprotein Level.
Lessons learned from cancer vaccine trials and target antigen choice.
Letter: Comparison of plasma carcinoembryonic antigen and alpha-fetoprotein in various tumours.
Levels of alpha-fetoprotein during pregnancy and early infancy in normal and disease states.
Limitations of predicting microvascular invasion in patients with hepatocellular cancer prior to liver transplantation.
Limited tumour progression beyond Milan criteria while on the waiting list does not result in unacceptable impairment of survival.
Lipid cell (steroid cell) tumor of the ovary: immunophenotype with analysis of potential pitfall due to endogenous biotin-like activity.
Lipiodolization for unresectable hepatocellular carcinoma: an analysis of 205 patients using univariate and multivariate analysis.
Lipopolysaccharide Enhances Beta2-Glycoprotein I Activation of Nuclear Factor ?B in Liver Cancer Cells.
Liver Imaging Reporting and Data System Category 5: MRI Predictors of Microvascular Invasion and Recurrence After Hepatectomy for Hepatocellular Carcinoma.
Liver resection associated with better outcomes for single large hepatocellular carcinoma located in the same section.
Liver resection for early hepatocellular cancer: Comparison of centers in 3 different countries.
Liver resection for hepatocellular carcinoma in patients with cirrhosis.
Liver Resection for Multiple Hepatocellular Carcinomas: A Japanese Nationwide Survey.
Liver stiffness in magnetic resonance elastography is prognostic for sorafenib-treated advanced hepatocellular carcinoma.
Liver Transplantation Beyond Milan Criteria.
Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations.
Liver transplantation for biliary atresia associated with malignant hepatic tumors.
Liver transplantation for hepatocellular cancer: should the current indication criteria be changed?
Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review.
Liver transplantation for hepatocellular carcinoma in Ireland: Pre-operative alpha-fetoprotein predicts tumour recurrence in a 14-year single-centre national experience.
Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
Liver transplantation for hepatocellular carcinoma using grafts from uncontrolled circulatory death donation.
Liver transplantation for hepatocellular carcinoma without preoperative tumor biopsy.
Liver transplantation for hepatocellular carcinoma.
Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival.
Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival.
Liver Transplantation for Hepatocellular Carcinoma: Impact of Wait Time at a Single Center.
Liver transplantation for hepatocellular carcinoma: University Hospital Essen experience and metaanalysis of prognostic factors.
Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China.
Liver transplantation for small hepatocellular carcinoma.
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.
Liver Transplantation is a Preferable Alternative to Palliative Therapy for Selected Patients with Advanced Hepatocellular Carcinoma.
Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China.
Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients with Hepatocellular Carcinoma Presenting Beyond Milan Criteria.
Living
Living donor liver transplantation for a child with recurrent pediatric adult-type hepatocellular carcinoma.
Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan.
Living donor liver transplantation in a pediatric patient with preexisting yolk sac tumor.
Living Donor Liver Transplantation: The Optimal Curative Treatment for Hepatocellular Carcinoma Even Beyond Milan Criteria.
LncRNA CASC9 promotes proliferation, migration and inhibits apoptosis of hepatocellular carcinoma cells by down-regulating miR-424-5p.
Local tumor control of thoracoabdominal wall seeding tumor from hepatocellular carcinoma with ultrasound-guided interventional treatment: A summarized study.
Localisation of malignant germ-cell tumours by external scanning after injection of radiolabelled anti-alpha-fetoprotein.
Localization of alpha-fetoprotein and human chorionic gonadotropin to specific histologic types of nonseminomatous testicular cancer.
Localization of alpha-fetoprotein by immunofluorescent method during induction of rat liver tumors by 3'-methyl-4-dimethylaminoazobenzene.
Localization of alpha-fetoprotein synthesis in malignancies other than hepatoma.
Localization of small liver tumors.
Localized pleural malignant mesothelioma.
Locoregional therapies for hepatocellular carcinoma: which patients are most likely to gain a survival advantage?
Logarithmic decrease of serum alpha-fetoprotein or human chorionic gonadotropin in response to chemotherapy can distinguish a subgroup with better prognosis among highly malignant intracranial non-germinomatous germ cell tumors.
Long-term clinical outcomes of patients receiving proton beam therapy for caudate lobe hepatocellular carcinoma.
Long-term functional outcome of sacrococcygeal teratoma in a UK regional center (1993 to 2006).
Long-term impact of a restrictive laboratory test ordering form on tumor marker prescriptions.
Long-Term Outcome After Liver Transplantation for Hepatocellular Carcinoma Following Yttrium-90 Radioembolization Bridging Treatment.
Long-term outcome after surgery for asymptomatic small hepatocellular carcinoma.
Long-Term Outcome of Liver Resection Versus Transplantation for Hepatocellular Carcinoma in a Region Where Living Donation is a Main Source.
Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinoma.
Long-term outcome of transcatheter arterial chemoembolization after radiofrequency ablation as a combined therapy for Chinese patients with hepatocellular carcinoma.
Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy.
Long-term outcomes in elderly patients with resectable large hepatocellular carcinoma undergoing hepatectomy.
Long-term outcomes of liver resection for multiple hepatocellular carcinomas: Single-institution experience with 187 patients.
Long-term results of gastrectomy for alpha-fetoprotein-producing gastric cancer.
Long-term surgical outcomes in patients with hepatocellular carcinoma undergoing laparoscopic vs. open liver resection: A retrospective and propensity score-matched study.
Long-Term Survival Outcomes After Liver Resection for Binodular Hepatocellular Carcinoma: A Multicenter Cohort Study.
Loss of heterozygosity on 10q23 is involved in metastatic recurrence of hepatocellular carcinoma.
Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus-related hepatocellular carcinoma metastasis through the upregulation of ADAM9.
Low alpha-fetoprotein HCC and the role of GGTP.
Low alpha-fetoprotein hepatocellular carcinoma.
Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis.
Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy.
Low cyclin F expression in hepatocellular carcinoma associates with poor differentiation and unfavorable prognosis.
Low expression of WW domain-containing oxidoreductase associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection.
Low metallothionein 1M expression association with poor hepatocellular carcinoma prognosis after curative resection.
Low PLCE1 levels are correlated with poor prognosis in hepatocellular carcinoma.
Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2b.
Lung carcinoma with metastasis to testicular seminoma.
Lymphoepithelioma-like hepatocellular carcinoma without Epstein-Barr virus infection: A case report and a review of the literature.
Lymphoid hyperplasia detected as a single mass in the gallbladder: report of a case.
Lysosomal cathepsins B and L and Stefin A blood levels in patients with hepatocellular carcinoma and/or liver cirrhosis: potential clinical implications.
Machine Learning Can Predict Total Death After Radiofrequency Ablation in Liver Cancer Patients.
Machine Learning to Improve Prognosis Prediction of Early Hepatocellular Carcinoma After Surgical Resection.
Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study.
Macroscopic Portal Vein Thrombosis in HCC Patients.
Major Hepatectomy in Elderly Patients with Large Hepatocellular Carcinoma: A Multicenter Retrospective Observational Study.
Malignancy markers in the cerebrospinal fluid.
Malignant ganglioneuroma arising from mediastinal mixed germ cell tumor.
Malignant germ cell tumors of the ovary.
Malignant hepatic tumor occurring 10 yrs after a histocompatible sibling donor bone marrow transplantation for severe aplastic anemia.
Malignant müllerian mixed tumor of the uterus with a prominent alpha-fetoprotein-producing component of yolk sac tumor.
Malignant melanotic neuroectodermal tumor arising from the pineal body.
Malignant mixed Mullerian tumor of the uterine corpus with alpha-fetoprotein-producing hepatoid adenocarcinoma component.
Malignant mixed müllerian tumor with malignant neuroectodermal components (teratoid carcinosarcoma) of the ovary: Report of a case with clinicopathologic findings.
Malignant ovarian germ cell tumors.
Malignant ovarian germ cell tumours: experience in the National University Hospital of Singapore.
Malignant rhabdoid tumor of the liver: case report and literature review.
Malignant sacrococcygeal germ cell tumors in childhood: The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience.
Malignant sacrococcygeal germ cell tumors in children in Taiwan: A retrospective single-center case series.
Mallory body forming cells express the preneoplastic hepatocyte phenotype.
Management and patient survival in hepatocellular carcinoma: does the physician's level of experience matter?
Management of advanced endodermal sinus tumor of the ovary with preservation of reproductive function.
Management of hepatocellular carcinoma in renal transplant recipients.
Management of pineal non-germinoma germ cell tumor with residual teratoma and normal alpha-fetoprotein.
Management of primary intracranial germ cell tumors.
Management of Stage II Germ Cell Tumors: Be Sure, Be Patient, Be Safe.
Manifestations of hypercholesterolaemia, hypoglycaemia, erythrocytosis and hypercalcaemia in patients with hepatocellular carcinoma: report of two cases.
Markedly increased alpha-fetoprotein concentration in serum in alcoholic liver disease: malignant tumor or nonneoplastic changes?
Markers and characteristics of human SCLC cell lines. Neuroendocrine markers, classical tumor markers, and chromosomal characteristics of permanent human small cell lung cancer cell lines.
Markers of bile duct tumors.
Maternal serum alpha-fetoprotein and epithelial tumour marker concentrations are not increased by fetal sacrococcygeal teratoma.
Matrix metalloproteinase 12 expression is associated with tumor FOXP3+ regulatory T cell infiltration and poor prognosis in hepatocellular carcinoma.
Mature and immature extracranial teratomas in children: the UK Children's Cancer Study Group Experience.
Mature sacrococcygeal teratoma: a case report and literature review.
Mature teratoma of the pineal region in the paediatric age group: A case report and review of the literature.
Mean arterial pressure, pregnancy induced hypertension, and preeclampsia. Evaluation as independent risk factors and as surrogates for high maternal serum alpha-protein in estimating breast cancer risk.
Measurement of tumor markers in chronic hemodialysis patients.
Mechanism of Cancer Growth Suppression of Alpha-Fetoprotein Derived Growth Inhibitory Peptides (GIP): Comparison of GIP-34 versus GIP-8 (AFPep). Updates and Prospects.
Mechanism of thrombocytosis in hepatoblastoma: a case report.
Mediastinal growing teratoma syndrome succesfully treated by multiple modality therapies.
Mediastinal growing teratoma syndrome.
Mediastinal teratoma and precocious puberty in a boy with mosaic Klinefelter syndrome.
Mediastinal teratomas: review of 15 pediatric cases.
Mediastinal yolk sac tumors associated with prominent multilocular cystic changes of thymic epithelium: a clinicopathologic and immunohistochemical study of five cases.
Melanotic neuroectodermal tumor of infancy. Report of a case.
Merged hepatopulmonary features in hepatoid adenocarcinoma of the lung: a systematic review.
Metastatic carcinoma involving the testis. Clinical and pathologic distinction from primary testicular neoplasms.
Metastatic endodermal sinus tumor: CT appearances.
Metastatic hepatocellular carcinoma of the breast, simulating gynecomastia: diagnosis by fine-needle aspiration biopsy.
Metastatic models of human liver cancer in nude mice orthotopically constructed by using histologically intact patient specimens.
Metastatic neuroendocrine carcinoma presenting as multifocal liver lesions with elevated alpha-fetoprotein.
Metastatic non-seminomatous germ cell tumour and dermatomyositis.
Metastatic pancreatic acinar cell carcinoma in a younger male with marked AFP production: A potential pitfall on fine needle aspiration biopsy.
Metastatic Recurrent Hepatocellular Carcinoma Post Liver Transplant With Marked Pretransplant Elevation of Alpha Fetoprotein and No Evidence of Primary Neoplasm.
Methylation of the alpha-fetoprotein gene in productive and nonproductive rat hepatocellular carcinomas.
Microchip-based multiplex electro-immunosensing system for the detection of cancer biomarkers.
Microcystic Leydig cell tumors mimicking yolk sac tumor: a report of four cases.
MicroRNA-18a promotes hepatocellular carcinoma proliferation, migration, and invasion by targeting Bcl2L10.
MicroRNA-195 vector influence on the development of gradually induced hepatocellular carcinoma in murine model.
MicroRNA-34a expression is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma.
microRNA-497 inhibits cell proliferation and induces apoptosis by targeting YAP1 in human hepatocellular carcinoma.
MicroRNAs as Appropriate Discriminators in Non-Specific Alpha-Fetoprotein (AFP) Elevation in Testicular Germ Cell Tumor Patients.
MicroRNAs in testicular cancer: implications for pathogenesis, diagnosis, prognosis and therapy.
Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma.
Microscopic vascular invasion by hepatocellular carcinoma in liver transplant patients.
Microvascular invasion and positive HB e antigen are associated with poorer survival after hepatectomy of early hepatocellular carcinoma: A retrospective cohort study.
Microvascular Invasion in Hepatocellular Carcinoma and Liver Transplant.
Microvascular invasion of single small hepatocellular carcinoma ?3 cm: Predictors and optimal treatments.
Microvessel density of hepatocellular carcinoma: its relationship with prognosis.
Mimics of hepatocellular carcinoma: a review and an approach to avoiding histopathological diagnostic missteps.
MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
miR-675 Mediates Downregulation of Twist1 and Rb in AFP-Secreting Hepatocellular Carcinoma.
Misleading leads: don't assume an alpha-fetoprotein secreting tumour is of germ cell or hepatic origin.
Mixed germ cell malignancy of the ovary concurrent with pregnancy.
Mixed germ-cell tumor of the brain. Pathologic study of six autopsy cases.
Mixed mesodermal tumor of the uterus (RJ-984): case report and in vitro study.
Modified neck dissection for metastatic testicular carcinoma.
Modulation of miR-29 expression by alpha-fetoprotein is linked to the hepatocellular carcinoma epigenome.
Molecular analysis of circulating tumor cells in peripheral blood from patients with germ cell tumor: a quantitative approach.
Monitoring of patients with non-seminomatous germ cell tumors of the testis by determination of alpha-fetoprotein and beta-human chorionic gonadotropin levels and by computed tomography.
Monocyte activation in patients with non-seminomatous germ cell tumour of the testis before and after tumour eradication.
Monocyte chemotaxis in patients with nonseminomatous testicular carcinoma. Effect of chemotherapy.
Morphologic features of human chorionic gonadotropin- or alpha-fetoprotein-producing germ cell tumors of the central nervous system: histological heterogeneity and surgical meaning.
Morphological features of advanced hepatocellular carcinoma as a predictor of downstaging and liver transplantation: an intention-to-treat analysis.
Mouse hepatoblastomas: a histologic, ultrastructural, and immunohistochemical study.
mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors.
Multi-institutional validation of novel models for predicting the prognosis of patients with huge hepatocellular carcinoma.
Multidisciplinary treatment in children with non-metastatic hepatoblastoma: treatment results at the National Cancer Institute, Cairo University.
Multifunctional nanocatalyst-based ultrasensitive detection of human tissue transglutaminase 2.
Multilayers enzyme-coated carbon nanotubes as biolabel for ultrasensitive chemiluminescence immunoassay of cancer biomarker.
Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: long-term survival in the experience of a single radiologic referral center.
Multiple biochemical markers in patients with gynecologic malignancies.
Multiple intracranial mixed germ cell tumors.
Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice.
Multiplex detection of tumor markers with photonic suspension array.
Multiplex determination of serological signatures in the sera of colorectal cancer patients using hydrogel biochips.
Multiplex electrochemiluminescence immunoassay of two tumor markers using multicolor quantum dots as labels and graphene asconductingbridge.
Multiplexed determination of protein biomarkers using metal-tagged antibodies and size exclusion chromatography--inductively coupled plasma mass spectrometry.
Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer Multiinstitutional Phase III Study.
Multivariate analysis of serum tumor markers for diagnosis of skeletal metastases.
Mutation analysis of the ATM gene in two Chinese patients with ataxia telangiectasia.
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer.
Nanobody medicated immunoassay for ultrasensitive detection of cancer biomarker alpha-fetoprotein.
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival.
Necrotic Hepatocellular Carcinoma Occurring within an Inflammatory Pseudotumor-like Nodule.
Needle track seeding after percutaneous radiofrequency ablation of hepatocellular carcinoma: 14-year experience at a single centre.
Negative impact of low body mass index on liver cirrhosis patients with hepatocellular carcinoma.
Neoadjuvant Transarterial Chemoembolization Improves Survival After Liver Transplant in Patients With Hepatocellular Carcinoma.
Neonatal hepatoblastoma in a newborn with severe phenotype of Beckwith-Wiedemann syndrome.
Neoplastic seeding after radiofrequency ablation for hepatocellular carcinoma.
Neuroendocrine carcinoma of the liver: an autopsy case.
Neuroendoscopic anatomy and surgery in pineal region tumors: role of neuroendoscopic procedure in the 'minimally-invasive preferential' management.
Neurohypophyseal granulomatous germinoma invading the right cavernous sinus: case report and review of the literature.
Neutrophil-to-Lymphocyte Ratio Predicts High-Risk Explant Features and Waitlist Survival But Is Not Independently Associated With Recurrence or Survival Following Liver Transplantation for Hepatocellular Carcinoma.
NIACE score for hepatocellular carcinoma patients treated by surgery or transarterial chemoembolization.
NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging.
Nimbolide inhibits tumor growth by restoring hepatic tight junction protein expression and reduced inflammation in an experimental hepatocarcinogenesis.
Nimesulide-induced fatal acute liver failure in an elderly woman with metastatic biliary adenocarcinoma. A case report.
Nine-year experience of doxorubicin-eluting beads chemoembolization for hepatocellular carcinoma.
NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma.
No association exists between E-cadherin gene polymorphism and tumor recurrence in patients with hepatocellular carcinoma after transplantation.
No evidence for post-transcriptional control of albumin and alpha-fetoprotein gene expression in developing rat liver neoplasia.
No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5?cm.
Nodal gliomatosis and alpha-fetoprotein production. Two unusual facets of grade I ovarian teratoma.
Nodular hepatocellular carcinoma. Treatment with subsegmental intraarterial injection of iodine 131-labeled iodized oil.
Nodules less than 20 mm and vascular invasion are predictors of survival in small hepatocellular carcinoma.
Nomogram Based on Systemic Immune Inflammation Index and Prognostic Nutrition Index Predicts Recurrence of Hepatocellular Carcinoma After Surgery.
Nomogram development and validation to predict hepatocellular carcinoma tumor behavior by preoperative gadoxetic acid-enhanced MRI.
Non-seminoma germ cell tumours (malignant teratoma) of the testis. Results of treatment and an analysis of prognostic factors.
Non-seminomatous ovarian germ cell tumours in children.
Non-tumoral elevation of alpha-fetoprotein (AFP): a 10 year follow-up in two subjects.
Nonhuman primate models for lymphoma, leukemia, and other neoplasms.
Nonpalpable testicular pure seminoma with elevated serum alpha-fetoprotein presenting with retroperitoneal metastasis: a case report.
Nonseminomatous Germ-Cell Tumor Presenting as Bilateral Adrenal Masses.
Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal?
Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
Novel biomarkers for hepatocellular carcinoma surveillance: has the future arrived?
Novel human alpha-fetoprotein mRNA isoform lacking exon 1 identified in ovarian yolk sac tumor.
Novel inflammation-based prognostic nomograms for individualized prediction in hepatocellular carcinoma after radical resection.
Novel Model to Predict HCC Recurrence after Liver Transplantation Obtained Using Deep Learning: A Multicenter Study.
NUT midline carcinoma mimicking a germ cell tumor: a case report.
Observation of efficacy of TACE combined with HIFU on patients with middle-advanced liver cancer.
Observations on reliability of commercial assay for alpha-fetoprotein.
Occult malignancy in neonatal sacrococcygeal teratomas. A report from a Combined Pediatric Oncology Group and Children's Cancer Group study.
Occurrence of alpha-fetoprotein, Regan isoenzyme, and variant alkaline phosphatase in the serum of a patient with gastric cancer.
Occurrence of Vascular Lake Phenomenon as a Predictor of Improved Tumor Response in HCC Patients That Underwent DEB-TACE.
On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir.
Oncocytic biliary cystadenocarcinoma: a case report and review of the literature.
Oncodevelopmental alpha-fetoprotein acts as a selective proangiogenic factor on endothelial cell from the fetomaternal unit.
Oncofetal antigens in sacrococcygeal teratomas.
Oncofetal protein glypican-3 in testicular germ-cell tumor.
Open-label Phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L.
Optimal drug therapy in the treatment of testicular cancer.
Optimal strategy of preoperative transcatheter arterial chemoembolization for hepatoblastoma.
Optimal tailored screening protocol after living donor liver transplantation for hepatocellular carcinoma.
Optimal treatment strategy for elderly patients with hepatocellular carcinoma.
Optoelectrofluidic sandwich immunoassays for detection of human tumor marker using surface-enhanced Raman scattering.
Oral-contraceptive-associated liver tumours: occurrence of malignancy and difficulties in diagnosis.
Orthotopic Liver Transplantation After Stereotactic Body Radiotherapy for Pediatric Hepatocellular Carcinoma with Central Biliary Obstruction and Nodal Involvement.
Outcome after curative resection for a huge (>/=10 cm) hepatocellular carcinoma and prognostic significance of gross tumor classification.
Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis.
Outcome of hepatitis B and C virus-associated hepatocellular carcinoma occurring after renal transplantation.
Outcome of TACE treatment in HIV infected patients with hepatocellular carcinoma.
Outcome of transarterial chemoembolization in patients with inoperable hepatocellular carcinoma eligible for radiofrequency ablation.
Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?
Ovarian clear cell adenocarcinoma producing alpha-fetoprotein: case report.
Ovarian clear cell carcinoma associated with endometriosis: a case report with immunohistochemical study.
Ovarian endometrioid adenocarcinoma with ectopic production of alpha-fetoprotein.
Ovarian endometrioid-like yolk sac tumor treated by surgery alone, with recurrence at 12 years.
Ovarian leiomyoma. Case report.
Ovarian mixed germ cell tumor composed of dysgerminoma, endodermal sinus tumor, choriocarcinoma and mature teratoma in a 44-year-old woman: case report and literature review.
Ovarian mixed germ cell tumor composed of polyembryoma and immature teratoma.
Ovarian mucinous cystadenocarcinoma producing alpha-fetoprotein.
Ovarian mucinous cystadenocarcinoma with yolk sac tumor in a 71-year-old woman.
Ovarian Sertoli-Leydig cell tumor with elevated serum alpha-fetoprotein.
Ovarian Sertoli-Leydig cell tumor with heterologous elements of gastrointestinal type associated with elevated serum alpha-fetoprotein level: an unusual case and literature review.
Ovarian Sertoli-Leydig cell tumor with heterologous gastrointestinal epithelium as a source of alpha-fetoprotein: a case report.
Ovarian Sertoli-Leydig Cell Tumor With Heterologous Hepatocytes and a Hepatocellular Carcinomatous Element.
Ovarian Sertoli-Leydig cell tumor with retiform and heterologous components. Report of a case with hepatocytic differentiation and elevated serum alpha-fetoprotein.
Ovarian Sertoli-Leydig cell tumor: success with salvage therapy.
Ovarian Sertoli-Leydig Cell Tumors: Epidemiological, Clinical and Prognostic Factors.
Ovarian tumors in the pediatric age group: 37 cases treated over an 8-year period.
Ovarian yolk sac tumor arising from an endometrioid carcinoma.
Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of alpha-fetoprotein, sex steroid receptors, and p53.
Ovarian yolk sac tumor with virilization during pregnancy: immunohistochemical demonstration of Leydig cells as functioning stroma.
Ovarian Yolk Sac Tumors; Does Age Matter?
Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma.
Overexpression of centromere protein K (CENP-K) gene in hepatocellular carcinoma promote cell proliferation by activating AKT/TP53 signal pathway.
Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma.
Overexpression of lncRNA MT1JP Mediates Apoptosis and Migration of Hepatocellular Carcinoma Cells by Regulating miR-24-3p.
Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma.
Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
Overexpression of p53 in hepatocellular carcinomas: a clinicopathological and prognostic correlation.
Overexpression of pituitary tumor-transforming gene-1 in hepatocellular carcinoma.
Overexpression of RPS6KB1 predicts worse prognosis in primary HCC patients.
Overexpression of TONSL might be an independent unfavorable prognostic indicator in hepatocellular carcinoma.
p53-targeted LSD1 functions in repression of chromatin structure and transcription in vivo.
Paclitaxel: an effective antineoplastic agent in the treatment of xenotransplanted hepatoblastoma.
Pancreatic acinar cell carcinoma with excessive alpha-fetoprotein expression.
Pancreatic-type mixed acinar-endocrine carcinoma with alpha-fetoprotein production arising from the stomach: a report of an extremely rare case.
Pancreatoblastoma, a Rare Childhood Tumor: A Case Report.
Pancreatoblastoma. Three original cases and review of the literature.
Pancreatoblastoma: A Case Report.
Paper-based colorimetric spot test utilizing smartphone sensing for detection of biomarkers.
Papers to appear in forthcoming issues
Paraneoplastic syndromes in patients with hepatocellular carcinoma in Taiwan.
Parkinsonism as an unusual presenting symptom of pineal gland teratoma.
PARP-1 serves as a novel molecular marker for hepatocellular carcinoma in a Southern Chinese Zhuang population.
Partial hepatectomy for hepatocellular carcinoma in a patient with hemophilia: a case report.
Pathobiology of intracranial germ-cell tumors: immunochemical, immunohistochemical, and electron microscopic investigations.
Pathologic complete response to chemoembolization improves survival outcomes after curative surgery for hepatocellular carcinoma: predictive factors of response.
Pathologic features and patient survival in hepatocellular carcinoma in relation to age.
Pathology of germ cell tumors of the testis.
Patient and tumour biology predict survival beyond the Milan criteria in liver transplantation for hepatocellular carcinoma.
Patient-derived xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management.
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice.
Pattern and management of recurrent hepatocellular carcinoma after liver transplantation.
Pediatric central nervous system germ cell tumors: a review.
Pediatric germ cell and human chorionic gonadotropin-producing tumors. Clinical and laboratory features.
Pediatric HBsAg chronic liver disease and adult asymptomatic carrier status: two stages of the same entity.
Pediatric ovarian immature teratoma: Histological grading and clinical characteristics.
Percentage of Teratoma in Orchiectomy and Risk of Retroperitoneal Teratoma at the Time of Postchemotherapy Retroperitoneal Lymph Node Dissection in Germ Cell Tumors.
Percutaneous cryoablation in combination with ethanol injection for unresectable hepatocellular carcinoma.
Percutaneous cryoablation of small hepatocellular carcinoma with US guidance and CT monitoring: initial experience.
Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation.
Percutaneous ethanol injection therapy for neoplasms located on the surface of the liver.
Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study.
Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors.
Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors.
Perforating abomasal ulcer caused by yolk sac tumor in a Holstein calf.
Performance evaluation of CA242 by flow fluorescence assay.
Performance evaluation of serum PIVKA-II measurement using HISCL-5000 and a method comparison of HISCL-5000, LUMIPULSE G1200, and ARCHITECT i2000.
Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis.
Peri-Transplant Change in AFP Level: a Useful Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation.
Peritoneal implantation of endodermal sinus tumor of the pineal region via a ventriculoperitoneal shunt. Cytodiagnosis with immunocytochemical demonstration of alpha-fetoprotein.
Periventricular metastases of a primary intracranial alpha-fetoprotein-producing germ cell tumor.
Persistently elevated alpha-fetoprotein associated with chronic hepatitis B during chemotherapy for malignant ovarian germ cell tumors: a case series and a review of the literature.
Personalized treatment of patients with very early hepatocellular carcinoma.
Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinoma.
Phase II study of transarterial embolization in European patients with hepatocellular carcinoma: need for controlled trials.
Phase II trial of edatrexate in patients with advanced hepatocellular carcinoma.
Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.
Pilot Study of Hepatic Arterial Infusion Chemotherapy with Interferon-beta and 5-fluorouracil: A New Chemotherapy for Patients with Advanced Hepatocellular Carcinoma.
Pineal region tumors in children.
Pineal region tumors: endocrinological aspects.
Pituitary Dysfunction in Patients with Intracranial Germ Cell Tumors Treated with Radiotherapy.
Placental involvement in congenital hepatoblastoma.
Plasma B-cell activating factor levels and polymorphisms in hepatitis B-related hepatocellular carcinoma: Clinical correlation and prognosis.
Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patients.
Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma.
Plasma lipids, tumor parameters and survival in HCC patients with HBV and HCV.
Plasma matrix metalloproteinase-9 (gelatinase B) in patients with hepatocellular carcinoma.
Plasma nitrite/nitrate concentrations as a tumor marker for hepatocellular carcinoma.
Plasma proteasome level is a reliable early marker of malignant transformation of liver cirrhosis.
Platelet-related phenotypic patterns in hepatocellular carcinoma patients.
Pluripotent teratocarcinoma-thymus somatic cell hybrids.
PLZF and PLZF-MAPK10 can predict the prognosis of postoperative patients with hepatocellular carcinoma.
Poorly differentiated hepatocellular carcinoma accompanied by anti-Hu antibody-positive paraneoplastic peripheral neuropathy.
Poorly Differentiated Hepatocellular Carcinoma in a Low-risk Patient with an Otherwise Normal Liver.
Population-level utilization of anatomic resection in early hepatocellular carcinoma (?5 cm): post-operative, middle- and long-term outcomes.
Positive feedback loop of AKR1B10P1/miR-138/SOX4 promotes cell growth in hepatocellular carcinoma cells.
Possible common origin of alpha-fetoprotein- and human chorionic gonadotropin--secreting cells in intracranial germ cell tumor. Case report.
Post-operative blood tests and multicentric recurrence of hepatocellular carcinoma.
Post-treatment persistent alpha-fetoprotein elevation in a patient with testicular cancer.
Postchemotherapy retroperitoneal residual mass in infantile yolk sac tumor.
Postchemotherapy sarcoma as a somatic-type malignancy derived from the gonadal yolk sac tumor in a patient with 46, XY pure gonadal dysgenesis.
Postoperative adjuvant TACE for patients of hepatocellular carcinoma in AJCC stage I: friend or foe? a propensity score analysis.
Postoperative Adjuvant Transarterial Chemoembolization Improves Short-Term Prognosis of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Propensity-Score Matching Study.
Postoperative Albumin-Bilirubin Grade Change Predicts the Prognosis of Patients with Hepatitis B-Related Hepatocellular Carcinoma Within the Milan Criteria.
Postoperative Transarterial Chemoembolization Benefits Patients with High ?-Glutamyl Transferase Levels after Curative Hepatectomy for Hepatocellular Carcinoma: A Survival Stratification Analysis.
Potential biomarkers for hepatoblastoma: Results from the SIOPEL-3 study.
Potential function of amniotic fluid in fetal development---novel insights by comparing the composition of human amniotic fluid with umbilical cord and maternal serum at mid and late gestation.
Potential role of ventricular tumor markers in CNS germ cell tumors.
Practical efficacy of sorafenib monotherapy for advanced hepatocellular carcinoma patients in a Hepatitis B virus-endemic area.
Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
Precore/basal core promoter mutants and hepatitis B viral DNA levels as predictors for liver deaths and hepatocellular carcinoma.
Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy.
Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters.
Predicting retroperitoneal histology in postchemotherapy testicular germ cell cancer: a model update and multicentre validation with more than 1000 patients.
Predicting survival time of Korean hepatocellular carcinoma patients using the Cox proportional hazards model: a retrospective study based on big data analysis.
Prediction of invasive activities in hepatocellular carcinomas with special reference to alpha-fetoprotein and des-gamma-carboxyprothrombin.
Prediction of microvascular invasion of hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging: Impact of intra-tumoral fat detected on chemical-shift images.
Prediction of necrosis after chemotherapy of advanced germ cell tumors: results of a prospective multicenter trial of the German Testicular Cancer Study Group.
Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers.
Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach.
Prediction of Tumor Recurrence by 18F-FDG PET in Liver Transplantation for Hepatocellular Carcinoma.
Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma.
Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. The Liver Cancer Study Group of Japan.
Predictive factors for recurrence after percutaneous ethanol injection for solitary hepatocellular carcinoma.
Predictive factors for the histologic nature of residual tumor mass after chemotherapy in patients with advanced testicular cancer.
Predictive factors in patients with hepatocellular carcinoma receiving sorafenib therapy using time-dependent receiver operating characteristic analysis.
Predictive Factors of Downstaging of Hepatocellular Carcinoma Beyond the Milan Criteria Treated with Intra-arterial Therapies.
Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients.
Predictive performance of the mHAP-II score in a real-life western cohort with hepatocellular carcinoma following trans-arterial chemoembolisation with drug-eluting beads (DEB-TACE).
Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation.
Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.
Predictive value of protein induced by absence of vitamin K absence or antagonist II, alpha-fetoprotein and gamma-glutamyltransferase/aspartate aminotransferase ratio for the diagnosis of hepatocellular carcinoma in transplantation candidates.
Predictive value of tumor markers in patients with recurrent hepatocellular carcinoma in different vascular invasion pattern.
Predictors of Futile Liver Resection for Patients with Barcelona Clinic Liver Cancer Stage B/C Hepatocellular Carcinoma.
Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.
Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
Predictors of tumor-free survival after liver transplant in patient with hepatocellular carcinoma.
Pregnancy following treatment of endodermal sinus tumor of the ovary with combination chemotherapy, including cis-platinum.
Preliminary analysis of a newly proposed prognostic scoring system (SLiDe score) for hepatocellular carcinoma.
Preliminary qualification of a novel, hypoxic-based radiologic signature for trans-arterial chemoembolization in hepatocellular carcinoma.
Preoperative Albumin-to-Globulin Ratio Predicts Prognosis in Hepatocellular Carcinoma: A Cohort Study Including Non-Hepatitis Virus-Infected Patients.
Preoperative Alpha-Fetoprotein Has No Prognostic Role in Small Hepatocellular Carcinoma in Non-Cirrhotic Patients After Surgical Resection.
Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation.
Preoperative Aspartate Aminotransferase to White Blood Cell Count Ratio Predicting Postoperative Outcomes of Hepatocellular Carcinoma.
Preoperative Assessment for Event-Free Survival With Hepatoblastoma in Pediatric Patients by Developing a CT-Based Radiomics Model.
Preoperative chemoembolization of hepatocellular carcinoma: a comparative study.
Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.
Preoperative Gadoxetic Acid-Enhanced MRI Based Nomogram Improves Prediction of Early HCC Recurrence After Ablation Therapy.
Preoperative investigation and indication for operation in hepatocellular carcinoma.
Preoperative portal vein embolization and surgical resection in patients with hepatocellular carcinoma and small future liver remnant volume: comparison with transarterial chemoembolization.
Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: A pilot study.
Preoperative prediction of microvascular invasion in non-metastatic hepatocellular carcinoma based on nomogram analysis.
Preoperative prediction of microvascular invasion of hepatocellular carcinoma using
Preoperative predictors of early recurrence after resection for hepatocellular carcinoma.
Preoperative predictors of survival after resection of small hepatocellular carcinomas.
Preoperative predictors of vascular invasion in hepatocellular carcinoma.
Preoperative radiologic and postoperative pathologic risk factors for early intra-hepatic recurrence in hepatocellular carcinoma patients who underwent curative resection.
Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT.
Preoperative risk stratification for early recurrence of HBV-related hepatocellular carcinoma after deceased donor liver transplantation: a five-eight model development and validation.
Preoperative transcatheter selective arterial chemoembolization in treatment of unresectable hepatoblastoma in infants and children.
PREPUBERTAL TESTIS TUMORS: ACTUAL PREVALENCE RATE OF HISTOLOGICAL TYPES.
Prepubertal yolk sac testicular tumors--report of the testicular tumor registry.
Presacral epidermal cyst found in an adult male with a high CEA content: report of an unusual case.
Presence of alpha-1-antitrypsin in pancreatic carcinoma. Report of four cases in association with hepatic storage of the protease inhibitor.
Presence of alpha-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma.
Preserved liver function, portal thrombosis and absence of oesophageal varices are risk factors for metastasis of hepatocellular carcinoma.
Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation.
Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.
Pretreatment prognostic factors for children with hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1.
Prevalence of abnormal levels of serum tumour markers in elderly people.
Prevention by melatonin of hepatocarcinogenesis in rats injected with N-nitrosodiethylamine.
Primary acinar cell carcinoma of the liver.
Primary cerebellar yolk sac tumor: case report.
Primary Chemotherapy in a 47-Year-Old Patient with Giant Ulcerative and Necrotizing Nonseminomatous Testicular Germ Cell Tumor.
Primary culture of liver cancer tissues with or without transcatheter arterial embolization and establishment of a cell strain.
Primary endodermal sinus tumor of the omentum.
Primary endodermal sinus tumor of the penis: a case report.
Primary extragonadal germ cell tumors of the retroperitoneum: differentiation of primary and secondary tumors.
Primary focal T-cell lymphoma of the liver: a case report and review of the literature.
Primary gastric choriocarcinoma. Report of an autopsy case with immunohistochemical study.
Primary hepatic B-cell lymphoma in a child.
Primary hepatic choriocarcinoma in an 83-year-old woman.
Primary hepatic lymphoma diagnosed using endoscopic ultrasound-guided liver biopsy: a case report.
Primary hepatic lymphoma in a patient with rheumatoid arthritis treated with methotrexate.
Primary Hepatic Lymphoma Mimicking a Hepatocellular Carcinoma in a Cirrhotic Patient: Case Report and Systematic Review of the Literature.
Primary hepatic malignant tumor with rhabdoid features. A histological, immunocytochemical, and electron microscopic study of four cases and a review of the literature.
Primary hepatic neuroendocrine tumors: A case report.
Primary hepatoid carcinoma of ovary in pregnancy.
Primary immature mediastinal teratoma in adulthood.
Primary intracranial germ-cell tumors. A clinicopathological study of 14 cases.
Primary intracranial yolk sac tumor: immunofluorescent demonstration of alpha-fetoprotein synthesis.
Primary intrapelvic seminoma in Klinefelter's syndrome.
Primary intratesticular rhabdomyosarcoma in children: a case report and review of the literature.
Primary liver cancers in Japan.
Primary Living-donor Liver Transplantation Is Not the Optimal Treatment Choice in Patients With Early Hepatocellular Carcinoma With Poor Tumor Biology.
Primary lymphoma of the liver: a case report and review.
Primary malignant tumor of liver in infants and children in Taiwan.
Primary mediastinal and retroperitoneal malignant germ cell tumors in children and adolescents: Results of the TGM95 trial, a study of the French Society of Pediatric Oncology (Société Française des Cancers de l'Enfant).
Primary mediastinal malignant germ cell tumour. Single institution experience in Chinese patients and correlation with specific alpha-fetoprotein bends.
Primary mediastinal pleomorphic rhabdomyosarcoma: a case report.
Primary mediastinal seminoma.
Primary mediastinal trophoblastic teratomas.
Primary neuroendocrine carcinoma coexisting with hemangioma in the liver: report of a case.
Primary neuroendocrine tumor of the testis: a study of clinicopathological features.
Primary pulmonary alpha-fetoprotein-producing malignant germ cell tumor.
Primary pulmonary hepatoid adenocarcinoma: A case report and review of the literature.
Primary retroperitoneal pure yolk-sac tumor in an adult male.
Primary vs metastatic hepatic carcinoma. An immunohistochemical study of 34 cases.
Primary yolk sac tumor concomitant with carcinosarcoma originating from the endometrium: Case report.
Primary yolk sac tumor of the endometrium: a case report and review of the literature.
Primary yolk sac tumor of the urachus.
Primary yolk sac tumor originating from the endometrium: A case report and literature review.
Primary yolk sac tumors of the mesentery. A report of two cases.
Primitive cystic hepatic neoplasm of infancy with mesothelial differentiation: report of a case.
PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis.
Production and secretion of endothelin by hepatocellular carcinoma.
Production of 13 plasma proteins by human testicular yolk sac tumor transplanted into nude mice.
Production of alpha-fetoprotein by human germ cell tumors in vivo and in vitro.
Production of immunoreactive calcitonin and some other tumor markers by established human carcinoma cell lines.
Prognosis following non-surgical second treatment in patients with recurrent hepatocellular carcinoma after percutaneous ablation therapy.
Prognosis following transcatheter arterial embolization for 121 patients with unresectable hepatocellular carcinoma with or without a history of treatment.
Prognosis of Early-Stage Hepatocellular Carcinoma: The Clinical Implications of Substages of Barcelona Clinic Liver Cancer System Based on a Cohort of 1265 Patients.
Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center.
Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems.
Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study.
Prognostic and clinicopathologic significance of SIRT1 expression in hepatocellular carcinoma.
Prognostic and clinicopathological significance of Gamma-Glutamyltransferase in patients with hepatocellular carcinoma: A PRISMA-compliant meta-analysis.
Prognostic and clinicopathological significance of hypoxia-inducible factors 1? and 2? in hepatocellular carcinoma: a systematic review with meta-analysis.
Prognostic and clinicopathological significance of PD-1 expression in hepatocellular carcinoma: a meta-analysis.
Prognostic and clinicopathological value of Nanog in hepatocellular carcinoma: A meta-analysis.
Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients.
Prognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinoma.
Prognostic factors and rational approach in the treatment of submucosal cancer of the stomach.
Prognostic factors and staging systems in childhood hepatoblastoma.
Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis.
Prognostic factors for portal venous invasion in patients with hepatocellular carcinoma.
Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation.
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma.
Prognostic factors in children with extracranial germ cell tumors treated with cisplatin-based chemotherapy.
Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer Group.
Prognostic factors in metastatic nonseminomatous germ cell tumours.
Prognostic factors in patients with HBV-related hepatocellular carcinoma following hepatic resection.
Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Identification of two groups of patients with prospects for prolonged survival.
Prognostic factors in resected hepatocellular carcinomas and therapeutic value of transcatheter arterial embolization for recurrences.
Prognostic factors in yolk sac tumors of the ovary. A clinicopathologic analysis of 29 cases.
Prognostic factors of patients with ovarian yolk sac tumors: a study in Chinese patients.
Prognostic factors of patients with yolk sac tumors of the ovary.
Prognostic Factors of Survival of Advanced Liver Cancer Patients Treated With Palliative Radiotherapy: A Retrospective Study.
Prognostic features and survival of hepatocellular carcinoma in Italy: impact of stage of disease.
Prognostic features and survival of inoperable hepatocellular carcinoma in Turkish patients with cirrhosis.
Prognostic Impact of Alpha Fetoprotein at Diagnosis on Overall Survival of Single Small Hepatocellular Carcinomas.
Prognostic impact of des-?-carboxyl prothrombin in living-donor liver transplantation for recurrent hepatocellular carcinoma.
Prognostic Implications of Arginase and Cytokeratin 19 Expression in Hepatocellular Carcinoma After Curative Hepatectomy: Correlation With Recurrence-Free Survival.
Prognostic Importance of 18F-FDG Uptake Pattern of Hepatocellular Cancer Patients Who Received SIRT.
Prognostic index of liver cirrhosis with ascites with and without hepatocellular carcinoma.
Prognostic influence of clinicopathologic features, DNA-ploidy, CD44H and p53 expression in a large series of resected hepatocellular carcinoma in France.
Prognostic model for hepatocellular carcinoma with time-dependent factors.
Prognostic Nomogram for Advanced Hepatocellular Carcinoma Treated with FOLFOX 4
Prognostic nomogram for hepatocellular carcinoma with fibrosis of varying degrees: a retrospective cohort study.
Prognostic nomogram for hepatocellular carcinoma with radiofrequency ablation: a retrospective cohort study.
Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection.
Prognostic nomograms for patients with resectable hepatocelluar carcinoma incorporating systemic inflammation and tumor characteristics.
Prognostic scores for sorafenib-treated hepatocellular carcinoma patients: A new application for the hepatoma arterial embolisation prognostic score.
Prognostic significance of a combination of pre- and post-treatment tumor markers for hepatocellular carcinoma curatively treated with hepatectomy.
Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors.
Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma.
Prognostic significance of E-cadherin expression in hepatocellular carcinoma: correlations with clinical features.
Prognostic significance of nucleolar organizer regions in hepatocellular carcinoma.
Prognostic significance of postoperative change of PALBI grade for patients with hepatocellular carcinoma after hepatectomy.
Prognostic significance of pretreatment albumin/globulin ratio in patients with hepatocellular carcinoma.
Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma.
Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma.
Prognostic significance of the CRP/Alb and neutrophil to lymphocyte ratios in hepatocellular carcinoma patients undergoing TACE and RFA.
Prognostic significance of the neutrophil-to-lymphocyte ratio in primary liver cancer: a meta-analysis.
Prognostic significance of urinary neopterin levels in patients with hepatocellular carcinoma.
Prognostic value of alpha-fetoprotein radioimmunoassay in surgically treated patients with embryonal cell carcinoma of the testis.
Prognostic value of combined preoperative fibrinogen and neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma after liver transplantation.
Prognostic value of glypican-3 in patients with HBV-associated hepatocellular carcinoma after liver transplantation.
Prognostic value of immunoscore to identify mortality outcomes in adults with HBV-related primary hepatocellular carcinoma.
Prognostic Value of Lactate Dehydrogenase in Patients with Hepatocellular Carcinoma: A Meta-Analysis.
Prognostic Value of Preoperative Serum Leucine Aminopeptidases in Hepatocellular Carcinoma Patients Who Underwent Liver Transplantation.
Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC.
Prognostic value of programmed cell death ligand 1 (PD-L1) for hepatocellular carcinoma: a meta-analysis.
Prognostic Value of Serum AFP, AFP-L3, and GP73 in Monitoring Short-term Treatment Response and Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation.
Prognostic value of serum biological markers in patients with hepatocellular carcinoma.
Prognostic value of subcutaneous adipose tissue volume in hepatocellular carcinoma treated with transcatheter intra-arterial therapy.
Prognostic value of tumor size, metastases, extension into bone, and increased tumor marker in children with malignant sacrococcygeal germ cell tumors: a prospective evaluation of 71 patients treated in the German cooperative protocols Maligne Keimzelltumoren (MAKEI) 83/86 and MAKEI 89.
Prognostic Values of alpha-fetoprotein and Protein Induced by Vitamin K Absence or Antagonist-II in Hepatitis B Virus-related Hepatocellular Carcinoma: A Prospective Study.
Prognostic values of normal preoperative serum cancer markers for gastric cancer.
Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features.
Prolonged survival after repeat resection of pulmonary metastasis from hepatocellular carcinoma.
Promotion of growth and differentiation of rat ductular oval cells in primary culture.
Propensity Score Matching Analysis of Changes in Alpha-Fetoprotein Levels after Combined Radiotherapy and Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
Proposal and validation of a new model to estimate survival for hepatocellular carcinoma patients.
Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma--a comparison between L-TAE with farmorubicin and L-TAE with adriamycin: preliminary results (second cooperative study). Cooperative Study Group for Liver Cancer Treatment of Japan.
Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan.
Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma.
Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery.
Prospective Randomized Comparison of Chemoembolization with Doxorubicin-Eluting Beads and Bland Embolization with BeadBlock for Hepatocellular Carcinoma.
Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma.
Protein composition of cyst fluids from mature teratoma in patients with nonseminomatous germ cell tumors of the testis.
Proteomic prediction of disease outcome in cancer : clinical framework and current status.
Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.
Proteomics in prostate cancer biomarker discovery.
Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis.
Proton beam therapy in apneic oxygenation treatment of an unresectable hepatocellular carcinoma: A case report and review of literature.
Pseudosarcomatous cystadenocarcinoma of the liver.
Puberty due to a mixed germ cell tumour of the hypothalamus secreting BhCG and alpha-fetoprotein.
Pulmonary blastoma with germ cell (yolk sac) differentiation: report of two cases.
Pure high-grade fetal adenocarcinoma of the lung: a case report.
Pure Primary Extragonadal Retroperitoneal Yolk Sac Tumour in a Young Child: A Case Report.
Pure yolk sac tumors in genital and extragenital sites: study on three pedriatic cases, with cytological findings on two.
Pure yolk-sac tumor of the lung.
Purification and characterization of a bioactive alpha-fetoprotein produced by HEK-293 cells.
Quantification of alpha-fetoprotein and beta-HCG in testis tumor patients.
Quantitative analysis of alpha-fetoprotein mRNA in circulating peripheral blood of patients with hepatocellular and alpha-fetoprotein-producing gastric carcinomas.
Quantitative comparison of alpha-fetoprotein and albumin mRNA levels in hepatocellular carcinoma/adenoma, non-tumor liver and blood: implications in cancer detection and monitoring.
Quantitative, label-free detection of five protein biomarkers using multiplexed arrays of silicon photonic microring resonators.
Rabbit alpha-fetoprotein: normal levels and breakage tolerance with haptenated homologous alpha-fetoprotein.
Radiation therapy: a primary treatment modality for seminoma.
Radio frequency ablation for hepatocellular carcinoma in cirrhotic patients: prognostic factors for survival.
Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.
Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome.
Radiofrequency ablation assisted by real-time virtual sonography for hepatocellular carcinoma inconspicuous under sonography and high-risk locations.
Radiofrequency ablation for the treatment of bone metastases from hepatocellular carcinoma.
Radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of overall survival and recurrence-free survival.
Radiofrequency ablation of hepatocellular carcinoma: Long-term results and prognostic factors in 235 Western patients with cirrhosis.
Radiofrequency ablation of recurrent hepatocellular carcinoma in a patient after liver transplantation: two-year follow-up.
Radiofrequency ablation with internally cooled versus perfused electrodes for the treatment of small hepatocellular carcinoma in patients with cirrhosis.
Radiographic features of hepatocellular carcinoma and their relation to prognosis in Canada.
Radioimmunoassay of alpha-fetoprotein in children with primary intracranial tumors.
Radioimmunoassay of serum alpha-fetoprotein in patients with different maliganant tumors.
Radioimmunodetection of cancer using antibodies to alpha-fetoprotein and carcinoembryonic antigen.
Radioimmunodetection of cancer with radiolabeled antibodies to alpha-fetoprotein.
Radioimmunodetection of cancers containing carcinoembryonic antigen and alpha-fetoprotein.
Radioimmunodetection of primary and metastatic germ cell tumors containing alpha-fetoprotein.
Radioimmunoelectrophoretic detection of alpha-fetoprotein in tumour specimens.
Radioimmunotherapy for unresectable hepatocellular carcinoma using 131I-Hepama-1 mAb: preliminary results.
Radioiodinated anti-hepatocellular carcinoma (HCC) ferritin. Targeting therapy, tumor imaging and anti-antibody response in HCC patients with hepatic arterial infusion.
Radiological and clinical features of sarcomatoid hepatocellular carcinoma in 11 cases.
Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection.
Radiological response and inflammation scores predict tumour recurrence in patients treated with transarterial chemoembolization before liver transplantation.
Radiotherapy for stages IIA/B testicular seminoma: final report of a prospective multicenter clinical trial.
Radiotherapy Plus Transarterial Chemoembolization for Hepatocellular Carcinoma Invading the Portal Vein: Long-Term Patient Outcomes.
Raised maternal serum alpha-fetoprotein levels during pregnancy following treatment of an endodermal sinus tumour. Case report.
Raised serum alpha-fetoprotein in Sertoli-Leydig cell tumor (androblastoma) of ovary: report of two cases.
Random Survival Forests to Predict Disease Control for Hepatocellular Carcinoma Treated With Transarterial Chemoembolization Combined With Sorafenib.
Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma.
Rapamycin blocks hepatoblastoma growth in vitro and in vivo implicating new treatment options in high-risk patients.
Rapid and sensitive chemiluminescent enzyme immunoassay for measuring tumor markers.
Rapid and sensitive lateral flow immunoassay method for determining alpha fetoprotein in serum using europium (III) chelate microparticles-based lateral flow test strips.
Rapid and simple immunosensing system for simultaneous detection of tumor markers based on negative-dielectrophoretic manipulation of microparticles.
Rapid decrease of serum alpha-fetoprotein and tumor volume predicts outcome in children with hepatoblastoma treated with neoadjuvant chemotherapy.
Rapid progression of hepatocellular carcinoma in a patient with autoimmune hepatitis.
Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
Rapidly growing hepatocellular carcinoma recurrence during direct-acting antiviral treatment for chronic hepatitis C.
Rare Case of Hepatic Gaucheroma in a Child on Enzyme Replacement Therapy.
Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (? 2 cm, Barcelona stage 0) - assessment with large number of cases.
Recent advances in the pathology and classification of ovarian germ cell tumors.
Recent developments in the first detection of hepatocellular carcinoma.
Recent developments in the pathology of germ cell tumors.
Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors.
Recognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avoid complications of transcatheter arterial chemoembolization.
Recombinant alpha-fetoprotein C-terminal fragment: the new recombinant vector for targeted delivery.
Rectal adenocarcinoma with germ-cell differentiation: report of a case.
Recurrence after resection of hepatocellular carcinoma.
Recurrence of a Mediastinal Germ-Cell Tumor as a Somatic-Type Malignancy: A Complex Case Report.
Recurrence of acute myeloid leukemia in cryptorchid testis: case report.
Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection.
Recurrence of primary intracranial germinomas after complete response with radiotherapy: recurrence patterns and therapy.
Recurrent alpha-fetoprotein secreting Sertoli-Leydig cell tumor of ovary with an unusual presentation.
Recurrent hepatocellular carcinoma after spontaneous regression.
Recurrent hepatocellular carcinoma has an increased risk of subsequent recurrence after curative treatment.
Recurrent mixed germ cell tumor of the ovary manifest as an unexplained elevated maternal serum alpha-fetoprotein.
Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey.
Refining prognosis after trans-arterial chemo-embolization for hepatocellular carcinoma.
Registries in Japan: current status of hepatocellular carcinoma in Japan. Liver Cancer Study Group of Japan.
Regression of hepatocellular cancer in a patient treated with arginine deiminase.
Regulation of alpha-fetoprotein by nuclear factor-kappaB protects hepatocytes from tumor necrosis factor-alpha cytotoxicity during fetal liver development and hepatic oncogenesis.
Regulation of Anti-Tumor Activity Using Monoclonal Antibodies to Alpha-Fetoprotein Receptor and after Immunization with This Protein.
Reimbursements and frequency of tests in privately insured testicular cancer patients in the United States: Implications to national guidelines.
Relapse and outcome patterns of patients with central nervous system mixed malignant germ cell tumors treated without irradiation: Findings from the third international central nervous system (CNS) germ cell tumor (GCT) study.
Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma.
Relationship between alpha-fetoprotein serum levels, tumour volume and growth rate of hepatocellular carcinoma in a western population.
Relationship between pathologic prognostic factors and abnormal levels of des-gamma-carboxy prothrombin and alpha-fetoprotein in hepatocellular carcinoma.
Relationship between polymorphism of angiotensin-converting enzyme gene insertion/deletion and risk of hepatocellular carcinoma in a Chinese Dai population.
Relationship Between Serum Tumor-related Markers and Dietary Intakes in Korean Healthy Adults.
Relationship between the serum CA-125 level and bone mineral density in healthy pre- and post-menopausal women.
Relationship of uptake of technetium-99m(Sn)-N-pyridoxyl-5-methyltryptophan by hepatocellular carcinoma to prognosis.
Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective.
Remission, relapse, and metastasis/death of small hepatocellular carcinoma treated with percutaneous ethanol injection.
Renal failure in patients with hepatocellular carcinoma and ascites undergoing transarterial chemoembolization.
Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States.
Resection after intraarterial chemotherapy of a hepatoblastoma originating in the caudate lobe.
Resection of a giant hepatocellular carcinoma weighing over ten kilograms.
Resection of Hepatocellular Carcinoma Without Cirrhosis.
Resection of hepatocellular carcinoma without preoperative tumor biopsy.
Resection of liver metastases from an alpha-fetoprotein-producing gastric cancer.
Resection of liver metastasis derived from alpha-fetoprotein-producing gastric cancer-report of 4 cases.
Resection of peritoneal implantation of hepatocellular carcinoma after hepatic resection: risk factors and prognostic analysis.
Residual pulmonary nodules after combination chemotherapy of testicular cancer.
Residual retroperitoneal mass following chemotherapy for infantile yolk sac tumor.
Resin versus Glass Microspheres for Yttrium-90 Transarterial Radioembolization: Comparing Survival in Unresectable Hepatocellular Carcinoma using Pretreatment Partition Model Dosimetry.
Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 Revised Version).
Results of retroperitoneal lymph node dissection after chemotherapy in patients with pure seminoma in the orchidectomy specimen but elevated serum alpha-fetoprotein.
Results of three-dimensional conformal radiotherapy and thalidomide for advanced hepatocellular carcinoma.
Retinoids in liver fibrosis and cancer.
Retroperitoneal extragonadal germ cell tumor presenting as a bulky pelvic mass of the obturator fossa.
Retroperitoneal lymph node dissection after chemotherapy in patients with elevated tumour markers: indications, histopathology and outcome.
Retroperitoneal lymph node dissection in the setting of elevated markers.
Retroperitoneal metastases in testicular cancer: role of CT measurements of residual masses in decision making for resection after chemotherapy.
Retrospective evaluation of DNA ploidy of hepatocarcinoma on cytologic samples.
Reversible increase in serum alpha-fetoprotein content associated with hepatic dysfunction during chemotherapy for seminoma.
Reversible limbic encephalitis caused by ovarian teratoma.
Review of 336 patients with hepatocellular carcinoma at Songklanagarind Hospital.
Review of the adenocarcinoma cell surface receptor for human alpha-fetoprotein; proposed identification of a widespread mucin as the tumor cell receptor.
Rex3 (reduced in expression 3) as a new tumor marker in mouse hepatocarcinogenesis.
Rheumatic syndromes: clues to occult neoplasia.
Rib metastasis revealing hepatocellular carcinoma.
Ribose-5-phosphate isomerase A regulates hepatocarcinogenesis via PP2A and ERK signaling.
Risk and prognostic nomograms for hepatocellular carcinoma with newly-diagnosed pulmonary metastasis using SEER data.
Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.
Risk factors for death in 224 cases of hepatocellular carcinoma after transcatheter arterial chemoembolization.
Risk factors for early death due to recurrence after resection of large hepatocellular carcinomas.
Risk factors for early recurrence of small hepatocellular carcinoma after curative resection.
Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
Risk factors for immediate post-operative fatal recurrence after curative resection of hepatocellular carcinoma.
Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma.
Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection.
Risk factors for intraocular metastasis of primary liver cancer in diabetic patients: Alpha-fetoprotein and cancer antigen 125.
Risk factors for local and distant recurrence of hepatocellular carcinomas after local ablation therapies.
Risk factors for local recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization with drug-eluting beads (DEB-TACE).
Risk factors of delay in restoration of hepatic reserve capacity and local recurrence after radiofrequency ablation therapy for hepatocellular carcinoma (HCC).
Risk factors of the recurrence of hepatocellular carcinoma originating from residual cancer cells after hepatectomy.
Risk of tumour progression in early-stage hepatocellular carcinoma after radiofrequency ablation.
Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma.
Risk Score Model for Microvascular Invasion in Hepatocellular Carcinoma: The Role of Tumor Burden and Alpha-Fetoprotein.
Risk-adapted management for patients with clinical stage I non-seminomatous germ cell tumour of the testis.
Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.
RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma.
Robb-Smith type malignant histiocytosis associated with a mediastinal germ cell tumor.
Role of High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Men With Previously Treated Germ Cell Tumors.
Role of human chorionic gonadotropin in patients with pure seminoma.
Role of monocyte-to-lymphocyte ratio in predicting sorafenib response in patients with advanced hepatocellular carcinoma.
Role of serum alpha-fetoprotein in pre- and post-orthotopic liver transplantation (OLT) for malignant disease.
Role of the pituitary tumor transforming gene 1 in the progression of hepatocellular carcinoma.
Roles of the miR-139-5p/CCT5 axis in hepatocellular carcinoma: a bioinformatic analysis.
Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization.
RPL39L is an example of a recently evolved ribosomal protein paralog that shows highly specific tissue expression patterns and is upregulated in ESCs and HCC tumors.
Ruptured metastatic liver tumor from an alpha-fetoprotein-producing gastric cancer.
S-Phase progression mediates activation of a silenced gene in synthetic nuclei.
Sacrococcygeal teratoma.
Sacrococcygeal teratomas: a review of 68 cases.
Sarcomatoid hepatocellular-carcinoma showing rhabdomyoblastic differentiation in the adult cirrhotic liver.
Schistosoma mansoni infection and the occurrence, characteristics, and survival of patients with hepatocellular carcinoma: an observational study over a decade.
Screening and Identifying a Novel ssDNA Aptamer against Alpha-fetoprotein Using CE-SELEX.
Screening differential circular RNA expression profiles reveals hsa_circ_0004018 is associated with hepatocellular carcinoma.
Screening for cancer: is it cost effective?
Search for Effective Serum Tumor Markers for Early Diagnosis of Hepatocellular Carcinoma Associated with Hepatitis C.
Second-look laparotomy in endodermal sinus tumor: a report of two patients with normal levels of alpha-fetoprotein and residual tumor at reexploration.
Secretion of human chorionic gonadotropin and alpha-fetoprotein by an ovarian germ cell tumor of apparent yolk sac origin.
Selected applications of immunoperoxidase techniques in surgical pathology.
Selecting an Optimal Staging System for Intermediate-Stage Hepatocellular Carcinoma: Comparison of 9 Currently Used Prognostic Models.
Selection and characterization of a novel affibody peptide and its application in a two-site ELISA for the detection of cancer biomarker alpha-fetoprotein.
Selection of a Clinical Lead TCR Targeting Alpha-Fetoprotein-Positive Liver Cancer Based on a Balance of Risk and Benefit.
Selection of patients of hepatocellular carcinoma beyond the Milan criteria for liver transplantation.
Selective effects of Lipiodolized antitumor agents.
Selective in vitro and in vivo growth inhibition against human yolk sac tumor cell lines by purified antibody against human alpha-fetoprotein conjugated with mitomycin C via human serum albumin.
Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma.
Self-healing mechanism and bioelectrochemical interface properties of core-shell guanosine-borate hydrogels.
Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival.
Seminal vesicle metastasis after partial hepatectomy for hepatocellular carcinoma.
Sensitive assay for detection of hepatocellular carcinoma associated gene transcription (alpha-fetoprotein mRNA) in blood.
Sensitive detection of human telomerase reverse transcriptase mRNA in the serum of patients with hepatocellular carcinoma.
Sensitive immunosensor for cancer biomarker based on dual signal amplification strategy of graphene sheets and multienzyme functionalized carbon nanospheres.
Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size.
Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma.
Separation of circulating cancer cells by unique microfluidic chip in colorectal cancer.
Sequential analysis of transplantable hepatocellular carcinomas.
Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
Serial monitoring of serum alpha-fetoprotein and chorionic gonadotropin in males with germ cell tumors.
Serial serum determination on alpha-fetoprotein as a marker of the effect of postoperative chemotherapy in ovarian endodermal sinus tumor.
Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients.
Serous papillary cystadenocarcinoma associated with alpha-fetoprotein production.
Sertoli Leydig cell tumor with malignant heterologous elements and raised alpha-fetoprotein: a case report.
Sertoli-Leydig cell tumor - a rare androgen secreting ovarian tumor in postmenopausal women. Case report and review of literature.
Sertoli-Leydig cell tumor of the ovary producing alpha-fetoprotein.
Sertoli-Leydig cell tumor of the ovary with alpha-fetoprotein production.
Sertoli-Leydig cell tumor of the ovary: a rare cause of amenorrhea.
Sertoli-Leydig cell tumors of ovary: A case series.
Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein.
Serum alpha 1-antitrypsin in patients with hepatocellular carcinoma.
Serum alpha fetoprotein in gynaecologic related malignancies.
Serum alpha-fetoprotein (AFP) in benign and malignant gastrointestinal diseases: evaluation of an immunoenzymatic assay.
Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma.
Serum alpha-fetoprotein and its lectin reactivity in liver diseases: a review.
Serum alpha-fetoprotein as a marker for the effect of post-operative radiation therapy and/or chemotherapy in eight cases of ovarian endodermal sinus tumour.
Serum Alpha-Fetoprotein Concentrations in Extremely-Low-Birth-Weight Infants.
Serum alpha-fetoprotein concentrations in urban and rural Southern African blacks with hepatocellular carcinoma.
Serum alpha-fetoprotein in a mouse strain (C3H-Avy fB) with spontaneous hepatocellular carcinomas.
Serum alpha-fetoprotein in patients with neoplasms of the gastrointestinal tract.
Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma.
Serum alpha-fetoprotein level per total tumor volume as a predictor of recurrence of hepatocellular carcinoma after resection.
Serum alpha-fetoprotein level per tumor volume reflects prognosis in patients with hepatocellular carcinoma after curative hepatectomy.
Serum alpha-fetoprotein levels in neonatal cholestasis.
Serum alpha-fetoprotein levels in patients with acute and chronic liver disease. Relation to hepatocellular regeneration and development of primary liver cell carcinoma.
Serum alpha-fetoprotein subfractions identified by Ricinus communis agglutinin I in hepatic malignancies, yolk sac tumor, benign hepatic diseases, and fetal stage.
Serum alpha-fetoprotein subfractions in hepatic malignancies identified by different reactivities with concanavalin A, lentil lectin or phytohemagglutinin-E.
Serum alpha-fetoprotein surge after the initiation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significance.
Serum alpha-fetoprotein values in dogs with various hepatic diseases.
Serum alpha-fetoprotein: I. Evaluation of quantitative assays adapted to automated immunoassay systems.
Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma.
Serum and cerebrospinal fluid human chorionic gonadotropin (hCG) and alpha-fetoprotein (AFP) in intracranial germ cell tumors.
Serum angiopoietin-2 level as a predictor of tumor invasiveness in patients with hepatocellular carcinoma.
Serum anti-Ku86 is a potential biomarker for early detection of hepatitis C virus-related hepatocellular carcinoma.
Serum B protein in hepatocellular carcinoma and liver cirrhosis.
Serum Chemerin Does Not Differentiate Colorectal Liver Metastases from Hepatocellular Carcinoma.
Serum ferritin level after resection of hepatocellular carcinoma. Correlation with alpha-fetoprotein level.
Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma.
Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma.
Serum immunoreactivity of SMP30 and its tissues expression in hepatocellular carcinoma.
Serum insulin-like growth factor-II and alpha-fetoprotein as tumor markers of hepatocellular carcinoma.
Serum insulin-like growth factor-II as a serologic marker of small hepatocellular carcinoma.
Serum KL-6 as a novel tumor marker for hepatocellular carcinoma in hepatitis C virus infected patients.
Serum lactate dehydrogenase isoenzyme 1 and prediction of death in patients with metastatic testicular germ cell tumors.
Serum lactic dehydrogenase as a tumor marker in dysgerminoma.
Serum levels of alpha-fetoprotein, human chorionic gonadotropin and carcinoembryonic antigen in patients with primary intracranial germ cell tumors.
Serum levels of CA 125 in patients with gastrointestinal cancers.
Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma.
Serum levels of gamma-glutamyl transpeptidase in relation to HCC human biology and prognosis.
Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis.
Serum prolactin, gonadotropins, androgens, estrogens, and gestagens in patients with malignant testicular germ cell tumor.
Serum pseudouridine as a biochemical marker in patients with hepatocellular carcinoma.
Serum tissue inhibitor of metalloproteinases in patients with chronic liver disease and with hepatocellular carcinoma.
Serum tissue polypeptide specific antigen as a noninvasive prognostic indicator for early recurrence of hepatocellular carcinoma after curative resection.
Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors.
Serum tumor markers for detection of bone metastasis in breast cancer patients.
Serum tumor markers in patients on dialysis and kidney transplantation.
Serum tumor markers in patients with hepatocellular carcinoma: diagnosis of alpha-fetoprotein -low or -negative patients.
Serum tumor markers.
Serum tumour markers in lung cancer: history, biology and clinical applications.
Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment.
Serum type IV collagen-degrading enzyme in hepatocellular carcinoma with metastasis.
Serum type-2 macro-creatine kinase isoenzyme is not a useful marker of severe liver diseases or neoplasia.
Serum unconjugated primary and secondary bile acids in patients with cholangiocarcinoma and hepatocellular carcinoma.
Serum-soluble interleukin-2 receptor concentrations in patients with gastric cancer.
Sex-Based Disparities in Hepatocellular Carcinoma Recurrence After Liver Transplantation.
Shadows Behind Using Simple Risk Models in Selection of Hepatocellular Carcinoma Patients for Liver Transplantation.
Short and long term efficacy of high intensity focused ultrasound therapy for advanced hepatocellular carcinoma.
Short- and Long-term Outcomes between Young and Older HCC Patients Exceeding The Milan Criteria after Hepatectomy.
Sialoblastoma: a clinicopathologic and immunohistochemical study of 7 cases.
Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
Significance of human chorionic gonadotropin, alpha-fetoprotein, and pregnancy-specific beta-1-glycoprotein in the detection of tumor relapse and partial remission in 126 patients with nonseminomatous testicular germ cell tumors.
Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
Significance of serum tumor markers in patients with carcinoma of the ovary.
Silencing alpha-fetoprotein inhibits VEGF and MMP-2/9 production in human hepatocellular carcinoma cell.
Simultaneous assays of cancer-associated antigens in various neoplastic disorders.
Simultaneous Detection of Multiple Tumor Markers in Blood by Functional Liquid Crystal Sensors Assisted with Target-Induced Dissociation of Aptamer.
Simultaneous determination of alpha-fetoprotein immune complexes and alpha-fetoprotein concentration in hepatocellular carcinoma using dual-label time-resolved immunofluorometric assays.
Simultaneous radioimmunoassay for carcinoembryonic antigen (CEA) and alpha-fetoprotein (alphaFP) in neoplasms of the gastro-intestinal tract.
Six2 is negatively correlated with prognosis and facilitates epithelial-mesenchymal transition via TGF-?/Smad signal pathway in hepatocellular carcinoma.
SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma.
Small cell undifferentiated histology in hepatoblastoma may be unfavorable.
Small hepatocellular carcinoma presenting as intrabiliary pedunculated polyp and obstructive jaundice.
Small hepatocellular carcinoma with minute satellite nodules.
Small Steatotic HCC: A Radiological Variant Associated With Improved Outcome After Ablation.
Somatostatin Receptor in Human Hepatocellular Carcinomas: Biological, Patient and Tumor Characteristics.
Some characteristics of Mozambican Shangaans with primary hepatocellular cancer.
Sonographic features of an intraductal polypoid mass: differentiation between hepatocellular carcinoma and intraductal cholangiocarcinoma.
Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma.
Sorafenib and hepatocellular carcinoma: is alpha-fetoprotein a biomarker predictive of tumor biology and primary resistance?
Sorafenib is associated with a reduced rate of tumour growth and liver function deterioration in HCV-induced hepatocellular carcinoma.
Sorafenib with concurrent multiple-line therapies improves overall survival in advanced stage hepatocellular carcinoma.
Specific diagnosis of hepatocellular carcinoma by delayed hepatobiliary imaging.
Specific immunoreaction-induced controlled release strategy for sensitive impedance immunoassay of a cancer marker.
Spectrum of hepatocellular carcinoma at Shifa International Hospital, Islamabad.
Spermatic cord beta-human chorionic gonadotropin levels in seminoma and their clinical implications.
Spindle cell tumors resected from male patients with germ cell tumors. A clinicopathologic study of 14 cases.
Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer.
Spontaneous drastic reduction of alpha-fetoprotein in hepatocellular carcinoma.
Spontaneous regression of a hepatocellular carcinoma--a case report.
Spontaneous regression of diffuse intrahepatic recurrence with portal vein tumor thrombus after resection of hepatocellular carcinoma.
Spontaneous regression of germinoma in the pineal region before endoscopic surgery: a pitfall of modern strategy for pineal germ cell tumors.
Spontaneous Regression of Hepatocellular Carcinoma due to Disruption of the Feeding Artery.
Spontaneous regression of hepatocellular carcinoma--a case report.
Spontaneous regression of hepatocellular carcinoma.
Spontaneous regression of hepatocellular carcinoma: a case report.
Spontaneous rupture of immature gastric teratoma with hemoperitoneum in a newborn with 3-year follow-up.
Spontaneous rupture of metastatic alpha-fetoprotein-producing gastric cancer of the liver.
Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence.
Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma.
Statistical evaluation of 2001 carcinoid cases with metastases, collected from literature: a comparative study between ordinary carcinoids and atypical varieties.
Steatotic hepatocellular carcinoma: a variant associated with metabolic factors and late tumour relapse.
Stimulation of tumor-cell growth by alpha-fetoprotein.
Strategy for hepatoblastoma management: Transplant versus nontransplant surgery.
Striking differences between the mouse and the human alpha-fetoprotein enhancers.
STROBE-clinical characteristics and prognosis factors of gastric cancer in young patients aged ?30 years.
Structures of disease-specific serum alpha-fetoprotein isoforms.
Studies of gene transcription and translation in regenerating rat liver.
Study of Fe?O?-PPy Core-Shell Nanocomposite in the Diagnosis of Tumor Markers in the Tissues of Early Gastric Cancer Patients.
Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Sub-Classification of Advance-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with Sorafenib.
Subclinical hepatocellular carcinoma: an analysis of 391 patients.
Subcutaneous and intrahepatic growth of human hepatoblastoma in immunodeficient mice.
Submandibular endodermal sinus (yolk sac) tumor in a female infant. A case report.
Subnormal albumin gene expression is associated with weight loss in immunodeficient/DNA-repair-impaired wasted mice.
Subtle hepatocellular carcinoma: a persisting role for alpha-fetoprotein monitoring in high-risk patients with cirrhosis.
Successful Embolization of Hepatocelluar Carcinoma With Yttrium-90 Glass Microspheres Prior to Liver Transplantation.
Successful resection for advanced hepatoblastoma, combined with perioperative chemotherapy.
Successful resection of a giant mediastinal non-seminomatous germ cell tumor showing fluorodeoxyglucose accumulation after neoadjuvant chemotherapy: report of a case.
Successful surgical management of pulmonary and adrenal metastases from hepatocellular carcinoma.
Successful therapy of subcutaneously growing human hepatoblastoma xenografts with topotecan.
Successful treatment of a primary endodermal sinus tumor of the liver.
Successful treatment of an endodermal sinus tumor of the vagina by chemotherapy alone: a rare case of an infant diagnosed by pathological examination of discharged tumor fragment.
Successful Treatment of Childhood High-Risk Hepatoblastoma With Dose-Intensive Multiagent Chemotherapy and Surgery: Final Results of the SIOPEL-3HR Study.
Successful treatment of large-size advanced hepatocellular carcinoma by transarterial chemoembolization followed by the combination therapy of percutaneous ethanol-lipiodol injection and radiofrequency ablation.
Successfully treated metachronous liver metastasis of alpha-fetoprotein-producing early gastric cancer: case report.
Sugar chain of alpha-fetoprotein produced in human yolk sac tumor.
Super-selection of a subgroup of hepatocellular carcinoma patients at minimal risk of recurrence for liver transplantation.
Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines.
Supplemental conventional transarterial embolization/chemoembolization therapy via extrahepatic arteries for hepatocellular carcinoma.
Supportive treatment, resection and transcatheter arterial chemoembolization in resectable hepatocellular carcinoma: an analysis of survival in 419 patients.
Suppressed MKP-1 is an independent predictor of outcome in patients with hepatocellular carcinoma.
Suppression of hepatocellular carcinoma growth in mice by the alkaloid coccidiostat halofuginone.
Suppression of hepatocellular carcinoma growth via oral immune regulation towards tumor-associated antigens is associated with increased NKT and CD8+ lymphocytes.
Suppression of human hepatoma in mice through adoptive transfer of immunity to the hepatitis B surface antigen.
Suppression of orthotopically implanted hepatocarcinoma in mice by umbilical cord-derived mesenchymal stem cells with sTRAIL gene expression driven by AFP promoter.
Suppression of Zinc Finger Homeobox 3 expression in tumor cells decreases the survival rate among non-small cell lung cancer patients.
Surgery for large primary liver cancer more than 10 cm in diameter.
Surgery for mixed hepatocellular and cholangiocellular carcinoma.
Surgical contribution to recurrence-free survival in patients with macrovascular-invasion-negative hepatocellular carcinoma.
Surgical management of hepatocellular carcinoma.
Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group.
Surgical Resection of Hepatocellular Carcinoma.
Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers.
Surgical strategies for hepatocellular carcinoma with special reference to anatomical hepatic resection and intraoperative contrast-enhanced ultrasonography.
Surgical treatment and outcome in patients with a hepatocellular carcinoma greater than 10 cm in diameter.
Surgical treatment of Epstein-Barr virus-associated lymphoepithelioma-like carcinoma occurring in both the posterior mediastinum and liver: Case report.
Surgical treatment of hepatocellular cancer in the era of hepatic transplantation.
Surgical treatment strategy for advanced hepatoblastoma: Resection versus transplantation.
Surveillance for gastrointestinal malignancies.
Survival after liver transplantation for hepatoblastoma: a 2-center experience.
Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
Survival Analysis of Hepatocellular Carcinoma: A Comparison Between Young Patients and Aged Patients.
Survival and prognostic factors in patients with hepatocellular carcinoma treated by percutaneous ethanol injection: a 10-year experience.
Survival and Tolerability of Transarterial Chemoembolization in Greater Versus less than 70 Years of Age Patients with Unresectable Hepatocellular Carcinoma: A Propensity Score Analysis.
Survival factors after resection of small hepatocellular carcinoma.
Survival of Patients with Advanced Hepatocellular Carcinoma: Sorafenib versus Other Treatments.
Survival of patients with nonseminomatous germ cell cancer: a review of the IGCC classification by Cox regression and recursive partitioning.
Synergistic action of purified alpha-fetoprotein and growth factors on the proliferation of porcine granulosa cells in monolayer culture.
Synergistic Impact of Alpha-Fetoprotein and Tumor Burden on Long-Term Outcomes Following Curative-Intent Resection of Hepatocellular Carcinoma.
Synthesis of alpha-fetoprotein and some other serum proteins in testicular tumors.
Synthesis of alpha-fetoprotein by human yolk sac tumor transplanted into nude mice.
Synthetic peptide derived from alpha-fetoprotein inhibits growth of human breast cancer: investigation of the pharmacophore and synthesis optimization.
Systematic review: risk prediction models for recurrence of hepatocellular carcinoma after liver transplantation.
TACE performed in patients with a single nodule of hepatocellular carcinoma.
Targeting alpha-fetoprotein (AFP)-MHC complex with CAR T cell therapy for liver cancer.
Targeting vascular endothelial growth factor with the monoclonal antibody bevacizumab inhibits human hepatocellular carcinoma cells growing in an orthotopic mouse model.
Technical considerations for fractionated stereotactic radiotherapy of hepatocellular carcinoma.
Telomerase activity correlates with cell cycle regulators in human hepatocellular carcinoma.
Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates.
Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
Testicular cancer and Hodgkin disease in the same patient.
Testicular cancer from diagnosis to epigenetic factors.
Testicular germ cell neoplasms.
Testicular germ cell tumors, an update. Results of the German cooperative studies 1982-1997.
Testicular germ-cell neoplasms: recent advances in diagnosis and therapy.
Testicular sex cord-stromal tumors in children: clinicopathologic study of sixteen children with review of the literature.
Testicular tumours in infancy and childhood--a review of 10 germ cell tumours and 10 non germ cell tumours.
Tg737 acts as a key driver of invasion and migration in liver cancer stem cells and correlates with poor prognosis in patients with hepatocellular carcinoma.
The adenocarcinoma cell surface mucin receptor for alpha-fetoprotein: is the same receptor present on circulating monocytes and macrophages? A commentary.
The best candidates for transarterial chemotherapy in patients with hepatocellular carcinoma awaiting liver transplantation: a cohort-based characterization of dropout times.
The biopathologic characteristics of DNA content of hepatocellular carcinomas.
The Carcinogenic Agent Diethylnitrosamine Induces Early Oxidative Stress, Inflammation and Proliferation in Rat Liver, Stomach and Colon: Protective Effect of Ginger Extract.
The chemotherapy of metastatic gastric adenocarcinomas with hypersecretion of alpha-fetoprotein or beta-human chorionic gonadotrophin: report of two cases.
The clinical application of tumor markers in the screening of malignancies and interstitial lung disease of dermatomyositis/polymyositis patients: A retrospective study.
The clinical significance in healthy men of the association between obesity related plasma hemodilution and tumor marker concentration.
The Clinical Significance of Alpha-Fetoprotein mRNAs in Patients with Hepatocellular Carcinoma.
The Clinicopathological Characteristics of Alpha-Fetoprotein-Producing Adenocarcinoma of the Gastrointestinal Tract-A Single-Center Retrospective Study.
The Degree of Lipiodol Accumulation Can Be an Indicator of Successful Treatment for Unresectable Hepatocellular Carcinoma (HCC) Patients - in the Case of Transcatheter Arterial Chemoembolization (TACE) and External Beam Radiotherapy (EBRT).
The development of laboratory tests for cancer in Japan with special reference to carcinoembryonic proteins.
The diagnostic and prognostic value of tumor markers in giant mediastinal endodermal sinus tumor with prolonged survival: Twelve-year follow up after radical resection.
The Diagnostic Value of Tumor Biomarkers for Detecting Hepatocellular Carcinoma Accompanied by Portal Vein Tumor Thrombosis.
The differential diagnosis of yolk sac tumor and seminoma. Usefulness of cytokeratin, alpha-fetoprotein, and alpha-1-antitrypsin immunoperoxidase reactions.
The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
The Effectiveness of ART Score in Selecting Patients for Transarterial Chemoembolization Retreatment: A Cohort Study in Taiwan.
The efficacy of modified docetaxel-cisplatin-5-fluorouracil regimen as first-line treatment in patients with alpha-fetoprotein producing gastric carcinoma.
The Efficacy of Serum Carcinoembryonic Antigen (CEA), Cancer Antigen 125 (CA125), Carbohydrate Antigen 19-9 (CA19-9), Carbohydrate Antigen 15-3 (CA15-3), alpha-Fetoprotein (AFP) and Human Chorionic Gonadotropin (hCG) Levels in Determining the Malignancy of Solitary Pulmonary Nodules.
The EpCAM overexpression is associated with clinicopathological significance and prognosis in hepatocellular carcinoma patients: A systematic review and meta-analysis.
The expressions of oncogenes and liver-specific genes in Morris hepatomas.
The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation study.
The extrahepatic events of Asian patients with primary biliary cholangitis: A 30-year cohort study.
The HDAC Inhibitor, SAHA, Combined with Cisplatin Synergistically Induces Apoptosis in Alpha-fetoprotein-producing Hepatoid Adenocarcinoma Cells.
The histogenetic-embryologic basis for reappearance of alpha-fetoprotein in endodermal sinus tumors (yolk sac tumors) and teratomas.
The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma.
The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status.
The immunoendocrinology of estrophilin.
The immunosuppression role of alpha-fetoprotein in human hepatocellular carcinoma.
The impact of filtered water-pipe smoke on healthy versus cancer cells and their neurodegenerative role on AMPA receptor.
The impact of interferon gamma receptor expression on the mechanism of escape from host immune surveillance in hepatocellular carcinoma.
The Impact of Tumor Differentiation on the Prognosis of HBV-Associated Solitary Hepatocellular Carcinoma Following Hepatectomy: A Propensity Score Matching Analysis.
The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology.
The loss of phenol sulfotransferase 1 in hepatocellular carcinogenesis.
The MAAPE score in intermediate and advanced hepatocellular carcinoma treated with Yttrium-90 resin microsphere radioembolization.
The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
The monitoring role of plasma CEA alone and in association with other tumor markers in colorectal and mammary carcinoma.
The mutation of hepatitis B virus and the prognosis of hepatocellular carcinoma after surgery: a pilot study.
The Number of Positive Tumor Marker Status Is Beneficial for the Selection of Therapeutic Modalities in Patients with Hepatocellular Carcinoma.
The Oncogenic Role of CENPA in Hepatocellular Carcinoma Development: Evidence from Bioinformatic Analysis.
The past and the future for cancer testing by alpha-fetoprotein. A review.
The pattern of gamma-glutamyl transpeptidase, alkaline phosphatase, serum glutamyl oxalate transaminase and serum glutamyl pyruvate transaminase in patients with disseminated non-seminomatous testicular tumors.
The potential value of immunohistologic techniques in the classification of ovarian and testicular tumors.
The power of kindness: curative treatment with metronomic combination in advanced hepatocellular carcinoma.
The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.
The Predictive Power of Serum ?-Fetoprotein and Des-?-Carboxy Prothrombin for Survival Varies by Tumor Size in Hepatocellular Carcinoma.
The present and the future for cancer testing by alpha-fetoprotein. A review.
The pretreatment neutrophil-lymphocyte ratio may predict prognosis of patients with liver cancer: A systematic review and meta-analysis.
The prognosis of hepatocellular carcinoma after curative hepatectomy in young patients.
The Prognostic Correlation of Heart Rate Variability at Diagnosis with Survival of Patients with Hepatocellular Carcinoma.
The Prognostic Role of Mitotic Index in Hepatocellular Carcinoma Patients after Curative Hepatectomy.
The prognostic significance of serum HBeAg on the recurrence and long-term survival after hepatectomy for hepatocellular carcinoma: A propensity score matching analysis.
The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.
The protective role of etoricoxib against diethylnitrosamine/2-acetylaminofluorene-induced hepatocarcinogenesis in Wistar rats: The impact of NF-?B/COX-2/PGE2 signaling.
The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation.
The receptor binding fragment of alpha-fetoprotein is a promising new vector for the selective delivery of antineoplastic agents.
The role of abdominal surgery in the treatment of advanced testicular germ cell tumours.
The role of contrast-enhanced sonography of focal liver lesions before percutaneous biopsy.
The role of hyperplastic nodules in dichloroacetic acid-induced hepatocarcinogenesis in B6C3F1 male mice.
The role of macroscopic classification in nodular-type hepatocellular carcinoma.
The Role of Preoperative Dynamic Contrast-enhanced 3.0-T MR Imaging in Predicting Early Recurrence in Patients With Early-Stage Hepatocellular Carcinomas After Curative Resection.
The role of sandostatin LAR in treating patients with advanced hepatocellular cancer.
The role of second-look surgery in the management of advanced germ cell malignancies.
The role of subfractionation of alpha-fetoprotein in the treatment of pediatric surgical patients.
The role of the MDR1 gene in the development of multidrug resistance in human hepatoblastoma: clinical course and in vivo model.
The role of the radioimmunoassay of serum alpha-fetoprotein and human chorionic gonadotropin in the intensive chemotherapy and surgery of metastatic testicular tumors.
The role of transplantation in small hepatocellular carcinoma complicating cirrhosis of the liver.
The role of tumor markers in gynecologic oncology.
The role of tumor size, ultrasonographic findings, and serum tumor markers in predicting the likelihood of malignant testicular histology.
The significance of alpha-fetoprotein and other tumour markers in differential immunocytochemistry of primary liver tumours.
The significance of alpha-fetoprotein in the serum of patients with malignant teratomas and related gonadal neoplasms.
The Singapore Liver Cancer Recurrence (SLICER) Score for relapse prediction in patients with surgically resected hepatocellular carcinoma.
The Spatial Distribution Characteristics of the Tumor Biomarker Alpha-fetoprotein: A Cross-section Study.
The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapy.
The Therapeutic Effect of Myrrh (Commiphora molmol) and Doxorubicin on Diethylnitrosamine Induced Hepatocarcinogenesis in Male Albino Rats.
The treatment of intermediate stage tumour beyond TACE: from surgery to systemic therapy.
The unrecognized extragonadal germ cell cancer syndrome.
The use of a monoclonal antibody against alpha-fetoprotein for the radioimmunodetection of hepatocellular carcinoma.
The use of a radioimmunoassay for alpha-fetoprotein in the diagnosis of malignancy.
The use of alpha-fetoprotein for the treatment of autoimmune diseases and cancer.
The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas.
The utility of alpha-fetoprotein screening in Beckwith-Wiedemann syndrome.
The utility of De Ritis Ratio in predicting prognosis in testicular cancer.
The value of cancer antigen-125 as a tumor marker in malignant germ cell tumors of the ovary.
The value of clinical and ultrasound features for the diagnosis of infantile hepatic hemangioma: Comparison with contrast-enhanced CT/MRI.
The value of serial measurement of both human chorionic gonadotropin and alpha-fetoprotein for monitoring germinal cell tumors.
The value of serial measurement of both human chorionic gonadotropin and alpha-fetoprotein for monitoring germinal cell tumors. 1976.
The value of serum alpha-fetoprotein in predicting tumor recurrence after liver transplantation for hepatocellular carcinoma.
The value of serum GPDA-F for the diagnosis of primary hepatocellular carcinoma.
The value of surveillance testing in childhood brain tumors.
The Value of TTPVI in Prediction of Microvascular Invasion in Hepatocellular Carcinoma.
Therapeutic Approaches to Gastric Hepatoid Adenocarcinoma: Current Perspectives.
Therapeutic effect of alpha-fetoprotein promoter-mediated tBid and chemotherapeutic agents on orthotopic liver tumor in mice.
Therapeutic effect of treatment with polyclonal or monoclonal antibodies to alpha-fetoprotein that have been conjugated to daunomycin via a dextran bridge: studies with an alpha-fetoprotein-producing rat hepatoma tumor model.
Therapeutic use of human alpha-fetoprotein in clinical patients : Is a cancer risk involved?
Thirty years of experience with pediatric primary malignant liver tumors.
Three cases of extrapulmonary small cell carcinoma occurring in the prostate, stomach, and pancreas.
Three different types of alpha-fetoprotein in the diagnosis of malignant solid tumors: use of a sensitive lectin-affinity immunoelectrophoresis.
Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma.
Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma.
Thyroid-like cholangiocarcinoma of the liver: an unusual morphologic variant with follicular, trabecular and insular patterns.
Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group.
Tissue AP-2gamma and Oct-3/4, and serum CA 125 as diagnostic and prognostic markers of malignant ovarian germ cell tumors.
Tissue-specific expression of herpes simplex virus thymidine kinase gene delivered by adeno-associated virus inhibits the growth of human hepatocellular carcinoma in athymic mice.
TOP2A Amplification and Overexpression in Hepatocellular Carcinoma Tissues.
Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation.
Total tumor volume predicts survival following liver resection in patients with hepatocellular carcinoma.
Toxicity and Survival of Hepatocellular Carcinoma Patients with Hepatitis B Infection Treated with Yttrium-90 Radioembolization: An Updated 15-Year Study.
Toxicogenomic analysis of aberrant gene expression in liver tumors and nontumorous livers of adult mice exposed in utero to inorganic arsenic.
TPA, TATI, CEA, AFP, beta-HCG, PSA, SCC, and CA 19-9 for monitoring transitional cell carcinoma of the bladder.
Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China.
Transarterial chemoembolization can prolong survival for patients with metastatic hepatocellular carcinoma: a propensity score matching analysis.
Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.
Transarterial chemoembolization extends long-term survival in patients with unresectable hepatocellular carcinoma.
Transarterial chemoembolization for early stage hepatocellular carcinoma decrease local tumor control and overall survival compared to radiofrequency ablation.
Transarterial Chemoembolization for the Treatment of Advanced-Stage Hepatocellular Carcinoma.
Transarterial chemoembolization in patients not eligible for liver transplantation: single-center results.
Transarterial chemoembolization in unresectable hepatocellular carcinoma--assessing the factors affecting the survival: An audit from a tertiary care center in northern India.
Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients.
Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma.
Transarterial chemoembolization with radiofrequency ablation versus hepatectomy in hepatocellular carcinoma beyond the Milan criteria: a retrospective study.
Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors.
Transcatheter arterial chemoembolization (TACE) in treatment of hepatocellular carcinoma.
Transcatheter arterial chemoembolization after stopping sorafenib therapy for advanced hepatocellular carcinoma.
Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child's grade A or B cirrhosis: a multivariate analysis of prognostic factors.
Transcatheter arterial chemoembolization in the treatment of hepatoblastoma.
Transcatheter arterial chemoembolization therapy for hepatocellular carcinoma using polylactic acid microspheres containing aclarubicin hydrochloride.
Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled study.
Transcription factor GATA-4 is expressed in pediatric yolk sac tumors.
Transcription factor interactions and chromatin modifications associated with p53-mediated, developmental repression of the alpha-fetoprotein gene.
Transferrin receptor 1 overexpression is associated with tumour de-differentiation and acts as a potential prognostic indicator of hepatocellular carcinoma.
Transformation of cultured fetal rat liver cells by MDAB and phenobarbital. Morphological, biochemical and immunocytochemical characterization of cell lines.
Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.
Transient therapy-related surge in serum tumor biomarkers: Characterizing behavior and postulating its biologic role.
Transplacental arsenic plus postnatal 12-O-teradecanoyl phorbol-13-acetate exposures associated with hepatocarcinogenesis induce similar aberrant gene expression patterns in male and female mouse liver.
Treatment of alpha-fetoprotein secreting hepatoblastoma by response of serum alpha-fetoprotein levels: a new concept.
Treatment of hepatocellular carcinoma by percutaneous laser hyperthermia.
Treatment of hepatocellular carcinoma by transarterial injection of anticancer agents in iodized oil suspension or of radioactive iodized oil solution.
Treatment of intracranial nongerminomatous malignant germ cell tumors producing alpha-fetoprotein.
Treatment of mediastinal immature teratoma in a child with precocious puberty and Klinefelter's syndrome.
Treatment of nongerminomatous germ-cell tumors of the pineal region.
Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients.
Treatment of small hepatocellular carcinomas.
Treatment of unresectable hepatocellular carcinoma with radiolabelled lipiodol.
Treatment outcomes with long acting octreotide in inoperable hepatocellular carcinoma: a local experience and review of literature.
Trends in Tumor Indices in Relation to Increased Hepatocellular Carcinoma Size: Evidence for Tumor Evolution as a Function of Growth.
Triple Positive Tumor Markers for Hepatocellular Carcinoma Are Useful Predictors of a Poor Survival.
Triple primary cancers involving kidney, urinary bladder, and liver in a dye worker.
Triple-phase MDCT of hepatocellular carcinoma.
Trophoblastic proteins as tumor markers in nonseminomatous germ cell tumors.
Tubular seminoma. An immunohistochemical and DNA flow-cytometric study of four cases.
Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib.
Tumor cell dissemination triggers an intrathecal immune response in neoplastic meningitis.
Tumor Characteristics and Long-Term Outcome of Incidental Hepatocellular Carcinoma After Orthotopic Liver Transplant.
Tumor DNA-dependent protein kinase catalytic subunit expression is associated with hepatitis B surface antigen status and tumor progression in patients with hepatocellular carcinoma.
Tumor doubling time predicts recurrence after surgery and describes the histological pattern of hepatocellular carcinoma on cirrhosis.
Tumor factors associated with clinical outcomes in patients with hepatitis B virus infection and hepatocellular carcinoma.
Tumor markers at the time of recurrence in patients with germ cell tumors.
Tumor markers CA 125 and CA 19-9 in cord blood and during infancy: developmental changes and use in pediatric germ cell tumors.
Tumor Markers for Hepatocellular Carcinoma: Simple and Significant Predictors of Outcome in Patients with HCC.
Tumor markers in biological fluids associated with pregnancy.
Tumor markers in chronic renal failure and hemodialysis patients.
Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma.
Tumor markers in hydrocele fluids of patients with benign and malignant scrotal diseases.
Tumor markers in patients with non-seminomatous germ cell tumors of the testis.
Tumor markers in testicular cancer.
Tumor markers in testis cancer.
Tumor markers in uremia: carcinoembryonic antigen, neuron-specific enolase, carbohydrate antigen CA-50 and alpha-fetoprotein.
Tumor multifocality and serum albumin levels can identify groups of patients with hepatocellular carcinoma and portal vein thrombosis having distinct survival outcomes.
Tumor of the liver (hepatocellular and high grade neuroendocrine carcinoma): a case report and review of the literature.
Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma.
Tumor Stiffness Measurements on MR Elastography for Single Nodular Hepatocellular Carcinomas Can Predict Tumor Recurrence After Hepatic Resection.
Tumor thrombus in the splenic vein originated from gastric carcinoma that produced alpha-fetoprotein.
Tumor vascularity and lens culinaris agglutinin reactive alpha-fetoprotein are predictors of long-term prognosis in patients with hepatocellular carcinoma after percutaneous ethanol injection therapy.
Tumor-associated antigen levels (carcinoembryonic antigen, human chorionic gonadotropin, and alpha-fetoprotein) antedating the diagnosis of cancer in the Framingham study.
Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma.
Tumorigenicity in nude mice of a human hepatoma cell line containing hepatitis B virus DNA.
Tumour marker prescriptions for cancer screening in the Hellenic primary care.
Tumour markers in gynaecologic oncology.
Tumour markers in testicular germ cell tumours. Five-year experience from the DATECA Study 1976-1980.
Tumour markers with clinically controlled cut-offs for suspected cancer.
Tumour-associated antigens and their anti-cancer applications.
Two cases of spontaneous regression of multicentric hepatocellular carcinoma after intraperitoneal rupture: possible role of immune mechanisms.
Two Synchronous Neonatal Tumors: An Extremely Rare Case.
Two-step selection criteria for living donor liver transplantation in patients with hepatocellular carcinoma.
Ubiquitin-specific protease 4 promotes hepatocellular carcinoma progression via cyclophilin A stabilization and deubiquitination.
Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progression.
Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma.
Ultrasound and magnetic resonance images of endodermal sinus tumor.
Ultrasound determination of liver size and assessment of patients with malignant liver disease.
Ultrasound-based radiomics score: a potential biomarker for the prediction of microvascular invasion in hepatocellular carcinoma.
Ultrastructure and immunohistochemical staining of a transplanted endodermal sinus tumor.
Ultrastructure and immunohistochemistry of a fetal-type Leydig cell tumor.
Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma.
Undifferentiated (embryonal) sarcoma of liver in adult: a case report.
Undifferentiated (embryonal) sarcoma of the liver. Epithelial features as shown by immunohistochemical analysis and electron microscopic examination.
Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-gamma-carboxy prothrombin and low serum alpha-fetoprotein.
Unique clinicopathological features of patients with primary malignant hepatic tumors who are seropositive for lectin-reactive alpha-fetoprotein alone: report of five cases.
Unique structure of glycopeptide from alpha-fetoprotein produced in human hepatoma cell line, as determined by 1H-nuclear magnetic resonance spectroscopy.
Unresectable hepatocellular carcinoma: survival and prognostic factors after lipiodol chemoembolisation in 89 patients.
Unresectable multifocal hepatoblastoma with cardiac extension: excellent response with HB-94 chemotherapy protocol.
Unsuspected primary malignancy in the setting of elevated serum alpha-fetoprotein.
Unusual anatomic location of a primary intracranial yolk sac tumor.
Up-regulation of BRCA1-associated RING Domain 1 Promotes Hepatocellular Carcinoma Progression by Targeting Akt Signaling.
Up-regulation of dbpA mRNA in hepatocellular carcinoma associated with metabolic syndrome.
Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma.
Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Uptake of radiolabeled alpha-fetoprotein by mouse mammary carcinomas and its usefulness in tumor scintigraphy.
Uptake of radiolabelled alpha-fetoprotein by experimental mammary adenocarcinoma and adenoma: in vivo and in vitro studies.
Urinary excretion of free and acetylated polyamines in hepatocellular carcinoma.
Use of a Novel Thyroid-Stimulating Hormone Model for Predicting the Progression of Hepatocellular Carcinoma.
Use of fructose 1,6-diphosphate aldolase to detect tumour necrosis after transcatheter arterial embolization of hepatocellular carcinoma.
Use of human chorionic gonadotropin and alpha-fetoprotein radioimmunoassays: specificity and apparent half-life determination after delivery and in patients with germ cell tumors.
Use of intra-arterial carbon-dioxide-enhanced ultrasonography for guidance of radiofrequency ablation and transcatheter arterial chemoembolization in hepatocellular carcinoma.
Use of intrahepatic chemotherapy to treat advanced pediatric hepatic malignancies.
Use of specific ELISA for the detection of antibodies directed against p53 protein in patients with hepatocellular carcinoma.
Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma.
Usefulness of Lens culinaris agglutinin A-reactive fraction of alpha-fetoprotein (AFP-L3) as a marker of distant metastasis from hepatocellular carcinoma.
Usefulness of plasma full-length glypican-3 as a predictive marker of hepatocellular carcinoma recurrence after radial surgery.
Usefulness of the novel oncofetal antigen glypican-3 for diagnosis of hepatocellular carcinoma and melanoma.
Usefulness of tumor pressure as a prognostic factor in cases of hepatocellular carcinoma where the diameter of the tumor is 3 cm or less.
Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma.
Uterine Carcinosarcoma with Alpha-Fetoprotein-Producing Hepatoid Component: A Case Report and Literature Review.
Uterine retiform sertoli-leydig cell tumor: report of a case providing additional evidence that uterine tumors resembling ovarian sex cord tumors have a histologic and immunohistochemical phenotype of genuine sex cord tumors.
Utility of Serum Inflammatory Markers for Predicting Microvascular Invasion and Survival for Patients with Hepatocellular Carcinoma.
Vaginal yolk sac (endodermal sinus) tumors in infancy presenting persistent vaginal bleeding.
Validated model for prediction of recurrent hepatocellular carcinoma after liver transplantation in Asian population.
Validated nomogram for the prediction of disease-free survival after hepatectomy for hepatocellular carcinoma within the Milan criteria: individualizing a surveillance strategy.
Validating a custom multiplex ELISA against individual commercial immunoassays using clinical samples.
Validation of a new prognostic staging system for hepatocellular carcinoma: a comparison of the biomarker-combined Japan Integrated Staging Score, the conventional Japan Integrated Staging Score and the BALAD Score.
Validation of an alpha-fetoprotein model to predict recurrence after liver resection for hepatocellular carcinoma.
Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinoma.
Validation of ZMYND8 as a new treatment target in hepatocellular carcinoma.
Validity of MR imaging for monitoring effects of percutaneous ethanol injection for HCC.
Value correlation of alpha-fetoprotein and human chorionic gonadotropin with the results of lymphadenectomy in non-seminomatous testicular tumours.
Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
Value of tumor markers in nonseminomatous germ cell tumor of the testis.
Value of tumor markers in the treatment of endodermal sinus tumors and choriocarcinomas in the pineal region.
Variable antigen expression in hepatoblastomas.
Variations in normal serum alpha-fetoprotein (AFP) levels in patients with testicular cancer on surveillance.
Variations of serum carcinoembryonic antigen, alpha-fetoprotein and immunoglobulin levels in patients with breast cancer.
Vascular endothelial growth factor receptor-1 levels in hepatocellular carcinoma and correlations with clinicopathological features.
Vascular invasion as a prognosticator of metastatic disease in nonseminomatous germ cell tumors of the testis. Importance in "surveillance only" protocols.
Very high alpha-fetoprotein in a young man due to concomitant presentation of hepatocellular carcinoma and Sertoli cell testis tumor.
Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen: can it be predicted using clinical parameters?
Vimentin-positive and Alpha-fetoprotein-elevated Nuclear Protein of the Testis Midline Carcinoma: A Case Report and Review of the Literature.
Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma.
VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.
What is the best surveillance for hepatocellular carcinoma in chronic carriers of hepatitis B?
When is a seminoma not a seminoma? The incidence, risk factors and management of patients with testicular seminoma with discordant elevated serum alpha-fetoprotein.
Which system is better to predict prognosis of patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization as initial therapy? Comparison between CLIP and JIS in a Japanese population.
Within- and between-subject biological variation data for tumor markers based on the European Biological Variation Study.
XIST and TSIX: Novel Cancer Immune Biomarkers in PD-L1-Overexpressing Breast Cancer Patients.
Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma.
Yolk sac carcinoma of the stomach with gastrin positivity.
Yolk sac tumor (endodermal sinus tumor) and alpha-fetoprotein. A report of three cases.
Yolk sac tumor and alpha-fetoprotein: clinicopathological study of four cases.
Yolk Sac Tumor in an Eight-Year-Old Girl: A Case Report and Literature Review.
Yolk sac tumor of the anterior mediastinum. Case report with light- and electron-microscopic examination and immunohistochemical study of alpha-fetoprotein.
Yolk sac tumor of the anterior mediastinum: the role of palliative surgery.
Yolk sac tumor of the liver combined with hepatocellular carcinoma.
Yolk Sac Tumor of the Ovary: A Report of 150 Cases and Review of the Literature.
Yolk sac tumor of the stomach with an adenocarcinomatous component: a case report with immunohistochemical analysis.
Yolk sac tumor of the testicle: is retroperitoneal lymph node dissection necessary?
Yolk sac tumors and alpha-fetoprotein in first year of life.
Yolk sac tumors of the mediastinum with prominent spindle cell features: a clinicopathologic study of three cases.
Yolk sac tumors of the ovary and the human yolk sac.
Yttrium-90 microspheres for the treatment of hepatocellular carcinoma.
Yttrium-90-Labeled Anti-Glypican 3 Radioimmunotherapy Halts Tumor Growth in an Orthotopic Xenograft Model of Hepatocellular Carcinoma.
Zinostatin stimalamer-transcatheter arterial embolization for hepatocellular carcinoma: a comparison with lipiodol-transcatheter arterial embolization.
Zygomatic bone metastasis from hepatocellular carcinoma and the therapeutic efficacy of apatinib: A case report and literature review.
[131I-labelled tumor-specific antibodies: a trials to concentrate radioisotoopes specifically in the tumor. II. The binding of 131I-labelled anti-human alpha-fetoprotein antibody to the cultured human hepatoma cells]
[A case of advanced gastric cancer showing pylorus stenosis with multiple liver metastases, that respond remarkably to neoadjuvant chemotherapy of combined TXL and low-dose FP]
[A case of alpha-fetoprotein producing embryonal carcinoma of the stomach]
[A case of alpha-fetoprotein producing mediastinal germ cell tumor treated with preoperative chemotherapy]
[A case of alpha-fetoprotein strongly positive cholecystic cancer associated with porcelain gallbladder (author's transl)]
[A case of an alpha-fetoprotein producing tumor of the chest wall]
[A case of arteriovenous hemangioma of the undescended testis]
[A case of bilateral germ cell tumor of the testis]
[A case of hepatocarcinoma preceded by several years by "isolated" increase in alphafetoprotein]
[A case of hepatocellular carcinoma responding to oral administration of 5'-DFUR]
[A case of immature mediastinal teratoma]
[A case of osteopetrosis with an abnormal CK-MB/T-CK ratio]
[A case of ovarian Sertoli-Leydig cell tumor associated with high serum alpha-fetoprotein (AFP) concentration]
[A case of pedunculated hepatoma suspected of adrenal tumor]
[A case of pineal region germinoma treated by interstitial brachytherapy]
[A case of primary mediastinal germ cell tumor with production of alpha-fetoprotein, successfully treated with chemotherapy (cis-platinum, vinblastine, peplomycin), and curative resection]
[A case of primary retroperitoneal tumor with combined histologic features of embryonal carcinoma and yolk sac tumor]
[A case of spontaneous regression of hepatocellular carcinoma with multiple lung metastases.]
[A case report for primary yolk sac tumor of endometrium].
[A case report of advanced hepatocellular carcinoma successfully treated with surgical multi-ablation therapy based on radio-frequency thermal ablation]
[A case report of distal gastrectomy with thrombectomy after NAC for Gastric cancer].
[A child with successfully treated posterior mediastinal endodermal sinus tumor]
[A complete response to one-shot hepatic arterial infusion of epirubicin in a patient with highly advanced hepatocellular carcinoma]
[A mini-review of targeting gene-virotherapy of cancer]
[A new method of preparation of doxorubicin-in-oil suspension using ultrasonificator attached with Cuphorn]
[A non-seminomatous extra-gonadal germ cell tumor responding to intensive treatment: a case report]
[A patient with advanced gastric cancer in the gastric tube whose QOL was improved by TS-1]
[A retroperitoneal embryonal carcinoma with a high HCG level]
[A suspected case of extra-gonadal germ cell tumor complicated with choriocarcinoma syndrome].
[Abdominal metastasis of a pineal region tumor through ventriculoperitoneal shunt. Case report]
[Accumulation of doxorubicin conjugates with dendritic polymer and vector protein in normal and tumor cells in vitro].
[Alpha-fetoprotein (AFP) in malignant ovarian tumours (author's transl)]
[alpha-Fetoprotein (biology)]
[Alpha-fetoprotein and human chorionic gonadotropin as tumor markers in intracranial and intraspinal germ cell tumors]
[Alpha-fetoprotein as a marker in cases of infantile germ cell tumors]
[Alpha-fetoprotein as a tumor marker]
[Alpha-fetoprotein immunotherapy as a stage of combined treatment of cancer patients]
[Alpha-fetoprotein in non-hepatocellular malignant tumors]
[Alpha-fetoprotein in the diagnosis of malignant neoplasms]
[Alpha-fetoprotein in the diagnosis of tumors in children]
[Alpha-fetoprotein, an indicator of malignancy in hepatic tissue (author's transl)]
[An Abnormal Alpha-Fetoprotein Fractionation Provides Additional Information: A Case of Retroperitoneal Germ Cell Tumor Accompanied by Liver Cirrhosis Type C].
[An autopsy case of double cancer (Hepatocellular carcinoma and mixed germ cell tumor of the testis)--significance of alpha-fetoprotein and human chorionic gonadotropin as tumor markers]
[An experimental study on alpha-fetoprotein producing yolk sac tumor (author's transl)]
[An unusual renal tumor, associating nephroblastoma, nephroblastomatosis, teratoma, and cystic dysplasia with arterial hypertension and secretion of alpha-fetoprotein]
[Analysis of risk factors of recurrence in patients with BCLC 0-A hepatocellular carcinoma after surgical resection].
[Analysis of the risk factors influencing the prognosis of orthotopic liver transplantation for hepatocellular carcinoma and summary of relevant clinical experience]
[Anti-tumor activity of an anti-human alpha-fetoprotein antibody-human serum albumin-mitomycin C conjugate against human yolk sac tumor maintained in vitro and in nude mice in vivo]
[Antitumor effects of human interferon on human tumors heterotransplanted into nude mice]
[Assay of chorionic gonadotrophin, follicle-stimulating hormone and alpha-fetoprotein in the efferent blood in germinal tumors of the testis]
[Atypical testicular masses: a case presentation.]
[Behavior of plasma alpha-fetoprotein in secondary neoplasms of the liver]
[Biological markers and germinal tumors of the testis. Value and limitations of the assay of chorionic gonadotrophin hormone and alpha-fetoprotein]
[Biological markers of cancer. Critical study]
[Biphasic pulmonary blastoma with germ cell differentiation: a challenge in diagnosis and treatment].
[Blood tumor markers in patients with lung cancer]
[Carcino-fetal antigens]
[Carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in malignant female genital neoplasms]
[Carcinoembryonic antigen and alpha-fetoprotein in patients with intraocular neoplasms (author's transl)]
[Carcinoid tumor of the liver]
[Case of germ cell tumor of the pineal region with elevation of serum and csf alpha-fetoprotein levels following histological change]
[Case of ovarian tumor with positive reaction for alpha-fetoprotein]
[Case of yolk sac tumor decreasing in size and the normalizing of alph-fetoprotein level by anticancer chemotherapy]
[Case of yolk sac tumor of the anterior mediastinum with superior vena cava syndrome]
[Cellular localization of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG), and carcinoembryonic antigen (CEA) in malignant germ cell tumors of the ovary using immunoperoxidase technique (author's transl)]
[Changes in the rhythms of the alpha-fetoprotein content of the blood serum of mice with hepatoma 22A and of tumor cell proliferation depending on the time of cyclophosphane administration]
[Chemical modification of anti-cancer drugs to increase their affinity to tumor antigens]
[Chemoembolization combined with hepatic arterial induction of endogenous TNF and anticancer agents for hepatocellular carcinoma--a case report]
[Chemoembolization in hepatocellular carcinoma: multivariate analysis of survival prognostic factors after the first session]
[Clinical and ultrasonographic features of testis tumor in children of different ages].
[Clinical evaluation of alpha-fetoprotein as tumor marker for hepatocellular carcinoma (author's transl)]
[Clinical features of solid malignant tumors in childhood].
[Clinical significance of alpha-fetoprotein assay as a tumor marker]
[Clinical significance of cysteinyl leukotriene receptor expression in primary hepatocellular carcinoma].
[Clinical studies of testicular tumor. I. Analysis of 27 patients with seminoma: the clinical significance of hCG-beta determination and of retroperitoneal lymph node dissection for stage I patients]
[Clinical study on serum 5'-nucleotide phosphodiesterase isoenzyme-V as a predictor of liver metastases in patients with gastric and colorectal cancers]
[Clinical usefulness of lectin-reactive fraction of alpha-fetoprotein in hepatocellular carcinoma]
[Clinical usefulness of tumor markers in the diagnosis of pleural effusions. Carcinoembryonic antigen, alpha-fetoprotein and orosomucoid]
[Combination chemotherapy and chemoembolization in the treatment of primary inoperable hepatoblastoma]
[Combined treatment with resection, intraoperative hypotonic and post-operative systemic chemotherapy using cis-platinum for a mediastinal yolk sac tumor: a case report]
[Complete remission with FLEP chemotherapy for multiple liver metastasis from alpha-fetoprotein-producing gastric cancer--report of a case]
[Conventional serum tumor markers in liver cancer. Retrospective analysis of 118 patients].
[Correlation analysis of Ki67, Ck19 with clinicopathological features and apparent diffusion coefficient value of hepatocellular carcinoma].
[Correlation between serum alpha-fetoprotein variant levels in patients with hepatocellular carcinoma and the presence of alpha-fetoprotein mRNA in the circulating blood]
[Correlation between the expression profile of cytokeratin 19/glypican 3 and recurrence of hepatocellular carcinoma after interventional therapy].
[Correlation of carcinoembryonic antigen (CEA) and serum and tissue alpha-fetoprotein (AFP) in malignant tumors of the female genital tract]
[CT diagnosis and pathological findings of testicular lesion]
[Current approaches to surgical treatment of liver tumors]
[Current considerations on the behavior of serum alpha-fetoprotein as a tumor marker]
[Detection of alpha-fetoprotein in the blood serum postoperatively in cancer patients]
[Detection of serum p53 antibodies in colorectal cancer patients and the clinical significance of postoperative monitoring]
[Determination of the lymphocytic and oncofetal antigen subpopulations in patients with adenocarcinomas of the stomach and of the colon and rectum (author's transl)]
[Diagnosis and therapy of malignant testicular neoplasms]
[Diagnostic possibilities of combining liver scintigraphy with the alpha-fetoprotein test in cancer patients]
[Diagnostic significance of the study of alpha-fetoprotein in liver cirrhosis and primary cancer of the liver]
[Diagnostic value of serum alpha-fetoprotein determinations in malignant tumors of the testes]
[Diagnostic value of serum alpha-fetoprotein, alpha-fetoprotein variant and abnormal prothrombin in primary hepatocellular carcinoma].
[Diagnostic value of the analysis of alpha fetoprotein levels in malignant neoplasms of the digestive system]
[Differentiation antigens in tumors: dependence on carcinogenesis mechanisms and progression (a hypothesis)]
[Distribution of human alpha-fetoprotein in animal tumor cells]
[Early changes in serum alpha-fetoprotein after chemotherapy in advanced testicular tumors]
[Early diagnosis and rational therapy of primary carcinoma of the liver. Principles of secondary prevention]
[Effect of a conjugate of adriamycin and an antibody to human alpha-fetoprotein (AFP) on AFP-producing hepatic tumors]
[Effect of anti-human alpha-fetoprotein serum on human endodermal sinus tumor transplanted in nude mice (author's transl)]
[Effect of cyclophosphamide on alpha-fetoprotein content in the blood serum of mice with hepatoma 22a depending upon the period of tumor development]
[Effect of preparations of placental albumin on serum alpha-fetoprotein levels]
[Effectiveness of radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma]
[Effects of alpha-fetoprotein on the expression of TRAIL death receptor-2 and its role on resisting the cytotoxicity of TRAIL in hepatoma cells].
[Embryonal carcinoma and vitelline tumor of the mediastinum. Diagnostic and prognostic value of alpha-fetoprotein levels. A propos of 5 cases]
[Epidemiology of hepatocellular carcinoma in the department of Calvados]
[Evaluation of alpha-fetoprotein concentration in patients with chronic liver diseases].
[Evaluation of detecting 9 tumor markers in serum for diagnosis of primary liver cancer]
[Evaluation of diagnostic performance of alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP) for HCV related hepatocellular carcinoma developed after long-term follow up].
[Evaluation of hepatic resection for hepatocellular carcinoma on cirrhotic livers]
[Experimental chemotherapy of human testicular carcinoma transplanted in nude mice]
[Experimental studies on the tumor imaging using antibodies to human alpha-fetoprotein. 1. Fluctuations in the iodine-labeled antibody activities]
[Experimental study on immune serum therapy of cancer]
[Experimental teratoma derived from mouse yolk sac (author's transl)]
[Expression and clinical significance of hepatocellular cancer antigen genes in human hepatocellular carcinoma]
[Expression and significance of c-jun-activation-domain binding protein (JAB1) in hepatocellular carcinoma]
[Expression and significance of EGF mRNA and EGFR mRNA in hepatocellular carcinoma]
[Expression and significance of epidermal growth factor receptor variant type III in hepatocellular carcinoma]
[Expression of MAGE-B genes in hepatocellular carcinoma]
[Expression of the Fra-1 gene in the peripheral blood of children with Wilms tumor].
[Extra-gonadal germ-cell tumors]
[Extraneural metastasis of pineal germinoma through a ventriculoperitoneal shunt, following histological change]
[False-positive elevation of alpha-fetoprotein during induction chemotherapy in patients with testicular cancer]
[Features of the histogenesis of testicular yolk sac tumors in children]
[Fibrolamellar carcinoma of the liver]
[Five-year survival analysis of a cohort of hepatocellular carcinoma patients who treated at the National Cancer Center, Korea]
[Gene therapy of primary cancers of the liver: hopes and realities]
[General concepts of alpha-fetoprotein (AFP)-secreting tumors, with special reference to the histogenesis]
[Germ cell tumor in the basal ganglia with elevated serum and CSF alpha-fetoprotein levels]
[Hepatocellular carcinoma in a non-cirrhotic liver. Presentation of series of 77 operated patients]
[Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic]
[Hepatocellular carcinoma--from macroscopy to molecular pathology]
[Hepatocellular carcinoma: rising incidence of hepatitis C virus-associated cases at a university clinic in Germany]
[Hepatocellular carcinoma]
[Hepatoid adenocarcinoma of the lung: a case report]
[Hepatoid adenocarcinoma of the stomach. A case report]
[High-dose chemotherapy with peripheral blood stem cell autotransplantation for patients with poor-risk testicular germ cell tumors--pilot study of the Japan Blood Cell Transplantation Study Group]
[High-efficient renaturation of immobilized recombinant C-terminal fragment of human alpha-fetoprotein].
[High-grade fetal adenocarcinoma of the lung; report of a case].
[Highly metastatic model of human hepatocellular carcinoma established in nude mice using orthotopic organ selection of metastatic variant from patient specimens]
[History of tumor markers for cancers of the digestive system].
[Human B-HCG and AFP as biological markers in germinal testicular tumors]
[Increase of alpha-fetoprotein in pancreatic endocrine tumors with hepatic metastases. Apropos of 2 cases]
[Is a timely diagnosis possible in pancreatic cancer?]
[Isolated tumor cells in primary malignant liver tumors]
[Laboratory diagnosis of tumors of the pancreato-biliary area in patients with mechanical jaundice]
[Lectin binding in immunohistologically AFP/HCG positive and negative testicular carcinoma]
[Levels of serum alpha-fetoprotein before and after transcatheter embolization of hepatocellular tumors with Lipiodol]
[Limitations of tumor marker surveillance after chemotherapy in advanced non-seminomatous testicular tumors]
[Liver transplantation for hepatocellular carcinoma: prognostic analysis of 89 cases]
[Loss of p53 gene and amplification of HER-2 oncogene in primary hepatocellular carcinoma and their clinical significance]
[Mature teratoma of the mediastinum: apropos of 2 cases]
[Mediastinal teratomas in children]
[Metastatic pancreatic endocrine tumor with elevation of alpha-fetoprotein]
[Microanalysis in oncological diagnosis]
[Molecular heterogeneity of alpha-fetoprotein in ovarian or extragonadal yolk sac tumor]
[Molecular staging of testicular cancer using polymerase chain reaction of the testicular cancer-specific genes]
[Mouse hepatoblastoma: comparative aspects]
[New protein vectors based on an alpha-fetoprotein fragment for targeted DNA delivery into cancer cells]
[On the alpha-fetoprotein in the diagnosis of primary liver carcinoma (author's transl)]
[Ovarian cysts assumed benign in the peripubertal period (10 to 16 years)]
[Ovarian serous adenocarcinoma with functioning stroma and production of estrogen and alpha-fetoprotein]
[Pancreatic endocrine tumor with metastases and increase of alpha-fetoprotein. A case report]
[Plasma levels of alpha-fetoprotein and carcinoembryonic antigen in patients with malignant gastrointestinal tumors]
[Practical value of alpha-fetoprotein in the diagnosis and postoperative surveillance of embryonal tumors of the testicle]
[Predictive Value of Platelet to Lymphocyte Ratio and Prognostic Nutritional Index on Prognosis of Hepatocellular Carcinoma after Liver Resection].
[Preparation of conjugates of adriamycin with antibodies to alpha-fetoprotein and their properties]
[Primary endodermal sinus tumor of the fourth ventricle (author's transl)]
[Primary extragonadal germ cell tumors. Clinical manifestations, differential diagnosis and therapy]
[Primary intracranial germ cell tumor with abnormal high value of alpha-fetoprotein after the radiation therapy]
[Primary intracranial malignant germ cell tumor associated with abnormal high value of alpha-fetoprotein and human chorionic gonadotropin]
[Primary mediastinal germ cell tumor with marked elevation of HCG and alpha-fetoprotein]
[Proceedings: Yolk sac tumor and alpha-fetoprotein]
[Prognostic factors influencing postoperative survival in patients with
[Prognostic factors of hepatocellular carcinoma after liver transplantation]
[Prognostic significance of albumin/globulin ratio on postoperative survival of patients with hepatocellular carcinoma].
[Prophylaxis and treatment of chronic viral hepatitis as the prevention of hepatocellular carcinoma]
[Prostatic cancer: immunochemical control over chemotherapy]
[Pure yolk sac tumor of the testis with brain metastasis: report of an adult case]
[Quantitation of alpha-fetoprotein messenger RNA in peripheral blood of nude mice and its relationship with tumor recurrence and metastasis after curative resection of hepatocellular carcinoma]
[Radiofrequency ablation: a new approach in the treatment of hepatocellular carcinoma]
[Radioimmunoassay of alpha-fetoprotein in primary and secondary cancer of the liver.]
[Radioimmunoassays in oncology]
[Radioimmunoimaging of hepatic tumors with 131I labeled polyclonal antibody against alpha-fetoprotein (AFP)]
[Radioimmunologic serum determinations of alpha-fetoprotein in patients with tumors of the testis (author's transl)]
[Radioimmunological determination of the carcinoembryonic antigen, alpha-fetoprotein and other tumor antigens in oncological patients before and after radiation therapy]
[Radioimmunological monitoring of the treatment of malignant neoplasms in childhood]
[Regulation of tumor marker gene expression]
[Relations between the morphological characteristics and alpha-fetoprotein in primary cancer of the liver (apropos of 92 cases]
[Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma]
[Relationship between structure and function of alpha-fetoprotein: conformational status and biological activity]
[Relationship between testicular microcalcifications and clinical characteristics in patients with testicular cancer].
[Research progress in prognostic factors of hepatitis B virus-associated end-stage liver disease].
[Research progress of alpha-fetoprotein vaccine in hepatocellular carcinoma].
[Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update]
[Retroperitoneal surgery in the treatment of germ-cell tumors of the testis: retroperitoneal lymph node dissection (RPLND).]
[Risk factors for early recurrence after surgical resection for hepatocellular carcinoma]
[Risk factors of morbidity and mortality following surgical resection for hepatocellular carcinoma]
[Serodiagnosis: tumor marker]
[Serum alpha-fetoprotein in patients with hepatic malignancies. I. Subfractions identified by Con A crossed-line affinity immunoelectrophoresis]
[Serum alpha-fetoprotein positive gastric tumor]
[Significance of AFP in gastric cancer]
[Significance of current bio- and molecular-markers in urological cancers]
[Significance of measurement of serum levels of tumor markers with germinal cell testicular tumor--value of beta-subunit human chorionic gonadotropin and alpha-fetoprotein (author's transl)]
[Significance of tumor markers in the treatment of urological malignancies]
[Small hepatocellular carcinoma. New concepts on intrahepatic recurrence after hepatectomy in orthotopic liver transplantation]
[Solid tumours of human primary hepatocellular carcinoma cell-lines in hypothymic mice: a model for biochemical and therapeutic studies (author's transl)]
[Sonographic characterization, Doppler ultrasonography and tumor markers in the diagnosis of malignancy of ovarian masses]
[Sonographic diagnosis in primary cancer of the liver]
[Spontaneous regression of hepatocellular carcinoma in a cirrhotic patient]
[Structure and expression of alpha-fetoprotein gene--current progress in research]
[Studies on the tumor markers in the germinal testicular tumors. Cellular localization of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG) and carcinoembryonic antigen (CEA) in germinal testicular tumors using an indirect immunoperoxidase method]
[Studies on tissue-localization of various tumormarkers in ovarian tumors by immunoperoxidase method]
[Study on the clinical significance and correlation of arginase-1 and inducible nitric oxide synthase expression in hepatocellular carcinoma].
[Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma]
[Study on the value of serum des-?-carboxy prothrombin in predicting hepatocellular carcinoma recurrence after liver transplantation].
[Surgery of mediastinal tumors.]
[Surgical therapy of hepatocellular carcinoma]
[Surveillance after curative resection of hepatocellular carcinoma]
[Synthesis of alpha-fetoprotein, albumin and transferrin by long-term cultured cells of murine hepatoma]
[Testicular and paratesticular tumors in prepubertal children].
[Testicular tumors: association between preoperative clinical, radiological and immuno-serological factors, and histology and stage]
[Testicular yolk sac tumor in children. Current view on diagnosis and treatment]
[The analysis of prognostic factors of primary hepatocellular carcinoma with Cox model]
[The clinical applications of serum tumor markers in gastroenterology]
[The diagnostic approach to hepatocellular carcinoma.]
[The distribution of iodine-125 labeled alpha-fetoprotein in the animal organism and its accumulation in the tumor].
[The efficacy and prognosis of transcatheter chemoembolization for hepatocellular carcinoma in the elderly]
[The evaluation of ratio of oncomarkers in search of initial focus of tumor: on the occasion of fiftieth anniversary of discovery of alpha-fetoprotein as an oncomarker].
[The importance of alpha-fetoprotein in the diagnosis of liver tumors]
[The incidence and clinical significance of paraneoplastic syndromes in patients with hepatocellular carcinoma]
[The level of embryonic antigens in the blood serum and cerebrospinal fluid of neuro-oncological patients]
[The place of tumor markers in breast and gynecologic neoplasms]
[The role of tumour markers in diagnosis and management of testicular germ cell tumours.]
[The significance of immunohistochemistry in the investigation of liver neoplasms: differential diagnosis, prognostic markers]
[The study of RNA markers in blood of patients with malignant tumors of gastrointestinal tract].
[The Value of Diffusion Kurtosis Imaging in Predicting Post-surgery Early Recurrence of Hepatocellular Carcinoma].
[Thyroxine-binding globulin--not a tumor marker of hepatocellular cancer]
[Transcatether chemoembolization in the treatment of hepatocellular carcinoma]
[Treatment of patients with stage I-II non-seminoma germ-cell tumors of the testis]
[Tumor marker diagnosis in non-seminomatous testicular tumors using human chorionic gonadotropin (HCG) and alpha fetoprotein (AFP)]
[Tumor markers for hepatocellular carcinoma]
[Tumor markers for hepatocellular carcinoma].
[Tumor markers in gynecologic malignancies]
[Tumor markers in internal medicine hepatology]
[Tumor markers of hepatocellular carcinoma]
[Tumor markers: neoplasmas in digestive organs]
[Two patients with liver cirrhosis who presented with alpha-fetoprotein values diagnostic of hepatocarcinoma but without evidence of neoplasms]
[Ultrasonographic and clinical features of common testicular germ cell tumors in children].
[Use of a lipid lymphographic agent, lipiodol, as a carrier of high molecular weight antitumor agent, smancs, for hepatocellular carcinoma]
[Usefulness of carcinoembryonic antigen and other markers in patients with hemoptysis]
[Usefulness of tumor markers in the treatment of germ cell tumors]
[Utility of measurement of tumor markers for preoperative staging of gastric cancer]
[Value of (18)F-FDG PET/CT and CECT in detecting postoperative recurrence and extrahepatic metastasis of hepatocellular carcinoma in patients with elevated serum alpha-fetoprotein].
[Value of determinations of serum levels of carcino-embryonic antigen (CEA) and alpha-fetoprotein (AFP) for early detection of malignant tumours (author's transl)]
[Yolk sac tumor by fetectomy in the rat: histopathological characteristics and histogenesis (author's transl)]
¹?F-fluorodeoxyglucose PET/CT findings of a solitary primary hepatic lymphoma: a case report.
Neoplasms, Germ Cell and Embryonal
A case of endodermal sinus tumor associated with the first pregnancy and successful management of the second pregnancy: a case report and review of the literature.
A case of primary ovarian pregnancy.
A human testicular germ cell tumor with borderline histology between seminoma and embryonal carcinoma secreted beta-human chorionic gonadotropin and alpha-fetoprotein only as a xenograft.
A personalized approach to cancer treatment: how biomarkers can help.
A study on the microheterogeneity of alpha-fetoproteins produced by yolk sac and germ cell tumors.
Acute changes of alpha-fetoprotein and human chorionic gonadotropin during induction chemotherapy of germ cell tumors.
Alpha-fetoprotein (AFP) and human chorionic gonadotropin (HCG) in testicular germ cell tumours. A comparison of histologic and serologic occurrence of tumour markers.
Alpha-fetoprotein (AFP) and human chorionic gonadotropin (HCG) in testicular germ cell tumours. A prospective immunohistochemical study.
Alpha-fetoprotein (AFP) in germ cell tumors of the testis.
Alpha-fetoprotein and germ cell tumors: a possible role of yolk sac tumor in production of alpha-fetoprotein.
Alpha-fetoprotein and human chorionic gonadotropin in a patient with a primary intracranial germ cell tumor.
Alpha-fetoprotein and mediastinal germ cell tumors.
Alpha-fetoprotein and the acute phase response. A study using acute pelvic inflammatory disease as a model system.
Alpha-fetoprotein in germ cell tumors. An immunohistochemical study.
Alpha-fetoprotein in malignant germ cell tumors of the ovary.
Alpha-fetoprotein in plasma and serum of healthy adults: preanalytical, analytical and biological sources of variation and construction of age-dependent reference intervals.
Alpha-fetoprotein in the management of germ cell tumors of the ovary.
Alpha-fetoprotein production by a malignant mixed Müllerian tumor of the ovary.
Alpha-fetoprotein secretion in a craniopharyngioma. Are craniopharyngiomas part of the germ cell tumor family?
Alpha-fetoprotein subfractions in germ cell tumors identified by Con A or LCH crossed-line affinity immunoelectrophoresis.
Alpha-fetoprotein surge following high-dose chemotherapy in germ cell tumours.
Alpha-fetoprotein, alpha-1-antitrypsin, and transferrin in gonadal yolk-sac tumours.
Alpha-fetoprotein-concanavalin A binding as a marker to discriminate between germ cell tumours and liver diseases.
Alpha-fetoprotein-lectin binding as a marker of tumour activity or liver damage.
Alpha-fetoprotein-producing carcinoma of the renal pelvis exhibiting hepatoid and urothelial differentiation.
Alpha-fetoprotein-producing non-germ cell tumours of the female genital tract.
Alpha-fetoprotein-producing ovarian clear cell adenocarcinoma with fetal gut differentiation: a rare case report and literature review.
An Unusual Case of Primary Retroperitoneal Germ Cell Tumour in a Young Man.
Antigenic markers in extragonadal germ cell tumors.
Biomarkers of Pineal Region Tumors: A Review.
Cardiac metastasis from yolk sac tumor: case report and review.
Cellular localization of alpha-fetoprotein and human chorionic gonadotropin in germ cell tumors of the testis using and indirect immunoperoxidase technique.
Central diabetes insipidus developing in a 6-year-old patient 4 years after the remission of unifocal bone Langerhans cell histiocytosis.
Central nervous system germ cell tumors: controversies in diagnosis and treatment.
Cerebrospinal fluid alpha-fetoprotein in germ cell neoplasms.
Changes in serum alpha-fetoprotein and chorionic gonadotropin in response to cancer therapy.
Chemotherapy of extragonadal germ cell tumors.
Clinical applications of the enzyme labeled antibody method. Immunoperoxidase methods in diagnostic histopathology.
Clinical study of intracranial nongerminomatous germ cell tumors producing alpha-fetoprotein.
Clinical use of tumor markers in childhood malignancies.
Clinical utility of circulating miR-371a-3p for the management of patients with intracranial malignant germ cell tumors.
Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor.
Concanavalin A affinity of alpha-fetoprotein. Its use in differentiating tumors.
Detection of AFP and HCG in metastatic testicular cancer after treatment with chemotherapy or radiation therapy.
Detection of alpha-fetoprotein mRNA in seminoma.
Development of testicular alpha-fetoprotein-secreting germ cell tumor 3 years after treatment of intracranial lesion identified as non-secreting germ cell tumor on the basis of clinical data--case report.
Diagnostic difficulties before definitive treatment of an extragonadal retroperitoneal germ cell tumor.
Diagnostic utility and correlation of tumor markers in the serum and cerebrospinal fluid of children with intracranial germ cell tumors.
Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system: a study of 77 cases.
Diagnostic value of lectin reactive alpha-fetoprotein for neoinfantile hepatic tumors and malignant germ cell tumors: preliminary study.
Distribution of tumor-associated antigens in the various histologic components of germ cell tumors of the testis.
Doctor's dilemma: incorporating tumor markers into clinical decision-making.
Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors?
Drug-resistance patterns assessed from tumor marker analysis.
Dysgerminoma with a slightly elevated alpha-fetoprotein level diagnosed as a mixed germ cell tumor after recurrence.
Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors.
Elevated alpha-fetoprotein secondary to Hodgkin's lymphoma.
Elevated lactate dehydrogenase isoenzyme 1 as a tumour marker in patients with germ cell testicular tumours.
Elevated serum levels of IGF-binding protein 2 in patients with non-seminomatous germ cell cancer: correlation with tumor markers alpha-fetoprotein and human chorionic gonadotropin.
Epidemiologic study of 230 cases of testicular/paratesticular tumors or masses: 15-year experience of a single center.
Evaluation of AFP glycosylation heterogeneity in cancer patients with AFP-producing tumors.
Exogenous estrogen therapy, testicular cancer, and the male to female transgender population: a case report.
Experience with serum alpha-fetoprotein and human chorionic gonadotropin in non-seminomatous testicular tumors.
Extremely elevated alpha-fetoprotein due to acute exacerbation of chronic hepatitis B without malignancy: a case report.
False elevations of alpha-fetoprotein associated with liver dysfunction in germ cell tumors.
Frequency of intratubular germ cell neoplasia with invasive testicular germ cell tumors. Histologic and immunocytochemical features.
Gastric cancer with adenocarcinoma and yolk sac tumor components: A rare entity.
Germ cell tumor in an adolescent with extensive testicular microlithiasis: concerns regarding future management.
Germ cell tumor in the basal ganglia: immunohistochemical demonstration of alpha-fetoprotein, human chorionic gonadotropin, and carcinoembryonic antigen.
Germ cell tumors express a specific alpha-fetoprotein variant detectable by isoelectric focusing.
Germ cell tumors of the mediastinum and testis: a comparative immunohistochemical study of 120 cases.
Germinoma with malignant transformation to nongerminomatous germ cell tumor.
Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour.
Gonadotropin releasing hormone-independent precocious puberty in a 5 year-old girl with suprasellar germ cell tumor secreting beta-hCG and alpha-fetoprotein.
Hepatocytic differentiation in retiform Sertoli-Leydig cell tumors: distinguishing a heterologous element from Leydig cells.
Hepatoid carcinoma of the ovary: characteristics of its immunoreactivity. A case report.
Hepatoid gastric carcinoma. A case report.
Hereditary persistence of alpha-fetoprotein in a child with testicular germ cell tumor.
Hereditary Persistence of Alpha-Fetoprotein in Chronic Liver Disease-Confusing Genes!
Hereditary persistence of alpha-fetoprotein. Case report and review of the literature.
High alpha-fetoprotein level in HCV-related nodular liver cell dysplasia.
Highly enhanced fucosylation of alpha-fetoprotein in patients with germ cell tumor.
Human chorionic gonadotrophin and alpha-fetoprotein in testicular germ cell tumours: a retrospective immunohistochemical study.
Human chorionic gonadotropin and alpha-fetoprotein in testicular germ cell tumors. An immunohistochemical study in comparison with tissue concentrations.
Imaging in gynecological disease (22): clinical?and?ultrasound characteristics of ovarian embryonal carcinomas, non-gestational choriocarcinomas and malignant mixed germ cell tumors.
Immature endodermal teratoma of the ovary: embryologic correlations and immunohistochemistry.
Immunohistochemical demonstration of alpha-fetoprotein in testicular germ cell tumors.
Immunohistochemical localisation of alpha-fetoprotein (AFP) in germ cell tumours: evidence for AFP production by tissues different from endodermal sinus tumour.
Infantile hepatic hemangioendothelioma with elevated serum alpha-fetoprotein.
Intracranial germ cell tumor indicating a high level of alpha-fetoprotein (AFP).
Intracranial germ cell tumors.
Is alpha-fetoprotein decline a prognostic factor of childhood non-seminomatous germ cell tumours? Results of the French TGM95 study.
Lectin-reactive alpha-fetoprotein (AFP-L3%) curability and prediction of clinical course after treatment of non-seminomatous germ cell tumors.
Lens Culinaris Agglutinin-reactive Fraction of Alpha-fetoprotein as a Tumor Marker in a Patient With Nonseminomatous Germ Cell Tumor With Normal Alpha-fetoprotein Level.
Localization of alpha-fetoprotein and human chorionic gonadotropin to specific histologic types of nonseminomatous testicular cancer.
Logarithmic decrease of serum alpha-fetoprotein or human chorionic gonadotropin in response to chemotherapy can distinguish a subgroup with better prognosis among highly malignant intracranial non-germinomatous germ cell tumors.
Lung carcinoma with metastasis to testicular seminoma.
Malignancy markers in the cerebrospinal fluid.
Malignant ganglioneuroma arising from mediastinal mixed germ cell tumor.
Management of pineal non-germinoma germ cell tumor with residual teratoma and normal alpha-fetoprotein.
Mediastinal growing teratoma syndrome succesfully treated by multiple modality therapies.
Mediastinal growing teratoma syndrome.
Mediastinal teratoma and precocious puberty in a boy with mosaic Klinefelter syndrome.
Metastatic carcinoma involving the testis. Clinical and pathologic distinction from primary testicular neoplasms.
Metastatic pancreatic acinar cell carcinoma in a younger male with marked AFP production: A potential pitfall on fine needle aspiration biopsy.
MicroRNAs as Appropriate Discriminators in Non-Specific Alpha-Fetoprotein (AFP) Elevation in Testicular Germ Cell Tumor Patients.
Mixed germ cell malignancy of the ovary concurrent with pregnancy.
Monitoring of patients with non-seminomatous germ cell tumors of the testis by determination of alpha-fetoprotein and beta-human chorionic gonadotropin levels and by computed tomography.
Morphologic features of human chorionic gonadotropin- or alpha-fetoprotein-producing germ cell tumors of the central nervous system: histological heterogeneity and surgical meaning.
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
Nonpalpable testicular pure seminoma with elevated serum alpha-fetoprotein presenting with retroperitoneal metastasis: a case report.
NUT midline carcinoma mimicking a germ cell tumor: a case report.
Observations on reliability of commercial assay for alpha-fetoprotein.
Ovarian clear cell adenocarcinoma producing alpha-fetoprotein: case report.
Ovarian mixed germ cell tumor composed of polyembryoma and immature teratoma.
Ovarian Yolk Sac Tumors; Does Age Matter?
Pathology of germ cell tumors of the testis.
Pediatric germ cell and human chorionic gonadotropin-producing tumors. Clinical and laboratory features.
Persistently elevated alpha-fetoprotein associated with chronic hepatitis B during chemotherapy for malignant ovarian germ cell tumors: a case series and a review of the literature.
Pituitary Dysfunction in Patients with Intracranial Germ Cell Tumors Treated with Radiotherapy.
Possible common origin of alpha-fetoprotein- and human chorionic gonadotropin--secreting cells in intracranial germ cell tumor. Case report.
Post-treatment persistent alpha-fetoprotein elevation in a patient with testicular cancer.
Potential role of ventricular tumor markers in CNS germ cell tumors.
Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy.
Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.
Primary Chemotherapy in a 47-Year-Old Patient with Giant Ulcerative and Necrotizing Nonseminomatous Testicular Germ Cell Tumor.
Primary endodermal sinus tumor of the penis: a case report.
Primary mediastinal malignant germ cell tumour. Single institution experience in Chinese patients and correlation with specific alpha-fetoprotein bends.
Primary mediastinal pleomorphic rhabdomyosarcoma: a case report.
Primary pulmonary alpha-fetoprotein-producing malignant germ cell tumor.
Primary yolk sac tumor originating from the endometrium: A case report and literature review.
Production of alpha-fetoprotein by human germ cell tumors in vivo and in vitro.
Prognostic factors of patients with yolk sac tumors of the ovary.
Prognostic value of tumor size, metastases, extension into bone, and increased tumor marker in children with malignant sacrococcygeal germ cell tumors: a prospective evaluation of 71 patients treated in the German cooperative protocols Maligne Keimzelltumoren (MAKEI) 83/86 and MAKEI 89.
Puberty due to a mixed germ cell tumour of the hypothalamus secreting BhCG and alpha-fetoprotein.
Radioimmunoassay of alpha-fetoprotein in children with primary intracranial tumors.
Radioimmunodetection of primary and metastatic germ cell tumors containing alpha-fetoprotein.
Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors.
Recurrent mixed germ cell tumor of the ovary manifest as an unexplained elevated maternal serum alpha-fetoprotein.
Retroperitoneal extragonadal germ cell tumor presenting as a bulky pelvic mass of the obturator fossa.
Retroperitoneal lymph node dissection in the setting of elevated markers.
Reversible increase in serum alpha-fetoprotein content associated with hepatic dysfunction during chemotherapy for seminoma.
Robb-Smith type malignant histiocytosis associated with a mediastinal germ cell tumor.
Secretion of human chorionic gonadotropin and alpha-fetoprotein by an ovarian germ cell tumor of apparent yolk sac origin.
Serial monitoring of serum alpha-fetoprotein and chorionic gonadotropin in males with germ cell tumors.
Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma.
Serum alpha-fetoprotein levels in neonatal cholestasis.
Serum and cerebrospinal fluid human chorionic gonadotropin (hCG) and alpha-fetoprotein (AFP) in intracranial germ cell tumors.
Serum lactate dehydrogenase isoenzyme 1 and prediction of death in patients with metastatic testicular germ cell tumors.
Serum lactic dehydrogenase as a tumor marker in dysgerminoma.
Serum levels of alpha-fetoprotein, human chorionic gonadotropin and carcinoembryonic antigen in patients with primary intracranial germ cell tumors.
Serum prolactin, gonadotropins, androgens, estrogens, and gestagens in patients with malignant testicular germ cell tumor.
Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors.
Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment.
Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
Significance of human chorionic gonadotropin, alpha-fetoprotein, and pregnancy-specific beta-1-glycoprotein in the detection of tumor relapse and partial remission in 126 patients with nonseminomatous testicular germ cell tumors.
Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
Structures of disease-specific serum alpha-fetoprotein isoforms.
Successful resection of a giant mediastinal non-seminomatous germ cell tumor showing fluorodeoxyglucose accumulation after neoadjuvant chemotherapy: report of a case.
Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers.
Synthesis of alpha-fetoprotein and some other serum proteins in testicular tumors.
Testicular germ cell tumors, an update. Results of the German cooperative studies 1982-1997.
The histogenetic-embryologic basis for reappearance of alpha-fetoprotein in endodermal sinus tumors (yolk sac tumors) and teratomas.
The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.
The role of second-look surgery in the management of advanced germ cell malignancies.
The role of tumor markers in gynecologic oncology.
The significance of alpha-fetoprotein in the serum of patients with malignant teratomas and related gonadal neoplasms.
The value of cancer antigen-125 as a tumor marker in malignant germ cell tumors of the ovary.
The value of surveillance testing in childhood brain tumors.
Treatment of intracranial nongerminomatous malignant germ cell tumors producing alpha-fetoprotein.
Trophoblastic proteins as tumor markers in nonseminomatous germ cell tumors.
Tumor markers at the time of recurrence in patients with germ cell tumors.
Tumor markers CA 125 and CA 19-9 in cord blood and during infancy: developmental changes and use in pediatric germ cell tumors.
Tumor markers in patients with non-seminomatous germ cell tumors of the testis.
Tumour markers in gynaecologic oncology.
Tumour markers in testicular germ cell tumours. Five-year experience from the DATECA Study 1976-1980.
Use of human chorionic gonadotropin and alpha-fetoprotein radioimmunoassays: specificity and apparent half-life determination after delivery and in patients with germ cell tumors.
Value of tumor markers in nonseminomatous germ cell tumor of the testis.
Variations in normal serum alpha-fetoprotein (AFP) levels in patients with testicular cancer on surveillance.
When is a seminoma not a seminoma? The incidence, risk factors and management of patients with testicular seminoma with discordant elevated serum alpha-fetoprotein.
[A case of alpha-fetoprotein producing mediastinal germ cell tumor treated with preoperative chemotherapy]
[A case of primary mediastinal germ cell tumor with production of alpha-fetoprotein, successfully treated with chemotherapy (cis-platinum, vinblastine, peplomycin), and curative resection]
[Alpha-fetoprotein and human chorionic gonadotropin as tumor markers in intracranial and intraspinal germ cell tumors]
[Alpha-fetoprotein as a marker in cases of infantile germ cell tumors]
[An Abnormal Alpha-Fetoprotein Fractionation Provides Additional Information: A Case of Retroperitoneal Germ Cell Tumor Accompanied by Liver Cirrhosis Type C].
[An autopsy case of double cancer (Hepatocellular carcinoma and mixed germ cell tumor of the testis)--significance of alpha-fetoprotein and human chorionic gonadotropin as tumor markers]
[Case of germ cell tumor of the pineal region with elevation of serum and csf alpha-fetoprotein levels following histological change]
[Cellular localization of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG), and carcinoembryonic antigen (CEA) in malignant germ cell tumors of the ovary using immunoperoxidase technique (author's transl)]
[Early changes in serum alpha-fetoprotein after chemotherapy in advanced testicular tumors]
[Germ cell tumor in the basal ganglia with elevated serum and CSF alpha-fetoprotein levels]
[Molecular staging of testicular cancer using polymerase chain reaction of the testicular cancer-specific genes]
[Primary intracranial germ cell tumor with abnormal high value of alpha-fetoprotein after the radiation therapy]
[Primary intracranial malignant germ cell tumor associated with abnormal high value of alpha-fetoprotein and human chorionic gonadotropin]
[Primary mediastinal germ cell tumor with marked elevation of HCG and alpha-fetoprotein]
[Structure and expression of alpha-fetoprotein gene--current progress in research]
[Surgery of mediastinal tumors.]
[Testicular tumors: association between preoperative clinical, radiological and immuno-serological factors, and histology and stage]
[The role of tumour markers in diagnosis and management of testicular germ cell tumours.]
[Usefulness of tumor markers in the treatment of germ cell tumors]
Neoplastic Cells, Circulating
A clinical scoring system for predicting tumor recurrence after percutaneous radiofrequency ablation for 3 cm or less hepatocellular carcinoma.
Current and Emerging Tools for Hepatocellular Carcinoma Surveillance.
Detection of germ-cell tumor cells in the peripheral blood by nested reverse transcription-polymerase chain reaction for alpha-fetoprotein-messenger RNA and beta human chorionic gonadotropin-messenger RNA.
Does surgical resection of hepatocellular carcinoma accelerate cancer dissemination?
Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection.
The Clinical Significance of Alpha-Fetoprotein mRNAs in Patients with Hepatocellular Carcinoma.
Neoplastic Processes
Bile acid secretion during rat liver carcinogenesis.
Nephrosis
Alpha-fetoprotein in antenatal diagnosis of congenital nephrosis.
Antenatal screening for congenital nephrosis in Finland by maternal serum alpha-fetoprotein.
Congenital nephrosis as a cause of elevated alpha-fetoprotein.
Congenital nephrosis: detection of index cases through maternal serum alpha-fetoprotein screening.
CRB2 mutations produce a phenotype resembling congenital nephrosis, Finnish type, with cerebral ventriculomegaly and raised alpha-fetoprotein.
Determination of subfractions of amniotic fluid alpha-fetoprotein in diagnosing spina bifida and congenital nephrosis.
Elevated maternal serum alpha-fetoprotein levels: what is the risk of fetal aneuploidy?
Expansion of phenotype and genotypic data in CRB2-related syndrome.
Fetal proteinuria in diagnosis of congenital nephrosis detected by raised alpha-fetoprotein in maternal serum.
Genetic and preimplantation diagnosis of cystic kidney disease with ventriculomegaly.
Improved prenatal diagnosis of the congenital nephrotic syndrome of the Finnish type based on DNA analysis.
Maternal serum alpha-fetoprotein levels in congenital nephrosis.
Maternal serum alpha-fetoprotein levels peak at 19-21?weeks' gestation and subsequently decline in a NPHS1 sequence variant heterozygote; implications for prenatal diagnosis of congenital nephrosis of the Finnish type.
Mechanisms by which amniotic-fluid alpha-fetoprotein may be increased in fetal abnormalities.
Prenatal diagnosis of congenital nephrosis by in utero kidney biopsy.
Prenatal diagnosis of congenital nephrosis in 23 high-risk families.
Nephrotic Syndrome
Amniotic alpha-fetoprotein in the prenatal diagnosis of congenital nephrotic syndrome of the Finnish type.
Congenital nephrotic syndrome: prenatal diagnosis and genetic counselling by estimation of aminotic-fluid and maternal serum alpha-fetoprotein.
Maternal serum alpha-fetoprotein levels in congenital nephrotic syndrome carrier pregnancies.
Normalization of maternal serum alpha-fetoprotein levels after 23 weeks' gestation in an NPHS1 nephrotic syndrome carrier pregnancy.
Proteinuria and prenatal diagnosis of congenital nephrosis in fetal carriers of nephrin gene mutations.
Why is congenital nephrotic syndrome associated with a rise in the concentration of alpha-fetoprotein in the amniotic fluid?
Nervous System Diseases
Identification of alpha-fetoprotein as an autoantigen in juvenile Batten disease.
Immunomodulation by alpha-fetoprotein in neurological disorders may involve.
Neural Tube Defects
A co-twin fetus papyraceus as a cause of elevated AFP and acetylcholinesterase in the amniotic fluid of the normal co-twin.
A comparison of amniotic fluid alpha-fetoprotein and acetylcholinesterase in the prenatal diagnosis of open neural tube defects and anterior abdominal wall defects.
A review of genetics in orthopaedics.
A study of the value of measuring maternal serum alpha-fetoprotein for the antenatal diagnosis of neural tube defects.
A survey of diagnostic amniocenteses in Oxford from 1974-1981.
Abnormal US appearance of the cerebellum (banana sign): indirect sign of spina bifida.
Adverse obstetric outcome in low- and high- risk pregnancies: predictive value of maternal serum screening.
Adverse perinatal outcome in patients screen-positive for neural tube defects and fetal Down syndrome.
AFP and age screening for Down syndrome.
All MoMs are not equal: some statistical properties associated with reporting results in the form of multiples of the median.
Alpha-fetoprotein and acetylcholinesterase in twins discordant for neural tube defect.
Alpha-fetoprotein and albumin in experimentally-induced exencephaly in the rat.
Alpha-fetoprotein and the prenatal detection of neural tube defects.
Alpha-fetoprotein and the prenatal diagnosis of neural tube defects.
Alpha-fetoprotein concanavalin A-binding variants in the diagnosis of neural tube defects and other communicating fetal abnormalities.
Alpha-fetoprotein detection of neural tube defects and the impact of standard ultrasound.
alpha-fetoprotein in antenatal diagnosis of neural tube defects.
Alpha-fetoprotein in antenatal diagnosis of neural tube defects.
Alpha-fetoprotein in obstetrics. Experience of a prenatal diagnosis center.
Alpha-fetoprotein levels in amniotic fluid and maternal serum as determined by radioimmunoassay: implications for prenatal diagnosis of fetal neural tube defects.
Alpha-fetoprotein.
Alpha-fetoprotein: an enhanced-sensitivity assay for neural tube defect and Down syndrome evaluation.
Alpha-fetoprotein: from a diagnostic biomarker to a key role in female fertility.
alpha-Fetoprotein: relationship between maternal serum and amniotic fluid levels.
Amniocentesis and chorionic villus sampling.
Amniotic and maternal serum alpha-fetoprotein levels of rats with induced neural tube defects.
Amniotic fluid acetylcholinesterase activity and alpha-fetoprotein in chromosomal anomalies and neural tube defects.
Amniotic fluid acetylcholinesterase measurement in the prenatal diagnosis of open neural tube defects. Second report of the Collaborative Acetylcholinesterase Study.
Amniotic fluid alpha-fetoprotein as a marker in prenatal diagnosis of neural tube defects.
Amniotic fluid alpha-fetoprotein elevation with fetal omphalocele and a possible mechanism for its occurrence.
Amniotic fluid alpha-fetoprotein in the antenatal diagnosis of neural tube defects.
Amniotic fluid alpha-fetoprotein in the prenatal diagnosis of fetal neural tube defects.
Amniotic fluid alpha-fetoprotein levels and the prenatal diagnosis of neural tube defects: a collaborative study of 2180 pregnancies in the Netherlands.
Amniotic fluid alpha-fetoprotein levels in antenatal diagnosis of neural tube defects.
Amniotic fluid analysis in prenatal diagnosis of neural tube defects: a comparison between six biochemical tests supplementary to the measurement of amniotic fluid alpha-fetoprotein.
Amniotic fluid and maternal serum alpha-fetoprotein determination in neural tube defects.
Amniotic fluid concentrations of alpha-fetoprotein (AFP) in early normal pregnancy, and pregnancy complicated by neural tube defects. A review of 18 months experience.
Amniotic fluid glial fibrillary acidic protein (AF-GFAP), a biomarker of open neural tube defects.
Amniotic fluid levels of fibrin(ogen) degradation fragment E and alpha-fetoprotein in normal pregnancy and with fetal neural tube defect.
Analysis of maternal alpha-fetoprotein: a comparison of three radioimmunoassays.
Aneuploidy with neural tube defects: another reason for complete evaluation in patients with suspected ultrasound anomalies or elevated maternal serum alpha-fetoprotein.
Antecedent circumstances surrounding neural tube defect births in 1990-1991. The Steering Committee of the National Confidential Enquiry into Counselling for Genetic Disorders.
Antenatal care for the normal patient.
Antenatal screening in Oxford for fetal neural tube defects.
Antepartum screening in the office-based practice: findings from the collaborative Ambulatory Research Network.
Are Down syndrome fetuses detected through maternal serum screening similar to those remaining undetected?
Between-pregnancy biological variability of maternal serum alpha-fetoprotein and free beta hCG: implications for Down syndrome screening in subsequent pregnancies.
Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?
Case-control study of severe pre-eclampsia of early onset.
Cholinesterase evaluation in the prenatal diagnosis of open neural tube defects.
Clinical evaluation of a single antibody RIA assay for alpha-fetoprotein.
Clinical interpretation of maternal serum alpha-fetoprotein concentrations.
Combination of elevated maternal serum alpha-fetoprotein (MSAFP) and low estriol is highly predictive of anencephaly.
Comparison of an ELISA with a RIA method for serum alpha-fetoprotein determination in screening for fetal neural tube defects.
Complement factors and alpha-fetoprotein as biomarkers for noninvasive prenatal diagnosis of neural tube defects.
Con A non-reactive fractions of human amniotic fluid alpha-fetoprotein in prenatal diagnosis of fetal neural tube defects and fetal abdominal wall defects. Predictive values, sensitivity, and specificity, and comparison to acetylcholinesterase and ultrasound scanning.
Concanavalin A binding of alpha-fetoprotein in amniotic fluid as an aid in the diagnosis of neural tube defects.
Concanavalin A reactivity pattern of human amniotic fluid AFP examined by crossed affino-immunoelectrophoresis. A definite test for neural tube defect?
Congenital nephrosis of the Finnish type: overview of placental pathology and literature review.
Cost benefit analysis of screening spina bifida.
Cotinine-assisted intervention in pregnancy to reduce smoking and low birthweight delivery.
Current issues in maternal serum alpha-fetoprotein screening.
Cut-off levels for maternal plasma alpha-fetoprotein in the diagnosis of neural tube defects: validation of the use of multiples of the normal median.
Detection of neural tube defects with alpha-fetoprotein measurement in amniotic fluid. A protocol for managing elevated values.
Diagnosis of fetal acrania during the first trimester nuchal translucency screening for Down syndrome.
Diagnostic effectiveness of ultrasound in detection of neural tube defect. The South Wales experience of 2509 scans (1977-1982) in high-risk mothers.
Early pregnancy screening for neural tube defects in Israel.
Effect of normal MSAFP screening on maternal age for genetic amniocentesis.
Effects of antenatal diagnosis and selective abortion on frequencies of genetic disorders.
Elevated levels of midtrimester maternal serum alpha-fetoprotein are associated with preterm delivery but not with fetal growth retardation.
Elevated maternal serum alpha-fetoprotein values. How low is high?
Elevated maternal serum alpha-fetoprotein with normal ultrasound: is amniocentesis always appropriate? A review of 26,069 screened patients.
Elevated maternal serum alpha-fetoprotein, second-trimester oligohydramnios, and pregnancy outcome.
Elevated second-trimester free beta-hCG as an isolated finding and pregnancy outcomes.
Establishment of a collaborative university-commercial maternal serum alpha-fetoprotein screening program: a model for tertiary center outreach.
Estimates of birth prevalence rates of spina bifida in the United States from computer-generated maps.
Estimating an individual's risk of having a fetus with open spina bifida and the value of repeat alpha-fetoprotein testing. Fourth report of the UK collaborative study on alpha-fetoprotein in relation to neural tube defects.
Evaluating health and maturation of the unborn: the role of the clinical laboratory.
Evaluation of a commercial immunoenzymometric assay for alpha-fetoprotein.
Evaluation of measurement of maternal plasma alpha-fetoprotein levels as a screening test for fetal neural tube defects.
Experience with 8 cases of prenatally diagnosed sacrococcygeal teratomas.
Expression and characterization of a recombinant Fab fragment derived from an anti-human alpha-fetoprotein monoclonal antibody.
External quality assessment of serum alpha-fetoprotein assays.
Extremely high maternal serum alpha-fetoprotein levels at second-trimester screening.
False-positive amniotic fluid acetylcholinesterase results: the need for a multifacet approach to the prenatal diagnosis of neural tube defects.
Fetal anomaly scan potentially will replace routine AFAFP assays for the detection of neural tube defects.
First-trimester biochemical screening for fetal chromosome abnormalities and neural tube defects.
First-Trimester Screening for Neural Tube Defects Using Alpha-Fetoprotein.
Four years' experience of maternal alpha-fetoprotein screening and its effect on the pattern of antenatal care.
Genetic aspects of prenatal diagnosis.
Hepatocellular carcinoma as a rare cause of an excessive increase in alpha-fetoprotein during pregnancy.
High levels of maternal serum alpha-fetoprotein and human chorionic gonadotrophins leading to the diagnosis of combined neural tube defect and partial mole.
Immunochemical determination of amniotic fluid acetylcholinesterase in the antenatal diagnosis of open neural tube defects.
Immunocytochemical characterization of amniotic fluid macrophages in cases of fetal neural tube defects.
Implementation of a screening program for diagnosing open neural tube defects: selection, evaluation, and utilization of alpha-fetoprotein methodology.
Increased amnionic fluid alpha-fetoprotein due to a holoacardium amorphous twin.
Increased levels of apo-transcobalamins I and II in amniotic fluid from pregnant women with previous neural tube defect offspring.
Increased maternal serum alpha-fetoprotein and human chorionic gonadotropin in compromised pregnancies other than for neural tube defects or Down syndrome.
Influence of provider characteristics and insurance status on maternal serum alpha-fetoprotein screening.
Is maternal alpha-fetoprotein screening still of value in a low-risk area for neural tube defects?
Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study.
Isoelectric focusing of amniotic fluid alpha-fetoprotein to improve diagnosis of neural tube defects.
Levels of alpha-fetoprotein in amniotic fluids of mice (curly-tail) with neural tube defects.
Life without amniocentesis: elevated maternal serum alpha-fetoprotein in the Manitoba program 1986-91.
Maternal alpha-fetoprotein screening: two years' experience in a low-risk district.
Maternal plasma alpha-fetoprotein screening for fetal neural tube defects.
Maternal serum alpha-fetoprotein (MSAFP) and fetal growth.
Maternal serum alpha-fetoprotein and birth weight.
Maternal serum alpha-fetoprotein and previous neural tube defects.
Maternal serum alpha-fetoprotein in presence of both neural tube defects and chromosome anomalies.
Maternal serum alpha-fetoprotein in the first trimester cannot predict neural tube defects.
Maternal serum alpha-fetoprotein in twin pregnancies uncomplicated by neural tube defect.
Maternal serum alpha-fetoprotein level and the relationship to ventriculomegaly in fetal neural tube defect: A retrospective cohort study.
Maternal serum alpha-fetoprotein screening for neural tube defects and other disorders using an ultramicro-ELISA. Collaborative study in Cuba and in the German Democratic Republic.
Maternal serum alpha-fetoprotein screening for neural tube defects. Report of a combined study in Germany and short overview on screening in populations with low birth prevalence of neural tube defects.
Maternal serum alpha-fetoprotein screening for neural tube defects. Report of a program with more than 30000 screened pregnancies.
Maternal serum alpha-fetoprotein screening for neural tube defects. Results of a consensus meeting.
Maternal serum alpha-fetoprotein screening for open neural tube defects in twin pregnancies.
Maternal serum alpha-fetoprotein screening for the detection of neural tube defects.
Maternal serum alpha-fetoprotein screening for the early antenatal detection of neural tube defects.
Maternal serum alpha-fetoprotein screening in a provincial Health District.
Maternal serum alpha-fetoprotein screening in Natal. Results of over 12 000 tests.
Maternal serum alpha-fetoprotein screening programs and quality control for laboratories performing maternal serum and amniotic fluid alpha-fetoprotein assays: policy statement. American Society of Human Genetics.
Maternal serum alpha-fetoprotein screening. III. Pitfalls in evaluating black gravid women.
Maternal serum alpha-fetoprotein screening: a cost-benefit analysis.
Maternal serum alpha-fetoprotein screening: low and high values for detection of genetic abnormalities.
Maternal serum alpha-fetoprotein screening: report of a Canadian pilot project.
Maternal serum and amniotic fluid alpha-fetoprotein testing: our approach to screening, diagnosis and counseling.
Maternal serum screening in Ontario using the triple marker test.
Maternal serum screening.
Maternal smoking during pregnancy and false positive maternal serum alpha-fetoprotein (MSAFP) screening for open neural tube defects.
Maternal zinc and selenium status in pregnancies with a neural tube defect or elevated plasma alpha-fetoprotein.
Medians for second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol; differences between races or ethnic groups.
Midtrimester screening for open neural tube defects: correlation of sonography with amniocentesis results.
Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects.
Neural tube defects and maternal serum zinc and copper concentrations in mid-pregnancy: a case-control study.
Neural tube defects, diabetes, and serum alpha-fetoprotein screening.
Neural tube defects/alpha-fetoprotein/Down's syndrome screening.
Neural tube defects: epidemiology, detection, and prevention.
Origin of amniotic fluid alpha-fetoprotein in normal and defective pregnancies.
Outcome in infants born to mothers with unexplained elevations of maternal serum alpha-fetoprotein.
Parent preferences and prenatal testing for neural tube defects.
Precision in estimating gestational age and its influence on sensitivity of alphafetoprotein screening.
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data.
Prenatal biochemical screening for Down's syndrome and neural tube defects.
Prenatal detection of neural tube defects by maternal serum alphafetoprotein assay.
Prenatal detection of neural tube defects. Comparison between alpha-fetoprotein and beta-trace protein assays.
Prenatal detection of neural tube defects: experience with alpha-fetoprotein assays of amniotic fluid.
Prenatal diagnosis by chorionic villus sampling.
Prenatal diagnosis of a neural tube defect: Meckel syndrome.
Prenatal diagnosis of genetic disorders.
Prenatal diagnosis of neural tube defects by measurement of serum alpha-fetoprotein in Havana City.
Prenatal diagnosis of neural tube defects. I. Problems and pitfalls: analysis of 2495 cases using the alpha-fetoprotein assay.
Prenatal diagnosis of neural tube defects. II. Analysis of false positive and false negative alpha-fetoprotein results.
Prenatal diagnosis of neural tube defects. III. A reevaluation of the alpha-fetoprotein assay.
Prenatal diagnosis of neural tube defects. IV. Maternal serum alpha-fetoprotein screening.
Prenatal diagnosis of neural tube defects. V. The value of amniotic fluid cholinesterase studies.
Prenatal diagnosis of neural tube defects. VIII. The importance of serum alpha-fetoprotein screening in diabetic pregnant women.
Prenatal diagnosis of neural tube defects: predictive value of AF-AFP in a low-risk population.
Prenatal diagnosis of open neural tube defects using the amniotic fluid acetylcholinesterase assay.
Prenatal diagnosis, fetal surgery, recurrence risk and differential diagnosis of neural tube defects.
Prenatal maternal dried blood screening with alpha-fetoprotein and free beta-human chorionic gonadotropin for open neural tube defect and Down syndrome.
Prenatal screening for Down syndrome and neural tube defects in twin pregnancies.
Prenatal screening for open neural tube defects.
Prenatal screening: when and for whom?
Prenatal serum alpha-fetoprotein screening for neural tube defects.
Prenatal testing for maternal serum alpha-fetoprotein.
Procedure-related fetal losses in transplacental versus nontransplacental genetic amniocentesis.
Quantification of the D2-glycoprotein in amniotic fluid and serum from pregnancies with fetal neural tube defects.
Rapid acetylcholinesterase screening test for neural tube defect.
Reactivity of amniotic fluid alpha-fetoprotein with concanavallin A in diagnosis of neural tube defects.
Refinements in managing maternal weight adjustment for interpreting prenatal screening results.
Regional variations in neural tube defects and alfa-fetoprotein screening in Denmark 1983-88.
Response to termination of pregnancy for genetic reasons.
Risk assessment of amniocentesis between 11 and 15 weeks: comparison to later amniocentesis controls.
Risk-benefit assessment of anticonvulsants in women of child-bearing potential.
Routine amniotic fluid alpha-fetoprotein measurement in 34,000 pregnancies.
Routine assessment of amniotic fluid alpha-Fetoprotein in early second-trimester amniocentesis is no longer justified.
Routine ultrasonography compared with maternal serum alpha-fetoprotein for neural tube defect screening.
S-100 protein and neuron-specific enolase in amniotic fluid as markers of abdominal wall and neural tube defects in the fetus.
Sacral meningocele with conotruncal heart defects: a possible autosomal recessive trait.
Screening for congenital dislocation of the hip, scoliosis, and other abnormalities affecting the musculoskeletal system.
Screening for Down's syndrome and neural tube defect in Croatia. A regional prospective study.
Screening for fetal and genetic abnormalities.
Screening for fetal malformations using ultrasound and measurements of alpha-fetoprotein in maternal serum.
Screening for fetal neural tube defects by maternal plasma alpha-fetoprotein determination.
Screening for open neural tube defects.
Screening.
Second trimester maternal serum alpha-fetoprotein as an indicator of fetal risk.
Second trimester serum predictors of congenital heart defects in pregnancies without chromosomal or neural tube defects.
Second-trimester placental changes associated with elevated maternal serum alpha-fetoprotein.
Sensitivity and specificity of ultrasound for the detection of neural tube and ventral wall defects in a high-risk population.
Serum alpha-fetoprotein and neural tube defects in the first trimester of pregnancy. MRC Vitamin Study Research Group.
Serum alpha-fetoprotein: I. Evaluation of quantitative assays adapted to automated immunoassay systems.
Sonography as a procedure complementary to alpha-fetoprotein testing for neural tube defects.
Sonography of fetal cerebrospinal anomalies.
Sonography, a complementary examination to alpha-fetoprotein testing for fetal neural tube defects.
Stage II ultrasound examination for the diagnosis of fetal abnormalities with an elevated amniotic fluid alpha-fetoprotein concentration.
Studies of an alpha-fetoprotein assay using dry blood-spot samples to be used for the detection of fetal neural tube defects.
Study of alpha-fetoprotein in amniotic fluid and its application in the prenatal diagnosis of neural tube defects.
The diagnostic accuracy of maternal serum alpha-fetoprotein variants (AFP-L2 and AFP-L3) in predicting fetal open neural tube defects and abdominal wall defects.
The effect of gestational age on the detection rate of Down's syndrome by maternal serum alpha-fetoprotein screening.
The effect of private attitudes on public policy. Prenatal screening for neural tube defects as a prototype.
The effects of analytical factors on second trimester risk estimations.
The fetal spine.
The importance of accurate gestational age estimation in screening for fetal neural tube defects using maternal serum alpha-fetoprotein levels.
The relation between maternal plasma alpha-fetoprotein and birth weight in twin pregnancies.
The role of ultrasonography and amniocentesis in the evaluation of pregnancies at risk for neural tube defects.
The role of ultrasound in evaluation of patients with elevated maternal serum alpha-fetoprotein: a review.
The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-1991.
The value of alpha-fetoprotein in the prenatal diagnosis of neural tube defects.
Triploid fetus: an important consideration in the evaluation of very high maternal serum alpha-fetoprotein.
Triploidy identified through second-trimester serum screening.
Trisomy 18 and maternal serum and amniotic fluid alpha-fetoprotein.
Twin pregnancies in the second trimester in women in an alpha-fetoprotein screening program: sonographic evaluation and outcome.
Ultrasonography and alpha-fetoprotein determination for antenatal detection of neural tube defects.
Ultrasound and amniotic fluid alpha-fetoprotein in the prenatal diagnosis of spina bifida.
Ultrasound detection of neural tube defects in patients with elevated maternal serum alpha-fetoprotein.
Ultrasound of the fetal central nervous system.
Unique structure of glycopeptide from alpha-fetoprotein produced in human hepatoma cell line, as determined by 1H-nuclear magnetic resonance spectroscopy.
Use of patients' data to control alpha-fetoprotein assays when screening for neural tube defects.
Women's attitudes to screening for neural tube defects.
[Acrania and spina bifida diagnosed by alpha-fetoprotein determination in 16th week of pregnancy]
[Amniotic fluid alpha-fetoprotein levels in neural tube defects]
[Biochemical screening for fetal abnormalities - alpha-fetoprotein.]
[Determination of alpha-fetoprotein, cholinesterase and alpha 2-macroglobulin in the amniotic fluid in the diagnosis of neural tube defects]
[Electrophoresis of cholinesterases of the amniotic fluid in the prenatal diagnosis of closure defects of the neural tube]
[First trimester sonographic diagnosis of acrania]
[Genetic amniocentesis: technique and results in 1,000 first trimester amniocenteses (author's transl)]
[Hepatocellular carcinoma as a rare cause of excessive rise in alpha-fetoprotein in pregnancy]
[Noninvasive serum test for prenatal detection of Down syndrome, other chromosome abnormalities and open neural tube defects--a prospective study]
[Percentage of concanavalin-A non-conjugating alpha-fetoprotein in amniotic fluid in the prenatal diagnosis of neural tube defects]
[Prenatal detection of open neural tube defects in a mass screening program by determination of alpha-fetoprotein concentration in maternal serum]
[Prenatal diagnosis and prevention of neural tube defects]
[Prenatal diagnosis of congenital defects through the determination of alpha fetoprotein]
[Prenatal diagnosis of Meckel-Gruber's syndrome by ultrasound (author's transl(]
[Present situation of prenatal diagnosis of neural tube defects]
[Progress in prenatal diagnosis]
[Quantitative acetylcholinesterase (AChE)--determination in amniotic fluid--potential for differential diagnosis in consistently high AFP levels during general AFP screening for prenatal diagnosis of open neural tube defects]
[Report on 8 years' experience in prenatal diagnosis of genetic defects. I. Indications and methods]
[Screening for neural tube defects. Determination of serum alpha-fetoprotein in women in the 16th to 18th weeks of pregnancy]
[The alpha-fetoprotein level analysis in open neural tube defects and chromosomal aberrations in the fetus]
[The determination of acetylcholinesterase activity in amniotic fluid as a further possibility for the prenatal diagnosis of open neural tube defects]
[Twin pregnancy with severe skull malformation of one twin]
Neuroblastoma
Clinical use of tumor markers in childhood malignancies.
Screening for cancer: is it cost effective?
Neurodegenerative Diseases
Identification and characterisation of a large Senataxin (SETX) gene duplication in ataxia with ocular apraxia type 2 (AOA2).
Neuroectodermal Tumor, Melanotic
Melanotic neuroectodermal tumor of infancy with high serum levels of alpha-fetoprotein. Ultrastructural study and immunological evidence of glial fibrillary protein and alpha-fetoprotein.
Neuroectodermal Tumors
Pigmented neuroectodermal tumor of infancy. A light microscopic and immunohistochemical study.
Neuroendocrine Tumors
Alpha-fetoprotein and human chorionic gonadotrophin-beta as prognostic markers in neuroendocrine tumour patients.
Alpha-fetoprotein producing pancreatic neuroendocrine tumor.
Immunohistochemical staining of hepatocellular carcinoma with monoclonal antibody against inhibin.
Metastatic neuroendocrine pancreatic tumor - Case report.
Pure alpha-fetoprotein-producing neuroendocrine carcinoma of the pancreas: a case report.
Neuroinflammatory Diseases
Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoprotein.
Neurologic Manifestations
[Ataxia telangiectasia. Clinical and biological study in 17 cases]
Neuronal Ceroid-Lipofuscinoses
Alpha-fetoprotein is an autoantigen in hepatocellular carcinoma and juvenile Batten disease.
Identification of alpha-fetoprotein as an autoantigen in juvenile Batten disease.
Neutropenia
Apparent Acetaminophen Toxicity in a Patient with Transaldolase Deficiency.
Nijmegen Breakage Syndrome
Radioresistant DNA synthesis and human genetic diseases.
Non-alcoholic Fatty Liver Disease
Abnormal fucosylation of alpha-fetoprotein in patients with non-alcoholic steatohepatitis.
Association between steatohepatitis biomarkers and hepatocellular carcinoma after hepatitis C elimination.
Biomarkers of Oncogenesis, Adipose Tissue Dysfunction and Systemic Inflammation for the Detection of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease.
Clinical, Epidemiological and Histopathological Aspects in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation
Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patients.
Serum alpha-fetoprotein in patients with nonalcoholic fatty liver disease.
Serum alpha-fetoprotein levels in liver steatosis.
Obesity
Association between alpha-fetoprotein and metabolic syndrome in a Chinese asymptomatic population: a cross-sectional study.
Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals.
Maternal thyroid function does not alter maternal serum alpha-fetoprotein interpretation.
Obstetric Labor, Premature
Congenital malformation syndromes and elevation of amniotic fluid alpha-fetoprotein.
Does unexplained second-trimester (15 to 20 weeks' gestation) maternal serum alpha-fetoprotein elevation presage adverse perinatal outcome? Pitfalls and preliminary studies with late second- and third-trimester maternal serum alpha-fetoprotein.
Maternal serum alpha-fetoprotein in placental abruption associated with preterm labor.
Placental sonolucency and pregnancy outcome in women with elevated second trimester serum alpha-fetoprotein levels.
Predicting risk of preterm delivery by second-trimester measurement of maternal plasma corticotropin-releasing hormone and alpha-fetoprotein concentrations.
Significance of opaque discolored amniotic fluid at second-trimester amniocentesis.
Transformed alpha-fetoprotein (t-AFP) levels in women with threatened preterm labor.
Unexplained elevated maternal serum alpha-fetoprotein in singleton pregnancies as a predictor of fetal risk.
Oculocerebrorenal Syndrome
Fetal oculocerebrorenal syndrome of Lowe associated with elevated maternal serum and amniotic fluid alpha-fetoprotein levels.
Oligohydramnios
Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements.
Diffuse mesangial sclerosis in a fetus.
Elevated alpha-fetoprotein and human chorionic gonadotropin as a marker for placental trisomy 16 in the second trimester?
Elevated maternal serum alpha-fetoprotein levels and oligohydramnios: poor prognosis for pregnancy outcome.
Elevated maternal serum alpha-fetoprotein with oligohydramnios: ultrasound evaluation and outcome.
Elevated maternal serum alpha-fetoprotein, second-trimester oligohydramnios, and pregnancy outcome.
Factors associated with fetal demise in fetal echogenic bowel.
Maternal serum alpha-fetoprotein levels and fetal outcome in early second-trimester oligohydramnios.
Maternal serum markers in second-trimester oligohydramnios.
Midtrimester diagnosis and anomalies in the dup(22q) syndrome: correlation of aneuploidy with low maternal serum alpha-fetoprotein and oligohydramnios.
Midtrimester Rh sensitization associated with circulating anticardiolipin antibodies and elevated maternal serum alpha-fetoprotein. A case report.
Origin of raised maternal serum alpha-fetoprotein levels in second-trimester oligohydramnios.
Outcome of mid-trimester pregnancies complicated by oligohydramnios. Quantitative evaluation of the prognostic value of maternal serum alpha-fetoprotein level.
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data.
Raised maternal serum alpha-fetoprotein, oligohydramnios, and the fetus.
Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome.
Sonography of placental abnormalities and oligohydramnios in women with elevated alpha-fetoprotein levels: comparison with control subjects.
The association of abnormal alpha-fetoprotein and adverse pregnancy outcome: does increased fetal surveillance affect pregnancy outcome?
The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
The branchio-oto-renal (BOR) syndrome: report of bilateral renal agenesis in three sibs.
Transcervical chorionic villus sampling and midtrimester oligohydramnios.
Osteogenesis Imperfecta
Reactivity of amniotic fluid alpha-fetoprotein with concanavallin A in diagnosis of neural tube defects.
Osteosarcoma
Advances in biological markers for cancer.
Ovarian Cysts
Maternal serum alpha-fetoprotein levels in ectopic pregnancy. A prospective study.
Measurement of CA125, carcinoembryonic antigen, and alpha-fetoprotein in ovarian cyst fluid: diagnostic adjunct to cytology.
Oncofetal antigens in ovarian cyst fluids.
Ovarian Neoplasms
An IgM lambda antibody to Escherichia coli produces false-positive results in multiple immunometric assays.
Diagnostic accuracy of preoperative alpha-fetoprotein as an ovarian tumor marker in children and adolescents: not as good as we thought?
Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum.
Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition.
Tumor markers for ovarian cancer.
Pancoast Syndrome
Hepatocellular carcinoma with Pancoast's syndrome as an initial symptom: a case report.
Hepatoid pancoast tumor. A case report and review of the literature.
Pancoast syndrome in a patient with malignant lymphoma.
Pancreatic Neoplasms
Alpha-fetoprotein production by pancreatic tumors exhibiting acinar cell differentiation: study of five cases, one arising in a mediastinal teratoma.
Alpha-fetoprotein-producing pancreatic cancer cells possess cancer stem cell characteristics.
An alpha-fetoprotein producing pancreatic cystadenocarcinoma.
Carbohydrate antigenic determinant (CA 19-9) and other tumor markers in gastrointestinal malignancies.
Detection of tumor cells in peritoneal lavages from patients with gastrointestinal cancer by multiplex reverse transcriptase PCR.
Exocrine-endocrine pancreatic cancer and alpha-fetoprotein.
Intra- and postoperative radiation therapy for an alpha-fetoprotein-producing pancreatic carcinoma.
Mesoporous TiO2-based architectures as promising sensing materials towards next-generation biosensing applications.
Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer.
Serum pancreatic oncofetal antigen: its clinical usefulness for screening pancreatic cancer in combination with tests for other tumor markers.
Successful resection of a liver metastasis from AFP-producing pancreatic cancer resulting in long-term survival: a case report and review of literature.
[Is a timely diagnosis possible in pancreatic cancer?]
Pancreatitis
Alpha-fetoprotein producing carcinoma of the gallbladder associated with anomalous arrangement of the pancreaticobiliary ductal system--early detection through an attack of acute pancreatitis.
Primary Pancreatic Yolk Sac Tumor Presenting as Diffusely Enlarged Pancreas in Initial 18F-FDG PET/CT.
Pancreatitis, Chronic
Carcinoembryonic antigen, alpha 1-antitrypsin, and alpha-fetoprotein in the pancreas of patients with cystic fibrosis.
[The use of the carbohydrate antigen CA-19-9, the carcinoembryonic antigen and alpha fetoprotein in the diagnosis of pancreatic cancer]
Papilloma
Clinical significance of circulating tumor cells via combined whole exome sequencing in early stage cancer screening: A case report.
Paraneoplastic Syndromes
Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes.
Paraproteinemias
Rheumatic syndromes: clues to occult neoplasia.
Parapsoriasis
Retroperitoneal liposarcoma associated with small plaque parapsoriasis.
Parkinson Disease
Right hepatic lobectomy for hepatocellular carcinoma which developed in primary biliary cirrhosis: report of a case.
Pelvic Inflammatory Disease
Alpha-fetoprotein and the acute phase response. A study using acute pelvic inflammatory disease as a model system.
Pemphigus
Retroperitoneal liposarcoma associated with small plaque parapsoriasis.
Perinatal Death
Alpha-fetoprotein: a biomarker for pregnancy outcome.
Amniotic fluid alpha-fetoprotein levels and pregnancy outcome.
Maternal serum alpha-fetoprotein in twin pregnancy.
Maternal serum alpha-fetoprotein, birthweight and perinatal death in twin pregnancy.
Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data.
Second trimester maternal serum alpha-fetoprotein as an indicator of fetal risk.
Second-trimester maternal serum levels of alpha-fetoprotein and the subsequent risk of sudden infant death syndrome.
Peripheral Nervous System Diseases
A novel c.5308_5311delGAGA mutation in Senataxin in a Cypriot family with an autosomal recessive cerebellar ataxia.
Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study.
Autosomal recessive ataxia with peripheral neuropathy and elevated AFP: novel mutations in SETX.
Autosomal recessive spinocerebellar ataxia and peripheral neuropathy with raised alpha-fetoprotein.
Clinical and molecular findings of ataxia with oculomotor apraxia type 2 in 4 families.
Cognitive functions in ataxia with oculomotor apraxia type 2.
Familial spinocerebellar ataxia with cerebellar atrophy, peripheral neuropathy, and elevated level of serum creatine kinase, gamma-globulin, and alpha-fetoprotein.
Peritoneal Diseases
Predictors, Presentation, and Treatment Outcomes of Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Large Single Center Experience.
Peritoneal Neoplasms
Hepatoid adenocarcinoma of the colon in a patient with inflammatory bowel disease.
Peritonitis
The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology.
Perivascular Epithelioid Cell Neoplasms
Contrast-enhanced ct and angiographic findings in hepatic perivascular epithelioid cell tumor.
Persistent Infection
A Comparison of Lenvatinib versus Sorafenib in the First-Line Treatment of Unresectable Hepatocellular Carcinoma: Selection Criteria to Guide Physician's Choice in a New Therapeutic Scenario.
[Incidence and natural history of hepatocellular carcinoma in patients with chronic hepatitis C virus infection]
Pinealoma
Intracranial germ cell tumor indicating a high level of alpha-fetoprotein (AFP).
Parkinsonism as an unusual presenting symptom of pineal gland teratoma.
Pineal region tumors: endocrinological aspects.
Stereotactic radiosurgery followed by whole ventricular irradiation for primary intracranial germinoma of the pineal region.
Pituitary Neoplasms
Estrogen induction of progestophilins in rat estrogen-sensitive cells grown in media supplemented with sera from castrated rats and from rats bearing an alpha-fetoprotein-secreting hepatoma.
Placenta Accreta
Elevated maternal serum alpha-fetoprotein associated with placenta accreta.
Life-threatening obstetric haemorrhage in second trimester from a placenta percreta with raised alpha-fetoprotein levels.
Midtrimester hemoperitoneum caused by placenta percreta in association with elevated maternal serum alpha-fetoprotein level.
Placenta accreta is associated with elevated maternal serum alpha-fetoprotein.
Second Trimester Biochemical Markers as Possible Predictors of Pathological Placentation: A Retrospective Case-Control Study.
Unexplained positive/elevated maternal serum alpha-fetoprotein associated with placenta increta. A case report.
Placenta Previa
Association between maternal serum alpha-fetoprotein and adverse outcomes in pregnancies with placenta previa.
Association of maternal serum alpha-fetoprotein with persistent placenta previa.
Placental Insufficiency
Ultrasound detection of placental insufficiency in women with elevated second trimester serum alpha-fetoprotein or human chorionic gonadotropin.
[Chronic glomerulonephritis and pregnancy]
Plasmacytoma
Accelerated plasmacytoma formation in mice treated with alpha-fetoprotein.
[A case of IgA-lambda producing gastric plasmacytoma associated with alpha-fetoprotein producing gastric carcinoma]
Pleural Effusion
[Cisplatin, vinblastine, and bleomycin combination chemotherapy in a stage IV pure endodermal sinus tumor of the ovary--a case report of a long-term survival]
[Clinical usefulness of tumor markers in the diagnosis of pleural effusions. Carcinoembryonic antigen, alpha-fetoprotein and orosomucoid]
Pneumonia
A Case Report: Can Citrin Deficiency Lead to Hepatocellular Carcinoma in Children?
Hepatocellular carcinoma responding to chemotherapy with 5-FU.
[The fetal proteins in prognosis of development of pneumonia in patients with ischemic stroke].
Polycystic Kidney Diseases
A case of recurrent infantile polycystic kidney associated with hydrops fetalis.
Sonographic identification of autosomal recessive polycystic kidney disease associated with increased maternal serum/amniotic fluid alpha-fetoprotein.
Polycystic Kidney, Autosomal Recessive
Sonographic identification of autosomal recessive polycystic kidney disease associated with increased maternal serum/amniotic fluid alpha-fetoprotein.
Polycythemia
Clinical evaluation of erythrocytosis in patients with hepatocellular carcinoma.
Erythropoietin production in hepatocellular carcinoma cells associated with polycythemia: immunohistochemical evidence.
Hepatocellular carcinoma associated with erythrocytosis and hypoglycemia in a yearling filly.
Polyhydramnios
A case of umbilical cord hemangioma: doppler studies and review of the literature.
Amniotic fluid alpha-fetoprotein in fetal obstructive uropathy.
Amniotic fluid alpha-fetoprotein levels and the prenatal diagnosis of neural tube defects: a collaborative study of 2180 pregnancies in the Netherlands.
Amniotic fluid biochemistry in isolated polyhydramnios: a series of 464 cases.
Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements.
Congenital malformation syndromes and elevation of amniotic fluid alpha-fetoprotein.
Cystic adenomatoid malformation of the lung: an obstetric and ultrasound perspective.
Experience with 8 cases of prenatally diagnosed sacrococcygeal teratomas.
Legal problems related to obstetrical ultrasound.
Open neural tube defects: immunocytochemical demonstration of neuroepithelial cells in amniotic fluid.
Polyhydramnios and elevated amniotic fluid alpha-fetoprotein caused by fetal supraventricular tachycardia.
Polyhydramnios associated with a ring chromosome and low maternal serum alpha-fetoprotein levels managed with indomethacin.
Prenatal diagnosis of Pena-Shokeir syndrome type 1.
Prenatal findings in epidermolysis bullosa with pyloric atresia in a family not known to be at risk.
Raised alpha-fetoprotein levels in amniotic fluid and maternal serum associated with distension of the fetal bladder caused by absence of urethra.
The importance of investigating for uniparental disomy in prenatally identified balanced acrocentric rearrangements.
[Giant placental angioma with polyhydramnios, high level of alpha-fetoprotein and neonatal congenital lactic acidosis]
[Hydramnios and fetal malformations. Use of estimating the level of alpha-fetoprotein and of bilirubin in the amniotic fluid during the last trimester of pregnancy (author's transl)]
Porphyria, Erythropoietic
The prenatal presentation of congenital erythropoietic porphyria: report of two siblings with elevated maternal serum alpha-fetoprotein.
Porphyrias, Hepatic
Normal serum alpha-fetoprotein in acute hepatic porphyria.
Pre-Eclampsia
A rat model of placental inflammation explains the unexplained elevated maternal serum alpha-fetoprotein associated with adverse pregnancy outcomes.
alpha-Fetoprotein elevation and proteinuric pre-eclampsia.
Analysis of mid-trimester corticotrophin-releasing hormone and alpha-fetoprotein concentrations for predicting pre-eclampsia.
Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements.
Can antenatal clinical and biochemical markers predict the development of severe preeclampsia?
Case-control study of severe pre-eclampsia of early onset.
Combination of PAPPA, fhCG?, AFP, PlGF, sTNFR1, and Maternal Characteristics in Prediction of Early-onset Preeclampsia.
Diverse maternal and fetal pathology associated with absent diastolic flow in the umbilical artery of high-risk fetuses.
Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes.
Elevated second-trimester human chorionic gonadotropin levels in association with poor pregnancy outcome.
First-trimester maternal serum alpha-fetoprotein is not a good predictor for adverse pregnancy outcomes: a retrospective study of 3325 cases.
Gender of offspring and maternal breast cancer risk.
Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia.
Mean arterial pressure, pregnancy induced hypertension, and preeclampsia. Evaluation as independent risk factors and as surrogates for high maternal serum alpha-protein in estimating breast cancer risk.
Mean arterial pressure, pregnancy-induced hypertension, and preeclampsia: evaluation as independent risk factors and as surrogates for high maternal serum alpha-fetoprotein in estimating breast cancer risk.
Mid-trimester triple test levels in early and late onset severe pre-eclampsia.
Midtrimester N-terminal proatrial natriuretic peptide, free beta hCG, and alpha-fetoprotein in predicting preeclampsia.
Midtrimester triple test levels in women with severe preeclampsia and HELLP syndrome.
Multiple marker second trimester serum screening for pre-eclampsia.
Placental sonolucency and pregnancy outcome in women with elevated second trimester serum alpha-fetoprotein levels.
Prediction and primary prevention of pre-eclampsia.
Reproductive factors and extreme levels of maternal serum alpha-fetoprotein: a population-based study.
Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy.
Screening preeclamptic cord plasma for proteins associated with decreased breast cancer susceptibility.
Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin a as predictors of preeclampsia in the third trimester of pregnancy.
Second-trimester maternal serum alpha-fetoprotein (MSAFP) is elevated in women with adverse pregnancy outcome associated with inherited thrombophilias.
Serum markers in quadruple screening associated with adverse pregnancy outcomes: A case-control study in China.
The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications.
The association of early-onset fetal growth restriction, elevated maternal serum alpha-fetoprotein, and the development of severe pre-eclampsia.
The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Toxemia of pregnancy: assessment of fetal distress by urinary estriol and circulating human placental lactogen and alpha-fetoprotein levels.
[Alpha-fetoprotein in the serum of puerperae]
[Placental hemangiomas]
Pregnancy Complications
Alterations of Circulating Biomarkers During Late Term Pregnancy Complications in the Horse Part II: Steroid Hormones and Alpha-Fetoprotein.
Amniotic fluid alpha-fetoprotein is not a useful biological marker of pregnancy outcome.
Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements.
Clinical follow-up of high mid-trimester maternal serum intact human chorionic gonadotrophin concentrations in singleton pregnancies.
Does unexplained second-trimester (15 to 20 weeks' gestation) maternal serum alpha-fetoprotein elevation presage adverse perinatal outcome? Pitfalls and preliminary studies with late second- and third-trimester maternal serum alpha-fetoprotein.
Elevated maternal serum alpha-fetoprotein levels and maternal risk factors. Their association with pregnancy complications.
Elevated maternal serum alpha-fetoprotein: association with placental sonolucencies, fetomaternal hemorrhage, vaginal bleeding, and pregnancy outcome in the absence of fetal anomalies.
Maternal midtrimester free beta-HCG and AFP serum levels in spontaneous singleton pregnancies complicated by gestational diabetes mellitus, pregnancy-induced hypertension or obstetric cholestasis.
Maternal serum biochemical screening for pregnancy complications other than aneuploidy.
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data.
Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein.
Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy.
Serum alpha-fetoprotein in the three trimesters of pregnancy: effects of maternal characteristics and medical history.
The C677T methylenetetrahydrofolate reductase variant and third trimester obstetrical complications in women with unexplained elevations of maternal serum alpha-fetoprotein.
Unexplained elevated maternal serum alpha-fetoprotein levels and pregnancy outcome in twins.
Velamentous umbilical cord insertion may be suspected from maternal serum alpha-fetoprotein and hCG.
[Correlation between elevated maternal serum alpha-fetoprotein, certain pregnancy complications and fetal death]
[Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype]
Pregnancy, Abdominal
Abdominal pregnancy associated with extremely elevated serum alpha-fetoprotein. Case report.
Advanced abdominal pregnancy complicated by bilateral ureteral obstruction. A case report.
Pregnancy, Ectopic
Alpha-fetoprotein and ectopic pregnancy.
hCG, progesterone, alpha-fetoprotein, and estradiol in the identification of ectopic pregnancy.
Maternal serum alpha-fetoprotein levels in ectopic pregnancy.
Maternal serum alpha-fetoprotein levels in ectopic pregnancy. A prospective study.
Pregnancy, High-Risk
Alpha-fetoprotein in the management of high-risk pregnancies.
Combining fetal nuchal fold thickness with second-trimester biochemistry to screen for trisomy 21.
Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data.
Screening for high-risk pregnancies with maternal serum alpha-fetoprotein (MSAFP). The Canadian Society of Clinical Chemists' Task Force on MSAFP Screening.
Serum alpha-fetoprotein: I. Evaluation of quantitative assays adapted to automated immunoassay systems.
Unconjugated estriol as maternal serum marker for the detection of Down syndrome pregnancies.
Pregnancy, Ovarian
A case of primary ovarian pregnancy.
Pregnancy, Tubal
Elevated maternal serum alpha-fetoprotein associated with an asymptomatic tubal pregnancy at 20 weeks' gestation.
Midtrimester tubal pregnancy with markedly elevated maternal serum alpha-fetoprotein. A case report.
Premature Birth
A rat model of placental inflammation explains the unexplained elevated maternal serum alpha-fetoprotein associated with adverse pregnancy outcomes.
Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements.
First-trimester maternal serum alpha-fetoprotein is not a good predictor for adverse pregnancy outcomes: a retrospective study of 3325 cases.
Inflammatory cytokines and antioxidants in midtrimester amniotic fluid: correlation with pregnancy outcome.
Is elevated maternal serum alpha-fetoprotein in the second trimester of pregnancy associated with increased preterm birth risk? A systematic review and meta-analysis.
Maternal and biochemical predictors of spontaneous preterm birth among nulliparous women: a systematic analysis in relation to the degree of prematurity.
Second-trimester maternal serum levels of alpha-fetoprotein and the subsequent risk of sudden infant death syndrome.
The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications.
The Preterm Prediction Study: the value of serum alkaline phosphatase, alpha-fetoprotein, plasma corticotropin-releasing hormone, and other serum markers for the prediction of spontaneous preterm birth.
The Preterm Prediction Study: toward a multiple-marker test for spontaneous preterm birth.
What we have learned about the predictors of preterm birth.
[Fetal fibronectin--biomarker for preterm labour]
Prostatic Neoplasms
Assessment of 54 biomarkers for biopsy-detectable prostate cancer.
Biologic markers in cancer diagnosis and treatment.
Doctor's dilemma: incorporating tumor markers into clinical decision-making.
Embryonal carcinoma of the testis associated with prostate cancer in a 72-year-old man.
Expression of alpha-fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reaction.
Vertical flow assays based on core-shell SERS nanotags for multiplex prostate cancer biomarker detection.
[Metastasis and markers]
Protein Deficiency
The expression of growth-arrest genes in the liver and kidney of the protein-restricted rat fetus.
Proteinuria
Fetal proteinuria in diagnosis of congenital nephrosis detected by raised alpha-fetoprotein in maternal serum.
Mechanisms by which amniotic-fluid alpha-fetoprotein may be increased in fetal abnormalities.
Protective effect of metformin on a rat model of lipopolysaccharide-induced preeclampsia.
Pruritus
LPAC syndrome associated with deletion of the full exon 4 in a ABCB4 genetic mutation in a patient with hepatitis C.
Psoriasis
MM-093, a recombinant human alpha-fetoprotein for the potential treatment of rheumatoid arthritis and other autoimmune diseases.
Puberty, Precocious
An immunohistochemical study of hepatoblastoma producing human chorionic gonadotropin.
Dysgerminoma of the ovary with precocious puberty: a case report.
Gonadotropin releasing hormone-independent precocious puberty in a 5 year-old girl with suprasellar germ cell tumor secreting beta-hCG and alpha-fetoprotein.
Hepatoblastoma presenting as precocious puberty: a case report.
Pediatric germ cell and human chorionic gonadotropin-producing tumors. Clinical and laboratory features.
Pineal region tumors: endocrinological aspects.
Pulmonary Blastoma
Alpha-fetoprotein producing pulmonary blastoma in a patient with systemic sclerosis: pathogenetic analysis.
Pulmonary blastoma with germ cell (yolk sac) differentiation: report of two cases.
[An autopsied case of pulmonary blastoma with high serum alpha-fetoprotein and carcinoembryonic antigen levels]
Pulmonary Fibrosis
[A case of cavernous hemangioma of the testis]
Pyelectasis
Fetal pyelectasis and Down syndrome: is genetic amniocentesis warranted?
Rectal Neoplasms
Alpha-fetoprotein-producing early rectal carcinoma: a rare case report and review.
Alpha-fetoprotein-producing rectal cancer: calculated tumor marker doubling time.
[A case of alpha-fetoprotein producing rectal cancer]
[A case with rectal cancer showing a high level of serum alpha-fetoprotein]
[Case of rectal cancer with high level of serum alpha-fetoprotein]
[Establishment of alpha-fetoprotein producing human rectal cancer cell line (RKK-YK) and its features]
Respiratory Distress Syndrome
[Alpha-fetoprotein and neonatology: Postnatal estimation of gestational age and idiopathic respiratory distress syndrome (author's transl)]
Retinoblastoma
Advances in biological markers for cancer.
Rh Isoimmunization
Alpha-fetoprotein in amniotic fluid and serum from pregnant women with severe rhesus isoimmunization.
Alpha-fetoprotein levels in amniotic fluid in pregnancies complicated by rhesus isoimmunization.
Midtrimester Rh sensitization associated with circulating anticardiolipin antibodies and elevated maternal serum alpha-fetoprotein. A case report.
[Alpha-fetoprotein in the amniotic fluid in pregnancies at high risk for congenital fetal defect and Rh isoimmunization]
Rhabdomyosarcoma
Alpha-fetoprotein producing rhabdomyosarcoma of the adult liver.
Alpha-fetoprotein production by rhabdomyosarcoma of the urinary bladder.
Testicular sex cord-stromal tumors in children: clinicopathologic study of sixteen children with review of the literature.
Testicular tumors in children.
Sarcoma
Carcinogenicity of aflatoxin B1 in rhesus monkeys: two additional cases of primary liver cancer.
Cervical sarcoma botryoides and ovarian Sertoli-Leydig cell tumor.
Increased production of alpha-fetoprotein by cyclic 3',5'-adenosine monophosphate-treated Yoshida ascites sarcoma cells in vitro.
The influence of alpha-fetoprotein on Moloney sarcoma virus oncogenesis: evidence for generation of antigen nonspecific suppressor T cells.
[A case report of uterine carcinosarcoma with alpha-fetoprotein (AFP) production]
Sarcoma, Avian
Antitumoral gene-based strategy involving nitric oxide synthase type III overexpression in hepatocellular carcinoma.
Nitric Oxide Synthase Type III Overexpression By Gene Therapy Exerts Antitumoral Activity In Mouse Hepatocellular Carcinoma.
Sarcoma, Endometrial Stromal
[A case report of uterine carcinosarcoma with alpha-fetoprotein (AFP) production]
Sarcoma, Kaposi
Eosinophilic globules in Kaposi's sarcoma. A histochemical, immunohistochemical, and ultrastructural study.
Sarcoma, Yoshida
alpha-Fetoprotein detected in rat transplantable hepatomas by radioimmunoassay.
Alpha-Fetoprotein synthesis in cultured cells: studies on Yoshida sarcoma and ascites hepatoma in vitro.
Sarcopenia
Association Between Sarcopenia and AFP Level in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.
Sarcopenia and Alpha-fetoprotein Level in Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation: In Response.
Skeletal Muscle Depletion Predicts the Prognosis of Patients With Hepatocellular Carcinoma Treated With Radiotherapy.
Schistosomiasis
Spontaneous regression of hepatocellular carcinoma.
Scleroderma, Systemic
Alpha-fetoprotein producing pulmonary blastoma in a patient with systemic sclerosis: pathogenetic analysis.
Rheumatic syndromes: clues to occult neoplasia.
Seizures
Interstitial deletion of the long arm of chromosome 4 [del(4)(q21.22q23)] and a liver tumor.
Management of epilepsy in women of childbearing age: practical recommendations.
Seminoma
A human testicular germ cell tumor with borderline histology between seminoma and embryonal carcinoma secreted beta-human chorionic gonadotropin and alpha-fetoprotein only as a xenograft.
Alpha-fetoprotein (AFP) and human chorionic gonadotropin (HCG) in testicular germ cell tumours. A comparison of histologic and serologic occurrence of tumour markers.
Alpha-fetoprotein (AFP) and human chorionic gonadotropin (HCG) in testicular germ cell tumours. A prospective immunohistochemical study.
Analysis of a non-ras 21-kDa protein in patients with metastatic testicular germ-cell tumors.
Biochemical markers for testicular germ-cell tumors in relation to histology and stage: some experiences from the Danish testicular cancer (DATECA) Study from 1976 through 1981.
Biological markers in urologic cancer.
Clinical evaluation of basic fetoprotein in testicular cancer.
Comparative immunohistochemical characterization of canine seminomas and Sertoli cell tumors.
Detection of alpha-fetoprotein mRNA in seminoma.
Elevated lactate dehydrogenase isoenzyme 1 as a tumour marker in patients with germ cell testicular tumours.
False positivity with one-step and conventional ELISA for alpha-fetoprotein in seminoma.
Fine needle aspiration cytology of primary mediastinal germ cell tumors.
Giant Testicular Seminoma.
Histologically pure seminoma with elevated alpha-fetoprotein: a clinicopathologic study of ten cases.
Human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP) in sera and tumor cells of patients with testicular seminoma: a prospective study.
Hypothesis: when is a seminoma not a seminoma?
Immunohistochemical and radioimmunological determination of beta-HCG and pregnancy-specific beta 1-protein in seminomas.
Immunohistochemical comparison between anaplastic seminoma and typical seminoma.
Immunohistochemical ferritin in testicular seminoma.
Large mononuclear cells in seminoma--an immunohistochemical analysis of 21 cases.
Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 cases.
MicroRNAs in testicular cancer: implications for pathogenesis, diagnosis, prognosis and therapy.
Multiple biochemical tumor markers in seminoma. A double-blind study.
Nonpalpable testicular pure seminoma with elevated serum alpha-fetoprotein presenting with retroperitoneal metastasis: a case report.
Patterns of seminoma tissue markers and deletions.
Prediction of necrosis after chemotherapy of advanced germ cell tumors: results of a prospective multicenter trial of the German Testicular Cancer Study Group.
Primary chemotherapy followed by a selective retroperitoneal lymphadenectomy in the management of clinical stage II testicular carcinoma: a preliminary report.
Primary prostatic endodermal sinus tumor (yolk sac tumor) combined with a small focal seminoma.
Quantification of alpha-fetoprotein and beta-HCG in testis tumor patients.
Radiation therapy: a primary treatment modality for seminoma.
Recent developments in the pathology of germ cell tumors.
Results of retroperitoneal lymph node dissection after chemotherapy in patients with pure seminoma in the orchidectomy specimen but elevated serum alpha-fetoprotein.
Retroperitoneal Histologic Findings of Patients With Elevated Serum Alpha-fetoprotein and Pure Seminoma at Orchiectomy.
Retroperitoneal Metastatic Germ Cell Tumor Presenting as a Psoas Abscess: A Diagnostic Pitfall.
Reversible increase in serum alpha-fetoprotein content associated with hepatic dysfunction during chemotherapy for seminoma.
Seminoma with conspicuous signet ring cells: a rare, previously uncharacterized morphologic variant.
Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma.
Synthesis of alpha-fetoprotein and some other serum proteins in testicular tumors.
The differential diagnosis of yolk sac tumor and seminoma. Usefulness of cytokeratin, alpha-fetoprotein, and alpha-1-antitrypsin immunoperoxidase reactions.
The role of alpha-fetoprotein and human chorionic gonadotropin in seminoma.
Tubular seminoma. An immunohistochemical and DNA flow-cytometric study of four cases.
Tumor markers and 18F-FDG PET/CT after orchiectomy in seminoma: Is there any correlation?
Tumor markers and18F-FDG PET/CT after orchiectomy in seminoma:Is there any correlation?
When is a seminoma not a seminoma? The incidence, risk factors and management of patients with testicular seminoma with discordant elevated serum alpha-fetoprotein.
[A Clinicopathologic Study of 6 Patients with Histologically Pure Seminoma But Elevated Serum Alpha-Fetoprotein].
[Alpha-fetoprotein and chorionic gonadotropin in seminoma of the testis]
[Importance of the intracellular detection of alpha-fetoprotein and beta-human chorionic gonadotropin in a testicular tumor using immunoperoxidase]
[Radioimmunologic serum determinations of alpha-fetoprotein in patients with tumors of the testis (author's transl)]
[Testicular tumors: association between preoperative clinical, radiological and immuno-serological factors, and histology and stage]
Sepsis
An IgM lambda antibody to Escherichia coli produces false-positive results in multiple immunometric assays.
Neonatal hemochromatosis in monochorionic twins.
The extrahepatic events of Asian patients with primary biliary cholangitis: A 30-year cohort study.
Sertoli-Leydig Cell Tumor
Androblastoma and raised serum alpha-fetoprotein with familial multinodular goitre. Case report.
Cervical sarcoma botryoides and ovarian Sertoli-Leydig cell tumor.
Elevated serum alpha-fetoprotein associated with Sertoli-Leydig cell tumors of the ovary.
Expression of alpha-fetoprotein by ovarian Sertoli-Leydig cell tumors. Case report and review of the literature.
Frequency of alpha-fetoprotein production by Sertoli-Leydig cell tumors of the ovary: an immunohistochemical study of eight cases.
Late presentation of an alpha-fetoprotein secreting isolated large upper abdominal retroperitoneal Sertoli-Leydig cell tumor recurrence.
Ovarian Sertoli-Leydig cell tumor with elevated serum alpha-fetoprotein.
Ovarian Sertoli-Leydig cell tumor with heterologous elements of gastrointestinal type associated with elevated serum alpha-fetoprotein level: an unusual case and literature review.
Ovarian Sertoli-Leydig cell tumor with heterologous gastrointestinal epithelium as a source of alpha-fetoprotein: a case report.
Ovarian Sertoli-Leydig cell tumor with retiform and heterologous components. Report of a case with hepatocytic differentiation and elevated serum alpha-fetoprotein.
Raised serum alpha-fetoprotein in Sertoli-Leydig cell tumor (androblastoma) of ovary: report of two cases.
Recurrent alpha-fetoprotein secreting Sertoli-Leydig cell tumor of ovary with an unusual presentation.
Sertoli Leydig cell tumor with malignant heterologous elements and raised alpha-fetoprotein: a case report.
Sertoli-Leydig cell tumor of the ovary producing alpha-fetoprotein.
Sertoli-Leydig cell tumor of the ovary with alpha-fetoprotein production.
Sertoli-Leydig cell tumor of the ovary: a rare cause of amenorrhea.
[A case of ovarian Sertoli-Leydig cell tumor associated with high serum alpha-fetoprotein (AFP) concentration]
Sex Chromosome Aberrations
Maternal serum alpha-fetoprotein screening and fetal chromosome anomalies: is lowering maternal age for amniocentesis preferable?
Siderosis
Neonatal hemochromatosis in monochorionic twins.
Single Umbilical Artery
Prenatal diagnosis of omphalocele associated with umbilical cord cyst.
Skin Diseases
Role of elevated alpha-fetoprotein in prenatal diagnosis of junctional epidermolysis bullosa and pyloric atresia.
Small Cell Lung Carcinoma
Markers and characteristics of human SCLC cell lines. Neuroendocrine markers, classical tumor markers, and chromosomal characteristics of permanent human small cell lung cancer cell lines.
Solitary Pulmonary Nodule
The Efficacy of Serum Carcinoembryonic Antigen (CEA), Cancer Antigen 125 (CA125), Carbohydrate Antigen 19-9 (CA19-9), Carbohydrate Antigen 15-3 (CA15-3), alpha-Fetoprotein (AFP) and Human Chorionic Gonadotropin (hCG) Levels in Determining the Malignancy of Solitary Pulmonary Nodules.
Spina Bifida Cystica
Alpha-fetoprotein screening for open spina bifida: effect of routine biparietal diameter measurement to estimate gestational age.
Amniotic and maternal serum alpha-fetoprotein levels of rats with induced neural tube defects.
Amniotic fluid alpha-fetoprotein levels in anencephaly and open spina bifida: validation of median cut-off limits.
Amniotic-fluid alpha-fetoprotein measurement in antenatal diagnosis of anencephaly and open spina bifida in early pregnancy. Second report of the U.K. Collaborative Study on Alpha-fetoprotein in Relation to Neural-tube Defects.
Can gestational dates routinely derived from very early ultrasound be used to interpret maternal serum alpha-fetoprotein measurements?
Concanavalin A binding of alpha-fetoprotein in amniotic fluid as an aid in the diagnosis of neural tube defects.
Elevated maternal serum AFP and normal ultrasound: what next?
Estimating an individual's risk of having a fetus with open spina bifida and the value of repeat alpha-fetoprotein testing. Fourth report of the UK collaborative study on alpha-fetoprotein in relation to neural tube defects.
First trimester maternal serum alpha-fetoprotein is not raised in pregnancies with open spina bifida.
Levels of alpha-fetoprotein in amniotic fluids of mice (curly-tail) with neural tube defects.
Maternal serum alpha-fetoprotein levels in pregnancies among black and white women with fetal open spina bifida: a United States collaborative study.
Midtrimester screening for open neural tube defects: correlation of sonography with amniocentesis results.
Nomogram for estimating an individual's risk of having a fetus with open spina bifida.
Prenatal diagnosis of diastematomyelia: presentation of eight cases and review of the literature.
Prenatal diagnosis of open and closed spina bifida.
Prenatal diagnosis, fetal surgery, recurrence risk and differential diagnosis of neural tube defects.
Ratio of amniotic fluid acetylcholinesterase to pseudocholinesterase as an antenatal diagnostic test for exomphalos and gastroschisis.
Ratio of immunochemically determined amniotic fluid acetylcholinesterase to butyrylcholinesterase in the differential diagnosis of fetal abnormalities.
Should maternal alpha-fetoprotein estimation be carried out in centers where ultrasound screening is routine? A sensitivity analysis approach.
Survival of infants with open spina bifida in relation to maternal serum alpha-fetoprotein level. Third report of the UK collaborative study on alpha-fetoprotein in relation to neural-tube defects.
Tables for estimation of individual risks of fetal neural tube and ventral wall defects, incorporating prior probability, maternal serum alpha-fetoprotein levels, and ultrasonographic examination results.
The California Maternal Serum alpha-Fetoprotein Screening Program: the role of ultrasonography in the detection of spina bifida.
The effect of adjusting maternal serum alpha-fetoprotein levels for maternal weight in pregnancies with fetal open spina bifida. A United States collaborative study.
[Prenatal diagnosis of anencephaly and open spina bifida by combined use of amniotic or maternal serum alpha-fetoprotein and maternal urine estrogen/creatinine ratio (author's transl)]
Spinal Dysraphism
A G-->A substitution in an HNF I binding site in the human alpha-fetoprotein gene is associated with hereditary persistence of alpha-fetoprotein (HPAFP).
Alpha-fetoprotein in antenatal diagnosis of anencephaly and spina bifida.
Alpha-fetoprotein in serum and amniotic fluid in the diagnosis of neonatal hepatitis syndrome, Indian childhood cirrhosis, cystic fibrosis, ataxia telangiectasia and spina bifida.
Alpha-fetoprotein in the antenatal diagnosis of anencephaly and spina bifida.
Alpha-fetoprotein testing: opinions of parents of children with spina bifida.
Amniotic fluid alpha-fetoprotein as a marker in prenatal diagnosis of neural tube defects.
Amniotic-fluid alpha-fetoprotein in the antenatal diagnosis of spina bifida.
Antecedent circumstances surrounding neural tube defect births in 1990-1991. The Steering Committee of the National Confidential Enquiry into Counselling for Genetic Disorders.
Comparison of amniotic-fluid and maternal serum alpha-fetoprotein levels in the early antenatal diagnosis of spina bifida and anencephaly.
Cost-benefit analysis of targeted ultrasonography for prenatal detection of spina bifida in patients with an elevated concentration of second-trimester maternal serum alpha-fetoprotein.
Determination of subfractions of amniotic fluid alpha-fetoprotein in diagnosing spina bifida and congenital nephrosis.
Early antenatal diagnosis of spina bifida in a twin fetus by ultrasonic examination and alpha-fetoprotein estimation.
Early prenatal diagnosis of neural-tube defects by ultrasound-guided fetoscopy.
Effects of folate deficiency on embryonic development.
Impact on spina bifida screening of shifting prenatal Down syndrome maternal serum screening from the second trimester to the first.
Is routine AFP screening in pregnancy reassuring?
Maternal serum alpha-fetoprotein in fetal neural tube and abdominal wall defects at 10 to 14 weeks of gestation.
Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects.
Polyacrylamide gel electrophoresis of amniotic fluid cholinesterases: a good prenatal test for neural tube defects.
Prenatal diagnosis of structural abnormalities.
Prenatal screening and diagnosis of neural tube defects in England and Wales in 1985.
Protein measurements in the early prenatal diagnosis of spina bifida.
Reactivity of amniotic fluid alpha-fetoprotein with concanavallin A in diagnosis of neural tube defects.
Relationship between some obstetric landmarks and the concentration of alpha-fetoprotein in maternal blood.
Role of Maternal Serum Alpha-Fetoprotein and Ultrasonography in Contemporary Detection of Spina Bifida.
Screening for neural tube defects.
Should maternal alpha-fetoprotein estimation be carried out in centers where ultrasound screening is routine? A sensitivity analysis approach.
Spina bifida: early antenatal diagnosis using amniotic fluid alpha-fetoprotein heterogeneity.
Spinal Hamartoma with Severe Kyphoscoliosis - A Rare Case of Spinal Mass in a Fetus.
The California Maternal Serum alpha-Fetoprotein Screening Program: the role of ultrasonography in the detection of spina bifida.
The improvement of the antenatal detection of fetal neural tube defects using discriminant analysis.
The molecular nature of alpha-fetoprotein in anencephaly and spina bifida.
The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-1991.
Trends in clinical characteristics of infants with spina bifida--Atlanta, 1972-1979.
Ultrasound and amniotic fluid alpha-fetoprotein in the prenatal diagnosis of spina bifida.
[Acrania and spina bifida diagnosed by alpha-fetoprotein determination in 16th week of pregnancy]
[Contents of alpha-fetoprotein in the blood of pregnant women as a criterion of the presence of congenital heart defects in the fetus]
[Unusual course of alpha-fetoprotein levels in a case of spina bifida detected by prenatal diagnosis]
Spinocerebellar Ataxias
Autosomal recessive spinocerebellar ataxia and peripheral neuropathy with raised alpha-fetoprotein.
Exome analysis reveals a Japanese family with spinocerebellar ataxia, autosomal recessive 1.
Familial spinocerebellar ataxia with cerebellar atrophy, peripheral neuropathy, and elevated level of serum creatine kinase, gamma-globulin, and alpha-fetoprotein.
Spinocerebellar Degenerations
Beyond Typical Ataxia Telangiectasia: How to Identify the Ataxia Telangiectasia-Like Disorders.
Identification and characterisation of a large Senataxin (SETX) gene duplication in ataxia with ocular apraxia type 2 (AOA2).
Stillbirth
A rat model of placental inflammation explains the unexplained elevated maternal serum alpha-fetoprotein associated with adverse pregnancy outcomes.
First-trimester maternal serum alpha-fetoprotein is not a good predictor for adverse pregnancy outcomes: a retrospective study of 3325 cases.
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data.
Protective effect of metformin on a rat model of lipopolysaccharide-induced preeclampsia.
Second-trimester maternal serum alpha-fetoprotein (MSAFP) is elevated in women with adverse pregnancy outcome associated with inherited thrombophilias.
Second-trimester maternal serum levels of alpha-fetoprotein and the subsequent risk of sudden infant death syndrome.
Significance of opaque discolored amniotic fluid at second-trimester amniocentesis.
Study of the relationship between elevated maternal serum alpha-fetoprotein and adverse pregnancy outcome.
Stomach Neoplasms
A case of alpha-fetoprotein-producing gastric cancer showing an exogastric growth pattern.
A case of alpha-fetoprotein-producing gastric cancer.
A case report of targeted therapy with apatinib in a patient with advanced gastric cancer and high serum level of alpha-fetoprotein.
A rare case of alpha-fetoprotein-producing early gastric cancer.
A rare case of recurrent alpha-fetoprotein-producing gastric cancer without re-elevation of serum AFP.
Alpha-fetoprotein for Gastric Cancer Staging: An Essential or Redundant Tumor Marker?
Alpha-fetoprotein is a significant prognostic factor for gastric cancer: Results from a propensity score matching analysis after curative resection.
Alpha-fetoprotein producing gastric cancer lacks transcription factor ATBF1.
Alpha-fetoprotein producing gastric cancer.
Alpha-fetoprotein- and des-gamma-carboxy prothrombin-producing advanced gastric cancer.
Alpha-fetoprotein-producing early gastric cancer accompanying liver cirrhosis: a case report.
Alpha-fetoprotein-producing early gastric cancer: report of two cases.
Alpha-Fetoprotein-Producing Gastric Cancer with Nonbiliary Pancreatitis.
Alpha-fetoprotein-producing gastric cancer.
Alpha-fetoprotein-producing gastric cancer: histochemical analysis of cell proliferation, apoptosis, and angiogenesis.
Alteration of the AT motif binding factor-1 expression in alpha-fetoprotein producing gastric cancer: is it an event for differentiation and proliferation of the tumors?
An isolate alpha-fetoprotein producing gastric cancer liver metastasis emerged in a patient previously affected by radiation induced liver disease.
ANGPTL6-mediated angiogenesis promotes alpha fetoprotein-producing gastric cancer progression.
Biological aggressiveness of alpha-fetoprotein (AFP)-positive gastric cancer.
c-Met expression in a gastric cancer cell line producing alpha-fetoprotein.
Carcino-fetal proteins and gastric cancer: the site of alpha-fetoprotein synthesis in gastric cancer.
Chemotherapy for alpha-fetoprotein producing gastric cancers expressing human epidermal growth factor receptor 2.
Clinical characteristics and treatments of patients with alpha-fetoprotein producing gastric carcinoma.
Clinical manifestations in patients with alpha-fetoprotein-producing gastric cancer.
Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: analysis of 104 cases.
Clinicopathologic features of gastric cancers producing alpha-fetoprotein.
Clinicopathological characteristics and prognosis of alpha-fetoprotein positive gastric cancer in Chinese patients.
Clinicopathological features of alpha-fetoprotein producing early gastric cancer with enteroblastic differentiation.
Clinicopathological features of early gastric cancer: results of 100 cases from a rural general hospital.
Clinicopathological variables associated with lymph node metastasis in submucosal invasive gastric cancer.
Co-expression of N-cadherin and alpha-fetoprotein in stomach cancer.
Combined Detection of Exosome Concentration and Tumor Markers in Gastric Cancer.
Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers.
Des-gamma carboxy prothrombin (PIVKA-II) and alpha-fetoprotein producing gastric cancer with multiple liver metastases.
Des-gamma carboxy prothrombin (PIVKA-II)- and alpha-fetoprotein (AFP)-producing gastric cancer.
Detection of tumor cells in peritoneal lavages from patients with gastrointestinal cancer by multiplex reverse transcriptase PCR.
Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
Diagnostic value of serum tumor markers in skeletal metastasis of carcinomas.
Double cancer of the stomach, one AFP-producing tumor.
Dynamic Change in Serum Alpha-fetoprotein Level Predicts Treatment Response and Prognosis of Alpha-fetoprotein-producing Gastric Cancer.
Establishment of an alpha-fetoprotein-producing gastric cancer cell line in serum-free media.
Evaluation of VEGF and VEGF-C expression in gastric cancer cells producing alpha-fetoprotein.
Expression of AFP and STAT3 is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in AFP-producing gastric cancer cells.
Expression of CD24, p21, p53, and c-myc in alpha-fetoprotein-producing gastric cancer: Correlation with clinicopathologic characteristics and survival.
Expression of liver-enriched nuclear factors and their isoforms in alpha-fetoprotein-producing gastric carcinoma cells.
Extremely high expression of serum alpha-fetoprotein level of gastric adenocarcinoma: a rare case with an unexpected well-prognosis.
Focus on small lesion of alpha-fetoprotein producing gastric cancer.
Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature.
Genetic alterations of the ATBF1 gene in gastric cancer.
High frequency of c-Met expression in gastric cancers producing alpha- fetoprotein.
High level of expression of alpha-fetoprotein receptor in gastric cancers.
Immunocytochemical presentation of alpha-fetoprotein-producing gastric cancer in ascitic fluid: a case study.
Immunohistochemical expression profiles of solute carrier transporters in alpha-fetoprotein-producing gastric cancer.
Impact of preoperative serum carcinoembryonic antigen, CA 19-9 and alpha fetoprotein levels in gastric cancer patients.
Long-term results of gastrectomy for alpha-fetoprotein-producing gastric cancer.
Long-term survival achieved by repeated resections of metachronous pulmonary and adrenal metastases of alpha-fetoprotein-producing gastric cancer: report of a case.
Measurements of serum C-reactive protein levels in patients with gastric cancer and quantification using silicon nanowire arrays.
miR-122-5p as a novel biomarker for alpha-fetoprotein-producing gastric cancer.
Novel characteristics of alpha-fetoprotein (AFP)-producing gastric cancer.
Occurrence of alpha-fetoprotein, Regan isoenzyme, and variant alkaline phosphatase in the serum of a patient with gastric cancer.
Overexpression of P-glycoprotein in untreated AFP-producing gastric carcinoma.
Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP.
Preoperative serum levels of CA 72-4, CEA, CA 19-9, and alpha-fetoprotein in patients with gastric cancer.
Production of alpha-fetoprotein, normal serum proteins, and human chorionic gonadotropin in stomach cancer: histologic and immunohistochemical analyses of 35 cases.
Prognostic significance of tumour markers in Chinese patients with gastric cancer.
Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
Prognostic value of serum alpha-fetoprotein levels in patients with gastric cancer: a meta-analysis.
Prognostic values of normal preoperative serum cancer markers for gastric cancer.
Prolonged Survival in a Case of Chemotherapy-Sensitive Gastric Cancer That Produced Alpha-Fetoprotein and Protein Induced by Vitamin K Antagonist-II.
Resection of liver metastasis derived from alpha-fetoprotein-producing gastric cancer-report of 4 cases.
Resection of liver metastasis from alpha-fetoprotein-producing early gastric cancer: report of a case.
Ruptured metastatic liver tumor from an alpha-fetoprotein-producing gastric cancer.
Serum alpha-fetoprotein subfractions identified by Ricinus communis agglutinin I in hepatic malignancies, yolk sac tumor, benign hepatic diseases, and fetal stage.
Serum alpha-fetoprotein subfractions in hepatic malignancies identified by different reactivities with concanavalin A, lentil lectin or phytohemagglutinin-E.
Serum alpha-fetoprotein subfractions in patients with primary hepatoma or hepatic metastasis of gastric cancer.
Significant response to ramucirumab monotherapy in chemotherapy-resistant recurrent alpha-fetoprotein-producing gastric cancer: A case report.
Study of Fe?O?-PPy Core-Shell Nanocomposite in the Diagnosis of Tumor Markers in the Tissues of Early Gastric Cancer Patients.
Successful paclitaxel-based chemotherapy for an alpha-fetoprotein-producing gastric cancer patient with multiple liver metastases.
Successful resection of metachronous liver metastasis from alpha-fetoprotein-producing gastric cancer: report of a case.
Successfully treated metachronous liver metastasis of alpha-fetoprotein-producing early gastric cancer: case report.
The clinicopathological features and prognosis of serum AFP positive gastric cancer: a report of 16 cases.
Tumor thrombus in the splenic vein originated from gastric carcinoma that produced alpha-fetoprotein.
Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets.
Xenotransplantation of alpha-fetoprotein-producing gastric cancers into nude mice. Characteristics and responses to chemotherapy.
[A case of postoperative liver metastasis of alpha-fetoprotein producing gastric cancer successfully treated with intrahepatic chemotherapy (adriamycin, cisplatin, irinotecan hydrochloride)]
[Alpha-fetoprotein producing gastric cancer responding to combined chemotherapy with UFT and adriamycin]
[Alpha-fetoprotein producing gastric cancer transplanted into athymic nude mice (author's transl)]
[Alpha-fetoprotein. 3. Evaluation of alpha-fetoprotein in gastric cancer and its liver metastasis]
[Carcinoembryonic antigen and alpha-fetoprotein in stomach cancer]
[Carcinoembryonic antigen, alpha-fetoprotein and human chorionic gonadotropin producing gastric cancer]
[Case of stomach cancer producing alpha-fetoprotein]
[Clinicopathological characteristics and prognosis of alpha-fetoprotein producing gastric cancer].
[Complete remission with FLEP chemotherapy for multiple liver metastasis from alpha-fetoprotein-producing gastric cancer--report of a case]
[Gastric cancer with liver metastasis producing alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist II (PIVKA-II); a case report]
[Significance of AFP in gastric cancer]
[The effect of anti-human AFP serum for AFP producing stomach cancer xenotransplanted nude mice]
[The prognosis and clinicopathological characteristics of 70 gastric cancer patients with elevated serum AFP].
[Two cases of alpha-fetoprotein producing early gastric cancers]
[Two cases of alpha-fetoprotein producing gastric cancer, showing marked response to continuous hepatic arterial infusion (HAI) chemotherapy with adriamycin]
[Utility of measurement of tumor markers for preoperative staging of gastric cancer]
Superior Vena Cava Syndrome
Alpha-fetoprotein elevation in NUT midline carcinoma: a case report.
Characteristics of thymoma successfully resected by videothoracoscopic surgery.
Primary mediastinal seminoma.
Tachycardia, Supraventricular
Polyhydramnios and elevated amniotic fluid alpha-fetoprotein caused by fetal supraventricular tachycardia.
Telangiectasis
Ataxia-pancytopenia syndrome.
Ataxia-without-telangiectasia. Progressive multisystem degeneration with IgE deficiency and chromosomal instability.
Beyond Typical Ataxia Telangiectasia: How to Identify the Ataxia Telangiectasia-Like Disorders.
Cytogenetic anomalies in a patient with ataxia, immune deficiency, and high alpha-fetoprotein in the absence of telangiectasia.
Further delineation of the Nijmegen breakage syndrome.
Identification and functional consequences of a novel MRE11 mutation affecting 10 Saudi Arabian patients with the ataxia telangiectasia-like disorder.
Mutation analysis of the ATM gene in two Chinese patients with ataxia telangiectasia.
Novel ATM mutations with ataxia-telangiectasia.
Radioresistant DNA synthesis and human genetic diseases.
Report of a Family with Fanconi Anemia and Ataxia-Telangiectasia.
Six Novel ATM Gene Variants in Sri Lankan Patients with Ataxia Telangiectasia.
Teratocarcinoma
alpha-Fetoprotein (AFP), human chorionic gonadotropin (HCG), and carcinoembryonic antigen (CEA) demonstrated in the immature glands of mediastinal teratocarcinoma: a case report.
Discordance of human chorionic gonadotropin and alpha-fetoprotein in testicular teratocarcinomas.
Endogenous and transfected mouse alpha-fetoprotein genes in undifferentiated F9 cells are activated in transient heterokaryons.
Immature teratoma of the ovary.
Immunocytochemical quantitative study of alpha-fetoprotein in normal and neoplastic neural development.
Induction of alpha-fetoprotein synthesis in differentiating F9 teratocarcinoma cells is accompanied by a genome-wide loss of DNA methylation.
Localization of alpha-fetoprotein in transplantable murine teratocarcinomas.
Locus unlinked to alpha-fetoprotein under the control of the murine raf and Rif genes.
Primary chemotherapy followed by a selective retroperitoneal lymphadenectomy in the management of clinical stage II testicular carcinoma: a preliminary report.
Retinoic acid differentially regulates retinoic acid receptor-mediated pathways in the Hep3B cell line.
Synthesis of alpha-fetoprotein and some other serum proteins in testicular tumors.
The ontogeny of expression of murine metallothionein: comparison with the alpha-fetoprotein gene.
[Comparative analysis of expression of TGFbeta family factors and their receptors in mouse embryonic stem and embryonic teratocarcinoma cells]
[Immunological localization of alpha-fetoprotein in the proximal endoderm and its significance in extra-embryonic differentiation of teratocarcinomas in the mouse]
[Radioimmunologic serum determinations of alpha-fetoprotein in patients with tumors of the testis (author's transl)]
Teratoma
A preterm infant with an extradural myxopapillary ependymona component of a teratoma and high levels of alpha-fetoprotein.
A Rare Manifestation of Cervical Yolk Sac Tumor in an Unfortunate Infant.
AFP in yolk sac tumor and solid teratoma of the ovary: significance of postoperative serum AFP.
Alpha-fetoprotein and mediastinal germ cell tumors.
Alpha-fetoprotein and teratomas of the testis.
Alpha-fetoprotein following neonatal resection of sacrococcygeal teratoma.
Alpha-fetoprotein in intracranial malignant teratoma.
Alpha-fetoprotein in ovarian teratoma with glial implants on the peritoneum.
Alpha-fetoprotein in the management of germ cell tumors of the ovary.
Alpha-fetoprotein levels correlate with the pathologic grade and surgical outcomes of pediatric retroperitoneal teratomas.
Alpha-fetoprotein localization in pure ovarian teratoma. An immunohistochemical study of 12 cases.
Alpha-fetoprotein production by pancreatic tumors exhibiting acinar cell differentiation: study of five cases, one arising in a mediastinal teratoma.
Alpha-fetoprotein subfractions in germ cell tumors identified by Con A or LCH crossed-line affinity immunoelectrophoresis.
An elevated maternal serum alpha-fetoprotein leading to the diagnosis of an immature teratoma.
Apoptosis and proliferative activity in mature and immature teratomas of the mediastinum.
Benign metachronous bilateral ovarian and mediastinal teratomas with an elevated alpha-fetoprotein.
Case report: a preterm infant with an extradural myxopapillary ependymoma component of a teratoma and high levels of alpha-fetoprotein.
Combined cystic teratoma and hepatoblastoma of the liver. Probable divergent differentiation of an uncommitted hepatic precursor cell.
Congenital malformation syndromes and elevation of amniotic fluid alpha-fetoprotein.
Congenital teratoma: a clinicopathologic study of 22 fetal and neonatal tumors.
Detection of alpha-fetoprotein mRNA in seminoma.
Diagnostic accuracy of serum alpha-fetoprotein levels in diagnosing recurrent sacrococcygeal teratoma: A systematic review.
Differentiated rhabdomyomatous tumors after chemotherapy for metastatic testicular germ-cell tumors: a clinicopathological study of seven cases mandating separation from rhabdomyosarcoma.
Elevated alpha-fetoprotein levels in a woman with ovarian teratoma.
Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma.
Epidemiological and clinical behavior of prepubertal testicular tumors in Korea.
Epidemiological features of testicular teratoma in a prepubertal population.
Establishment and characterization of HUOT, a human ovarian malignant teratoma cell line producing alpha-fetoprotein.
Evidence of malignant features in histologically mature teratoma.
Extreme levels of alpha-fetoprotein in a newborn with a benign intrapericardial teratoma.
Factors affecting functional prognosis in survivors of primary central nervous system germinal tumors.
Generation of induced pluripotent stem cells from newborn marmoset skin fibroblasts.
Germ cell tumor in an adolescent with extensive testicular microlithiasis: concerns regarding future management.
Gliomatosis peritonei. Report of two cases and review of literature.
Half-life of alpha-fetoprotein in neonatal sacrococcygeal teratoma.
Half-life of alpha-fetoprotein in patients with a teratoma, endodermal sinus tumor, or hepatoblastoma.
Immature endodermal teratoma of the ovary: embryologic correlations and immunohistochemistry.
Immature intrapericardial teratoma in a newborn with elevated alpha-fetoprotein.
Immature teratoma of the ovary. Correlation between serum alpha-fetoprotein value and immunohistochemical analysis.
Immature teratoma producing alpha-fetoprotein without components of yolk sac tumor in the pineal region.
Immunocytochemical evidence of heterogeneous origin of alpha-fetoprotein in immature teratoma of the ovary.
Immunocytochemical localization of neuroendocrine hormones and oncofetal antigens in ovarian teratomas.
Improved staging for testicular cancer using biologic tumor markers: a prospective study.
Isolation of three stem cell lines from human sacrococcygeal teratomas.
Long-Term Outcomes of Sacrococcygeal Germ Cell Tumors in Infancy and Childhood.
Long-term survival in malignant intracranial germ-cell tumors: a report of two cases and a review of the literature.
Malignant cervical teratoma: report of a case in a newborn.
Malignant ovarian germ cell tumors in pediatric patients: The AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) study.
Management of pineal non-germinoma germ cell tumor with residual teratoma and normal alpha-fetoprotein.
Maternal serum alpha-fetoprotein and epithelial tumour marker concentrations are not increased by fetal sacrococcygeal teratoma.
Maternal serum alpha-fetoprotein and human chorionic gonadotrophin in a pregnancy complicated by fetal sacrococcygeal teratoma.
Metastatic endodermal sinus tumor: CT appearances.
Nasopharyngeal teratoma. Report of a case with prenatal diagnosis and postnatal management.
Nodal gliomatosis and alpha-fetoprotein production. Two unusual facets of grade I ovarian teratoma.
Non-seminomatous ovarian germ cell tumours in children.
Origin of embryo-derived yolk sac carcinomas.
Ovarian mixed germ cell tumor composed of dysgerminoma, endodermal sinus tumor, choriocarcinoma and mature teratoma in a 44-year-old woman: case report and literature review.
Ovarian mixed germ cell tumor composed of polyembryoma and immature teratoma.
Ovarian teratoma with gliomatosis peritonei.
Ovarian teratoma with peritoneal gliomatosis and elevated serum alpha-fetoprotein.
Ovarian tumors in the pediatric age group: 37 cases treated over an 8-year period.
Percentage of Teratoma in Orchiectomy and Risk of Retroperitoneal Teratoma at the Time of Postchemotherapy Retroperitoneal Lymph Node Dissection in Germ Cell Tumors.
Perinatal (fetal and neonatal) germ cell tumors.
Pineal region teratoma with high serum and CSF alpha-fetoprotein levels.
Progression from an immature teratoma with miliary gliomatosis peritonei to growing teratoma syndrome with nodular gliomatosis peritonei.
Prolonged survival in a patient with disseminated malignant teratoma in the presence of a persistently elevated serum alpha-fetoprotein level.
Rapid growth of congenital diffuse brain tumor considered to be teratoma: case report.
Recurrent immature teratoma: lack of correlation between serum level and immunohistochemical detection of serum alpha-fetoprotein.
Recurrent yolk sac tumor following resection of a neonatal immature gastric teratoma.
Resection of residual masses after chemotherapy for advanced non-seminomatous germ cell tumours, a monocentric analysis of pre-operative prognosticators.
Results of retroperitoneal lymph node dissection after chemotherapy in patients with pure seminoma in the orchidectomy specimen but elevated serum alpha-fetoprotein.
Retroperitoneal immature teratoma producing alpha-fetoprotein.
Retroperitoneal lymph node dissection after chemotherapy in patients with elevated tumour markers: indications, histopathology and outcome.
RNA-binding protein LIN28 is a sensitive marker of pediatric yolk sac tumors.
Robb-Smith type malignant histiocytosis associated with a mediastinal germ cell tumor.
Sacrococcygeal teratoma associated with a normal alpha-fetoprotein concentration.
Sacrococcygeal Teratoma: Clinical Characteristics, Management, and Long-term Outcomes in a Prospective Study from a Tertiary Care Center.
Suprasellar malignant teratoma with 11-year survival--case report.
Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group.
Synthesis of alpha-fetoprotein and some other serum proteins in testicular tumors.
Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
Testicular cancer from diagnosis to epigenetic factors.
Testicular teratoma demanded in-depth pathological exploration to rule out malignancy: A pediatric case report.
The diagnosis of immature teratoma by maternal serum alpha-fetoprotein screening.
The diagnostic value of alpha-fetoprotein in an infant with sacrococcygeal teratoma.
The diagnostic value of alpha-fetoprotein in infants and children with teratomas: a questionnaire survey in Japan.
The histogenetic-embryologic basis for reappearance of alpha-fetoprotein in endodermal sinus tumors (yolk sac tumors) and teratomas.
The significance of alpha-fetoprotein in the serum of patients with malignant teratomas and related gonadal neoplasms.
Tumor markers CA 125 and CA 19-9 in cord blood and during infancy: developmental changes and use in pediatric germ cell tumors.
[A case of immature mediastinal teratoma]
[An unusual renal tumor, associating nephroblastoma, nephroblastomatosis, teratoma, and cystic dysplasia with arterial hypertension and secretion of alpha-fetoprotein]
[Letter: Tissular localization of alpha-fetoprotein from an immature dysembryoma]
[Mediastinal teratomas in children]
[Sacrococcygeal teratoma and normal alpha-fetoprotein levels in the amniotic fluid]
[Serological examinations in children with hepatoma and teratoma of alpha-fetoprotein and alpha-2-H-globulin and the diagnostic and prognostic value (author's transl)]
[Studies on marker substances in cell lines derived from various human gynecologic tumors (author's transl)]
Testicular Neoplasms
A case report of retroperitoneal extrahepatic hepatocellular carcinoma presented with elevated level of Alpha fetoprotein.
A presumed extragonadal germ cell tumor that turned out to be a gastric cancer-a case report.
Adenomatoid tumor of intratesticular localization.
Alpha-fetoprotein and HCG assays in testicular cancer.
Alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
Alpha-fetoprotein half-life as a predictor of residual testicular tumor. Effect of the analytic strategy on test sensitivity and specificity.
Alpha-fetoprotein synthesis in tissue culture of human testicular tumors and an examination of experimental yolk sac tumors in the rat.
Beta-human chorionic gonadotropin and alpha-fetoprotein in central and peripheral venous blood of patients with testicular tumors.
Biological markers in urologic cancer.
Changes in serum alpha-fetoprotein and chorionic gonadotropin in response to cancer therapy.
Chorionic gonadotrophin and alpha-fetoprotein markers for testicular cancer.
Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein.
Comparative immunohistochemical characterization of canine seminomas and Sertoli cell tumors.
Detection of alpha-fetoprotein mRNA in seminoma.
Detection of circulating testicular cancer cells in peripheral blood.
Determination of pre-orchiectomy serum levels of alpha-fetoprotein and human choriogonadotrophin in testicular cancer.
Effect of DTPA conjugation on the antigen binding activity and biodistribution of monoclonal antibodies against alpha-fetoprotein.
Embryonal carcinoma of the testis associated with prostate cancer in a 72-year-old man.
Embryonal carcinoma with falsely positive elevation of serum alpha-fetoprotein after curative therapy: a case report.
Errors in measurement and reporting of serum markers in patients with germ cell tumors.
Experience with serum alpha-fetoprotein and human chorionic gonadotropin in non-seminomatous testicular tumors.
Ferritin - another tumor marker for testicular malignancies.
Hepatoid carcinoma of the lung with production of alpha-fetoprotein and abnormal prothrombin: an autopsy case report.
Hepatoid pancoast tumor. A case report and review of the literature.
Hereditary persistence of alpha-fetoprotein mimicking testicular cancer in a patient with acute epididymitis.
Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer.
Imaging diagnosis of testicular lymphoma.
Immunochemical determination of human chorionic gonadotropin and alpha-fetoprotein in sera and tumors of patients with testicular cancer.
Immunocytochemical discordance in localization of pregnancy specific beta-1 glycoprotein, alpha-fetoprotein and human chorionic gonadotropin in testicular cancers.
In vitro synthesis of alpha-fetoprotein and human chorionic gonadotropin in testicular cancer.
Lactic dehydrogenase in the monitoring and prognosis of testicular cancer.
Late relapse of testicular cancer 21 years after first complete remission: a case report.
Lectin-reactive alpha-fetoprotein as a marker for testicular tumor activity.
Letter: Alpha-fetoprotein and testicular tumours.
Localization of alpha-fetoprotein and human chorionic gonadotropin to specific histologic types of nonseminomatous testicular cancer.
Metastatic non-seminomatous germ cell tumour and dermatomyositis.
Metastatic testicular melanoma. Case report.
Mildly Elevated Serum Alpha-Fetoprotein (AFP) Among Patients With Testicular Cancer May Not Be Associated With Residual Cancer Or Need For Treatment.
Monitoring of patients with non-seminomatous germ cell tumors of the testis by determination of alpha-fetoprotein and beta-human chorionic gonadotropin levels and by computed tomography.
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
Neopterin as tumour marker serum and urinary neopterin concentrations in malignant diseases.
Post-treatment persistent alpha-fetoprotein elevation in a patient with testicular cancer.
Prognostic significance of marker half-life during chemotherapy in non-seminomatous germ cell testicular tumors.
Re: alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
Re: Determination of pre-orchiectomy serum levels of alpha-fetoprotein and human choriogonadotrophin in testicular cancer. Sophie D. Fosså and M. Mason. Br. J. Urol., 69, 108, 1992.
Residual pulmonary nodules after combination chemotherapy of testicular cancer.
Retroperitoneal lymph node dissection in the setting of elevated markers.
Retroperitoneal mass and elevation of alpha-fetoprotein following lymphadenectomy and adjuvant chemotherapy for nonseminomatous testicular cancer.
Role of human chorionic gonadotropin in patients with pure seminoma.
Sarcoidosis and testicular tumors.
Serum alpha-fetoprotein and beta-human chorionic gonadotropin levels in patients with non-seminomatous germ cell testicular cancer.
Serum alpha-fetoprotein and human chorionic gonadotropin as markers for the effect of postoperative radiation therapy and/or chemotherapy in testicular cancer.
Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
Serum alpha-fetoprotein and human chorionic gonadotropin in the treatment of patients with testicular tumors.
Serum alpha-fetoprotein surge after the initiation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significance.
Serum and cellular biologic tumor markers in patients with urologic cancer.
Serum markers in testicular tumors.
Synthesis of alpha-fetoprotein and some other serum proteins in testicular tumors.
Testicular cancer and Hodgkin disease in the same patient.
Testicular Germ Cell Tumors: Serological and Immunohistochemical Diagnosis.
Testicular germ-cell neoplasms: recent advances in diagnosis and therapy.
Testicular mixed germ cell tumor with polyembryoma component in brothers.
Testicular tumour markers in spermatic vein blood.
The role of radioimmunodetection in the management of testicular cancer.
The role of the radioimmunoassay of serum alpha-fetoprotein and human chorionic gonadotropin in the intensive chemotherapy and surgery of metastatic testicular tumors.
The utility of De Ritis Ratio in predicting prognosis in testicular cancer.
The value of alpha-fetoprotein and beta-human chorionic gonadotrophin in the management of testicular tumours.
Tissue alpha-fetoprotein and human chorionic gonadotrophin in non-seminomatous testicular tumours. A comparative study with serum levels.
VAB-6 chemotherapy causes spurious elevation of alpha-fetoprotein associated with liver dysfunctions.
Value correlation of alpha-fetoprotein and human chorionic gonadotropin with the results of lymphadenectomy in non-seminomatous testicular tumours.
Variations in normal serum alpha-fetoprotein (AFP) levels in patients with testicular cancer on surveillance.
[A case report of infantile testicular cancer: dissection of paraaortic lymph node involvement indicated by gradual rise in serum alpha-fetoprotein after orchiectomy]
[A giant testicular tumor detected with dyspnea due to lung metastases: a case report]
[Early changes in serum alpha-fetoprotein after chemotherapy in advanced testicular tumors]
[False-positive elevation of alpha-fetoprotein during induction chemotherapy in patients with testicular cancer]
[Germ cell testicular tumors: understanding the kinetics of serum alpha-fetoprotein (AFP) during chemotherapy]
[High alpha-fetoprotein persistence after orchiectomy. On a case of uncommon etiology].
[Immunohistochemical study of testicular tumor on cellular localization of HCG beta-subunit, alpha-fetoprotein and beta 1-pregnancy specific glycoprotein (author's transl)]
[Importance of the intracellular detection of alpha-fetoprotein and beta-human chorionic gonadotropin in a testicular tumor using immunoperoxidase]
[Introduction to the problem of markers in urologic oncology]
[Limitations of tumor marker surveillance after chemotherapy in advanced non-seminomatous testicular tumors]
[Metastasis and markers]
[Primary carcinoid tumor of the testis: a case report]
[Significance of current bio- and molecular-markers in urological cancers]
[Significance of tumor markers in the treatment of urological malignancies]
[Studies on the tumor markers in the germinal testicular tumors. Cellular localization of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG) and carcinoembryonic antigen (CEA) in germinal testicular tumors using an indirect immunoperoxidase method]
[The current concept of tumor markers in oncologic urology--cytoplasmic markers]
[The diagnostic and prognostic value of tumor markers in nonseminomatous stage-III to -IV testicular tumors]
[Tissue concentrations of alpha-fetoprotein in various testicular tumors]
[Tumor marker in urology]
[Two cases of testicular tumors with high alpha-fetoprotein levels: a case report]
[Value and problems of alpha-fetoprotein determinations in testicular neoplasms]
Tetanus
Transport of proteins across the human placenta.
Thrombocytopenia
Apparent Acetaminophen Toxicity in a Patient with Transaldolase Deficiency.
Neither diabetes mellitus nor overweight is a risk factor for hepatocellular carcinoma in a dual HBV and HCV endemic area: community cross-sectional and case-control studies.
Primary lymphoma of the spleen with hepatocellular carcinoma.
Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma.
Thrombocytosis
A trend of improved survival of childhood hepatoblastoma treated with cisplatin and doxorubicin in Taiwanese children.
Aplasia cutis congenita, elevated alpha-fetoprotein, and a distinct amniotic fluid acetylcholinesterase electrophoretic band.
Embryonal/Fetal subtype hepatoblastoma: a case report.
Patterns of hepatoblastoma and hepatocellular carcinoma in children after universal hepatitis B vaccination in taiwan: a report from a single institution in southern Taiwan.
The effect of chemotherapy on hepatoblastoma.
Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma.
Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma.
Thrombophilia
Second-trimester maternal serum alpha-fetoprotein (MSAFP) is elevated in women with adverse pregnancy outcome associated with inherited thrombophilias.
Thrombosis
A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators.
A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.
A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
A single-center retrospective analysis of liver transplantation on 255 patients with hepatocellular carcinoma.
Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania.
Alpha-fetoprotein and 18F-FDG standard uptake value predict tumor recurrence after liver transplantation for hepatocellular carcinoma with portal vein tumor thrombosis: Preliminary experience.
Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization.
Analysis of prognostic factors of more/equal to10 years of survival for liver cancer patients after liver transplantation.
Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype.
C-reactive protein and hepatocellular carcinoma: analysis of its relationships to tumor factors.
Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter.
Circulating Tumor Cells for Predicting the Prognostic of Patients with Hepatocellular Carcinoma: A Meta Analysis.
Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes.
Clinical effects of intra-arterial infusion chemotherapy with cisplatin, mitomycin C, leucovorin and 5-flourouracil for unresectable advanced hepatocellular carcinoma.
Clinical efficacy of endovascular radiofrequency ablation in the treatment of portal vein tumor thrombus of primary hepatocellular carcinoma.
Clinical features, biochemical parameters, and virological profiles of patients with hepatocellular carcinoma in Hong Kong.
Clinical significance and function of RDH16 as a tumor-suppressing gene in hepatocellular carcinoma.
Clinical significance of vascular endothelial growth factor in hepatitis C related hepatocellular carcinoma in Egyptian patients.
Clinicopathological features, post-surgical survival and prognostic indicators of elderly patients with hepatocellular carcinoma.
Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma.
Combined Chemoembolization and Radiotherapy Versus Chemoembolization Alone for Hepatocellular Carcinoma Invading the Hepatic Vein or Inferior Vena Cava.
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome.
Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
Complete remission of unresectable hepatocellular carcinoma on healthy liver by the combination of aggressive surgery and high-dose-intensity chemotherapy by CPT-11.
CT volume measurement for prognostic evaluation of unresectable hepatocellular carcinoma after TACE.
Development of a predictive nomogram for early recurrence of hepatocellular carcinoma in patients undergoing liver transplantation.
Endolymphatic immunotherapy in inoperable hepatocellular carcinoma.
Erratum to: Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis.
Evaluation of model for end stage liver disease (MELD)-based systems as prognostic index for hepatocellular carcinoma.
Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
Factors predictive for long-term survival of male patients with hepatocellular carcinoma after curative resection.
Feasibility of SBRT for hepatocellular carcinoma in Brazil - a prospective pilot study.
Growth velocity of the portal vein tumor thrombus accelerated by its progression, alpha-fetoprotein level, and liver fibrosis stage in patients with hepatocellular carcinoma.
Hepatocellular carcinoma in Lebanon: Etiology and prognostic factors associated with short-term survival.
Hepatocellular carcinoma with inferior vena cava and right atrial tumor thrombus: A case report.
High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma.
High serum alpha-fetoprotein concentration associated with pseudoinfarction of a cirrhotic liver: report of a case.
How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system.
Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCs.
Identification of two clinical hepatocellular carcinoma patient phenotypes from results of standard screening parameters.
Impact of hepatologists to extend survival of hepatocellular carcinoma patients with cirrhosis: a comparison with non-hepatologists.
Inflammatory markers C-reactive protein and PLR in relation to HCC characteristics.
Influence of prognostic factors on the outcome of liver transplantation for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis.
Irreversible Electroporation for Unresectable Hepatocellular Carcinoma: Initial Experience.
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?
Is the Cancer of the Liver Italian Program system an adequate weighting for survival of hepatocellular carcinoma? Evaluation of intrascore prognostic value among 36 subgroups.
Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China.
Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis.
Management and patient survival in hepatocellular carcinoma: does the physician's level of experience matter?
MR imaging in diffuse-type hepatocellular carcinoma with synchronous portal vein thrombi.
Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival.
NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma.
Optimal treatment strategy for elderly patients with hepatocellular carcinoma.
Paraneoplastic syndromes in patients with hepatocellular carcinoma in Taiwan.
Placental pathology at term associated with elevated midtrimester maternal serum alpha-fetoprotein concentration.
Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patients.
Plasma lipids, tumor parameters and survival in HCC patients with HBV and HCV.
Platelet-related phenotypic patterns in hepatocellular carcinoma patients.
PLZF and PLZF-MAPK10 can predict the prognosis of postoperative patients with hepatocellular carcinoma.
Predictive Role of AURKA rs 1047972 Gene Polymorphism and the Risk of Development of Hepatocellular Carcinoma.
Predictors of Futile Liver Resection for Patients with Barcelona Clinic Liver Cancer Stage B/C Hepatocellular Carcinoma.
Preliminary analysis of a newly proposed prognostic scoring system (SLiDe score) for hepatocellular carcinoma.
Preoperative Aspartate Aminotransferase to White Blood Cell Count Ratio Predicting Postoperative Outcomes of Hepatocellular Carcinoma.
Preoperative radiologic and postoperative pathologic risk factors for early intra-hepatic recurrence in hepatocellular carcinoma patients who underwent curative resection.
Preserved liver function, portal thrombosis and absence of oesophageal varices are risk factors for metastasis of hepatocellular carcinoma.
Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis.
Prognostic Factors of Survival of Advanced Liver Cancer Patients Treated With Palliative Radiotherapy: A Retrospective Study.
Prognostic features and survival of hepatocellular carcinoma in Italy: impact of stage of disease.
Prognostic features and survival of inoperable hepatocellular carcinoma in Turkish patients with cirrhosis.
Prognostic index of liver cirrhosis with ascites with and without hepatocellular carcinoma.
Prognostic significance of the CRP/Alb and neutrophil to lymphocyte ratios in hepatocellular carcinoma patients undergoing TACE and RFA.
Propensity Score Matching Analysis of Changes in Alpha-Fetoprotein Levels after Combined Radiotherapy and Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma.
Relationship between pathologic prognostic factors and abnormal levels of des-gamma-carboxy prothrombin and alpha-fetoprotein in hepatocellular carcinoma.
Results of three-dimensional conformal radiotherapy and thalidomide for advanced hepatocellular carcinoma.
Review of 336 patients with hepatocellular carcinoma at Songklanagarind Hospital.
Role of monocyte-to-lymphocyte ratio in predicting sorafenib response in patients with advanced hepatocellular carcinoma.
Role of the pituitary tumor transforming gene 1 in the progression of hepatocellular carcinoma.
Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization.
Serum angiopoietin-2 level as a predictor of tumor invasiveness in patients with hepatocellular carcinoma.
Serum levels of gamma-glutamyl transpeptidase in relation to HCC human biology and prognosis.
Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma.
Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma.
Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Successful resection for advanced hepatoblastoma, combined with perioperative chemotherapy.
Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection--a single-center analysis including 132 patients.
Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems.
The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
The MAAPE score in intermediate and advanced hepatocellular carcinoma treated with Yttrium-90 resin microsphere radioembolization.
Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study.
Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma.
Toxicity and Survival of Hepatocellular Carcinoma Patients with Hepatitis B Infection Treated with Yttrium-90 Radioembolization: An Updated 15-Year Study.
Transarterial chemoembolization extends long-term survival in patients with unresectable hepatocellular carcinoma.
Transarterial chemoembolization in unresectable hepatocellular carcinoma--assessing the factors affecting the survival: An audit from a tertiary care center in northern India.
Trends in Tumor Indices in Relation to Increased Hepatocellular Carcinoma Size: Evidence for Tumor Evolution as a Function of Growth.
Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a case cohort study.
Tumor thrombus in the splenic vein originated from gastric carcinoma that produced alpha-fetoprotein.
Ultrasonographic diagnosis of a large placental intervillous thrombosis associated with elevated maternal serum alpha-fetoprotein level.
Unresectable multifocal hepatoblastoma with cardiac extension: excellent response with HB-94 chemotherapy protocol.
Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma.
Use of a Novel Thyroid-Stimulating Hormone Model for Predicting the Progression of Hepatocellular Carcinoma.
Usefulness of Lens culinaris agglutinin A-reactive fraction of alpha-fetoprotein (AFP-L3) as a marker of distant metastasis from hepatocellular carcinoma.
Vascular endothelial growth factor receptor-1 levels in hepatocellular carcinoma and correlations with clinicopathological features.
[A comparison of patients with hepatocellular carcinoma between a short-term (less than 6 months) survival group and a long-term (over 24 months) survival group after treatment with transcatheter arterial chemoembolization]
[A complete response to one-shot hepatic arterial infusion of epirubicin in a patient with highly advanced hepatocellular carcinoma]
[Correlation analysis of Ki67, Ck19 with clinicopathological features and apparent diffusion coefficient value of hepatocellular carcinoma].
[Expression and significance of EGF mRNA and EGFR mRNA in hepatocellular carcinoma]
[Five-year survival analysis of a cohort of hepatocellular carcinoma patients who treated at the National Cancer Center, Korea]
[Massive venous thrombosis with cardiac invasion as primary manifestation of hepatocarcinoma]
[Prognostic factors of hepatocellular carcinoma after liver transplantation]
[Tumor thrombus arising from the superior vena cava and extending into the right atrium in a patient with advanced testicular germ cell tumor]
Thymoma
Induction of CD4+ murine natural killer T-like cells by immunization with syngeneic thymoma expressing embryonic alpha-fetoprotein.
Thyroid Diseases
Maternal thyroid function does not alter maternal serum alpha-fetoprotein interpretation.
Thyroid Neoplasms
Advances in biological markers for cancer.
Biologic markers in cancer diagnosis and treatment.
[Biological markers of cancer. Critical study]
Thyroiditis, Autoimmune
Modulation of T cell function by alpha-fetoprotein: An in vivo study on porcine thyroid peroxidase-induced experimental autoimmune thyroiditis in transgenic mice producing human alpha-fetoprotein.
Toxemia
CGH in the detection of confined placental mosaicism (CPM) in placentas of abnormal pregnancies.
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data.
Toxemia of pregnancy: assessment of fetal distress by urinary estriol and circulating human placental lactogen and alpha-fetoprotein levels.
Toxoplasmosis, Congenital
[A preliminary study on the antenatal diagnosis and prevention of the fetus toxoplasmosis infection]
transaldolase deficiency
Hypergonadotrophic hypogonadism in a patient with transaldolase deficiency: novel mutation in the pentose phosphate pathway.
Tricuspid Valve Insufficiency
First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.
Trisomy 13 Syndrome
Amniotic fluid acetylcholinesterase activity and alpha-fetoprotein in chromosomal anomalies and neural tube defects.
Decreased levels of amniotic fluid alpha-fetoprotein associated with Down syndrome.
First trimester maternal serum AFP and total hCG in aneuploidies other than trisomy 21.
First trimester maternal serum alpha-fetoprotein in fetal trisomies.
Heterochrony and human malformation.
Maternal serum alpha-fetoprotein and dimeric inhibin A detect aneuploidies other than Down syndrome.
Partial trisomy 13 [46,XY,dup(13)(q14-31)]: a case report.
[Unusual increase in amniotic fluid alpha fetoprotein and trisomy 13]
Trisomy 18 Syndrome
A maternal serum screen for trisomy 18: an extension of maternal serum screening for Down syndrome.
A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol.
A retrospective evaluation of second-trimester serum screening for fetal trisomy 18: experience of two laboratories.
Amniotic fluid alpha-fetoprotein levels during midtrimester of trisomy pregnancies.
An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities.
Effectiveness of alpha-fetoprotein variants L2 and L3 as substitutes of alpha-fetoprotein in screening for fetal Trisomy 18.
Fetal hepatic alpha-fetoprotein mRNA expression in fetuses with trisomy 21 and 18 at 12-15 weeks gestation.
First trimester maternal serum AFP and total hCG in aneuploidies other than trisomy 21.
First trimester maternal serum alpha-fetoprotein in fetal trisomies.
Maternal serum alpha-fetoprotein and dimeric inhibin A detect aneuploidies other than Down syndrome.
Maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, and unconjugated estriol levels in midtrimester trisomy 18 pregnancies.
Maternal serum screening for trisomy 18: assessing different statistical models to optimize detection rates.
Multiple-marker screening in pregnancies with hydropic and nonhydropic Turner syndrome.
Prospective evaluation of prenatal maternal serum screening for trisomy 18.
Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin.
Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin.
Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review.
Second trimester two-step trisomy 18 screening using maternal serum markers.
Serum parameters and nuchal translucency in first trimester screening for fetal chromosomal abnormalities.
Significance of a false-positive trisomy 18 multiple-marker screening test.
The advantages of using triple-marker screening for chromosomal abnormalities.
The effects of analytical factors on second trimester risk estimations.
Triploidy identified through second-trimester serum screening.
Trisomy 18 and maternal serum and amniotic fluid alpha-fetoprotein.
Weights of fetuses with autosomal trisomies at termination of pregnancy: an investigation of the etiologic factors of low serum alpha-fetoprotein values.
[Concanavalin A reactivity of alpha-fetoprotein in the amniotic fluid in autosomal trisomies of the fetus]
[Prenatal diagnosis of trisomy 18 via hydramnion detected by echosonography (author's transl)]
Trophoblastic Neoplasms
A rare case of combined placental site trophoblastic tumour with mature cystic teratoma and mixed germ cell tumour in the testis.
CSF and serum AFP in patients without gestational or neoplastic AFP-secretion.
Immunohistochemistry of germ cell and trophoblastic neoplasms.
Testicular germ cell tumor composed of placental site trophoblastic tumor and teratoma.
Trophoblastic Tumor, Placental Site
A rare case of combined placental site trophoblastic tumour with mature cystic teratoma and mixed germ cell tumour in the testis.
Testicular germ cell tumor composed of placental site trophoblastic tumor and teratoma.
Turner Syndrome
Alpha-fetoprotein and ultrasound scanning in the prenatal diagnosis of Turner's syndrome.
Amniotic fluid alpha-fetoprotein and Turner's syndrome.
Amniotic fluid levels of alpha-fetoprotein and other proteins in a case of Turner's syndrome of the fetus.
Amniotic-fluid alpha-fetoprotein in Turner syndrome.
Amniotic-fluid alpha-fetoprotein levels in Turner's syndrome.
Detection of fetal Turner syndrome with multiple-marker screening.
Elevated second-trimester maternal serum ?-human chorionic gonadotropin and amniotic fluid alpha-fetoprotein as indicators of adverse obstetric outcomes in fetal Turner syndrome.
First trimester maternal serum AFP and total hCG in aneuploidies other than trisomy 21.
Free beta hCG screening of hydropic and non-hydropic Turner syndrome pregnancies.
Letter: Raised amniotic-fluid alpha-fetoprotein in Turner syndrome.
Maternal serum alpha-fetoprotein and dimeric inhibin A detect aneuploidies other than Down syndrome.
Multiple marker screening test: identification of fetal cystic hygroma, hydrops, and sex chromosome aneuploidy.
Prenatal diagnosis of Turner syndrome using cells cultured from cystic hygromas in two pregnancies with normal maternal serum alpha-fetoprotein.
Reactivity of amniotic fluid alpha-fetoprotein with concanavallin A in diagnosis of neural tube defects.
[Cause for increased alpha-fetoprotein values in amniotic fluid in prenatal diagnosis of genetic defects (author's transl)]
Tyrosinemias
Evidence for liver disease preceding amino acid abnormalities in hereditary tyrosinemia.
Lectin-reactive alpha-fetoprotein in patients with tyrosinemia type I and hepatocellular carcinoma.
Serum levels of oncofetal markers CA 125, CA 19-9, and alpha-fetoprotein in children with hereditary tyrosinemia type I.
The efficacy of liver transplantation in malignant liver tumors associated with tyrosinemia: clinical and laboratory findings of five cases.
Tyrosinemia type I: a clinico-laboratory case report.
[Hereditary tyrosinemia and alpha-1-fetoprotein. I. Clinical value of alpha-fetoprotein in hereditary tyrosinemia]
[Hereditary tyrosinemia and alpha-1-fetoprotein. II. Comparative tissue levels of alpha-fetoprotein in 2 cases of hereditary tyrosinemia. Considerations on the ontogenesis of human fetoprotein]
[Infantile cirrhosis associated with neoproduction of alpha-fetoprotein. Further perspectives in hereditary tyrosinemia]
Uremia
Tumor markers in uremia: carcinoembryonic antigen, neuron-specific enolase, carbohydrate antigen CA-50 and alpha-fetoprotein.
Urinary Bladder Neoplasms
Hepatoid adenocarcinoma in the urinary bladder. Unusual localization of a newly recognized tumor type.
Triple primary cancers involving kidney, urinary bladder, and liver in a dye worker.
Well-differentiated gall bladder hepatoid carcinoma producing alpha-fetoprotein: a case report.
[A case of bladder cancer producing alpha-fetoprotein (AFP)]
[A case of hepatoid adenocarcinoma of the urinary bladder]
Urogenital Diseases
Alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
Uterine Cervical Neoplasms
Elevated serum alpha-fetoprotein levels as a presenting sign of epidural recurrence from cervical cancer.
Uterine Hemorrhage
Alpha-fetoprotein (AFP) in maternal serum and human gonadotropin (hCG) in urine in 77 patients with vaginal bleeding in early pregnancy.
Alpha-fetoprotein, vaginal bleeding and pregnancy risk.
Elevated maternal serum alpha-fetoprotein: association with placental sonolucencies, fetomaternal hemorrhage, vaginal bleeding, and pregnancy outcome in the absence of fetal anomalies.
Endodermal sinus tumor of the infant vagina treated exclusively with chemotherapy.
Low birth weight and preterm delivery in relation to early-gestation vaginal bleeding and elevated maternal serum alpha-fetoprotein.
Maternal serum alpha-fetoprotein in placental abruption associated with preterm labor.
Taking account of vaginal bleeding in screening for Down's syndrome.
[A case report for primary yolk sac tumor of endometrium].
Uterine Neoplasms
Significance of serum tumor markers in patients with carcinoma of the ovary.
Uveitis
MM-093, a recombinant human alpha-fetoprotein for the potential treatment of rheumatoid arthritis and other autoimmune diseases.
Vaginal Discharge
Alpha-fetoprotein as a tool to distinguish amniotic fluid from urine, vaginal discharge, and semen.
Varicose Veins
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome.
Elevated maternal serum alpha-fetoprotein, umbilical vein varix, and mesenchymal dysplasia: are they related?
Five-year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment-naïve patients with chronic hepatitis B-related compensated cirrhosis in Taiwan.
Hepatocellular carcinoma in Taiwan: clinicopathological study of 440 cases from a consecutive 6000 autopsies.
Importance of Multislice Computed Tomography in Determining the Severity of Chronic Liver Disease State.
Incidence of the appearance of the red color sign on esophageal varices and its predictive factors: long-term observations of 359 patients with cirrhosis.
Preserved liver function, portal thrombosis and absence of oesophageal varices are risk factors for metastasis of hepatocellular carcinoma.
Preventive care in chronic liver disease.
Usefulness of tumor pressure as a prognostic factor in cases of hepatocellular carcinoma where the diameter of the tumor is 3 cm or less.
[Successful Treatment for Advanced Hepatocellular Carcinoma by Hepatic Arterial Infusion of CDDP Powder as Second-Line Chemotherapy.]
Venous Thrombosis
Analysis of prognostic factors in patients receiving transarterial radioembolization for unresectable hepatocellular carcinoma.
Survival improvement in Child-Pugh C cirrhotic patients with hepatocellular carcinoma diagnosed during 1990-2002.
Transarterial chemoembolization in patients not eligible for liver transplantation: single-center results.
Viremia
Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients.
Predictors of Virological Response in 3,235 Chronic HCV Egyptian Patients Treated with Peginterferon Alpha-2a Compared with Peginterferon Alpha-2b Using Statistical Methods and Data Mining Techniques.
Virus Diseases
A case of an alpha-fetoprotein-producing intrahepatic cholangiocarcinoma suggests probable cancer stem cell origin.
Alpha-fetoprotein in the woodchuck model of hepadnavirus infection and disease: normal physiological patterns and responses to woodchuck hepatitis virus infection and hepatocellular carcinoma.
Characteristics of hepatocellular carcinoma in hemodialysis patients in hepatitis B endemic area.
Clinicopathologic analysis of risk factors for distant metastasis of hepatocellular carcinoma.
Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Clinicopathological features and surgical outcome of patients with fibrolamellar hepatocellular carcinoma (experience with 22 patients over a 15-year period).
Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases.
Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis C virus infection receiving interferon therapy: a single center study.
Detection of alpha-fetoprotein and hepatitis-B surface antigen in blood spotted on filter paper: use as a screen for hepatocellular carcinoma in Alaska Natives.
Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.
Efficacy of on-demand intrahepatic arterial therapy in combination with sorafenib for advanced hepatocellular carcinoma.
Fibrolamellar variant of hepatocellular carcinoma presenting during pregnancy: management dilemmas.
Hepatocellular carcinoma with a central scar and a scalloped tumor margin resembling focal nodular hyperplasia in macroscopic appearance.
Hepatocellular carcinoma with right atrial extension in a young patient with congenitally unguarded tricuspid orifice.
High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
Immunohistochemical detection of aberrant p53 expression in hepatocellular carcinoma: correlation with cell proliferative activity indices, including mitotic index and MIB-1 immunostaining.
Is the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection?
Isolation of Human Fetal Liver Progenitors and Their Enhanced Proliferation by Three-Dimensional Coculture with Endothelial Cells.
Isolation of human fetal liver progenitors and their enhanced proliferation by three-dimensional coculture with endothelial cells.
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers.
Polymer adhesive surface as flexible generic platform for multiplexed assays biochip production.
Prognostic factors in patients with HBV-related hepatocellular carcinoma following hepatic resection.
Prognostic significance of E-cadherin expression in hepatocellular carcinoma: correlations with clinical features.
Role of Matrix Metallopeptidase 12 in the Development of Hepatocellular Carcinoma.
Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis.
Upregulation of heat shock factor 1 transcription activity is associated with hepatocellular carcinoma progression.
[Expression and clinical significance of hepatocellular cancer antigen genes in human hepatocellular carcinoma]
[Expression of MAGE-B genes in hepatocellular carcinoma]
Vision Disorders
Puberty due to a mixed germ cell tumour of the hypothalamus secreting BhCG and alpha-fetoprotein.
Vitamin D Deficiency
Severe Vitamin D Deficiency Increases Mortality Among Patients With Liver Cirrhosis Regardless of the Presence of HCC.
Vitamin E Deficiency
Typical Friedreich's ataxia without GAA expansions and GAA expansion without typical Friedreich's ataxia.
Vitamin K Deficiency
A case of spontaneous regression of hepatocellular carcinoma with multiple lung metastases.
Spontaneous regression of hepatocellular carcinoma: two case reports and a literature review.
[Large hepatocellular carcinoma successfully treated with transarterial chemoembolization using cisplatin]
Wilms Tumor
A cystic partially differentiated nephroblastoma producing alpha-fetoprotein.
A teratoid Wilms' tumor with raised serum alpha-fetoprotein level.
A unilateral teratoid Wilms' tumor with raised serum alpha-fetoprotein level.
Alpha-fetoprotein producing tumor cells in children with Wilms' tumor.
Elevated serum alpha-fetoprotein in Wilms tumor may follow the same pattern of other fetal neoplasms after treatment: evidence from three cases.
Familial synchronous bilateral teratoid Wilms tumor with elevated alpha-fetoprotein level.
Further studies on aberrant gene expression associated with arsenic-induced malignant transformation in rat liver TRL1215 cells.
Wilms tumor associated with elevated alpha-fetoprotein level.
[An unusual renal tumor, associating nephroblastoma, nephroblastomatosis, teratoma, and cystic dysplasia with arterial hypertension and secretion of alpha-fetoprotein]